data_2mpb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mpb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -80.15 164.23 23.48 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.762 -1.211 . . . . 0.0 110.364 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.09 65.06 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.34 -44.12 97.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.392 1.477 . . . . 0.0 111.572 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.77 -43.19 56.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.163 0.985 . . . . 0.0 111.013 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.32 -47.53 83.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 111.289 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.11 -47.46 78.07 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.13 -0.981 . . . . 0.0 111.296 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.46 69.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 tt -80.02 -39.01 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.196 1.362 . . . . 0.0 112.715 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.5 t -58.64 -43.28 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 120.145 1.339 . . . . 0.0 110.808 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -62.23 -27.94 69.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.96 69.79 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.48 -0.762 . . . . 0.0 112.672 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.36 -42.8 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.211 1.005 . . . . 0.0 109.612 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.47 -34.26 66.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.061 1.344 . . . . 0.0 113.493 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.49 -24.93 41.98 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.58 58.77 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.424 1.011 . . . . 0.0 111.952 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -54.74 -28.53 49.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.088 1.355 . . . . 0.0 112.267 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.69 6.58 37.82 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.719 -1.863 . . . . 0.0 112.623 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.49 -15.01 6.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 113.922 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 t -160.95 140.06 10.34 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.186 1.394 . . . . 0.0 109.541 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -80.63 39.01 0.46 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 112.727 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.97 158.0 27.03 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 125.536 1.541 . . . . 0.0 110.892 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.34 142.91 46.52 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -155.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.83 97.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.592 1.157 . . . . 0.0 111.084 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -106.9 145.05 32.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.659 1.184 . . . . 0.0 111.856 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.61 133.54 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.066 1.346 . . . . 0.0 109.243 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -119.15 115.96 25.34 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.939 1.296 . . . . 0.0 111.927 168.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.2 tp -103.52 126.92 50.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.323 1.049 . . . . 0.0 111.315 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 46' ' ' ARG . 37.4 tt0 -146.65 162.15 39.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.663 1.22 . . . . 0.0 111.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.33 -77.15 0.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.464 1.106 . . . . 0.0 112.013 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 t -153.69 165.23 36.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.648 1.979 . . . . 0.0 109.902 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.5 m -115.33 154.66 28.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.325 1.45 . . . . 0.0 111.235 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -92.06 -13.48 30.8 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.054 -1.029 . . . . 0.0 112.645 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 pt -130.37 -163.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.126 1.77 . . . . 0.0 110.702 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -72.52 136.57 45.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.405 0.622 . . . . 0.0 112.464 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.53 -35.14 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.98 0.912 . . . . 0.0 111.716 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.57 -54.89 28.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.299 0.954 . . . . 0.0 112.423 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -63.14 -39.26 94.15 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.647 0.779 . . . . 0.0 111.184 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 36' ' ' GLU . 52.9 ttt85 -61.45 -45.22 95.19 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.713 -0.617 . . . . 0.0 111.754 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.43 94.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.824 0.738 . . . . 0.0 111.277 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.9 ttp -62.52 -43.0 99.88 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 112.386 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.3 -48.65 77.2 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.953 -1.092 . . . . 0.0 111.748 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.6 -42.53 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.899 0.88 . . . . 0.0 111.789 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -57.3 -49.15 77.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.536 1.135 . . . . 0.0 111.157 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -71.59 -38.03 70.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.202 1.001 . . . . 0.0 112.056 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.9 -43.15 93.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.104 1.362 . . . . 0.0 112.773 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.05 -3.62 20.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.193 0.997 . . . . 0.0 112.901 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.8 tttt 64.76 38.21 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.648 1.979 . . . . 0.0 112.296 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.7 mtp -77.04 -12.78 59.98 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -0.89 7.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.226 1.01 . . . . 0.0 113.057 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -74.48 31.08 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.633 1.973 . . . . 0.0 114.457 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -99.87 156.16 17.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.682 1.993 . . . . 0.0 110.881 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -73.85 -30.48 62.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.454 1.102 . . . . 0.0 112.429 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.14 -7.21 16.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 67.33 47.41 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.306 . . . . 0.0 110.851 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -137.97 40.45 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.323 1.049 . . . . 0.0 113.607 -164.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.54 142.68 16.19 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 167.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.72 144.44 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.594 1.158 . . . . 0.0 110.463 169.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -117.2 129.25 55.82 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.167 1.387 . . . . 0.0 109.939 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 mt -103.23 96.85 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.11 119.0 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.193 0.597 . . . . 0.0 110.114 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.66 129.78 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.703 0.801 . . . . 0.0 110.143 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.11 102.88 12.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.717 1.207 . . . . 0.0 109.256 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.91 -22.18 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -170.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.14 -49.42 23.8 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.229 0.538 . . . . 0.0 111.689 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.37 -15.08 56.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.455 1.102 . . . . 0.0 111.729 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 tttt 75.23 19.8 2.17 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.517 2.327 . . . . 0.0 112.415 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.1 p -98.13 162.59 13.13 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 111.785 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.87 139.32 36.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.741 1.217 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.59 147.62 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.516 1.527 . . . . 0.0 107.786 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.38 125.96 60.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -139.04 120.76 15.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.0 110.244 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.3 152.91 17.63 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 125.523 1.535 . . . . 0.0 111.025 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -66.75 164.57 16.81 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 123.141 1.448 . . . . 0.0 111.654 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -53.54 -37.6 62.99 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 114.39 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.7 -18.92 70.73 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.47 1.033 . . . . 0.0 113.807 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -81.12 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.122 1.461 . . . . 0.0 108.783 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -53.52 -37.6 62.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.657 0.783 . . . . 0.0 113.032 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.14 -17.46 58.59 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.719 1.207 . . . . 0.0 113.011 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.14 -21.62 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.9 m -114.9 179.47 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.756 1.162 . . . . 0.0 111.838 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.1 p -121.98 171.1 9.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.368 1.867 . . . . 0.0 112.392 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.0 -29.09 70.56 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.864 -1.147 . . . . 0.0 112.448 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.3 -38.81 91.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.893 1.277 . . . . 0.0 111.537 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.65 -46.13 87.04 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.376 0.67 . . . . 0.0 110.351 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.244 1.418 . . . . 0.0 114.63 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.81 -39.59 74.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.444 1.098 . . . . 0.0 111.613 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -61.21 -47.12 87.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.636 0.774 . . . . 0.0 111.807 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 m -58.31 -50.34 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.269 1.828 . . . . 0.0 110.413 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -59.13 -51.05 71.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.393 1.077 . . . . 0.0 111.994 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.34 -41.28 96.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.014 0.824 . . . . 0.0 112.698 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.53 79.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.897 0.771 . . . . 0.0 112.928 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.97 -50.37 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.52 1.128 . . . . 0.0 110.956 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -53.87 -48.03 70.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.619 1.167 . . . . 0.0 111.403 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.67 -33.41 75.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -85.61 -38.14 18.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.32 -37.21 79.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.506 0.594 . . . . 0.0 111.432 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.19 -27.27 67.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.969 1.308 . . . . 0.0 113.387 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.71 -32.65 53.08 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.896 0.771 . . . . 0.0 110.445 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.01 3.18 26.52 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 126.636 2.065 . . . . 0.0 114.252 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.49 84.17 2.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.492 1.146 . . . . 0.0 111.109 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -56.94 -41.52 78.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.813 0.845 . . . . 0.0 112.585 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.93 -57.65 11.58 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.467 -0.771 . . . . 0.0 112.465 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.46 -43.15 83.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.223 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.2 98.42 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.351 0.978 . . . . 0.0 113.618 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.73 -48.43 66.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.755 -1.117 . . . . 0.0 111.035 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.03 -48.36 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.309 1.044 . . . . 0.0 112.241 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -67.3 -34.68 77.9 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.266 0.485 . . . . 0.0 111.688 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.58 -41.05 90.55 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.228 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.07 -44.39 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.663 1.185 . . . . 0.0 109.617 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.17 -51.78 65.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.877 0.871 . . . . 0.0 111.976 -178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.96 -41.78 95.18 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.615 0.766 . . . . 0.0 111.269 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.23 78.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.554 0.742 . . . . 0.0 110.928 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.5 -46.53 87.78 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.01 0.823 . . . . 0.0 112.108 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.7 mtp -65.55 -35.96 82.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.049 0.925 . . . . 0.0 113.087 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.6 61.01 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 111.112 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.85 -37.36 85.99 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.371 1.468 . . . . 0.0 111.46 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.33 -18.51 11.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.392 1.477 . . . . 0.0 114.355 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -72.43 -40.88 66.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.33 -1.481 . . . . 0.0 112.105 170.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -85.9 -28.89 24.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.735 1.214 . . . . 0.0 112.276 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -136.58 76.62 47.96 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.668 1.987 . . . . 0.0 108.669 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.83 143.1 78.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.841 1.694 . . . . 0.0 110.498 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -63.1 143.89 57.38 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -118.99 144.84 46.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.412 1.485 . . . . 0.0 109.402 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -60.71 -32.95 72.18 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 112.636 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -82.93 5.43 21.96 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.881 1.272 . . . . 0.0 113.446 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -58.84 150.46 23.95 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.013 0.925 . . . . 0.0 112.943 -172.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.215 -0.743 0 CA-C-O 122.721 1.248 . . . . 0.0 111.509 -165.367 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 121.616 0.59 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -77.84 -10.23 59.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.2 m -57.3 131.24 49.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.363 1.465 . . . . 0.0 109.72 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.03 137.76 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.43 -0.794 . . . . 0.0 108.863 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.7 m -92.28 142.92 26.94 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.422 -0.798 . . . . 0.0 111.844 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.86 150.68 52.14 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.424 1.09 . . . . 0.0 110.568 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.714 170.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.23 0.078 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 p -75.11 167.39 22.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.6 64.34 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.772 -1.205 . . . . 0.0 112.759 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -66.94 -36.0 81.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.17 1.388 . . . . 0.0 111.701 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.71 -45.46 13.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.32 1.048 . . . . 0.0 111.228 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -60.96 -40.95 95.32 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.802 1.241 . . . . 0.0 111.166 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.14 -48.15 81.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.163 -0.961 . . . . 0.0 112.07 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.25 97.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 tt -72.01 -35.46 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.52 -32.76 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.014 0.825 . . . . 0.0 111.462 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.92 -35.99 75.0 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.342 -0.849 . . . . 0.0 112.588 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.82 93.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.926 0.49 . . . . 0.0 111.388 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.38 -48.02 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.816 0.846 . . . . 0.0 110.814 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -55.08 -33.73 63.01 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.85 -25.74 32.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.91 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.091 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -73.27 14.65 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.699 1.2 . . . . 0.0 113.373 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -116.96 3.21 12.81 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.892 -1.755 . . . . 0.0 112.272 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -121.26 -18.36 7.4 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.23 1.412 . . . . 0.0 113.207 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -144.14 163.43 33.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.559 2.343 . . . . 0.0 108.771 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -100.83 31.41 3.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.53 1.532 . . . . 0.0 112.384 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.88 118.06 1.5 Allowed Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.352 -1.468 . . . . 0.0 111.902 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -85.21 137.11 33.21 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -156.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.18 119.83 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 123.003 1.382 . . . . 0.0 111.485 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -124.74 151.68 44.76 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.308 1.443 . . . . 0.0 112.452 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 144.3 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.011 1.724 . . . . 0.0 110.692 171.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -125.12 122.4 37.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 167.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.09 130.64 54.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.558 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 14.8 tt0 -146.87 169.2 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.892 1.33 . . . . 0.0 110.682 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 65.4 mttt -78.85 -73.36 0.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.393 1.077 . . . . 0.0 112.508 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -148.42 142.97 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.574 1.949 . . . . 0.0 109.247 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.8 p -86.84 146.81 26.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.965 0.888 . . . . 0.0 112.484 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 -10.61 38.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.235 1.014 . . . . 0.0 112.301 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.5 -163.46 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.392 2.677 . . . . 0.0 108.946 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.31 138.62 55.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.678 -1.264 . . . . 0.0 112.072 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.92 -37.6 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.366 0.666 . . . . 0.0 111.794 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.46 -52.56 64.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.581 0.752 . . . . 0.0 112.197 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.02 -39.65 87.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.91 0.484 . . . . 0.0 111.178 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -58.81 -47.04 86.2 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.118 -0.989 . . . . 0.0 112.118 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.75 96.76 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.568 0.747 . . . . 0.0 111.419 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 ttp -62.37 -43.75 98.07 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 111.815 173.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.07 -46.59 86.74 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.254 -0.904 . . . . 0.0 112.021 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.13 -43.62 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.22 -46.66 85.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.335 1.054 . . . . 0.0 111.808 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.69 -35.78 60.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.278 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -63.84 -44.07 94.28 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.429 -1.419 . . . . 0.0 111.159 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.75 -6.38 44.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.714 1.205 . . . . 0.0 113.268 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 62.33 41.14 10.55 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.3 mtp -73.29 -22.54 60.34 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.43 -8.74 6.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 114.046 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 62.95 0.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.179 1.792 . . . . 0.0 110.793 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -133.4 140.32 47.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.613 1.165 . . . . 0.0 110.581 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -58.16 -43.64 87.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 111.889 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.3 mt -94.82 -3.68 48.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 59.73 57.06 3.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.04 28.94 3.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 112.255 -168.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.87 131.57 10.48 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.393 -0.817 . . . . 0.0 111.206 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.6 t -102.65 138.79 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.268 1.027 . . . . 0.0 110.321 168.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.04 121.54 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.062 1.345 . . . . 0.0 110.963 164.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.4 mt -97.25 101.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -81.93 125.19 30.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.256 0.622 . . . . 0.0 110.917 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.1 129.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.753 0.706 . . . . 0.0 111.406 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.27 100.78 12.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.894 1.678 . . . . 0.0 110.273 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.27 -12.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.88 -54.49 5.54 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.474 -0.766 . . . . 0.0 110.495 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.33 -11.85 59.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.179 0.992 . . . . 0.0 112.315 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt 71.68 27.27 2.95 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.6 2.36 . . . . 0.0 112.356 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -106.06 134.36 49.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.995 1.318 . . . . 0.0 110.53 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -106.41 143.78 34.04 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 110.199 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 t -134.36 143.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.505 1.922 . . . . 0.0 108.259 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.0 mt -123.63 130.12 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -140.62 132.54 27.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.996 1.319 . . . . 0.0 110.026 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.52 163.68 21.2 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 123.872 0.749 . . . . 0.0 111.309 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.69 161.31 4.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.899 1.333 . . . . 0.0 114.121 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.4 -35.61 65.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.522 1.529 . . . . 0.0 113.777 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.37 -27.95 73.06 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 120.259 1.39 . . . . 0.0 112.939 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.6 mt -69.43 -60.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.2 1.5 . . . . 0.0 109.425 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -52.01 -37.57 53.78 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.71 0.804 . . . . 0.0 112.973 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.92 -21.7 59.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.032 -1.043 . . . . 0.0 113.436 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.73 -32.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.6 179.31 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.701 1.2 . . . . 0.0 111.004 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 -178.9 6.13 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.666 -1.271 . . . . 0.0 113.775 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -52.44 -36.31 54.24 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -71.69 -20.01 61.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.498 1.045 . . . . 0.0 112.943 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -78.57 -49.24 13.63 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.285 1.034 . . . . 0.0 109.275 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -62.68 -31.43 72.31 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.611 1.564 . . . . 0.0 113.611 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.72 -29.75 68.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.225 1.01 . . . . 0.0 111.621 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.5 p -69.96 -43.07 72.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.542 0.61 . . . . 0.0 111.651 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 m -55.94 -51.62 67.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.371 1.869 . . . . 0.0 111.014 172.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -59.3 -48.42 81.69 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.61 0.764 . . . . 0.0 111.528 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -59.76 -45.89 90.84 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.585 1.084 . . . . 0.0 112.581 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.52 93.89 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.217 0.917 . . . . 0.0 112.826 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.57 -52.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.953 0.901 . . . . 0.0 110.212 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -57.36 -44.48 84.4 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.045 1.338 . . . . 0.0 112.626 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.42 -34.0 77.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.533 0.606 . . . . 0.0 112.161 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -85.89 -38.84 17.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.04 0.936 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.29 -40.37 77.63 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.233 -0.917 . . . . 0.0 111.767 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.91 -23.05 67.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.951 1.3 . . . . 0.0 113.364 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.36 -25.26 21.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.631 0.772 . . . . 0.0 112.153 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.51 37.62 Favored Glycine 0 N--CA 1.477 1.431 0 C-N-CA 125.468 1.509 . . . . 0.0 113.664 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.9 64.35 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.415 1.486 . . . . 0.0 110.839 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -53.43 -44.0 68.47 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.942 0.897 . . . . 0.0 112.876 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.02 -54.01 45.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.395 1.078 . . . . 0.0 111.872 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -63.74 -43.36 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.05 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.74 96.08 Favored Glycine 0 N--CA 1.469 0.877 0 CA-C-N 119.167 0.894 . . . . 0.0 113.065 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -72.5 -45.38 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.999 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.59 -51.21 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.484 1.038 . . . . 0.0 111.473 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.3 -40.35 90.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 0.0 111.423 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.75 92.08 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.916 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.51 -52.67 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.556 1.178 . . . . 0.0 109.744 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.91 -46.15 88.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.158 0.583 . . . . 0.0 111.868 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.67 -40.66 76.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.917 0.887 . . . . 0.0 111.729 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.84 76.17 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.56 0.618 . . . . 0.0 109.926 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.15 -48.74 77.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.583 0.611 . . . . 0.0 113.347 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.29 -35.97 82.13 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.95 -41.26 59.95 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.118 -0.364 . . . . 0.0 110.799 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.3 mt -63.06 -40.1 96.71 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.927 1.691 . . . . 0.0 111.882 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.47 44.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 113.847 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.82 -41.01 92.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.503 -0.748 . . . . 0.0 111.842 172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.0 -46.75 13.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.204 1.402 . . . . 0.0 111.344 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.97 83.5 37.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 126.641 1.977 . . . . 0.0 110.516 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.34 143.16 62.81 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.837 2.358 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -60.16 145.58 46.45 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.32 0.581 . . . . 0.0 112.038 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -120.59 144.81 47.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.039 0.936 . . . . 0.0 109.423 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.14 -20.09 65.75 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 120.671 -1.268 . . . . 0.0 113.318 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -95.99 2.52 53.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.167 2.587 . . . . 0.0 113.739 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -58.6 151.87 19.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.426 1.49 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.51 0 C-N-CA 123.657 0.783 . . . . 0.0 110.988 -165.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--O 1.24 0.579 0 CA-C-O 121.052 0.355 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.79 -3.54 44.94 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.6 p -70.16 161.87 29.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.173 1.789 . . . . 0.0 113.01 -171.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 66.5 mt -82.79 138.41 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.849 1.26 . . . . 0.0 110.05 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.5 t -101.65 142.95 32.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.614 0.766 . . . . 0.0 110.395 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -145.61 151.46 38.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 C-N-CA 125.949 1.738 . . . . 0.0 113.045 165.277 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.241 0.641 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -78.47 163.38 25.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.861 0.864 . . . . 0.0 111.208 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.08 19.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.276 1.43 . . . . 0.0 112.988 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -61.41 -45.88 92.46 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.618 1.567 . . . . 0.0 112.552 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.78 -45.26 83.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.02 -38.78 89.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.785 0.834 . . . . 0.0 112.305 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 -44.83 92.28 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.257 -0.902 . . . . 0.0 111.004 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.53 97.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.146 0.979 . . . . 0.0 113.354 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -72.11 -37.53 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.175 0.898 . . . . 0.0 112.696 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.3 t -61.61 -32.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.231 0.923 . . . . 0.0 112.27 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -41.64 97.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.181 0.992 . . . . 0.0 112.06 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.64 95.38 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.908 -0.495 . . . . 0.0 111.729 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.58 -40.1 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.831 0.852 . . . . 0.0 111.449 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -64.38 -38.53 91.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.778 0.831 . . . . 0.0 112.567 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.43 -31.44 65.48 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 112.952 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.36 -38.85 85.43 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.498 0.719 . . . . 0.0 112.711 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -62.01 -17.48 57.37 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.268 1.033 . . . . 0.0 113.316 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -94.45 3.79 54.69 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.278 -1.514 . . . . 0.0 112.659 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -119.78 -13.51 9.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 114.221 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -155.86 161.79 40.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.766 2.026 . . . . 0.0 109.417 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 p -104.08 26.27 8.97 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 112.823 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.11 148.12 19.52 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 124.497 1.046 . . . . 0.0 111.124 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -103.07 134.84 45.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.72 0.771 . . . . 0.0 112.443 -151.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.97 129.83 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 119.003 -2.311 . . . . 0.0 111.286 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -142.56 152.5 42.66 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.129 1.372 . . . . 0.0 110.931 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -121.12 141.0 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.922 1.689 . . . . 0.0 110.555 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -127.24 130.99 50.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.636 1.174 . . . . 0.0 112.336 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tp -119.38 120.85 38.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 111.63 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -138.08 156.04 48.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.525 1.13 . . . . 0.0 110.564 171.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.48 -69.7 0.26 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.283 -1.511 . . . . 0.0 113.852 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.3 t -152.75 142.25 21.74 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.896 1.678 . . . . 0.0 109.307 -166.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 p -100.12 144.51 29.06 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -81.79 -26.46 34.38 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 pt -110.62 -177.1 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 110.411 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.36 136.48 57.16 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.65 0.738 . . . . 0.0 112.489 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.03 -32.88 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.853 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -64.11 -49.36 72.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.609 1.095 . . . . 0.0 111.986 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.96 -43.08 88.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.3 1.04 . . . . 0.0 110.398 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -57.04 -48.87 77.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.997 0.519 . . . . 0.0 111.999 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.47 88.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.486 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -61.23 -46.84 88.76 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 111.703 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.72 -44.29 82.02 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.48 -44.48 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 0.0 110.2 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.26 -55.81 30.16 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.813 1.245 . . . . 0.0 111.197 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -68.57 -34.04 75.12 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -67.57 -41.81 83.59 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.431 -0.793 . . . . 0.0 112.325 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.31 0.12 15.33 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.9 0.88 . . . . 0.0 112.873 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 tttt 63.73 31.86 14.03 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.914 1.686 . . . . 0.0 112.295 168.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 29.8 mtt -66.7 -33.91 76.68 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.115 -0.99 . . . . 0.0 111.867 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.4 -16.54 9.49 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.171 2.589 . . . . 0.0 114.904 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.04 76.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.723 -1.236 . . . . 0.0 111.293 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -123.3 160.57 26.39 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.234 1.014 . . . . 0.0 110.148 162.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -59.4 -44.78 92.76 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.067 -1.021 . . . . 0.0 112.429 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.68 -8.94 27.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.444 -1.265 . . . . 0.0 113.443 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 68.54 47.61 0.89 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.67 1.588 . . . . 0.0 109.512 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -116.85 25.64 10.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.839 1.256 . . . . 0.0 112.557 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.33 124.76 10.1 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 111.154 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.64 133.6 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 110.234 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.2 tp -114.44 132.46 56.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.872 1.32 . . . . 0.0 111.685 164.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.2 mt -110.27 92.7 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -76.18 120.64 21.74 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.734 0.814 . . . . 0.0 110.516 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -117.07 130.06 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.046 1.338 . . . . 0.0 109.917 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.94 105.47 15.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.408 1.083 . . . . 0.0 110.373 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.43 -19.79 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.81 -47.62 20.96 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.474 1.488 . . . . 0.0 111.157 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -79.98 -15.84 56.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.444 1.097 . . . . 0.0 113.317 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 70.11 33.14 2.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.656 1.582 . . . . 0.0 112.205 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -114.09 167.92 10.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.39 1.476 . . . . 0.0 111.018 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.26 141.67 22.47 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.718 1.207 . . . . 0.0 109.63 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.86 135.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.088 1.355 . . . . 0.0 108.213 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 mt -115.13 130.28 69.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -140.88 149.79 42.39 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.738 0.815 . . . . 0.0 110.113 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.76 158.77 27.82 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.92 170.07 5.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.388 1.566 . . . . 0.0 114.084 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.65 -30.28 70.61 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.585 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.55 -48.0 59.27 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 119.916 1.235 . . . . 0.0 111.612 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.75 -56.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.068 0.934 . . . . 0.0 109.365 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -53.05 -44.7 67.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.982 0.913 . . . . 0.0 112.588 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.86 -8.28 58.68 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.848 1.659 . . . . 0.0 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -23.49 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.87 173.79 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.808 1.64 . . . . 0.0 111.955 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -125.13 171.06 10.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.13 -31.63 63.5 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.12 -31.36 69.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 112.548 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -74.3 -33.42 63.2 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.644 0.778 . . . . 0.0 110.558 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -77.04 -23.68 52.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.241 1.816 . . . . 0.0 114.16 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.35 -36.05 81.91 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.711 -1.243 . . . . 0.0 112.163 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.1 m -58.35 -39.71 80.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.363 1.465 . . . . 0.0 111.675 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -60.67 -54.98 38.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.377 1.871 . . . . 0.0 111.381 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -60.29 -45.11 94.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 110.471 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -56.96 -45.13 83.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -47.98 83.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.262 0.937 . . . . 0.0 112.642 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.5 mt -66.02 -48.36 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.798 0.839 . . . . 0.0 110.091 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.36 -42.32 98.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.073 0.949 . . . . 0.0 113.294 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.68 -41.22 96.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.821 0.737 . . . . 0.0 111.489 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -74.19 -37.11 64.02 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.553 0.741 . . . . 0.0 111.765 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.84 -40.26 96.17 Favored 'General case' 0 C--N 1.346 0.444 0 O-C-N 121.428 -0.795 . . . . 0.0 111.81 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.26 -40.35 97.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.169 174.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -65.39 -41.53 93.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.812 0.845 . . . . 0.0 111.493 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.09 6.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.49 1.043 . . . . 0.0 114.439 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -110.4 84.08 1.87 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.414 1.486 . . . . 0.0 111.287 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -64.64 -45.66 85.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -57.33 -51.68 68.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.152 -0.927 . . . . 0.0 111.402 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -56.86 -42.37 79.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.67 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.44 -39.04 97.29 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 119.456 1.025 . . . . 0.0 113.915 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.13 -48.27 30.53 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 110.722 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.15 -57.71 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.781 1.633 . . . . 0.0 110.788 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -61.94 -29.77 70.45 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.579 0.751 . . . . 0.0 111.256 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 -37.31 59.62 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.434 0.54 . . . . 0.0 113.427 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.1 mt -66.53 -44.82 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.601 1.2 . . . . 0.0 110.137 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -59.17 -44.25 92.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.918 0.887 . . . . 0.0 112.253 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -67.95 -30.06 69.26 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.891 -1.13 . . . . 0.0 113.082 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.98 -53.43 26.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 118.814 -0.612 . . . . 0.0 109.786 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.06 -48.31 80.56 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.554 1.073 . . . . 0.0 112.327 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.7 ttm -62.81 -38.85 92.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.373 1.087 . . . . 0.0 112.595 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.63 -45.4 45.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.52 0.6 . . . . 0.0 111.436 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt -62.84 -35.42 79.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.492 1.517 . . . . 0.0 111.046 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.06 37.4 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.13 -31.34 61.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.589 1.086 . . . . 0.0 111.603 171.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.52 -37.48 15.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.143 1.377 . . . . 0.0 111.916 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.95 82.34 68.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.552 1.941 . . . . 0.0 110.585 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.92 134.89 30.99 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.422 2.748 . . . . 0.0 111.003 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -63.14 139.03 58.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.244 1.018 . . . . 0.0 112.731 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -116.16 155.53 28.09 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.764 1.625 . . . . 0.0 110.567 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.32 -21.59 66.26 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 119.243 -2.16 . . . . 0.0 112.913 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -101.36 18.2 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.861 1.664 . . . . 0.0 112.892 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.28 153.25 22.95 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.123 0.963 . . . . 0.0 112.739 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.466 0.347 0 O-C-N 121.418 -0.801 . . . . 0.0 112.019 -166.252 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.459 -0.532 0 CA-C-O 122.054 0.773 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -89.35 3.75 51.16 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.8 p -72.23 159.04 34.75 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.24 137.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.689 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 t -98.26 139.06 34.61 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.258 1.023 . . . . 0.0 109.797 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -140.69 164.69 29.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.612 0.765 . . . . 0.0 110.711 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 CA-C-O 117.991 -1.45 . . . . 0.0 113.725 177.711 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -73.23 162.59 29.21 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.607 -0.683 . . . . 0.0 109.85 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.13 41.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.36 -42.9 87.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.484 1.114 . . . . 0.0 111.334 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -71.16 -45.12 64.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.409 1.484 . . . . 0.0 111.345 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.52 -46.03 90.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.224 1.41 . . . . 0.0 111.778 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -56.76 -43.28 80.64 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.368 -0.832 . . . . 0.0 111.834 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.64 89.36 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.764 0.711 . . . . 0.0 112.761 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -75.35 -33.41 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.224 -0.923 . . . . 0.0 112.831 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.07 -37.78 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.665 1.12 . . . . 0.0 111.259 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -63.81 -30.98 72.02 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.211 1.004 . . . . 0.0 112.775 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.76 85.95 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.073 -1.017 . . . . 0.0 111.911 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mm -59.89 -47.71 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.611 0.641 . . . . 0.0 110.003 172.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm105 -59.68 -34.04 72.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.24 -23.93 32.53 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.92 68.4 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.111 0.964 . . . . 0.0 112.734 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' CD ' HD22 ' A' ' 140' ' ' ASN . 92.6 mt-10 -56.5 -40.94 75.83 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 110.882 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -73.59 6.06 3.39 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 119.733 -1.854 . . . . 0.0 113.325 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -123.63 -7.98 7.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.382 2.273 . . . . 0.0 114.284 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -163.79 147.25 10.0 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.24 1.382 . . . . 0.0 110.545 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -81.79 12.12 4.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 113.987 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.11 143.74 16.82 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.21 1.386 . . . . 0.0 111.16 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -101.75 139.0 37.98 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.018 0.927 . . . . 0.0 113.074 -164.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.11 138.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.291 1.436 . . . . 0.0 109.573 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -153.39 155.59 36.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.474 1.11 . . . . 0.0 111.0 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.42 139.47 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.921 1.689 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -122.43 125.86 46.73 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.751 1.221 . . . . 0.0 112.244 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.86 115.15 26.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.888 0.875 . . . . 0.0 110.169 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.26 163.19 29.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.083 1.753 . . . . 0.0 109.812 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -80.35 -72.51 0.41 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.666 -1.271 . . . . 0.0 113.264 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.6 t -148.8 158.27 44.04 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 126.676 1.991 . . . . 0.0 109.292 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -107.03 159.0 16.62 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 126.189 1.796 . . . . 0.0 110.18 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.58 -27.79 18.89 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.738 -1.226 . . . . 0.0 112.148 166.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 mt -100.1 -125.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.329 1.052 . . . . 0.0 108.697 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -115.88 142.55 46.62 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.001 1.72 . . . . 0.0 109.349 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.09 -46.72 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.54 -50.21 74.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.039 0.836 . . . . 0.0 112.441 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -70.03 -39.47 75.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.344 0.658 . . . . 0.0 111.251 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -59.7 -46.55 88.73 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.646 0.778 . . . . 0.0 111.889 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.07 93.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.307 1.043 . . . . 0.0 111.691 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.0 ttp -63.56 -46.16 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 111.606 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.06 -48.81 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.165 0.439 . . . . 0.0 110.929 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.8 -45.39 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.518 1.127 . . . . 0.0 111.553 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -56.29 -53.52 56.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.64 1.176 . . . . 0.0 110.803 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -69.05 -33.73 74.05 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 112.05 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.26 -33.4 75.24 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.238 -1.539 . . . . 0.0 112.453 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.58 -3.18 52.61 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.98 0.912 . . . . 0.0 112.987 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 60.23 34.29 20.98 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.904 1.682 . . . . 0.0 112.697 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.2 mtp -65.02 -18.37 65.24 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -3.94 7.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.492 1.517 . . . . 0.0 113.066 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.79 59.8 2.65 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 111.422 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.1 p -125.93 143.28 51.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.463 1.905 . . . . 0.0 109.142 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -63.09 -48.69 77.54 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.848 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.17 -2.0 57.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.633 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 57.54 37.68 27.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.98 1.263 . . . . 0.0 109.463 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 27.45 9.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.543 1.537 . . . . 0.0 112.0 -172.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.1 124.52 6.78 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 124.098 0.856 . . . . 0.0 112.093 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.3 t -111.55 132.44 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.384 1.073 . . . . 0.0 110.147 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -118.6 123.81 45.92 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.245 1.022 . . . . 0.0 111.455 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.67 96.33 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 125.474 1.509 . . . . 0.0 108.328 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.07 127.7 34.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.644 0.778 . . . . 0.0 111.379 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.36 125.86 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.318 0.647 . . . . 0.0 110.646 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.35 108.02 20.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.661 1.584 . . . . 0.0 110.236 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.79 -20.71 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -73.67 -64.11 1.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.988 0.813 . . . . 0.0 108.808 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.2 -9.52 58.62 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.8 tttt 65.45 32.57 9.44 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 m -100.76 132.55 46.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.603 1.561 . . . . 0.0 109.207 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.62 139.41 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.534 1.134 . . . . 0.0 108.385 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.58 143.83 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.012 1.325 . . . . 0.0 108.229 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.3 mt -122.79 135.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -147.64 129.36 15.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.857 1.663 . . . . 0.0 108.604 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.13 172.55 16.62 Favored Glycine 0 C--O 1.236 0.28 0 C-N-CA 125.353 1.454 . . . . 0.0 112.002 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -60.81 166.64 3.24 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.664 1.586 . . . . 0.0 113.551 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -53.08 -34.67 57.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.226 1.41 . . . . 0.0 113.717 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.95 -29.25 69.33 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.968 1.258 . . . . 0.0 114.185 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.65 -56.2 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.17 1.485 . . . . 0.0 108.529 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -51.64 -34.35 37.5 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.522 1.529 . . . . 0.0 113.747 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -78.42 -24.61 46.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.408 1.483 . . . . 0.0 113.081 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.48 -22.85 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.78 159.98 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.495 1.043 . . . . 0.0 112.715 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.7 p -95.01 174.13 7.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.69 -21.74 66.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.926 -1.109 . . . . 0.0 113.535 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.28 -17.91 55.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -73.17 -46.18 52.21 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 165.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -65.56 -32.2 73.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.543 1.137 . . . . 0.0 113.492 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.66 -36.85 70.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.969 1.308 . . . . 0.0 112.297 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.2 p -61.21 -45.25 95.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.752 0.821 . . . . 0.0 112.01 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 m -65.34 -45.87 82.5 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.811 1.644 . . . . 0.0 110.961 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.98 -51.42 67.79 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.542 . . . . 0.0 111.187 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -56.61 -48.09 78.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.884 0.766 . . . . 0.0 111.711 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.57 82.93 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.908 -1.12 . . . . 0.0 113.453 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.1 mt -70.46 -50.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.165 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -55.6 -44.27 76.81 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.282 1.033 . . . . 0.0 112.559 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.91 -34.02 74.03 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.01 -38.84 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.721 1.208 . . . . 0.0 111.251 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.98 -38.59 82.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.473 -0.767 . . . . 0.0 111.174 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.13 -27.08 67.77 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.272 1.429 . . . . 0.0 113.419 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.2 -20.98 39.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.935 0.894 . . . . 0.0 111.736 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.07 7.03 44.68 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.219 1.39 . . . . 0.0 114.549 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.08 97.81 7.54 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.805 1.303 . . . . 0.0 111.586 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -72.5 -37.05 68.5 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.604 -0.685 . . . . 0.0 110.898 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -57.73 -57.91 10.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.336 -0.852 . . . . 0.0 111.381 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.6 -41.1 94.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.268 0.627 . . . . 0.0 111.396 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.81 98.32 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 118.598 0.635 . . . . 0.0 113.469 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.41 -50.44 59.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.149 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.1 t -59.11 -48.31 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.0 0.818 . . . . 0.0 111.743 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.6 -29.84 66.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.286 0.493 . . . . 0.0 112.268 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.2 -34.48 64.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 118.722 0.692 . . . . 0.0 112.522 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.31 -52.59 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.454 1.102 . . . . 0.0 110.828 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.36 -42.33 91.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.597 1.09 . . . . 0.0 111.04 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.69 -46.58 89.08 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.177 -0.952 . . . . 0.0 112.116 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.01 96.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.426 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.77 -44.63 97.19 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.172 0.897 . . . . 0.0 112.425 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.1 mtp -65.02 -35.97 82.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.831 0.816 . . . . 0.0 113.112 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.87 -44.39 61.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.972 0.509 . . . . 0.0 111.644 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.55 -38.12 88.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 0.0 111.925 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.16 -24.81 43.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -73.08 -31.4 64.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.625 -1.297 . . . . 0.0 112.502 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -83.36 -38.01 22.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.88 1.272 . . . . 0.0 111.95 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -130.64 90.8 39.41 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.543 1.537 . . . . 0.0 109.178 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 139.82 50.85 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.478 2.119 . . . . 0.0 110.173 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -64.95 149.13 50.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.597 0.713 . . . . 0.0 112.698 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.03 145.89 50.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.122 1.369 . . . . 0.0 110.427 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -62.51 -20.68 64.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.8 0.18 54.67 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.564 1.946 . . . . 0.0 112.629 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -50.36 151.99 1.98 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.358 2.263 . . . . 0.0 115.735 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.328 1.051 . . . . 0.0 112.389 -163.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.463 HD22 ' CD ' ' A' ' 24' ' ' GLU . 2.3 m-80 -85.23 0.23 52.53 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.1 p -71.73 153.52 41.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.264 1.425 . . . . 0.0 111.106 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.5 mt -72.25 139.38 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.566 0.747 . . . . 0.0 109.109 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.4 t -101.17 139.1 37.32 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.824 -1.172 . . . . 0.0 110.533 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -136.43 151.02 49.04 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 112.204 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.455 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.217 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -101.05 162.22 13.05 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.573 -1.329 . . . . 0.0 109.98 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.83 -18.13 58.88 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.33 -48.15 57.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.225 1.375 . . . . 0.0 110.531 166.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.74 -40.82 92.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.144 0.978 . . . . 0.0 111.471 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -70.04 -42.95 72.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.357 1.063 . . . . 0.0 112.402 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.64 -45.42 85.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.503 -0.748 . . . . 0.0 111.817 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.17 94.75 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.35 -0.844 . . . . 0.0 113.095 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.78 -49.33 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.427 1.091 . . . . 0.0 110.25 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.36 -48.2 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.527 1.131 . . . . 0.0 111.846 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.62 -27.75 66.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.04 -32.57 67.25 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.134 -0.978 . . . . 0.0 112.487 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.49 -52.82 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.353 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -51.76 -23.96 5.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -89.95 -25.22 21.03 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.176 1.39 . . . . 0.0 113.019 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.11 74.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.522 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -63.61 -20.37 65.61 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.762 0.71 . . . . 0.0 112.736 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -83.86 3.97 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 119.641 -1.912 . . . . 0.0 113.136 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -129.97 -5.72 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.281 1.432 . . . . 0.0 113.427 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -162.55 155.54 19.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.565 1.546 . . . . 0.0 109.339 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -79.87 7.02 9.6 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.239 1.016 . . . . 0.0 113.722 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.9 152.85 20.2 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -111.17 129.55 55.91 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.497 1.119 . . . . 0.0 110.572 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.74 128.73 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.394 -0.816 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -141.3 160.36 40.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.484 1.114 . . . . 0.0 111.903 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.7 t -132.45 136.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.3 1.44 . . . . 0.0 109.216 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -119.55 119.4 33.69 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.816 1.246 . . . . 0.0 112.593 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 tp -100.88 130.8 46.95 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.97 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.26 165.14 34.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.152 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -80.85 -67.37 0.78 Allowed 'General case' 0 C--O 1.24 0.564 0 O-C-N 120.24 -1.537 . . . . 0.0 112.335 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 142.42 24.94 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.545 1.538 . . . . 0.0 110.125 -167.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -92.6 133.02 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.375 0.67 . . . . 0.0 111.961 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.68 -28.07 60.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 112.63 171.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -118.01 -164.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.432 1.893 . . . . 0.0 109.66 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.27 137.11 48.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.808 -1.183 . . . . 0.0 112.647 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.45 -37.79 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.433 0.693 . . . . 0.0 111.905 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -64.06 -48.98 74.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.324 0.65 . . . . 0.0 111.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.94 -37.01 81.09 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 112.098 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -62.75 -47.19 84.61 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.439 0.563 . . . . 0.0 111.24 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.17 96.33 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.727 0.811 . . . . 0.0 110.824 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.2 ttp -60.96 -47.49 86.18 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.509 0.723 . . . . 0.0 112.568 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.1 -37.93 81.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.315 0.961 . . . . 0.0 111.944 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.07 -41.46 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.856 0.753 . . . . 0.0 111.819 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.7 -47.78 83.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.465 1.106 . . . . 0.0 111.882 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -75.45 -34.72 60.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.594 0.757 . . . . 0.0 112.288 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -61.65 -41.91 98.17 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.466 1.107 . . . . 0.0 112.03 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.42 -0.67 20.78 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.359 -0.838 . . . . 0.0 112.938 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 59.67 33.51 21.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.317 1.447 . . . . 0.0 112.352 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.8 mtp -71.21 -23.35 62.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.483 1.113 . . . . 0.0 112.853 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -67.7 -16.3 64.07 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.353 1.861 . . . . 0.0 113.598 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.44 72.61 8.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.045 1.338 . . . . 0.0 111.291 172.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.0 m -135.85 135.67 39.96 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.243 1.817 . . . . 0.0 107.803 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -49.09 -49.94 39.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -93.07 0.57 57.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.258 1.023 . . . . 0.0 113.749 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 61.65 43.95 9.39 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.777 1.231 . . . . 0.0 111.041 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -121.03 47.37 1.84 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.493 1.517 . . . . 0.0 112.347 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 131.6 10.8 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.929 0.776 . . . . 0.0 112.749 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.35 139.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 118.221 1.01 . . . . 0.0 111.605 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.1 tp -125.93 120.81 31.37 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.457 1.503 . . . . 0.0 111.085 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -96.76 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.812 0.845 . . . . 0.0 109.796 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -78.06 119.92 22.17 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.696 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.38 130.71 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.744 0.818 . . . . 0.0 110.159 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.24 94.75 5.68 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.389 1.476 . . . . 0.0 110.231 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.1 m -70.5 -15.81 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -170.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -83.01 -34.23 26.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.825 0.85 . . . . 0.0 111.176 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -97.44 -15.63 20.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.99 1.316 . . . . 0.0 113.833 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.5 tttt 71.98 21.91 3.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.134 2.174 . . . . 0.0 112.43 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.8 p -99.94 163.59 12.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.193 -0.942 . . . . 0.0 111.48 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.21 145.61 35.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.137 1.375 . . . . 0.0 108.863 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -137.68 136.12 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 125.748 1.619 . . . . 0.0 107.54 175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 mt -111.56 126.06 68.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -121.85 150.56 41.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.298 1.439 . . . . 0.0 109.702 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.78 149.65 21.69 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -65.32 160.86 20.79 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 123.249 1.499 . . . . 0.0 112.156 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -53.46 -35.89 61.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.233 1.813 . . . . 0.0 113.334 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.51 76.83 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.344 -1.253 . . . . 0.0 114.083 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.35 -54.4 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.916 1.858 . . . . 0.0 108.731 167.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -52.87 -35.41 57.69 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.22 -16.14 56.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.922 1.289 . . . . 0.0 113.171 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 m -111.51 -29.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 119.555 1.071 . . . . 0.0 113.84 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.79 163.08 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.032 0.833 . . . . 0.0 111.287 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.1 m -119.42 169.58 9.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.318 1.447 . . . . 0.0 111.736 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -56.82 -32.59 65.89 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.237 1.38 . . . . 0.0 113.681 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.55 -21.05 66.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.554 1.142 . . . . 0.0 113.297 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -79.01 -41.91 27.83 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.476 -0.765 . . . . 0.0 110.462 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -69.47 -30.35 68.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.74 -36.17 69.44 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.183 0.593 . . . . 0.0 112.548 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -62.13 -44.76 95.92 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.915 0.779 . . . . 0.0 111.289 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -61.73 -47.63 84.39 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.136 1.775 . . . . 0.0 110.896 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.82 -43.7 98.31 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.369 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -65.18 -42.98 93.13 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.754 1.161 . . . . 0.0 112.45 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.88 78.28 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.718 1.145 . . . . 0.0 112.34 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.49 -51.38 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.822 0.449 . . . . 0.0 111.031 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.02 -44.74 96.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.935 1.294 . . . . 0.0 113.341 -174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.21 -38.47 91.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.631 0.772 . . . . 0.0 111.573 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.11 -38.46 36.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.067 0.947 . . . . 0.0 111.352 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -59.29 -40.05 84.92 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.333 -0.854 . . . . 0.0 111.637 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.67 -25.46 68.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.183 0.993 . . . . 0.0 113.267 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -87.41 -25.48 23.78 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.822 1.249 . . . . 0.0 111.797 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 10.55 40.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.301 1.429 . . . . 0.0 113.58 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.58 59.05 0.8 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.431 1.493 . . . . 0.0 110.83 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -49.46 -44.82 46.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 114.047 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -52.19 -51.43 58.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 124.584 1.154 . . . . 0.0 112.592 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -68.87 -33.86 74.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.76 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.54 -42.79 97.29 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-N 119.035 0.834 . . . . 0.0 112.75 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.86 -51.63 57.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.225 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.32 -47.38 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.089 0.956 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.73 -40.98 92.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.87 -39.39 75.59 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.856 -0.528 . . . . 0.0 112.312 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.05 -39.08 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.671 1.188 . . . . 0.0 110.648 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.74 -51.07 66.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.193 0.997 . . . . 0.0 112.363 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.44 -40.04 96.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.532 -0.73 . . . . 0.0 112.053 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -50.88 72.01 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.652 172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.46 -49.18 75.29 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.076 0.853 . . . . 0.0 112.585 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.0 mtp -60.99 -35.72 77.56 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.929 0.864 . . . . 0.0 112.898 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.13 -39.56 29.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.193 0.997 . . . . 0.0 111.868 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.6 mt -62.18 -36.0 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.83 -17.52 36.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.338 1.455 . . . . 0.0 114.449 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.01 -38.48 64.08 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.062 -1.024 . . . . 0.0 112.223 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -80.98 -49.81 10.48 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 124.486 1.114 . . . . 0.0 111.68 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -123.96 91.59 49.44 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.409 1.483 . . . . 0.0 109.682 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.41 148.94 68.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.877 2.385 . . . . 0.0 110.828 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -70.75 127.63 33.31 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.813 -0.554 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -100.35 155.89 17.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.203 1.801 . . . . 0.0 109.596 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.28 -24.46 63.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 119.866 -1.771 . . . . 0.0 112.768 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -98.33 16.5 21.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.865 2.066 . . . . 0.0 113.18 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.02 163.0 5.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.682 1.23 . . . . 0.0 112.065 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--N 1.331 -0.223 0 C-N-CA 125.539 1.536 . . . . 0.0 110.903 -173.635 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.444 -1.401 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.87 31.76 0.26 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.395 1.878 . . . . 0.0 111.726 -172.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 t -97.08 164.0 12.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.774 1.629 . . . . 0.0 111.285 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.29 131.22 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -93.17 144.61 25.12 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.781 0.832 . . . . 0.0 109.633 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -142.29 135.99 29.3 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.511 -0.743 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.564 0 CA-C-O 115.983 -2.565 . . . . 0.0 113.963 173.835 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -73.6 169.43 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.339 0.656 . . . . 0.0 111.059 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.56 -42.57 64.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.107 -0.996 . . . . 0.0 113.66 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.4 -31.27 63.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.263 0.625 . . . . 0.0 112.264 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.57 -43.93 65.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.323 -0.861 . . . . 0.0 110.943 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -63.48 -31.07 72.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.979 1.312 . . . . 0.0 112.004 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.59 -46.33 59.6 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.533 -1.355 . . . . 0.0 111.279 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.6 96.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.438 1.095 . . . . 0.0 112.701 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.65 -39.86 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.394 0.997 . . . . 0.0 113.17 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.76 -34.31 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.578 0.626 . . . . 0.0 111.26 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.88 -28.9 67.11 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.55 71.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.234 0.47 . . . . 0.0 111.761 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.65 -46.54 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.67 0.788 . . . . 0.0 109.681 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.57 -43.28 93.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.836 1.255 . . . . 0.0 112.439 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.62 -37.66 85.31 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.182 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.97 93.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.09 0.556 . . . . 0.0 112.022 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.22 -18.99 61.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.735 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -98.39 11.14 39.05 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.232 -1.542 . . . . 0.0 112.737 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -121.97 -16.15 7.63 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.024 1.729 . . . . 0.0 113.752 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.3 t -163.65 154.54 16.13 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.88 1.672 . . . . 0.0 109.682 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.0 m -78.38 1.65 21.31 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.82 154.78 27.14 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 124.999 1.285 . . . . 0.0 111.51 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -131.74 123.78 28.38 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -163.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.1 mt -115.63 101.08 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 120.837 -1.164 . . . . 0.0 111.812 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -97.34 156.2 16.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.33 1.452 . . . . 0.0 111.66 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 140.98 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.34 1.456 . . . . 0.0 110.876 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -125.81 132.38 52.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 112.324 171.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -118.2 132.94 56.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.401 1.08 . . . . 0.0 111.289 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -153.23 160.49 42.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.573 1.549 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.57 -80.54 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.728 -1.233 . . . . 0.0 112.231 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -140.86 154.01 45.99 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.577 1.551 . . . . 0.0 111.205 -176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -98.83 142.98 29.66 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -79.16 -15.37 58.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.267 1.427 . . . . 0.0 112.984 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 pt -136.32 -171.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 128.687 2.795 . . . . 0.0 109.134 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -62.63 140.32 58.67 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.41 -34.53 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.93 -51.62 66.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.341 0.656 . . . . 0.0 111.497 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -66.51 -37.62 85.44 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.612 -0.68 . . . . 0.0 111.258 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -59.41 -49.59 77.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.985 -1.072 . . . . 0.0 111.638 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.79 96.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.474 0.71 . . . . 0.0 111.212 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.28 -41.58 89.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.144 0.978 . . . . 0.0 112.691 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.99 -33.67 59.74 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.161 -0.962 . . . . 0.0 112.72 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.33 -43.2 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.728 1.149 . . . . 0.0 110.931 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.36 -47.07 82.59 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.787 1.235 . . . . 0.0 110.849 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -76.12 -35.21 59.38 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.302 1.041 . . . . 0.0 112.404 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -62.39 -41.09 98.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.315 1.046 . . . . 0.0 111.459 172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.75 -2.2 25.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.091 1.356 . . . . 0.0 113.669 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 55.82 38.84 30.53 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.343 1.457 . . . . 0.0 112.851 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.73 -18.33 64.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.31 -3.66 0.99 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.623 1.969 . . . . 0.0 115.148 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -73.28 5.84 3.29 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.118 1.767 . . . . 0.0 115.347 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.1 p -83.18 156.46 23.2 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.45 -40.1 70.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.677 0.791 . . . . 0.0 112.637 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.81 -13.39 33.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.511 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 69.26 58.39 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.105 1.362 . . . . 0.0 108.657 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -145.66 33.92 1.04 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.746 1.218 . . . . 0.0 113.121 -162.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.01 147.57 23.82 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.684 1.135 . . . . 0.0 110.407 166.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.23 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.722 1.609 . . . . 0.0 108.809 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.3 tp -125.5 118.93 26.85 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.834 1.254 . . . . 0.0 111.122 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -90.22 97.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -78.88 125.08 28.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.157 -0.964 . . . . 0.0 110.187 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -121.75 127.24 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.247 1.019 . . . . 0.0 111.28 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.54 95.98 8.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.555 1.542 . . . . 0.0 109.866 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.16 -19.55 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -76.99 -41.36 43.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.166 0.587 . . . . 0.0 112.156 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.36 -27.81 24.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.301 1.441 . . . . 0.0 111.331 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 88.42 14.76 0.07 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.24 2.616 . . . . 0.0 111.383 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -97.78 157.64 15.96 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.063 -1.023 . . . . 0.0 111.059 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -134.78 149.58 50.42 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.453 1.101 . . . . 0.0 109.389 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.11 139.98 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 108.101 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -108.9 129.08 64.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -141.17 138.55 33.47 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.835 0.743 . . . . 0.0 110.553 172.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.7 159.18 24.11 Favored Glycine 0 C--O 1.24 0.517 0 C-N-CA 124.722 1.153 . . . . 0.0 110.314 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.45 161.93 21.68 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 123.194 1.474 . . . . 0.0 114.629 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.38 -31.49 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.375 1.47 . . . . 0.0 114.119 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.08 -31.43 57.67 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 119.552 1.069 . . . . 0.0 113.641 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.29 -57.25 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.554 1.177 . . . . 0.0 109.231 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -55.37 -38.08 68.36 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.031 0.932 . . . . 0.0 113.133 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.66 -11.75 60.76 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -114.0 -30.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -105.25 147.86 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.02 1.282 . . . . 0.0 112.446 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -92.22 171.75 8.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.547 1.139 . . . . 0.0 112.888 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -52.45 -38.6 59.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.387 1.875 . . . . 0.0 115.181 165.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.51 -28.15 67.59 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.804 -1.185 . . . . 0.0 112.895 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.03 -30.08 63.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.909 0.484 . . . . 0.0 110.953 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.31 -29.46 38.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.515 1.126 . . . . 0.0 113.502 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.41 -42.82 70.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.43 1.492 . . . . 0.0 113.085 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.0 p -59.0 -37.24 76.42 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.9 0.88 . . . . 0.0 112.281 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -54.99 40.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 0.0 110.834 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -57.35 -48.33 79.29 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 124.21 1.004 . . . . 0.0 110.112 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.1 -36.78 84.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.72 73.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.049 0.84 . . . . 0.0 112.308 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.25 -53.93 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.858 0.863 . . . . 0.0 109.89 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.17 1.788 . . . . 0.0 112.804 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.23 -51.64 62.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.55 1.068 . . . . 0.0 111.183 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.94 -35.32 62.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 119.047 -0.502 . . . . 0.0 110.806 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -58.8 -45.94 88.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.048 0.84 . . . . 0.0 110.448 171.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -58.8 -41.79 87.59 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.944 0.793 . . . . 0.0 111.699 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.28 -12.76 61.55 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.03 1.75 67.01 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.019 1.771 . . . . 0.0 114.559 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.99 75.03 1.64 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.477 1.511 . . . . 0.0 111.855 -174.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -51.85 -43.86 63.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.191 1.396 . . . . 0.0 112.909 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -54.34 -57.59 10.66 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.27 0.628 . . . . 0.0 111.517 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -62.23 -34.31 76.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.628 1.171 . . . . 0.0 111.585 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.72 83.22 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 118.585 0.63 . . . . 0.0 113.382 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.93 -48.79 64.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.333 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.77 -51.52 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.091 0.956 . . . . 0.0 111.115 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.33 -25.35 63.26 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.155 -0.965 . . . . 0.0 113.054 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.35 -41.68 84.82 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.391 171.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.71 -53.03 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.982 1.313 . . . . 0.0 110.229 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -55.76 -48.4 75.34 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.936 0.895 . . . . 0.0 113.36 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -70.92 -36.61 72.73 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.953 -0.467 . . . . 0.0 111.447 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.53 99.11 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.565 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.9 -48.17 86.94 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-N 119.429 1.013 . . . . 0.0 111.773 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 50.9 ttp -56.23 -48.76 75.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.226 1.013 . . . . 0.0 111.674 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.83 69.8 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.104 0.562 . . . . 0.0 111.839 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.87 -33.62 76.26 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.323 1.449 . . . . 0.0 111.336 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.04 -16.77 60.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.42 -45.81 75.03 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.557 -1.339 . . . . 0.0 110.823 168.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -76.19 -47.3 24.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.329 1.452 . . . . 0.0 111.538 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -127.87 85.2 61.25 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 109.864 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.49 151.29 80.11 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.874 2.383 . . . . 0.0 111.11 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -62.95 149.95 43.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -132.07 152.03 51.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.38 -30.02 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.243 . . . . 0.0 113.722 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.2 18.6 13.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.575 1.15 . . . . 0.0 112.702 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.11 146.55 27.29 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.976 0.893 . . . . 0.0 112.247 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.22 -0.473 0 C-N-CA 124.899 1.28 . . . . 0.0 111.241 -169.625 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 CA-C-O 121.817 0.674 . . . . 0.0 112.852 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -78.35 -4.28 47.31 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.594 1.557 . . . . 0.0 114.354 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 p -76.38 155.88 33.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.791 -1.193 . . . . 0.0 112.18 -170.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.3 mt -79.69 128.4 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.95 0.9 . . . . 0.0 109.578 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 t -89.87 145.12 25.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.986 0.514 . . . . 0.0 111.684 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.63 147.35 31.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 111.351 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 C-N-CA 125.899 1.714 . . . . 0.0 116.191 -176.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--O 1.237 0.397 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.35 155.98 19.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.878 0.471 . . . . 0.0 110.545 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.95 -29.04 26.47 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -74.41 -35.32 63.41 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -73.17 -48.08 38.31 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.643 1.577 . . . . 0.0 109.938 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.44 -45.64 92.14 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.796 1.638 . . . . 0.0 111.241 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.79 -33.91 73.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.566 -1.334 . . . . 0.0 112.794 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -44.13 67.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -67.86 -39.34 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.136 0.88 . . . . 0.0 111.974 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.46 -39.13 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 121.65 -0.656 . . . . 0.0 111.955 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.8 -27.49 63.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.02 87.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.016 0.825 . . . . 0.0 111.776 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.18 -47.87 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.193 0.597 . . . . 0.0 111.19 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -60.28 -30.76 69.67 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.26 -35.86 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.72 -1.238 . . . . 0.0 111.141 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.75 98.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.38 1.072 . . . . 0.0 112.336 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -57.05 -29.77 63.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.222 1.409 . . . . 0.0 112.12 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -88.31 3.23 50.45 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.042 -1.662 . . . . 0.0 112.326 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.63 -15.64 7.45 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.376 1.871 . . . . 0.0 113.682 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -154.24 160.16 41.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.547 1.939 . . . . 0.0 109.82 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 p -92.11 23.04 3.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.61 153.66 18.32 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 126.385 1.945 . . . . 0.0 112.187 -174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -106.0 137.26 44.22 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -166.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.8 128.69 75.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -135.37 142.37 45.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.635 0.774 . . . . 0.0 111.541 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 81.2 t -107.82 135.28 47.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.694 1.197 . . . . 0.0 109.465 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -115.99 138.51 51.14 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.705 1.202 . . . . 0.0 112.326 166.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.9 tp -126.11 129.44 49.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.518 1.127 . . . . 0.0 111.822 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -158.88 156.62 29.91 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.521 1.528 . . . . 0.0 109.312 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -79.83 -70.61 0.5 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 121.034 -1.041 . . . . 0.0 112.464 -173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 t -144.04 152.05 40.49 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 111.552 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -104.48 137.18 42.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.267 1.427 . . . . 0.0 111.524 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.87 -14.57 57.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 112.977 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.81 -152.64 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.589 1.955 . . . . 0.0 110.171 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.46 134.71 36.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 112.349 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -39.73 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.271 -0.893 . . . . 0.0 112.151 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.12 -43.47 82.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.551 1.069 . . . . 0.0 111.527 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.62 -43.04 98.02 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.679 -0.638 . . . . 0.0 111.88 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -58.43 -45.45 88.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.784 0.72 . . . . 0.0 111.669 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.4 87.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 117.442 -1.266 . . . . 0.0 111.405 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 51.1 ttp -60.29 -50.01 75.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.175 1.352 . . . . 0.0 111.077 170.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.495 0.588 . . . . 0.0 111.724 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.5 t -63.68 -45.31 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.397 1.079 . . . . 0.0 111.703 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.26 -48.82 80.1 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.632 0.773 . . . . 0.0 111.068 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -70.28 -39.67 74.76 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.139 0.976 . . . . 0.0 111.619 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -61.65 -42.96 99.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.412 1.485 . . . . 0.0 112.926 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.93 -2.83 10.7 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.479 -0.763 . . . . 0.0 112.882 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.81 37.49 18.66 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.797 1.639 . . . . 0.0 111.713 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.6 mtp -74.48 -17.96 60.69 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.48 -4.87 9.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 170.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.03 52.16 0.7 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.531 1.532 . . . . 0.0 113.38 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 p -135.3 149.63 49.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.147 0.979 . . . . 0.0 112.05 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -67.4 -25.58 66.02 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.17 -1.81 13.57 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.139 1.376 . . . . 0.0 113.4 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 56.22 54.88 7.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.089 1.356 . . . . 0.0 111.112 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -133.09 41.99 3.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.526 0.731 . . . . 0.0 112.699 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.48 147.51 18.66 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.756 1.17 . . . . 0.0 111.552 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.77 138.84 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.531 1.133 . . . . 0.0 110.354 172.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.5 tp -115.06 128.52 56.29 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.79 1.236 . . . . 0.0 110.14 165.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -101.95 93.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 124.132 0.973 . . . . 0.0 109.005 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -75.52 123.42 25.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.034 0.934 . . . . 0.0 109.912 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.11 122.43 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.67 1.188 . . . . 0.0 110.731 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.07 89.22 5.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.901 1.28 . . . . 0.0 109.621 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.51 -16.49 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -75.24 -35.17 61.45 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.439 -0.788 . . . . 0.0 112.274 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -95.77 -8.01 35.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.095 1.358 . . . . 0.0 112.54 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.3 tttt 70.17 24.75 4.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.658 1.983 . . . . 0.0 112.722 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 p -108.93 167.96 9.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.086 1.354 . . . . 0.0 112.519 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.81 147.39 31.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 110.585 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.3 149.28 24.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.544 1.937 . . . . 0.0 108.166 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.85 127.02 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -136.92 129.73 30.57 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.429 0.691 . . . . 0.0 110.235 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.27 15.19 Favored Glycine 0 CA--C 1.513 -0.078 0 C-N-CA 124.825 1.202 . . . . 0.0 112.065 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -69.9 161.35 30.1 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.384 1.087 . . . . 0.0 113.378 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -52.14 -38.31 57.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.604 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.72 -11.6 69.35 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.009 -1.44 . . . . 0.0 115.047 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 93.3 mt -89.02 -57.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.483 1.641 . . . . 0.0 108.752 160.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -55.58 -33.76 64.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.87 -15.57 58.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.099 1.76 . . . . 0.0 113.639 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.86 -28.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.39 168.63 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.655 1.116 . . . . 0.0 112.673 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.9 p -114.85 177.75 4.53 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.912 1.285 . . . . 0.0 112.681 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -63.16 -26.8 68.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.656 -1.278 . . . . 0.0 113.574 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.75 -34.92 79.47 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.996 1.319 . . . . 0.0 111.701 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -71.09 -30.59 66.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.987 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -82.33 -31.87 29.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 0.0 112.666 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.39 -41.46 84.92 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.001 0.92 . . . . 0.0 111.689 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -60.83 -33.92 73.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.766 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 m -64.53 -52.13 59.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.673 0.789 . . . . 0.0 110.083 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.5 -45.99 91.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.407 0.683 . . . . 0.0 111.207 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.81 -41.93 96.65 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.11 -50.83 68.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.999 0.428 . . . . 0.0 112.085 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.48 -49.19 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.449 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -57.93 -42.71 85.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.099 1.36 . . . . 0.0 112.608 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.49 -53.29 57.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 111.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.92 -31.1 66.02 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 122.161 -0.337 . . . . 0.0 111.695 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -67.82 -39.98 83.88 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.737 0.699 . . . . 0.0 112.288 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.27 -34.22 77.19 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.159 0.984 . . . . 0.0 111.855 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -71.35 -31.08 66.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.994 0.918 . . . . 0.0 112.316 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 7.53 30.78 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.266 1.412 . . . . 0.0 114.593 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -101.87 72.59 1.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.803 1.641 . . . . 0.0 110.897 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -51.17 -46.52 62.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.84 1.256 . . . . 0.0 113.082 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -46.76 -60.25 2.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -65.8 -35.91 82.03 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.984 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.43 75.21 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 120.04 1.291 . . . . 0.0 113.327 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.03 -51.63 52.42 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.455 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.11 -51.63 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.717 0.807 . . . . 0.0 111.5 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.93 -34.18 77.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.307 0.958 . . . . 0.0 111.768 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -42.24 95.04 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.303 0.954 . . . . 0.0 112.16 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.25 -44.26 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.608 1.563 . . . . 0.0 111.348 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.12 -42.13 94.13 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.845 0.831 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -71.39 -39.79 70.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 120.642 -1.286 . . . . 0.0 112.049 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.99 90.4 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.359 0.664 . . . . 0.0 110.409 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.85 39.1 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.846 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.9 mmm -64.04 -26.36 68.52 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.26 -52.21 11.41 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.781 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -58.23 -37.39 74.76 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 112.296 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.7 62.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.447 1.499 . . . . 0.0 113.312 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -67.53 -29.07 68.37 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.105 -0.997 . . . . 0.0 112.52 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.43 -32.62 11.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.112 1.365 . . . . 0.0 112.161 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.79 79.11 75.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.132 1.773 . . . . 0.0 110.053 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.11 136.01 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.259 1.972 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -63.44 139.66 58.79 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.309 1.043 . . . . 0.0 112.896 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -113.37 156.05 24.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.683 1.23 . . . . 0.0 112.911 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.49 -14.77 58.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.81 -1.806 . . . . 0.0 114.267 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -121.43 35.64 4.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.166 1.786 . . . . 0.0 110.571 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 151.24 26.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.538 -0.726 . . . . 0.0 112.887 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.217 -0.61 0 C-N-CA 124.341 1.056 . . . . 0.0 111.752 -166.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.456 -0.702 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -2.64 12.38 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.0 m -78.18 124.45 28.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.831 1.252 . . . . 0.0 110.763 -163.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.81 128.47 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.703 1.201 . . . . 0.0 108.905 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.8 t -87.22 135.43 33.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.55 139.35 42.13 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.903 -1.123 . . . . 0.0 109.998 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 CA-C-O 117.135 -1.925 . . . . 0.0 110.947 170.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -73.57 143.04 46.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.087 0.955 . . . . 0.0 110.673 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.09 -29.26 3.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.17 -46.81 79.21 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.067 0.947 . . . . 0.0 112.754 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.26 -31.68 58.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.231 1.012 . . . . 0.0 111.17 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.433 ' HG2' ' HZ3' ' A' ' 110' ' ' LYS . 37.3 mt-10 -70.89 -38.16 73.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.865 0.866 . . . . 0.0 111.558 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.23 -41.59 99.13 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.493 -1.379 . . . . 0.0 111.628 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.09 98.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.616 0.767 . . . . 0.0 112.833 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.28 -38.25 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 120.979 -1.076 . . . . 0.0 112.167 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.55 -40.17 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.546 0.612 . . . . 0.0 110.845 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.68 -32.99 73.21 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.92 65.54 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -72.28 -46.49 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.41 1.084 . . . . 0.0 110.521 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -56.28 -30.67 62.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.024 0.93 . . . . 0.0 112.967 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.06 -28.17 60.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 113.548 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.86 62.37 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.101 0.96 . . . . 0.0 111.936 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.55 -7.88 23.08 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.733 1.254 . . . . 0.0 113.27 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -95.16 3.08 55.07 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.428 -2.045 . . . . 0.0 112.944 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -125.49 -17.66 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.941 2.097 . . . . 0.0 114.053 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 t -151.41 151.75 32.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.85 1.66 . . . . 0.0 108.927 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -90.84 49.72 1.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.179 0.991 . . . . 0.0 110.859 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.02 128.88 2.41 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.144 -1.597 . . . . 0.0 111.062 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -96.9 126.9 42.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.733 0.813 . . . . 0.0 112.843 -153.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -113.43 115.29 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 111.397 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.46 HH11 ' CG ' ' A' ' 56' ' ' MET . 73.4 mtp180 -118.21 153.55 33.7 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.384 1.473 . . . . 0.0 112.647 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.63 141.94 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.913 1.685 . . . . 0.0 111.3 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -131.46 123.25 27.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.251 1.02 . . . . 0.0 112.358 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.06 127.84 55.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.819 0.848 . . . . 0.0 111.216 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -149.46 163.47 37.7 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.134 0.974 . . . . 0.0 110.301 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -79.34 -66.63 0.84 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.374 -1.454 . . . . 0.0 112.016 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -159.6 151.77 20.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.47 1.108 . . . . 0.0 112.53 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 p -105.26 144.02 32.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 112.321 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -77.87 -11.96 59.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.692 1.197 . . . . 0.0 113.518 170.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.68 -164.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 127.962 2.505 . . . . 0.0 110.028 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -79.42 136.76 37.04 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.43 -1.419 . . . . 0.0 112.579 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -58.66 -40.33 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -59.12 -46.83 87.32 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.934 0.788 . . . . 0.0 112.211 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -72.6 -38.72 67.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.718 0.407 . . . . 0.0 111.86 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -60.28 -47.58 85.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.24 -0.287 . . . . 0.0 111.026 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.02 89.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.3 ttp -62.56 -50.67 70.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.768 0.827 . . . . 0.0 111.543 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.73 -49.06 79.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.987 0.915 . . . . 0.0 111.918 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.41 -41.1 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.041 0.936 . . . . 0.0 112.026 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.09 -46.09 90.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.988 0.813 . . . . 0.0 111.842 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -72.99 -32.78 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 112.438 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.35 -32.75 70.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.895 1.278 . . . . 0.0 112.807 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.9 mt -78.72 -11.51 59.98 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.3 -0.875 . . . . 0.0 112.82 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 64.49 35.68 9.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.34 1.456 . . . . 0.0 112.909 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.46 ' CG ' HH11 ' A' ' 32' ' ' ARG . 69.3 mtp -67.25 -22.62 65.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.898 1.279 . . . . 0.0 114.275 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.5 -7.93 8.16 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.722 2.009 . . . . 0.0 112.715 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -74.98 47.21 0.34 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.263 1.825 . . . . 0.0 112.719 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.6 p -119.34 150.74 39.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.864 1.666 . . . . 0.0 110.657 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HZ2' HG13 ' A' ' 135' ' ' ILE . 86.8 mttt -64.64 -43.9 92.2 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.911 -1.118 . . . . 0.0 112.494 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.45 -9.69 37.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 67.5 55.18 0.65 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.668 1.587 . . . . 0.0 108.58 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -126.17 29.87 5.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.554 1.141 . . . . 0.0 112.975 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.99 132.44 12.2 Favored Glycine 0 N--CA 1.47 0.964 0 O-C-N 120.424 -1.423 . . . . 0.0 110.988 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -111.77 134.5 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.528 1.131 . . . . 0.0 109.5 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -117.75 130.59 56.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.81 0.844 . . . . 0.0 110.693 166.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.5 mt -106.16 95.34 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -75.32 125.63 29.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.6 1.16 . . . . 0.0 110.723 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -117.27 131.19 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.04 1.336 . . . . 0.0 110.332 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.27 95.32 6.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.003 1.721 . . . . 0.0 110.414 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.65 -16.36 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -75.27 -51.62 12.83 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.43 -5.75 55.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.94 1.296 . . . . 0.0 113.861 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.1 tttt 65.02 31.17 11.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.23 2.212 . . . . 0.0 112.751 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.5 p -111.06 163.54 13.76 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.028 0.931 . . . . 0.0 111.115 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 147.65 42.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.164 1.385 . . . . 0.0 109.534 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.89 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.758 1.623 . . . . 0.0 108.126 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.5 133.93 63.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -147.04 138.45 24.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.077 1.351 . . . . 0.0 110.036 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.71 164.3 21.15 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 124.756 1.169 . . . . 0.0 112.214 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -70.83 166.54 20.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 123.257 1.503 . . . . 0.0 112.705 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.42 -39.16 67.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.153 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.33 -46.49 78.11 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.386 1.47 . . . . 0.0 112.991 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.41 -59.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 118.208 1.004 . . . . 0.0 109.46 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.01 -22.67 64.75 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.72 -29.34 25.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.65 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -24.63 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.14 164.14 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.668 1.187 . . . . 0.0 112.649 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.2 p -107.93 174.42 5.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.694 1.198 . . . . 0.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.94 -33.41 73.12 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.342 -1.474 . . . . 0.0 113.359 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.1 -23.92 63.12 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -68.12 -37.59 81.29 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 117.698 0.226 . . . . 0.0 110.608 169.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -77.01 -25.57 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.3 -36.3 79.72 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.687 0.676 . . . . 0.0 112.715 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.3 m -55.98 -45.39 78.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.634 0.773 . . . . 0.0 111.427 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -47.68 84.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.305 1.442 . . . . 0.0 110.842 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -59.34 -47.84 83.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -64.86 -35.5 81.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.448 1.099 . . . . 0.0 113.368 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.67 -53.26 43.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.936 0.789 . . . . 0.0 111.692 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.33 -48.46 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.014 0.526 . . . . 0.0 110.459 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -60.07 -43.2 95.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.073 1.349 . . . . 0.0 112.905 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.26 -42.17 93.51 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 119.55 1.068 . . . . 0.0 111.827 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -74.88 -38.9 61.79 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.799 0.44 . . . . 0.0 111.926 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.76 -40.11 91.25 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.353 0.978 . . . . 0.0 112.054 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.57 -32.14 73.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.918 1.287 . . . . 0.0 112.078 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -74.59 -39.28 62.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.792 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.41 -2.21 12.59 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.23 1.872 . . . . 0.0 113.062 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.24 71.27 8.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.367 1.467 . . . . 0.0 111.102 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -52.73 -42.34 64.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.144 0.977 . . . . 0.0 112.407 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HZ3' ' HG2' ' A' ' 13' ' ' GLU . 19.2 tptt -64.93 -48.52 73.82 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -55.37 -47.51 75.69 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.528 0.731 . . . . 0.0 109.695 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.31 95.95 Favored Glycine 0 N--CA 1.467 0.741 0 CA-C-N 119.245 0.929 . . . . 0.0 113.695 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.45 -43.03 74.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.14 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.66 -50.42 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.599 1.16 . . . . 0.0 110.68 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -69.47 -25.05 63.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.875 1.27 . . . . 0.0 112.718 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.93 -41.85 26.74 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.083 0.849 . . . . 0.0 112.614 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.0 mt -60.61 -43.61 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.109 0.955 . . . . 0.0 111.166 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.23 -49.21 77.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.831 0.853 . . . . 0.0 112.621 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -71.55 -36.5 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.012 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.21 78.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.875 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.09 68.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.703 1.138 . . . . 0.0 112.341 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -64.17 -33.58 76.11 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.5 -46.55 38.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.794 0.725 . . . . 0.0 111.193 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.46 -39.26 83.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.215 1.406 . . . . 0.0 110.47 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.09 52.33 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.1 -41.67 99.42 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.859 -1.151 . . . . 0.0 110.805 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -84.84 -47.58 10.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.262 1.825 . . . . 0.0 111.144 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -114.38 78.18 4.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.725 2.01 . . . . 0.0 111.061 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.91 140.57 42.45 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.838 2.358 . . . . 0.0 111.256 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -59.39 141.75 53.86 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -115.42 149.26 38.29 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 123.892 0.877 . . . . 0.0 110.937 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.69 -25.82 67.65 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.29 -1.506 . . . . 0.0 112.297 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.07 22.14 7.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.655 1.582 . . . . 0.0 113.452 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.55 158.75 5.59 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.508 HG13 ' HZ2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 C-N-CA 124.721 1.209 . . . . 0.0 112.572 -172.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.448 -1.168 0 CA-C-O 121.615 0.59 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -74.29 4.15 6.22 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.2 p -72.72 168.97 17.64 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.653 1.181 . . . . 0.0 111.387 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.42 144.45 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 120.535 -1.353 . . . . 0.0 111.132 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 t -99.99 146.78 26.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.682 1.193 . . . . 0.0 111.026 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -153.18 94.86 1.88 Allowed 'General case' 0 CA--C 1.553 1.094 0 O-C-N 120.908 -1.12 . . . . 0.0 112.92 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 C-N-CA 125.05 1.31 . . . . 0.0 114.904 -173.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -72.59 170.2 14.93 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.371 0.532 . . . . 0.0 111.386 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.38 68.64 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.111 -0.993 . . . . 0.0 112.752 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -60.7 -34.79 74.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.661 1.184 . . . . 0.0 112.395 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -84.43 -42.47 15.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.0 0.92 . . . . 0.0 110.902 -176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -57.22 -50.46 72.8 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.555 1.142 . . . . 0.0 111.774 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.16 -39.08 69.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.819 -1.175 . . . . 0.0 112.569 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.62 69.47 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 tt -71.43 -39.23 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.825 0.738 . . . . 0.0 111.136 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.7 t -59.55 -29.21 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.065 1.346 . . . . 0.0 112.641 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -72.86 -41.01 65.21 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.284 1.434 . . . . 0.0 113.557 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.15 77.58 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.03 -49.42 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.961 0.905 . . . . 0.0 110.594 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -60.06 -24.68 64.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.07 -18.43 32.42 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.765 0.826 . . . . 0.0 111.985 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.95 -39.87 29.27 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.993 0.917 . . . . 0.0 111.262 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.59 -27.44 39.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.325 1.45 . . . . 0.0 112.557 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -90.66 1.7 56.57 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.706 -1.871 . . . . 0.0 113.615 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -112.81 -20.73 11.51 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.233 1.813 . . . . 0.0 111.938 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -160.56 148.55 16.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.526 1.13 . . . . 0.0 110.574 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.6 p -81.3 38.25 0.48 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.295 1.038 . . . . 0.0 111.815 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.49 143.27 14.93 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.041 1.781 . . . . 0.0 109.884 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.9 124.77 51.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.156 -165.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.84 130.89 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -145.93 150.15 35.55 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.353 1.461 . . . . 0.0 110.67 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.96 135.92 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.612 1.565 . . . . 0.0 109.887 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -117.4 122.66 44.42 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.974 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -114.43 130.31 56.7 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.457 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -155.21 163.44 40.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.043 0.925 . . . . 0.0 110.764 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.05 -75.88 0.16 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.736 1.215 . . . . 0.0 112.086 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 t -138.15 173.19 11.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.774 2.029 . . . . 0.0 109.044 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 p -140.99 141.11 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.413 -0.805 . . . . 0.0 111.036 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.29 -7.19 59.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.76 -150.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.219 1.808 . . . . 0.0 111.137 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -85.83 121.07 27.96 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.29 -1.506 . . . . 0.0 111.365 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.58 -42.53 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.98 -47.54 84.38 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.107 -0.995 . . . . 0.0 112.444 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.17 -36.59 69.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.362 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -68.99 -40.92 78.46 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.528 -0.732 . . . . 0.0 112.319 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.0 74.8 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.365 -0.834 . . . . 0.0 110.649 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.2 ttp -65.56 -44.37 86.98 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.976 0.807 . . . . 0.0 111.072 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.09 -52.46 65.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.335 0.97 . . . . 0.0 111.433 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.07 -45.06 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.964 1.305 . . . . 0.0 111.542 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.93 -50.46 73.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.431 1.014 . . . . 0.0 112.402 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -69.53 -36.48 76.43 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.427 1.091 . . . . 0.0 112.338 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -63.87 -40.24 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.853 1.261 . . . . 0.0 112.079 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.26 -6.37 45.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.326 1.05 . . . . 0.0 113.582 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 57.66 39.3 27.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.888 1.275 . . . . 0.0 111.79 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.8 mtp -66.81 -20.66 65.98 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.919 -1.113 . . . . 0.0 112.469 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.94 -15.78 14.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.998 2.119 . . . . 0.0 112.318 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -73.79 50.66 0.35 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.169 2.188 . . . . 0.0 111.818 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -125.3 123.95 40.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.734 2.014 . . . . 0.0 107.972 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -45.61 -50.34 13.35 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.672 1.189 . . . . 0.0 113.617 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.9 mt -87.0 -6.59 58.7 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 68.04 40.14 2.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.19 1.396 . . . . 0.0 110.966 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -114.65 41.46 2.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.361 1.464 . . . . 0.0 112.33 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.07 10.51 Favored Glycine 0 N--CA 1.477 1.388 0 O-C-N 121.451 -0.781 . . . . 0.0 112.843 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.97 133.67 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.808 1.304 . . . . 0.0 111.043 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.4 tp -116.51 133.54 55.9 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.372 1.069 . . . . 0.0 111.485 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.5 mt -106.83 93.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.658 0.742 . . . . 0.0 109.633 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -77.34 113.67 15.36 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.955 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.32 134.26 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.861 1.264 . . . . 0.0 110.595 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.82 15.15 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 110.042 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.78 -18.32 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -81.62 -37.95 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.515 1.126 . . . . 0.0 111.908 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.23 -10.15 31.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.082 1.353 . . . . 0.0 112.53 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt 65.4 32.27 9.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.658 1.583 . . . . 0.0 112.257 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.1 p -111.15 160.42 16.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.265 1.826 . . . . 0.0 111.848 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.98 134.64 23.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.649 1.18 . . . . 0.0 110.065 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.53 138.38 54.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.994 1.318 . . . . 0.0 108.098 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.19 131.55 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -137.25 136.81 38.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.631 0.772 . . . . 0.0 110.245 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 139.43 11.95 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -59.66 160.19 7.61 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 123.626 1.679 . . . . 0.0 110.628 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.3 -34.25 60.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.545 1.938 . . . . 0.0 113.71 -168.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.64 77.56 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-O 118.666 -1.075 . . . . 0.0 112.85 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.97 -55.78 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.277 1.538 . . . . 0.0 109.399 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -50.84 -34.58 28.46 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.78 -25.79 44.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.06 -27.16 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.8 161.54 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.059 0.845 . . . . 0.0 113.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 m -113.63 173.27 6.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.57 1.548 . . . . 0.0 113.829 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -50.97 -41.67 59.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.929 1.692 . . . . 0.0 114.553 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.6 -12.88 60.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.366 1.467 . . . . 0.0 113.395 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -83.96 -28.0 28.1 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.927 -1.733 . . . . 0.0 111.227 166.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -84.98 -21.0 29.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 113.279 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -60.72 -44.27 96.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.438 1.095 . . . . 0.0 111.576 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.1 p -57.52 -45.82 84.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.574 1.149 . . . . 0.0 111.351 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -57.36 -51.33 69.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.385 1.474 . . . . 0.0 111.028 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.68 -48.75 80.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.615 1.166 . . . . 0.0 111.627 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.63 -45.58 93.5 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.07 50.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.938 0.79 . . . . 0.0 112.577 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.44 -46.3 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.704 -0.622 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.72 -36.99 86.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.215 1.006 . . . . 0.0 112.743 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.88 -41.83 97.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.703 1.138 . . . . 0.0 111.2 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -83.32 -31.19 26.98 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.901 -0.571 . . . . 0.0 112.282 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -63.47 -38.06 89.69 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 119.122 0.874 . . . . 0.0 112.699 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.44 -35.82 82.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.885 0.874 . . . . 0.0 111.908 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -71.29 -36.38 71.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.031 0.932 . . . . 0.0 111.267 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 7.01 32.56 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 126.324 1.916 . . . . 0.0 113.936 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -90.32 72.05 7.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.645 1.222 . . . . 0.0 110.984 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -57.16 -36.79 71.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.352 1.061 . . . . 0.0 113.539 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -56.29 -51.95 66.32 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 111.323 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.41 -34.26 77.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.107 1.363 . . . . 0.0 111.262 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.72 47.09 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 118.744 0.702 . . . . 0.0 112.733 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 -47.02 76.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.174 0.487 . . . . 0.0 111.177 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.81 -40.95 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.357 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.77 -37.5 79.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 111.608 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 -41.78 99.8 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.19 -47.75 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.211 1.004 . . . . 0.0 110.443 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -56.48 -52.68 63.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.571 1.149 . . . . 0.0 111.569 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.62 -38.79 84.41 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.603 0.761 . . . . 0.0 111.817 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.71 90.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 118.898 0.772 . . . . 0.0 111.252 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.3 98.6 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 119.032 0.833 . . . . 0.0 112.068 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mmm -62.34 -39.64 93.74 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.041 1.42 . . . . 0.0 113.078 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.63 -44.35 50.93 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.57 0.748 . . . . 0.0 111.546 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.84 -35.23 77.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.163 0.985 . . . . 0.0 111.424 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.63 -16.18 35.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.973 1.309 . . . . 0.0 114.305 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.3 -30.14 57.62 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.736 -1.227 . . . . 0.0 112.177 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -93.28 -31.12 14.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.735 1.214 . . . . 0.0 112.919 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -139.94 88.26 12.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.431 1.492 . . . . 0.0 109.236 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.14 148.02 55.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.399 2.066 . . . . 0.0 110.972 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -64.49 155.81 31.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.218 1.008 . . . . 0.0 113.456 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -136.18 151.23 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.704 1.601 . . . . 0.0 110.371 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.8 -25.57 67.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.534 -1.979 . . . . 0.0 112.684 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.9 15.71 28.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.015 1.726 . . . . 0.0 112.091 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.72 162.78 6.23 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.848 0.859 . . . . 0.0 112.483 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.324 -0.528 0 C-N-CA 124.129 0.972 . . . . 0.0 111.23 -168.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 0 N--CA 1.445 -1.356 0 CA-C-O 121.805 0.669 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.35 4.5 20.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.526 1.93 . . . . 0.0 114.844 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.2 p -74.92 161.82 29.17 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.207 1.403 . . . . 0.0 111.224 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.96 119.32 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.697 -1.252 . . . . 0.0 110.079 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.7 m -76.03 139.23 41.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.459 0.647 . . . . 0.0 111.427 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -136.61 131.54 33.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 C-N-CA 125.067 1.318 . . . . 0.0 114.646 177.061 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 m -65.94 157.1 31.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.1 0.96 . . . . 0.0 109.2 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.53 52.97 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.302 -1.499 . . . . 0.0 112.484 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -69.23 -23.6 63.9 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.711 1.204 . . . . 0.0 112.916 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.4 -46.24 9.82 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.529 1.532 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.29 -48.38 80.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 111.233 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.52 -47.79 69.62 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.968 -1.083 . . . . 0.0 111.883 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.23 83.84 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.302 1.041 . . . . 0.0 113.349 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -72.73 -38.66 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.852 0.751 . . . . 0.0 111.92 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.12 -40.38 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.807 0.843 . . . . 0.0 112.061 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.37 -33.43 74.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.254 0.934 . . . . 0.0 112.427 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.22 66.76 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.9 mt -61.21 -50.04 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.506 1.122 . . . . 0.0 109.935 167.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -57.97 -33.97 69.43 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.66 -26.38 60.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.03 42.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.095 0.958 . . . . 0.0 112.385 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -61.33 -23.67 65.9 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.264 1.026 . . . . 0.0 111.573 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -84.05 6.05 23.61 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.449 -2.032 . . . . 0.0 112.348 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -125.18 -7.8 7.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.111 1.764 . . . . 0.0 114.047 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -169.92 152.38 4.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.198 1.399 . . . . 0.0 110.491 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.412 ' HG ' ' CG ' ' A' ' 134' ' ' ASP . 1.3 m -82.27 21.65 0.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.249 1.42 . . . . 0.0 112.637 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.67 138.32 14.85 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 126.588 2.042 . . . . 0.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.62 125.25 52.39 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.03 0.915 . . . . 0.0 110.274 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 mt -117.39 125.95 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 119.935 -1.728 . . . . 0.0 112.628 -175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -129.22 131.18 47.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.475 1.51 . . . . 0.0 112.417 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.46 139.44 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.748 1.219 . . . . 0.0 112.867 170.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -128.55 125.81 39.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.974 1.31 . . . . 0.0 112.626 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 tp -115.76 133.01 56.46 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 111.294 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -159.09 158.24 32.6 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 109.546 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -75.2 -63.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.123 -1.611 . . . . 0.0 113.852 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -157.74 164.28 37.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.395 1.478 . . . . 0.0 110.825 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.9 p -114.56 144.79 42.81 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.419 1.487 . . . . 0.0 112.557 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.25 -19.1 43.81 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.043 -1.036 . . . . 0.0 111.948 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.12 -162.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.666 1.587 . . . . 0.0 111.516 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -77.71 139.09 39.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.895 0.878 . . . . 0.0 112.373 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.49 -35.09 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.988 0.915 . . . . 0.0 112.714 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -65.46 -51.47 59.92 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.779 0.718 . . . . 0.0 110.834 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.66 -42.29 98.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.613 1.165 . . . . 0.0 112.324 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -62.1 -47.28 85.32 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.371 -0.831 . . . . 0.0 112.129 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.89 89.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.495 -0.753 . . . . 0.0 111.469 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.6 ttp -62.01 -48.95 78.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.707 0.803 . . . . 0.0 111.891 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -61.01 -46.48 90.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.273 1.029 . . . . 0.0 110.952 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.21 -45.91 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.111 0.964 . . . . 0.0 111.88 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -56.75 -50.72 71.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.673 1.189 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.91 -35.45 74.6 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.31 0.644 . . . . 0.0 111.202 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -68.09 -32.36 72.63 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.365 1.066 . . . . 0.0 113.853 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.7 mt -78.61 -0.51 30.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.237 1.015 . . . . 0.0 112.534 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 58.44 32.2 21.83 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.285 1.834 . . . . 0.0 112.032 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.6 mtp -69.51 -16.67 63.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.991 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.23 -15.8 63.91 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.658 1.183 . . . . 0.0 113.193 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -85.04 55.55 3.54 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.389 -1.444 . . . . 0.0 112.083 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -110.0 160.82 16.09 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 0.0 110.369 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -72.21 -42.12 66.13 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.974 -1.078 . . . . 0.0 113.62 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.07 -11.63 32.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 74.21 28.15 1.44 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.382 1.473 . . . . 0.0 110.145 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -112.66 45.46 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.572 1.549 . . . . 0.0 111.481 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.9 131.03 10.58 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.782 1.182 . . . . 0.0 112.331 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.2 t -111.62 136.39 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.052 1.341 . . . . 0.0 110.8 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 tp -115.28 134.18 55.36 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.148 1.379 . . . . 0.0 111.405 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.23 89.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.002 1.321 . . . . 0.0 108.725 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -78.92 123.13 26.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.3 1.44 . . . . 0.0 111.547 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.3 t -124.85 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.066 -1.022 . . . . 0.0 111.825 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.06 116.17 28.57 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.195 1.398 . . . . 0.0 110.44 164.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.43 -25.19 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.93 -57.99 3.56 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 118.205 0.457 . . . . 0.0 110.216 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.65 -4.13 55.36 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.2 tttt 68.39 27.53 6.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.682 1.593 . . . . 0.0 111.79 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 m -100.44 113.7 26.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.958 1.703 . . . . 0.0 110.491 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -88.95 141.9 28.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.0 0.92 . . . . 0.0 110.155 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.34 149.5 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.867 2.067 . . . . 0.0 108.143 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.8 mt -134.12 131.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -145.29 127.18 15.42 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.65 1.18 . . . . 0.0 109.534 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.38 149.68 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.6 162.82 3.59 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 122.964 1.364 . . . . 0.0 110.954 168.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -54.31 -35.67 62.91 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.488 1.515 . . . . 0.0 112.872 -168.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.83 -41.61 98.75 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.615 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mt -61.15 -56.16 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.294 1.547 . . . . 0.0 109.649 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -64.46 -19.47 65.58 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.07 -35.02 22.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.485 1.114 . . . . 0.0 111.367 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.5 p -93.57 -24.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.04 171.07 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 119.858 1.208 . . . . 0.0 111.998 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.5 p -113.13 172.22 7.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.989 1.316 . . . . 0.0 113.184 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -61.45 -30.82 70.83 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.839 -1.163 . . . . 0.0 112.551 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 -18.52 63.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.206 1.402 . . . . 0.0 112.668 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -81.22 -37.3 28.84 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.869 1.267 . . . . 0.0 111.915 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -73.71 -26.61 60.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.816 1.246 . . . . 0.0 113.568 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.37 -31.18 68.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.716 1.207 . . . . 0.0 113.677 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.7 p -70.02 -43.32 71.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.925 1.29 . . . . 0.0 111.517 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.0 m -56.88 -51.38 69.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.881 2.072 . . . . 0.0 110.779 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -58.71 -47.0 86.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.308 1.043 . . . . 0.0 111.63 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.12 -32.75 74.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.5 -53.39 29.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.326 0.967 . . . . 0.0 111.854 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt -61.28 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.625 0.37 . . . . 0.0 110.799 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.43 -44.05 92.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.399 1.08 . . . . 0.0 112.752 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.64 -39.83 85.65 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.785 0.72 . . . . 0.0 112.433 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.42 -32.66 20.77 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.43 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.71 -41.06 98.96 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.809 1.186 . . . . 0.0 111.063 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.01 -38.11 72.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.2 1.0 . . . . 0.0 111.625 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -75.67 -35.82 60.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.598 0.759 . . . . 0.0 111.988 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.65 5.99 21.83 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.802 1.667 . . . . 0.0 114.582 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -99.25 78.41 2.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.729 1.212 . . . . 0.0 110.428 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.09 -49.35 69.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.128 0.971 . . . . 0.0 112.416 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -50.58 -53.81 27.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.052 0.541 . . . . 0.0 111.353 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -62.53 -42.88 99.81 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.524 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.7 -35.56 74.07 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.504 1.047 . . . . 0.0 112.946 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.49 -44.71 77.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.306 0.642 . . . . 0.0 111.142 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.64 -52.58 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.434 1.094 . . . . 0.0 111.279 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -57.77 -40.72 80.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.293 0.951 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -43.32 87.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.044 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.25 -41.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.2 1.5 . . . . 0.0 112.123 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -63.73 -47.47 80.94 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.749 0.704 . . . . 0.0 110.944 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -66.56 -44.07 83.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.845 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.11 69.57 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.259 0.624 . . . . 0.0 111.028 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.14 89.39 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.045 0.839 . . . . 0.0 112.891 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.6 mtp -64.06 -36.31 83.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.871 1.335 . . . . 0.0 112.288 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.62 37.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.049 0.939 . . . . 0.0 111.229 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -62.38 -35.15 78.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.134 0.974 . . . . 0.0 111.534 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.92 -20.9 62.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.696 1.198 . . . . 0.0 114.03 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -71.59 -41.98 68.31 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.022 -1.049 . . . . 0.0 111.444 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -75.12 -46.64 33.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.926 0.89 . . . . 0.0 111.611 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -122.87 88.34 50.48 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.623 1.569 . . . . 0.0 109.986 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.59 138.48 35.27 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.458 2.105 . . . . 0.0 110.454 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -62.86 135.51 57.36 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -106.53 154.31 21.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.155 0.982 . . . . 0.0 110.205 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.68 -27.04 68.65 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.933 -1.729 . . . . 0.0 112.259 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.71 19.64 15.54 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 126.184 1.794 . . . . 0.0 113.108 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.412 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 6.7 t0 -58.99 159.6 6.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.281 1.032 . . . . 0.0 113.321 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 123.086 1.422 . . . . 0.0 113.083 -167.768 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.453 -0.875 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.04 21.83 0.68 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.304 1.042 . . . . 0.0 112.857 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -77.24 150.55 35.37 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.925 2.09 . . . . 0.0 111.887 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.5 mt -80.97 130.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.149 0.98 . . . . 0.0 109.532 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.2 m -87.89 142.42 27.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.429 170.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.76 140.82 31.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.667 0.787 . . . . 0.0 110.837 -174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.28 1.895 . . . . 0.0 109.972 164.484 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -74.78 162.93 28.22 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.429 1.092 . . . . 0.0 109.532 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.46 -41.21 39.58 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -61.79 -30.49 70.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.88 1.272 . . . . 0.0 113.55 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -81.87 -47.49 12.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -62.37 -41.55 98.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.908 1.283 . . . . 0.0 110.691 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -55.56 -55.16 35.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.857 -1.152 . . . . 0.0 111.444 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.36 81.28 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -74.16 -30.34 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.167 0.894 . . . . 0.0 113.302 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.22 -42.46 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.478 -1.389 . . . . 0.0 111.047 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -63.58 -32.44 73.9 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.811 0.844 . . . . 0.0 112.347 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.26 85.71 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.273 -0.892 . . . . 0.0 112.596 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 mm -59.05 -45.99 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.093 0.957 . . . . 0.0 111.285 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -58.29 -31.16 67.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -81.97 -29.05 32.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.74 84.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.815 0.734 . . . . 0.0 111.34 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -56.12 -26.98 52.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.794 1.638 . . . . 0.0 113.41 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.84 5.18 37.98 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 112.826 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.83 -8.05 5.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.983 1.713 . . . . 0.0 114.29 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -148.37 159.88 43.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.926 1.69 . . . . 0.0 109.316 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.2 p -94.26 37.01 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.17 0.988 . . . . 0.0 111.688 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.44 146.24 15.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 123.955 0.788 . . . . 0.0 112.611 -171.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -108.33 131.8 54.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.689 0.756 . . . . 0.0 111.605 -151.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.47 134.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.802 -1.186 . . . . 0.0 110.661 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -144.26 153.48 42.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.18 1.392 . . . . 0.0 111.862 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.03 136.91 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.081 1.352 . . . . 0.0 109.704 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -118.57 118.52 31.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.003 1.721 . . . . 0.0 111.937 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.8 tp -107.15 129.28 54.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 112.086 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.521 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.0 tt0 -154.78 168.15 27.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.015 1.326 . . . . 0.0 111.897 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.18 -95.25 0.06 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.222 1.409 . . . . 0.0 113.479 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 p -116.05 165.21 13.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.332 2.253 . . . . 0.0 109.548 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 p -113.07 162.28 16.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.864 0.84 . . . . 0.0 111.977 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -95.36 -15.19 23.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.989 1.316 . . . . 0.0 113.009 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.42 -150.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.978 2.111 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -85.47 137.63 32.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.486 1.039 . . . . 0.0 112.01 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.29 -39.02 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.566 1.146 . . . . 0.0 112.422 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.94 -49.93 70.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.961 0.801 . . . . 0.0 111.764 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.59 -41.78 96.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 111.272 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.521 HH21 ' CD ' ' A' ' 36' ' ' GLU . 59.0 ttt85 -59.52 -48.89 79.9 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.042 0.937 . . . . 0.0 112.574 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.97 97.11 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.537 0.735 . . . . 0.0 111.077 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.18 -47.24 87.09 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.972 0.909 . . . . 0.0 112.172 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.87 -42.59 97.48 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.061 -1.024 . . . . 0.0 112.57 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.7 -41.99 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.867 0.867 . . . . 0.0 111.969 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.26 -48.77 78.46 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 111.971 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -75.16 -31.64 61.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.799 0.84 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -62.09 -48.28 80.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.096 0.959 . . . . 0.0 111.132 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -72.77 -7.59 51.38 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.105 0.962 . . . . 0.0 113.524 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 63.45 42.82 6.38 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 112.208 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.4 mtt -71.29 -21.53 62.06 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -8.96 8.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.026 2.13 . . . . 0.0 113.705 171.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -79.41 56.49 2.15 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.349 1.86 . . . . 0.0 111.081 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.7 p -128.99 145.18 51.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.549 1.94 . . . . 0.0 108.637 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -59.76 -39.66 85.59 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.5 mt -100.3 -8.82 23.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.081 -1.438 . . . . 0.0 114.519 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 69.93 39.73 1.38 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.708 1.203 . . . . 0.0 110.355 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -106.72 20.29 19.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.445 1.898 . . . . 0.0 113.735 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.07 121.36 6.52 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.296 -0.878 . . . . 0.0 112.569 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.5 t -104.43 133.57 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.357 1.863 . . . . 0.0 109.932 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.5 tp -120.79 130.16 53.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.318 1.047 . . . . 0.0 111.988 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 53.5 mt -105.78 100.16 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 0.0 108.593 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -81.36 125.88 30.92 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.282 0.633 . . . . 0.0 110.051 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.93 131.54 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.916 0.886 . . . . 0.0 110.954 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 102.0 11.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.114 1.366 . . . . 0.0 109.721 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.22 -19.3 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 -44.28 20.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.332 0.653 . . . . 0.0 111.1 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -86.73 -11.17 51.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.068 0.947 . . . . 0.0 112.524 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.4 tttt 72.77 29.08 1.98 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.108 2.163 . . . . 0.0 111.614 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -109.57 162.83 14.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.189 1.396 . . . . 0.0 111.198 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.45 146.13 41.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.135 1.374 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.01 135.5 45.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 126.119 1.768 . . . . 0.0 107.256 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.3 mt -118.52 127.85 75.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -136.21 125.46 24.72 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 125.342 1.457 . . . . 0.0 109.961 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 158.26 14.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.855 1.217 . . . . 0.0 110.644 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -65.31 164.8 12.81 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.605 1.669 . . . . 0.0 111.874 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -50.72 -33.67 23.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.04 2.136 . . . . 0.0 114.075 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.54 -43.36 98.18 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 119.985 1.266 . . . . 0.0 111.906 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.66 -58.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.585 1.192 . . . . 0.0 109.86 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -60.05 -25.37 65.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.083 -1.011 . . . . 0.0 113.571 -173.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.94 -8.09 44.18 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.59 -22.84 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 118.191 -0.909 . . . . 0.0 113.035 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.8 172.46 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.045 1.293 . . . . 0.0 112.233 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.66 171.98 7.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.669 1.588 . . . . 0.0 112.631 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.89 -34.01 75.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.01 -35.12 79.18 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.826 0.739 . . . . 0.0 111.97 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -64.41 -41.99 96.33 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.027 0.531 . . . . 0.0 110.761 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -70.02 -26.81 64.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.89 -35.65 75.3 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.153 0.888 . . . . 0.0 111.575 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 p -60.39 -46.84 88.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.494 0.717 . . . . 0.0 111.938 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 m -61.18 -48.94 79.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.591 1.957 . . . . 0.0 111.071 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -60.0 -47.36 86.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.263 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -62.54 -43.78 97.98 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.63 -48.74 76.86 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.021 0.828 . . . . 0.0 111.928 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.78 -48.28 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.749 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -59.99 -44.15 94.69 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.99 -38.25 87.89 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.152 -0.968 . . . . 0.0 112.497 -176.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -80.88 -37.59 29.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.28 1.032 . . . . 0.0 111.67 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.44 -38.96 82.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.442 -0.786 . . . . 0.0 111.645 171.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.01 -28.83 70.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.961 0.904 . . . . 0.0 113.136 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -79.59 -27.86 41.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.751 1.16 . . . . 0.0 110.802 172.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.91 25.12 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 126.309 1.909 . . . . 0.0 113.631 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -107.34 73.07 0.9 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.356 1.462 . . . . 0.0 110.951 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -58.08 -40.33 80.83 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.771 0.828 . . . . 0.0 113.225 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -60.22 -53.92 51.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.013 -0.429 . . . . 0.0 111.456 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.6 -39.49 88.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.646 0.778 . . . . 0.0 111.069 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.33 96.51 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.738 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.58 -48.44 66.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.457 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.71 -45.23 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.528 1.058 . . . . 0.0 112.391 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -67.26 -36.96 82.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.463 1.105 . . . . 0.0 112.14 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.5 95.89 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 121.649 -0.657 . . . . 0.0 112.547 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.02 -45.62 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.789 1.236 . . . . 0.0 110.564 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.68 -50.6 71.81 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.824 0.849 . . . . 0.0 111.33 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -66.59 -41.88 87.81 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.079 0.952 . . . . 0.0 111.24 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.18 79.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.448 172.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.62 97.42 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.402 1.001 . . . . 0.0 113.18 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.74 -40.4 95.24 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.603 1.202 . . . . 0.0 112.839 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.55 -47.58 31.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.411 1.084 . . . . 0.0 111.368 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.78 -38.74 79.18 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 125.567 1.547 . . . . 0.0 110.735 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.6 -19.11 46.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.45 -32.62 64.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.536 -1.353 . . . . 0.0 111.837 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -89.32 -33.93 16.74 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.857 1.263 . . . . 0.0 112.676 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.52 85.93 41.54 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.733 2.013 . . . . 0.0 110.275 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.49 135.02 25.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.65 2.233 . . . . 0.0 109.513 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -57.19 137.18 56.24 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -106.6 148.04 28.77 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.15 -0.968 . . . . 0.0 110.421 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.67 -33.23 72.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.295 -1.503 . . . . 0.0 112.487 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.71 17.16 13.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.447 1.499 . . . . 0.0 113.528 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.21 157.92 5.78 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 124.049 0.939 . . . . 0.0 111.554 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.534 0.483 0 CA-C-O 121.029 0.346 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -78.47 14.26 1.31 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.829 1.251 . . . . 0.0 113.568 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.0 p -85.56 165.25 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.049 1.74 . . . . 0.0 111.383 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.07 134.0 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.796 -0.565 . . . . 0.0 109.602 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.0 m -91.16 141.21 29.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.624 0.726 . . . . 0.0 110.669 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -140.8 154.75 46.38 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.73 -1.231 . . . . 0.0 111.157 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 C-N-CA 126.427 1.965 . . . . 0.0 111.862 173.786 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -63.34 152.5 37.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.17 0.988 . . . . 0.0 111.019 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.29 16.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.84 -41.91 77.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.851 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -72.1 -42.37 66.21 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.658 1.183 . . . . 0.0 110.088 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.87 -39.36 94.21 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.503 1.521 . . . . 0.0 113.135 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -61.11 -50.17 74.32 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 119.65 -1.906 . . . . 0.0 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.54 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 tt -69.13 -41.56 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.588 1.085 . . . . 0.0 112.676 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.2 -40.58 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.092 1.315 . . . . 0.0 111.244 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.57 -28.5 67.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.226 0.921 . . . . 0.0 113.076 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.6 75.63 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.46 -0.775 . . . . 0.0 112.246 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.77 -45.38 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.772 0.829 . . . . 0.0 109.946 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -62.54 -23.78 67.16 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -84.37 -29.4 26.27 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.978 -1.076 . . . . 0.0 111.308 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.73 75.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.7 1.136 . . . . 0.0 112.361 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.08 -15.35 62.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.506 1.523 . . . . 0.0 113.454 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -92.71 4.67 53.29 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.754 -1.216 . . . . 0.0 111.866 171.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -131.91 -14.35 3.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.93 1.692 . . . . 0.0 115.139 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -153.44 145.58 23.78 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.493 1.497 . . . . 0.0 110.652 171.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -82.17 24.9 0.62 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.997 1.719 . . . . 0.0 113.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 -179.82 21.19 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 124.828 1.204 . . . . 0.0 110.997 166.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -135.73 133.48 38.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.767 0.794 . . . . 0.0 111.495 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mt -124.56 141.04 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.057 -1.652 . . . . 0.0 110.626 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -142.73 147.82 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.4 1.88 . . . . 0.0 111.027 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.41 137.13 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.214 1.006 . . . . 0.0 111.071 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -120.47 121.02 37.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.116 1.766 . . . . 0.0 112.759 172.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 131.47 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.883 1.273 . . . . 0.0 111.87 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -152.25 162.78 40.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.521 -0.737 . . . . 0.0 110.686 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -78.75 -75.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.736 -1.227 . . . . 0.0 112.366 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 p -142.07 148.65 38.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.477 1.911 . . . . 0.0 110.42 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -85.04 161.08 19.86 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.039 0.936 . . . . 0.0 112.976 170.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -98.23 -16.73 19.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.228 1.811 . . . . 0.0 112.31 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -119.56 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.101 1.76 . . . . 0.0 110.934 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -78.67 134.56 37.12 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.57 . . . . 0.0 111.41 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.04 -38.12 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.046 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.7 -46.52 89.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.79 -42.67 70.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.507 0.323 . . . . 0.0 110.785 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -56.68 -47.79 79.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.485 0.314 . . . . 0.0 111.687 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.06 75.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.899 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.9 ttp -67.19 -50.59 60.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 0.0 112.049 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -64.48 -43.95 92.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.245 0.93 . . . . 0.0 111.72 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.64 -45.02 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.129 0.971 . . . . 0.0 110.738 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.92 -50.19 74.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.117 0.967 . . . . 0.0 112.111 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -74.37 -30.96 62.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.328 1.051 . . . . 0.0 112.891 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -73.1 -35.84 66.66 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.659 -1.276 . . . . 0.0 111.917 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.28 -7.25 52.13 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.728 1.211 . . . . 0.0 112.947 170.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 62.21 31.1 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.468 1.507 . . . . 0.0 111.991 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.7 mmm -64.43 -19.79 65.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.304 1.042 . . . . 0.0 113.078 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.25 -12.48 60.29 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.258 1.823 . . . . 0.0 113.65 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -83.58 73.48 10.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.335 1.054 . . . . 0.0 111.249 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -123.74 151.42 43.25 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.717 2.007 . . . . 0.0 110.431 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -63.14 -37.97 89.32 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.378 -0.826 . . . . 0.0 113.02 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.41 -6.98 21.34 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 117.766 -1.112 . . . . 0.0 113.589 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 66.22 47.97 1.74 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.668 1.187 . . . . 0.0 109.433 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -119.8 26.27 9.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.807 1.243 . . . . 0.0 113.456 -172.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.75 127.23 7.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.312 0.958 . . . . 0.0 112.357 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.03 132.77 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 126.7 2.0 . . . . 0.0 109.985 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.5 tp -121.84 129.51 52.66 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.116 0.967 . . . . 0.0 110.781 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.15 99.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.984 0.914 . . . . 0.0 108.632 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -80.2 122.69 27.16 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.529 0.732 . . . . 0.0 110.744 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.863 0.865 . . . . 0.0 110.807 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.95 102.72 15.29 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.367 1.467 . . . . 0.0 109.277 171.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -73.16 -24.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -74.13 -40.75 62.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.962 -0.462 . . . . 0.0 111.472 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -97.27 -6.47 34.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.538 1.535 . . . . 0.0 112.837 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt 67.29 33.19 5.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.779 1.632 . . . . 0.0 112.156 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 m -107.6 129.43 54.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.353 1.461 . . . . 0.0 110.053 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -106.66 141.45 37.91 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.765 1.226 . . . . 0.0 109.876 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.0 t -138.8 140.86 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.198 1.399 . . . . 0.0 108.103 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 mt -125.39 127.57 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -129.74 138.18 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.863 0.865 . . . . 0.0 109.72 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.87 160.41 16.27 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.69 162.32 16.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.518 1.627 . . . . 0.0 112.618 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.84 -38.98 65.19 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.603 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.35 -37.22 93.64 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.612 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -63.0 -58.28 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.317 1.559 . . . . 0.0 110.166 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -59.26 -25.35 63.99 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -80.43 -27.68 37.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.466 1.507 . . . . 0.0 112.462 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.96 -22.82 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.99 167.65 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.836 1.198 . . . . 0.0 112.21 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 m -116.29 169.91 8.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.618 1.167 . . . . 0.0 113.122 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -56.88 -33.0 66.42 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.533 -1.354 . . . . 0.0 113.764 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -20.88 62.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.791 1.236 . . . . 0.0 113.249 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -77.66 -34.17 53.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.449 0.7 . . . . 0.0 110.647 170.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -75.76 -25.66 56.7 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -65.56 -32.96 74.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.402 -0.811 . . . . 0.0 112.376 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.3 p -65.86 -42.67 90.14 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 111.755 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 m -53.7 -55.37 26.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.908 2.083 . . . . 0.0 110.275 172.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -55.95 -49.27 74.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.92 0.888 . . . . 0.0 111.202 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.65 -37.32 81.14 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.46 -51.84 52.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.055 0.843 . . . . 0.0 111.78 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.2 mt -58.22 -51.68 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.044 0.538 . . . . 0.0 110.126 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.797 1.639 . . . . 0.0 113.035 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.09 -46.08 89.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.18 -30.42 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -64.69 -39.35 93.51 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.304 0.956 . . . . 0.0 111.29 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.9 -27.76 69.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.054 0.942 . . . . 0.0 112.331 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -77.77 -38.58 46.45 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.575 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.82 12.46 14.4 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.379 1.942 . . . . 0.0 113.791 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.26 84.89 2.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.204 1.401 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -61.39 -46.62 89.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.575 0.75 . . . . 0.0 111.928 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -49.11 -54.95 13.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -63.51 -41.77 98.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.061 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.42 -36.38 77.64 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.1 0.864 . . . . 0.0 113.346 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.96 -40.7 78.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 111.798 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.8 t -67.28 -50.43 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 111.5 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -73.47 -26.12 60.77 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.15 0.886 . . . . 0.0 112.495 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.09 -38.31 92.29 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.275 -0.891 . . . . 0.0 111.833 169.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.8 mt -62.24 -51.49 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.479 1.139 . . . . 0.0 110.872 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -61.01 -40.14 92.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.495 1.043 . . . . 0.0 112.854 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -73.91 -36.85 64.77 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.723 -1.235 . . . . 0.0 111.422 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.21 73.85 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.803 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.16 -46.66 93.82 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.481 1.037 . . . . 0.0 112.628 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 41.9 tpp -60.8 -43.35 98.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.924 0.862 . . . . 0.0 112.976 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.19 75.69 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.994 0.361 . . . . 0.0 111.215 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.27 -37.9 87.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.455 1.502 . . . . 0.0 111.143 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.43 -24.49 63.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.538 1.135 . . . . 0.0 113.83 173.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -67.8 -27.64 66.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.206 -1.559 . . . . 0.0 112.561 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -93.18 -38.89 11.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.033 1.333 . . . . 0.0 112.031 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.4 76.19 78.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.126 1.77 . . . . 0.0 111.484 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.26 132.19 35.24 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.144 2.563 . . . . 0.0 111.339 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -57.92 146.29 32.69 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -118.57 150.45 39.63 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.004 1.322 . . . . 0.0 109.816 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.53 -27.4 67.73 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.438 -2.039 . . . . 0.0 112.888 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.79 15.04 23.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.659 1.584 . . . . 0.0 112.242 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.38 158.34 9.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.515 1.126 . . . . 0.0 113.185 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.294 0 C-N-CA 124.53 1.132 . . . . 0.0 110.64 -172.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 N--CA 1.457 -0.622 0 CA-C-O 122.119 0.8 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -89.0 -5.76 57.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 m -56.23 141.26 41.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.19 1.396 . . . . 0.0 109.683 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.54 130.95 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.61 152.71 18.38 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.107 0.563 . . . . 0.0 110.848 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -160.99 158.02 27.29 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.074 0 CA-C-O 116.592 -2.226 . . . . 0.0 112.803 171.025 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -69.52 160.6 31.15 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.739 0.7 . . . . 0.0 110.737 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.64 53.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.33 -40.99 77.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.508 1.523 . . . . 0.0 110.92 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -72.06 -44.38 63.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.551 1.141 . . . . 0.0 111.376 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 144' ' ' LYS . 75.0 mt-10 -63.74 -44.77 92.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.322 1.049 . . . . 0.0 111.823 176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -55.56 -47.2 76.76 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.706 -1.246 . . . . 0.0 111.461 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.67 84.45 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.4 tt -76.59 -38.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.568 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.86 -40.34 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.98 1.264 . . . . 0.0 111.253 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.98 -33.45 75.42 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.827 0.851 . . . . 0.0 112.966 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.11 62.0 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.709 0.804 . . . . 0.0 112.412 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.51 -48.66 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -55.49 -27.64 49.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.3 -28.76 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.239 -0.913 . . . . 0.0 113.086 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.07 75.62 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.574 1.149 . . . . 0.0 111.922 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -71.94 14.11 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.824 0.85 . . . . 0.0 113.282 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -120.72 12.5 11.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.322 1.849 . . . . 0.0 112.43 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.92 -14.33 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.807 2.043 . . . . 0.0 113.512 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -159.88 176.03 12.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.445 2.298 . . . . 0.0 108.531 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -125.51 6.22 7.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.347 1.459 . . . . 0.0 114.594 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.98 161.06 31.53 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 155.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -126.84 136.08 51.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 118.192 0.996 . . . . 0.0 112.0 -165.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.7 mt -113.05 124.69 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 110.746 -169.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -135.51 153.59 51.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.124 0.964 . . . . 0.0 111.456 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.9 t -133.99 128.43 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.494 1.518 . . . . 0.0 108.601 -168.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.87 108.75 13.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.569 1.548 . . . . 0.0 113.987 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 tt -93.96 130.94 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.514 0.726 . . . . 0.0 111.023 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.11 163.11 37.95 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.02 1.328 . . . . 0.0 111.317 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.3 -79.38 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.595 1.558 . . . . 0.0 113.369 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -144.54 147.81 33.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.982 2.513 . . . . 0.0 109.044 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -99.38 169.96 8.97 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.39 1.09 . . . . 0.0 112.163 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -101.66 -19.62 15.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.786 1.635 . . . . 0.0 112.685 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 pt -125.04 -148.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -85.17 142.5 29.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.278 1.399 . . . . 0.0 112.604 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.42 -32.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.449 0.7 . . . . 0.0 111.164 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.06 -50.08 73.41 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.736 0.815 . . . . 0.0 111.54 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.39 -39.55 94.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.329 0.652 . . . . 0.0 111.451 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.9 -43.43 98.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.354 0.662 . . . . 0.0 111.841 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.9 96.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.927 0.785 . . . . 0.0 110.982 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.8 ttp -63.26 -47.36 82.73 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.908 0.777 . . . . 0.0 112.327 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.57 -44.25 97.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.217 -0.927 . . . . 0.0 112.131 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.55 -43.96 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.63 1.172 . . . . 0.0 111.109 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.56 -49.71 76.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.995 0.816 . . . . 0.0 111.182 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -67.44 -44.23 79.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.481 1.112 . . . . 0.0 111.828 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.06 -39.84 91.38 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.857 -1.152 . . . . 0.0 113.816 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.56 1.64 18.89 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 56.5 36.59 27.81 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.706 1.202 . . . . 0.0 111.632 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.8 mtp -72.09 -13.49 61.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.131 1.772 . . . . 0.0 113.294 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -75.58 -2.4 28.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.584 1.954 . . . . 0.0 114.25 167.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -79.36 60.53 3.18 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.003 1.321 . . . . 0.0 111.872 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.2 p -129.53 149.97 51.07 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.86 0.838 . . . . 0.0 110.134 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.74 -27.79 68.57 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 113.063 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -107.25 -5.7 17.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.435 1.094 . . . . 0.0 113.1 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 60.05 40.23 18.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.967 1.307 . . . . 0.0 110.87 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -109.78 36.7 2.89 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.391 1.476 . . . . 0.0 112.073 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.11 121.95 5.69 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.714 -1.241 . . . . 0.0 112.464 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.31 135.84 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.118 0.959 . . . . 0.0 110.603 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -120.55 129.73 53.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.448 1.499 . . . . 0.0 111.502 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.47 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.915 0.886 . . . . 0.0 109.957 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -79.64 120.39 23.9 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.473 0.709 . . . . 0.0 110.8 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.61 132.8 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.809 0.844 . . . . 0.0 110.48 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.37 97.15 7.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.199 1.4 . . . . 0.0 109.173 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.29 -13.49 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -77.16 -56.78 4.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.379 0.536 . . . . 0.0 111.038 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.95 -8.4 59.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.278 1.431 . . . . 0.0 114.154 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttt 72.21 27.78 2.52 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.846 1.659 . . . . 0.0 112.443 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -102.39 173.4 6.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.123 0.969 . . . . 0.0 111.475 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -147.64 139.45 24.06 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.359 1.464 . . . . 0.0 109.353 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.0 t -127.9 134.32 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.695 1.198 . . . . 0.0 107.923 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.1 mt -111.97 131.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -137.33 124.95 22.24 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.559 1.544 . . . . 0.0 110.46 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.31 17.48 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -64.37 163.71 12.65 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.325 1.06 . . . . 0.0 111.534 165.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -57.87 -31.83 67.09 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.19 0.996 . . . . 0.0 112.84 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.04 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.724 1.147 . . . . 0.0 113.786 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.13 -61.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.2 1.5 . . . . 0.0 108.638 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -51.5 -41.55 61.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.335 1.054 . . . . 0.0 112.921 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.32 -13.61 59.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.692 1.197 . . . . 0.0 112.932 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.11 -31.92 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.588 1.086 . . . . 0.0 113.525 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 m -108.08 165.94 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.49 1.041 . . . . 0.0 112.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.04 172.39 6.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.427 1.091 . . . . 0.0 113.456 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.867 -1.145 . . . . 0.0 112.84 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -61.42 -25.75 67.41 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.388 1.075 . . . . 0.0 113.57 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -74.96 -46.17 37.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.612 0.765 . . . . 0.0 109.544 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.64 -31.24 72.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.497 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -57.63 -33.75 68.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.771 1.228 . . . . 0.0 112.193 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 p -66.54 -43.11 86.01 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.895 0.478 . . . . 0.0 111.699 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -52.09 66.9 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.285 1.834 . . . . 0.0 110.131 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -59.0 -50.04 75.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.61 0.764 . . . . 0.0 111.148 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -58.23 -43.69 87.86 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.21 -49.75 68.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.46 -47.97 90.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.013 0.925 . . . . 0.0 110.515 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -60.31 -45.98 91.5 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.571 1.148 . . . . 0.0 112.879 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.22 -35.82 76.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.341 0.656 . . . . 0.0 112.528 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -87.01 -34.87 19.09 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.207 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.21 -35.59 73.88 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.933 0.788 . . . . 0.0 111.631 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -68.42 -31.73 71.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 112.979 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.37 -35.12 70.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.464 1.105 . . . . 0.0 110.441 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 6.85 25.43 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.957 1.741 . . . . 0.0 114.533 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -98.64 94.13 6.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.071 0.949 . . . . 0.0 111.259 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -70.52 -37.2 74.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.46 0.704 . . . . 0.0 111.826 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -54.76 -56.94 13.94 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.964 0.906 . . . . 0.0 111.03 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -61.09 -42.6 98.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.27 97.13 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.191 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.17 -46.57 67.21 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.834 -1.079 . . . . 0.0 111.207 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -70.73 -41.0 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.681 1.128 . . . . 0.0 113.064 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.6 -35.78 81.82 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.832 0.742 . . . . 0.0 110.982 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.58 95.52 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.976 174.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.25 -43.49 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.575 1.187 . . . . 0.0 111.352 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -58.87 -52.18 66.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 0.0 110.671 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -66.62 -39.75 88.46 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.835 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.84 72.44 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.729 0.695 . . . . 0.0 111.389 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.87 95.74 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.689 1.131 . . . . 0.0 112.496 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.55 -39.24 88.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.135 -1.214 . . . . 0.0 112.919 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 -48.15 48.85 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.895 0.878 . . . . 0.0 110.602 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.1 mt -60.63 -36.2 78.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.74 1.616 . . . . 0.0 110.767 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.14 50.3 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.34 -37.59 68.81 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.406 -1.434 . . . . 0.0 111.995 170.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -85.04 -32.56 22.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 112.586 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.07 88.34 31.81 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.436 1.895 . . . . 0.0 109.329 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.81 139.82 34.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.541 2.827 . . . . 0.0 110.097 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -64.46 131.46 47.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -103.7 145.8 29.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.007 0.923 . . . . 0.0 110.299 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.43 -30.09 68.24 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 119.675 -1.891 . . . . 0.0 113.908 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -92.2 12.18 23.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.311 1.444 . . . . 0.0 113.177 -176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.82 154.19 7.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -172.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 122.304 1.049 . . . . 0.0 111.562 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 N-CA-C 111.018 -0.416 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -77.51 8.55 4.16 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.712 1.205 . . . . 0.0 113.663 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -75.76 153.25 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.907 1.683 . . . . 0.0 110.9 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.24 130.78 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.173 0.989 . . . . 0.0 108.664 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.1 m -82.8 142.41 31.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.351 1.06 . . . . 0.0 110.251 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 13' ' ' GLU . 92.6 mttt -140.73 138.57 34.28 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.581 -1.325 . . . . 0.0 111.686 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.83 2.633 . . . . 0.0 114.082 -179.025 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -71.57 157.53 37.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.923 0.889 . . . . 0.0 109.406 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -24.31 8.43 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -75.13 -36.46 61.61 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.742 -1.224 . . . . 0.0 112.37 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -76.8 -42.82 39.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.17 1.788 . . . . 0.0 110.209 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.68 -49.08 76.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.32 -46.98 69.64 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.28 -0.888 . . . . 0.0 111.645 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.54 -28.57 67.91 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -80.59 -37.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 120.692 1.587 . . . . 0.0 112.191 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.54 -44.16 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.459 1.027 . . . . 0.0 110.944 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -57.97 -39.56 78.46 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.216 1.406 . . . . 0.0 112.707 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.59 -32.23 71.99 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.59 -0.693 . . . . 0.0 112.384 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.5 mt -67.9 -46.56 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.072 0.851 . . . . 0.0 110.008 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.64 -31.63 64.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.298 1.039 . . . . 0.0 113.157 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -79.35 -27.78 42.02 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.038 0.835 . . . . 0.0 113.109 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.48 -35.83 70.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.479 0.712 . . . . 0.0 111.695 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.43 -1.56 0.56 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.024 2.13 . . . . 0.0 113.933 167.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -117.61 9.66 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.055 1.742 . . . . 0.0 112.388 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -126.22 -14.66 5.92 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.045 1.338 . . . . 0.0 114.097 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -162.28 140.62 8.89 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.722 1.209 . . . . 0.0 109.459 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -83.11 46.5 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.73 0.812 . . . . 0.0 111.243 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.92 137.86 7.69 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.203 1.383 . . . . 0.0 109.686 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -113.84 128.08 56.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.933 0.873 . . . . 0.0 112.064 -152.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.7 mt -120.74 116.66 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.284 -1.51 . . . . 0.0 110.733 -172.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.74 147.92 37.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.887 2.075 . . . . 0.0 110.78 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.83 136.86 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.416 1.086 . . . . 0.0 110.695 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -118.32 118.97 33.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.403 1.881 . . . . 0.0 112.374 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 tp -108.11 129.06 55.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.949 0.9 . . . . 0.0 111.972 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.87 166.96 27.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.108 1.363 . . . . 0.0 110.312 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -81.03 -72.48 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.548 -1.345 . . . . 0.0 113.14 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -144.18 -175.95 4.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 128.22 2.608 . . . . 0.0 108.433 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.5 p -152.27 160.1 43.4 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.215 -0.928 . . . . 0.0 113.226 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.08 -3.27 41.61 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 pt -135.2 -146.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.501 -1.374 . . . . 0.0 110.997 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -95.54 141.24 29.3 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.564 1.529 . . . . 0.0 111.796 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.81 -32.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.259 -0.901 . . . . 0.0 112.544 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.65 -46.27 72.91 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.295 0.498 . . . . 0.0 110.904 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -60.06 -43.52 95.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.152 0.581 . . . . 0.0 111.537 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -60.5 -47.1 87.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.83 77.08 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.014 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.6 ttp -66.21 -52.46 47.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.764 0.711 . . . . 0.0 111.644 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.82 -44.99 91.0 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.989 0.813 . . . . 0.0 112.499 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.04 -40.8 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.247 1.019 . . . . 0.0 110.73 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.41 -51.09 70.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.985 0.811 . . . . 0.0 110.933 173.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.75 -39.13 80.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.578 0.751 . . . . 0.0 112.564 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.68 -38.21 89.46 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.212 1.405 . . . . 0.0 113.554 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.12 -4.74 46.0 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.061 -1.024 . . . . 0.0 113.274 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 58.85 34.04 23.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.711 1.204 . . . . 0.0 112.311 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.3 mmm -59.14 -22.43 60.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.044 2.138 . . . . 0.0 113.93 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -72.52 -6.94 47.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.38 2.272 . . . . 0.0 113.534 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.4 56.64 2.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.469 1.907 . . . . 0.0 110.956 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.1 p -127.75 137.79 52.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.113 2.165 . . . . 0.0 109.317 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -60.99 -36.45 79.51 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.29 -0.881 . . . . 0.0 112.456 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.9 mt -93.82 -9.44 37.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.932 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 66.63 49.35 1.31 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.397 1.453 . . . . 0.0 109.456 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.9 16.12 13.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.828 1.651 . . . . 0.0 113.994 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.38 136.47 30.13 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.05 -1.032 . . . . 0.0 112.187 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.58 138.4 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.649 1.179 . . . . 0.0 110.61 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 tp -117.98 127.57 53.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.277 1.431 . . . . 0.0 110.122 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.2 mt -103.66 96.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -81.06 126.45 31.45 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.903 -0.498 . . . . 0.0 110.391 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.18 127.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.128 0.971 . . . . 0.0 110.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.66 118.0 34.39 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.257 1.023 . . . . 0.0 110.483 167.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.0 m -76.59 -24.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -77.0 -55.97 4.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.207 0.458 . . . . 0.0 110.288 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -84.69 -1.31 55.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.629 1.171 . . . . 0.0 112.54 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.2 tttt 67.4 19.88 10.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 113.393 172.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.3 m -94.67 115.43 27.54 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.365 1.466 . . . . 0.0 110.874 -170.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -90.35 143.56 26.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.984 1.314 . . . . 0.0 110.004 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.08 150.86 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.726 1.61 . . . . 0.0 108.462 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.69 127.66 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -140.19 127.08 20.67 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.924 0.89 . . . . 0.0 110.599 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.6 158.2 14.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.579 1.085 . . . . 0.0 111.373 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.87 173.77 7.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 123.155 1.455 . . . . 0.0 112.638 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -60.72 -37.46 81.78 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.505 1.522 . . . . 0.0 113.685 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.09 -47.13 55.62 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.732 1.158 . . . . 0.0 112.588 -175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -54.7 -55.6 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.601 1.2 . . . . 0.0 109.36 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -79.16 -38.76 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.127 1.371 . . . . 0.0 111.598 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.5 m -92.75 -26.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 169.6 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 119.929 1.24 . . . . 0.0 113.055 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 p -119.17 171.59 8.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.125 1.37 . . . . 0.0 113.31 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.24 -30.25 71.11 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.674 -1.266 . . . . 0.0 113.338 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 0.0 112.344 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.22 -38.88 55.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.747 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -70.12 -28.86 65.72 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 125.08 1.352 . . . . 0.0 113.432 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.56 -31.62 72.84 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.6 m -62.32 -43.26 99.23 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.689 0.677 . . . . 0.0 111.062 171.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -60.21 -48.44 81.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.329 1.452 . . . . 0.0 111.516 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -59.57 -48.09 83.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.693 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -63.67 -35.26 79.96 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.91 61.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.18 0.9 . . . . 0.0 111.793 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.64 -49.9 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.315 0.646 . . . . 0.0 110.583 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.64 -39.9 85.88 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.907 1.283 . . . . 0.0 112.724 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.31 -45.06 96.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.649 1.113 . . . . 0.0 111.954 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -79.14 -37.04 39.51 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.944 -0.473 . . . . 0.0 110.971 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -59.55 -39.83 85.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.186 0.903 . . . . 0.0 111.887 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -64.39 -31.59 72.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.786 1.634 . . . . 0.0 113.034 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -73.06 -34.8 66.49 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 118.756 0.707 . . . . 0.0 111.299 168.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 8.18 11.74 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 126.192 1.853 . . . . 0.0 113.793 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -107.43 78.52 1.22 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 0.0 111.816 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -53.39 -46.5 69.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.412 1.485 . . . . 0.0 112.952 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.7 -49.62 74.58 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.545 -0.722 . . . . 0.0 111.539 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.61 -44.35 90.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.826 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.74 97.08 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 119.003 0.819 . . . . 0.0 113.387 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.31 -47.19 68.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.46 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.54 -51.65 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.364 1.066 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.26 -41.94 98.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.114 0.966 . . . . 0.0 111.2 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -17.78 76.28 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 121.049 -1.032 . . . . 0.0 113.5 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.96 -50.63 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.649 1.58 . . . . 0.0 109.825 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.91 -51.65 68.28 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.775 1.171 . . . . 0.0 111.982 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.35 -37.6 86.29 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.058 -1.026 . . . . 0.0 112.122 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.27 88.41 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.886 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.41 87.09 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.116 0.871 . . . . 0.0 111.231 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 59.9 ttm -59.96 -43.47 95.04 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.027 0.913 . . . . 0.0 112.503 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.45 -47.31 64.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.25 0.62 . . . . 0.0 111.78 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.55 -36.41 82.55 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.284 1.034 . . . . 0.0 111.466 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.27 -22.47 61.2 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -66.14 -41.71 90.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.866 1.212 . . . . 0.0 111.438 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -81.59 -27.39 34.29 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.029 1.731 . . . . 0.0 113.001 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -138.86 76.35 34.48 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 126.594 1.957 . . . . 0.0 110.097 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.56 143.86 64.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.326 2.684 . . . . 0.0 111.144 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -66.7 137.21 56.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -118.03 150.82 38.65 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.787 1.635 . . . . 0.0 110.149 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -67.15 -19.63 65.62 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.181 -1.574 . . . . 0.0 113.524 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -106.72 17.75 22.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.054 2.941 . . . . 0.0 112.037 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -52.7 153.84 3.0 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.044 1.338 . . . . 0.0 112.19 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.316 0 O-C-N 120.735 -1.228 . . . . 0.0 111.848 -167.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 CA--C 1.533 0.455 0 N-CA-C 111.669 -0.166 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -57.39 -14.07 4.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.7 m -50.32 140.39 13.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.44 134.82 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.551 1.14 . . . . 0.0 109.582 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 m -93.56 138.62 31.64 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.387 1.089 . . . . 0.0 111.982 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.21 157.29 46.19 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.778 1.631 . . . . 0.0 109.28 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 C-N-CA 125.169 1.366 . . . . 0.0 111.786 172.786 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -86.33 170.22 12.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.739 0.781 . . . . 0.0 110.375 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.26 -29.47 5.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.137 1.375 . . . . 0.0 114.636 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -80.22 -38.47 31.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 0.0 111.979 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -76.67 -44.49 33.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.949 1.3 . . . . 0.0 111.036 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.47 -45.66 92.04 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.057 1.343 . . . . 0.0 111.168 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.04 -40.01 79.83 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.895 -1.128 . . . . 0.0 111.603 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.94 80.32 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 0.594 . . . . 0.0 111.962 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.05 -37.32 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.319 0.963 . . . . 0.0 112.909 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.95 -40.88 84.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 118.953 0.797 . . . . 0.0 111.283 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -72.64 -29.28 63.32 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.143 0.883 . . . . 0.0 113.31 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.01 76.68 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.522 -0.736 . . . . 0.0 112.645 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.54 -40.53 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -61.43 -31.21 71.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.865 0.866 . . . . 0.0 112.134 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.01 -31.13 62.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.422 1.089 . . . . 0.0 112.685 172.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.37 -39.25 59.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.824 1.25 . . . . 0.0 113.027 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.94 -23.72 63.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 112.564 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.8 8.84 26.99 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.527 -1.358 . . . . 0.0 113.39 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -130.62 -8.96 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.912 1.685 . . . . 0.0 113.78 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -157.48 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.501 1.521 . . . . 0.0 108.888 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 27.8 1.52 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.686 0.794 . . . . 0.0 112.162 174.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.09 151.35 17.34 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.248 1.404 . . . . 0.0 111.443 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -112.28 127.89 56.11 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -161.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.37 119.96 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.401 -1.437 . . . . 0.0 110.216 -172.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -128.58 147.07 50.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.443 1.097 . . . . 0.0 112.071 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.23 141.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.024 1.33 . . . . 0.0 110.203 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -126.96 123.38 37.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.172 0.989 . . . . 0.0 110.869 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 tp -104.77 147.79 27.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 0.0 111.463 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.44 166.36 32.41 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.882 1.325 . . . . 0.0 109.644 159.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -59.62 -78.28 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 C-N-CA 126.236 1.814 . . . . 0.0 113.073 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -138.08 -177.03 4.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.536 1.534 . . . . 0.0 110.71 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -137.46 142.57 41.56 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.397 1.479 . . . . 0.0 111.434 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -81.07 -27.84 35.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.041 0.936 . . . . 0.0 112.947 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 pt -115.71 -146.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.099 1.759 . . . . 0.0 110.636 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.85 133.74 36.28 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.578 -1.326 . . . . 0.0 111.875 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.21 -36.89 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.853 0.861 . . . . 0.0 112.314 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.78 -49.75 64.89 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.866 1.212 . . . . 0.0 111.7 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -60.63 -42.59 97.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.158 0.583 . . . . 0.0 112.192 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.552 ' NH2' ' HH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -63.08 -36.93 85.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 176.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.65 88.32 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.848 -1.157 . . . . 0.0 111.763 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.6 ttp -63.18 -49.93 72.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.376 0.67 . . . . 0.0 111.439 170.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.08 -47.96 79.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.845 0.748 . . . . 0.0 111.087 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.29 -42.02 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 111.814 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.59 -53.2 60.84 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.598 1.09 . . . . 0.0 111.054 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.21 -32.3 62.98 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.376 0.67 . . . . 0.0 112.353 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.626 -1.296 . . . . 0.0 112.824 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.1 -6.55 58.95 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.164 0.985 . . . . 0.0 112.559 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 tttt 61.44 36.02 17.43 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.802 1.641 . . . . 0.0 111.625 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.5 mtp -72.7 -5.5 38.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -77.57 -2.5 36.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.631 1.972 . . . . 0.0 113.18 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -73.26 33.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.293 1.837 . . . . 0.0 114.318 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 p -111.44 153.98 25.33 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.037 1.735 . . . . 0.0 111.947 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.75 -39.17 87.81 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.04 -4.2 22.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.188 -0.91 . . . . 0.0 113.39 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 67.78 31.49 5.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.662 1.585 . . . . 0.0 110.021 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.37 33.03 3.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.454 1.902 . . . . 0.0 112.594 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.31 123.55 6.38 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.358 0.98 . . . . 0.0 112.999 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -112.18 138.42 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.449 1.1 . . . . 0.0 112.011 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.9 tp -117.01 128.54 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.475 1.51 . . . . 0.0 111.228 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -104.38 97.93 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.456 1.102 . . . . 0.0 108.963 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.552 ' HH ' ' NH2' ' A' ' 46' ' ' ARG . 42.0 t80 -81.12 125.0 29.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 111.017 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.38 134.29 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.108 0.963 . . . . 0.0 111.115 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.24 105.93 16.14 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.107 1.763 . . . . 0.0 110.613 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -77.77 -13.03 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -78.46 -40.74 34.72 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.174 0.897 . . . . 0.0 112.07 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.81 -10.6 26.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.824 1.249 . . . . 0.0 112.219 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.0 tttt 71.96 24.28 3.32 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.738 1.615 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.3 p -105.85 165.03 11.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.313 1.045 . . . . 0.0 111.607 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -143.32 144.52 32.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 109.616 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -138.97 139.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.95 1.7 . . . . 0.0 107.719 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.7 mt -116.0 133.3 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -138.58 126.94 23.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.207 1.003 . . . . 0.0 110.401 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.93 150.54 18.42 Favored Glycine 0 N--CA 1.462 0.398 0 C-N-CA 125.174 1.368 . . . . 0.0 112.208 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -64.17 164.03 11.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 122.598 1.19 . . . . 0.0 112.319 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -53.85 -35.12 61.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.435 1.494 . . . . 0.0 112.377 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -28.08 73.65 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 119.626 1.103 . . . . 0.0 114.387 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.39 -58.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.283 1.541 . . . . 0.0 109.798 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -54.6 -32.94 59.58 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.308 1.443 . . . . 0.0 113.869 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -76.87 -24.13 52.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 m -103.91 -35.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.908 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.7 169.17 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 120.004 1.274 . . . . 0.0 112.632 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -119.46 177.77 4.79 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.563 1.545 . . . . 0.0 113.271 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -61.73 -33.46 74.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.683 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.39 -20.21 62.96 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.03 0.932 . . . . 0.0 112.557 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -77.87 -30.66 50.97 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -83.99 -26.34 29.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -54.86 -44.03 73.65 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.963 1.305 . . . . 0.0 112.416 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.8 p -63.12 -35.29 79.78 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 m -66.43 -51.16 59.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.476 1.91 . . . . 0.0 110.245 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -60.9 -44.57 96.95 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.146 0.978 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -57.19 -47.22 81.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.874 0.761 . . . . 0.0 112.524 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.45 -48.2 82.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.436 1.017 . . . . 0.0 111.841 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.12 -49.15 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.946 0.898 . . . . 0.0 110.352 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -59.86 -42.13 93.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.999 1.32 . . . . 0.0 112.356 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.89 -38.36 86.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.74 -32.84 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.391 0.541 . . . . 0.0 111.172 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -62.39 -39.05 91.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.637 0.775 . . . . 0.0 111.645 168.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -59.38 -31.32 69.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.683 1.193 . . . . 0.0 113.038 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.36 -41.04 22.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.378 1.071 . . . . 0.0 111.257 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.36 1.23 8.58 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.581 1.563 . . . . 0.0 114.843 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -93.63 80.69 4.28 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.815 1.307 . . . . 0.0 111.532 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -59.77 -44.44 93.87 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.789 1.235 . . . . 0.0 112.609 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -50.99 -58.67 5.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.314 1.045 . . . . 0.0 111.363 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.004 0.921 . . . . 0.0 111.698 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.04 -37.41 94.18 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 118.72 0.691 . . . . 0.0 113.664 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.08 -44.94 59.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.448 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.68 -51.67 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.326 0.65 . . . . 0.0 111.12 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.88 -33.75 76.77 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.346 0.659 . . . . 0.0 112.3 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.23 83.77 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.338 -0.851 . . . . 0.0 112.667 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.94 -46.67 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.167 1.483 . . . . 0.0 109.877 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.24 -47.63 81.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.305 0.642 . . . . 0.0 111.29 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -61.63 -38.69 88.58 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 121.547 -0.72 . . . . 0.0 112.202 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.66 64.24 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.322 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.3 -45.61 74.21 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 120.37 1.441 . . . . 0.0 113.284 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mtp -63.37 -38.11 89.89 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.158 -1.201 . . . . 0.0 112.907 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.38 -38.84 40.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 110.901 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.49 -33.14 70.89 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.453 1.501 . . . . 0.0 112.549 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.49 41.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -71.85 -29.56 64.52 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.112 -0.992 . . . . 0.0 113.429 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -91.62 -35.54 14.17 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.777 1.231 . . . . 0.0 111.527 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -136.34 90.99 16.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.328 1.851 . . . . 0.0 109.879 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.37 144.17 60.81 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.639 2.226 . . . . 0.0 111.299 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -62.93 161.53 12.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.6 0.76 . . . . 0.0 112.747 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -142.9 159.28 42.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -62.27 -29.25 70.29 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.542 -1.349 . . . . 0.0 113.236 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -99.82 29.15 4.3 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.651 1.581 . . . . 0.0 112.4 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.33 151.17 44.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.834 -1.166 . . . . 0.0 112.003 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.219 -0.523 0 C-N-CA 124.24 1.016 . . . . 0.0 110.887 -167.146 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 111.046 -0.405 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -83.83 2.52 37.87 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.6 p -76.33 160.9 29.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.989 1.316 . . . . 0.0 112.325 -166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.94 140.49 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.536 0.735 . . . . 0.0 109.815 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.4 t -110.07 140.66 43.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.668 -1.27 . . . . 0.0 111.942 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -134.88 137.37 43.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 C-N-CA 124.993 1.282 . . . . 0.0 114.793 169.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -64.05 150.64 44.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.066 1.346 . . . . 0.0 109.38 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.45 55.73 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.249 -1.532 . . . . 0.0 113.983 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -68.67 -35.63 77.47 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.357 1.463 . . . . 0.0 113.566 174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.54 -35.24 78.67 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.499 -1.376 . . . . 0.0 111.152 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.82 -44.19 97.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.875 0.87 . . . . 0.0 110.956 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -45.3 87.22 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.013 -1.054 . . . . 0.0 111.162 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.58 76.27 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.0 -38.8 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 119.846 1.203 . . . . 0.0 112.21 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.75 -39.63 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 119.67 1.123 . . . . 0.0 111.934 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.42 -35.37 77.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.477 1.111 . . . . 0.0 112.741 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.34 87.63 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.859 0.463 . . . . 0.0 111.631 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.6 mt -66.31 -46.56 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.79 1.236 . . . . 0.0 110.243 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -57.7 -28.9 64.25 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.23 -30.29 34.23 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.048 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.74 85.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.922 1.289 . . . . 0.0 112.25 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' CD ' HD22 ' A' ' 140' ' ' ASN . 95.6 mt-10 -54.02 -17.4 2.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.514 1.525 . . . . 0.0 113.787 168.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -106.63 14.42 26.98 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.034 -1.666 . . . . 0.0 112.396 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -130.68 -15.92 3.43 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.83 1.652 . . . . 0.0 113.961 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -152.39 152.84 32.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.845 1.258 . . . . 0.0 110.577 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -81.03 3.5 22.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.276 1.03 . . . . 0.0 112.812 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 -161.74 21.85 Favored Glycine 0 C--N 1.343 0.934 0 C-N-CA 125.996 1.76 . . . . 0.0 111.668 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -162.86 129.52 3.48 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.246 0.618 . . . . 0.0 112.159 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.78 116.15 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.37 1.068 . . . . 0.0 110.634 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -121.78 153.09 38.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.622 1.169 . . . . 0.0 111.218 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.11 132.78 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.65 1.18 . . . . 0.0 110.725 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -117.3 124.22 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.257 1.027 . . . . 0.0 112.515 169.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.33 126.15 52.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.069 1.347 . . . . 0.0 112.401 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -150.6 161.63 42.21 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.462 1.105 . . . . 0.0 110.21 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -73.7 -68.98 0.46 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.645 -1.284 . . . . 0.0 113.302 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -156.57 157.66 35.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.434 1.894 . . . . 0.0 110.277 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.1 p -115.8 147.93 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.585 1.554 . . . . 0.0 112.77 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -80.5 -29.23 37.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.15 0.98 . . . . 0.0 111.566 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -107.8 -167.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.843 1.657 . . . . 0.0 111.447 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -68.75 134.39 49.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.594 1.158 . . . . 0.0 112.678 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.87 -38.06 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.967 0.907 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.24 -51.25 68.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.682 0.674 . . . . 0.0 112.109 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.17 -43.02 93.07 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.135 0.574 . . . . 0.0 111.47 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -58.51 -42.33 87.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.669 0.788 . . . . 0.0 112.418 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.29 -35.13 77.38 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.902 0.881 . . . . 0.0 111.555 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.2 ttp -63.68 -49.21 74.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.545 0.738 . . . . 0.0 111.119 170.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.08 -52.45 65.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.049 0.939 . . . . 0.0 111.464 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.14 -42.5 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.506 1.122 . . . . 0.0 111.448 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.54 -46.44 90.15 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.45 1.1 . . . . 0.0 112.003 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -70.15 -36.96 75.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.443 1.497 . . . . 0.0 111.872 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.24 -22.36 59.37 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.768 1.227 . . . . 0.0 114.058 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.79 -8.82 57.87 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.684 1.194 . . . . 0.0 112.421 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 65.74 32.89 8.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.232 1.413 . . . . 0.0 112.712 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.7 mtp -64.98 -23.63 67.28 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.36 -13.41 1.4 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.584 1.954 . . . . 0.0 114.709 168.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -73.79 43.89 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.486 1.915 . . . . 0.0 112.915 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.2 m -120.74 129.7 53.74 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.658 1.583 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.78 -39.45 65.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.449 1.499 . . . . 0.0 113.83 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.44 2.82 42.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 0.0 113.707 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 62.87 32.73 15.63 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.288 1.035 . . . . 0.0 111.169 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -107.82 27.15 9.5 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.372 1.469 . . . . 0.0 113.12 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.18 125.8 7.29 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.203 0.906 . . . . 0.0 112.077 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.23 135.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.979 1.312 . . . . 0.0 109.714 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.17 127.99 54.66 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.241 1.02 . . . . 0.0 111.315 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -101.55 96.19 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.621 1.568 . . . . 0.0 109.215 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -84.16 124.37 31.08 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.151 -0.968 . . . . 0.0 110.805 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -120.9 131.92 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.224 1.01 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 90.96 3.54 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.131 1.773 . . . . 0.0 110.609 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.29 -14.82 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -75.61 -34.97 60.62 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 122.847 0.459 . . . . 0.0 111.252 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.45 -12.22 16.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.116 2.167 . . . . 0.0 112.757 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 73.03 26.0 2.26 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.127 1.771 . . . . 0.0 112.441 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -110.01 167.44 10.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.073 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -148.39 148.64 30.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.298 1.039 . . . . 0.0 110.644 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.9 142.37 40.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.63 128.26 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -145.84 125.64 13.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.621 1.168 . . . . 0.0 109.606 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.35 161.98 13.38 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.527 1.061 . . . . 0.0 112.023 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -64.58 162.91 14.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 123.212 1.482 . . . . 0.0 111.798 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.008 1.723 . . . . 0.0 113.451 -170.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.48 -25.44 72.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.259 -1.301 . . . . 0.0 114.534 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 -58.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.971 1.885 . . . . 0.0 109.302 167.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -59.69 -25.15 64.53 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.5 -18.24 34.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.472 1.109 . . . . 0.0 113.884 174.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -104.11 -20.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.11 167.47 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.844 1.257 . . . . 0.0 111.287 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -120.25 173.06 7.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.54 1.136 . . . . 0.0 113.101 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -49.41 -38.49 29.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -31.0 72.04 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.88 -32.78 69.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.656 0.782 . . . . 0.0 111.636 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -78.99 -26.35 43.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.289 1.436 . . . . 0.0 113.334 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.99 -41.56 87.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.57 0.748 . . . . 0.0 112.646 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -59.53 -43.05 93.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.255 0.479 . . . . 0.0 111.287 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -61.34 -51.16 70.0 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 125.72 1.608 . . . . 0.0 110.401 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.08 -48.51 79.93 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 118.075 -0.965 . . . . 0.0 110.587 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.85 -41.69 96.35 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.207 1.367 . . . . 0.0 113.362 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.09 79.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.917 1.235 . . . . 0.0 111.327 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.33 -54.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.934 0.894 . . . . 0.0 110.451 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -52.37 -44.94 65.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.304 1.842 . . . . 0.0 113.174 -175.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.37 -30.54 62.03 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.215 0.606 . . . . 0.0 112.557 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -82.36 -39.65 22.45 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.75 0.82 . . . . 0.0 111.063 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.98 -43.25 91.37 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.407 0.683 . . . . 0.0 111.406 170.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.06 -37.31 71.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.264 1.025 . . . . 0.0 112.06 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -71.89 -41.08 68.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.337 1.055 . . . . 0.0 111.409 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.13 4.78 6.42 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 126.323 1.916 . . . . 0.0 113.648 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -102.46 81.4 2.05 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 119.0 1.4 . . . . 0.0 111.71 -171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -60.03 -43.61 95.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.754 0.822 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.43 -52.69 64.37 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.783 -0.573 . . . . 0.0 111.515 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -56.93 -44.76 82.79 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.06 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.92 96.08 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.344 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.75 -52.22 64.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.754 0.777 . . . . 0.0 111.021 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.3 t -63.77 -49.15 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.163 . . . . 0.0 110.907 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.37 -32.72 74.29 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.845 0.748 . . . . 0.0 111.834 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.99 -45.42 73.14 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.57 -47.85 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.015 1.326 . . . . 0.0 111.309 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.87 -49.56 76.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.577 0.751 . . . . 0.0 111.483 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -63.48 -34.75 78.45 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.387 -0.82 . . . . 0.0 112.466 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.52 79.52 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.023 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.76 -39.76 97.89 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.51 1.05 . . . . 0.0 112.776 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 78.5 mtp -61.46 -48.41 81.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.046 0.923 . . . . 0.0 112.379 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.85 65.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.657 0.783 . . . . 0.0 112.308 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.65 -37.92 85.8 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 111.185 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.12 -23.59 67.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -62.22 -45.6 92.61 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.494 -1.379 . . . . 0.0 111.225 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -74.03 -39.44 63.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.21 1.004 . . . . 0.0 111.988 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.42 82.56 65.95 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 125.986 1.715 . . . . 0.0 110.567 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.83 136.58 53.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.36 2.04 . . . . 0.0 109.622 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -57.54 135.75 56.67 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -108.75 146.29 33.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.885 1.274 . . . . 0.0 110.003 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -24.48 67.39 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.426 -1.421 . . . . 0.0 113.541 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -105.51 19.42 20.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.016 1.326 . . . . 0.0 113.467 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.8 162.1 1.91 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.269 1.428 . . . . 0.0 113.66 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 122.622 1.201 . . . . 0.0 112.221 -170.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 CA-C-O 121.169 0.404 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.405 HD22 ' CD ' ' A' ' 24' ' ' GLU . 35.0 m-80 -72.63 -1.33 15.79 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -62.62 150.49 40.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.077 0.951 . . . . 0.0 111.445 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.6 133.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.67 0.788 . . . . 0.0 108.996 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.76 143.88 27.32 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.614 -0.678 . . . . 0.0 112.295 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -145.85 147.45 31.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.217 -0.927 . . . . 0.0 112.168 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 C-N-CA 126.731 2.11 . . . . 0.0 112.026 165.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 m -58.79 157.15 10.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.066 0.947 . . . . 0.0 110.31 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.81 -44.03 18.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -51.14 -40.43 58.52 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 173.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -79.49 -39.95 30.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.025 0.93 . . . . 0.0 111.434 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.06 -46.03 75.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -57.95 -48.93 78.48 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.355 -1.466 . . . . 0.0 110.7 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.35 85.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.18 -38.68 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.951 1.25 . . . . 0.0 112.678 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.12 -46.19 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.634 0.652 . . . . 0.0 110.719 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.15 -35.73 79.67 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.885 0.874 . . . . 0.0 112.828 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.38 96.93 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.897 0.772 . . . . 0.0 111.437 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.39 -45.01 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.628 -0.67 . . . . 0.0 110.51 172.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -56.92 -27.46 60.95 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -83.64 -28.85 28.13 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.105 0.866 . . . . 0.0 112.3 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.37 97.63 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.767 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.58 18.4 0.17 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.952 1.301 . . . . 0.0 113.637 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.96 11.44 8.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.823 2.049 . . . . 0.0 111.376 166.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.44 -10.74 3.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.832 1.653 . . . . 0.0 113.378 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -150.5 171.0 17.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.021 1.728 . . . . 0.0 110.171 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -101.35 5.09 42.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.974 1.71 . . . . 0.0 112.776 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.5 126.44 6.52 Favored Glycine 0 C--N 1.343 0.959 0 C-N-CA 124.992 1.282 . . . . 0.0 112.425 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -94.23 142.32 27.55 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -156.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mt -114.76 134.91 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.505 1.122 . . . . 0.0 111.293 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -144.11 149.35 36.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.947 1.299 . . . . 0.0 112.131 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.79 141.79 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.918 1.687 . . . . 0.0 110.327 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -124.39 127.0 46.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.686 1.594 . . . . 0.0 112.0 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -112.77 123.05 49.43 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.393 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 46' ' ' ARG . 26.1 tt0 -143.14 159.07 42.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.036 0.934 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -68.61 -73.29 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.739 -1.226 . . . . 0.0 110.824 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -153.98 159.19 41.55 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.27 1.828 . . . . 0.0 110.671 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.473 ' HG ' HG23 ' A' ' 43' ' ' VAL . 29.9 m -105.21 159.8 15.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.69 1.596 . . . . 0.0 110.361 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -94.48 -27.58 15.92 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.227 -0.921 . . . . 0.0 112.766 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.33 -150.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 126.112 1.765 . . . . 0.0 111.334 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.84 136.51 34.1 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.549 1.139 . . . . 0.0 111.696 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' A' ' 39' ' ' SER . 51.7 t -68.27 -37.24 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.076 0.95 . . . . 0.0 112.146 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -64.3 -47.43 79.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.372 0.987 . . . . 0.0 111.933 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -44.32 97.09 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.473 1.509 . . . . 0.0 110.387 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 36' ' ' GLU . 47.6 ttt85 -61.04 -45.69 93.75 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.623 1.169 . . . . 0.0 113.409 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.4 98.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.791 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.0 ttp -60.58 -43.17 97.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.963 0.905 . . . . 0.0 113.048 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -61.47 -54.46 43.09 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.933 -1.104 . . . . 0.0 112.228 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.98 -41.57 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.116 0.566 . . . . 0.0 111.86 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.99 -49.89 76.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.88 1.272 . . . . 0.0 111.919 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -74.76 -32.91 62.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.144 0.978 . . . . 0.0 112.059 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -64.99 -36.31 84.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.045 -1.659 . . . . 0.0 112.463 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.97 -8.04 57.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.823 1.249 . . . . 0.0 113.279 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 65.45 35.89 7.07 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 126.226 1.81 . . . . 0.0 112.214 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.4 mtp -69.64 -25.26 63.85 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.865 -1.147 . . . . 0.0 112.79 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -69.64 -12.73 61.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.304 2.241 . . . . 0.0 114.411 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -84.77 63.45 8.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.24 1.416 . . . . 0.0 110.937 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.2 m -132.01 133.94 45.0 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.884 1.673 . . . . 0.0 109.546 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -48.99 -54.73 14.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 113.45 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.24 -9.9 51.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.736 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 62.72 55.39 2.14 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.174 1.79 . . . . 0.0 109.956 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -125.8 28.93 6.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.537 1.135 . . . . 0.0 111.904 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.86 133.78 17.69 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 120.669 -1.269 . . . . 0.0 111.335 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.79 135.84 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.014 1.326 . . . . 0.0 111.273 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.0 tp -118.52 121.37 40.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.916 1.286 . . . . 0.0 110.781 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -95.14 96.55 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -78.64 123.02 26.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.391 0.677 . . . . 0.0 110.03 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.4 127.13 75.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.637 1.175 . . . . 0.0 110.212 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.62 92.69 4.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.77 1.228 . . . . 0.0 109.531 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.05 -6.11 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -171.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.24 -49.89 15.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.786 0.721 . . . . 0.0 109.726 170.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.2 -9.43 53.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 112.629 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.3 tttt 71.72 20.59 4.58 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.005 2.122 . . . . 0.0 113.133 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.3 p -102.6 169.34 8.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.957 1.303 . . . . 0.0 111.805 -174.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.46 145.92 31.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.59 1.156 . . . . 0.0 110.595 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.49 136.46 48.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 126.241 1.817 . . . . 0.0 107.103 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.39 127.62 73.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -130.11 147.0 51.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 109.758 173.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.64 154.78 26.04 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -58.52 162.54 3.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.174 1.464 . . . . 0.0 113.767 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -53.23 -36.71 61.35 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.344 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -45.18 94.6 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 120.647 1.567 . . . . 0.0 112.433 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 61.2 mt -58.97 -57.44 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 118.301 1.05 . . . . 0.0 109.854 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -58.57 -29.7 66.59 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -81.59 -16.68 50.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 112.851 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.89 -34.79 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.63 165.93 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.176 1.353 . . . . 0.0 112.016 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.1 m -115.39 165.4 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.055 1.342 . . . . 0.0 112.382 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -61.03 -26.03 67.33 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.83 -1.169 . . . . 0.0 112.997 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.68 -23.3 56.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.154 0.981 . . . . 0.0 112.81 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.21 -27.4 47.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.639 1.576 . . . . 0.0 111.578 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -79.8 -29.43 40.28 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -49.52 -48.04 48.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.566 1.147 . . . . 0.0 112.599 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -54.33 -44.72 72.31 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.533 1.533 . . . . 0.0 112.293 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.3 m -64.94 -48.67 73.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.911 1.284 . . . . 0.0 110.691 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -56.74 -46.39 81.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.377 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.58 -45.6 92.19 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 112.817 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.62 -50.52 71.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.922 1.237 . . . . 0.0 112.362 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.5 -50.99 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.652 0.781 . . . . 0.0 110.655 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -60.29 -46.79 88.63 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.534 1.533 . . . . 0.0 112.012 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.11 -33.61 74.77 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.224 0.609 . . . . 0.0 112.381 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -84.1 -40.18 18.59 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.442 1.097 . . . . 0.0 112.191 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.7 -36.81 77.26 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.569 -0.707 . . . . 0.0 111.186 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -62.7 -29.93 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.996 1.318 . . . . 0.0 113.505 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -80.31 -29.31 38.12 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.942 -1.099 . . . . 0.0 110.866 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 -1.8 33.37 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 126.015 1.769 . . . . 0.0 113.801 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -86.57 92.14 8.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.39 1.095 . . . . 0.0 111.039 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.73 -38.26 88.66 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.032 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -59.98 -59.66 5.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.265 0.626 . . . . 0.0 111.153 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.45 -40.94 96.31 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.913 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.85 97.16 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.923 1.238 . . . . 0.0 114.019 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.1 mt -71.16 -45.65 63.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.395 0.598 . . . . 0.0 111.481 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.87 -50.45 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.307 0.958 . . . . 0.0 112.009 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.501 1.12 . . . . 0.0 111.104 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.53 -47.55 88.54 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 123.574 0.607 . . . . 0.0 111.633 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.27 -42.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.734 1.214 . . . . 0.0 111.333 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.65 -39.82 94.37 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.198 1.399 . . . . 0.0 112.001 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -72.46 -43.59 63.51 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.905 -1.122 . . . . 0.0 111.526 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.02 75.47 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.343 1.057 . . . . 0.0 111.095 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.47 -44.22 96.87 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.256 0.935 . . . . 0.0 112.088 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -67.16 -26.2 66.54 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.566 -0.961 . . . . 0.0 113.557 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.22 -50.27 12.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.084 1.353 . . . . 0.0 111.426 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.2 mt -58.63 -38.17 77.47 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.763 2.025 . . . . 0.0 111.789 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.55 -14.15 12.0 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -80.53 -35.39 34.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 120.454 -1.404 . . . . 0.0 111.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -84.18 -38.81 20.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 113.041 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.52 86.26 53.72 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.02 1.728 . . . . 0.0 109.235 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.42 135.32 26.35 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.712 2.275 . . . . 0.0 110.466 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -56.33 146.28 24.49 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -125.45 153.64 43.2 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.709 1.204 . . . . 0.0 110.986 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -62.04 -35.86 79.88 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.858 -1.151 . . . . 0.0 113.063 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.3 13.77 9.13 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 113.64 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.38 158.62 28.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.853 0.861 . . . . 0.0 112.732 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 126.041 1.736 . . . . 0.0 110.73 -173.392 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.451 -0.983 0 CA-C-O 121.245 0.435 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -64.92 1.39 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.1 1.76 . . . . 0.0 115.189 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 p -71.39 141.99 50.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.826 -1.171 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 82.4 mt -73.46 136.36 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.245 1.018 . . . . 0.0 109.706 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -96.1 145.91 25.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 120.906 -1.122 . . . . 0.0 111.009 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -144.98 142.46 29.83 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.416 -1.427 . . . . 0.0 112.816 -172.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.406 0 C-N-CA 125.761 1.648 . . . . 0.0 112.814 169.453 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 p -84.7 166.48 17.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 111.889 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.28 77.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 112.121 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.7 -48.74 78.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.147 1.379 . . . . 0.0 111.052 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HA ' ' HZ2' ' A' ' 110' ' ' LYS . 84.6 mt-10 -64.32 -44.23 92.19 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.282 0.633 . . . . 0.0 111.366 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.85 -29.51 62.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.486 1.514 . . . . 0.0 113.424 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -65.93 -37.73 86.8 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.01 -1.681 . . . . 0.0 111.7 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.86 -39.42 35.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.84 -37.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.505 -1.372 . . . . 0.0 112.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.13 -36.14 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.662 0.664 . . . . 0.0 110.846 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -72.2 -25.24 61.59 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.556 1.142 . . . . 0.0 112.754 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -40.32 72.87 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.687 -0.633 . . . . 0.0 111.587 172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.93 -44.89 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.349 -0.844 . . . . 0.0 110.991 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -57.52 -32.5 67.11 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -79.74 -30.36 40.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.636 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.75 74.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -55.39 -19.41 9.0 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.276 1.431 . . . . 0.0 112.461 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -103.51 9.9 37.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.526 . . . . 0.0 112.926 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -124.95 -12.92 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.983 1.313 . . . . 0.0 113.712 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -164.35 149.28 10.02 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 109.391 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.9 p -85.32 5.7 29.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.054 0.942 . . . . 0.0 112.92 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.94 168.65 43.42 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.831 1.205 . . . . 0.0 110.304 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -137.18 121.95 18.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.934 . . . . 0.0 113.054 -166.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.45 137.72 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.209 1.404 . . . . 0.0 111.04 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -146.55 153.85 40.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.274 1.429 . . . . 0.0 110.433 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.48 138.4 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.919 1.287 . . . . 0.0 110.203 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -116.3 115.69 26.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 110.964 165.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.9 tp -98.17 134.22 41.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.484 0.714 . . . . 0.0 111.143 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.03 162.36 41.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.181 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.83 -69.37 0.44 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.722 1.209 . . . . 0.0 112.673 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -160.36 152.38 20.24 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.539 1.135 . . . . 0.0 113.289 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.6 p -109.96 141.64 42.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.667 1.587 . . . . 0.0 113.181 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.57 -28.51 56.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.482 0.658 . . . . 0.0 112.498 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -109.95 -172.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.113 2.165 . . . . 0.0 111.641 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.12 132.74 51.36 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.755 1.222 . . . . 0.0 112.812 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.57 -41.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.816 1.246 . . . . 0.0 111.467 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -48.5 79.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.645 0.778 . . . . 0.0 112.11 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.51 -42.09 83.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.871 0.868 . . . . 0.0 110.992 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -60.02 -46.34 89.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.213 1.005 . . . . 0.0 112.156 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.58 -37.92 88.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.211 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.7 ttp -63.94 -48.89 74.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.859 0.754 . . . . 0.0 111.654 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.78 -46.8 89.07 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.238 0.615 . . . . 0.0 111.054 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.61 -43.04 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.66 1.184 . . . . 0.0 111.79 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.04 -48.43 81.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.497 1.044 . . . . 0.0 112.185 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -72.39 -33.41 67.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.582 1.153 . . . . 0.0 112.606 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -65.36 -42.79 92.41 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.607 -1.308 . . . . 0.0 111.809 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.42 -1.21 32.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.537 1.135 . . . . 0.0 112.947 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 59.75 37.92 21.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.811 1.244 . . . . 0.0 112.28 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtp -75.44 -21.17 58.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 112.511 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.81 -13.12 9.08 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.308 2.643 . . . . 0.0 114.415 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -64.45 -7.89 11.57 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -55.02 140.01 39.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.642 1.977 . . . . 0.0 111.074 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -66.43 -36.07 81.89 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.381 -0.824 . . . . 0.0 112.177 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.52 -1.45 56.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 62.06 27.86 16.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.247 1.023 . . . . 0.0 111.311 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -107.92 39.42 1.95 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.161 1.784 . . . . 0.0 112.752 -171.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.13 128.33 9.44 Favored Glycine 0 N--CA 1.479 1.53 0 C-N-CA 124.473 1.035 . . . . 0.0 112.262 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.66 132.26 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.209 1.803 . . . . 0.0 109.911 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.39 128.1 54.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.122 0.969 . . . . 0.0 111.194 170.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.61 97.41 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.671 1.189 . . . . 0.0 107.804 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -81.84 122.74 28.11 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.081 0.952 . . . . 0.0 111.039 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.34 125.62 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.913 0.885 . . . . 0.0 110.284 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 100.27 11.28 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.657 1.583 . . . . 0.0 110.188 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.19 -19.47 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -74.23 -47.14 37.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.655 1.116 . . . . 0.0 111.153 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -88.86 -11.61 44.18 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.7 1.2 . . . . 0.0 113.612 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.5 tttt 71.82 30.11 2.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.01 1.724 . . . . 0.0 112.717 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -113.3 133.39 55.14 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.391 1.477 . . . . 0.0 110.052 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -114.43 143.23 45.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.022 1.329 . . . . 0.0 109.371 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.99 134.27 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.027 1.331 . . . . 0.0 108.194 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 mt -112.48 129.58 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -135.84 124.13 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.728 0.811 . . . . 0.0 110.45 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.83 154.49 17.0 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.559 1.076 . . . . 0.0 110.785 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -67.93 168.4 11.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 122.374 1.083 . . . . 0.0 111.929 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.38 -26.52 63.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.952 1.301 . . . . 0.0 114.452 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.66 55.0 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.812 1.187 . . . . 0.0 111.492 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.93 -54.91 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.538 1.169 . . . . 0.0 109.272 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -60.9 -30.72 70.34 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -78.24 -38.12 43.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.873 0.869 . . . . 0.0 112.113 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 m -89.17 -23.06 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.59 162.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.231 0.923 . . . . 0.0 112.232 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -113.11 173.38 6.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.424 1.49 . . . . 0.0 112.462 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -58.24 -29.41 65.73 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.281 -1.512 . . . . 0.0 114.598 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.73 -23.78 61.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.89 1.276 . . . . 0.0 111.994 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -76.12 -31.02 58.43 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.314 -0.866 . . . . 0.0 111.065 168.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -80.55 -32.18 36.76 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.25 -45.04 68.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.268 1.427 . . . . 0.0 113.005 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -58.12 -34.97 70.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.528 1.131 . . . . 0.0 113.067 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.5 m -72.5 -50.21 27.55 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 127.029 2.132 . . . . 0.0 109.345 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -60.93 -43.29 98.83 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.787 0.435 . . . . 0.0 111.2 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.46 -38.3 80.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.03 -50.72 65.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.566 0.621 . . . . 0.0 111.371 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.68 -48.75 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.067 0.947 . . . . 0.0 110.783 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -61.93 -40.55 95.89 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.292 1.437 . . . . 0.0 113.091 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.2 tp -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.6 0.636 . . . . 0.0 111.484 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -34.99 48.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.543 -0.723 . . . . 0.0 112.665 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.39 -40.81 98.24 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.839 0.855 . . . . 0.0 111.16 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.09 -35.43 80.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 112.143 172.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.87 -21.59 60.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.723 1.209 . . . . 0.0 113.138 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.38 -5.43 44.82 Favored Glycine 0 N--CA 1.48 1.585 0 C-N-CA 126.16 1.838 . . . . 0.0 114.943 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -97.82 82.8 3.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.832 1.253 . . . . 0.0 111.54 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.56 -48.2 82.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.506 0.722 . . . . 0.0 112.469 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HZ2' ' HA ' ' A' ' 12' ' ' GLU . 75.4 tttt -54.57 -53.62 52.16 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.283 0.492 . . . . 0.0 111.644 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.81 -41.21 77.35 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.591 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.92 -36.76 65.22 Favored Glycine 0 N--CA 1.472 1.075 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.775 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.5 -52.07 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.536 0.668 . . . . 0.0 109.995 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.74 -45.18 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.647 0.779 . . . . 0.0 111.585 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.6 -45.65 93.22 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.343 1.457 . . . . 0.0 111.3 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.91 -36.84 91.65 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.742 0.686 . . . . 0.0 113.388 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.22 -51.58 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.461 1.104 . . . . 0.0 110.424 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.43 -41.03 98.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.234 1.014 . . . . 0.0 111.856 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.08 -39.56 78.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.34 0.656 . . . . 0.0 112.586 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.08 96.13 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.632 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.7 -49.36 78.26 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-N 119.162 0.892 . . . . 0.0 112.004 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.32 -34.45 73.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.692 1.246 . . . . 0.0 113.793 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.92 -46.52 15.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.368 0.667 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -59.52 -37.59 78.74 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 110.675 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.99 -15.66 57.0 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -76.57 -33.73 58.47 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.512 -1.368 . . . . 0.0 111.295 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -81.58 -39.78 24.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.061 1.344 . . . . 0.0 111.224 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.54 79.52 72.04 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.752 2.021 . . . . 0.0 111.501 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 138.35 39.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.229 2.62 . . . . 0.0 112.192 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.7 t90 -64.87 135.88 56.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.37 151.86 30.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.799 1.639 . . . . 0.0 111.605 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -69.99 -3.09 14.66 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.542 -1.349 . . . . 0.0 114.353 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -115.86 7.4 14.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.151 1.781 . . . . 0.0 112.576 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -58.22 148.62 26.48 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.434 1.093 . . . . 0.0 112.236 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 111.317 -169.047 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 CA-C-O 121.103 0.376 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -61.15 -7.07 2.37 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.612 2.365 . . . . 0.0 116.836 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.2 m -58.11 152.5 16.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.584 1.154 . . . . 0.0 111.788 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.45 130.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.648 1.179 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t -88.11 141.34 28.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.404 0.682 . . . . 0.0 110.651 171.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -151.7 135.39 16.3 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 116.595 -2.225 . . . . 0.0 114.164 -174.295 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -77.17 166.15 23.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.23 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.847 -1.158 . . . . 0.0 111.726 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.3 -48.08 82.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.733 1.213 . . . . 0.0 110.917 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.9 -39.91 72.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.479 1.111 . . . . 0.0 111.235 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.87 -46.45 74.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.044 1.338 . . . . 0.0 112.325 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -56.91 -47.31 80.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.448 -1.408 . . . . 0.0 111.081 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.89 84.8 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 tt -74.16 -35.84 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.047 -1.033 . . . . 0.0 112.171 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.42 -42.86 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.625 1.102 . . . . 0.0 111.392 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.92 -27.42 68.17 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.22 -43.37 74.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.474 0.579 . . . . 0.0 111.548 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.63 -43.75 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.391 0.677 . . . . 0.0 110.256 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -60.31 -25.57 65.87 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.97 -36.27 23.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.256 1.389 . . . . 0.0 111.986 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.53 97.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.175 0.99 . . . . 0.0 112.198 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.72 -4.63 9.42 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -106.85 11.76 29.69 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.009 -1.682 . . . . 0.0 112.529 170.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.77 -6.44 5.09 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.65 1.98 . . . . 0.0 114.084 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -164.3 151.4 11.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.148 2.179 . . . . 0.0 109.729 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -88.11 11.57 15.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.742 1.217 . . . . 0.0 113.853 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.41 133.13 10.37 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 125.742 1.639 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -104.19 138.21 40.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.349 1.06 . . . . 0.0 112.642 -155.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.03 139.66 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 120.356 -1.465 . . . . 0.0 111.247 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -139.13 146.45 40.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.932 1.693 . . . . 0.0 111.296 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.76 136.26 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.929 1.291 . . . . 0.0 109.608 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -122.3 120.3 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.272 1.429 . . . . 0.0 113.058 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.55 125.23 54.03 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.557 1.143 . . . . 0.0 111.392 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -154.08 160.63 42.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.961 1.304 . . . . 0.0 109.983 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.26 -72.1 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 m -143.26 165.19 28.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.363 2.265 . . . . 0.0 107.892 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.7 m -124.7 155.85 38.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.315 1.046 . . . . 0.0 110.46 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.94 -1.75 57.79 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 pt -134.55 -131.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 126.57 1.948 . . . . 0.0 111.181 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -101.77 142.11 33.6 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.438 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.18 -36.0 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.006 0.522 . . . . 0.0 111.84 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.49 -50.39 71.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.743 0.817 . . . . 0.0 111.937 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.26 -33.46 75.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.106 0.563 . . . . 0.0 111.47 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -65.66 -46.63 78.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.902 0.881 . . . . 0.0 112.568 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.15 90.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.664 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -59.12 -49.9 76.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.337 0.655 . . . . 0.0 111.715 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.4 -45.89 91.1 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.759 -0.588 . . . . 0.0 111.717 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.38 -35.17 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.715 -0.659 . . . . 0.0 110.785 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.7 -50.56 73.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.536 1.062 . . . . 0.0 111.718 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -72.72 -34.46 67.1 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.436 0.695 . . . . 0.0 111.608 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -70.37 -26.74 63.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.56 6.91 47.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.355 1.462 . . . . 0.0 112.425 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 60.92 26.39 16.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.625 1.57 . . . . 0.0 112.284 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.0 -18.1 60.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.723 1.209 . . . . 0.0 112.326 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -74.06 -8.21 55.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.424 2.29 . . . . 0.0 113.756 169.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -98.83 82.69 2.82 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 121.562 -0.711 . . . . 0.0 110.474 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.5 p -139.2 152.82 47.67 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.044 1.337 . . . . 0.0 110.501 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -57.86 -37.34 73.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.9 mt -105.96 -7.95 17.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.61 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 70.94 29.26 3.05 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.953 1.301 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -105.41 35.11 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.094 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.75 117.0 4.79 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.127 -0.818 . . . . 0.0 111.851 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.6 t -98.98 139.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.583 1.553 . . . . 0.0 110.232 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.5 tp -129.16 133.94 47.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.29 100.12 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.705 1.202 . . . . 0.0 109.409 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.58 128.0 32.91 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.072 -1.018 . . . . 0.0 109.994 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -124.26 127.52 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.911 0.884 . . . . 0.0 110.657 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.11 95.12 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.542 1.537 . . . . 0.0 110.035 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.42 -21.0 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -165.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.64 -28.69 45.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.51 1.05 . . . . 0.0 111.825 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -97.47 -4.99 37.02 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.443 1.097 . . . . 0.0 112.714 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 61.39 23.01 13.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.996 1.718 . . . . 0.0 112.003 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -105.36 169.02 8.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.597 1.559 . . . . 0.0 110.781 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -146.73 143.95 29.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.173 1.789 . . . . 0.0 108.749 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.8 140.43 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.146 1.378 . . . . 0.0 107.299 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.3 mt -118.68 133.34 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -139.4 138.18 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.259 1.423 . . . . 0.0 109.128 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.85 155.42 21.21 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -66.72 172.48 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 123.556 1.646 . . . . 0.0 111.82 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -61.45 -33.56 73.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.64 -1.172 . . . . 0.0 112.707 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -48.7 76.39 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 120.242 1.383 . . . . 0.0 112.31 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.97 -56.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.202 1.001 . . . . 0.0 109.774 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.6 -24.71 66.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -78.25 -38.36 43.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.014 1.325 . . . . 0.0 110.397 173.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 p -90.8 -29.22 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.89 156.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.842 1.656 . . . . 0.0 113.004 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.7 m -102.36 172.72 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.531 1.533 . . . . 0.0 114.803 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -61.12 -34.33 74.8 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.88 -24.42 67.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 0.0 113.029 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -77.22 -39.36 48.83 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.18 -0.95 . . . . 0.0 111.281 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -70.85 -29.62 65.79 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.191 1.396 . . . . 0.0 114.108 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.62 -37.97 74.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.505 0.722 . . . . 0.0 112.759 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 m -62.05 -43.57 98.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.696 0.798 . . . . 0.0 111.086 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -59.11 -53.81 54.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.673 1.989 . . . . 0.0 110.583 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -56.68 -50.26 72.66 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.659 1.184 . . . . 0.0 111.204 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -57.91 -36.44 72.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.248 1.019 . . . . 0.0 113.621 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.46 20.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.788 0.835 . . . . 0.0 112.019 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.12 -49.54 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.187 0.995 . . . . 0.0 109.639 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.3 -42.54 91.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.118 1.367 . . . . 0.0 113.382 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.64 -45.44 90.19 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.063 0.545 . . . . 0.0 110.869 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.02 -29.35 55.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.16 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.51 -39.64 81.16 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.358 0.981 . . . . 0.0 111.481 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.85 -43.54 94.58 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.555 0.742 . . . . 0.0 111.09 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.49 -35.23 79.77 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.991 -0.528 . . . . 0.0 111.935 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.88 10.28 24.89 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.834 1.683 . . . . 0.0 114.674 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.79 83.44 2.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -62.52 -39.62 94.15 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.764 1.225 . . . . 0.0 112.705 -171.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -54.78 -56.01 23.97 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -60.81 -42.21 97.19 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.904 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.93 -41.58 97.32 Favored Glycine 0 N--CA 1.473 1.101 0 CA-C-N 120.187 1.358 . . . . 0.0 112.378 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.63 -47.21 73.31 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.547 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.32 -48.49 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 118.852 0.751 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -63.41 -35.36 80.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.982 0.81 . . . . 0.0 112.021 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.91 -43.98 92.7 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.067 -0.852 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.9 -47.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.929 1.292 . . . . 0.0 111.362 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.98 -49.51 77.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.712 0.805 . . . . 0.0 111.504 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -65.28 -38.73 91.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.828 -0.545 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.39 74.08 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.844 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.15 87.57 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 119.669 1.122 . . . . 0.0 112.469 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.3 mtp -58.36 -42.22 86.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.987 0.894 . . . . 0.0 112.908 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.69 57.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.501 0.721 . . . . 0.0 111.586 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.1 mt -62.07 -36.58 82.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.795 1.238 . . . . 0.0 111.131 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.05 -18.22 32.82 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -70.99 -34.58 71.52 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.246 -1.534 . . . . 0.0 112.198 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -90.12 -35.78 15.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.37 1.468 . . . . 0.0 112.981 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -131.89 85.2 51.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.937 1.695 . . . . 0.0 110.044 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.52 147.47 93.1 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.381 2.054 . . . . 0.0 110.497 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -69.54 146.68 51.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.332 1.063 . . . . 0.0 111.783 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -134.73 151.17 50.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.604 1.161 . . . . 0.0 109.611 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.42 -35.95 72.85 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.373 -0.83 . . . . 0.0 112.814 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -90.32 18.09 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.881 1.672 . . . . 0.0 113.224 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.31 151.12 28.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.094 1.358 . . . . 0.0 113.203 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 125.626 1.57 . . . . 0.0 113.332 -154.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 CA-C-O 121.763 0.651 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -74.13 3.39 7.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.4 p -70.65 156.33 39.6 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 128.21 2.604 . . . . 0.0 112.487 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 84.2 mt -78.26 134.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.699 1.2 . . . . 0.0 108.406 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.3 m -91.93 142.14 27.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.464 0.649 . . . . 0.0 109.458 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -129.8 151.15 50.69 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.171 -0.956 . . . . 0.0 110.698 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.966 0 C-N-CA 126.192 1.853 . . . . 0.0 113.76 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -74.65 167.29 22.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.148 0.431 . . . . 0.0 110.214 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.74 58.57 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 113.21 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -55.2 -41.79 72.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.291 1.436 . . . . 0.0 113.278 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.14 -42.69 25.61 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 110.63 -173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -62.69 -45.14 94.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.362 1.065 . . . . 0.0 111.373 172.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -57.74 -47.55 82.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.344 -0.847 . . . . 0.0 111.888 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.75 88.51 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.347 1.059 . . . . 0.0 113.438 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.18 -41.64 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 117.935 -1.031 . . . . 0.0 112.269 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.53 -42.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.783 1.174 . . . . 0.0 111.464 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.37 -28.73 69.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.138 0.881 . . . . 0.0 113.149 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.98 67.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.93 0.786 . . . . 0.0 112.015 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mm -64.78 -50.51 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.91 0.884 . . . . 0.0 110.127 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -54.28 -29.28 46.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.33 1.052 . . . . 0.0 113.475 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -83.19 -30.2 27.95 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.019 1.328 . . . . 0.0 112.185 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.0 75.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.69 1.132 . . . . 0.0 111.424 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.13 2.34 0.81 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.606 1.562 . . . . 0.0 114.099 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.79 5.41 24.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 119.39 -2.069 . . . . 0.0 113.031 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -126.96 -8.08 6.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.72 1.608 . . . . 0.0 113.522 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -160.07 161.29 33.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.235 1.814 . . . . 0.0 109.157 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -99.04 10.79 40.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.57 172.49 17.64 Favored Glycine 0 N--CA 1.473 1.16 0 O-C-N 120.549 -1.344 . . . . 0.0 110.823 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -123.67 122.24 37.61 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 122.803 0.441 . . . . 0.0 111.67 -160.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 mt -108.71 112.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.336 1.054 . . . . 0.0 110.693 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -123.24 151.1 42.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.754 0.822 . . . . 0.0 113.19 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 t -130.52 134.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.581 1.153 . . . . 0.0 109.008 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -122.11 121.99 38.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 111.991 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.16 132.37 53.11 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.178 0.991 . . . . 0.0 111.462 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -160.23 155.18 24.48 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.786 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.35 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.744 1.218 . . . . 0.0 113.233 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.6 t -137.47 169.76 17.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.193 1.797 . . . . 0.0 110.316 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 p -123.23 157.26 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.501 1.52 . . . . 0.0 113.162 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -90.75 -9.85 45.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.955 1.302 . . . . 0.0 113.293 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 -141.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.049 1.739 . . . . 0.0 111.159 -164.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -102.42 135.24 44.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.634 1.561 . . . . 0.0 112.266 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -62.47 -38.97 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.019 0.928 . . . . 0.0 112.099 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.02 0.827 . . . . 0.0 111.856 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.44 -39.88 85.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.804 0.842 . . . . 0.0 110.781 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -59.02 -47.53 84.86 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.583 -0.698 . . . . 0.0 111.788 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.97 -42.28 99.78 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.604 0.762 . . . . 0.0 110.978 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -58.55 -53.91 52.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.556 1.142 . . . . 0.0 111.247 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -64.63 -37.15 86.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.776 -1.203 . . . . 0.0 112.054 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.85 -47.22 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.346 1.058 . . . . 0.0 111.326 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -56.71 -45.92 81.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.421 1.488 . . . . 0.0 111.987 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -73.39 -40.47 64.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.834 1.254 . . . . 0.0 112.979 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -63.89 -39.31 93.89 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.992 0.815 . . . . 0.0 112.378 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.52 0.23 20.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 113.418 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 62.33 24.41 14.53 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.036 1.334 . . . . 0.0 113.271 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.69 -30.09 68.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 0.0 112.412 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -49.73 -31.14 10.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.073 1.749 . . . . 0.0 112.601 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -77.67 65.05 3.08 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.085 -1.01 . . . . 0.0 113.02 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.0 m -118.9 134.78 54.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.155 2.182 . . . . 0.0 106.705 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.32 -44.5 72.08 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.826 1.194 . . . . 0.0 112.776 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.64 -2.27 58.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 114.017 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 66.2 19.37 11.08 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.727 1.211 . . . . 0.0 113.222 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -99.33 46.83 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.211 1.005 . . . . 0.0 112.061 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.19 121.45 6.71 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.775 1.179 . . . . 0.0 111.907 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.39 140.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 118.311 1.056 . . . . 0.0 109.567 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 tp -120.97 127.16 51.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.985 0.898 . . . . 0.0 111.5 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.1 mt -102.75 97.59 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.492 1.517 . . . . 0.0 108.31 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -82.1 125.3 30.69 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.604 -0.685 . . . . 0.0 110.514 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.11 131.07 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.729 -0.607 . . . . 0.0 110.695 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 100.15 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.892 1.677 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.6 m -80.52 -14.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -81.26 -49.45 10.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.057 0.844 . . . . 0.0 110.58 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -76.09 -16.84 59.84 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.818 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 67.93 41.41 2.11 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.955 1.702 . . . . 0.0 111.172 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.1 p -119.26 172.33 7.67 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.486 1.914 . . . . 0.0 110.245 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -154.74 134.27 12.69 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.005 0.922 . . . . 0.0 109.597 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.17 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.085 1.754 . . . . 0.0 108.214 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.8 mt -125.99 136.9 59.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -154.92 121.29 5.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.225 1.41 . . . . 0.0 109.086 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.99 168.27 12.52 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 124.15 0.881 . . . . 0.0 111.178 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -69.84 165.61 21.17 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.126 1.441 . . . . 0.0 112.278 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.23 -33.29 8.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.93 2.092 . . . . 0.0 113.588 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.67 -44.2 98.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 120.885 1.675 . . . . 0.0 112.296 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.2 -56.53 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.371 1.086 . . . . 0.0 109.787 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -57.43 -31.28 65.73 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.34 -14.75 42.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.572 1.549 . . . . 0.0 113.161 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.95 -18.45 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.01 172.6 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.789 1.177 . . . . 0.0 111.943 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.3 p -118.17 175.67 5.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.949 1.7 . . . . 0.0 113.725 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.75 -21.16 65.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 119.675 -1.891 . . . . 0.0 112.96 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.2 -29.02 66.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.521 1.128 . . . . 0.0 111.936 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -79.02 -32.75 45.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 111.907 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -80.0 -30.02 39.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.452 1.501 . . . . 0.0 114.035 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.37 -33.63 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.941 0.791 . . . . 0.0 112.42 -174.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 p -65.36 -42.87 92.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.69 0.796 . . . . 0.0 111.162 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.0 m -57.83 -49.42 76.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 111.497 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -58.05 -50.93 71.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.985 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -60.22 -37.56 80.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.69 58.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.171 0.896 . . . . 0.0 111.549 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.01 -48.54 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.421 0.688 . . . . 0.0 110.727 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -58.64 -40.86 84.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.576 1.55 . . . . 0.0 113.893 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.01 -45.23 67.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.889 0.768 . . . . 0.0 111.152 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -35.61 74.64 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.038 0.535 . . . . 0.0 111.629 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.961 0.801 . . . . 0.0 111.57 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -59.34 -39.26 82.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.858 0.753 . . . . 0.0 111.533 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -74.68 -22.49 58.83 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.893 0.877 . . . . 0.0 112.363 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.11 55.07 Favored Glycine 0 N--CA 1.48 1.6 0 C-N-CA 125.1 1.333 . . . . 0.0 114.162 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -96.09 71.37 2.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.878 1.271 . . . . 0.0 111.369 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -55.88 -46.06 78.39 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -51.24 -57.52 8.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.89 0.876 . . . . 0.0 111.014 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -59.99 -42.73 94.85 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.492 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.68 95.57 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 119.866 1.212 . . . . 0.0 113.225 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 mt -69.09 -48.61 62.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.57 0.685 . . . . 0.0 111.341 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.88 -53.2 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.76 0.709 . . . . 0.0 111.605 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.42 -35.69 81.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.078 0.951 . . . . 0.0 111.858 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.18 -38.05 63.41 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 121.378 -0.827 . . . . 0.0 112.824 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.38 -42.77 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.009 1.324 . . . . 0.0 111.378 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -55.38 -52.45 63.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.694 1.198 . . . . 0.0 110.579 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -65.57 -34.71 78.89 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.09 90.81 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.338 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.42 -44.99 97.03 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 119.431 -0.649 . . . . 0.0 112.286 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.4 mtp -59.85 -42.47 93.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.395 1.097 . . . . 0.0 113.59 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.37 -44.56 51.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.741 0.816 . . . . 0.0 111.129 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.03 -36.64 84.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.408 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.92 -26.87 62.78 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.059 0.944 . . . . 0.0 113.327 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -65.66 -34.78 79.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.401 -1.437 . . . . 0.0 111.472 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.82 -39.9 23.33 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.796 1.238 . . . . 0.0 111.879 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.08 79.51 73.75 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.607 1.563 . . . . 0.0 111.454 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.98 135.32 27.28 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.628 2.218 . . . . 0.0 110.959 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -56.89 147.9 22.36 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -125.62 150.48 47.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.479 1.112 . . . . 0.0 110.157 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -67.14 -26.09 66.5 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.053 -1.655 . . . . 0.0 113.235 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.14 9.11 34.93 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.241 2.216 . . . . 0.0 112.206 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -58.13 138.96 55.71 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 126.132 1.773 . . . . 0.0 113.282 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.19 0 C-N-CA 124.571 1.148 . . . . 0.0 110.597 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.459 -0.511 0 N-CA-C 109.51 -0.996 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -71.63 -4.94 29.97 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -60.68 140.15 57.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.089 2.155 . . . . 0.0 111.207 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.7 mt -64.59 140.21 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.012 1.325 . . . . 0.0 110.392 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 m -96.57 143.46 27.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.191 0.596 . . . . 0.0 110.452 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -143.79 137.24 27.9 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.364 -0.835 . . . . 0.0 110.551 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.392 0 CA-C-O 117.984 -1.454 . . . . 0.0 112.649 176.155 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 t -66.73 -36.27 82.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.383 1.473 . . . . 0.0 112.043 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -81.05 109.23 15.42 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.51 -1.369 . . . . 0.0 110.812 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -81.57 -16.37 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -64.49 -33.77 76.67 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.787 1.635 . . . . 0.0 113.857 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -135.97 108.17 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.716 1.207 . . . . 0.0 108.448 -173.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -65.1 -26.79 68.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.426 1.091 . . . . 0.0 113.865 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.21 149.6 47.3 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.999 1.32 . . . . 0.0 108.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -80.15 164.23 23.48 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.762 -1.211 . . . . 0.0 110.364 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.09 65.06 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.34 -44.12 97.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.392 1.477 . . . . 0.0 111.572 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.77 -43.19 56.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.163 0.985 . . . . 0.0 111.013 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.32 -47.53 83.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 111.289 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.11 -47.46 78.07 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.13 -0.981 . . . . 0.0 111.296 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.46 69.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 tt -80.02 -39.01 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.196 1.362 . . . . 0.0 112.715 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.5 t -58.64 -43.28 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 120.145 1.339 . . . . 0.0 110.808 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -62.23 -27.94 69.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.96 69.79 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.48 -0.762 . . . . 0.0 112.672 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.36 -42.8 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.211 1.005 . . . . 0.0 109.612 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.47 -34.26 66.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.061 1.344 . . . . 0.0 113.493 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.49 -24.93 41.98 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.58 58.77 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.424 1.011 . . . . 0.0 111.952 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -54.74 -28.53 49.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.088 1.355 . . . . 0.0 112.267 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.69 6.58 37.82 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.719 -1.863 . . . . 0.0 112.623 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.49 -15.01 6.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 113.922 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 t -160.95 140.06 10.34 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.186 1.394 . . . . 0.0 109.541 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -80.63 39.01 0.46 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 112.727 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.97 158.0 27.03 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 125.536 1.541 . . . . 0.0 110.892 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.34 142.91 46.52 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -155.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.83 97.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.592 1.157 . . . . 0.0 111.084 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -106.9 145.05 32.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.659 1.184 . . . . 0.0 111.856 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.61 133.54 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.066 1.346 . . . . 0.0 109.243 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -119.15 115.96 25.34 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.939 1.296 . . . . 0.0 111.927 168.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.2 tp -103.52 126.92 50.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.323 1.049 . . . . 0.0 111.315 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 46' ' ' ARG . 37.4 tt0 -146.65 162.15 39.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.663 1.22 . . . . 0.0 111.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.33 -77.15 0.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.464 1.106 . . . . 0.0 112.013 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 t -153.69 165.23 36.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.648 1.979 . . . . 0.0 109.902 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.5 m -115.33 154.66 28.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.325 1.45 . . . . 0.0 111.235 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -92.06 -13.48 30.8 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.054 -1.029 . . . . 0.0 112.645 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 pt -130.37 -163.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.126 1.77 . . . . 0.0 110.702 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -72.52 136.57 45.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.405 0.622 . . . . 0.0 112.464 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.53 -35.14 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.98 0.912 . . . . 0.0 111.716 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.57 -54.89 28.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.299 0.954 . . . . 0.0 112.423 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -63.14 -39.26 94.15 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.647 0.779 . . . . 0.0 111.184 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 36' ' ' GLU . 52.9 ttt85 -61.45 -45.22 95.19 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.713 -0.617 . . . . 0.0 111.754 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.43 94.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.824 0.738 . . . . 0.0 111.277 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.9 ttp -62.52 -43.0 99.88 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 112.386 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.3 -48.65 77.2 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.953 -1.092 . . . . 0.0 111.748 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.6 -42.53 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.899 0.88 . . . . 0.0 111.789 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -57.3 -49.15 77.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.536 1.135 . . . . 0.0 111.157 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -71.59 -38.03 70.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.202 1.001 . . . . 0.0 112.056 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.9 -43.15 93.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.104 1.362 . . . . 0.0 112.773 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.05 -3.62 20.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.193 0.997 . . . . 0.0 112.901 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.8 tttt 64.76 38.21 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.648 1.979 . . . . 0.0 112.296 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.7 mtp -77.04 -12.78 59.98 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -0.89 7.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.226 1.01 . . . . 0.0 113.057 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -74.48 31.08 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.633 1.973 . . . . 0.0 114.457 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -99.87 156.16 17.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.682 1.993 . . . . 0.0 110.881 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -73.85 -30.48 62.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.454 1.102 . . . . 0.0 112.429 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.14 -7.21 16.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 67.33 47.41 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.306 . . . . 0.0 110.851 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -137.97 40.45 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.323 1.049 . . . . 0.0 113.607 -164.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.54 142.68 16.19 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 167.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.72 144.44 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.594 1.158 . . . . 0.0 110.463 169.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -117.2 129.25 55.82 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.167 1.387 . . . . 0.0 109.939 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 mt -103.23 96.85 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.11 119.0 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.193 0.597 . . . . 0.0 110.114 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.66 129.78 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.703 0.801 . . . . 0.0 110.143 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.11 102.88 12.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.717 1.207 . . . . 0.0 109.256 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.91 -22.18 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -170.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.14 -49.42 23.8 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.229 0.538 . . . . 0.0 111.689 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.37 -15.08 56.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.455 1.102 . . . . 0.0 111.729 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 tttt 75.23 19.8 2.17 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.517 2.327 . . . . 0.0 112.415 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.1 p -98.13 162.59 13.13 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 111.785 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.87 139.32 36.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.741 1.217 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.59 147.62 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.516 1.527 . . . . 0.0 107.786 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.38 125.96 60.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -139.04 120.76 15.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.0 110.244 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.3 152.91 17.63 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 125.523 1.535 . . . . 0.0 111.025 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -66.75 164.57 16.81 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 123.141 1.448 . . . . 0.0 111.654 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -53.54 -37.6 62.99 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 114.39 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.7 -18.92 70.73 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.47 1.033 . . . . 0.0 113.807 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -81.12 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.122 1.461 . . . . 0.0 108.783 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -53.52 -37.6 62.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.657 0.783 . . . . 0.0 113.032 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.14 -17.46 58.59 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.719 1.207 . . . . 0.0 113.011 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.14 -21.62 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.9 m -114.9 179.47 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.756 1.162 . . . . 0.0 111.838 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.1 p -121.98 171.1 9.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.368 1.867 . . . . 0.0 112.392 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.0 -29.09 70.56 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.864 -1.147 . . . . 0.0 112.448 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.3 -38.81 91.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.893 1.277 . . . . 0.0 111.537 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -63.65 -46.13 87.04 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.376 0.67 . . . . 0.0 110.351 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.244 1.418 . . . . 0.0 114.63 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.81 -39.59 74.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.444 1.098 . . . . 0.0 111.613 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -61.21 -47.12 87.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.636 0.774 . . . . 0.0 111.807 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 m -58.31 -50.34 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.269 1.828 . . . . 0.0 110.413 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -59.13 -51.05 71.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.393 1.077 . . . . 0.0 111.994 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.34 -41.28 96.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.014 0.824 . . . . 0.0 112.698 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.53 79.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.897 0.771 . . . . 0.0 112.928 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.97 -50.37 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.52 1.128 . . . . 0.0 110.956 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -53.87 -48.03 70.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.619 1.167 . . . . 0.0 111.403 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.67 -33.41 75.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -85.61 -38.14 18.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.32 -37.21 79.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.506 0.594 . . . . 0.0 111.432 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.19 -27.27 67.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.969 1.308 . . . . 0.0 113.387 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.71 -32.65 53.08 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.896 0.771 . . . . 0.0 110.445 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.01 3.18 26.52 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 126.636 2.065 . . . . 0.0 114.252 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.49 84.17 2.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.492 1.146 . . . . 0.0 111.109 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -56.94 -41.52 78.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.813 0.845 . . . . 0.0 112.585 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.93 -57.65 11.58 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.467 -0.771 . . . . 0.0 112.465 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.46 -43.15 83.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.223 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.2 98.42 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.351 0.978 . . . . 0.0 113.618 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.73 -48.43 66.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.755 -1.117 . . . . 0.0 111.035 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.03 -48.36 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.309 1.044 . . . . 0.0 112.241 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -67.3 -34.68 77.9 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.266 0.485 . . . . 0.0 111.688 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.58 -41.05 90.55 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.228 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.07 -44.39 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.663 1.185 . . . . 0.0 109.617 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.17 -51.78 65.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.877 0.871 . . . . 0.0 111.976 -178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.96 -41.78 95.18 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.615 0.766 . . . . 0.0 111.269 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.23 78.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.554 0.742 . . . . 0.0 110.928 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.5 -46.53 87.78 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.01 0.823 . . . . 0.0 112.108 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.7 mtp -65.55 -35.96 82.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.049 0.925 . . . . 0.0 113.087 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.6 61.01 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 111.112 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.85 -37.36 85.99 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.371 1.468 . . . . 0.0 111.46 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.33 -18.51 11.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.392 1.477 . . . . 0.0 114.355 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -72.43 -40.88 66.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.33 -1.481 . . . . 0.0 112.105 170.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -85.9 -28.89 24.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.735 1.214 . . . . 0.0 112.276 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -136.58 76.62 47.96 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.668 1.987 . . . . 0.0 108.669 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.83 143.1 78.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.841 1.694 . . . . 0.0 110.498 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -63.1 143.89 57.38 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -118.99 144.84 46.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.412 1.485 . . . . 0.0 109.402 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -60.71 -32.95 72.18 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 112.636 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -82.93 5.43 21.96 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.881 1.272 . . . . 0.0 113.446 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -58.84 150.46 23.95 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.013 0.925 . . . . 0.0 112.943 -172.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.63 138.06 54.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-O 122.721 1.248 . . . . 0.0 111.509 -165.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -98.57 101.24 12.61 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.052 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -95.55 -37.46 10.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.428 1.491 . . . . 0.0 113.195 -166.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.87 165.4 13.32 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.125 0.97 . . . . 0.0 110.353 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -99.41 157.13 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 124.248 3.298 . . . . 0.0 112.344 170.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -77.84 -10.23 59.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.2 m -57.3 131.24 49.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.363 1.465 . . . . 0.0 109.72 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.03 137.76 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.43 -0.794 . . . . 0.0 108.863 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.7 m -92.28 142.92 26.94 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.422 -0.798 . . . . 0.0 111.844 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.86 150.68 52.14 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.424 1.09 . . . . 0.0 110.568 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.714 170.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -66.95 146.24 54.6 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.012 1.733 . . . . 0.0 110.833 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -56.27 -30.37 62.37 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.089 -1.007 . . . . 0.0 113.59 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.25 -61.51 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.846 1.658 . . . . 0.0 109.904 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.93 -20.51 63.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.011 2.124 . . . . 0.0 113.414 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -68.53 -36.31 78.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.881 1.272 . . . . 0.0 111.835 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -81.15 -63.63 1.36 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.098 0.959 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt -145.24 146.55 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.176 1.791 . . . . 0.0 108.895 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 p -75.11 167.39 22.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.6 64.34 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.772 -1.205 . . . . 0.0 112.759 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -66.94 -36.0 81.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.17 1.388 . . . . 0.0 111.701 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.71 -45.46 13.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.32 1.048 . . . . 0.0 111.228 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -60.96 -40.95 95.32 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.802 1.241 . . . . 0.0 111.166 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.14 -48.15 81.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.163 -0.961 . . . . 0.0 112.07 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.25 97.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 tt -72.01 -35.46 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.52 -32.76 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.014 0.825 . . . . 0.0 111.462 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.92 -35.99 75.0 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.342 -0.849 . . . . 0.0 112.588 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.82 93.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.926 0.49 . . . . 0.0 111.388 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.38 -48.02 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.816 0.846 . . . . 0.0 110.814 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -55.08 -33.73 63.01 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.85 -25.74 32.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.91 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.091 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -73.27 14.65 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.699 1.2 . . . . 0.0 113.373 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -116.96 3.21 12.81 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.892 -1.755 . . . . 0.0 112.272 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -121.26 -18.36 7.4 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.23 1.412 . . . . 0.0 113.207 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -144.14 163.43 33.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.559 2.343 . . . . 0.0 108.771 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -100.83 31.41 3.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.53 1.532 . . . . 0.0 112.384 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.88 118.06 1.5 Allowed Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.352 -1.468 . . . . 0.0 111.902 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -85.21 137.11 33.21 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -156.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.18 119.83 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 123.003 1.382 . . . . 0.0 111.485 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -124.74 151.68 44.76 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.308 1.443 . . . . 0.0 112.452 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 144.3 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.011 1.724 . . . . 0.0 110.692 171.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -125.12 122.4 37.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 167.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.09 130.64 54.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.558 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 14.8 tt0 -146.87 169.2 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.892 1.33 . . . . 0.0 110.682 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 65.4 mttt -78.85 -73.36 0.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.393 1.077 . . . . 0.0 112.508 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -148.42 142.97 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.574 1.949 . . . . 0.0 109.247 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.8 p -86.84 146.81 26.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.965 0.888 . . . . 0.0 112.484 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 -10.61 38.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.235 1.014 . . . . 0.0 112.301 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.5 -163.46 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.392 2.677 . . . . 0.0 108.946 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.31 138.62 55.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.678 -1.264 . . . . 0.0 112.072 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.92 -37.6 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.366 0.666 . . . . 0.0 111.794 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.46 -52.56 64.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.581 0.752 . . . . 0.0 112.197 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.02 -39.65 87.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.91 0.484 . . . . 0.0 111.178 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -58.81 -47.04 86.2 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.118 -0.989 . . . . 0.0 112.118 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.75 96.76 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.568 0.747 . . . . 0.0 111.419 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 ttp -62.37 -43.75 98.07 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 111.815 173.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.07 -46.59 86.74 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.254 -0.904 . . . . 0.0 112.021 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.13 -43.62 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.22 -46.66 85.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.335 1.054 . . . . 0.0 111.808 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.69 -35.78 60.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.278 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -63.84 -44.07 94.28 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.429 -1.419 . . . . 0.0 111.159 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.75 -6.38 44.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.714 1.205 . . . . 0.0 113.268 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 62.33 41.14 10.55 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.3 mtp -73.29 -22.54 60.34 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.43 -8.74 6.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 114.046 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 62.95 0.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.179 1.792 . . . . 0.0 110.793 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -133.4 140.32 47.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.613 1.165 . . . . 0.0 110.581 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -58.16 -43.64 87.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 111.889 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.3 mt -94.82 -3.68 48.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 59.73 57.06 3.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.04 28.94 3.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 112.255 -168.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.87 131.57 10.48 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.393 -0.817 . . . . 0.0 111.206 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.6 t -102.65 138.79 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.268 1.027 . . . . 0.0 110.321 168.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.04 121.54 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.062 1.345 . . . . 0.0 110.963 164.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.4 mt -97.25 101.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -81.93 125.19 30.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.256 0.622 . . . . 0.0 110.917 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.1 129.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.753 0.706 . . . . 0.0 111.406 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.27 100.78 12.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.894 1.678 . . . . 0.0 110.273 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.27 -12.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.88 -54.49 5.54 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.474 -0.766 . . . . 0.0 110.495 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.33 -11.85 59.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.179 0.992 . . . . 0.0 112.315 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt 71.68 27.27 2.95 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.6 2.36 . . . . 0.0 112.356 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -106.06 134.36 49.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.995 1.318 . . . . 0.0 110.53 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -106.41 143.78 34.04 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 110.199 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 t -134.36 143.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.505 1.922 . . . . 0.0 108.259 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.0 mt -123.63 130.12 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -140.62 132.54 27.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.996 1.319 . . . . 0.0 110.026 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.52 163.68 21.2 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 123.872 0.749 . . . . 0.0 111.309 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.69 161.31 4.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.899 1.333 . . . . 0.0 114.121 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.4 -35.61 65.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.522 1.529 . . . . 0.0 113.777 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.37 -27.95 73.06 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 120.259 1.39 . . . . 0.0 112.939 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.6 mt -69.43 -60.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.2 1.5 . . . . 0.0 109.425 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -52.01 -37.57 53.78 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.71 0.804 . . . . 0.0 112.973 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.92 -21.7 59.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.032 -1.043 . . . . 0.0 113.436 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.73 -32.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.6 179.31 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.701 1.2 . . . . 0.0 111.004 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 -178.9 6.13 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.666 -1.271 . . . . 0.0 113.775 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -52.44 -36.31 54.24 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -71.69 -20.01 61.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.498 1.045 . . . . 0.0 112.943 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -78.57 -49.24 13.63 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.285 1.034 . . . . 0.0 109.275 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -62.68 -31.43 72.31 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.611 1.564 . . . . 0.0 113.611 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.72 -29.75 68.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.225 1.01 . . . . 0.0 111.621 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.5 p -69.96 -43.07 72.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.542 0.61 . . . . 0.0 111.651 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 m -55.94 -51.62 67.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.371 1.869 . . . . 0.0 111.014 172.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -59.3 -48.42 81.69 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.61 0.764 . . . . 0.0 111.528 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -59.76 -45.89 90.84 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.585 1.084 . . . . 0.0 112.581 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.52 93.89 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.217 0.917 . . . . 0.0 112.826 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.57 -52.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.953 0.901 . . . . 0.0 110.212 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -57.36 -44.48 84.4 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.045 1.338 . . . . 0.0 112.626 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.42 -34.0 77.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.533 0.606 . . . . 0.0 112.161 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -85.89 -38.84 17.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.04 0.936 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.29 -40.37 77.63 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.233 -0.917 . . . . 0.0 111.767 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.91 -23.05 67.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.951 1.3 . . . . 0.0 113.364 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.36 -25.26 21.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.631 0.772 . . . . 0.0 112.153 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.51 37.62 Favored Glycine 0 N--CA 1.477 1.431 0 C-N-CA 125.468 1.509 . . . . 0.0 113.664 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.9 64.35 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.415 1.486 . . . . 0.0 110.839 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -53.43 -44.0 68.47 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.942 0.897 . . . . 0.0 112.876 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.02 -54.01 45.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.395 1.078 . . . . 0.0 111.872 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -63.74 -43.36 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.05 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.74 96.08 Favored Glycine 0 N--CA 1.469 0.877 0 CA-C-N 119.167 0.894 . . . . 0.0 113.065 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -72.5 -45.38 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.999 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.59 -51.21 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.484 1.038 . . . . 0.0 111.473 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.3 -40.35 90.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 0.0 111.423 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.75 92.08 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.916 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.51 -52.67 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.556 1.178 . . . . 0.0 109.744 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.91 -46.15 88.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.158 0.583 . . . . 0.0 111.868 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.67 -40.66 76.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.917 0.887 . . . . 0.0 111.729 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.84 76.17 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.56 0.618 . . . . 0.0 109.926 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.15 -48.74 77.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.583 0.611 . . . . 0.0 113.347 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.29 -35.97 82.13 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.95 -41.26 59.95 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.118 -0.364 . . . . 0.0 110.799 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.3 mt -63.06 -40.1 96.71 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.927 1.691 . . . . 0.0 111.882 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.47 44.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 113.847 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.82 -41.01 92.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.503 -0.748 . . . . 0.0 111.842 172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.0 -46.75 13.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.204 1.402 . . . . 0.0 111.344 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.97 83.5 37.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 126.641 1.977 . . . . 0.0 110.516 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.34 143.16 62.81 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.837 2.358 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -60.16 145.58 46.45 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.32 0.581 . . . . 0.0 112.038 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -120.59 144.81 47.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.039 0.936 . . . . 0.0 109.423 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.14 -20.09 65.75 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 120.671 -1.268 . . . . 0.0 113.318 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -95.99 2.52 53.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.167 2.587 . . . . 0.0 113.739 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -58.6 151.87 19.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.426 1.49 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.54 142.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 123.657 0.783 . . . . 0.0 110.988 -165.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -93.58 107.42 19.28 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 111.546 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.66 -29.91 17.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.491 1.116 . . . . 0.0 113.217 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.82 152.76 50.41 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 119.991 1.269 . . . . 0.0 111.571 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.98 147.94 19.25 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.249 2.633 . . . . 0.0 111.255 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.79 -3.54 44.94 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.6 p -70.16 161.87 29.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.173 1.789 . . . . 0.0 113.01 -171.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 66.5 mt -82.79 138.41 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.849 1.26 . . . . 0.0 110.05 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.5 t -101.65 142.95 32.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.614 0.766 . . . . 0.0 110.395 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -145.61 151.46 38.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 C-N-CA 125.949 1.738 . . . . 0.0 113.045 165.277 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 C--O 1.209 -1.044 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -52.85 -34.9 56.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 122.063 2.21 . . . . 0.0 114.232 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -77.48 -17.28 58.18 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 pt -164.87 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.848 2.459 . . . . 0.0 110.984 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.71 44.5 0.82 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.599 -1.313 . . . . 0.0 114.005 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 69.32 -6.11 1.01 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.515 2.326 . . . . 0.0 114.356 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -51.87 -60.28 3.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.636 1.974 . . . . 0.0 114.0 -173.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.7 mt -134.66 149.48 50.53 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.155 1.382 . . . . 0.0 110.167 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -78.47 163.38 25.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.861 0.864 . . . . 0.0 111.208 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.08 19.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.276 1.43 . . . . 0.0 112.988 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -61.41 -45.88 92.46 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.618 1.567 . . . . 0.0 112.552 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.78 -45.26 83.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.02 -38.78 89.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.785 0.834 . . . . 0.0 112.305 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 -44.83 92.28 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.257 -0.902 . . . . 0.0 111.004 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.53 97.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.146 0.979 . . . . 0.0 113.354 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -72.11 -37.53 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.175 0.898 . . . . 0.0 112.696 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.3 t -61.61 -32.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.231 0.923 . . . . 0.0 112.27 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -41.64 97.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.181 0.992 . . . . 0.0 112.06 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.64 95.38 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.908 -0.495 . . . . 0.0 111.729 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.58 -40.1 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.831 0.852 . . . . 0.0 111.449 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -64.38 -38.53 91.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.778 0.831 . . . . 0.0 112.567 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.43 -31.44 65.48 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 112.952 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.36 -38.85 85.43 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.498 0.719 . . . . 0.0 112.711 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -62.01 -17.48 57.37 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.268 1.033 . . . . 0.0 113.316 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -94.45 3.79 54.69 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.278 -1.514 . . . . 0.0 112.659 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -119.78 -13.51 9.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 114.221 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -155.86 161.79 40.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.766 2.026 . . . . 0.0 109.417 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 p -104.08 26.27 8.97 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 112.823 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.11 148.12 19.52 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 124.497 1.046 . . . . 0.0 111.124 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -103.07 134.84 45.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.72 0.771 . . . . 0.0 112.443 -151.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.97 129.83 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 119.003 -2.311 . . . . 0.0 111.286 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -142.56 152.5 42.66 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.129 1.372 . . . . 0.0 110.931 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -121.12 141.0 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.922 1.689 . . . . 0.0 110.555 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -127.24 130.99 50.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.636 1.174 . . . . 0.0 112.336 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tp -119.38 120.85 38.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 111.63 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -138.08 156.04 48.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.525 1.13 . . . . 0.0 110.564 171.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.48 -69.7 0.26 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.283 -1.511 . . . . 0.0 113.852 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.3 t -152.75 142.25 21.74 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.896 1.678 . . . . 0.0 109.307 -166.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 p -100.12 144.51 29.06 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -81.79 -26.46 34.38 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 pt -110.62 -177.1 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 110.411 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.36 136.48 57.16 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.65 0.738 . . . . 0.0 112.489 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.03 -32.88 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.853 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -64.11 -49.36 72.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.609 1.095 . . . . 0.0 111.986 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.96 -43.08 88.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.3 1.04 . . . . 0.0 110.398 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -57.04 -48.87 77.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.997 0.519 . . . . 0.0 111.999 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.47 88.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.486 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -61.23 -46.84 88.76 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 111.703 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.72 -44.29 82.02 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.48 -44.48 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 0.0 110.2 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.26 -55.81 30.16 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.813 1.245 . . . . 0.0 111.197 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -68.57 -34.04 75.12 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -67.57 -41.81 83.59 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.431 -0.793 . . . . 0.0 112.325 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.31 0.12 15.33 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.9 0.88 . . . . 0.0 112.873 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 tttt 63.73 31.86 14.03 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.914 1.686 . . . . 0.0 112.295 168.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 29.8 mtt -66.7 -33.91 76.68 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.115 -0.99 . . . . 0.0 111.867 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.4 -16.54 9.49 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.171 2.589 . . . . 0.0 114.904 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.04 76.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.723 -1.236 . . . . 0.0 111.293 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -123.3 160.57 26.39 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.234 1.014 . . . . 0.0 110.148 162.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -59.4 -44.78 92.76 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.067 -1.021 . . . . 0.0 112.429 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.68 -8.94 27.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.444 -1.265 . . . . 0.0 113.443 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 68.54 47.61 0.89 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.67 1.588 . . . . 0.0 109.512 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -116.85 25.64 10.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.839 1.256 . . . . 0.0 112.557 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.33 124.76 10.1 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 111.154 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.64 133.6 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 110.234 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.2 tp -114.44 132.46 56.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.872 1.32 . . . . 0.0 111.685 164.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.2 mt -110.27 92.7 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -76.18 120.64 21.74 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.734 0.814 . . . . 0.0 110.516 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -117.07 130.06 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.046 1.338 . . . . 0.0 109.917 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.94 105.47 15.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.408 1.083 . . . . 0.0 110.373 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.43 -19.79 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.81 -47.62 20.96 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.474 1.488 . . . . 0.0 111.157 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -79.98 -15.84 56.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.444 1.097 . . . . 0.0 113.317 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 70.11 33.14 2.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.656 1.582 . . . . 0.0 112.205 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -114.09 167.92 10.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.39 1.476 . . . . 0.0 111.018 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.26 141.67 22.47 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.718 1.207 . . . . 0.0 109.63 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.86 135.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.088 1.355 . . . . 0.0 108.213 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 mt -115.13 130.28 69.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -140.88 149.79 42.39 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.738 0.815 . . . . 0.0 110.113 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.76 158.77 27.82 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.92 170.07 5.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.388 1.566 . . . . 0.0 114.084 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.65 -30.28 70.61 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.585 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.55 -48.0 59.27 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 119.916 1.235 . . . . 0.0 111.612 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.75 -56.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.068 0.934 . . . . 0.0 109.365 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -53.05 -44.7 67.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.982 0.913 . . . . 0.0 112.588 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.86 -8.28 58.68 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.848 1.659 . . . . 0.0 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -23.49 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.87 173.79 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.808 1.64 . . . . 0.0 111.955 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -125.13 171.06 10.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.13 -31.63 63.5 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.12 -31.36 69.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 112.548 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -74.3 -33.42 63.2 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.644 0.778 . . . . 0.0 110.558 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -77.04 -23.68 52.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.241 1.816 . . . . 0.0 114.16 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.35 -36.05 81.91 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.711 -1.243 . . . . 0.0 112.163 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.1 m -58.35 -39.71 80.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.363 1.465 . . . . 0.0 111.675 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -60.67 -54.98 38.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.377 1.871 . . . . 0.0 111.381 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -60.29 -45.11 94.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 110.471 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -56.96 -45.13 83.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -47.98 83.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.262 0.937 . . . . 0.0 112.642 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.5 mt -66.02 -48.36 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.798 0.839 . . . . 0.0 110.091 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.36 -42.32 98.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.073 0.949 . . . . 0.0 113.294 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.68 -41.22 96.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.821 0.737 . . . . 0.0 111.489 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -74.19 -37.11 64.02 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.553 0.741 . . . . 0.0 111.765 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.84 -40.26 96.17 Favored 'General case' 0 C--N 1.346 0.444 0 O-C-N 121.428 -0.795 . . . . 0.0 111.81 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.26 -40.35 97.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.169 174.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -65.39 -41.53 93.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.812 0.845 . . . . 0.0 111.493 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.09 6.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.49 1.043 . . . . 0.0 114.439 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -110.4 84.08 1.87 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.414 1.486 . . . . 0.0 111.287 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -64.64 -45.66 85.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -57.33 -51.68 68.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.152 -0.927 . . . . 0.0 111.402 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -56.86 -42.37 79.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.67 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.44 -39.04 97.29 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 119.456 1.025 . . . . 0.0 113.915 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.13 -48.27 30.53 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 110.722 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.15 -57.71 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.781 1.633 . . . . 0.0 110.788 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -61.94 -29.77 70.45 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.579 0.751 . . . . 0.0 111.256 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 -37.31 59.62 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.434 0.54 . . . . 0.0 113.427 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.1 mt -66.53 -44.82 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.601 1.2 . . . . 0.0 110.137 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -59.17 -44.25 92.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.918 0.887 . . . . 0.0 112.253 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -67.95 -30.06 69.26 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.891 -1.13 . . . . 0.0 113.082 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.98 -53.43 26.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 118.814 -0.612 . . . . 0.0 109.786 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.06 -48.31 80.56 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.554 1.073 . . . . 0.0 112.327 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.7 ttm -62.81 -38.85 92.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.373 1.087 . . . . 0.0 112.595 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.63 -45.4 45.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.52 0.6 . . . . 0.0 111.436 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt -62.84 -35.42 79.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.492 1.517 . . . . 0.0 111.046 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.06 37.4 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.13 -31.34 61.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.589 1.086 . . . . 0.0 111.603 171.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.52 -37.48 15.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.143 1.377 . . . . 0.0 111.916 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.95 82.34 68.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.552 1.941 . . . . 0.0 110.585 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.92 134.89 30.99 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.422 2.748 . . . . 0.0 111.003 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -63.14 139.03 58.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.244 1.018 . . . . 0.0 112.731 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -116.16 155.53 28.09 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.764 1.625 . . . . 0.0 110.567 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.32 -21.59 66.26 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 119.243 -2.16 . . . . 0.0 112.913 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -101.36 18.2 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.861 1.664 . . . . 0.0 112.892 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.28 153.25 22.95 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.123 0.963 . . . . 0.0 112.739 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.99 106.51 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 121.418 -0.801 . . . . 0.0 112.019 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -54.32 102.96 0.07 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.227 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.83 -24.65 26.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.11 134.22 9.4 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.505 1.122 . . . . 0.0 109.915 -162.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.97 153.59 67.79 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.771 2.314 . . . . 0.0 112.514 -170.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -89.35 3.75 51.16 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.8 p -72.23 159.04 34.75 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.24 137.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.689 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 t -98.26 139.06 34.61 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.258 1.023 . . . . 0.0 109.797 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -140.69 164.69 29.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.612 0.765 . . . . 0.0 110.711 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 CA-C-O 117.991 -1.45 . . . . 0.0 113.725 177.711 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -29.64 67.91 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.532 1.515 . . . . 0.0 113.692 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -135.63 136.78 41.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 109.965 172.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.41 -43.39 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.838 0.744 . . . . 0.0 111.867 -174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.06 -16.76 63.82 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -114.57 79.07 1.22 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.369 1.467 . . . . 0.0 109.159 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -56.9 -36.19 69.86 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.91 140.4 45.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.664 1.586 . . . . 0.0 108.334 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -73.23 162.59 29.21 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.607 -0.683 . . . . 0.0 109.85 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.13 41.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.36 -42.9 87.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.484 1.114 . . . . 0.0 111.334 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -71.16 -45.12 64.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.409 1.484 . . . . 0.0 111.345 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.52 -46.03 90.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.224 1.41 . . . . 0.0 111.778 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -56.76 -43.28 80.64 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.368 -0.832 . . . . 0.0 111.834 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.64 89.36 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.764 0.711 . . . . 0.0 112.761 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -75.35 -33.41 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.224 -0.923 . . . . 0.0 112.831 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.07 -37.78 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.665 1.12 . . . . 0.0 111.259 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -63.81 -30.98 72.02 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.211 1.004 . . . . 0.0 112.775 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.76 85.95 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.073 -1.017 . . . . 0.0 111.911 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mm -59.89 -47.71 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.611 0.641 . . . . 0.0 110.003 172.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm105 -59.68 -34.04 72.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.24 -23.93 32.53 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.92 68.4 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.111 0.964 . . . . 0.0 112.734 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' CD ' HD22 ' A' ' 140' ' ' ASN . 92.6 mt-10 -56.5 -40.94 75.83 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 110.882 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -73.59 6.06 3.39 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 119.733 -1.854 . . . . 0.0 113.325 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -123.63 -7.98 7.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.382 2.273 . . . . 0.0 114.284 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -163.79 147.25 10.0 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.24 1.382 . . . . 0.0 110.545 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -81.79 12.12 4.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 113.987 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.11 143.74 16.82 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.21 1.386 . . . . 0.0 111.16 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -101.75 139.0 37.98 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.018 0.927 . . . . 0.0 113.074 -164.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.11 138.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.291 1.436 . . . . 0.0 109.573 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -153.39 155.59 36.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.474 1.11 . . . . 0.0 111.0 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.42 139.47 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.921 1.689 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -122.43 125.86 46.73 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.751 1.221 . . . . 0.0 112.244 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.86 115.15 26.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.888 0.875 . . . . 0.0 110.169 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.26 163.19 29.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.083 1.753 . . . . 0.0 109.812 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -80.35 -72.51 0.41 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.666 -1.271 . . . . 0.0 113.264 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.6 t -148.8 158.27 44.04 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 126.676 1.991 . . . . 0.0 109.292 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -107.03 159.0 16.62 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 126.189 1.796 . . . . 0.0 110.18 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.58 -27.79 18.89 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.738 -1.226 . . . . 0.0 112.148 166.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 mt -100.1 -125.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.329 1.052 . . . . 0.0 108.697 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -115.88 142.55 46.62 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.001 1.72 . . . . 0.0 109.349 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.09 -46.72 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.54 -50.21 74.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.039 0.836 . . . . 0.0 112.441 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -70.03 -39.47 75.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.344 0.658 . . . . 0.0 111.251 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -59.7 -46.55 88.73 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.646 0.778 . . . . 0.0 111.889 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.07 93.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.307 1.043 . . . . 0.0 111.691 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.0 ttp -63.56 -46.16 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 111.606 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.06 -48.81 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.165 0.439 . . . . 0.0 110.929 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.8 -45.39 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.518 1.127 . . . . 0.0 111.553 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -56.29 -53.52 56.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.64 1.176 . . . . 0.0 110.803 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -69.05 -33.73 74.05 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 112.05 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.26 -33.4 75.24 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.238 -1.539 . . . . 0.0 112.453 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.58 -3.18 52.61 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.98 0.912 . . . . 0.0 112.987 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 60.23 34.29 20.98 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.904 1.682 . . . . 0.0 112.697 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.2 mtp -65.02 -18.37 65.24 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -3.94 7.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.492 1.517 . . . . 0.0 113.066 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.79 59.8 2.65 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 111.422 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.1 p -125.93 143.28 51.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.463 1.905 . . . . 0.0 109.142 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -63.09 -48.69 77.54 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.848 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.17 -2.0 57.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.633 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 57.54 37.68 27.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.98 1.263 . . . . 0.0 109.463 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 27.45 9.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.543 1.537 . . . . 0.0 112.0 -172.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.1 124.52 6.78 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 124.098 0.856 . . . . 0.0 112.093 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.3 t -111.55 132.44 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.384 1.073 . . . . 0.0 110.147 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.1 tp -118.6 123.81 45.92 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.245 1.022 . . . . 0.0 111.455 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.67 96.33 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 125.474 1.509 . . . . 0.0 108.328 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.07 127.7 34.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.644 0.778 . . . . 0.0 111.379 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.36 125.86 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.318 0.647 . . . . 0.0 110.646 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.35 108.02 20.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.661 1.584 . . . . 0.0 110.236 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.79 -20.71 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -73.67 -64.11 1.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.988 0.813 . . . . 0.0 108.808 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.2 -9.52 58.62 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.8 tttt 65.45 32.57 9.44 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 m -100.76 132.55 46.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.603 1.561 . . . . 0.0 109.207 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.62 139.41 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.534 1.134 . . . . 0.0 108.385 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.58 143.83 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.012 1.325 . . . . 0.0 108.229 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.3 mt -122.79 135.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -147.64 129.36 15.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.857 1.663 . . . . 0.0 108.604 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.13 172.55 16.62 Favored Glycine 0 C--O 1.236 0.28 0 C-N-CA 125.353 1.454 . . . . 0.0 112.002 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -60.81 166.64 3.24 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.664 1.586 . . . . 0.0 113.551 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -53.08 -34.67 57.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.226 1.41 . . . . 0.0 113.717 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.95 -29.25 69.33 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.968 1.258 . . . . 0.0 114.185 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.65 -56.2 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.17 1.485 . . . . 0.0 108.529 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -51.64 -34.35 37.5 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.522 1.529 . . . . 0.0 113.747 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -78.42 -24.61 46.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.408 1.483 . . . . 0.0 113.081 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.48 -22.85 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.78 159.98 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.495 1.043 . . . . 0.0 112.715 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.7 p -95.01 174.13 7.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.69 -21.74 66.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.926 -1.109 . . . . 0.0 113.535 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.28 -17.91 55.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -73.17 -46.18 52.21 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 165.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -65.56 -32.2 73.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.543 1.137 . . . . 0.0 113.492 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.66 -36.85 70.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.969 1.308 . . . . 0.0 112.297 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.2 p -61.21 -45.25 95.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.752 0.821 . . . . 0.0 112.01 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 m -65.34 -45.87 82.5 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.811 1.644 . . . . 0.0 110.961 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.98 -51.42 67.79 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.542 . . . . 0.0 111.187 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -56.61 -48.09 78.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.884 0.766 . . . . 0.0 111.711 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.57 82.93 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.908 -1.12 . . . . 0.0 113.453 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 29.1 mt -70.46 -50.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.165 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -55.6 -44.27 76.81 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.282 1.033 . . . . 0.0 112.559 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.91 -34.02 74.03 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.01 -38.84 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.721 1.208 . . . . 0.0 111.251 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.98 -38.59 82.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.473 -0.767 . . . . 0.0 111.174 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.13 -27.08 67.77 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.272 1.429 . . . . 0.0 113.419 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.2 -20.98 39.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.935 0.894 . . . . 0.0 111.736 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.07 7.03 44.68 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.219 1.39 . . . . 0.0 114.549 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.08 97.81 7.54 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.805 1.303 . . . . 0.0 111.586 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -72.5 -37.05 68.5 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.604 -0.685 . . . . 0.0 110.898 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -57.73 -57.91 10.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.336 -0.852 . . . . 0.0 111.381 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.6 -41.1 94.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.268 0.627 . . . . 0.0 111.396 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.81 98.32 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 118.598 0.635 . . . . 0.0 113.469 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.41 -50.44 59.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.149 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.1 t -59.11 -48.31 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.0 0.818 . . . . 0.0 111.743 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.6 -29.84 66.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.286 0.493 . . . . 0.0 112.268 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.2 -34.48 64.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 118.722 0.692 . . . . 0.0 112.522 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.31 -52.59 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.454 1.102 . . . . 0.0 110.828 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.36 -42.33 91.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.597 1.09 . . . . 0.0 111.04 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.69 -46.58 89.08 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.177 -0.952 . . . . 0.0 112.116 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.01 96.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.426 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.77 -44.63 97.19 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.172 0.897 . . . . 0.0 112.425 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.1 mtp -65.02 -35.97 82.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.831 0.816 . . . . 0.0 113.112 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.87 -44.39 61.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.972 0.509 . . . . 0.0 111.644 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.55 -38.12 88.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 0.0 111.925 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.16 -24.81 43.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -73.08 -31.4 64.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.625 -1.297 . . . . 0.0 112.502 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -83.36 -38.01 22.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.88 1.272 . . . . 0.0 111.95 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -130.64 90.8 39.41 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.543 1.537 . . . . 0.0 109.178 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 139.82 50.85 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.478 2.119 . . . . 0.0 110.173 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -64.95 149.13 50.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.597 0.713 . . . . 0.0 112.698 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.03 145.89 50.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.122 1.369 . . . . 0.0 110.427 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -62.51 -20.68 64.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.8 0.18 54.67 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.564 1.946 . . . . 0.0 112.629 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -50.36 151.99 1.98 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.358 2.263 . . . . 0.0 115.735 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.28 112.12 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.328 1.051 . . . . 0.0 112.389 -163.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -94.05 105.31 17.32 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.393 1.477 . . . . 0.0 108.661 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -116.21 5.33 13.68 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.59 152.56 46.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 120.326 1.421 . . . . 0.0 113.58 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.26 137.73 13.61 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 110.262 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.463 HD22 ' CD ' ' A' ' 24' ' ' GLU . 2.3 m-80 -85.23 0.23 52.53 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.1 p -71.73 153.52 41.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.264 1.425 . . . . 0.0 111.106 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.5 mt -72.25 139.38 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.566 0.747 . . . . 0.0 109.109 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.4 t -101.17 139.1 37.32 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.824 -1.172 . . . . 0.0 110.533 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -136.43 151.02 49.04 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 112.204 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.455 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.217 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mmm . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -61.07 -32.5 72.14 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.75 119.89 39.29 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.997 -1.064 . . . . 0.0 111.233 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.2 mt -57.66 -25.28 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.58 1.152 . . . . 0.0 112.454 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -49.97 -34.43 20.88 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.342 1.857 . . . . 0.0 114.046 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.06 120.8 5.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.257 1.023 . . . . 0.0 108.356 -166.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.87 -58.36 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.832 0.853 . . . . 0.0 111.893 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -94.26 177.35 5.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.37 1.468 . . . . 0.0 110.221 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -101.05 162.22 13.05 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.573 -1.329 . . . . 0.0 109.98 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.83 -18.13 58.88 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.33 -48.15 57.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.225 1.375 . . . . 0.0 110.531 166.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.74 -40.82 92.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.144 0.978 . . . . 0.0 111.471 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -70.04 -42.95 72.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.357 1.063 . . . . 0.0 112.402 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.64 -45.42 85.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.503 -0.748 . . . . 0.0 111.817 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.17 94.75 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.35 -0.844 . . . . 0.0 113.095 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.78 -49.33 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.427 1.091 . . . . 0.0 110.25 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.36 -48.2 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.527 1.131 . . . . 0.0 111.846 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.62 -27.75 66.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.04 -32.57 67.25 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.134 -0.978 . . . . 0.0 112.487 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.49 -52.82 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.353 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -51.76 -23.96 5.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -89.95 -25.22 21.03 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.176 1.39 . . . . 0.0 113.019 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.11 74.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.522 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -63.61 -20.37 65.61 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.762 0.71 . . . . 0.0 112.736 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -83.86 3.97 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 119.641 -1.912 . . . . 0.0 113.136 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -129.97 -5.72 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.281 1.432 . . . . 0.0 113.427 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -162.55 155.54 19.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.565 1.546 . . . . 0.0 109.339 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -79.87 7.02 9.6 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.239 1.016 . . . . 0.0 113.722 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.9 152.85 20.2 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -111.17 129.55 55.91 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.497 1.119 . . . . 0.0 110.572 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.74 128.73 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.394 -0.816 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -141.3 160.36 40.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.484 1.114 . . . . 0.0 111.903 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.7 t -132.45 136.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.3 1.44 . . . . 0.0 109.216 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -119.55 119.4 33.69 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.816 1.246 . . . . 0.0 112.593 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 tp -100.88 130.8 46.95 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.97 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.26 165.14 34.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.152 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -80.85 -67.37 0.78 Allowed 'General case' 0 C--O 1.24 0.564 0 O-C-N 120.24 -1.537 . . . . 0.0 112.335 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 142.42 24.94 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.545 1.538 . . . . 0.0 110.125 -167.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -92.6 133.02 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.375 0.67 . . . . 0.0 111.961 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.68 -28.07 60.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 112.63 171.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -118.01 -164.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.432 1.893 . . . . 0.0 109.66 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.27 137.11 48.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.808 -1.183 . . . . 0.0 112.647 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.45 -37.79 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.433 0.693 . . . . 0.0 111.905 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -64.06 -48.98 74.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.324 0.65 . . . . 0.0 111.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.94 -37.01 81.09 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 112.098 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -62.75 -47.19 84.61 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.439 0.563 . . . . 0.0 111.24 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.17 96.33 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.727 0.811 . . . . 0.0 110.824 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.2 ttp -60.96 -47.49 86.18 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.509 0.723 . . . . 0.0 112.568 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.1 -37.93 81.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.315 0.961 . . . . 0.0 111.944 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.07 -41.46 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.856 0.753 . . . . 0.0 111.819 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.7 -47.78 83.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.465 1.106 . . . . 0.0 111.882 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -75.45 -34.72 60.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.594 0.757 . . . . 0.0 112.288 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -61.65 -41.91 98.17 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.466 1.107 . . . . 0.0 112.03 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.42 -0.67 20.78 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.359 -0.838 . . . . 0.0 112.938 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 59.67 33.51 21.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.317 1.447 . . . . 0.0 112.352 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.8 mtp -71.21 -23.35 62.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.483 1.113 . . . . 0.0 112.853 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -67.7 -16.3 64.07 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.353 1.861 . . . . 0.0 113.598 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.44 72.61 8.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.045 1.338 . . . . 0.0 111.291 172.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.0 m -135.85 135.67 39.96 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.243 1.817 . . . . 0.0 107.803 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -49.09 -49.94 39.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -93.07 0.57 57.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.258 1.023 . . . . 0.0 113.749 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 61.65 43.95 9.39 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.777 1.231 . . . . 0.0 111.041 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -121.03 47.37 1.84 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.493 1.517 . . . . 0.0 112.347 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 131.6 10.8 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.929 0.776 . . . . 0.0 112.749 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.35 139.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 118.221 1.01 . . . . 0.0 111.605 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.1 tp -125.93 120.81 31.37 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.457 1.503 . . . . 0.0 111.085 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -96.76 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.812 0.845 . . . . 0.0 109.796 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -78.06 119.92 22.17 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.696 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.38 130.71 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.744 0.818 . . . . 0.0 110.159 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.24 94.75 5.68 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.389 1.476 . . . . 0.0 110.231 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.1 m -70.5 -15.81 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -170.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -83.01 -34.23 26.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.825 0.85 . . . . 0.0 111.176 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -97.44 -15.63 20.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.99 1.316 . . . . 0.0 113.833 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.5 tttt 71.98 21.91 3.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.134 2.174 . . . . 0.0 112.43 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.8 p -99.94 163.59 12.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.193 -0.942 . . . . 0.0 111.48 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.21 145.61 35.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.137 1.375 . . . . 0.0 108.863 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -137.68 136.12 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 125.748 1.619 . . . . 0.0 107.54 175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 mt -111.56 126.06 68.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -121.85 150.56 41.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.298 1.439 . . . . 0.0 109.702 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.78 149.65 21.69 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -65.32 160.86 20.79 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 123.249 1.499 . . . . 0.0 112.156 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -53.46 -35.89 61.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.233 1.813 . . . . 0.0 113.334 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.51 76.83 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.344 -1.253 . . . . 0.0 114.083 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.35 -54.4 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.916 1.858 . . . . 0.0 108.731 167.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -52.87 -35.41 57.69 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.22 -16.14 56.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.922 1.289 . . . . 0.0 113.171 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 m -111.51 -29.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 119.555 1.071 . . . . 0.0 113.84 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.79 163.08 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.032 0.833 . . . . 0.0 111.287 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.1 m -119.42 169.58 9.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.318 1.447 . . . . 0.0 111.736 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -56.82 -32.59 65.89 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.237 1.38 . . . . 0.0 113.681 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.55 -21.05 66.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.554 1.142 . . . . 0.0 113.297 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -79.01 -41.91 27.83 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.476 -0.765 . . . . 0.0 110.462 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -69.47 -30.35 68.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.74 -36.17 69.44 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.183 0.593 . . . . 0.0 112.548 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -62.13 -44.76 95.92 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.915 0.779 . . . . 0.0 111.289 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -61.73 -47.63 84.39 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.136 1.775 . . . . 0.0 110.896 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.82 -43.7 98.31 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.369 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -65.18 -42.98 93.13 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.754 1.161 . . . . 0.0 112.45 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.88 78.28 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.718 1.145 . . . . 0.0 112.34 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.49 -51.38 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.822 0.449 . . . . 0.0 111.031 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.02 -44.74 96.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.935 1.294 . . . . 0.0 113.341 -174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.21 -38.47 91.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.631 0.772 . . . . 0.0 111.573 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.11 -38.46 36.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.067 0.947 . . . . 0.0 111.352 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -59.29 -40.05 84.92 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.333 -0.854 . . . . 0.0 111.637 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.67 -25.46 68.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.183 0.993 . . . . 0.0 113.267 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -87.41 -25.48 23.78 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.822 1.249 . . . . 0.0 111.797 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 10.55 40.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.301 1.429 . . . . 0.0 113.58 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.58 59.05 0.8 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.431 1.493 . . . . 0.0 110.83 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -49.46 -44.82 46.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 114.047 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -52.19 -51.43 58.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 124.584 1.154 . . . . 0.0 112.592 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -68.87 -33.86 74.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.76 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.54 -42.79 97.29 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-N 119.035 0.834 . . . . 0.0 112.75 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.86 -51.63 57.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.225 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.32 -47.38 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.089 0.956 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.73 -40.98 92.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.87 -39.39 75.59 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.856 -0.528 . . . . 0.0 112.312 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.05 -39.08 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.671 1.188 . . . . 0.0 110.648 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.74 -51.07 66.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.193 0.997 . . . . 0.0 112.363 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.44 -40.04 96.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.532 -0.73 . . . . 0.0 112.053 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -50.88 72.01 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.652 172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.46 -49.18 75.29 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.076 0.853 . . . . 0.0 112.585 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.0 mtp -60.99 -35.72 77.56 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.929 0.864 . . . . 0.0 112.898 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.13 -39.56 29.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.193 0.997 . . . . 0.0 111.868 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.6 mt -62.18 -36.0 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.83 -17.52 36.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.338 1.455 . . . . 0.0 114.449 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.01 -38.48 64.08 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.062 -1.024 . . . . 0.0 112.223 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -80.98 -49.81 10.48 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 124.486 1.114 . . . . 0.0 111.68 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -123.96 91.59 49.44 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.409 1.483 . . . . 0.0 109.682 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.41 148.94 68.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.877 2.385 . . . . 0.0 110.828 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -70.75 127.63 33.31 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.813 -0.554 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -100.35 155.89 17.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.203 1.801 . . . . 0.0 109.596 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.28 -24.46 63.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 119.866 -1.771 . . . . 0.0 112.768 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -98.33 16.5 21.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.865 2.066 . . . . 0.0 113.18 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.02 163.0 5.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.682 1.23 . . . . 0.0 112.065 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.51 163.44 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.539 1.536 . . . . 0.0 110.903 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.8 107.6 10.02 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -92.32 -31.14 15.48 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.661 0.785 . . . . 0.0 111.627 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.51 151.71 45.48 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.084 0.954 . . . . 0.0 110.592 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -82.0 144.46 13.49 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.246 1.964 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.87 31.76 0.26 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.395 1.878 . . . . 0.0 111.726 -172.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 t -97.08 164.0 12.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.774 1.629 . . . . 0.0 111.285 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.29 131.22 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -93.17 144.61 25.12 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.781 0.832 . . . . 0.0 109.633 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -142.29 135.99 29.3 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.511 -0.743 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.564 0 CA-C-O 115.983 -2.565 . . . . 0.0 113.963 173.835 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.66 -29.82 70.82 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 121.01 1.732 . . . . 0.0 113.801 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -127.55 132.81 49.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.583 1.553 . . . . 0.0 110.641 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.2 mt -134.44 135.28 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.367 1.867 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.89 59.93 0.75 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.121 1.368 . . . . 0.0 110.047 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.58 21.92 10.62 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.229 1.012 . . . . 0.0 113.189 167.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -85.94 -85.05 0.16 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.347 1.459 . . . . 0.0 111.059 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 mt -128.88 142.85 50.82 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.727 1.611 . . . . 0.0 108.386 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -73.6 169.43 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.339 0.656 . . . . 0.0 111.059 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.56 -42.57 64.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.107 -0.996 . . . . 0.0 113.66 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.4 -31.27 63.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.263 0.625 . . . . 0.0 112.264 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.57 -43.93 65.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.323 -0.861 . . . . 0.0 110.943 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -63.48 -31.07 72.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.979 1.312 . . . . 0.0 112.004 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.59 -46.33 59.6 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.533 -1.355 . . . . 0.0 111.279 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.6 96.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.438 1.095 . . . . 0.0 112.701 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.65 -39.86 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.394 0.997 . . . . 0.0 113.17 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.76 -34.31 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.578 0.626 . . . . 0.0 111.26 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.88 -28.9 67.11 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.55 71.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.234 0.47 . . . . 0.0 111.761 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.65 -46.54 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.67 0.788 . . . . 0.0 109.681 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.57 -43.28 93.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.836 1.255 . . . . 0.0 112.439 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.62 -37.66 85.31 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.182 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.97 93.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.09 0.556 . . . . 0.0 112.022 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.22 -18.99 61.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.735 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -98.39 11.14 39.05 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.232 -1.542 . . . . 0.0 112.737 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -121.97 -16.15 7.63 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.024 1.729 . . . . 0.0 113.752 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.3 t -163.65 154.54 16.13 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.88 1.672 . . . . 0.0 109.682 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.0 m -78.38 1.65 21.31 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.82 154.78 27.14 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 124.999 1.285 . . . . 0.0 111.51 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -131.74 123.78 28.38 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -163.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.1 mt -115.63 101.08 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 120.837 -1.164 . . . . 0.0 111.812 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -97.34 156.2 16.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.33 1.452 . . . . 0.0 111.66 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 140.98 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.34 1.456 . . . . 0.0 110.876 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -125.81 132.38 52.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 112.324 171.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -118.2 132.94 56.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.401 1.08 . . . . 0.0 111.289 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -153.23 160.49 42.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.573 1.549 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.57 -80.54 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.728 -1.233 . . . . 0.0 112.231 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -140.86 154.01 45.99 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.577 1.551 . . . . 0.0 111.205 -176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -98.83 142.98 29.66 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -79.16 -15.37 58.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.267 1.427 . . . . 0.0 112.984 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 pt -136.32 -171.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 128.687 2.795 . . . . 0.0 109.134 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -62.63 140.32 58.67 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.41 -34.53 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.93 -51.62 66.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.341 0.656 . . . . 0.0 111.497 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -66.51 -37.62 85.44 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.612 -0.68 . . . . 0.0 111.258 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -59.41 -49.59 77.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.985 -1.072 . . . . 0.0 111.638 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.79 96.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.474 0.71 . . . . 0.0 111.212 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.28 -41.58 89.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.144 0.978 . . . . 0.0 112.691 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.99 -33.67 59.74 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.161 -0.962 . . . . 0.0 112.72 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.33 -43.2 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.728 1.149 . . . . 0.0 110.931 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.36 -47.07 82.59 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.787 1.235 . . . . 0.0 110.849 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -76.12 -35.21 59.38 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.302 1.041 . . . . 0.0 112.404 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -62.39 -41.09 98.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.315 1.046 . . . . 0.0 111.459 172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.75 -2.2 25.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.091 1.356 . . . . 0.0 113.669 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 55.82 38.84 30.53 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.343 1.457 . . . . 0.0 112.851 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.73 -18.33 64.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.31 -3.66 0.99 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.623 1.969 . . . . 0.0 115.148 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -73.28 5.84 3.29 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.118 1.767 . . . . 0.0 115.347 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.1 p -83.18 156.46 23.2 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.45 -40.1 70.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.677 0.791 . . . . 0.0 112.637 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.81 -13.39 33.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.511 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 69.26 58.39 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.105 1.362 . . . . 0.0 108.657 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -145.66 33.92 1.04 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.746 1.218 . . . . 0.0 113.121 -162.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.01 147.57 23.82 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.684 1.135 . . . . 0.0 110.407 166.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.23 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.722 1.609 . . . . 0.0 108.809 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.3 tp -125.5 118.93 26.85 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.834 1.254 . . . . 0.0 111.122 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -90.22 97.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -78.88 125.08 28.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.157 -0.964 . . . . 0.0 110.187 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -121.75 127.24 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.247 1.019 . . . . 0.0 111.28 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.54 95.98 8.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.555 1.542 . . . . 0.0 109.866 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.16 -19.55 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -76.99 -41.36 43.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.166 0.587 . . . . 0.0 112.156 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.36 -27.81 24.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.301 1.441 . . . . 0.0 111.331 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 88.42 14.76 0.07 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.24 2.616 . . . . 0.0 111.383 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -97.78 157.64 15.96 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.063 -1.023 . . . . 0.0 111.059 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -134.78 149.58 50.42 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.453 1.101 . . . . 0.0 109.389 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.11 139.98 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 108.101 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -108.9 129.08 64.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -141.17 138.55 33.47 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.835 0.743 . . . . 0.0 110.553 172.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.7 159.18 24.11 Favored Glycine 0 C--O 1.24 0.517 0 C-N-CA 124.722 1.153 . . . . 0.0 110.314 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.45 161.93 21.68 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 123.194 1.474 . . . . 0.0 114.629 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.38 -31.49 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.375 1.47 . . . . 0.0 114.119 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.08 -31.43 57.67 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 119.552 1.069 . . . . 0.0 113.641 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.29 -57.25 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.554 1.177 . . . . 0.0 109.231 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -55.37 -38.08 68.36 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.031 0.932 . . . . 0.0 113.133 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.66 -11.75 60.76 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -114.0 -30.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -105.25 147.86 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.02 1.282 . . . . 0.0 112.446 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -92.22 171.75 8.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.547 1.139 . . . . 0.0 112.888 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -52.45 -38.6 59.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.387 1.875 . . . . 0.0 115.181 165.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.51 -28.15 67.59 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.804 -1.185 . . . . 0.0 112.895 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -73.03 -30.08 63.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.909 0.484 . . . . 0.0 110.953 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -80.31 -29.46 38.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.515 1.126 . . . . 0.0 113.502 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.41 -42.82 70.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.43 1.492 . . . . 0.0 113.085 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.0 p -59.0 -37.24 76.42 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.9 0.88 . . . . 0.0 112.281 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -54.99 40.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 0.0 110.834 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -57.35 -48.33 79.29 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 124.21 1.004 . . . . 0.0 110.112 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.1 -36.78 84.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.72 73.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.049 0.84 . . . . 0.0 112.308 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.25 -53.93 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.858 0.863 . . . . 0.0 109.89 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.17 1.788 . . . . 0.0 112.804 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.23 -51.64 62.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.55 1.068 . . . . 0.0 111.183 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.94 -35.32 62.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 119.047 -0.502 . . . . 0.0 110.806 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -58.8 -45.94 88.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.048 0.84 . . . . 0.0 110.448 171.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -58.8 -41.79 87.59 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.944 0.793 . . . . 0.0 111.699 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.28 -12.76 61.55 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.03 1.75 67.01 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.019 1.771 . . . . 0.0 114.559 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.99 75.03 1.64 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.477 1.511 . . . . 0.0 111.855 -174.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -51.85 -43.86 63.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.191 1.396 . . . . 0.0 112.909 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -54.34 -57.59 10.66 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.27 0.628 . . . . 0.0 111.517 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -62.23 -34.31 76.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.628 1.171 . . . . 0.0 111.585 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.72 83.22 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 118.585 0.63 . . . . 0.0 113.382 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.93 -48.79 64.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.333 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.77 -51.52 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.091 0.956 . . . . 0.0 111.115 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.33 -25.35 63.26 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.155 -0.965 . . . . 0.0 113.054 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.35 -41.68 84.82 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.391 171.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.71 -53.03 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.982 1.313 . . . . 0.0 110.229 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -55.76 -48.4 75.34 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.936 0.895 . . . . 0.0 113.36 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -70.92 -36.61 72.73 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.953 -0.467 . . . . 0.0 111.447 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.53 99.11 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.565 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.9 -48.17 86.94 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-N 119.429 1.013 . . . . 0.0 111.773 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 50.9 ttp -56.23 -48.76 75.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.226 1.013 . . . . 0.0 111.674 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.8 -42.83 69.8 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.104 0.562 . . . . 0.0 111.839 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.87 -33.62 76.26 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.323 1.449 . . . . 0.0 111.336 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.04 -16.77 60.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.42 -45.81 75.03 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.557 -1.339 . . . . 0.0 110.823 168.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -76.19 -47.3 24.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.329 1.452 . . . . 0.0 111.538 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -127.87 85.2 61.25 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 109.864 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.49 151.29 80.11 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.874 2.383 . . . . 0.0 111.11 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -62.95 149.95 43.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -132.07 152.03 51.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.38 -30.02 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.243 . . . . 0.0 113.722 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.2 18.6 13.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.575 1.15 . . . . 0.0 112.702 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.11 146.55 27.29 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.976 0.893 . . . . 0.0 112.247 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.1 176.12 2.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 124.899 1.28 . . . . 0.0 111.241 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.1 114.59 9.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -105.36 -27.54 11.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.809 1.644 . . . . 0.0 111.778 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.6 mt -114.5 143.95 30.87 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.28 148.54 61.92 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.757 2.971 . . . . 0.0 112.852 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -78.35 -4.28 47.31 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.594 1.557 . . . . 0.0 114.354 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 p -76.38 155.88 33.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.791 -1.193 . . . . 0.0 112.18 -170.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.3 mt -79.69 128.4 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.95 0.9 . . . . 0.0 109.578 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 t -89.87 145.12 25.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.986 0.514 . . . . 0.0 111.684 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.63 147.35 31.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 111.351 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 C-N-CA 125.899 1.714 . . . . 0.0 116.191 -176.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -166.69 150.06 6.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.109 0.868 . . . . 0.0 110.923 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 5' ' ' GLU . 56.6 tttt -84.25 113.26 20.98 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.135 -0.978 . . . . 0.0 111.409 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.03 -39.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.583 -0.698 . . . . 0.0 111.823 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 36.2 mt-10 -77.39 53.87 1.08 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.906 2.082 . . . . 0.0 111.399 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -94.34 -41.62 9.33 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.856 -1.152 . . . . 0.0 111.338 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -61.33 -34.48 75.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 113.018 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt -132.54 154.66 49.76 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.081 1.752 . . . . 0.0 109.512 -172.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.35 155.98 19.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.878 0.471 . . . . 0.0 110.545 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.95 -29.04 26.47 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -74.41 -35.32 63.41 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -73.17 -48.08 38.31 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.643 1.577 . . . . 0.0 109.938 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.44 -45.64 92.14 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.796 1.638 . . . . 0.0 111.241 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.79 -33.91 73.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.566 -1.334 . . . . 0.0 112.794 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -44.13 67.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -67.86 -39.34 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.136 0.88 . . . . 0.0 111.974 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.46 -39.13 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 121.65 -0.656 . . . . 0.0 111.955 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.8 -27.49 63.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.02 87.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.016 0.825 . . . . 0.0 111.776 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.18 -47.87 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.193 0.597 . . . . 0.0 111.19 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -60.28 -30.76 69.67 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.26 -35.86 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.72 -1.238 . . . . 0.0 111.141 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.75 98.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.38 1.072 . . . . 0.0 112.336 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -57.05 -29.77 63.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.222 1.409 . . . . 0.0 112.12 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -88.31 3.23 50.45 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.042 -1.662 . . . . 0.0 112.326 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.63 -15.64 7.45 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.376 1.871 . . . . 0.0 113.682 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -154.24 160.16 41.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.547 1.939 . . . . 0.0 109.82 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 p -92.11 23.04 3.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.61 153.66 18.32 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 126.385 1.945 . . . . 0.0 112.187 -174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -106.0 137.26 44.22 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -166.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.8 128.69 75.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -135.37 142.37 45.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.635 0.774 . . . . 0.0 111.541 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 81.2 t -107.82 135.28 47.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.694 1.197 . . . . 0.0 109.465 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -115.99 138.51 51.14 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.705 1.202 . . . . 0.0 112.326 166.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.9 tp -126.11 129.44 49.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.518 1.127 . . . . 0.0 111.822 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -158.88 156.62 29.91 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.521 1.528 . . . . 0.0 109.312 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -79.83 -70.61 0.5 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 121.034 -1.041 . . . . 0.0 112.464 -173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 t -144.04 152.05 40.49 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 111.552 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -104.48 137.18 42.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.267 1.427 . . . . 0.0 111.524 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.87 -14.57 57.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 112.977 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.81 -152.64 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.589 1.955 . . . . 0.0 110.171 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.46 134.71 36.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 112.349 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -39.73 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.271 -0.893 . . . . 0.0 112.151 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.12 -43.47 82.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.551 1.069 . . . . 0.0 111.527 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.62 -43.04 98.02 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.679 -0.638 . . . . 0.0 111.88 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -58.43 -45.45 88.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.784 0.72 . . . . 0.0 111.669 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.4 87.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 117.442 -1.266 . . . . 0.0 111.405 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 51.1 ttp -60.29 -50.01 75.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.175 1.352 . . . . 0.0 111.077 170.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.495 0.588 . . . . 0.0 111.724 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.5 t -63.68 -45.31 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.397 1.079 . . . . 0.0 111.703 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.26 -48.82 80.1 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.632 0.773 . . . . 0.0 111.068 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -70.28 -39.67 74.76 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.139 0.976 . . . . 0.0 111.619 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -61.65 -42.96 99.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.412 1.485 . . . . 0.0 112.926 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.93 -2.83 10.7 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.479 -0.763 . . . . 0.0 112.882 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.81 37.49 18.66 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.797 1.639 . . . . 0.0 111.713 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.6 mtp -74.48 -17.96 60.69 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.48 -4.87 9.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 170.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.03 52.16 0.7 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.531 1.532 . . . . 0.0 113.38 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 p -135.3 149.63 49.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.147 0.979 . . . . 0.0 112.05 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -67.4 -25.58 66.02 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.17 -1.81 13.57 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.139 1.376 . . . . 0.0 113.4 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 56.22 54.88 7.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.089 1.356 . . . . 0.0 111.112 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -133.09 41.99 3.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.526 0.731 . . . . 0.0 112.699 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.48 147.51 18.66 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.756 1.17 . . . . 0.0 111.552 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.77 138.84 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.531 1.133 . . . . 0.0 110.354 172.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.5 tp -115.06 128.52 56.29 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.79 1.236 . . . . 0.0 110.14 165.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -101.95 93.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 124.132 0.973 . . . . 0.0 109.005 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -75.52 123.42 25.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.034 0.934 . . . . 0.0 109.912 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.11 122.43 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.67 1.188 . . . . 0.0 110.731 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.07 89.22 5.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.901 1.28 . . . . 0.0 109.621 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.51 -16.49 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -75.24 -35.17 61.45 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.439 -0.788 . . . . 0.0 112.274 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -95.77 -8.01 35.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.095 1.358 . . . . 0.0 112.54 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.3 tttt 70.17 24.75 4.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.658 1.983 . . . . 0.0 112.722 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 p -108.93 167.96 9.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.086 1.354 . . . . 0.0 112.519 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.81 147.39 31.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 110.585 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.3 149.28 24.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.544 1.937 . . . . 0.0 108.166 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.85 127.02 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -136.92 129.73 30.57 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.429 0.691 . . . . 0.0 110.235 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.27 15.19 Favored Glycine 0 CA--C 1.513 -0.078 0 C-N-CA 124.825 1.202 . . . . 0.0 112.065 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -69.9 161.35 30.1 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.384 1.087 . . . . 0.0 113.378 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -52.14 -38.31 57.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.604 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.72 -11.6 69.35 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.009 -1.44 . . . . 0.0 115.047 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 93.3 mt -89.02 -57.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.483 1.641 . . . . 0.0 108.752 160.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -55.58 -33.76 64.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.87 -15.57 58.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.099 1.76 . . . . 0.0 113.639 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.86 -28.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.39 168.63 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.655 1.116 . . . . 0.0 112.673 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.9 p -114.85 177.75 4.53 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.912 1.285 . . . . 0.0 112.681 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -63.16 -26.8 68.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.656 -1.278 . . . . 0.0 113.574 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.75 -34.92 79.47 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.996 1.319 . . . . 0.0 111.701 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -71.09 -30.59 66.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.987 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -82.33 -31.87 29.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 0.0 112.666 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.39 -41.46 84.92 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.001 0.92 . . . . 0.0 111.689 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -60.83 -33.92 73.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.766 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 m -64.53 -52.13 59.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.673 0.789 . . . . 0.0 110.083 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.5 -45.99 91.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.407 0.683 . . . . 0.0 111.207 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.81 -41.93 96.65 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.11 -50.83 68.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.999 0.428 . . . . 0.0 112.085 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.48 -49.19 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.449 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -57.93 -42.71 85.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.099 1.36 . . . . 0.0 112.608 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.49 -53.29 57.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 111.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.92 -31.1 66.02 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 122.161 -0.337 . . . . 0.0 111.695 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -67.82 -39.98 83.88 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.737 0.699 . . . . 0.0 112.288 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.27 -34.22 77.19 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.159 0.984 . . . . 0.0 111.855 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -71.35 -31.08 66.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.994 0.918 . . . . 0.0 112.316 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 7.53 30.78 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.266 1.412 . . . . 0.0 114.593 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -101.87 72.59 1.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.803 1.641 . . . . 0.0 110.897 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -51.17 -46.52 62.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.84 1.256 . . . . 0.0 113.082 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -46.76 -60.25 2.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -65.8 -35.91 82.03 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.984 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.43 75.21 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 120.04 1.291 . . . . 0.0 113.327 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.03 -51.63 52.42 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.455 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.11 -51.63 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.717 0.807 . . . . 0.0 111.5 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.93 -34.18 77.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.307 0.958 . . . . 0.0 111.768 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -42.24 95.04 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.303 0.954 . . . . 0.0 112.16 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.25 -44.26 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.608 1.563 . . . . 0.0 111.348 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.12 -42.13 94.13 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.845 0.831 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -71.39 -39.79 70.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 120.642 -1.286 . . . . 0.0 112.049 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.99 90.4 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.359 0.664 . . . . 0.0 110.409 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.85 39.1 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.846 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.9 mmm -64.04 -26.36 68.52 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.26 -52.21 11.41 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.781 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -58.23 -37.39 74.76 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 112.296 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.7 62.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.447 1.499 . . . . 0.0 113.312 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -67.53 -29.07 68.37 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.105 -0.997 . . . . 0.0 112.52 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.43 -32.62 11.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.112 1.365 . . . . 0.0 112.161 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.79 79.11 75.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.132 1.773 . . . . 0.0 110.053 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.11 136.01 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.259 1.972 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -63.44 139.66 58.79 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.309 1.043 . . . . 0.0 112.896 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -113.37 156.05 24.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.683 1.23 . . . . 0.0 112.911 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.49 -14.77 58.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.81 -1.806 . . . . 0.0 114.267 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -121.43 35.64 4.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.166 1.786 . . . . 0.0 110.571 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 151.24 26.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.538 -0.726 . . . . 0.0 112.887 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.16 105.44 10.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 124.341 1.056 . . . . 0.0 111.752 -166.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.25 111.24 10.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.82 -32.7 12.55 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 126.608 1.963 . . . . 0.0 111.466 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.27 163.0 18.76 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 123.827 0.851 . . . . 0.0 111.42 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.52 154.28 7.75 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.273 2.648 . . . . 0.0 110.415 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -2.64 12.38 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.0 m -78.18 124.45 28.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.831 1.252 . . . . 0.0 110.763 -163.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.81 128.47 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.703 1.201 . . . . 0.0 108.905 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.8 t -87.22 135.43 33.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.55 139.35 42.13 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.903 -1.123 . . . . 0.0 109.998 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 CA-C-O 117.135 -1.925 . . . . 0.0 110.947 170.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 mtm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.623 -1.18 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -51.1 -39.03 55.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 121.844 2.111 . . . . 0.0 114.433 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -59.43 -24.74 63.75 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.8 pt -112.74 -3.64 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 126.374 1.87 . . . . 0.0 113.05 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -72.14 -54.48 9.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 109.897 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -102.28 113.79 27.39 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.01 -34.23 74.51 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.987 -0.446 . . . . 0.0 111.628 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -143.36 138.85 29.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.509 2.324 . . . . 0.0 109.184 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -73.57 143.04 46.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.087 0.955 . . . . 0.0 110.673 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.09 -29.26 3.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.17 -46.81 79.21 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.067 0.947 . . . . 0.0 112.754 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.26 -31.68 58.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.231 1.012 . . . . 0.0 111.17 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.433 ' HG2' ' HZ3' ' A' ' 110' ' ' LYS . 37.3 mt-10 -70.89 -38.16 73.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.865 0.866 . . . . 0.0 111.558 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.23 -41.59 99.13 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.493 -1.379 . . . . 0.0 111.628 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.09 98.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.616 0.767 . . . . 0.0 112.833 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.28 -38.25 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 120.979 -1.076 . . . . 0.0 112.167 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.55 -40.17 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.546 0.612 . . . . 0.0 110.845 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.68 -32.99 73.21 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.92 65.54 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -72.28 -46.49 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.41 1.084 . . . . 0.0 110.521 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -56.28 -30.67 62.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.024 0.93 . . . . 0.0 112.967 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.06 -28.17 60.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 113.548 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.86 62.37 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.101 0.96 . . . . 0.0 111.936 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.55 -7.88 23.08 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.733 1.254 . . . . 0.0 113.27 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -95.16 3.08 55.07 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.428 -2.045 . . . . 0.0 112.944 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -125.49 -17.66 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.941 2.097 . . . . 0.0 114.053 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 t -151.41 151.75 32.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.85 1.66 . . . . 0.0 108.927 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -90.84 49.72 1.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.179 0.991 . . . . 0.0 110.859 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.02 128.88 2.41 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.144 -1.597 . . . . 0.0 111.062 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -96.9 126.9 42.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.733 0.813 . . . . 0.0 112.843 -153.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -113.43 115.29 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 111.397 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.46 HH11 ' CG ' ' A' ' 56' ' ' MET . 73.4 mtp180 -118.21 153.55 33.7 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.384 1.473 . . . . 0.0 112.647 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.63 141.94 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.913 1.685 . . . . 0.0 111.3 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -131.46 123.25 27.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.251 1.02 . . . . 0.0 112.358 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.06 127.84 55.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.819 0.848 . . . . 0.0 111.216 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -149.46 163.47 37.7 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.134 0.974 . . . . 0.0 110.301 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -79.34 -66.63 0.84 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.374 -1.454 . . . . 0.0 112.016 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -159.6 151.77 20.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.47 1.108 . . . . 0.0 112.53 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 p -105.26 144.02 32.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 112.321 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -77.87 -11.96 59.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.692 1.197 . . . . 0.0 113.518 170.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.68 -164.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 127.962 2.505 . . . . 0.0 110.028 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -79.42 136.76 37.04 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.43 -1.419 . . . . 0.0 112.579 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -58.66 -40.33 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -59.12 -46.83 87.32 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.934 0.788 . . . . 0.0 112.211 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -72.6 -38.72 67.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.718 0.407 . . . . 0.0 111.86 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -60.28 -47.58 85.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.24 -0.287 . . . . 0.0 111.026 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.02 89.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.3 ttp -62.56 -50.67 70.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.768 0.827 . . . . 0.0 111.543 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.73 -49.06 79.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.987 0.915 . . . . 0.0 111.918 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.41 -41.1 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.041 0.936 . . . . 0.0 112.026 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.09 -46.09 90.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.988 0.813 . . . . 0.0 111.842 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -72.99 -32.78 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 112.438 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.35 -32.75 70.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.895 1.278 . . . . 0.0 112.807 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.9 mt -78.72 -11.51 59.98 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.3 -0.875 . . . . 0.0 112.82 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 64.49 35.68 9.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.34 1.456 . . . . 0.0 112.909 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.46 ' CG ' HH11 ' A' ' 32' ' ' ARG . 69.3 mtp -67.25 -22.62 65.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.898 1.279 . . . . 0.0 114.275 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.5 -7.93 8.16 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.722 2.009 . . . . 0.0 112.715 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -74.98 47.21 0.34 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.263 1.825 . . . . 0.0 112.719 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.6 p -119.34 150.74 39.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.864 1.666 . . . . 0.0 110.657 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HZ2' HG13 ' A' ' 135' ' ' ILE . 86.8 mttt -64.64 -43.9 92.2 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.911 -1.118 . . . . 0.0 112.494 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.45 -9.69 37.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 67.5 55.18 0.65 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.668 1.587 . . . . 0.0 108.58 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -126.17 29.87 5.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.554 1.141 . . . . 0.0 112.975 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.99 132.44 12.2 Favored Glycine 0 N--CA 1.47 0.964 0 O-C-N 120.424 -1.423 . . . . 0.0 110.988 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -111.77 134.5 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.528 1.131 . . . . 0.0 109.5 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 tp -117.75 130.59 56.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.81 0.844 . . . . 0.0 110.693 166.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.5 mt -106.16 95.34 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -75.32 125.63 29.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.6 1.16 . . . . 0.0 110.723 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -117.27 131.19 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.04 1.336 . . . . 0.0 110.332 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.27 95.32 6.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.003 1.721 . . . . 0.0 110.414 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 m -72.65 -16.36 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -75.27 -51.62 12.83 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.43 -5.75 55.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.94 1.296 . . . . 0.0 113.861 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.1 tttt 65.02 31.17 11.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.23 2.212 . . . . 0.0 112.751 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.5 p -111.06 163.54 13.76 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.028 0.931 . . . . 0.0 111.115 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 147.65 42.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.164 1.385 . . . . 0.0 109.534 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.89 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.758 1.623 . . . . 0.0 108.126 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.5 133.93 63.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -147.04 138.45 24.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.077 1.351 . . . . 0.0 110.036 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.71 164.3 21.15 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 124.756 1.169 . . . . 0.0 112.214 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -70.83 166.54 20.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 123.257 1.503 . . . . 0.0 112.705 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.42 -39.16 67.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.153 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.33 -46.49 78.11 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.386 1.47 . . . . 0.0 112.991 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.41 -59.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 118.208 1.004 . . . . 0.0 109.46 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.01 -22.67 64.75 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.72 -29.34 25.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.65 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -24.63 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.14 164.14 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.668 1.187 . . . . 0.0 112.649 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.2 p -107.93 174.42 5.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.694 1.198 . . . . 0.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.94 -33.41 73.12 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.342 -1.474 . . . . 0.0 113.359 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.1 -23.92 63.12 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -68.12 -37.59 81.29 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 117.698 0.226 . . . . 0.0 110.608 169.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -77.01 -25.57 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.3 -36.3 79.72 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.687 0.676 . . . . 0.0 112.715 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.3 m -55.98 -45.39 78.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.634 0.773 . . . . 0.0 111.427 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -47.68 84.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.305 1.442 . . . . 0.0 110.842 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -59.34 -47.84 83.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -64.86 -35.5 81.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.448 1.099 . . . . 0.0 113.368 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.67 -53.26 43.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.936 0.789 . . . . 0.0 111.692 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.33 -48.46 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.014 0.526 . . . . 0.0 110.459 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -60.07 -43.2 95.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.073 1.349 . . . . 0.0 112.905 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.26 -42.17 93.51 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 119.55 1.068 . . . . 0.0 111.827 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -74.88 -38.9 61.79 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.799 0.44 . . . . 0.0 111.926 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.76 -40.11 91.25 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.353 0.978 . . . . 0.0 112.054 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.57 -32.14 73.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.918 1.287 . . . . 0.0 112.078 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -74.59 -39.28 62.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.792 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.41 -2.21 12.59 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.23 1.872 . . . . 0.0 113.062 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.24 71.27 8.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.367 1.467 . . . . 0.0 111.102 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -52.73 -42.34 64.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.144 0.977 . . . . 0.0 112.407 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HZ3' ' HG2' ' A' ' 13' ' ' GLU . 19.2 tptt -64.93 -48.52 73.82 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -55.37 -47.51 75.69 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.528 0.731 . . . . 0.0 109.695 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.31 95.95 Favored Glycine 0 N--CA 1.467 0.741 0 CA-C-N 119.245 0.929 . . . . 0.0 113.695 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.45 -43.03 74.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.14 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.66 -50.42 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.599 1.16 . . . . 0.0 110.68 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -69.47 -25.05 63.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.875 1.27 . . . . 0.0 112.718 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.93 -41.85 26.74 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.083 0.849 . . . . 0.0 112.614 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.0 mt -60.61 -43.61 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.109 0.955 . . . . 0.0 111.166 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.23 -49.21 77.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.831 0.853 . . . . 0.0 112.621 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -71.55 -36.5 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.012 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.21 78.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.875 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.09 68.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.703 1.138 . . . . 0.0 112.341 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -64.17 -33.58 76.11 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.5 -46.55 38.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.794 0.725 . . . . 0.0 111.193 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.46 -39.26 83.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.215 1.406 . . . . 0.0 110.47 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.09 52.33 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.1 -41.67 99.42 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.859 -1.151 . . . . 0.0 110.805 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -84.84 -47.58 10.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.262 1.825 . . . . 0.0 111.144 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -114.38 78.18 4.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.725 2.01 . . . . 0.0 111.061 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.91 140.57 42.45 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.838 2.358 . . . . 0.0 111.256 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -59.39 141.75 53.86 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -115.42 149.26 38.29 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 123.892 0.877 . . . . 0.0 110.937 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.69 -25.82 67.65 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.29 -1.506 . . . . 0.0 112.297 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.07 22.14 7.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.655 1.582 . . . . 0.0 113.452 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.55 158.75 5.59 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.508 HG13 ' HZ2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -131.8 124.25 53.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.721 1.209 . . . . 0.0 112.572 -172.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -84.27 95.67 8.77 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 125.998 1.719 . . . . 0.0 109.087 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.2 -31.62 17.83 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.873 -1.142 . . . . 0.0 113.151 -170.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.2 mt -111.7 166.04 11.66 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.29 1.036 . . . . 0.0 109.489 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -95.05 146.51 1.53 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.417 2.078 . . . . 0.0 111.332 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -74.29 4.15 6.22 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.2 p -72.72 168.97 17.64 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.653 1.181 . . . . 0.0 111.387 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.42 144.45 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 120.535 -1.353 . . . . 0.0 111.132 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 t -99.99 146.78 26.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.682 1.193 . . . . 0.0 111.026 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -153.18 94.86 1.88 Allowed 'General case' 0 CA--C 1.553 1.094 0 O-C-N 120.908 -1.12 . . . . 0.0 112.92 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 C-N-CA 125.05 1.31 . . . . 0.0 114.904 -173.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -53.63 -42.55 67.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.434 -1.416 . . . . 0.0 111.841 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.87 -18.54 65.26 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.62 -20.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.486 1.114 . . . . 0.0 112.827 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.25 -34.23 77.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.599 1.56 . . . . 0.0 112.613 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -146.58 125.96 13.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.857 1.263 . . . . 0.0 109.038 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -68.46 -41.76 79.73 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.651 0.781 . . . . 0.0 112.709 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt -142.76 137.33 29.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.958 2.103 . . . . 0.0 108.245 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -72.59 170.2 14.93 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.371 0.532 . . . . 0.0 111.386 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.38 68.64 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.111 -0.993 . . . . 0.0 112.752 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -60.7 -34.79 74.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.661 1.184 . . . . 0.0 112.395 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -84.43 -42.47 15.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.0 0.92 . . . . 0.0 110.902 -176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -57.22 -50.46 72.8 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.555 1.142 . . . . 0.0 111.774 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.16 -39.08 69.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.819 -1.175 . . . . 0.0 112.569 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.62 69.47 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 tt -71.43 -39.23 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.825 0.738 . . . . 0.0 111.136 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.7 t -59.55 -29.21 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.065 1.346 . . . . 0.0 112.641 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -72.86 -41.01 65.21 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.284 1.434 . . . . 0.0 113.557 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.15 77.58 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.03 -49.42 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.961 0.905 . . . . 0.0 110.594 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -60.06 -24.68 64.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.07 -18.43 32.42 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.765 0.826 . . . . 0.0 111.985 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.95 -39.87 29.27 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.993 0.917 . . . . 0.0 111.262 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.59 -27.44 39.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.325 1.45 . . . . 0.0 112.557 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -90.66 1.7 56.57 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.706 -1.871 . . . . 0.0 113.615 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -112.81 -20.73 11.51 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.233 1.813 . . . . 0.0 111.938 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -160.56 148.55 16.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.526 1.13 . . . . 0.0 110.574 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.6 p -81.3 38.25 0.48 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.295 1.038 . . . . 0.0 111.815 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.49 143.27 14.93 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.041 1.781 . . . . 0.0 109.884 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.9 124.77 51.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.156 -165.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.84 130.89 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -145.93 150.15 35.55 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.353 1.461 . . . . 0.0 110.67 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.96 135.92 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.612 1.565 . . . . 0.0 109.887 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -117.4 122.66 44.42 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.974 170.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -114.43 130.31 56.7 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.457 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -155.21 163.44 40.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.043 0.925 . . . . 0.0 110.764 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.05 -75.88 0.16 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.736 1.215 . . . . 0.0 112.086 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 t -138.15 173.19 11.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.774 2.029 . . . . 0.0 109.044 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 p -140.99 141.11 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.413 -0.805 . . . . 0.0 111.036 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.29 -7.19 59.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.76 -150.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.219 1.808 . . . . 0.0 111.137 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -85.83 121.07 27.96 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.29 -1.506 . . . . 0.0 111.365 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.58 -42.53 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.98 -47.54 84.38 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.107 -0.995 . . . . 0.0 112.444 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.17 -36.59 69.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.362 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -68.99 -40.92 78.46 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.528 -0.732 . . . . 0.0 112.319 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.0 74.8 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.365 -0.834 . . . . 0.0 110.649 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.2 ttp -65.56 -44.37 86.98 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.976 0.807 . . . . 0.0 111.072 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.09 -52.46 65.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.335 0.97 . . . . 0.0 111.433 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.07 -45.06 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.964 1.305 . . . . 0.0 111.542 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.93 -50.46 73.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.431 1.014 . . . . 0.0 112.402 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -69.53 -36.48 76.43 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.427 1.091 . . . . 0.0 112.338 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -63.87 -40.24 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.853 1.261 . . . . 0.0 112.079 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.26 -6.37 45.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.326 1.05 . . . . 0.0 113.582 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 57.66 39.3 27.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.888 1.275 . . . . 0.0 111.79 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.8 mtp -66.81 -20.66 65.98 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.919 -1.113 . . . . 0.0 112.469 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.94 -15.78 14.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.998 2.119 . . . . 0.0 112.318 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -73.79 50.66 0.35 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.169 2.188 . . . . 0.0 111.818 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -125.3 123.95 40.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.734 2.014 . . . . 0.0 107.972 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -45.61 -50.34 13.35 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.672 1.189 . . . . 0.0 113.617 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.9 mt -87.0 -6.59 58.7 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 68.04 40.14 2.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.19 1.396 . . . . 0.0 110.966 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -114.65 41.46 2.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.361 1.464 . . . . 0.0 112.33 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.07 10.51 Favored Glycine 0 N--CA 1.477 1.388 0 O-C-N 121.451 -0.781 . . . . 0.0 112.843 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.97 133.67 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.808 1.304 . . . . 0.0 111.043 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.4 tp -116.51 133.54 55.9 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.372 1.069 . . . . 0.0 111.485 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.5 mt -106.83 93.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.658 0.742 . . . . 0.0 109.633 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -77.34 113.67 15.36 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.955 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.32 134.26 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.861 1.264 . . . . 0.0 110.595 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.82 15.15 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 110.042 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.6 m -75.78 -18.32 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -81.62 -37.95 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.515 1.126 . . . . 0.0 111.908 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.23 -10.15 31.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.082 1.353 . . . . 0.0 112.53 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt 65.4 32.27 9.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.658 1.583 . . . . 0.0 112.257 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.1 p -111.15 160.42 16.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.265 1.826 . . . . 0.0 111.848 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.98 134.64 23.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.649 1.18 . . . . 0.0 110.065 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.53 138.38 54.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.994 1.318 . . . . 0.0 108.098 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.19 131.55 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -137.25 136.81 38.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.631 0.772 . . . . 0.0 110.245 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 139.43 11.95 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -59.66 160.19 7.61 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 123.626 1.679 . . . . 0.0 110.628 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.3 -34.25 60.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.545 1.938 . . . . 0.0 113.71 -168.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.64 77.56 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-O 118.666 -1.075 . . . . 0.0 112.85 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.97 -55.78 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.277 1.538 . . . . 0.0 109.399 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -50.84 -34.58 28.46 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.78 -25.79 44.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.06 -27.16 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.8 161.54 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.059 0.845 . . . . 0.0 113.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 m -113.63 173.27 6.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.57 1.548 . . . . 0.0 113.829 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -50.97 -41.67 59.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.929 1.692 . . . . 0.0 114.553 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.6 -12.88 60.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.366 1.467 . . . . 0.0 113.395 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -83.96 -28.0 28.1 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.927 -1.733 . . . . 0.0 111.227 166.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -84.98 -21.0 29.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 113.279 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -60.72 -44.27 96.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.438 1.095 . . . . 0.0 111.576 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.1 p -57.52 -45.82 84.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.574 1.149 . . . . 0.0 111.351 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -57.36 -51.33 69.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.385 1.474 . . . . 0.0 111.028 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.68 -48.75 80.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.615 1.166 . . . . 0.0 111.627 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.63 -45.58 93.5 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.07 50.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.938 0.79 . . . . 0.0 112.577 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.44 -46.3 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.704 -0.622 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.72 -36.99 86.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.215 1.006 . . . . 0.0 112.743 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.88 -41.83 97.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.703 1.138 . . . . 0.0 111.2 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -83.32 -31.19 26.98 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.901 -0.571 . . . . 0.0 112.282 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -63.47 -38.06 89.69 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 119.122 0.874 . . . . 0.0 112.699 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.44 -35.82 82.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.885 0.874 . . . . 0.0 111.908 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -71.29 -36.38 71.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.031 0.932 . . . . 0.0 111.267 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 7.01 32.56 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 126.324 1.916 . . . . 0.0 113.936 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -90.32 72.05 7.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.645 1.222 . . . . 0.0 110.984 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -57.16 -36.79 71.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.352 1.061 . . . . 0.0 113.539 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -56.29 -51.95 66.32 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 111.323 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.41 -34.26 77.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.107 1.363 . . . . 0.0 111.262 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.72 47.09 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 118.744 0.702 . . . . 0.0 112.733 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 -47.02 76.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.174 0.487 . . . . 0.0 111.177 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.81 -40.95 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.357 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.77 -37.5 79.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 111.608 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 -41.78 99.8 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.19 -47.75 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.211 1.004 . . . . 0.0 110.443 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -56.48 -52.68 63.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.571 1.149 . . . . 0.0 111.569 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.62 -38.79 84.41 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.603 0.761 . . . . 0.0 111.817 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.71 90.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 118.898 0.772 . . . . 0.0 111.252 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.3 98.6 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 119.032 0.833 . . . . 0.0 112.068 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mmm -62.34 -39.64 93.74 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.041 1.42 . . . . 0.0 113.078 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.63 -44.35 50.93 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.57 0.748 . . . . 0.0 111.546 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.84 -35.23 77.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.163 0.985 . . . . 0.0 111.424 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.63 -16.18 35.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.973 1.309 . . . . 0.0 114.305 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.3 -30.14 57.62 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.736 -1.227 . . . . 0.0 112.177 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -93.28 -31.12 14.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.735 1.214 . . . . 0.0 112.919 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -139.94 88.26 12.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.431 1.492 . . . . 0.0 109.236 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.14 148.02 55.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.399 2.066 . . . . 0.0 110.972 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -64.49 155.81 31.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.218 1.008 . . . . 0.0 113.456 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -136.18 151.23 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.704 1.601 . . . . 0.0 110.371 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.8 -25.57 67.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.534 -1.979 . . . . 0.0 112.684 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.9 15.71 28.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.015 1.726 . . . . 0.0 112.091 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.72 162.78 6.23 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.848 0.859 . . . . 0.0 112.483 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp -131.83 122.57 49.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 124.129 0.972 . . . . 0.0 111.23 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.81 106.88 18.38 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -94.61 -26.87 16.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.047 -0.978 . . . . 0.0 113.296 -171.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.9 mp -107.35 158.94 31.91 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 120.327 1.422 . . . . 0.0 111.652 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.83 149.94 14.16 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 124.069 3.179 . . . . 0.0 110.658 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.35 4.5 20.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.526 1.93 . . . . 0.0 114.844 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.2 p -74.92 161.82 29.17 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.207 1.403 . . . . 0.0 111.224 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.96 119.32 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.697 -1.252 . . . . 0.0 110.079 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.7 m -76.03 139.23 41.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.459 0.647 . . . . 0.0 111.427 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -136.61 131.54 33.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 C-N-CA 125.067 1.318 . . . . 0.0 114.646 177.061 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -76.07 -27.91 57.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.522 1.51 . . . . 0.0 112.625 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -56.2 -26.52 51.26 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 pt -94.28 -10.32 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 124.617 1.167 . . . . 0.0 113.701 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -81.37 -34.9 31.41 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.405 1.082 . . . . 0.0 110.119 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -160.23 140.27 11.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.514 1.926 . . . . 0.0 108.988 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -76.03 -32.89 59.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.86 140.55 34.62 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 126.95 2.1 . . . . 0.0 106.774 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 m -65.94 157.1 31.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.1 0.96 . . . . 0.0 109.2 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.53 52.97 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.302 -1.499 . . . . 0.0 112.484 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -69.23 -23.6 63.9 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.711 1.204 . . . . 0.0 112.916 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.4 -46.24 9.82 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.529 1.532 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.29 -48.38 80.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 111.233 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.52 -47.79 69.62 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.968 -1.083 . . . . 0.0 111.883 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.23 83.84 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.302 1.041 . . . . 0.0 113.349 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -72.73 -38.66 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.852 0.751 . . . . 0.0 111.92 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.12 -40.38 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.807 0.843 . . . . 0.0 112.061 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.37 -33.43 74.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.254 0.934 . . . . 0.0 112.427 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.22 66.76 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.9 mt -61.21 -50.04 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.506 1.122 . . . . 0.0 109.935 167.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -57.97 -33.97 69.43 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.66 -26.38 60.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.03 42.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.095 0.958 . . . . 0.0 112.385 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -61.33 -23.67 65.9 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.264 1.026 . . . . 0.0 111.573 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -84.05 6.05 23.61 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.449 -2.032 . . . . 0.0 112.348 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -125.18 -7.8 7.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.111 1.764 . . . . 0.0 114.047 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -169.92 152.38 4.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.198 1.399 . . . . 0.0 110.491 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.412 ' HG ' ' CG ' ' A' ' 134' ' ' ASP . 1.3 m -82.27 21.65 0.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.249 1.42 . . . . 0.0 112.637 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.67 138.32 14.85 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 126.588 2.042 . . . . 0.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.62 125.25 52.39 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.03 0.915 . . . . 0.0 110.274 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 mt -117.39 125.95 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 119.935 -1.728 . . . . 0.0 112.628 -175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -129.22 131.18 47.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.475 1.51 . . . . 0.0 112.417 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.46 139.44 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.748 1.219 . . . . 0.0 112.867 170.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -128.55 125.81 39.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.974 1.31 . . . . 0.0 112.626 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 tp -115.76 133.01 56.46 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 111.294 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -159.09 158.24 32.6 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 109.546 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -75.2 -63.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.123 -1.611 . . . . 0.0 113.852 -170.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -157.74 164.28 37.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.395 1.478 . . . . 0.0 110.825 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.9 p -114.56 144.79 42.81 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.419 1.487 . . . . 0.0 112.557 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.25 -19.1 43.81 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.043 -1.036 . . . . 0.0 111.948 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.12 -162.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.666 1.587 . . . . 0.0 111.516 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -77.71 139.09 39.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.895 0.878 . . . . 0.0 112.373 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.49 -35.09 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.988 0.915 . . . . 0.0 112.714 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -65.46 -51.47 59.92 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.779 0.718 . . . . 0.0 110.834 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.66 -42.29 98.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.613 1.165 . . . . 0.0 112.324 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -62.1 -47.28 85.32 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.371 -0.831 . . . . 0.0 112.129 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.89 89.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.495 -0.753 . . . . 0.0 111.469 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.6 ttp -62.01 -48.95 78.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.707 0.803 . . . . 0.0 111.891 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -61.01 -46.48 90.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.273 1.029 . . . . 0.0 110.952 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.21 -45.91 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.111 0.964 . . . . 0.0 111.88 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -56.75 -50.72 71.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.673 1.189 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.91 -35.45 74.6 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.31 0.644 . . . . 0.0 111.202 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -68.09 -32.36 72.63 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.365 1.066 . . . . 0.0 113.853 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.7 mt -78.61 -0.51 30.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.237 1.015 . . . . 0.0 112.534 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 58.44 32.2 21.83 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.285 1.834 . . . . 0.0 112.032 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.6 mtp -69.51 -16.67 63.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.991 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.23 -15.8 63.91 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.658 1.183 . . . . 0.0 113.193 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -85.04 55.55 3.54 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.389 -1.444 . . . . 0.0 112.083 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -110.0 160.82 16.09 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 0.0 110.369 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -72.21 -42.12 66.13 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.974 -1.078 . . . . 0.0 113.62 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.07 -11.63 32.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 74.21 28.15 1.44 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.382 1.473 . . . . 0.0 110.145 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -112.66 45.46 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.572 1.549 . . . . 0.0 111.481 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.9 131.03 10.58 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.782 1.182 . . . . 0.0 112.331 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.2 t -111.62 136.39 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.052 1.341 . . . . 0.0 110.8 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 tp -115.28 134.18 55.36 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.148 1.379 . . . . 0.0 111.405 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.23 89.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.002 1.321 . . . . 0.0 108.725 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -78.92 123.13 26.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.3 1.44 . . . . 0.0 111.547 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.3 t -124.85 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.066 -1.022 . . . . 0.0 111.825 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.06 116.17 28.57 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.195 1.398 . . . . 0.0 110.44 164.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.43 -25.19 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.93 -57.99 3.56 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 118.205 0.457 . . . . 0.0 110.216 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.65 -4.13 55.36 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.2 tttt 68.39 27.53 6.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.682 1.593 . . . . 0.0 111.79 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 m -100.44 113.7 26.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.958 1.703 . . . . 0.0 110.491 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -88.95 141.9 28.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.0 0.92 . . . . 0.0 110.155 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.34 149.5 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.867 2.067 . . . . 0.0 108.143 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.8 mt -134.12 131.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -145.29 127.18 15.42 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.65 1.18 . . . . 0.0 109.534 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.38 149.68 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.6 162.82 3.59 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 122.964 1.364 . . . . 0.0 110.954 168.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -54.31 -35.67 62.91 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.488 1.515 . . . . 0.0 112.872 -168.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.83 -41.61 98.75 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.615 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mt -61.15 -56.16 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.294 1.547 . . . . 0.0 109.649 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -64.46 -19.47 65.58 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.07 -35.02 22.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.485 1.114 . . . . 0.0 111.367 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.5 p -93.57 -24.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 m -118.04 171.07 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 119.858 1.208 . . . . 0.0 111.998 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.5 p -113.13 172.22 7.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.989 1.316 . . . . 0.0 113.184 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -61.45 -30.82 70.83 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.839 -1.163 . . . . 0.0 112.551 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 -18.52 63.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.206 1.402 . . . . 0.0 112.668 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -81.22 -37.3 28.84 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.869 1.267 . . . . 0.0 111.915 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -73.71 -26.61 60.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.816 1.246 . . . . 0.0 113.568 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.37 -31.18 68.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.716 1.207 . . . . 0.0 113.677 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.7 p -70.02 -43.32 71.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.925 1.29 . . . . 0.0 111.517 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.0 m -56.88 -51.38 69.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.881 2.072 . . . . 0.0 110.779 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -58.71 -47.0 86.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.308 1.043 . . . . 0.0 111.63 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.12 -32.75 74.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.5 -53.39 29.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.326 0.967 . . . . 0.0 111.854 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt -61.28 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.625 0.37 . . . . 0.0 110.799 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.43 -44.05 92.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.399 1.08 . . . . 0.0 112.752 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.64 -39.83 85.65 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.785 0.72 . . . . 0.0 112.433 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.42 -32.66 20.77 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.43 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.71 -41.06 98.96 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.809 1.186 . . . . 0.0 111.063 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.01 -38.11 72.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.2 1.0 . . . . 0.0 111.625 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -75.67 -35.82 60.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.598 0.759 . . . . 0.0 111.988 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.65 5.99 21.83 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.802 1.667 . . . . 0.0 114.582 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -99.25 78.41 2.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.729 1.212 . . . . 0.0 110.428 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.09 -49.35 69.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.128 0.971 . . . . 0.0 112.416 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -50.58 -53.81 27.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.052 0.541 . . . . 0.0 111.353 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -62.53 -42.88 99.81 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.524 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.7 -35.56 74.07 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.504 1.047 . . . . 0.0 112.946 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.49 -44.71 77.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.306 0.642 . . . . 0.0 111.142 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.64 -52.58 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.434 1.094 . . . . 0.0 111.279 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -57.77 -40.72 80.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.293 0.951 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -43.32 87.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.044 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.25 -41.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.2 1.5 . . . . 0.0 112.123 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -63.73 -47.47 80.94 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.749 0.704 . . . . 0.0 110.944 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -66.56 -44.07 83.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.845 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.11 69.57 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.259 0.624 . . . . 0.0 111.028 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.14 89.39 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.045 0.839 . . . . 0.0 112.891 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.6 mtp -64.06 -36.31 83.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.871 1.335 . . . . 0.0 112.288 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.67 -43.62 37.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.049 0.939 . . . . 0.0 111.229 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -62.38 -35.15 78.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.134 0.974 . . . . 0.0 111.534 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.92 -20.9 62.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.696 1.198 . . . . 0.0 114.03 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -71.59 -41.98 68.31 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.022 -1.049 . . . . 0.0 111.444 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -75.12 -46.64 33.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.926 0.89 . . . . 0.0 111.611 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -122.87 88.34 50.48 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.623 1.569 . . . . 0.0 109.986 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.59 138.48 35.27 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.458 2.105 . . . . 0.0 110.454 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -62.86 135.51 57.36 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -106.53 154.31 21.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.155 0.982 . . . . 0.0 110.205 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.68 -27.04 68.65 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.933 -1.729 . . . . 0.0 112.259 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.71 19.64 15.54 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 126.184 1.794 . . . . 0.0 113.108 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.412 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 6.7 t0 -58.99 159.6 6.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.281 1.032 . . . . 0.0 113.321 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.12 109.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 123.086 1.422 . . . . 0.0 113.083 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -93.21 100.58 12.93 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.214 1.406 . . . . 0.0 108.512 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -98.28 -8.44 27.22 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.001 0.921 . . . . 0.0 112.818 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp -99.12 154.46 37.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 120.329 -1.482 . . . . 0.0 111.578 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.84 141.2 10.62 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.751 2.301 . . . . 0.0 110.151 167.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.04 21.83 0.68 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.304 1.042 . . . . 0.0 112.857 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -77.24 150.55 35.37 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.925 2.09 . . . . 0.0 111.887 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.5 mt -80.97 130.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.149 0.98 . . . . 0.0 109.532 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.2 m -87.89 142.42 27.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.429 170.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.76 140.82 31.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.667 0.787 . . . . 0.0 110.837 -174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.28 1.895 . . . . 0.0 109.972 164.484 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttp . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.6 p -71.14 -16.51 62.55 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.8 1.636 . . . . 0.0 114.517 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -88.92 129.59 35.59 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.132 -0.98 . . . . 0.0 110.533 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.61 -27.31 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.55 -21.38 62.71 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -134.62 81.49 1.91 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.705 1.202 . . . . 0.0 109.497 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -50.82 -45.43 59.44 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.083 1.353 . . . . 0.0 112.598 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.5 mt -129.11 133.12 47.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.789 1.636 . . . . 0.0 108.382 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -74.78 162.93 28.22 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.429 1.092 . . . . 0.0 109.532 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.46 -41.21 39.58 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -61.79 -30.49 70.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.88 1.272 . . . . 0.0 113.55 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -81.87 -47.49 12.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -62.37 -41.55 98.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.908 1.283 . . . . 0.0 110.691 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -55.56 -55.16 35.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.857 -1.152 . . . . 0.0 111.444 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.36 81.28 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -74.16 -30.34 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.167 0.894 . . . . 0.0 113.302 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.22 -42.46 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.478 -1.389 . . . . 0.0 111.047 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -63.58 -32.44 73.9 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.811 0.844 . . . . 0.0 112.347 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.26 85.71 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.273 -0.892 . . . . 0.0 112.596 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 mm -59.05 -45.99 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.093 0.957 . . . . 0.0 111.285 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -58.29 -31.16 67.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -81.97 -29.05 32.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.74 84.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.815 0.734 . . . . 0.0 111.34 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -56.12 -26.98 52.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.794 1.638 . . . . 0.0 113.41 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.84 5.18 37.98 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 112.826 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.83 -8.05 5.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.983 1.713 . . . . 0.0 114.29 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -148.37 159.88 43.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.926 1.69 . . . . 0.0 109.316 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.2 p -94.26 37.01 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.17 0.988 . . . . 0.0 111.688 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.44 146.24 15.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 123.955 0.788 . . . . 0.0 112.611 -171.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -108.33 131.8 54.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.689 0.756 . . . . 0.0 111.605 -151.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.47 134.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.802 -1.186 . . . . 0.0 110.661 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -144.26 153.48 42.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.18 1.392 . . . . 0.0 111.862 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.03 136.91 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.081 1.352 . . . . 0.0 109.704 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -118.57 118.52 31.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.003 1.721 . . . . 0.0 111.937 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.8 tp -107.15 129.28 54.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 112.086 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.0 tt0 -154.78 168.15 27.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.015 1.326 . . . . 0.0 111.897 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.18 -95.25 0.06 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.222 1.409 . . . . 0.0 113.479 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 p -116.05 165.21 13.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.332 2.253 . . . . 0.0 109.548 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 p -113.07 162.28 16.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.864 0.84 . . . . 0.0 111.977 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -95.36 -15.19 23.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.989 1.316 . . . . 0.0 113.009 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.42 -150.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.978 2.111 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -85.47 137.63 32.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.486 1.039 . . . . 0.0 112.01 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.29 -39.02 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.566 1.146 . . . . 0.0 112.422 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.94 -49.93 70.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.961 0.801 . . . . 0.0 111.764 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.59 -41.78 96.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 111.272 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.521 HH21 ' CD ' ' A' ' 36' ' ' GLU . 59.0 ttt85 -59.52 -48.89 79.9 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.042 0.937 . . . . 0.0 112.574 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.97 97.11 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.537 0.735 . . . . 0.0 111.077 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.18 -47.24 87.09 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.972 0.909 . . . . 0.0 112.172 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.87 -42.59 97.48 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.061 -1.024 . . . . 0.0 112.57 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.7 -41.99 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.867 0.867 . . . . 0.0 111.969 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.26 -48.77 78.46 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 111.971 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -75.16 -31.64 61.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.799 0.84 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -62.09 -48.28 80.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.096 0.959 . . . . 0.0 111.132 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -72.77 -7.59 51.38 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.105 0.962 . . . . 0.0 113.524 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 63.45 42.82 6.38 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 112.208 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.4 mtt -71.29 -21.53 62.06 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -8.96 8.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.026 2.13 . . . . 0.0 113.705 171.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -79.41 56.49 2.15 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.349 1.86 . . . . 0.0 111.081 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.7 p -128.99 145.18 51.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.549 1.94 . . . . 0.0 108.637 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -59.76 -39.66 85.59 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.5 mt -100.3 -8.82 23.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.081 -1.438 . . . . 0.0 114.519 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 69.93 39.73 1.38 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.708 1.203 . . . . 0.0 110.355 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -106.72 20.29 19.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.445 1.898 . . . . 0.0 113.735 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.07 121.36 6.52 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.296 -0.878 . . . . 0.0 112.569 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.5 t -104.43 133.57 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.357 1.863 . . . . 0.0 109.932 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.5 tp -120.79 130.16 53.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.318 1.047 . . . . 0.0 111.988 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 53.5 mt -105.78 100.16 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 0.0 108.593 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -81.36 125.88 30.92 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.282 0.633 . . . . 0.0 110.051 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.93 131.54 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.916 0.886 . . . . 0.0 110.954 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 102.0 11.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.114 1.366 . . . . 0.0 109.721 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.22 -19.3 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 -44.28 20.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.332 0.653 . . . . 0.0 111.1 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -86.73 -11.17 51.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.068 0.947 . . . . 0.0 112.524 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.4 tttt 72.77 29.08 1.98 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.108 2.163 . . . . 0.0 111.614 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -109.57 162.83 14.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.189 1.396 . . . . 0.0 111.198 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.45 146.13 41.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.135 1.374 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.01 135.5 45.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 126.119 1.768 . . . . 0.0 107.256 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.3 mt -118.52 127.85 75.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -136.21 125.46 24.72 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 125.342 1.457 . . . . 0.0 109.961 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 158.26 14.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.855 1.217 . . . . 0.0 110.644 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -65.31 164.8 12.81 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.605 1.669 . . . . 0.0 111.874 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -50.72 -33.67 23.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.04 2.136 . . . . 0.0 114.075 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.54 -43.36 98.18 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 119.985 1.266 . . . . 0.0 111.906 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.66 -58.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.585 1.192 . . . . 0.0 109.86 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -60.05 -25.37 65.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.083 -1.011 . . . . 0.0 113.571 -173.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.94 -8.09 44.18 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 p -113.59 -22.84 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 118.191 -0.909 . . . . 0.0 113.035 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.8 172.46 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.045 1.293 . . . . 0.0 112.233 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.66 171.98 7.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.669 1.588 . . . . 0.0 112.631 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.89 -34.01 75.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.01 -35.12 79.18 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.826 0.739 . . . . 0.0 111.97 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -64.41 -41.99 96.33 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.027 0.531 . . . . 0.0 110.761 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -70.02 -26.81 64.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.89 -35.65 75.3 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.153 0.888 . . . . 0.0 111.575 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 p -60.39 -46.84 88.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.494 0.717 . . . . 0.0 111.938 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 m -61.18 -48.94 79.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.591 1.957 . . . . 0.0 111.071 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -60.0 -47.36 86.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.263 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -62.54 -43.78 97.98 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.63 -48.74 76.86 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.021 0.828 . . . . 0.0 111.928 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.78 -48.28 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.749 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -59.99 -44.15 94.69 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.99 -38.25 87.89 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.152 -0.968 . . . . 0.0 112.497 -176.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -80.88 -37.59 29.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.28 1.032 . . . . 0.0 111.67 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.44 -38.96 82.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.442 -0.786 . . . . 0.0 111.645 171.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.01 -28.83 70.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.961 0.904 . . . . 0.0 113.136 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -79.59 -27.86 41.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.751 1.16 . . . . 0.0 110.802 172.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.91 25.12 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 126.309 1.909 . . . . 0.0 113.631 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -107.34 73.07 0.9 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.356 1.462 . . . . 0.0 110.951 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -58.08 -40.33 80.83 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.771 0.828 . . . . 0.0 113.225 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -60.22 -53.92 51.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.013 -0.429 . . . . 0.0 111.456 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.6 -39.49 88.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.646 0.778 . . . . 0.0 111.069 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.33 96.51 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.738 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.58 -48.44 66.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.457 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.71 -45.23 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.528 1.058 . . . . 0.0 112.391 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -67.26 -36.96 82.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.463 1.105 . . . . 0.0 112.14 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.5 95.89 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 121.649 -0.657 . . . . 0.0 112.547 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.02 -45.62 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.789 1.236 . . . . 0.0 110.564 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.68 -50.6 71.81 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.824 0.849 . . . . 0.0 111.33 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -66.59 -41.88 87.81 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.079 0.952 . . . . 0.0 111.24 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.18 79.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.448 172.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.62 97.42 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.402 1.001 . . . . 0.0 113.18 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.74 -40.4 95.24 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.603 1.202 . . . . 0.0 112.839 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.55 -47.58 31.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.411 1.084 . . . . 0.0 111.368 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.78 -38.74 79.18 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 125.567 1.547 . . . . 0.0 110.735 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.6 -19.11 46.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.45 -32.62 64.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.536 -1.353 . . . . 0.0 111.837 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -89.32 -33.93 16.74 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.857 1.263 . . . . 0.0 112.676 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.52 85.93 41.54 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.733 2.013 . . . . 0.0 110.275 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.49 135.02 25.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.65 2.233 . . . . 0.0 109.513 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -57.19 137.18 56.24 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -106.6 148.04 28.77 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.15 -0.968 . . . . 0.0 110.421 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.67 -33.23 72.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.295 -1.503 . . . . 0.0 112.487 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.71 17.16 13.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.447 1.499 . . . . 0.0 113.528 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.21 157.92 5.78 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.25 116.52 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.049 0.939 . . . . 0.0 111.554 -171.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -86.58 99.59 11.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 109.679 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -80.61 -31.05 36.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.737 1.215 . . . . 0.0 113.787 -172.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.2 mt -116.67 147.27 39.48 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.708 1.203 . . . . 0.0 110.702 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.94 147.23 26.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.152 1.901 . . . . 0.0 111.685 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -78.47 14.26 1.31 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.829 1.251 . . . . 0.0 113.568 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.0 p -85.56 165.25 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.049 1.74 . . . . 0.0 111.383 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.07 134.0 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.796 -0.565 . . . . 0.0 109.602 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.0 m -91.16 141.21 29.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.624 0.726 . . . . 0.0 110.669 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -140.8 154.75 46.38 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.73 -1.231 . . . . 0.0 111.157 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 C-N-CA 126.427 1.965 . . . . 0.0 111.862 173.786 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -156.35 156.05 33.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.03 0.932 . . . . 0.0 110.837 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -51.0 -44.5 60.93 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 0.0 112.199 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -115.65 139.1 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.807 1.243 . . . . 0.0 108.311 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -109.22 -57.04 2.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.423 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -115.28 127.24 55.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.309 1.844 . . . . 0.0 108.451 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -19.23 42.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.772 1.229 . . . . 0.0 112.972 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.05 137.22 49.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.56 2.344 . . . . 0.0 108.529 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -63.34 152.5 37.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.17 0.988 . . . . 0.0 111.019 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.29 16.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.84 -41.91 77.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.851 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -72.1 -42.37 66.21 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.658 1.183 . . . . 0.0 110.088 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.87 -39.36 94.21 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.503 1.521 . . . . 0.0 113.135 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -61.11 -50.17 74.32 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 119.65 -1.906 . . . . 0.0 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.54 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 tt -69.13 -41.56 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.588 1.085 . . . . 0.0 112.676 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.2 -40.58 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.092 1.315 . . . . 0.0 111.244 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.57 -28.5 67.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.226 0.921 . . . . 0.0 113.076 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.6 75.63 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.46 -0.775 . . . . 0.0 112.246 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.77 -45.38 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.772 0.829 . . . . 0.0 109.946 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -62.54 -23.78 67.16 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -84.37 -29.4 26.27 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.978 -1.076 . . . . 0.0 111.308 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.73 75.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.7 1.136 . . . . 0.0 112.361 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.08 -15.35 62.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.506 1.523 . . . . 0.0 113.454 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -92.71 4.67 53.29 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.754 -1.216 . . . . 0.0 111.866 171.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -131.91 -14.35 3.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.93 1.692 . . . . 0.0 115.139 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -153.44 145.58 23.78 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.493 1.497 . . . . 0.0 110.652 171.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -82.17 24.9 0.62 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.997 1.719 . . . . 0.0 113.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 -179.82 21.19 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 124.828 1.204 . . . . 0.0 110.997 166.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -135.73 133.48 38.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.767 0.794 . . . . 0.0 111.495 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mt -124.56 141.04 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.057 -1.652 . . . . 0.0 110.626 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -142.73 147.82 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.4 1.88 . . . . 0.0 111.027 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.41 137.13 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.214 1.006 . . . . 0.0 111.071 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -120.47 121.02 37.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.116 1.766 . . . . 0.0 112.759 172.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 131.47 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.883 1.273 . . . . 0.0 111.87 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -152.25 162.78 40.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.521 -0.737 . . . . 0.0 110.686 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -78.75 -75.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.736 -1.227 . . . . 0.0 112.366 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 p -142.07 148.65 38.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.477 1.911 . . . . 0.0 110.42 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -85.04 161.08 19.86 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.039 0.936 . . . . 0.0 112.976 170.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -98.23 -16.73 19.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.228 1.811 . . . . 0.0 112.31 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -119.56 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.101 1.76 . . . . 0.0 110.934 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -78.67 134.56 37.12 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.57 . . . . 0.0 111.41 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.04 -38.12 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.046 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.7 -46.52 89.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.79 -42.67 70.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.507 0.323 . . . . 0.0 110.785 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -56.68 -47.79 79.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.485 0.314 . . . . 0.0 111.687 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.06 75.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.899 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.9 ttp -67.19 -50.59 60.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 0.0 112.049 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -64.48 -43.95 92.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.245 0.93 . . . . 0.0 111.72 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.64 -45.02 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.129 0.971 . . . . 0.0 110.738 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.92 -50.19 74.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.117 0.967 . . . . 0.0 112.111 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -74.37 -30.96 62.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.328 1.051 . . . . 0.0 112.891 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -73.1 -35.84 66.66 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.659 -1.276 . . . . 0.0 111.917 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.28 -7.25 52.13 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.728 1.211 . . . . 0.0 112.947 170.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 62.21 31.1 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.468 1.507 . . . . 0.0 111.991 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.7 mmm -64.43 -19.79 65.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.304 1.042 . . . . 0.0 113.078 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.25 -12.48 60.29 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.258 1.823 . . . . 0.0 113.65 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -83.58 73.48 10.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.335 1.054 . . . . 0.0 111.249 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -123.74 151.42 43.25 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.717 2.007 . . . . 0.0 110.431 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -63.14 -37.97 89.32 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.378 -0.826 . . . . 0.0 113.02 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.41 -6.98 21.34 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 117.766 -1.112 . . . . 0.0 113.589 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 66.22 47.97 1.74 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.668 1.187 . . . . 0.0 109.433 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -119.8 26.27 9.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.807 1.243 . . . . 0.0 113.456 -172.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.75 127.23 7.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.312 0.958 . . . . 0.0 112.357 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.03 132.77 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 126.7 2.0 . . . . 0.0 109.985 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.5 tp -121.84 129.51 52.66 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.116 0.967 . . . . 0.0 110.781 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.15 99.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.984 0.914 . . . . 0.0 108.632 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -80.2 122.69 27.16 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.529 0.732 . . . . 0.0 110.744 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.863 0.865 . . . . 0.0 110.807 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.95 102.72 15.29 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.367 1.467 . . . . 0.0 109.277 171.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -73.16 -24.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -74.13 -40.75 62.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.962 -0.462 . . . . 0.0 111.472 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -97.27 -6.47 34.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.538 1.535 . . . . 0.0 112.837 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt 67.29 33.19 5.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.779 1.632 . . . . 0.0 112.156 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 m -107.6 129.43 54.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.353 1.461 . . . . 0.0 110.053 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -106.66 141.45 37.91 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.765 1.226 . . . . 0.0 109.876 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.0 t -138.8 140.86 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.198 1.399 . . . . 0.0 108.103 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 mt -125.39 127.57 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -129.74 138.18 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.863 0.865 . . . . 0.0 109.72 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.87 160.41 16.27 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.69 162.32 16.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.518 1.627 . . . . 0.0 112.618 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.84 -38.98 65.19 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.603 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.35 -37.22 93.64 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.612 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -63.0 -58.28 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.317 1.559 . . . . 0.0 110.166 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -59.26 -25.35 63.99 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -80.43 -27.68 37.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.466 1.507 . . . . 0.0 112.462 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.96 -22.82 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.99 167.65 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.836 1.198 . . . . 0.0 112.21 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 m -116.29 169.91 8.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.618 1.167 . . . . 0.0 113.122 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -56.88 -33.0 66.42 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.533 -1.354 . . . . 0.0 113.764 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -20.88 62.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.791 1.236 . . . . 0.0 113.249 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -77.66 -34.17 53.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.449 0.7 . . . . 0.0 110.647 170.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -75.76 -25.66 56.7 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -65.56 -32.96 74.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.402 -0.811 . . . . 0.0 112.376 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.3 p -65.86 -42.67 90.14 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 111.755 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 m -53.7 -55.37 26.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.908 2.083 . . . . 0.0 110.275 172.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -55.95 -49.27 74.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.92 0.888 . . . . 0.0 111.202 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.65 -37.32 81.14 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.46 -51.84 52.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.055 0.843 . . . . 0.0 111.78 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.2 mt -58.22 -51.68 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.044 0.538 . . . . 0.0 110.126 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.797 1.639 . . . . 0.0 113.035 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.09 -46.08 89.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.18 -30.42 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -64.69 -39.35 93.51 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.304 0.956 . . . . 0.0 111.29 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.9 -27.76 69.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.054 0.942 . . . . 0.0 112.331 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -77.77 -38.58 46.45 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.575 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.82 12.46 14.4 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.379 1.942 . . . . 0.0 113.791 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.26 84.89 2.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.204 1.401 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -61.39 -46.62 89.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.575 0.75 . . . . 0.0 111.928 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -49.11 -54.95 13.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -63.51 -41.77 98.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.061 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.42 -36.38 77.64 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.1 0.864 . . . . 0.0 113.346 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.96 -40.7 78.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 111.798 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.8 t -67.28 -50.43 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 111.5 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -73.47 -26.12 60.77 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.15 0.886 . . . . 0.0 112.495 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.09 -38.31 92.29 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.275 -0.891 . . . . 0.0 111.833 169.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.8 mt -62.24 -51.49 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.479 1.139 . . . . 0.0 110.872 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -61.01 -40.14 92.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.495 1.043 . . . . 0.0 112.854 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -73.91 -36.85 64.77 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.723 -1.235 . . . . 0.0 111.422 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.21 73.85 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.803 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.16 -46.66 93.82 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.481 1.037 . . . . 0.0 112.628 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 41.9 tpp -60.8 -43.35 98.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.924 0.862 . . . . 0.0 112.976 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.38 -44.19 75.69 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.994 0.361 . . . . 0.0 111.215 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.27 -37.9 87.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.455 1.502 . . . . 0.0 111.143 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.43 -24.49 63.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.538 1.135 . . . . 0.0 113.83 173.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -67.8 -27.64 66.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.206 -1.559 . . . . 0.0 112.561 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -93.18 -38.89 11.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.033 1.333 . . . . 0.0 112.031 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.4 76.19 78.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.126 1.77 . . . . 0.0 111.484 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.26 132.19 35.24 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.144 2.563 . . . . 0.0 111.339 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -57.92 146.29 32.69 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -118.57 150.45 39.63 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.004 1.322 . . . . 0.0 109.816 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.53 -27.4 67.73 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.438 -2.039 . . . . 0.0 112.888 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.79 15.04 23.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.659 1.584 . . . . 0.0 112.242 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.38 158.34 9.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.515 1.126 . . . . 0.0 113.185 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.32 120.7 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.53 1.132 . . . . 0.0 110.64 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.06 103.78 11.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -77.81 -21.08 52.11 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -119.28 169.1 8.67 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 124.87 1.268 . . . . 0.0 111.101 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -99.03 153.91 0.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.615 2.877 . . . . 0.0 111.153 168.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -89.0 -5.76 57.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 m -56.23 141.26 41.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.19 1.396 . . . . 0.0 109.683 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.54 130.95 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.61 152.71 18.38 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.107 0.563 . . . . 0.0 110.848 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -160.99 158.02 27.29 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.074 0 CA-C-O 116.592 -2.226 . . . . 0.0 112.803 171.025 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -76.11 131.47 39.45 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 119.954 -1.716 . . . . 0.0 112.056 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.75 -24.95 53.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.067 -1.02 . . . . 0.0 113.372 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.3 -38.57 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.568 1.147 . . . . 0.0 111.445 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.29 -6.46 58.52 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.552 1.141 . . . . 0.0 113.659 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.58 -17.7 61.15 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.401 -0.812 . . . . 0.0 112.238 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.43 -30.16 65.74 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -148.98 134.85 18.93 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.81 1.644 . . . . 0.0 108.017 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -69.52 160.6 31.15 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.739 0.7 . . . . 0.0 110.737 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.64 53.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.33 -40.99 77.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.508 1.523 . . . . 0.0 110.92 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -72.06 -44.38 63.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.551 1.141 . . . . 0.0 111.376 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 144' ' ' LYS . 75.0 mt-10 -63.74 -44.77 92.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.322 1.049 . . . . 0.0 111.823 176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -55.56 -47.2 76.76 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.706 -1.246 . . . . 0.0 111.461 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.67 84.45 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.4 tt -76.59 -38.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.568 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.86 -40.34 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.98 1.264 . . . . 0.0 111.253 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.98 -33.45 75.42 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.827 0.851 . . . . 0.0 112.966 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.11 62.0 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.709 0.804 . . . . 0.0 112.412 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.51 -48.66 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -55.49 -27.64 49.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.3 -28.76 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.239 -0.913 . . . . 0.0 113.086 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.07 75.62 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.574 1.149 . . . . 0.0 111.922 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -71.94 14.11 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.824 0.85 . . . . 0.0 113.282 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -120.72 12.5 11.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.322 1.849 . . . . 0.0 112.43 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.92 -14.33 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.807 2.043 . . . . 0.0 113.512 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -159.88 176.03 12.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.445 2.298 . . . . 0.0 108.531 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -125.51 6.22 7.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.347 1.459 . . . . 0.0 114.594 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.98 161.06 31.53 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 155.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -126.84 136.08 51.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 118.192 0.996 . . . . 0.0 112.0 -165.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.7 mt -113.05 124.69 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 110.746 -169.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -135.51 153.59 51.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.124 0.964 . . . . 0.0 111.456 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.9 t -133.99 128.43 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.494 1.518 . . . . 0.0 108.601 -168.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.87 108.75 13.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.569 1.548 . . . . 0.0 113.987 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 tt -93.96 130.94 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.514 0.726 . . . . 0.0 111.023 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.11 163.11 37.95 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.02 1.328 . . . . 0.0 111.317 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.3 -79.38 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.595 1.558 . . . . 0.0 113.369 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -144.54 147.81 33.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.982 2.513 . . . . 0.0 109.044 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -99.38 169.96 8.97 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.39 1.09 . . . . 0.0 112.163 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -101.66 -19.62 15.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.786 1.635 . . . . 0.0 112.685 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 pt -125.04 -148.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -85.17 142.5 29.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.278 1.399 . . . . 0.0 112.604 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.42 -32.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.449 0.7 . . . . 0.0 111.164 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.06 -50.08 73.41 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.736 0.815 . . . . 0.0 111.54 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.39 -39.55 94.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.329 0.652 . . . . 0.0 111.451 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.9 -43.43 98.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.354 0.662 . . . . 0.0 111.841 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.9 96.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.927 0.785 . . . . 0.0 110.982 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.8 ttp -63.26 -47.36 82.73 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.908 0.777 . . . . 0.0 112.327 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.57 -44.25 97.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.217 -0.927 . . . . 0.0 112.131 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.55 -43.96 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.63 1.172 . . . . 0.0 111.109 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.56 -49.71 76.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.995 0.816 . . . . 0.0 111.182 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -67.44 -44.23 79.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.481 1.112 . . . . 0.0 111.828 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.06 -39.84 91.38 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.857 -1.152 . . . . 0.0 113.816 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.56 1.64 18.89 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 56.5 36.59 27.81 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.706 1.202 . . . . 0.0 111.632 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.8 mtp -72.09 -13.49 61.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.131 1.772 . . . . 0.0 113.294 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -75.58 -2.4 28.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.584 1.954 . . . . 0.0 114.25 167.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -79.36 60.53 3.18 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.003 1.321 . . . . 0.0 111.872 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.2 p -129.53 149.97 51.07 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.86 0.838 . . . . 0.0 110.134 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.74 -27.79 68.57 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 113.063 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -107.25 -5.7 17.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.435 1.094 . . . . 0.0 113.1 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 60.05 40.23 18.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.967 1.307 . . . . 0.0 110.87 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -109.78 36.7 2.89 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.391 1.476 . . . . 0.0 112.073 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.11 121.95 5.69 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.714 -1.241 . . . . 0.0 112.464 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.31 135.84 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.118 0.959 . . . . 0.0 110.603 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -120.55 129.73 53.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.448 1.499 . . . . 0.0 111.502 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.47 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.915 0.886 . . . . 0.0 109.957 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -79.64 120.39 23.9 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.473 0.709 . . . . 0.0 110.8 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.61 132.8 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.809 0.844 . . . . 0.0 110.48 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.37 97.15 7.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.199 1.4 . . . . 0.0 109.173 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.29 -13.49 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -77.16 -56.78 4.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.379 0.536 . . . . 0.0 111.038 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.95 -8.4 59.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.278 1.431 . . . . 0.0 114.154 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttt 72.21 27.78 2.52 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.846 1.659 . . . . 0.0 112.443 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -102.39 173.4 6.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.123 0.969 . . . . 0.0 111.475 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -147.64 139.45 24.06 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.359 1.464 . . . . 0.0 109.353 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.0 t -127.9 134.32 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.695 1.198 . . . . 0.0 107.923 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.1 mt -111.97 131.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -137.33 124.95 22.24 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.559 1.544 . . . . 0.0 110.46 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.31 17.48 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -64.37 163.71 12.65 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.325 1.06 . . . . 0.0 111.534 165.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -57.87 -31.83 67.09 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.19 0.996 . . . . 0.0 112.84 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.04 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.724 1.147 . . . . 0.0 113.786 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.13 -61.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.2 1.5 . . . . 0.0 108.638 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -51.5 -41.55 61.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.335 1.054 . . . . 0.0 112.921 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.32 -13.61 59.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.692 1.197 . . . . 0.0 112.932 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.11 -31.92 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.588 1.086 . . . . 0.0 113.525 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 m -108.08 165.94 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.49 1.041 . . . . 0.0 112.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.04 172.39 6.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.427 1.091 . . . . 0.0 113.456 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.867 -1.145 . . . . 0.0 112.84 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -61.42 -25.75 67.41 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.388 1.075 . . . . 0.0 113.57 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -74.96 -46.17 37.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.612 0.765 . . . . 0.0 109.544 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.64 -31.24 72.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.497 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -57.63 -33.75 68.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.771 1.228 . . . . 0.0 112.193 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 p -66.54 -43.11 86.01 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.895 0.478 . . . . 0.0 111.699 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -52.09 66.9 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.285 1.834 . . . . 0.0 110.131 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -59.0 -50.04 75.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.61 0.764 . . . . 0.0 111.148 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -58.23 -43.69 87.86 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.21 -49.75 68.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.46 -47.97 90.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.013 0.925 . . . . 0.0 110.515 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -60.31 -45.98 91.5 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.571 1.148 . . . . 0.0 112.879 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.22 -35.82 76.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.341 0.656 . . . . 0.0 112.528 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -87.01 -34.87 19.09 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.207 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.21 -35.59 73.88 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.933 0.788 . . . . 0.0 111.631 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -68.42 -31.73 71.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 112.979 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.37 -35.12 70.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.464 1.105 . . . . 0.0 110.441 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 6.85 25.43 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.957 1.741 . . . . 0.0 114.533 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -98.64 94.13 6.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.071 0.949 . . . . 0.0 111.259 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -70.52 -37.2 74.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.46 0.704 . . . . 0.0 111.826 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -54.76 -56.94 13.94 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.964 0.906 . . . . 0.0 111.03 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -61.09 -42.6 98.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.27 97.13 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.191 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.17 -46.57 67.21 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.834 -1.079 . . . . 0.0 111.207 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -70.73 -41.0 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.681 1.128 . . . . 0.0 113.064 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.6 -35.78 81.82 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.832 0.742 . . . . 0.0 110.982 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.58 95.52 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.976 174.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.25 -43.49 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.575 1.187 . . . . 0.0 111.352 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -58.87 -52.18 66.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 0.0 110.671 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -66.62 -39.75 88.46 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.835 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.84 72.44 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.729 0.695 . . . . 0.0 111.389 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.87 95.74 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.689 1.131 . . . . 0.0 112.496 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.55 -39.24 88.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.135 -1.214 . . . . 0.0 112.919 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 -48.15 48.85 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.895 0.878 . . . . 0.0 110.602 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.1 mt -60.63 -36.2 78.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.74 1.616 . . . . 0.0 110.767 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.14 50.3 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.34 -37.59 68.81 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.406 -1.434 . . . . 0.0 111.995 170.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -85.04 -32.56 22.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 112.586 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.07 88.34 31.81 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.436 1.895 . . . . 0.0 109.329 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.81 139.82 34.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.541 2.827 . . . . 0.0 110.097 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -64.46 131.46 47.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -103.7 145.8 29.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.007 0.923 . . . . 0.0 110.299 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.43 -30.09 68.24 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 119.675 -1.891 . . . . 0.0 113.908 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -92.2 12.18 23.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.311 1.444 . . . . 0.0 113.177 -176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.82 154.19 7.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -172.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.78 112.18 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 122.304 1.049 . . . . 0.0 111.562 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.2 111.99 23.76 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 106.577 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -115.25 -36.85 4.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.944 0.897 . . . . 0.0 112.412 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.82 143.11 34.96 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.872 1.269 . . . . 0.0 109.721 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.35 140.09 24.12 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.164 1.909 . . . . 0.0 111.018 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -77.51 8.55 4.16 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.712 1.205 . . . . 0.0 113.663 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -75.76 153.25 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.907 1.683 . . . . 0.0 110.9 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.24 130.78 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.173 0.989 . . . . 0.0 108.664 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.1 m -82.8 142.41 31.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.351 1.06 . . . . 0.0 110.251 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HZ1' ' CD ' ' A' ' 13' ' ' GLU . 92.6 mttt -140.73 138.57 34.28 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.581 -1.325 . . . . 0.0 111.686 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.83 2.633 . . . . 0.0 114.082 -179.025 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -64.32 147.74 51.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.382 1.446 . . . . 0.0 112.696 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.34 126.59 33.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.9 0.857 . . . . 0.0 111.765 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.1 pt -74.71 17.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 125.451 1.5 . . . . 0.0 114.189 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -88.47 -32.86 18.05 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.907 -1.121 . . . . 0.0 110.674 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -104.36 79.34 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.322 1.449 . . . . 0.0 109.407 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -61.87 -31.57 71.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.95 133.83 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.256 1.822 . . . . 0.0 108.333 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -71.57 157.53 37.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.923 0.889 . . . . 0.0 109.406 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -24.31 8.43 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -75.13 -36.46 61.61 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.742 -1.224 . . . . 0.0 112.37 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -76.8 -42.82 39.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.17 1.788 . . . . 0.0 110.209 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.68 -49.08 76.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.32 -46.98 69.64 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.28 -0.888 . . . . 0.0 111.645 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.54 -28.57 67.91 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -80.59 -37.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 120.692 1.587 . . . . 0.0 112.191 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.54 -44.16 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.459 1.027 . . . . 0.0 110.944 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -57.97 -39.56 78.46 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.216 1.406 . . . . 0.0 112.707 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.59 -32.23 71.99 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.59 -0.693 . . . . 0.0 112.384 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.5 mt -67.9 -46.56 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.072 0.851 . . . . 0.0 110.008 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.64 -31.63 64.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.298 1.039 . . . . 0.0 113.157 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -79.35 -27.78 42.02 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.038 0.835 . . . . 0.0 113.109 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.48 -35.83 70.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.479 0.712 . . . . 0.0 111.695 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.43 -1.56 0.56 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.024 2.13 . . . . 0.0 113.933 167.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -117.61 9.66 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.055 1.742 . . . . 0.0 112.388 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -126.22 -14.66 5.92 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.045 1.338 . . . . 0.0 114.097 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -162.28 140.62 8.89 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.722 1.209 . . . . 0.0 109.459 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -83.11 46.5 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.73 0.812 . . . . 0.0 111.243 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.92 137.86 7.69 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.203 1.383 . . . . 0.0 109.686 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -113.84 128.08 56.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.933 0.873 . . . . 0.0 112.064 -152.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.7 mt -120.74 116.66 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.284 -1.51 . . . . 0.0 110.733 -172.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.74 147.92 37.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.887 2.075 . . . . 0.0 110.78 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.83 136.86 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.416 1.086 . . . . 0.0 110.695 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -118.32 118.97 33.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.403 1.881 . . . . 0.0 112.374 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 tp -108.11 129.06 55.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.949 0.9 . . . . 0.0 111.972 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.87 166.96 27.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.108 1.363 . . . . 0.0 110.312 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -81.03 -72.48 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.548 -1.345 . . . . 0.0 113.14 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -144.18 -175.95 4.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 128.22 2.608 . . . . 0.0 108.433 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.5 p -152.27 160.1 43.4 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.215 -0.928 . . . . 0.0 113.226 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.08 -3.27 41.61 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 pt -135.2 -146.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.501 -1.374 . . . . 0.0 110.997 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -95.54 141.24 29.3 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.564 1.529 . . . . 0.0 111.796 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.81 -32.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.259 -0.901 . . . . 0.0 112.544 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.65 -46.27 72.91 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.295 0.498 . . . . 0.0 110.904 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -60.06 -43.52 95.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.152 0.581 . . . . 0.0 111.537 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -60.5 -47.1 87.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.83 77.08 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.014 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.6 ttp -66.21 -52.46 47.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.764 0.711 . . . . 0.0 111.644 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.82 -44.99 91.0 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.989 0.813 . . . . 0.0 112.499 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.04 -40.8 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.247 1.019 . . . . 0.0 110.73 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.41 -51.09 70.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.985 0.811 . . . . 0.0 110.933 173.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.75 -39.13 80.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.578 0.751 . . . . 0.0 112.564 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.68 -38.21 89.46 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.212 1.405 . . . . 0.0 113.554 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.12 -4.74 46.0 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.061 -1.024 . . . . 0.0 113.274 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 58.85 34.04 23.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.711 1.204 . . . . 0.0 112.311 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.3 mmm -59.14 -22.43 60.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.044 2.138 . . . . 0.0 113.93 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -72.52 -6.94 47.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.38 2.272 . . . . 0.0 113.534 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.4 56.64 2.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.469 1.907 . . . . 0.0 110.956 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.1 p -127.75 137.79 52.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.113 2.165 . . . . 0.0 109.317 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -60.99 -36.45 79.51 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.29 -0.881 . . . . 0.0 112.456 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.9 mt -93.82 -9.44 37.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.932 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 66.63 49.35 1.31 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.397 1.453 . . . . 0.0 109.456 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.9 16.12 13.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.828 1.651 . . . . 0.0 113.994 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.38 136.47 30.13 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.05 -1.032 . . . . 0.0 112.187 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.58 138.4 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.649 1.179 . . . . 0.0 110.61 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 tp -117.98 127.57 53.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.277 1.431 . . . . 0.0 110.122 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.2 mt -103.66 96.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -81.06 126.45 31.45 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.903 -0.498 . . . . 0.0 110.391 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.18 127.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.128 0.971 . . . . 0.0 110.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.66 118.0 34.39 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.257 1.023 . . . . 0.0 110.483 167.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.0 m -76.59 -24.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -77.0 -55.97 4.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.207 0.458 . . . . 0.0 110.288 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -84.69 -1.31 55.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.629 1.171 . . . . 0.0 112.54 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.2 tttt 67.4 19.88 10.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 113.393 172.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.3 m -94.67 115.43 27.54 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.365 1.466 . . . . 0.0 110.874 -170.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -90.35 143.56 26.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.984 1.314 . . . . 0.0 110.004 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.08 150.86 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.726 1.61 . . . . 0.0 108.462 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.69 127.66 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -140.19 127.08 20.67 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.924 0.89 . . . . 0.0 110.599 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.6 158.2 14.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.579 1.085 . . . . 0.0 111.373 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.87 173.77 7.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 123.155 1.455 . . . . 0.0 112.638 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -60.72 -37.46 81.78 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.505 1.522 . . . . 0.0 113.685 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.09 -47.13 55.62 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.732 1.158 . . . . 0.0 112.588 -175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -54.7 -55.6 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.601 1.2 . . . . 0.0 109.36 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -79.16 -38.76 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.127 1.371 . . . . 0.0 111.598 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.5 m -92.75 -26.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 169.6 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 119.929 1.24 . . . . 0.0 113.055 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 p -119.17 171.59 8.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.125 1.37 . . . . 0.0 113.31 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.24 -30.25 71.11 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.674 -1.266 . . . . 0.0 113.338 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 0.0 112.344 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.22 -38.88 55.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.747 172.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -70.12 -28.86 65.72 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 125.08 1.352 . . . . 0.0 113.432 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.56 -31.62 72.84 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.6 m -62.32 -43.26 99.23 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.689 0.677 . . . . 0.0 111.062 171.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -60.21 -48.44 81.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.329 1.452 . . . . 0.0 111.516 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -59.57 -48.09 83.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.693 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -63.67 -35.26 79.96 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.91 61.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.18 0.9 . . . . 0.0 111.793 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.64 -49.9 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.315 0.646 . . . . 0.0 110.583 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.64 -39.9 85.88 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.907 1.283 . . . . 0.0 112.724 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.31 -45.06 96.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.649 1.113 . . . . 0.0 111.954 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -79.14 -37.04 39.51 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.944 -0.473 . . . . 0.0 110.971 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -59.55 -39.83 85.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.186 0.903 . . . . 0.0 111.887 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -64.39 -31.59 72.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.786 1.634 . . . . 0.0 113.034 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -73.06 -34.8 66.49 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 118.756 0.707 . . . . 0.0 111.299 168.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 8.18 11.74 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 126.192 1.853 . . . . 0.0 113.793 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -107.43 78.52 1.22 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 0.0 111.816 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -53.39 -46.5 69.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.412 1.485 . . . . 0.0 112.952 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.7 -49.62 74.58 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.545 -0.722 . . . . 0.0 111.539 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.61 -44.35 90.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.826 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.74 97.08 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 119.003 0.819 . . . . 0.0 113.387 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.31 -47.19 68.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.46 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.54 -51.65 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.364 1.066 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.26 -41.94 98.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.114 0.966 . . . . 0.0 111.2 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -17.78 76.28 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 121.049 -1.032 . . . . 0.0 113.5 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.96 -50.63 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.649 1.58 . . . . 0.0 109.825 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.91 -51.65 68.28 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.775 1.171 . . . . 0.0 111.982 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.35 -37.6 86.29 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.058 -1.026 . . . . 0.0 112.122 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.27 88.41 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.886 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.41 87.09 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.116 0.871 . . . . 0.0 111.231 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 59.9 ttm -59.96 -43.47 95.04 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.027 0.913 . . . . 0.0 112.503 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.45 -47.31 64.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.25 0.62 . . . . 0.0 111.78 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.55 -36.41 82.55 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.284 1.034 . . . . 0.0 111.466 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.27 -22.47 61.2 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -66.14 -41.71 90.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.866 1.212 . . . . 0.0 111.438 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -81.59 -27.39 34.29 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.029 1.731 . . . . 0.0 113.001 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -138.86 76.35 34.48 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 126.594 1.957 . . . . 0.0 110.097 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.56 143.86 64.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.326 2.684 . . . . 0.0 111.144 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -66.7 137.21 56.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -118.03 150.82 38.65 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.787 1.635 . . . . 0.0 110.149 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -67.15 -19.63 65.62 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.181 -1.574 . . . . 0.0 113.524 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -106.72 17.75 22.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.054 2.941 . . . . 0.0 112.037 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -52.7 153.84 3.0 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.044 1.338 . . . . 0.0 112.19 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.08 125.38 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 120.735 -1.228 . . . . 0.0 111.848 -167.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.84 88.09 7.1 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.278 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -74.77 -30.34 61.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.57 0.748 . . . . 0.0 112.721 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.35 158.19 49.4 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.295 1.438 . . . . 0.0 110.953 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -91.31 136.76 1.97 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.347 2.698 . . . . 0.0 111.669 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -57.39 -14.07 4.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.7 m -50.32 140.39 13.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.44 134.82 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.551 1.14 . . . . 0.0 109.582 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 m -93.56 138.62 31.64 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.387 1.089 . . . . 0.0 111.982 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.21 157.29 46.19 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.778 1.631 . . . . 0.0 109.28 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 C-N-CA 125.169 1.366 . . . . 0.0 111.786 172.786 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mtp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -167.73 152.51 6.78 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.931 0.892 . . . . 0.0 109.937 -161.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.78 -4.17 55.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.832 0.853 . . . . 0.0 113.124 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -139.63 156.57 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 128.042 2.537 . . . . 0.0 108.68 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.85 -166.43 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -163.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -77.87 -24.96 48.36 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.386 -0.821 . . . . 0.0 112.469 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.6 -70.43 0.16 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.792 1.637 . . . . 0.0 111.622 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.8 mt -133.3 143.35 48.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 109.086 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -86.33 170.22 12.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.739 0.781 . . . . 0.0 110.375 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.26 -29.47 5.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.137 1.375 . . . . 0.0 114.636 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -80.22 -38.47 31.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 0.0 111.979 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -76.67 -44.49 33.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.949 1.3 . . . . 0.0 111.036 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.47 -45.66 92.04 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.057 1.343 . . . . 0.0 111.168 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.04 -40.01 79.83 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.895 -1.128 . . . . 0.0 111.603 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.94 80.32 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 0.594 . . . . 0.0 111.962 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.05 -37.32 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.319 0.963 . . . . 0.0 112.909 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.95 -40.88 84.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 118.953 0.797 . . . . 0.0 111.283 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -72.64 -29.28 63.32 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.143 0.883 . . . . 0.0 113.31 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.01 76.68 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.522 -0.736 . . . . 0.0 112.645 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.54 -40.53 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -61.43 -31.21 71.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.865 0.866 . . . . 0.0 112.134 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.01 -31.13 62.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.422 1.089 . . . . 0.0 112.685 172.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.37 -39.25 59.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.824 1.25 . . . . 0.0 113.027 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.94 -23.72 63.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 112.564 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.8 8.84 26.99 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.527 -1.358 . . . . 0.0 113.39 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -130.62 -8.96 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.912 1.685 . . . . 0.0 113.78 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -157.48 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.501 1.521 . . . . 0.0 108.888 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 27.8 1.52 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.686 0.794 . . . . 0.0 112.162 174.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.09 151.35 17.34 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.248 1.404 . . . . 0.0 111.443 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -112.28 127.89 56.11 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -161.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.37 119.96 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.401 -1.437 . . . . 0.0 110.216 -172.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -128.58 147.07 50.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.443 1.097 . . . . 0.0 112.071 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.23 141.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.024 1.33 . . . . 0.0 110.203 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -126.96 123.38 37.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.172 0.989 . . . . 0.0 110.869 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 tp -104.77 147.79 27.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 0.0 111.463 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.44 166.36 32.41 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.882 1.325 . . . . 0.0 109.644 159.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -59.62 -78.28 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 C-N-CA 126.236 1.814 . . . . 0.0 113.073 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -138.08 -177.03 4.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.536 1.534 . . . . 0.0 110.71 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -137.46 142.57 41.56 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.397 1.479 . . . . 0.0 111.434 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -81.07 -27.84 35.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.041 0.936 . . . . 0.0 112.947 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 pt -115.71 -146.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.099 1.759 . . . . 0.0 110.636 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.85 133.74 36.28 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.578 -1.326 . . . . 0.0 111.875 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.21 -36.89 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.853 0.861 . . . . 0.0 112.314 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.78 -49.75 64.89 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.866 1.212 . . . . 0.0 111.7 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -60.63 -42.59 97.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.158 0.583 . . . . 0.0 112.192 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.552 ' NH2' ' HH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -63.08 -36.93 85.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 176.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.65 88.32 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.848 -1.157 . . . . 0.0 111.763 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.6 ttp -63.18 -49.93 72.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.376 0.67 . . . . 0.0 111.439 170.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.08 -47.96 79.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.845 0.748 . . . . 0.0 111.087 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.29 -42.02 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 111.814 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.59 -53.2 60.84 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.598 1.09 . . . . 0.0 111.054 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.21 -32.3 62.98 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.376 0.67 . . . . 0.0 112.353 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.626 -1.296 . . . . 0.0 112.824 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.1 -6.55 58.95 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.164 0.985 . . . . 0.0 112.559 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 tttt 61.44 36.02 17.43 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.802 1.641 . . . . 0.0 111.625 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.5 mtp -72.7 -5.5 38.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -77.57 -2.5 36.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.631 1.972 . . . . 0.0 113.18 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -73.26 33.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.293 1.837 . . . . 0.0 114.318 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 p -111.44 153.98 25.33 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.037 1.735 . . . . 0.0 111.947 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.75 -39.17 87.81 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.04 -4.2 22.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.188 -0.91 . . . . 0.0 113.39 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 67.78 31.49 5.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.662 1.585 . . . . 0.0 110.021 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.37 33.03 3.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.454 1.902 . . . . 0.0 112.594 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.31 123.55 6.38 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.358 0.98 . . . . 0.0 112.999 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -112.18 138.42 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.449 1.1 . . . . 0.0 112.011 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.9 tp -117.01 128.54 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.475 1.51 . . . . 0.0 111.228 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -104.38 97.93 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.456 1.102 . . . . 0.0 108.963 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.552 ' HH ' ' NH2' ' A' ' 46' ' ' ARG . 42.0 t80 -81.12 125.0 29.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 111.017 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.38 134.29 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.108 0.963 . . . . 0.0 111.115 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.24 105.93 16.14 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.107 1.763 . . . . 0.0 110.613 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -77.77 -13.03 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -78.46 -40.74 34.72 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.174 0.897 . . . . 0.0 112.07 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.81 -10.6 26.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.824 1.249 . . . . 0.0 112.219 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.0 tttt 71.96 24.28 3.32 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.738 1.615 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.3 p -105.85 165.03 11.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.313 1.045 . . . . 0.0 111.607 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -143.32 144.52 32.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 109.616 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -138.97 139.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.95 1.7 . . . . 0.0 107.719 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.7 mt -116.0 133.3 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -138.58 126.94 23.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.207 1.003 . . . . 0.0 110.401 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.93 150.54 18.42 Favored Glycine 0 N--CA 1.462 0.398 0 C-N-CA 125.174 1.368 . . . . 0.0 112.208 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -64.17 164.03 11.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 122.598 1.19 . . . . 0.0 112.319 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -53.85 -35.12 61.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.435 1.494 . . . . 0.0 112.377 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -28.08 73.65 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 119.626 1.103 . . . . 0.0 114.387 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.39 -58.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.283 1.541 . . . . 0.0 109.798 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -54.6 -32.94 59.58 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.308 1.443 . . . . 0.0 113.869 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -76.87 -24.13 52.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 m -103.91 -35.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.908 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.7 169.17 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 120.004 1.274 . . . . 0.0 112.632 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -119.46 177.77 4.79 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.563 1.545 . . . . 0.0 113.271 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -61.73 -33.46 74.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.683 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.39 -20.21 62.96 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.03 0.932 . . . . 0.0 112.557 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -77.87 -30.66 50.97 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 169.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -83.99 -26.34 29.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -54.86 -44.03 73.65 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.963 1.305 . . . . 0.0 112.416 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.8 p -63.12 -35.29 79.78 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 m -66.43 -51.16 59.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.476 1.91 . . . . 0.0 110.245 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -60.9 -44.57 96.95 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.146 0.978 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -57.19 -47.22 81.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.874 0.761 . . . . 0.0 112.524 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.45 -48.2 82.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.436 1.017 . . . . 0.0 111.841 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.12 -49.15 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.946 0.898 . . . . 0.0 110.352 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -59.86 -42.13 93.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.999 1.32 . . . . 0.0 112.356 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.89 -38.36 86.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.74 -32.84 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.391 0.541 . . . . 0.0 111.172 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -62.39 -39.05 91.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.637 0.775 . . . . 0.0 111.645 168.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -59.38 -31.32 69.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.683 1.193 . . . . 0.0 113.038 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.36 -41.04 22.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.378 1.071 . . . . 0.0 111.257 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.36 1.23 8.58 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.581 1.563 . . . . 0.0 114.843 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -93.63 80.69 4.28 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.815 1.307 . . . . 0.0 111.532 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -59.77 -44.44 93.87 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.789 1.235 . . . . 0.0 112.609 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -50.99 -58.67 5.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.314 1.045 . . . . 0.0 111.363 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.004 0.921 . . . . 0.0 111.698 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.04 -37.41 94.18 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 118.72 0.691 . . . . 0.0 113.664 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.08 -44.94 59.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.448 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.68 -51.67 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.326 0.65 . . . . 0.0 111.12 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.88 -33.75 76.77 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.346 0.659 . . . . 0.0 112.3 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.23 83.77 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.338 -0.851 . . . . 0.0 112.667 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.94 -46.67 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.167 1.483 . . . . 0.0 109.877 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.24 -47.63 81.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.305 0.642 . . . . 0.0 111.29 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -61.63 -38.69 88.58 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 121.547 -0.72 . . . . 0.0 112.202 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.66 64.24 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.322 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.3 -45.61 74.21 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 120.37 1.441 . . . . 0.0 113.284 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mtp -63.37 -38.11 89.89 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.158 -1.201 . . . . 0.0 112.907 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.38 -38.84 40.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 110.901 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.49 -33.14 70.89 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.453 1.501 . . . . 0.0 112.549 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.49 41.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -71.85 -29.56 64.52 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.112 -0.992 . . . . 0.0 113.429 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -91.62 -35.54 14.17 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.777 1.231 . . . . 0.0 111.527 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -136.34 90.99 16.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.328 1.851 . . . . 0.0 109.879 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.37 144.17 60.81 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.639 2.226 . . . . 0.0 111.299 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -62.93 161.53 12.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.6 0.76 . . . . 0.0 112.747 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -142.9 159.28 42.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -62.27 -29.25 70.29 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.542 -1.349 . . . . 0.0 113.236 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -99.82 29.15 4.3 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.651 1.581 . . . . 0.0 112.4 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.33 151.17 44.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.834 -1.166 . . . . 0.0 112.003 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.79 114.4 35.24 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 C-N-CA 124.24 1.016 . . . . 0.0 110.887 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -78.21 93.65 4.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.515 0.726 . . . . 0.0 109.41 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.48 -27.28 34.63 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.14 158.95 32.35 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.202 1.401 . . . . 0.0 110.312 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.36 159.09 14.93 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.413 2.742 . . . . 0.0 111.046 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -83.83 2.52 37.87 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.6 p -76.33 160.9 29.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.989 1.316 . . . . 0.0 112.325 -166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.94 140.49 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.536 0.735 . . . . 0.0 109.815 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.4 t -110.07 140.66 43.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.668 -1.27 . . . . 0.0 111.942 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -134.88 137.37 43.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 C-N-CA 124.993 1.282 . . . . 0.0 114.793 169.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 p -45.44 -43.83 11.73 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -111.61 136.53 50.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.142 0.977 . . . . 0.0 113.362 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.1 tt -77.42 124.83 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.478 1.511 . . . . 0.0 111.882 172.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -72.65 152.5 41.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.975 0.91 . . . . 0.0 111.301 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -80.27 79.21 6.88 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.709 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -59.21 -38.42 79.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.149 0.979 . . . . 0.0 112.65 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.599 1.959 . . . . 0.0 109.724 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -64.05 150.64 44.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.066 1.346 . . . . 0.0 109.38 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.45 55.73 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.249 -1.532 . . . . 0.0 113.983 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -68.67 -35.63 77.47 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.357 1.463 . . . . 0.0 113.566 174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.54 -35.24 78.67 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.499 -1.376 . . . . 0.0 111.152 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.82 -44.19 97.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.875 0.87 . . . . 0.0 110.956 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -45.3 87.22 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.013 -1.054 . . . . 0.0 111.162 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.58 76.27 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.0 -38.8 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 119.846 1.203 . . . . 0.0 112.21 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.75 -39.63 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 119.67 1.123 . . . . 0.0 111.934 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.42 -35.37 77.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.477 1.111 . . . . 0.0 112.741 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.34 87.63 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.859 0.463 . . . . 0.0 111.631 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.6 mt -66.31 -46.56 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.79 1.236 . . . . 0.0 110.243 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -57.7 -28.9 64.25 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.23 -30.29 34.23 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.048 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.74 85.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.922 1.289 . . . . 0.0 112.25 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' CD ' HD22 ' A' ' 140' ' ' ASN . 95.6 mt-10 -54.02 -17.4 2.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.514 1.525 . . . . 0.0 113.787 168.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -106.63 14.42 26.98 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.034 -1.666 . . . . 0.0 112.396 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -130.68 -15.92 3.43 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.83 1.652 . . . . 0.0 113.961 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -152.39 152.84 32.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.845 1.258 . . . . 0.0 110.577 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -81.03 3.5 22.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.276 1.03 . . . . 0.0 112.812 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 -161.74 21.85 Favored Glycine 0 C--N 1.343 0.934 0 C-N-CA 125.996 1.76 . . . . 0.0 111.668 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -162.86 129.52 3.48 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.246 0.618 . . . . 0.0 112.159 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.78 116.15 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.37 1.068 . . . . 0.0 110.634 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -121.78 153.09 38.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.622 1.169 . . . . 0.0 111.218 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.11 132.78 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.65 1.18 . . . . 0.0 110.725 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -117.3 124.22 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.257 1.027 . . . . 0.0 112.515 169.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.33 126.15 52.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.069 1.347 . . . . 0.0 112.401 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -150.6 161.63 42.21 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.462 1.105 . . . . 0.0 110.21 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -73.7 -68.98 0.46 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.645 -1.284 . . . . 0.0 113.302 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -156.57 157.66 35.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.434 1.894 . . . . 0.0 110.277 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.1 p -115.8 147.93 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.585 1.554 . . . . 0.0 112.77 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -80.5 -29.23 37.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.15 0.98 . . . . 0.0 111.566 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -107.8 -167.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.843 1.657 . . . . 0.0 111.447 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -68.75 134.39 49.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.594 1.158 . . . . 0.0 112.678 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.87 -38.06 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.967 0.907 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.24 -51.25 68.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.682 0.674 . . . . 0.0 112.109 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.17 -43.02 93.07 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.135 0.574 . . . . 0.0 111.47 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -58.51 -42.33 87.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.669 0.788 . . . . 0.0 112.418 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.29 -35.13 77.38 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.902 0.881 . . . . 0.0 111.555 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.2 ttp -63.68 -49.21 74.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.545 0.738 . . . . 0.0 111.119 170.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.08 -52.45 65.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.049 0.939 . . . . 0.0 111.464 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.14 -42.5 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.506 1.122 . . . . 0.0 111.448 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.54 -46.44 90.15 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.45 1.1 . . . . 0.0 112.003 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -70.15 -36.96 75.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.443 1.497 . . . . 0.0 111.872 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.24 -22.36 59.37 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.768 1.227 . . . . 0.0 114.058 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.79 -8.82 57.87 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.684 1.194 . . . . 0.0 112.421 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 65.74 32.89 8.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.232 1.413 . . . . 0.0 112.712 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.7 mtp -64.98 -23.63 67.28 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.36 -13.41 1.4 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.584 1.954 . . . . 0.0 114.709 168.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -73.79 43.89 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.486 1.915 . . . . 0.0 112.915 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.2 m -120.74 129.7 53.74 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.658 1.583 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.78 -39.45 65.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.449 1.499 . . . . 0.0 113.83 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.44 2.82 42.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 0.0 113.707 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 62.87 32.73 15.63 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.288 1.035 . . . . 0.0 111.169 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -107.82 27.15 9.5 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.372 1.469 . . . . 0.0 113.12 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.18 125.8 7.29 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.203 0.906 . . . . 0.0 112.077 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.23 135.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.979 1.312 . . . . 0.0 109.714 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.17 127.99 54.66 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.241 1.02 . . . . 0.0 111.315 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -101.55 96.19 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.621 1.568 . . . . 0.0 109.215 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -84.16 124.37 31.08 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.151 -0.968 . . . . 0.0 110.805 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -120.9 131.92 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.224 1.01 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 90.96 3.54 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.131 1.773 . . . . 0.0 110.609 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.29 -14.82 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -75.61 -34.97 60.62 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 122.847 0.459 . . . . 0.0 111.252 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.45 -12.22 16.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.116 2.167 . . . . 0.0 112.757 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 73.03 26.0 2.26 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.127 1.771 . . . . 0.0 112.441 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -110.01 167.44 10.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.073 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -148.39 148.64 30.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.298 1.039 . . . . 0.0 110.644 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.9 142.37 40.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.63 128.26 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -145.84 125.64 13.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.621 1.168 . . . . 0.0 109.606 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.35 161.98 13.38 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.527 1.061 . . . . 0.0 112.023 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -64.58 162.91 14.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 123.212 1.482 . . . . 0.0 111.798 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.008 1.723 . . . . 0.0 113.451 -170.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.48 -25.44 72.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.259 -1.301 . . . . 0.0 114.534 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 -58.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.971 1.885 . . . . 0.0 109.302 167.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -59.69 -25.15 64.53 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.5 -18.24 34.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.472 1.109 . . . . 0.0 113.884 174.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -104.11 -20.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.11 167.47 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.844 1.257 . . . . 0.0 111.287 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -120.25 173.06 7.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.54 1.136 . . . . 0.0 113.101 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -49.41 -38.49 29.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -31.0 72.04 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.88 -32.78 69.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.656 0.782 . . . . 0.0 111.636 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -78.99 -26.35 43.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.289 1.436 . . . . 0.0 113.334 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.99 -41.56 87.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.57 0.748 . . . . 0.0 112.646 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -59.53 -43.05 93.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.255 0.479 . . . . 0.0 111.287 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -61.34 -51.16 70.0 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 125.72 1.608 . . . . 0.0 110.401 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.08 -48.51 79.93 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 118.075 -0.965 . . . . 0.0 110.587 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.85 -41.69 96.35 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.207 1.367 . . . . 0.0 113.362 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.09 79.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.917 1.235 . . . . 0.0 111.327 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.33 -54.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.934 0.894 . . . . 0.0 110.451 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -52.37 -44.94 65.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.304 1.842 . . . . 0.0 113.174 -175.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.37 -30.54 62.03 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.215 0.606 . . . . 0.0 112.557 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -82.36 -39.65 22.45 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.75 0.82 . . . . 0.0 111.063 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.98 -43.25 91.37 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.407 0.683 . . . . 0.0 111.406 170.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.06 -37.31 71.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.264 1.025 . . . . 0.0 112.06 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -71.89 -41.08 68.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.337 1.055 . . . . 0.0 111.409 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.13 4.78 6.42 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 126.323 1.916 . . . . 0.0 113.648 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -102.46 81.4 2.05 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 119.0 1.4 . . . . 0.0 111.71 -171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -60.03 -43.61 95.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.754 0.822 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.43 -52.69 64.37 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.783 -0.573 . . . . 0.0 111.515 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -56.93 -44.76 82.79 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.06 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.92 96.08 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.344 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.75 -52.22 64.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.754 0.777 . . . . 0.0 111.021 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.3 t -63.77 -49.15 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.163 . . . . 0.0 110.907 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.37 -32.72 74.29 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.845 0.748 . . . . 0.0 111.834 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.99 -45.42 73.14 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.57 -47.85 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.015 1.326 . . . . 0.0 111.309 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.87 -49.56 76.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.577 0.751 . . . . 0.0 111.483 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -63.48 -34.75 78.45 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.387 -0.82 . . . . 0.0 112.466 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.52 79.52 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.023 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.76 -39.76 97.89 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.51 1.05 . . . . 0.0 112.776 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 78.5 mtp -61.46 -48.41 81.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.046 0.923 . . . . 0.0 112.379 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.62 -41.85 65.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.657 0.783 . . . . 0.0 112.308 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.65 -37.92 85.8 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 111.185 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.12 -23.59 67.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -62.22 -45.6 92.61 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.494 -1.379 . . . . 0.0 111.225 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -74.03 -39.44 63.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.21 1.004 . . . . 0.0 111.988 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.42 82.56 65.95 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 125.986 1.715 . . . . 0.0 110.567 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.83 136.58 53.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.36 2.04 . . . . 0.0 109.622 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -57.54 135.75 56.67 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -108.75 146.29 33.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.885 1.274 . . . . 0.0 110.003 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -24.48 67.39 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.426 -1.421 . . . . 0.0 113.541 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -105.51 19.42 20.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.016 1.326 . . . . 0.0 113.467 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.8 162.1 1.91 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.269 1.428 . . . . 0.0 113.66 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.89 116.66 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 122.622 1.201 . . . . 0.0 112.221 -170.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -101.31 104.13 15.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.088 1.755 . . . . 0.0 109.597 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -115.63 -17.84 11.03 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 mp -84.67 160.07 56.85 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 120.201 1.364 . . . . 0.0 110.533 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -95.95 141.91 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.162 3.241 . . . . 0.0 111.271 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.405 HD22 ' CD ' ' A' ' 24' ' ' GLU . 35.0 m-80 -72.63 -1.33 15.79 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -62.62 150.49 40.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.077 0.951 . . . . 0.0 111.445 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.6 133.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.67 0.788 . . . . 0.0 108.996 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.76 143.88 27.32 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.614 -0.678 . . . . 0.0 112.295 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -145.85 147.45 31.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.217 -0.927 . . . . 0.0 112.168 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 C-N-CA 126.731 2.11 . . . . 0.0 112.026 165.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mtp . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -81.87 -27.95 33.22 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -130.59 147.1 52.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.408 1.083 . . . . 0.0 109.666 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -104.75 -1.63 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.423 1.089 . . . . 0.0 113.112 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.77 -34.38 75.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.755 1.622 . . . . 0.0 112.788 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -136.62 122.73 20.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.781 2.032 . . . . 0.0 108.085 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -75.53 -25.31 57.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.3 126.53 18.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.601 1.56 . . . . 0.0 107.516 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 m -58.79 157.15 10.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.066 0.947 . . . . 0.0 110.31 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.81 -44.03 18.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -51.14 -40.43 58.52 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 173.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -79.49 -39.95 30.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.025 0.93 . . . . 0.0 111.434 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.06 -46.03 75.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -57.95 -48.93 78.48 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.355 -1.466 . . . . 0.0 110.7 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.35 85.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.18 -38.68 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.951 1.25 . . . . 0.0 112.678 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.12 -46.19 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.634 0.652 . . . . 0.0 110.719 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.15 -35.73 79.67 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.885 0.874 . . . . 0.0 112.828 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.38 96.93 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.897 0.772 . . . . 0.0 111.437 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.39 -45.01 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.628 -0.67 . . . . 0.0 110.51 172.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -56.92 -27.46 60.95 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -83.64 -28.85 28.13 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.105 0.866 . . . . 0.0 112.3 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.37 97.63 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.767 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.58 18.4 0.17 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.952 1.301 . . . . 0.0 113.637 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.96 11.44 8.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.823 2.049 . . . . 0.0 111.376 166.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.44 -10.74 3.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.832 1.653 . . . . 0.0 113.378 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -150.5 171.0 17.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.021 1.728 . . . . 0.0 110.171 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -101.35 5.09 42.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.974 1.71 . . . . 0.0 112.776 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.5 126.44 6.52 Favored Glycine 0 C--N 1.343 0.959 0 C-N-CA 124.992 1.282 . . . . 0.0 112.425 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -94.23 142.32 27.55 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -156.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mt -114.76 134.91 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.505 1.122 . . . . 0.0 111.293 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -144.11 149.35 36.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.947 1.299 . . . . 0.0 112.131 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.79 141.79 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.918 1.687 . . . . 0.0 110.327 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -124.39 127.0 46.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.686 1.594 . . . . 0.0 112.0 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -112.77 123.05 49.43 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.393 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 46' ' ' ARG . 26.1 tt0 -143.14 159.07 42.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.036 0.934 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -68.61 -73.29 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.739 -1.226 . . . . 0.0 110.824 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -153.98 159.19 41.55 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.27 1.828 . . . . 0.0 110.671 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.473 ' HG ' HG23 ' A' ' 43' ' ' VAL . 29.9 m -105.21 159.8 15.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.69 1.596 . . . . 0.0 110.361 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -94.48 -27.58 15.92 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.227 -0.921 . . . . 0.0 112.766 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.33 -150.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 126.112 1.765 . . . . 0.0 111.334 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.84 136.51 34.1 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.549 1.139 . . . . 0.0 111.696 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' A' ' 39' ' ' SER . 51.7 t -68.27 -37.24 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.076 0.95 . . . . 0.0 112.146 -174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -64.3 -47.43 79.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.372 0.987 . . . . 0.0 111.933 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -44.32 97.09 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.473 1.509 . . . . 0.0 110.387 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 36' ' ' GLU . 47.6 ttt85 -61.04 -45.69 93.75 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.623 1.169 . . . . 0.0 113.409 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.4 98.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.791 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.0 ttp -60.58 -43.17 97.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.963 0.905 . . . . 0.0 113.048 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -61.47 -54.46 43.09 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.933 -1.104 . . . . 0.0 112.228 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.98 -41.57 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.116 0.566 . . . . 0.0 111.86 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.99 -49.89 76.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.88 1.272 . . . . 0.0 111.919 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -74.76 -32.91 62.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.144 0.978 . . . . 0.0 112.059 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -64.99 -36.31 84.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.045 -1.659 . . . . 0.0 112.463 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.97 -8.04 57.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.823 1.249 . . . . 0.0 113.279 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 65.45 35.89 7.07 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 126.226 1.81 . . . . 0.0 112.214 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.4 mtp -69.64 -25.26 63.85 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.865 -1.147 . . . . 0.0 112.79 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -69.64 -12.73 61.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.304 2.241 . . . . 0.0 114.411 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -84.77 63.45 8.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.24 1.416 . . . . 0.0 110.937 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.2 m -132.01 133.94 45.0 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.884 1.673 . . . . 0.0 109.546 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -48.99 -54.73 14.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 113.45 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.24 -9.9 51.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.736 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 62.72 55.39 2.14 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.174 1.79 . . . . 0.0 109.956 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -125.8 28.93 6.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.537 1.135 . . . . 0.0 111.904 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.86 133.78 17.69 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 120.669 -1.269 . . . . 0.0 111.335 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.79 135.84 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.014 1.326 . . . . 0.0 111.273 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.0 tp -118.52 121.37 40.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.916 1.286 . . . . 0.0 110.781 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -95.14 96.55 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -78.64 123.02 26.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.391 0.677 . . . . 0.0 110.03 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.4 127.13 75.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.637 1.175 . . . . 0.0 110.212 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.62 92.69 4.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.77 1.228 . . . . 0.0 109.531 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.05 -6.11 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -171.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.24 -49.89 15.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.786 0.721 . . . . 0.0 109.726 170.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.2 -9.43 53.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 112.629 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.3 tttt 71.72 20.59 4.58 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.005 2.122 . . . . 0.0 113.133 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.3 p -102.6 169.34 8.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.957 1.303 . . . . 0.0 111.805 -174.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.46 145.92 31.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.59 1.156 . . . . 0.0 110.595 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.49 136.46 48.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 126.241 1.817 . . . . 0.0 107.103 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.39 127.62 73.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -130.11 147.0 51.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 109.758 173.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.64 154.78 26.04 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -58.52 162.54 3.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.174 1.464 . . . . 0.0 113.767 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -53.23 -36.71 61.35 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.344 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -45.18 94.6 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 120.647 1.567 . . . . 0.0 112.433 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 61.2 mt -58.97 -57.44 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 118.301 1.05 . . . . 0.0 109.854 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -58.57 -29.7 66.59 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -81.59 -16.68 50.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 112.851 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.89 -34.79 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.63 165.93 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.176 1.353 . . . . 0.0 112.016 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.1 m -115.39 165.4 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.055 1.342 . . . . 0.0 112.382 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -61.03 -26.03 67.33 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.83 -1.169 . . . . 0.0 112.997 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.68 -23.3 56.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.154 0.981 . . . . 0.0 112.81 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.21 -27.4 47.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.639 1.576 . . . . 0.0 111.578 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -79.8 -29.43 40.28 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -49.52 -48.04 48.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.566 1.147 . . . . 0.0 112.599 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -54.33 -44.72 72.31 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.533 1.533 . . . . 0.0 112.293 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.3 m -64.94 -48.67 73.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.911 1.284 . . . . 0.0 110.691 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -56.74 -46.39 81.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.377 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.58 -45.6 92.19 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 112.817 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.62 -50.52 71.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.922 1.237 . . . . 0.0 112.362 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.5 -50.99 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.652 0.781 . . . . 0.0 110.655 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -60.29 -46.79 88.63 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.534 1.533 . . . . 0.0 112.012 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.11 -33.61 74.77 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.224 0.609 . . . . 0.0 112.381 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -84.1 -40.18 18.59 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.442 1.097 . . . . 0.0 112.191 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.7 -36.81 77.26 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.569 -0.707 . . . . 0.0 111.186 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -62.7 -29.93 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.996 1.318 . . . . 0.0 113.505 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -80.31 -29.31 38.12 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.942 -1.099 . . . . 0.0 110.866 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 -1.8 33.37 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 126.015 1.769 . . . . 0.0 113.801 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -86.57 92.14 8.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.39 1.095 . . . . 0.0 111.039 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.73 -38.26 88.66 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.032 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -59.98 -59.66 5.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.265 0.626 . . . . 0.0 111.153 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.45 -40.94 96.31 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.913 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.85 97.16 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.923 1.238 . . . . 0.0 114.019 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.1 mt -71.16 -45.65 63.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.395 0.598 . . . . 0.0 111.481 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.87 -50.45 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.307 0.958 . . . . 0.0 112.009 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.501 1.12 . . . . 0.0 111.104 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.53 -47.55 88.54 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 123.574 0.607 . . . . 0.0 111.633 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.27 -42.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.734 1.214 . . . . 0.0 111.333 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.65 -39.82 94.37 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.198 1.399 . . . . 0.0 112.001 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -72.46 -43.59 63.51 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.905 -1.122 . . . . 0.0 111.526 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.02 75.47 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.343 1.057 . . . . 0.0 111.095 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.47 -44.22 96.87 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.256 0.935 . . . . 0.0 112.088 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -67.16 -26.2 66.54 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.566 -0.961 . . . . 0.0 113.557 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.22 -50.27 12.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.084 1.353 . . . . 0.0 111.426 172.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.2 mt -58.63 -38.17 77.47 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.763 2.025 . . . . 0.0 111.789 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.55 -14.15 12.0 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -80.53 -35.39 34.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 120.454 -1.404 . . . . 0.0 111.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -84.18 -38.81 20.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 113.041 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.52 86.26 53.72 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.02 1.728 . . . . 0.0 109.235 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.42 135.32 26.35 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.712 2.275 . . . . 0.0 110.466 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -56.33 146.28 24.49 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -125.45 153.64 43.2 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.709 1.204 . . . . 0.0 110.986 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -62.04 -35.86 79.88 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.858 -1.151 . . . . 0.0 113.063 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.3 13.77 9.13 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 113.64 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.38 158.62 28.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.853 0.861 . . . . 0.0 112.732 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.2 168.28 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.041 1.736 . . . . 0.0 110.73 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.61 106.13 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.044 1.738 . . . . 0.0 106.905 -174.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.96 -32.07 20.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.02 0.928 . . . . 0.0 113.087 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.7 mt -109.97 141.72 24.36 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.153 0.981 . . . . 0.0 111.174 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.81 141.08 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.398 2.065 . . . . 0.0 111.288 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -64.92 1.39 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.1 1.76 . . . . 0.0 115.189 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 p -71.39 141.99 50.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.826 -1.171 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 82.4 mt -73.46 136.36 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.245 1.018 . . . . 0.0 109.706 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -96.1 145.91 25.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 120.906 -1.122 . . . . 0.0 111.009 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -144.98 142.46 29.83 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.416 -1.427 . . . . 0.0 112.816 -172.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.406 0 C-N-CA 125.761 1.648 . . . . 0.0 112.814 169.453 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 115.513 -2.184 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -24.77 -32.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -159.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -34.6 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 119.983 -1.698 . . . . 0.0 114.133 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 pt -142.85 138.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.26 2.624 . . . . 0.0 109.499 -173.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -133.98 -95.69 0.29 Allowed 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.055 -1.028 . . . . 0.0 110.785 -168.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.31 -35.54 7.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.46 1.027 . . . . 0.0 112.06 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -46.19 -55.41 7.14 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -148.78 157.46 43.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.329 1.852 . . . . 0.0 110.292 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 p -84.7 166.48 17.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 111.889 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.28 77.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 112.121 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.7 -48.74 78.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.147 1.379 . . . . 0.0 111.052 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HA ' ' HZ2' ' A' ' 110' ' ' LYS . 84.6 mt-10 -64.32 -44.23 92.19 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.282 0.633 . . . . 0.0 111.366 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.85 -29.51 62.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.486 1.514 . . . . 0.0 113.424 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -65.93 -37.73 86.8 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.01 -1.681 . . . . 0.0 111.7 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.86 -39.42 35.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.84 -37.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.505 -1.372 . . . . 0.0 112.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.13 -36.14 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.662 0.664 . . . . 0.0 110.846 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -72.2 -25.24 61.59 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.556 1.142 . . . . 0.0 112.754 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -40.32 72.87 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.687 -0.633 . . . . 0.0 111.587 172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.93 -44.89 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.349 -0.844 . . . . 0.0 110.991 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -57.52 -32.5 67.11 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -79.74 -30.36 40.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.636 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.75 74.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -55.39 -19.41 9.0 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.276 1.431 . . . . 0.0 112.461 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -103.51 9.9 37.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.526 . . . . 0.0 112.926 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -124.95 -12.92 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.983 1.313 . . . . 0.0 113.712 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -164.35 149.28 10.02 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 109.391 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.9 p -85.32 5.7 29.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.054 0.942 . . . . 0.0 112.92 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.94 168.65 43.42 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.831 1.205 . . . . 0.0 110.304 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -137.18 121.95 18.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.934 . . . . 0.0 113.054 -166.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.45 137.72 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.209 1.404 . . . . 0.0 111.04 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -146.55 153.85 40.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.274 1.429 . . . . 0.0 110.433 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.48 138.4 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.919 1.287 . . . . 0.0 110.203 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -116.3 115.69 26.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 110.964 165.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.9 tp -98.17 134.22 41.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.484 0.714 . . . . 0.0 111.143 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.03 162.36 41.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.181 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.83 -69.37 0.44 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.722 1.209 . . . . 0.0 112.673 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -160.36 152.38 20.24 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.539 1.135 . . . . 0.0 113.289 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.6 p -109.96 141.64 42.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.667 1.587 . . . . 0.0 113.181 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.57 -28.51 56.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.482 0.658 . . . . 0.0 112.498 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -109.95 -172.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.113 2.165 . . . . 0.0 111.641 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.12 132.74 51.36 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.755 1.222 . . . . 0.0 112.812 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.57 -41.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.816 1.246 . . . . 0.0 111.467 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -48.5 79.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.645 0.778 . . . . 0.0 112.11 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.51 -42.09 83.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.871 0.868 . . . . 0.0 110.992 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -60.02 -46.34 89.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.213 1.005 . . . . 0.0 112.156 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.58 -37.92 88.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.211 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.7 ttp -63.94 -48.89 74.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.859 0.754 . . . . 0.0 111.654 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.78 -46.8 89.07 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.238 0.615 . . . . 0.0 111.054 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.61 -43.04 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.66 1.184 . . . . 0.0 111.79 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.04 -48.43 81.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.497 1.044 . . . . 0.0 112.185 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -72.39 -33.41 67.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.582 1.153 . . . . 0.0 112.606 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -65.36 -42.79 92.41 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.607 -1.308 . . . . 0.0 111.809 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.42 -1.21 32.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.537 1.135 . . . . 0.0 112.947 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 59.75 37.92 21.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.811 1.244 . . . . 0.0 112.28 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtp -75.44 -21.17 58.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 112.511 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.81 -13.12 9.08 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.308 2.643 . . . . 0.0 114.415 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -64.45 -7.89 11.57 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -55.02 140.01 39.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.642 1.977 . . . . 0.0 111.074 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -66.43 -36.07 81.89 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.381 -0.824 . . . . 0.0 112.177 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.52 -1.45 56.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 62.06 27.86 16.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.247 1.023 . . . . 0.0 111.311 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -107.92 39.42 1.95 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.161 1.784 . . . . 0.0 112.752 -171.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.13 128.33 9.44 Favored Glycine 0 N--CA 1.479 1.53 0 C-N-CA 124.473 1.035 . . . . 0.0 112.262 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.66 132.26 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.209 1.803 . . . . 0.0 109.911 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.6 tp -117.39 128.1 54.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.122 0.969 . . . . 0.0 111.194 170.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.61 97.41 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.671 1.189 . . . . 0.0 107.804 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -81.84 122.74 28.11 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.081 0.952 . . . . 0.0 111.039 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.34 125.62 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.913 0.885 . . . . 0.0 110.284 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 100.27 11.28 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.657 1.583 . . . . 0.0 110.188 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.19 -19.47 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -74.23 -47.14 37.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.655 1.116 . . . . 0.0 111.153 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -88.86 -11.61 44.18 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.7 1.2 . . . . 0.0 113.612 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.5 tttt 71.82 30.11 2.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.01 1.724 . . . . 0.0 112.717 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -113.3 133.39 55.14 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.391 1.477 . . . . 0.0 110.052 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -114.43 143.23 45.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.022 1.329 . . . . 0.0 109.371 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.99 134.27 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.027 1.331 . . . . 0.0 108.194 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 mt -112.48 129.58 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -135.84 124.13 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.728 0.811 . . . . 0.0 110.45 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.83 154.49 17.0 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.559 1.076 . . . . 0.0 110.785 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -67.93 168.4 11.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 122.374 1.083 . . . . 0.0 111.929 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.38 -26.52 63.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.952 1.301 . . . . 0.0 114.452 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.66 55.0 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.812 1.187 . . . . 0.0 111.492 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.93 -54.91 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.538 1.169 . . . . 0.0 109.272 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -60.9 -30.72 70.34 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -78.24 -38.12 43.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.873 0.869 . . . . 0.0 112.113 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 m -89.17 -23.06 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.59 162.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.231 0.923 . . . . 0.0 112.232 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -113.11 173.38 6.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.424 1.49 . . . . 0.0 112.462 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -58.24 -29.41 65.73 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.281 -1.512 . . . . 0.0 114.598 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.73 -23.78 61.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.89 1.276 . . . . 0.0 111.994 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -76.12 -31.02 58.43 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.314 -0.866 . . . . 0.0 111.065 168.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -80.55 -32.18 36.76 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.25 -45.04 68.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.268 1.427 . . . . 0.0 113.005 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -58.12 -34.97 70.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.528 1.131 . . . . 0.0 113.067 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.5 m -72.5 -50.21 27.55 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 127.029 2.132 . . . . 0.0 109.345 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -60.93 -43.29 98.83 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.787 0.435 . . . . 0.0 111.2 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.46 -38.3 80.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.03 -50.72 65.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.566 0.621 . . . . 0.0 111.371 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.68 -48.75 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.067 0.947 . . . . 0.0 110.783 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -61.93 -40.55 95.89 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.292 1.437 . . . . 0.0 113.091 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.2 tp -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.6 0.636 . . . . 0.0 111.484 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -34.99 48.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.543 -0.723 . . . . 0.0 112.665 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.39 -40.81 98.24 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.839 0.855 . . . . 0.0 111.16 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.09 -35.43 80.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 112.143 172.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.87 -21.59 60.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.723 1.209 . . . . 0.0 113.138 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.38 -5.43 44.82 Favored Glycine 0 N--CA 1.48 1.585 0 C-N-CA 126.16 1.838 . . . . 0.0 114.943 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -97.82 82.8 3.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.832 1.253 . . . . 0.0 111.54 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.56 -48.2 82.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.506 0.722 . . . . 0.0 112.469 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HZ2' ' HA ' ' A' ' 12' ' ' GLU . 75.4 tttt -54.57 -53.62 52.16 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.283 0.492 . . . . 0.0 111.644 177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.81 -41.21 77.35 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.591 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.92 -36.76 65.22 Favored Glycine 0 N--CA 1.472 1.075 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.775 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.5 -52.07 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.536 0.668 . . . . 0.0 109.995 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.74 -45.18 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.647 0.779 . . . . 0.0 111.585 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.6 -45.65 93.22 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.343 1.457 . . . . 0.0 111.3 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.91 -36.84 91.65 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.742 0.686 . . . . 0.0 113.388 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.22 -51.58 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.461 1.104 . . . . 0.0 110.424 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.43 -41.03 98.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.234 1.014 . . . . 0.0 111.856 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.08 -39.56 78.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.34 0.656 . . . . 0.0 112.586 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.08 96.13 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.632 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.7 -49.36 78.26 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-N 119.162 0.892 . . . . 0.0 112.004 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.32 -34.45 73.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.692 1.246 . . . . 0.0 113.793 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.92 -46.52 15.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.368 0.667 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -59.52 -37.59 78.74 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 110.675 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.99 -15.66 57.0 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -76.57 -33.73 58.47 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.512 -1.368 . . . . 0.0 111.295 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -81.58 -39.78 24.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.061 1.344 . . . . 0.0 111.224 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.54 79.52 72.04 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.752 2.021 . . . . 0.0 111.501 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 138.35 39.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.229 2.62 . . . . 0.0 112.192 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.7 t90 -64.87 135.88 56.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.37 151.86 30.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.799 1.639 . . . . 0.0 111.605 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -69.99 -3.09 14.66 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.542 -1.349 . . . . 0.0 114.353 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -115.86 7.4 14.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.151 1.781 . . . . 0.0 112.576 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -58.22 148.62 26.48 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.434 1.093 . . . . 0.0 112.236 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.01 135.58 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 111.317 -169.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -75.75 108.48 8.62 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.507 1.123 . . . . 0.0 109.706 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -89.56 -35.91 15.64 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.211 -0.93 . . . . 0.0 112.283 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.56 157.69 43.63 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.472 1.509 . . . . 0.0 111.039 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -90.8 141.0 3.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.882 3.055 . . . . 0.0 111.254 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -61.15 -7.07 2.37 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.612 2.365 . . . . 0.0 116.836 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.2 m -58.11 152.5 16.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.584 1.154 . . . . 0.0 111.788 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.45 130.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.648 1.179 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t -88.11 141.34 28.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.404 0.682 . . . . 0.0 110.651 171.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -151.7 135.39 16.3 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 116.595 -2.225 . . . . 0.0 114.164 -174.295 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 118.731 -0.652 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 m -54.9 146.58 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.667 1.121 . . . . 0.0 112.335 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.8 -30.07 70.17 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.643 -1.285 . . . . 0.0 113.662 -173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mt -111.83 121.7 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -116.94 -28.51 6.26 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.409 0.683 . . . . 0.0 110.99 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -141.66 125.54 17.1 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.162 1.785 . . . . 0.0 110.357 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.27 -5.3 57.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 112.59 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.78 144.74 50.51 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 109.212 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -77.17 166.15 23.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.23 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.847 -1.158 . . . . 0.0 111.726 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.3 -48.08 82.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.733 1.213 . . . . 0.0 110.917 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.9 -39.91 72.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.479 1.111 . . . . 0.0 111.235 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.87 -46.45 74.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.044 1.338 . . . . 0.0 112.325 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -56.91 -47.31 80.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.448 -1.408 . . . . 0.0 111.081 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.89 84.8 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 tt -74.16 -35.84 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.047 -1.033 . . . . 0.0 112.171 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.42 -42.86 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.625 1.102 . . . . 0.0 111.392 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.92 -27.42 68.17 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.22 -43.37 74.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.474 0.579 . . . . 0.0 111.548 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.63 -43.75 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.391 0.677 . . . . 0.0 110.256 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -60.31 -25.57 65.87 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.97 -36.27 23.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.256 1.389 . . . . 0.0 111.986 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.53 97.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.175 0.99 . . . . 0.0 112.198 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.72 -4.63 9.42 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -106.85 11.76 29.69 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.009 -1.682 . . . . 0.0 112.529 170.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.77 -6.44 5.09 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.65 1.98 . . . . 0.0 114.084 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -164.3 151.4 11.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.148 2.179 . . . . 0.0 109.729 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -88.11 11.57 15.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.742 1.217 . . . . 0.0 113.853 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.41 133.13 10.37 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 125.742 1.639 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -104.19 138.21 40.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.349 1.06 . . . . 0.0 112.642 -155.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.03 139.66 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 120.356 -1.465 . . . . 0.0 111.247 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -139.13 146.45 40.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.932 1.693 . . . . 0.0 111.296 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.76 136.26 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.929 1.291 . . . . 0.0 109.608 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -122.3 120.3 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.272 1.429 . . . . 0.0 113.058 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.55 125.23 54.03 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.557 1.143 . . . . 0.0 111.392 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -154.08 160.63 42.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.961 1.304 . . . . 0.0 109.983 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.26 -72.1 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 m -143.26 165.19 28.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.363 2.265 . . . . 0.0 107.892 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.7 m -124.7 155.85 38.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.315 1.046 . . . . 0.0 110.46 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.94 -1.75 57.79 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 pt -134.55 -131.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 126.57 1.948 . . . . 0.0 111.181 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -101.77 142.11 33.6 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.438 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.18 -36.0 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.006 0.522 . . . . 0.0 111.84 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.49 -50.39 71.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.743 0.817 . . . . 0.0 111.937 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.26 -33.46 75.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.106 0.563 . . . . 0.0 111.47 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -65.66 -46.63 78.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.902 0.881 . . . . 0.0 112.568 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.15 90.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.664 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -59.12 -49.9 76.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.337 0.655 . . . . 0.0 111.715 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.4 -45.89 91.1 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.759 -0.588 . . . . 0.0 111.717 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.38 -35.17 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.715 -0.659 . . . . 0.0 110.785 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.7 -50.56 73.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.536 1.062 . . . . 0.0 111.718 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -72.72 -34.46 67.1 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.436 0.695 . . . . 0.0 111.608 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -70.37 -26.74 63.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.56 6.91 47.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.355 1.462 . . . . 0.0 112.425 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 60.92 26.39 16.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.625 1.57 . . . . 0.0 112.284 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.0 -18.1 60.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.723 1.209 . . . . 0.0 112.326 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -74.06 -8.21 55.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.424 2.29 . . . . 0.0 113.756 169.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -98.83 82.69 2.82 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 121.562 -0.711 . . . . 0.0 110.474 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.5 p -139.2 152.82 47.67 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.044 1.337 . . . . 0.0 110.501 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -57.86 -37.34 73.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.9 mt -105.96 -7.95 17.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.61 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 70.94 29.26 3.05 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.953 1.301 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -105.41 35.11 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.094 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.75 117.0 4.79 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.127 -0.818 . . . . 0.0 111.851 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.6 t -98.98 139.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.583 1.553 . . . . 0.0 110.232 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.5 tp -129.16 133.94 47.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.29 100.12 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.705 1.202 . . . . 0.0 109.409 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.58 128.0 32.91 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.072 -1.018 . . . . 0.0 109.994 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -124.26 127.52 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.911 0.884 . . . . 0.0 110.657 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.11 95.12 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.542 1.537 . . . . 0.0 110.035 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.42 -21.0 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -165.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.64 -28.69 45.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.51 1.05 . . . . 0.0 111.825 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -97.47 -4.99 37.02 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.443 1.097 . . . . 0.0 112.714 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 61.39 23.01 13.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.996 1.718 . . . . 0.0 112.003 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -105.36 169.02 8.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.597 1.559 . . . . 0.0 110.781 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -146.73 143.95 29.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.173 1.789 . . . . 0.0 108.749 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.8 140.43 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.146 1.378 . . . . 0.0 107.299 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.3 mt -118.68 133.34 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -139.4 138.18 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.259 1.423 . . . . 0.0 109.128 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.85 155.42 21.21 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -66.72 172.48 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 123.556 1.646 . . . . 0.0 111.82 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -61.45 -33.56 73.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.64 -1.172 . . . . 0.0 112.707 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -48.7 76.39 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 120.242 1.383 . . . . 0.0 112.31 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.97 -56.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.202 1.001 . . . . 0.0 109.774 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.6 -24.71 66.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -78.25 -38.36 43.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.014 1.325 . . . . 0.0 110.397 173.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 p -90.8 -29.22 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.89 156.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.842 1.656 . . . . 0.0 113.004 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.7 m -102.36 172.72 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.531 1.533 . . . . 0.0 114.803 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -61.12 -34.33 74.8 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.88 -24.42 67.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 0.0 113.029 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -77.22 -39.36 48.83 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.18 -0.95 . . . . 0.0 111.281 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -70.85 -29.62 65.79 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.191 1.396 . . . . 0.0 114.108 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.62 -37.97 74.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.505 0.722 . . . . 0.0 112.759 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 m -62.05 -43.57 98.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.696 0.798 . . . . 0.0 111.086 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -59.11 -53.81 54.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.673 1.989 . . . . 0.0 110.583 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -56.68 -50.26 72.66 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.659 1.184 . . . . 0.0 111.204 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -57.91 -36.44 72.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.248 1.019 . . . . 0.0 113.621 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.46 20.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.788 0.835 . . . . 0.0 112.019 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.12 -49.54 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.187 0.995 . . . . 0.0 109.639 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.3 -42.54 91.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.118 1.367 . . . . 0.0 113.382 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.64 -45.44 90.19 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.063 0.545 . . . . 0.0 110.869 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.02 -29.35 55.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.16 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.51 -39.64 81.16 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.358 0.981 . . . . 0.0 111.481 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.85 -43.54 94.58 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.555 0.742 . . . . 0.0 111.09 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.49 -35.23 79.77 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.991 -0.528 . . . . 0.0 111.935 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.88 10.28 24.89 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.834 1.683 . . . . 0.0 114.674 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.79 83.44 2.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -62.52 -39.62 94.15 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.764 1.225 . . . . 0.0 112.705 -171.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -54.78 -56.01 23.97 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -60.81 -42.21 97.19 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.904 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.93 -41.58 97.32 Favored Glycine 0 N--CA 1.473 1.101 0 CA-C-N 120.187 1.358 . . . . 0.0 112.378 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.63 -47.21 73.31 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.547 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.32 -48.49 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 118.852 0.751 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -63.41 -35.36 80.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.982 0.81 . . . . 0.0 112.021 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.91 -43.98 92.7 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.067 -0.852 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.9 -47.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.929 1.292 . . . . 0.0 111.362 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.98 -49.51 77.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.712 0.805 . . . . 0.0 111.504 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -65.28 -38.73 91.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.828 -0.545 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.39 74.08 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.844 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.15 87.57 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 119.669 1.122 . . . . 0.0 112.469 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.3 mtp -58.36 -42.22 86.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.987 0.894 . . . . 0.0 112.908 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.69 57.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.501 0.721 . . . . 0.0 111.586 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.1 mt -62.07 -36.58 82.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.795 1.238 . . . . 0.0 111.131 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.05 -18.22 32.82 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -70.99 -34.58 71.52 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.246 -1.534 . . . . 0.0 112.198 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -90.12 -35.78 15.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.37 1.468 . . . . 0.0 112.981 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -131.89 85.2 51.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.937 1.695 . . . . 0.0 110.044 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.52 147.47 93.1 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.381 2.054 . . . . 0.0 110.497 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -69.54 146.68 51.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.332 1.063 . . . . 0.0 111.783 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -134.73 151.17 50.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.604 1.161 . . . . 0.0 109.611 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.42 -35.95 72.85 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.373 -0.83 . . . . 0.0 112.814 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -90.32 18.09 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.881 1.672 . . . . 0.0 113.224 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.31 151.12 28.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.094 1.358 . . . . 0.0 113.203 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.0 74.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.626 1.57 . . . . 0.0 113.332 -154.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -64.64 108.99 1.86 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.125 1.37 . . . . 0.0 111.014 170.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -114.09 -6.2 13.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.148 1.379 . . . . 0.0 113.139 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.39 145.37 34.2 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.493 1.117 . . . . 0.0 111.384 -165.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.47 132.07 5.77 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.611 2.207 . . . . 0.0 110.971 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -74.13 3.39 7.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.4 p -70.65 156.33 39.6 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 128.21 2.604 . . . . 0.0 112.487 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 84.2 mt -78.26 134.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.699 1.2 . . . . 0.0 108.406 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.3 m -91.93 142.14 27.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.464 0.649 . . . . 0.0 109.458 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -129.8 151.15 50.69 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.171 -0.956 . . . . 0.0 110.698 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.966 0 C-N-CA 126.192 1.853 . . . . 0.0 113.76 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.6 mtm . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 p -175.7 155.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.653 1.581 . . . . 0.0 108.396 -174.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt 56.23 52.76 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.235 1.017 . . . . 0.0 111.051 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.54 -33.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.303 -1.498 . . . . 0.0 111.936 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -76.53 -33.11 58.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.821 1.248 . . . . 0.0 113.016 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -137.44 125.92 23.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.873 1.669 . . . . 0.0 107.427 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -68.23 -25.13 65.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.126 -0.984 . . . . 0.0 112.623 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.3 mt -140.99 142.6 34.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.978 2.511 . . . . 0.0 107.985 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -74.65 167.29 22.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.148 0.431 . . . . 0.0 110.214 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.74 58.57 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 113.21 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -55.2 -41.79 72.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.291 1.436 . . . . 0.0 113.278 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.14 -42.69 25.61 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 110.63 -173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -62.69 -45.14 94.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.362 1.065 . . . . 0.0 111.373 172.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -57.74 -47.55 82.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.344 -0.847 . . . . 0.0 111.888 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.75 88.51 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.347 1.059 . . . . 0.0 113.438 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.18 -41.64 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 117.935 -1.031 . . . . 0.0 112.269 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.53 -42.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.783 1.174 . . . . 0.0 111.464 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.37 -28.73 69.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.138 0.881 . . . . 0.0 113.149 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.98 67.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.93 0.786 . . . . 0.0 112.015 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mm -64.78 -50.51 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.91 0.884 . . . . 0.0 110.127 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -54.28 -29.28 46.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.33 1.052 . . . . 0.0 113.475 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -83.19 -30.2 27.95 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.019 1.328 . . . . 0.0 112.185 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.0 75.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.69 1.132 . . . . 0.0 111.424 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.13 2.34 0.81 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.606 1.562 . . . . 0.0 114.099 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.79 5.41 24.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 119.39 -2.069 . . . . 0.0 113.031 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -126.96 -8.08 6.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.72 1.608 . . . . 0.0 113.522 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -160.07 161.29 33.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.235 1.814 . . . . 0.0 109.157 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -99.04 10.79 40.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.57 172.49 17.64 Favored Glycine 0 N--CA 1.473 1.16 0 O-C-N 120.549 -1.344 . . . . 0.0 110.823 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -123.67 122.24 37.61 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 122.803 0.441 . . . . 0.0 111.67 -160.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 mt -108.71 112.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.336 1.054 . . . . 0.0 110.693 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -123.24 151.1 42.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.754 0.822 . . . . 0.0 113.19 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 t -130.52 134.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.581 1.153 . . . . 0.0 109.008 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -122.11 121.99 38.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 111.991 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.16 132.37 53.11 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.178 0.991 . . . . 0.0 111.462 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -160.23 155.18 24.48 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.786 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.35 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.744 1.218 . . . . 0.0 113.233 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.6 t -137.47 169.76 17.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.193 1.797 . . . . 0.0 110.316 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 p -123.23 157.26 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.501 1.52 . . . . 0.0 113.162 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -90.75 -9.85 45.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.955 1.302 . . . . 0.0 113.293 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 -141.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.049 1.739 . . . . 0.0 111.159 -164.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -102.42 135.24 44.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.634 1.561 . . . . 0.0 112.266 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -62.47 -38.97 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.019 0.928 . . . . 0.0 112.099 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.02 0.827 . . . . 0.0 111.856 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.44 -39.88 85.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.804 0.842 . . . . 0.0 110.781 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -59.02 -47.53 84.86 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.583 -0.698 . . . . 0.0 111.788 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.97 -42.28 99.78 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.604 0.762 . . . . 0.0 110.978 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -58.55 -53.91 52.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.556 1.142 . . . . 0.0 111.247 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -64.63 -37.15 86.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.776 -1.203 . . . . 0.0 112.054 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.85 -47.22 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.346 1.058 . . . . 0.0 111.326 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -56.71 -45.92 81.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.421 1.488 . . . . 0.0 111.987 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -73.39 -40.47 64.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.834 1.254 . . . . 0.0 112.979 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -63.89 -39.31 93.89 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.992 0.815 . . . . 0.0 112.378 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.52 0.23 20.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 113.418 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 62.33 24.41 14.53 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.036 1.334 . . . . 0.0 113.271 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.69 -30.09 68.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 0.0 112.412 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -49.73 -31.14 10.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.073 1.749 . . . . 0.0 112.601 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -77.67 65.05 3.08 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.085 -1.01 . . . . 0.0 113.02 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.0 m -118.9 134.78 54.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.155 2.182 . . . . 0.0 106.705 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.32 -44.5 72.08 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.826 1.194 . . . . 0.0 112.776 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.64 -2.27 58.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 114.017 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 66.2 19.37 11.08 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.727 1.211 . . . . 0.0 113.222 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -99.33 46.83 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.211 1.005 . . . . 0.0 112.061 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.19 121.45 6.71 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.775 1.179 . . . . 0.0 111.907 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.39 140.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 118.311 1.056 . . . . 0.0 109.567 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 tp -120.97 127.16 51.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.985 0.898 . . . . 0.0 111.5 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.1 mt -102.75 97.59 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.492 1.517 . . . . 0.0 108.31 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -82.1 125.3 30.69 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.604 -0.685 . . . . 0.0 110.514 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.11 131.07 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.729 -0.607 . . . . 0.0 110.695 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 100.15 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.892 1.677 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.6 m -80.52 -14.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -81.26 -49.45 10.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.057 0.844 . . . . 0.0 110.58 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -76.09 -16.84 59.84 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.818 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 67.93 41.41 2.11 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.955 1.702 . . . . 0.0 111.172 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.1 p -119.26 172.33 7.67 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.486 1.914 . . . . 0.0 110.245 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -154.74 134.27 12.69 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.005 0.922 . . . . 0.0 109.597 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.17 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.085 1.754 . . . . 0.0 108.214 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.8 mt -125.99 136.9 59.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -154.92 121.29 5.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.225 1.41 . . . . 0.0 109.086 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.99 168.27 12.52 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 124.15 0.881 . . . . 0.0 111.178 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -69.84 165.61 21.17 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.126 1.441 . . . . 0.0 112.278 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.23 -33.29 8.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.93 2.092 . . . . 0.0 113.588 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.67 -44.2 98.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 120.885 1.675 . . . . 0.0 112.296 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.2 -56.53 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.371 1.086 . . . . 0.0 109.787 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -57.43 -31.28 65.73 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.34 -14.75 42.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.572 1.549 . . . . 0.0 113.161 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.95 -18.45 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.01 172.6 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.789 1.177 . . . . 0.0 111.943 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.3 p -118.17 175.67 5.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.949 1.7 . . . . 0.0 113.725 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.75 -21.16 65.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 119.675 -1.891 . . . . 0.0 112.96 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.2 -29.02 66.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.521 1.128 . . . . 0.0 111.936 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -79.02 -32.75 45.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 111.907 174.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -80.0 -30.02 39.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.452 1.501 . . . . 0.0 114.035 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.37 -33.63 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.941 0.791 . . . . 0.0 112.42 -174.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 p -65.36 -42.87 92.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.69 0.796 . . . . 0.0 111.162 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.0 m -57.83 -49.42 76.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 111.497 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -58.05 -50.93 71.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.985 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -60.22 -37.56 80.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.69 58.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.171 0.896 . . . . 0.0 111.549 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.01 -48.54 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.421 0.688 . . . . 0.0 110.727 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -58.64 -40.86 84.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.576 1.55 . . . . 0.0 113.893 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.01 -45.23 67.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.889 0.768 . . . . 0.0 111.152 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -35.61 74.64 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.038 0.535 . . . . 0.0 111.629 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.961 0.801 . . . . 0.0 111.57 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -59.34 -39.26 82.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.858 0.753 . . . . 0.0 111.533 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -74.68 -22.49 58.83 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.893 0.877 . . . . 0.0 112.363 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.11 55.07 Favored Glycine 0 N--CA 1.48 1.6 0 C-N-CA 125.1 1.333 . . . . 0.0 114.162 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -96.09 71.37 2.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.878 1.271 . . . . 0.0 111.369 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -55.88 -46.06 78.39 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -51.24 -57.52 8.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.89 0.876 . . . . 0.0 111.014 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -59.99 -42.73 94.85 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.492 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.68 95.57 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 119.866 1.212 . . . . 0.0 113.225 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 mt -69.09 -48.61 62.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.57 0.685 . . . . 0.0 111.341 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.88 -53.2 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.76 0.709 . . . . 0.0 111.605 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.42 -35.69 81.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.078 0.951 . . . . 0.0 111.858 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.18 -38.05 63.41 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 121.378 -0.827 . . . . 0.0 112.824 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.38 -42.77 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.009 1.324 . . . . 0.0 111.378 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -55.38 -52.45 63.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.694 1.198 . . . . 0.0 110.579 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -65.57 -34.71 78.89 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.09 90.81 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.338 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.42 -44.99 97.03 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 119.431 -0.649 . . . . 0.0 112.286 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.4 mtp -59.85 -42.47 93.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.395 1.097 . . . . 0.0 113.59 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.37 -44.56 51.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.741 0.816 . . . . 0.0 111.129 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.03 -36.64 84.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.408 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.92 -26.87 62.78 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.059 0.944 . . . . 0.0 113.327 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -65.66 -34.78 79.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.401 -1.437 . . . . 0.0 111.472 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.82 -39.9 23.33 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.796 1.238 . . . . 0.0 111.879 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.08 79.51 73.75 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.607 1.563 . . . . 0.0 111.454 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.98 135.32 27.28 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.628 2.218 . . . . 0.0 110.959 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -56.89 147.9 22.36 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -125.62 150.48 47.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.479 1.112 . . . . 0.0 110.157 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -67.14 -26.09 66.5 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.053 -1.655 . . . . 0.0 113.235 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.14 9.11 34.93 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.241 2.216 . . . . 0.0 112.206 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -58.13 138.96 55.71 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 126.132 1.773 . . . . 0.0 113.282 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.83 135.68 49.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 124.571 1.148 . . . . 0.0 110.597 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -97.65 95.65 7.74 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 127.005 2.122 . . . . 0.0 107.198 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.62 -42.51 13.38 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -161.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.6 mt -97.92 160.56 28.17 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 120.137 1.335 . . . . 0.0 111.316 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.68 137.79 9.14 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.79 2.327 . . . . 0.0 109.51 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -71.63 -4.94 29.97 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -60.68 140.15 57.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.089 2.155 . . . . 0.0 111.207 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.7 mt -64.59 140.21 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.012 1.325 . . . . 0.0 110.392 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 m -96.57 143.46 27.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.191 0.596 . . . . 0.0 110.452 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -143.79 137.24 27.9 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.364 -0.835 . . . . 0.0 110.551 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.392 0 CA-C-O 117.984 -1.454 . . . . 0.0 112.649 176.155 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -80.15 164.23 23.48 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.762 -1.211 . . . . 0.0 110.364 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.09 65.06 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.34 -44.12 97.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.392 1.477 . . . . 0.0 111.572 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.77 -43.19 56.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.163 0.985 . . . . 0.0 111.013 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.32 -47.53 83.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 111.289 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.11 -47.46 78.07 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.13 -0.981 . . . . 0.0 111.296 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.46 69.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 tt -80.02 -39.01 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.196 1.362 . . . . 0.0 112.715 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.5 t -58.64 -43.28 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 120.145 1.339 . . . . 0.0 110.808 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -62.23 -27.94 69.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.96 69.79 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.48 -0.762 . . . . 0.0 112.672 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.36 -42.8 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.211 1.005 . . . . 0.0 109.612 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.47 -34.26 66.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.061 1.344 . . . . 0.0 113.493 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.49 -24.93 41.98 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.58 58.77 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.424 1.011 . . . . 0.0 111.952 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -54.74 -28.53 49.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.088 1.355 . . . . 0.0 112.267 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.69 6.58 37.82 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.719 -1.863 . . . . 0.0 112.623 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.49 -15.01 6.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 113.922 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 t -160.95 140.06 10.34 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.186 1.394 . . . . 0.0 109.541 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -80.63 39.01 0.46 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 112.727 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.97 158.0 27.03 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 125.536 1.541 . . . . 0.0 110.892 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.34 142.91 46.52 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -155.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.83 97.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.592 1.157 . . . . 0.0 111.084 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -106.9 145.05 32.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.659 1.184 . . . . 0.0 111.856 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.61 133.54 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.066 1.346 . . . . 0.0 109.243 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -119.15 115.96 25.34 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.939 1.296 . . . . 0.0 111.927 168.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.2 tp -103.52 126.92 50.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.323 1.049 . . . . 0.0 111.315 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.65 162.15 39.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.663 1.22 . . . . 0.0 111.396 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -68.33 -77.15 0.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.464 1.106 . . . . 0.0 112.013 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 t -153.69 165.23 36.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.648 1.979 . . . . 0.0 109.902 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.5 m -115.33 154.66 28.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.325 1.45 . . . . 0.0 111.235 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -92.06 -13.48 30.8 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.054 -1.029 . . . . 0.0 112.645 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 pt -130.37 -163.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.126 1.77 . . . . 0.0 110.702 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -72.52 136.57 45.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.405 0.622 . . . . 0.0 112.464 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.53 -35.14 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.98 0.912 . . . . 0.0 111.716 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.57 -54.89 28.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.299 0.954 . . . . 0.0 112.423 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -63.14 -39.26 94.15 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.647 0.779 . . . . 0.0 111.184 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -61.45 -45.22 95.19 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.713 -0.617 . . . . 0.0 111.754 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.43 94.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.824 0.738 . . . . 0.0 111.277 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.9 ttp -62.52 -43.0 99.88 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 112.386 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.3 -48.65 77.2 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.953 -1.092 . . . . 0.0 111.748 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.6 -42.53 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.899 0.88 . . . . 0.0 111.789 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -57.3 -49.15 77.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.536 1.135 . . . . 0.0 111.157 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -71.59 -38.03 70.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.202 1.001 . . . . 0.0 112.056 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.9 -43.15 93.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.104 1.362 . . . . 0.0 112.773 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.05 -3.62 20.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.193 0.997 . . . . 0.0 112.901 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.8 tttt 64.76 38.21 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.648 1.979 . . . . 0.0 112.296 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.7 mtp -77.04 -12.78 59.98 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -0.89 7.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.226 1.01 . . . . 0.0 113.057 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -74.48 31.08 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.633 1.973 . . . . 0.0 114.457 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -99.87 156.16 17.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.682 1.993 . . . . 0.0 110.881 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -73.85 -30.48 62.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.454 1.102 . . . . 0.0 112.429 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.14 -7.21 16.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 67.33 47.41 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.306 . . . . 0.0 110.851 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -137.97 40.45 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.323 1.049 . . . . 0.0 113.607 -164.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.54 142.68 16.19 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 167.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.72 144.44 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.594 1.158 . . . . 0.0 110.463 169.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -117.2 129.25 55.82 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.167 1.387 . . . . 0.0 109.939 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 mt -103.23 96.85 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.11 119.0 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.193 0.597 . . . . 0.0 110.114 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.66 129.78 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.703 0.801 . . . . 0.0 110.143 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.11 102.88 12.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.717 1.207 . . . . 0.0 109.256 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 37' ' ' LYS . 33.3 m -70.91 -22.18 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -170.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.14 -49.42 23.8 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.229 0.538 . . . . 0.0 111.689 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.37 -15.08 56.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.455 1.102 . . . . 0.0 111.729 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 tttt 75.23 19.8 2.17 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.517 2.327 . . . . 0.0 112.415 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.1 p -98.13 162.59 13.13 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 111.785 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.87 139.32 36.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.741 1.217 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.59 147.62 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.516 1.527 . . . . 0.0 107.786 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.38 125.96 60.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -139.04 120.76 15.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.0 110.244 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.3 152.91 17.63 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 125.523 1.535 . . . . 0.0 111.025 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -66.75 164.57 16.81 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 123.141 1.448 . . . . 0.0 111.654 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -53.54 -37.6 62.99 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 114.39 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.7 -18.92 70.73 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.47 1.033 . . . . 0.0 113.807 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -81.12 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.122 1.461 . . . . 0.0 108.783 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -53.52 -37.6 62.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.657 0.783 . . . . 0.0 113.032 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.14 -17.46 58.59 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.719 1.207 . . . . 0.0 113.011 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.14 -21.62 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.9 m -114.9 179.47 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.756 1.162 . . . . 0.0 111.838 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.1 p -121.98 171.1 9.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.368 1.867 . . . . 0.0 112.392 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.0 -29.09 70.56 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.864 -1.147 . . . . 0.0 112.448 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.3 -38.81 91.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.893 1.277 . . . . 0.0 111.537 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 52.1 t80 -63.65 -46.13 87.04 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.376 0.67 . . . . 0.0 110.351 172.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.244 1.418 . . . . 0.0 114.63 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.81 -39.59 74.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.444 1.098 . . . . 0.0 111.613 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -61.21 -47.12 87.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.636 0.774 . . . . 0.0 111.807 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 m -58.31 -50.34 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.269 1.828 . . . . 0.0 110.413 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -59.13 -51.05 71.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.393 1.077 . . . . 0.0 111.994 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.34 -41.28 96.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.014 0.824 . . . . 0.0 112.698 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.53 79.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.897 0.771 . . . . 0.0 112.928 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.97 -50.37 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.52 1.128 . . . . 0.0 110.956 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -53.87 -48.03 70.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.619 1.167 . . . . 0.0 111.403 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.67 -33.41 75.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -85.61 -38.14 18.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.32 -37.21 79.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.506 0.594 . . . . 0.0 111.432 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.19 -27.27 67.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.969 1.308 . . . . 0.0 113.387 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.71 -32.65 53.08 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.896 0.771 . . . . 0.0 110.445 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.01 3.18 26.52 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 126.636 2.065 . . . . 0.0 114.252 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.49 84.17 2.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.492 1.146 . . . . 0.0 111.109 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -56.94 -41.52 78.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.813 0.845 . . . . 0.0 112.585 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.93 -57.65 11.58 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.467 -0.771 . . . . 0.0 112.465 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.46 -43.15 83.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.223 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.2 98.42 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.351 0.978 . . . . 0.0 113.618 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.73 -48.43 66.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.755 -1.117 . . . . 0.0 111.035 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.03 -48.36 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.309 1.044 . . . . 0.0 112.241 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -67.3 -34.68 77.9 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.266 0.485 . . . . 0.0 111.688 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.58 -41.05 90.55 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.228 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.07 -44.39 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.663 1.185 . . . . 0.0 109.617 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.17 -51.78 65.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.877 0.871 . . . . 0.0 111.976 -178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.96 -41.78 95.18 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.615 0.766 . . . . 0.0 111.269 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.23 78.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.554 0.742 . . . . 0.0 110.928 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.5 -46.53 87.78 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.01 0.823 . . . . 0.0 112.108 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.7 mtp -65.55 -35.96 82.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.049 0.925 . . . . 0.0 113.087 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.483 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.93 -44.6 61.01 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 111.112 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.85 -37.36 85.99 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.371 1.468 . . . . 0.0 111.46 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.33 -18.51 11.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.392 1.477 . . . . 0.0 114.355 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -72.43 -40.88 66.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.33 -1.481 . . . . 0.0 112.105 170.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -85.9 -28.89 24.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.735 1.214 . . . . 0.0 112.276 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -136.58 76.62 47.96 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.668 1.987 . . . . 0.0 108.669 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.83 143.1 78.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.841 1.694 . . . . 0.0 110.498 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -63.1 143.89 57.38 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -118.99 144.84 46.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.412 1.485 . . . . 0.0 109.402 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -60.71 -32.95 72.18 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 112.636 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -82.93 5.43 21.96 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.881 1.272 . . . . 0.0 113.446 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -58.84 150.46 23.95 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.013 0.925 . . . . 0.0 112.943 -172.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.215 -0.743 0 CA-C-O 122.721 1.248 . . . . 0.0 111.509 -165.367 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 121.616 0.59 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -77.84 -10.23 59.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.2 m -57.3 131.24 49.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.363 1.465 . . . . 0.0 109.72 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.03 137.76 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.43 -0.794 . . . . 0.0 108.863 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.7 m -92.28 142.92 26.94 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.422 -0.798 . . . . 0.0 111.844 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.86 150.68 52.14 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.424 1.09 . . . . 0.0 110.568 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.714 170.868 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.23 0.078 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 p -75.11 167.39 22.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.6 64.34 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.772 -1.205 . . . . 0.0 112.759 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -66.94 -36.0 81.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.17 1.388 . . . . 0.0 111.701 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.71 -45.46 13.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.32 1.048 . . . . 0.0 111.228 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -60.96 -40.95 95.32 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.802 1.241 . . . . 0.0 111.166 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.14 -48.15 81.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.163 -0.961 . . . . 0.0 112.07 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.25 97.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 tt -72.01 -35.46 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.52 -32.76 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.014 0.825 . . . . 0.0 111.462 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.92 -35.99 75.0 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.342 -0.849 . . . . 0.0 112.588 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.82 93.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.926 0.49 . . . . 0.0 111.388 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.38 -48.02 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.816 0.846 . . . . 0.0 110.814 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -55.08 -33.73 63.01 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.85 -25.74 32.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.91 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.091 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -73.27 14.65 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.699 1.2 . . . . 0.0 113.373 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -116.96 3.21 12.81 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.892 -1.755 . . . . 0.0 112.272 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -121.26 -18.36 7.4 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.23 1.412 . . . . 0.0 113.207 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -144.14 163.43 33.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.559 2.343 . . . . 0.0 108.771 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -100.83 31.41 3.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.53 1.532 . . . . 0.0 112.384 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.88 118.06 1.5 Allowed Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.352 -1.468 . . . . 0.0 111.902 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -85.21 137.11 33.21 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -156.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.18 119.83 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 123.003 1.382 . . . . 0.0 111.485 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -124.74 151.68 44.76 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.308 1.443 . . . . 0.0 112.452 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 144.3 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.011 1.724 . . . . 0.0 110.692 171.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 66' ' ' LEU . 27.6 t60 -125.12 122.4 37.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.09 130.64 54.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.558 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 14.8 tt0 -146.87 169.2 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.892 1.33 . . . . 0.0 110.682 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 65.4 mttt -78.85 -73.36 0.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.393 1.077 . . . . 0.0 112.508 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -148.42 142.97 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.574 1.949 . . . . 0.0 109.247 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.8 p -86.84 146.81 26.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.965 0.888 . . . . 0.0 112.484 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 -10.61 38.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.235 1.014 . . . . 0.0 112.301 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.5 -163.46 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.392 2.677 . . . . 0.0 108.946 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.31 138.62 55.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.678 -1.264 . . . . 0.0 112.072 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.92 -37.6 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.366 0.666 . . . . 0.0 111.794 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.46 -52.56 64.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.581 0.752 . . . . 0.0 112.197 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.02 -39.65 87.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.91 0.484 . . . . 0.0 111.178 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -58.81 -47.04 86.2 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.118 -0.989 . . . . 0.0 112.118 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.75 96.76 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.568 0.747 . . . . 0.0 111.419 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 ttp -62.37 -43.75 98.07 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 111.815 173.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.07 -46.59 86.74 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.254 -0.904 . . . . 0.0 112.021 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.13 -43.62 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.22 -46.66 85.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.335 1.054 . . . . 0.0 111.808 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.69 -35.78 60.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.278 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -63.84 -44.07 94.28 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.429 -1.419 . . . . 0.0 111.159 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.75 -6.38 44.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.714 1.205 . . . . 0.0 113.268 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 62.33 41.14 10.55 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 66' ' ' LEU . 72.3 mtp -73.29 -22.54 60.34 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.43 -8.74 6.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 114.046 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 62.95 0.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.179 1.792 . . . . 0.0 110.793 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -133.4 140.32 47.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.613 1.165 . . . . 0.0 110.581 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -58.16 -43.64 87.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 111.889 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.3 mt -94.82 -3.68 48.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 59.73 57.06 3.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.04 28.94 3.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 112.255 -168.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.87 131.57 10.48 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.393 -0.817 . . . . 0.0 111.206 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.6 t -102.65 138.79 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.268 1.027 . . . . 0.0 110.321 168.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' HIS . 17.8 tp -119.04 121.54 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.062 1.345 . . . . 0.0 110.963 164.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.4 mt -97.25 101.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -81.93 125.19 30.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.256 0.622 . . . . 0.0 110.917 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.1 129.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.753 0.706 . . . . 0.0 111.406 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.27 100.78 12.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.894 1.678 . . . . 0.0 110.273 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.27 -12.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.88 -54.49 5.54 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.474 -0.766 . . . . 0.0 110.495 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.33 -11.85 59.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.179 0.992 . . . . 0.0 112.315 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt 71.68 27.27 2.95 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.6 2.36 . . . . 0.0 112.356 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -106.06 134.36 49.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.995 1.318 . . . . 0.0 110.53 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -106.41 143.78 34.04 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 110.199 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 t -134.36 143.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.505 1.922 . . . . 0.0 108.259 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.0 mt -123.63 130.12 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -140.62 132.54 27.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.996 1.319 . . . . 0.0 110.026 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.52 163.68 21.2 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 123.872 0.749 . . . . 0.0 111.309 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.69 161.31 4.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.899 1.333 . . . . 0.0 114.121 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.4 -35.61 65.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.522 1.529 . . . . 0.0 113.777 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.37 -27.95 73.06 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 120.259 1.39 . . . . 0.0 112.939 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.6 mt -69.43 -60.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.2 1.5 . . . . 0.0 109.425 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -52.01 -37.57 53.78 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.71 0.804 . . . . 0.0 112.973 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.92 -21.7 59.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.032 -1.043 . . . . 0.0 113.436 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 88' ' ' VAL . 1.5 p -106.73 -32.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 87' ' ' VAL . 4.4 m -110.6 179.31 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.701 1.2 . . . . 0.0 111.004 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 -178.9 6.13 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.666 -1.271 . . . . 0.0 113.775 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -52.44 -36.31 54.24 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -71.69 -20.01 61.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.498 1.045 . . . . 0.0 112.943 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 29.1 t80 -78.57 -49.24 13.63 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.285 1.034 . . . . 0.0 109.275 168.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -62.68 -31.43 72.31 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.611 1.564 . . . . 0.0 113.611 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.72 -29.75 68.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.225 1.01 . . . . 0.0 111.621 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.5 p -69.96 -43.07 72.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.542 0.61 . . . . 0.0 111.651 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 m -55.94 -51.62 67.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.371 1.869 . . . . 0.0 111.014 172.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -59.3 -48.42 81.69 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.61 0.764 . . . . 0.0 111.528 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -59.76 -45.89 90.84 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.585 1.084 . . . . 0.0 112.581 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.52 93.89 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.217 0.917 . . . . 0.0 112.826 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.57 -52.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.953 0.901 . . . . 0.0 110.212 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -57.36 -44.48 84.4 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.045 1.338 . . . . 0.0 112.626 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.42 -34.0 77.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.533 0.606 . . . . 0.0 112.161 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -85.89 -38.84 17.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.04 0.936 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.29 -40.37 77.63 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.233 -0.917 . . . . 0.0 111.767 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.91 -23.05 67.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.951 1.3 . . . . 0.0 113.364 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.36 -25.26 21.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.631 0.772 . . . . 0.0 112.153 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.51 37.62 Favored Glycine 0 N--CA 1.477 1.431 0 C-N-CA 125.468 1.509 . . . . 0.0 113.664 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.9 64.35 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.415 1.486 . . . . 0.0 110.839 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -53.43 -44.0 68.47 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.942 0.897 . . . . 0.0 112.876 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.02 -54.01 45.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.395 1.078 . . . . 0.0 111.872 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -63.74 -43.36 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.05 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.74 96.08 Favored Glycine 0 N--CA 1.469 0.877 0 CA-C-N 119.167 0.894 . . . . 0.0 113.065 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -72.5 -45.38 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.999 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.59 -51.21 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.484 1.038 . . . . 0.0 111.473 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.3 -40.35 90.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 0.0 111.423 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.75 92.08 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.916 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.51 -52.67 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.556 1.178 . . . . 0.0 109.744 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.91 -46.15 88.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.158 0.583 . . . . 0.0 111.868 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.67 -40.66 76.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.917 0.887 . . . . 0.0 111.729 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.84 76.17 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.56 0.618 . . . . 0.0 109.926 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.15 -48.74 77.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.583 0.611 . . . . 0.0 113.347 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.29 -35.97 82.13 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.95 -41.26 59.95 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.118 -0.364 . . . . 0.0 110.799 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.3 mt -63.06 -40.1 96.71 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.927 1.691 . . . . 0.0 111.882 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.47 44.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 113.847 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.82 -41.01 92.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.503 -0.748 . . . . 0.0 111.842 172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.0 -46.75 13.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.204 1.402 . . . . 0.0 111.344 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.97 83.5 37.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 126.641 1.977 . . . . 0.0 110.516 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.34 143.16 62.81 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.837 2.358 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -60.16 145.58 46.45 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.32 0.581 . . . . 0.0 112.038 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -120.59 144.81 47.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.039 0.936 . . . . 0.0 109.423 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.14 -20.09 65.75 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 120.671 -1.268 . . . . 0.0 113.318 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -95.99 2.52 53.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.167 2.587 . . . . 0.0 113.739 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -58.6 151.87 19.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.426 1.49 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.51 0 C-N-CA 123.657 0.783 . . . . 0.0 110.988 -165.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--O 1.24 0.579 0 CA-C-O 121.052 0.355 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.79 -3.54 44.94 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.6 p -70.16 161.87 29.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.173 1.789 . . . . 0.0 113.01 -171.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 66.5 mt -82.79 138.41 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.849 1.26 . . . . 0.0 110.05 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.5 t -101.65 142.95 32.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.614 0.766 . . . . 0.0 110.395 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -145.61 151.46 38.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 C-N-CA 125.949 1.738 . . . . 0.0 113.045 165.277 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.241 0.641 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -78.47 163.38 25.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.861 0.864 . . . . 0.0 111.208 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.08 19.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.276 1.43 . . . . 0.0 112.988 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -61.41 -45.88 92.46 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.618 1.567 . . . . 0.0 112.552 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.78 -45.26 83.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.02 -38.78 89.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.785 0.834 . . . . 0.0 112.305 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 -44.83 92.28 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.257 -0.902 . . . . 0.0 111.004 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.53 97.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.146 0.979 . . . . 0.0 113.354 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -72.11 -37.53 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.175 0.898 . . . . 0.0 112.696 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.3 t -61.61 -32.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.231 0.923 . . . . 0.0 112.27 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -41.64 97.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.181 0.992 . . . . 0.0 112.06 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.64 95.38 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.908 -0.495 . . . . 0.0 111.729 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.58 -40.1 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.831 0.852 . . . . 0.0 111.449 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -64.38 -38.53 91.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.778 0.831 . . . . 0.0 112.567 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.43 -31.44 65.48 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 112.952 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.36 -38.85 85.43 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.498 0.719 . . . . 0.0 112.711 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -62.01 -17.48 57.37 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.268 1.033 . . . . 0.0 113.316 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -94.45 3.79 54.69 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.278 -1.514 . . . . 0.0 112.659 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -119.78 -13.51 9.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 114.221 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -155.86 161.79 40.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.766 2.026 . . . . 0.0 109.417 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 p -104.08 26.27 8.97 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 112.823 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.11 148.12 19.52 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 124.497 1.046 . . . . 0.0 111.124 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -103.07 134.84 45.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.72 0.771 . . . . 0.0 112.443 -151.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.97 129.83 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 119.003 -2.311 . . . . 0.0 111.286 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -142.56 152.5 42.66 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.129 1.372 . . . . 0.0 110.931 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -121.12 141.0 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.922 1.689 . . . . 0.0 110.555 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 66' ' ' LEU . 51.3 t60 -127.24 130.99 50.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.636 1.174 . . . . 0.0 112.336 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tp -119.38 120.85 38.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 111.63 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -138.08 156.04 48.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.525 1.13 . . . . 0.0 110.564 171.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.48 -69.7 0.26 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.283 -1.511 . . . . 0.0 113.852 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.3 t -152.75 142.25 21.74 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.896 1.678 . . . . 0.0 109.307 -166.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 p -100.12 144.51 29.06 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -81.79 -26.46 34.38 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 pt -110.62 -177.1 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 110.411 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.36 136.48 57.16 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.65 0.738 . . . . 0.0 112.489 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.03 -32.88 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.853 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -64.11 -49.36 72.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.609 1.095 . . . . 0.0 111.986 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.96 -43.08 88.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.3 1.04 . . . . 0.0 110.398 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -57.04 -48.87 77.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.997 0.519 . . . . 0.0 111.999 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.47 88.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.486 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -61.23 -46.84 88.76 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 111.703 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.72 -44.29 82.02 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.48 -44.48 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 0.0 110.2 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.26 -55.81 30.16 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.813 1.245 . . . . 0.0 111.197 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -68.57 -34.04 75.12 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -67.57 -41.81 83.59 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.431 -0.793 . . . . 0.0 112.325 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.31 0.12 15.33 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.9 0.88 . . . . 0.0 112.873 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 tttt 63.73 31.86 14.03 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.914 1.686 . . . . 0.0 112.295 168.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 66' ' ' LEU . 29.8 mtt -66.7 -33.91 76.68 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.115 -0.99 . . . . 0.0 111.867 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.4 -16.54 9.49 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.171 2.589 . . . . 0.0 114.904 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.04 76.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.723 -1.236 . . . . 0.0 111.293 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -123.3 160.57 26.39 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.234 1.014 . . . . 0.0 110.148 162.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -59.4 -44.78 92.76 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.067 -1.021 . . . . 0.0 112.429 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.68 -8.94 27.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.444 -1.265 . . . . 0.0 113.443 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 68.54 47.61 0.89 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.67 1.588 . . . . 0.0 109.512 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -116.85 25.64 10.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.839 1.256 . . . . 0.0 112.557 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.33 124.76 10.1 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 111.154 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.64 133.6 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 110.234 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.2 tp -114.44 132.46 56.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.872 1.32 . . . . 0.0 111.685 164.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.2 mt -110.27 92.7 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -76.18 120.64 21.74 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.734 0.814 . . . . 0.0 110.516 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -117.07 130.06 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.046 1.338 . . . . 0.0 109.917 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.94 105.47 15.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.408 1.083 . . . . 0.0 110.373 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.43 -19.79 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.81 -47.62 20.96 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.474 1.488 . . . . 0.0 111.157 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -79.98 -15.84 56.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.444 1.097 . . . . 0.0 113.317 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 70.11 33.14 2.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.656 1.582 . . . . 0.0 112.205 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -114.09 167.92 10.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.39 1.476 . . . . 0.0 111.018 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.26 141.67 22.47 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.718 1.207 . . . . 0.0 109.63 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.86 135.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.088 1.355 . . . . 0.0 108.213 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 mt -115.13 130.28 69.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -140.88 149.79 42.39 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.738 0.815 . . . . 0.0 110.113 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.76 158.77 27.82 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.92 170.07 5.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.388 1.566 . . . . 0.0 114.084 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.65 -30.28 70.61 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.585 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.55 -48.0 59.27 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 119.916 1.235 . . . . 0.0 111.612 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.75 -56.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.068 0.934 . . . . 0.0 109.365 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -53.05 -44.7 67.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.982 0.913 . . . . 0.0 112.588 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.86 -8.28 58.68 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.848 1.659 . . . . 0.0 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -23.49 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.87 173.79 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.808 1.64 . . . . 0.0 111.955 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -125.13 171.06 10.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.13 -31.63 63.5 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.12 -31.36 69.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 112.548 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 57.7 t80 -74.3 -33.42 63.2 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.644 0.778 . . . . 0.0 110.558 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -77.04 -23.68 52.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.241 1.816 . . . . 0.0 114.16 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.35 -36.05 81.91 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.711 -1.243 . . . . 0.0 112.163 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.1 m -58.35 -39.71 80.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.363 1.465 . . . . 0.0 111.675 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -60.67 -54.98 38.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.377 1.871 . . . . 0.0 111.381 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -60.29 -45.11 94.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 110.471 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -56.96 -45.13 83.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -47.98 83.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.262 0.937 . . . . 0.0 112.642 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.5 mt -66.02 -48.36 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.798 0.839 . . . . 0.0 110.091 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.36 -42.32 98.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.073 0.949 . . . . 0.0 113.294 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.68 -41.22 96.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.821 0.737 . . . . 0.0 111.489 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -74.19 -37.11 64.02 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.553 0.741 . . . . 0.0 111.765 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.84 -40.26 96.17 Favored 'General case' 0 C--N 1.346 0.444 0 O-C-N 121.428 -0.795 . . . . 0.0 111.81 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.26 -40.35 97.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.169 174.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -65.39 -41.53 93.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.812 0.845 . . . . 0.0 111.493 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.09 6.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.49 1.043 . . . . 0.0 114.439 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -110.4 84.08 1.87 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.414 1.486 . . . . 0.0 111.287 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -64.64 -45.66 85.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -57.33 -51.68 68.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.152 -0.927 . . . . 0.0 111.402 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -56.86 -42.37 79.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.67 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.44 -39.04 97.29 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 119.456 1.025 . . . . 0.0 113.915 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.13 -48.27 30.53 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 110.722 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.15 -57.71 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.781 1.633 . . . . 0.0 110.788 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -61.94 -29.77 70.45 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.579 0.751 . . . . 0.0 111.256 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 -37.31 59.62 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.434 0.54 . . . . 0.0 113.427 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.1 mt -66.53 -44.82 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.601 1.2 . . . . 0.0 110.137 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -59.17 -44.25 92.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.918 0.887 . . . . 0.0 112.253 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -67.95 -30.06 69.26 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.891 -1.13 . . . . 0.0 113.082 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.98 -53.43 26.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 118.814 -0.612 . . . . 0.0 109.786 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.06 -48.31 80.56 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.554 1.073 . . . . 0.0 112.327 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.7 ttm -62.81 -38.85 92.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.373 1.087 . . . . 0.0 112.595 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -74.63 -45.4 45.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.52 0.6 . . . . 0.0 111.436 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt -62.84 -35.42 79.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.492 1.517 . . . . 0.0 111.046 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.06 37.4 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.13 -31.34 61.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.589 1.086 . . . . 0.0 111.603 171.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.52 -37.48 15.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.143 1.377 . . . . 0.0 111.916 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.95 82.34 68.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.552 1.941 . . . . 0.0 110.585 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.92 134.89 30.99 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.422 2.748 . . . . 0.0 111.003 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -63.14 139.03 58.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.244 1.018 . . . . 0.0 112.731 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -116.16 155.53 28.09 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.764 1.625 . . . . 0.0 110.567 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.32 -21.59 66.26 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 119.243 -2.16 . . . . 0.0 112.913 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -101.36 18.2 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.861 1.664 . . . . 0.0 112.892 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.28 153.25 22.95 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.123 0.963 . . . . 0.0 112.739 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.466 0.347 0 O-C-N 121.418 -0.801 . . . . 0.0 112.019 -166.252 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.459 -0.532 0 CA-C-O 122.054 0.773 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -89.35 3.75 51.16 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.8 p -72.23 159.04 34.75 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.24 137.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.689 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 t -98.26 139.06 34.61 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.258 1.023 . . . . 0.0 109.797 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -140.69 164.69 29.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.612 0.765 . . . . 0.0 110.711 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 CA-C-O 117.991 -1.45 . . . . 0.0 113.725 177.711 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -73.23 162.59 29.21 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.607 -0.683 . . . . 0.0 109.85 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.13 41.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.36 -42.9 87.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.484 1.114 . . . . 0.0 111.334 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -71.16 -45.12 64.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.409 1.484 . . . . 0.0 111.345 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.52 -46.03 90.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.224 1.41 . . . . 0.0 111.778 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -56.76 -43.28 80.64 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.368 -0.832 . . . . 0.0 111.834 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.64 89.36 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.764 0.711 . . . . 0.0 112.761 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -75.35 -33.41 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.224 -0.923 . . . . 0.0 112.831 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.07 -37.78 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.665 1.12 . . . . 0.0 111.259 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -63.81 -30.98 72.02 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.211 1.004 . . . . 0.0 112.775 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.76 85.95 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.073 -1.017 . . . . 0.0 111.911 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mm -59.89 -47.71 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.611 0.641 . . . . 0.0 110.003 172.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm105 -59.68 -34.04 72.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.24 -23.93 32.53 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.92 68.4 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.111 0.964 . . . . 0.0 112.734 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CD ' HD21 ' A' ' 140' ' ' ASN . 92.6 mt-10 -56.5 -40.94 75.83 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 110.882 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -73.59 6.06 3.39 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 119.733 -1.854 . . . . 0.0 113.325 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -123.63 -7.98 7.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.382 2.273 . . . . 0.0 114.284 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -163.79 147.25 10.0 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.24 1.382 . . . . 0.0 110.545 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -81.79 12.12 4.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 113.987 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.11 143.74 16.82 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.21 1.386 . . . . 0.0 111.16 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -101.75 139.0 37.98 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.018 0.927 . . . . 0.0 113.074 -164.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.11 138.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.291 1.436 . . . . 0.0 109.573 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -153.39 155.59 36.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.474 1.11 . . . . 0.0 111.0 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.42 139.47 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.921 1.689 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.427 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.9 t60 -122.43 125.86 46.73 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.751 1.221 . . . . 0.0 112.244 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.86 115.15 26.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.888 0.875 . . . . 0.0 110.169 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.26 163.19 29.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.083 1.753 . . . . 0.0 109.812 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.8 mttt -80.35 -72.51 0.41 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.666 -1.271 . . . . 0.0 113.264 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.6 t -148.8 158.27 44.04 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 126.676 1.991 . . . . 0.0 109.292 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -107.03 159.0 16.62 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 126.189 1.796 . . . . 0.0 110.18 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.58 -27.79 18.89 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.738 -1.226 . . . . 0.0 112.148 166.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 mt -100.1 -125.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.329 1.052 . . . . 0.0 108.697 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -115.88 142.55 46.62 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.001 1.72 . . . . 0.0 109.349 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.09 -46.72 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.54 -50.21 74.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.039 0.836 . . . . 0.0 112.441 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -70.03 -39.47 75.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.344 0.658 . . . . 0.0 111.251 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -59.7 -46.55 88.73 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.646 0.778 . . . . 0.0 111.889 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.07 93.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.307 1.043 . . . . 0.0 111.691 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.0 ttp -63.56 -46.16 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 111.606 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.06 -48.81 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.165 0.439 . . . . 0.0 110.929 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.8 -45.39 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.518 1.127 . . . . 0.0 111.553 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -56.29 -53.52 56.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.64 1.176 . . . . 0.0 110.803 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -69.05 -33.73 74.05 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 112.05 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.26 -33.4 75.24 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.238 -1.539 . . . . 0.0 112.453 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.58 -3.18 52.61 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.98 0.912 . . . . 0.0 112.987 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 60.23 34.29 20.98 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.904 1.682 . . . . 0.0 112.697 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.2 mtp -65.02 -18.37 65.24 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -3.94 7.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.492 1.517 . . . . 0.0 113.066 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.79 59.8 2.65 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 111.422 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.1 p -125.93 143.28 51.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.463 1.905 . . . . 0.0 109.142 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -63.09 -48.69 77.54 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.848 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.17 -2.0 57.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.633 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 57.54 37.68 27.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.98 1.263 . . . . 0.0 109.463 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 27.45 9.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.543 1.537 . . . . 0.0 112.0 -172.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.1 124.52 6.78 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 124.098 0.856 . . . . 0.0 112.093 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.3 t -111.55 132.44 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.384 1.073 . . . . 0.0 110.147 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 34' ' ' HIS . 27.1 tp -118.6 123.81 45.92 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.245 1.022 . . . . 0.0 111.455 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.67 96.33 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 125.474 1.509 . . . . 0.0 108.328 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.07 127.7 34.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.644 0.778 . . . . 0.0 111.379 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.36 125.86 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.318 0.647 . . . . 0.0 110.646 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.35 108.02 20.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.661 1.584 . . . . 0.0 110.236 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 37' ' ' LYS . 29.6 m -75.79 -20.71 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -73.67 -64.11 1.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.988 0.813 . . . . 0.0 108.808 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.2 -9.52 58.62 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.8 tttt 65.45 32.57 9.44 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 m -100.76 132.55 46.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.603 1.561 . . . . 0.0 109.207 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.62 139.41 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.534 1.134 . . . . 0.0 108.385 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.58 143.83 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.012 1.325 . . . . 0.0 108.229 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 100' ' ' ILE . 12.3 mt -122.79 135.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -147.64 129.36 15.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.857 1.663 . . . . 0.0 108.604 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.13 172.55 16.62 Favored Glycine 0 C--O 1.236 0.28 0 C-N-CA 125.353 1.454 . . . . 0.0 112.002 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -60.81 166.64 3.24 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.664 1.586 . . . . 0.0 113.551 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -53.08 -34.67 57.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.226 1.41 . . . . 0.0 113.717 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.95 -29.25 69.33 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.968 1.258 . . . . 0.0 114.185 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.65 -56.2 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.17 1.485 . . . . 0.0 108.529 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -51.64 -34.35 37.5 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.522 1.529 . . . . 0.0 113.747 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -78.42 -24.61 46.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.408 1.483 . . . . 0.0 113.081 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.48 -22.85 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.78 159.98 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.495 1.043 . . . . 0.0 112.715 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.7 p -95.01 174.13 7.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.69 -21.74 66.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.926 -1.109 . . . . 0.0 113.535 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.28 -17.91 55.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 48.1 t80 -73.17 -46.18 52.21 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 165.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -65.56 -32.2 73.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.543 1.137 . . . . 0.0 113.492 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.66 -36.85 70.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.969 1.308 . . . . 0.0 112.297 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.2 p -61.21 -45.25 95.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.752 0.821 . . . . 0.0 112.01 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 m -65.34 -45.87 82.5 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.811 1.644 . . . . 0.0 110.961 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.98 -51.42 67.79 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.542 . . . . 0.0 111.187 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -56.61 -48.09 78.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.884 0.766 . . . . 0.0 111.711 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.57 82.93 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.908 -1.12 . . . . 0.0 113.453 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 78' ' ' ILE . 29.1 mt -70.46 -50.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.165 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -55.6 -44.27 76.81 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.282 1.033 . . . . 0.0 112.559 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.91 -34.02 74.03 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.01 -38.84 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.721 1.208 . . . . 0.0 111.251 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.98 -38.59 82.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.473 -0.767 . . . . 0.0 111.174 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.13 -27.08 67.77 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.272 1.429 . . . . 0.0 113.419 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.2 -20.98 39.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.935 0.894 . . . . 0.0 111.736 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.07 7.03 44.68 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.219 1.39 . . . . 0.0 114.549 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.08 97.81 7.54 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.805 1.303 . . . . 0.0 111.586 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -72.5 -37.05 68.5 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.604 -0.685 . . . . 0.0 110.898 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -57.73 -57.91 10.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.336 -0.852 . . . . 0.0 111.381 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.6 -41.1 94.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.268 0.627 . . . . 0.0 111.396 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.81 98.32 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 118.598 0.635 . . . . 0.0 113.469 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.41 -50.44 59.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.149 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.1 t -59.11 -48.31 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.0 0.818 . . . . 0.0 111.743 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.6 -29.84 66.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.286 0.493 . . . . 0.0 112.268 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.2 -34.48 64.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 118.722 0.692 . . . . 0.0 112.522 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.31 -52.59 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.454 1.102 . . . . 0.0 110.828 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.36 -42.33 91.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.597 1.09 . . . . 0.0 111.04 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.69 -46.58 89.08 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.177 -0.952 . . . . 0.0 112.116 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.01 96.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.426 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.77 -44.63 97.19 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.172 0.897 . . . . 0.0 112.425 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.1 mtp -65.02 -35.97 82.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.831 0.816 . . . . 0.0 113.112 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.411 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.87 -44.39 61.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.972 0.509 . . . . 0.0 111.644 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.55 -38.12 88.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 0.0 111.925 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.16 -24.81 43.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -73.08 -31.4 64.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.625 -1.297 . . . . 0.0 112.502 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -83.36 -38.01 22.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.88 1.272 . . . . 0.0 111.95 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -130.64 90.8 39.41 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.543 1.537 . . . . 0.0 109.178 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 139.82 50.85 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.478 2.119 . . . . 0.0 110.173 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -64.95 149.13 50.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.597 0.713 . . . . 0.0 112.698 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.03 145.89 50.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.122 1.369 . . . . 0.0 110.427 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -62.51 -20.68 64.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.8 0.18 54.67 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.564 1.946 . . . . 0.0 112.629 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -50.36 151.99 1.98 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.358 2.263 . . . . 0.0 115.735 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.328 1.051 . . . . 0.0 112.389 -163.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.404 HD21 ' CD ' ' A' ' 24' ' ' GLU . 2.3 m-80 -85.23 0.23 52.53 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.1 p -71.73 153.52 41.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.264 1.425 . . . . 0.0 111.106 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.5 mt -72.25 139.38 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.566 0.747 . . . . 0.0 109.109 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.4 t -101.17 139.1 37.32 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.824 -1.172 . . . . 0.0 110.533 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -136.43 151.02 49.04 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 112.204 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.455 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.217 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -101.05 162.22 13.05 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.573 -1.329 . . . . 0.0 109.98 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.83 -18.13 58.88 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.33 -48.15 57.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.225 1.375 . . . . 0.0 110.531 166.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.74 -40.82 92.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.144 0.978 . . . . 0.0 111.471 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -70.04 -42.95 72.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.357 1.063 . . . . 0.0 112.402 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.64 -45.42 85.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.503 -0.748 . . . . 0.0 111.817 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -59.84 -43.17 94.75 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.35 -0.844 . . . . 0.0 113.095 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.78 -49.33 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.427 1.091 . . . . 0.0 110.25 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.36 -48.2 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.527 1.131 . . . . 0.0 111.846 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.62 -27.75 66.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.04 -32.57 67.25 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.134 -0.978 . . . . 0.0 112.487 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.49 -52.82 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.353 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -51.76 -23.96 5.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -89.95 -25.22 21.03 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.176 1.39 . . . . 0.0 113.019 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.11 74.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.522 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -63.61 -20.37 65.61 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.762 0.71 . . . . 0.0 112.736 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -83.86 3.97 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 119.641 -1.912 . . . . 0.0 113.136 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -129.97 -5.72 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.281 1.432 . . . . 0.0 113.427 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -162.55 155.54 19.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.565 1.546 . . . . 0.0 109.339 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -79.87 7.02 9.6 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.239 1.016 . . . . 0.0 113.722 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.9 152.85 20.2 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -111.17 129.55 55.91 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.497 1.119 . . . . 0.0 110.572 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.74 128.73 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.394 -0.816 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -141.3 160.36 40.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.484 1.114 . . . . 0.0 111.903 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.7 t -132.45 136.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.3 1.44 . . . . 0.0 109.216 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.3 t60 -119.55 119.4 33.69 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.816 1.246 . . . . 0.0 112.593 172.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.47 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.9 tp -100.88 130.8 46.95 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.97 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.26 165.14 34.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.152 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -80.85 -67.37 0.78 Allowed 'General case' 0 C--O 1.24 0.564 0 O-C-N 120.24 -1.537 . . . . 0.0 112.335 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 142.42 24.94 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.545 1.538 . . . . 0.0 110.125 -167.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -92.6 133.02 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.375 0.67 . . . . 0.0 111.961 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.68 -28.07 60.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 112.63 171.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -118.01 -164.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.432 1.893 . . . . 0.0 109.66 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.27 137.11 48.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.808 -1.183 . . . . 0.0 112.647 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.45 -37.79 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.433 0.693 . . . . 0.0 111.905 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -64.06 -48.98 74.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.324 0.65 . . . . 0.0 111.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.94 -37.01 81.09 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 112.098 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -62.75 -47.19 84.61 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.439 0.563 . . . . 0.0 111.24 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.17 96.33 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.727 0.811 . . . . 0.0 110.824 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.2 ttp -60.96 -47.49 86.18 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.509 0.723 . . . . 0.0 112.568 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.1 -37.93 81.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.315 0.961 . . . . 0.0 111.944 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.07 -41.46 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.856 0.753 . . . . 0.0 111.819 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.7 -47.78 83.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.465 1.106 . . . . 0.0 111.882 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -75.45 -34.72 60.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.594 0.757 . . . . 0.0 112.288 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -61.65 -41.91 98.17 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.466 1.107 . . . . 0.0 112.03 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.42 -0.67 20.78 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.359 -0.838 . . . . 0.0 112.938 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 59.67 33.51 21.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.317 1.447 . . . . 0.0 112.352 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.8 mtp -71.21 -23.35 62.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.483 1.113 . . . . 0.0 112.853 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -67.7 -16.3 64.07 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.353 1.861 . . . . 0.0 113.598 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.44 72.61 8.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.045 1.338 . . . . 0.0 111.291 172.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.0 m -135.85 135.67 39.96 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.243 1.817 . . . . 0.0 107.803 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -49.09 -49.94 39.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -93.07 0.57 57.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.258 1.023 . . . . 0.0 113.749 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 61.65 43.95 9.39 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.777 1.231 . . . . 0.0 111.041 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -121.03 47.37 1.84 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.493 1.517 . . . . 0.0 112.347 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 131.6 10.8 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.929 0.776 . . . . 0.0 112.749 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.35 139.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 118.221 1.01 . . . . 0.0 111.605 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.1 tp -125.93 120.81 31.37 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.457 1.503 . . . . 0.0 111.085 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -96.76 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.812 0.845 . . . . 0.0 109.796 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -78.06 119.92 22.17 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.696 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.38 130.71 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.744 0.818 . . . . 0.0 110.159 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.24 94.75 5.68 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.389 1.476 . . . . 0.0 110.231 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 35' ' ' LEU . 20.1 m -70.5 -15.81 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -170.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -83.01 -34.23 26.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.825 0.85 . . . . 0.0 111.176 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -97.44 -15.63 20.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.99 1.316 . . . . 0.0 113.833 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.5 tttt 71.98 21.91 3.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.134 2.174 . . . . 0.0 112.43 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.8 p -99.94 163.59 12.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.193 -0.942 . . . . 0.0 111.48 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.21 145.61 35.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.137 1.375 . . . . 0.0 108.863 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -137.68 136.12 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 125.748 1.619 . . . . 0.0 107.54 175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 mt -111.56 126.06 68.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -121.85 150.56 41.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.298 1.439 . . . . 0.0 109.702 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.78 149.65 21.69 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -65.32 160.86 20.79 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 123.249 1.499 . . . . 0.0 112.156 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -53.46 -35.89 61.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.233 1.813 . . . . 0.0 113.334 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.51 76.83 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.344 -1.253 . . . . 0.0 114.083 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.35 -54.4 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.916 1.858 . . . . 0.0 108.731 167.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -52.87 -35.41 57.69 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.22 -16.14 56.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.922 1.289 . . . . 0.0 113.171 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 m -111.51 -29.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 119.555 1.071 . . . . 0.0 113.84 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.79 163.08 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.032 0.833 . . . . 0.0 111.287 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.1 m -119.42 169.58 9.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.318 1.447 . . . . 0.0 111.736 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -56.82 -32.59 65.89 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.237 1.38 . . . . 0.0 113.681 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.55 -21.05 66.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.554 1.142 . . . . 0.0 113.297 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -79.01 -41.91 27.83 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.476 -0.765 . . . . 0.0 110.462 171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -69.47 -30.35 68.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.74 -36.17 69.44 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.183 0.593 . . . . 0.0 112.548 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -62.13 -44.76 95.92 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.915 0.779 . . . . 0.0 111.289 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -61.73 -47.63 84.39 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.136 1.775 . . . . 0.0 110.896 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.82 -43.7 98.31 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.369 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -65.18 -42.98 93.13 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.754 1.161 . . . . 0.0 112.45 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.88 78.28 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.718 1.145 . . . . 0.0 112.34 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.49 -51.38 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.822 0.449 . . . . 0.0 111.031 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.02 -44.74 96.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.935 1.294 . . . . 0.0 113.341 -174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.21 -38.47 91.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.631 0.772 . . . . 0.0 111.573 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.11 -38.46 36.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.067 0.947 . . . . 0.0 111.352 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -59.29 -40.05 84.92 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.333 -0.854 . . . . 0.0 111.637 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.67 -25.46 68.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.183 0.993 . . . . 0.0 113.267 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -87.41 -25.48 23.78 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.822 1.249 . . . . 0.0 111.797 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 10.55 40.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.301 1.429 . . . . 0.0 113.58 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.58 59.05 0.8 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.431 1.493 . . . . 0.0 110.83 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -49.46 -44.82 46.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 114.047 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 49.9 tttm -52.19 -51.43 58.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 124.584 1.154 . . . . 0.0 112.592 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -68.87 -33.86 74.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.76 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.54 -42.79 97.29 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-N 119.035 0.834 . . . . 0.0 112.75 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.86 -51.63 57.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.225 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.32 -47.38 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.089 0.956 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.73 -40.98 92.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.87 -39.39 75.59 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.856 -0.528 . . . . 0.0 112.312 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.05 -39.08 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.671 1.188 . . . . 0.0 110.648 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.74 -51.07 66.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.193 0.997 . . . . 0.0 112.363 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.44 -40.04 96.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.532 -0.73 . . . . 0.0 112.053 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -50.88 72.01 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.652 172.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.46 -49.18 75.29 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.076 0.853 . . . . 0.0 112.585 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.0 mtp -60.99 -35.72 77.56 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.929 0.864 . . . . 0.0 112.898 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -80.13 -39.56 29.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.193 0.997 . . . . 0.0 111.868 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.6 mt -62.18 -36.0 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.83 -17.52 36.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.338 1.455 . . . . 0.0 114.449 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.01 -38.48 64.08 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.062 -1.024 . . . . 0.0 112.223 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -80.98 -49.81 10.48 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 124.486 1.114 . . . . 0.0 111.68 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -123.96 91.59 49.44 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.409 1.483 . . . . 0.0 109.682 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.41 148.94 68.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.877 2.385 . . . . 0.0 110.828 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -70.75 127.63 33.31 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.813 -0.554 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -100.35 155.89 17.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.203 1.801 . . . . 0.0 109.596 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.28 -24.46 63.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 119.866 -1.771 . . . . 0.0 112.768 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -98.33 16.5 21.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.865 2.066 . . . . 0.0 113.18 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.02 163.0 5.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.682 1.23 . . . . 0.0 112.065 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--N 1.331 -0.223 0 C-N-CA 125.539 1.536 . . . . 0.0 110.903 -173.635 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.444 -1.401 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.87 31.76 0.26 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.395 1.878 . . . . 0.0 111.726 -172.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 t -97.08 164.0 12.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.774 1.629 . . . . 0.0 111.285 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.29 131.22 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -93.17 144.61 25.12 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.781 0.832 . . . . 0.0 109.633 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -142.29 135.99 29.3 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.511 -0.743 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.564 0 CA-C-O 115.983 -2.565 . . . . 0.0 113.963 173.835 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -73.6 169.43 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.339 0.656 . . . . 0.0 111.059 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.56 -42.57 64.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.107 -0.996 . . . . 0.0 113.66 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.4 -31.27 63.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.263 0.625 . . . . 0.0 112.264 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.57 -43.93 65.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.323 -0.861 . . . . 0.0 110.943 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -63.48 -31.07 72.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.979 1.312 . . . . 0.0 112.004 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.59 -46.33 59.6 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.533 -1.355 . . . . 0.0 111.279 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.6 96.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.438 1.095 . . . . 0.0 112.701 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.65 -39.86 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.394 0.997 . . . . 0.0 113.17 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.76 -34.31 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.578 0.626 . . . . 0.0 111.26 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.88 -28.9 67.11 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.55 71.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.234 0.47 . . . . 0.0 111.761 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.65 -46.54 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.67 0.788 . . . . 0.0 109.681 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.57 -43.28 93.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.836 1.255 . . . . 0.0 112.439 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.62 -37.66 85.31 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.182 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.97 93.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.09 0.556 . . . . 0.0 112.022 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.22 -18.99 61.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.735 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -98.39 11.14 39.05 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.232 -1.542 . . . . 0.0 112.737 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -121.97 -16.15 7.63 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.024 1.729 . . . . 0.0 113.752 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.3 t -163.65 154.54 16.13 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.88 1.672 . . . . 0.0 109.682 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.0 m -78.38 1.65 21.31 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.82 154.78 27.14 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 124.999 1.285 . . . . 0.0 111.51 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -131.74 123.78 28.38 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -163.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.1 mt -115.63 101.08 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 120.837 -1.164 . . . . 0.0 111.812 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -97.34 156.2 16.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.33 1.452 . . . . 0.0 111.66 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 140.98 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.34 1.456 . . . . 0.0 110.876 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.435 ' HB2' HD11 ' A' ' 66' ' ' LEU . 41.9 t60 -125.81 132.38 52.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 112.324 171.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -118.2 132.94 56.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.401 1.08 . . . . 0.0 111.289 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -153.23 160.49 42.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.573 1.549 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.57 -80.54 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.728 -1.233 . . . . 0.0 112.231 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -140.86 154.01 45.99 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.577 1.551 . . . . 0.0 111.205 -176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -98.83 142.98 29.66 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -79.16 -15.37 58.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.267 1.427 . . . . 0.0 112.984 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 pt -136.32 -171.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 128.687 2.795 . . . . 0.0 109.134 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -62.63 140.32 58.67 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.41 -34.53 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.93 -51.62 66.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.341 0.656 . . . . 0.0 111.497 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -66.51 -37.62 85.44 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.612 -0.68 . . . . 0.0 111.258 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -59.41 -49.59 77.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.985 -1.072 . . . . 0.0 111.638 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.79 96.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.474 0.71 . . . . 0.0 111.212 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.28 -41.58 89.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.144 0.978 . . . . 0.0 112.691 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.99 -33.67 59.74 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.161 -0.962 . . . . 0.0 112.72 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.33 -43.2 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.728 1.149 . . . . 0.0 110.931 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.36 -47.07 82.59 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.787 1.235 . . . . 0.0 110.849 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -76.12 -35.21 59.38 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.302 1.041 . . . . 0.0 112.404 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -62.39 -41.09 98.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.315 1.046 . . . . 0.0 111.459 172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.75 -2.2 25.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.091 1.356 . . . . 0.0 113.669 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 55.82 38.84 30.53 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.343 1.457 . . . . 0.0 112.851 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.73 -18.33 64.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.31 -3.66 0.99 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.623 1.969 . . . . 0.0 115.148 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -73.28 5.84 3.29 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.118 1.767 . . . . 0.0 115.347 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.1 p -83.18 156.46 23.2 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.45 -40.1 70.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.677 0.791 . . . . 0.0 112.637 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.81 -13.39 33.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.511 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 69.26 58.39 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.105 1.362 . . . . 0.0 108.657 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -145.66 33.92 1.04 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.746 1.218 . . . . 0.0 113.121 -162.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.01 147.57 23.82 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.684 1.135 . . . . 0.0 110.407 166.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.23 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.722 1.609 . . . . 0.0 108.809 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 34' ' ' HIS . 26.3 tp -125.5 118.93 26.85 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.834 1.254 . . . . 0.0 111.122 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -90.22 97.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -78.88 125.08 28.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.157 -0.964 . . . . 0.0 110.187 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -121.75 127.24 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.247 1.019 . . . . 0.0 111.28 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.54 95.98 8.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.555 1.542 . . . . 0.0 109.866 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.16 -19.55 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -76.99 -41.36 43.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.166 0.587 . . . . 0.0 112.156 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.36 -27.81 24.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.301 1.441 . . . . 0.0 111.331 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 88.42 14.76 0.07 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.24 2.616 . . . . 0.0 111.383 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -97.78 157.64 15.96 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.063 -1.023 . . . . 0.0 111.059 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -134.78 149.58 50.42 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.453 1.101 . . . . 0.0 109.389 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.11 139.98 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 108.101 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 50.3 mt -108.9 129.08 64.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -141.17 138.55 33.47 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.835 0.743 . . . . 0.0 110.553 172.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.7 159.18 24.11 Favored Glycine 0 C--O 1.24 0.517 0 C-N-CA 124.722 1.153 . . . . 0.0 110.314 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.45 161.93 21.68 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 123.194 1.474 . . . . 0.0 114.629 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.38 -31.49 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.375 1.47 . . . . 0.0 114.119 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.08 -31.43 57.67 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 119.552 1.069 . . . . 0.0 113.641 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.29 -57.25 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.554 1.177 . . . . 0.0 109.231 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -55.37 -38.08 68.36 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.031 0.932 . . . . 0.0 113.133 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.66 -11.75 60.76 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -114.0 -30.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -105.25 147.86 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.02 1.282 . . . . 0.0 112.446 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -92.22 171.75 8.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.547 1.139 . . . . 0.0 112.888 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -52.45 -38.6 59.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.387 1.875 . . . . 0.0 115.181 165.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.51 -28.15 67.59 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.804 -1.185 . . . . 0.0 112.895 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.426 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.5 t80 -73.03 -30.08 63.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.909 0.484 . . . . 0.0 110.953 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 8.4 m95 -80.31 -29.46 38.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.515 1.126 . . . . 0.0 113.502 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.41 -42.82 70.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.43 1.492 . . . . 0.0 113.085 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.0 p -59.0 -37.24 76.42 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.9 0.88 . . . . 0.0 112.281 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -54.99 40.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 0.0 110.834 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -57.35 -48.33 79.29 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 124.21 1.004 . . . . 0.0 110.112 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.1 -36.78 84.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.72 73.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.049 0.84 . . . . 0.0 112.308 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.25 -53.93 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.858 0.863 . . . . 0.0 109.89 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.17 1.788 . . . . 0.0 112.804 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.23 -51.64 62.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.55 1.068 . . . . 0.0 111.183 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.94 -35.32 62.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 119.047 -0.502 . . . . 0.0 110.806 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -58.8 -45.94 88.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.048 0.84 . . . . 0.0 110.448 171.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -58.8 -41.79 87.59 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.944 0.793 . . . . 0.0 111.699 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.28 -12.76 61.55 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.03 1.75 67.01 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.019 1.771 . . . . 0.0 114.559 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.99 75.03 1.64 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.477 1.511 . . . . 0.0 111.855 -174.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -51.85 -43.86 63.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.191 1.396 . . . . 0.0 112.909 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -54.34 -57.59 10.66 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.27 0.628 . . . . 0.0 111.517 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -62.23 -34.31 76.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.628 1.171 . . . . 0.0 111.585 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.72 83.22 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 118.585 0.63 . . . . 0.0 113.382 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.93 -48.79 64.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.333 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.77 -51.52 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.091 0.956 . . . . 0.0 111.115 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.33 -25.35 63.26 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.155 -0.965 . . . . 0.0 113.054 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.35 -41.68 84.82 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.391 171.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.71 -53.03 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.982 1.313 . . . . 0.0 110.229 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -55.76 -48.4 75.34 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.936 0.895 . . . . 0.0 113.36 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -70.92 -36.61 72.73 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.953 -0.467 . . . . 0.0 111.447 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.53 99.11 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.565 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.9 -48.17 86.94 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-N 119.429 1.013 . . . . 0.0 111.773 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 50.9 ttp -56.23 -48.76 75.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.226 1.013 . . . . 0.0 111.674 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -70.8 -42.83 69.8 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.104 0.562 . . . . 0.0 111.839 -172.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.87 -33.62 76.26 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.323 1.449 . . . . 0.0 111.336 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.04 -16.77 60.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.42 -45.81 75.03 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.557 -1.339 . . . . 0.0 110.823 168.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -76.19 -47.3 24.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.329 1.452 . . . . 0.0 111.538 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -127.87 85.2 61.25 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 109.864 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.49 151.29 80.11 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.874 2.383 . . . . 0.0 111.11 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -62.95 149.95 43.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -132.07 152.03 51.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.38 -30.02 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.243 . . . . 0.0 113.722 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.2 18.6 13.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.575 1.15 . . . . 0.0 112.702 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.11 146.55 27.29 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.976 0.893 . . . . 0.0 112.247 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.22 -0.473 0 C-N-CA 124.899 1.28 . . . . 0.0 111.241 -169.625 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 CA-C-O 121.817 0.674 . . . . 0.0 112.852 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -78.35 -4.28 47.31 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.594 1.557 . . . . 0.0 114.354 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 p -76.38 155.88 33.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.791 -1.193 . . . . 0.0 112.18 -170.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.3 mt -79.69 128.4 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.95 0.9 . . . . 0.0 109.578 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 t -89.87 145.12 25.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.986 0.514 . . . . 0.0 111.684 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.63 147.35 31.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 111.351 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 C-N-CA 125.899 1.714 . . . . 0.0 116.191 -176.8 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--O 1.237 0.397 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.35 155.98 19.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.878 0.471 . . . . 0.0 110.545 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.95 -29.04 26.47 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -74.41 -35.32 63.41 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -73.17 -48.08 38.31 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.643 1.577 . . . . 0.0 109.938 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.44 -45.64 92.14 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.796 1.638 . . . . 0.0 111.241 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.79 -33.91 73.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.566 -1.334 . . . . 0.0 112.794 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -44.13 67.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -67.86 -39.34 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.136 0.88 . . . . 0.0 111.974 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.46 -39.13 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 121.65 -0.656 . . . . 0.0 111.955 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.8 -27.49 63.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.02 87.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.016 0.825 . . . . 0.0 111.776 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.18 -47.87 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.193 0.597 . . . . 0.0 111.19 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -60.28 -30.76 69.67 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.26 -35.86 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.72 -1.238 . . . . 0.0 111.141 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.75 98.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.38 1.072 . . . . 0.0 112.336 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -57.05 -29.77 63.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.222 1.409 . . . . 0.0 112.12 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -88.31 3.23 50.45 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.042 -1.662 . . . . 0.0 112.326 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.63 -15.64 7.45 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.376 1.871 . . . . 0.0 113.682 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 29' ' ' GLY . 6.7 t -154.24 160.16 41.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.547 1.939 . . . . 0.0 109.82 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 p -92.11 23.04 3.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.53 ' H ' HG23 ' A' ' 27' ' ' THR . . . -125.61 153.66 18.32 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 126.385 1.945 . . . . 0.0 112.187 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -106.0 137.26 44.22 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -166.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.8 128.69 75.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -135.37 142.37 45.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.635 0.774 . . . . 0.0 111.541 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 81.2 t -107.82 135.28 47.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.694 1.197 . . . . 0.0 109.465 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.467 ' HB2' HD11 ' A' ' 66' ' ' LEU . 68.6 t60 -115.99 138.51 51.14 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.705 1.202 . . . . 0.0 112.326 166.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.9 tp -126.11 129.44 49.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.518 1.127 . . . . 0.0 111.822 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -158.88 156.62 29.91 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.521 1.528 . . . . 0.0 109.312 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -79.83 -70.61 0.5 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 121.034 -1.041 . . . . 0.0 112.464 -173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 t -144.04 152.05 40.49 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 111.552 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -104.48 137.18 42.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.267 1.427 . . . . 0.0 111.524 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.87 -14.57 57.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 112.977 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.81 -152.64 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.589 1.955 . . . . 0.0 110.171 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.46 134.71 36.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 112.349 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -39.73 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.271 -0.893 . . . . 0.0 112.151 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.12 -43.47 82.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.551 1.069 . . . . 0.0 111.527 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.62 -43.04 98.02 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.679 -0.638 . . . . 0.0 111.88 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -58.43 -45.45 88.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.784 0.72 . . . . 0.0 111.669 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.4 87.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 117.442 -1.266 . . . . 0.0 111.405 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 51.1 ttp -60.29 -50.01 75.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.175 1.352 . . . . 0.0 111.077 170.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.495 0.588 . . . . 0.0 111.724 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.5 t -63.68 -45.31 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.397 1.079 . . . . 0.0 111.703 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.26 -48.82 80.1 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.632 0.773 . . . . 0.0 111.068 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -70.28 -39.67 74.76 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.139 0.976 . . . . 0.0 111.619 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -61.65 -42.96 99.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.412 1.485 . . . . 0.0 112.926 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.93 -2.83 10.7 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.479 -0.763 . . . . 0.0 112.882 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.81 37.49 18.66 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.797 1.639 . . . . 0.0 111.713 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.6 mtp -74.48 -17.96 60.69 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.48 -4.87 9.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 170.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.03 52.16 0.7 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.531 1.532 . . . . 0.0 113.38 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 p -135.3 149.63 49.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.147 0.979 . . . . 0.0 112.05 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -67.4 -25.58 66.02 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.17 -1.81 13.57 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.139 1.376 . . . . 0.0 113.4 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 56.22 54.88 7.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.089 1.356 . . . . 0.0 111.112 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -133.09 41.99 3.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.526 0.731 . . . . 0.0 112.699 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.48 147.51 18.66 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.756 1.17 . . . . 0.0 111.552 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.77 138.84 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.531 1.133 . . . . 0.0 110.354 172.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.5 tp -115.06 128.52 56.29 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.79 1.236 . . . . 0.0 110.14 165.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -101.95 93.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 124.132 0.973 . . . . 0.0 109.005 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -75.52 123.42 25.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.034 0.934 . . . . 0.0 109.912 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.11 122.43 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.67 1.188 . . . . 0.0 110.731 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.07 89.22 5.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.901 1.28 . . . . 0.0 109.621 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.51 -16.49 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -75.24 -35.17 61.45 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.439 -0.788 . . . . 0.0 112.274 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -95.77 -8.01 35.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.095 1.358 . . . . 0.0 112.54 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.3 tttt 70.17 24.75 4.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.658 1.983 . . . . 0.0 112.722 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 p -108.93 167.96 9.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.086 1.354 . . . . 0.0 112.519 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.81 147.39 31.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 110.585 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.3 149.28 24.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.544 1.937 . . . . 0.0 108.166 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.85 127.02 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -136.92 129.73 30.57 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.429 0.691 . . . . 0.0 110.235 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.27 15.19 Favored Glycine 0 CA--C 1.513 -0.078 0 C-N-CA 124.825 1.202 . . . . 0.0 112.065 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -69.9 161.35 30.1 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.384 1.087 . . . . 0.0 113.378 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -52.14 -38.31 57.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.604 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.72 -11.6 69.35 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.009 -1.44 . . . . 0.0 115.047 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 93.3 mt -89.02 -57.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.483 1.641 . . . . 0.0 108.752 160.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -55.58 -33.76 64.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.87 -15.57 58.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.099 1.76 . . . . 0.0 113.639 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.86 -28.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.39 168.63 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.655 1.116 . . . . 0.0 112.673 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.9 p -114.85 177.75 4.53 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.912 1.285 . . . . 0.0 112.681 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -63.16 -26.8 68.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.656 -1.278 . . . . 0.0 113.574 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.75 -34.92 79.47 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.996 1.319 . . . . 0.0 111.701 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.1 t80 -71.09 -30.59 66.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.987 174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -82.33 -31.87 29.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 0.0 112.666 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.39 -41.46 84.92 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.001 0.92 . . . . 0.0 111.689 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -60.83 -33.92 73.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.766 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 m -64.53 -52.13 59.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.673 0.789 . . . . 0.0 110.083 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.5 -45.99 91.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.407 0.683 . . . . 0.0 111.207 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.81 -41.93 96.65 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.11 -50.83 68.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.999 0.428 . . . . 0.0 112.085 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.48 -49.19 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.449 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -57.93 -42.71 85.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.099 1.36 . . . . 0.0 112.608 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.49 -53.29 57.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 111.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.92 -31.1 66.02 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 122.161 -0.337 . . . . 0.0 111.695 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -67.82 -39.98 83.88 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.737 0.699 . . . . 0.0 112.288 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.27 -34.22 77.19 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.159 0.984 . . . . 0.0 111.855 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -71.35 -31.08 66.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.994 0.918 . . . . 0.0 112.316 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 7.53 30.78 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.266 1.412 . . . . 0.0 114.593 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -101.87 72.59 1.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.803 1.641 . . . . 0.0 110.897 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -51.17 -46.52 62.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.84 1.256 . . . . 0.0 113.082 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -46.76 -60.25 2.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -65.8 -35.91 82.03 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.984 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.43 75.21 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 120.04 1.291 . . . . 0.0 113.327 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.03 -51.63 52.42 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.455 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.11 -51.63 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.717 0.807 . . . . 0.0 111.5 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.93 -34.18 77.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.307 0.958 . . . . 0.0 111.768 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -42.24 95.04 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.303 0.954 . . . . 0.0 112.16 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.25 -44.26 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.608 1.563 . . . . 0.0 111.348 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.12 -42.13 94.13 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.845 0.831 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -71.39 -39.79 70.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 120.642 -1.286 . . . . 0.0 112.049 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.99 90.4 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.359 0.664 . . . . 0.0 110.409 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.85 39.1 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.846 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.9 mmm -64.04 -26.36 68.52 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.26 -52.21 11.41 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.781 170.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -58.23 -37.39 74.76 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 112.296 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.7 62.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.447 1.499 . . . . 0.0 113.312 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -67.53 -29.07 68.37 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.105 -0.997 . . . . 0.0 112.52 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.43 -32.62 11.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.112 1.365 . . . . 0.0 112.161 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.79 79.11 75.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.132 1.773 . . . . 0.0 110.053 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.11 136.01 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.259 1.972 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -63.44 139.66 58.79 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.309 1.043 . . . . 0.0 112.896 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -113.37 156.05 24.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.683 1.23 . . . . 0.0 112.911 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.49 -14.77 58.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.81 -1.806 . . . . 0.0 114.267 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -121.43 35.64 4.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.166 1.786 . . . . 0.0 110.571 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 151.24 26.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.538 -0.726 . . . . 0.0 112.887 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.217 -0.61 0 C-N-CA 124.341 1.056 . . . . 0.0 111.752 -166.897 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.456 -0.702 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -2.64 12.38 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.0 m -78.18 124.45 28.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.831 1.252 . . . . 0.0 110.763 -163.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.81 128.47 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.703 1.201 . . . . 0.0 108.905 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.8 t -87.22 135.43 33.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.55 139.35 42.13 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.903 -1.123 . . . . 0.0 109.998 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 CA-C-O 117.135 -1.925 . . . . 0.0 110.947 170.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.478 HD13 ' CD ' ' A' ' 110' ' ' LYS . 23.0 mt . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -73.57 143.04 46.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.087 0.955 . . . . 0.0 110.673 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.09 -29.26 3.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.17 -46.81 79.21 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.067 0.947 . . . . 0.0 112.754 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.26 -31.68 58.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.231 1.012 . . . . 0.0 111.17 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 37.3 mt-10 -70.89 -38.16 73.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.865 0.866 . . . . 0.0 111.558 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.23 -41.59 99.13 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.493 -1.379 . . . . 0.0 111.628 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.09 98.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.616 0.767 . . . . 0.0 112.833 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.28 -38.25 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 120.979 -1.076 . . . . 0.0 112.167 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.55 -40.17 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.546 0.612 . . . . 0.0 110.845 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.68 -32.99 73.21 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.92 65.54 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -72.28 -46.49 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.41 1.084 . . . . 0.0 110.521 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -56.28 -30.67 62.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.024 0.93 . . . . 0.0 112.967 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.06 -28.17 60.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 113.548 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.86 62.37 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.101 0.96 . . . . 0.0 111.936 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.55 -7.88 23.08 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.733 1.254 . . . . 0.0 113.27 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -95.16 3.08 55.07 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.428 -2.045 . . . . 0.0 112.944 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -125.49 -17.66 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.941 2.097 . . . . 0.0 114.053 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 t -151.41 151.75 32.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.85 1.66 . . . . 0.0 108.927 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -90.84 49.72 1.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.179 0.991 . . . . 0.0 110.859 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.02 128.88 2.41 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.144 -1.597 . . . . 0.0 111.062 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -96.9 126.9 42.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.733 0.813 . . . . 0.0 112.843 -153.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -113.43 115.29 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 111.397 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.499 HH11 ' CG ' ' A' ' 56' ' ' MET . 73.4 mtp180 -118.21 153.55 33.7 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.384 1.473 . . . . 0.0 112.647 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.63 141.94 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.913 1.685 . . . . 0.0 111.3 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -131.46 123.25 27.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.251 1.02 . . . . 0.0 112.358 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.3 tp -111.06 127.84 55.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.819 0.848 . . . . 0.0 111.216 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -149.46 163.47 37.7 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.134 0.974 . . . . 0.0 110.301 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -79.34 -66.63 0.84 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.374 -1.454 . . . . 0.0 112.016 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -159.6 151.77 20.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.47 1.108 . . . . 0.0 112.53 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 p -105.26 144.02 32.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 112.321 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -77.87 -11.96 59.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.692 1.197 . . . . 0.0 113.518 170.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.68 -164.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 127.962 2.505 . . . . 0.0 110.028 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -79.42 136.76 37.04 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.43 -1.419 . . . . 0.0 112.579 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -58.66 -40.33 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -59.12 -46.83 87.32 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.934 0.788 . . . . 0.0 112.211 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -72.6 -38.72 67.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.718 0.407 . . . . 0.0 111.86 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -60.28 -47.58 85.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.24 -0.287 . . . . 0.0 111.026 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.02 89.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.3 ttp -62.56 -50.67 70.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.768 0.827 . . . . 0.0 111.543 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.73 -49.06 79.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.987 0.915 . . . . 0.0 111.918 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.41 -41.1 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.041 0.936 . . . . 0.0 112.026 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.09 -46.09 90.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.988 0.813 . . . . 0.0 111.842 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -72.99 -32.78 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 112.438 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.35 -32.75 70.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.895 1.278 . . . . 0.0 112.807 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.9 mt -78.72 -11.51 59.98 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.3 -0.875 . . . . 0.0 112.82 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 64.49 35.68 9.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.34 1.456 . . . . 0.0 112.909 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.499 ' CG ' HH11 ' A' ' 32' ' ' ARG . 69.3 mtp -67.25 -22.62 65.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.898 1.279 . . . . 0.0 114.275 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.5 -7.93 8.16 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.722 2.009 . . . . 0.0 112.715 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -74.98 47.21 0.34 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.263 1.825 . . . . 0.0 112.719 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.6 p -119.34 150.74 39.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.864 1.666 . . . . 0.0 110.657 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -64.64 -43.9 92.2 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.911 -1.118 . . . . 0.0 112.494 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.45 -9.69 37.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 67.5 55.18 0.65 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.668 1.587 . . . . 0.0 108.58 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -126.17 29.87 5.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.554 1.141 . . . . 0.0 112.975 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.99 132.44 12.2 Favored Glycine 0 N--CA 1.47 0.964 0 O-C-N 120.424 -1.423 . . . . 0.0 110.988 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -111.77 134.5 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.528 1.131 . . . . 0.0 109.5 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 34' ' ' HIS . 16.2 tp -117.75 130.59 56.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.81 0.844 . . . . 0.0 110.693 166.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.5 mt -106.16 95.34 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -75.32 125.63 29.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.6 1.16 . . . . 0.0 110.723 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -117.27 131.19 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.04 1.336 . . . . 0.0 110.332 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.27 95.32 6.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.003 1.721 . . . . 0.0 110.414 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 35' ' ' LEU . 19.5 m -72.65 -16.36 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -75.27 -51.62 12.83 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.43 -5.75 55.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.94 1.296 . . . . 0.0 113.861 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.1 tttt 65.02 31.17 11.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.23 2.212 . . . . 0.0 112.751 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.5 p -111.06 163.54 13.76 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.028 0.931 . . . . 0.0 111.115 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 147.65 42.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.164 1.385 . . . . 0.0 109.534 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.89 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.758 1.623 . . . . 0.0 108.126 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.5 133.93 63.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -147.04 138.45 24.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.077 1.351 . . . . 0.0 110.036 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.71 164.3 21.15 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 124.756 1.169 . . . . 0.0 112.214 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -70.83 166.54 20.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 123.257 1.503 . . . . 0.0 112.705 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.42 -39.16 67.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.153 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.33 -46.49 78.11 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.386 1.47 . . . . 0.0 112.991 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.41 -59.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 118.208 1.004 . . . . 0.0 109.46 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.01 -22.67 64.75 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.72 -29.34 25.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.65 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -24.63 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.14 164.14 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.668 1.187 . . . . 0.0 112.649 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.2 p -107.93 174.42 5.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.694 1.198 . . . . 0.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.94 -33.41 73.12 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.342 -1.474 . . . . 0.0 113.359 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.1 -23.92 63.12 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -68.12 -37.59 81.29 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 117.698 0.226 . . . . 0.0 110.608 169.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -77.01 -25.57 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.3 -36.3 79.72 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.687 0.676 . . . . 0.0 112.715 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.3 m -55.98 -45.39 78.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.634 0.773 . . . . 0.0 111.427 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -47.68 84.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.305 1.442 . . . . 0.0 110.842 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -59.34 -47.84 83.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -64.86 -35.5 81.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.448 1.099 . . . . 0.0 113.368 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.67 -53.26 43.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.936 0.789 . . . . 0.0 111.692 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.33 -48.46 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.014 0.526 . . . . 0.0 110.459 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -60.07 -43.2 95.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.073 1.349 . . . . 0.0 112.905 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.26 -42.17 93.51 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 119.55 1.068 . . . . 0.0 111.827 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -74.88 -38.9 61.79 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.799 0.44 . . . . 0.0 111.926 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.76 -40.11 91.25 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.353 0.978 . . . . 0.0 112.054 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.57 -32.14 73.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.918 1.287 . . . . 0.0 112.078 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -74.59 -39.28 62.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.792 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.41 -2.21 12.59 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.23 1.872 . . . . 0.0 113.062 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.24 71.27 8.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.367 1.467 . . . . 0.0 111.102 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -52.73 -42.34 64.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.144 0.977 . . . . 0.0 112.407 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' CD ' HD13 ' A' ' 8' ' ' LEU . 19.2 tptt -64.93 -48.52 73.82 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -55.37 -47.51 75.69 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.528 0.731 . . . . 0.0 109.695 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.31 95.95 Favored Glycine 0 N--CA 1.467 0.741 0 CA-C-N 119.245 0.929 . . . . 0.0 113.695 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.45 -43.03 74.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.14 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.66 -50.42 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.599 1.16 . . . . 0.0 110.68 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -69.47 -25.05 63.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.875 1.27 . . . . 0.0 112.718 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.93 -41.85 26.74 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.083 0.849 . . . . 0.0 112.614 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.0 mt -60.61 -43.61 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.109 0.955 . . . . 0.0 111.166 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.23 -49.21 77.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.831 0.853 . . . . 0.0 112.621 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -71.55 -36.5 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.012 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.21 78.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.875 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.09 68.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.703 1.138 . . . . 0.0 112.341 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -64.17 -33.58 76.11 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.5 -46.55 38.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.794 0.725 . . . . 0.0 111.193 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.46 -39.26 83.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.215 1.406 . . . . 0.0 110.47 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.09 52.33 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.1 -41.67 99.42 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.859 -1.151 . . . . 0.0 110.805 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -84.84 -47.58 10.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.262 1.825 . . . . 0.0 111.144 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -114.38 78.18 4.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.725 2.01 . . . . 0.0 111.061 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.91 140.57 42.45 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.838 2.358 . . . . 0.0 111.256 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -59.39 141.75 53.86 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -115.42 149.26 38.29 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 123.892 0.877 . . . . 0.0 110.937 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.69 -25.82 67.65 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.29 -1.506 . . . . 0.0 112.297 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.07 22.14 7.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.655 1.582 . . . . 0.0 113.452 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.55 158.75 5.59 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 C-N-CA 124.721 1.209 . . . . 0.0 112.572 -172.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.448 -1.168 0 CA-C-O 121.615 0.59 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -74.29 4.15 6.22 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.2 p -72.72 168.97 17.64 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.653 1.181 . . . . 0.0 111.387 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.42 144.45 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 120.535 -1.353 . . . . 0.0 111.132 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 t -99.99 146.78 26.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.682 1.193 . . . . 0.0 111.026 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -153.18 94.86 1.88 Allowed 'General case' 0 CA--C 1.553 1.094 0 O-C-N 120.908 -1.12 . . . . 0.0 112.92 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 C-N-CA 125.05 1.31 . . . . 0.0 114.904 -173.698 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -72.59 170.2 14.93 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.371 0.532 . . . . 0.0 111.386 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.38 68.64 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.111 -0.993 . . . . 0.0 112.752 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -60.7 -34.79 74.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.661 1.184 . . . . 0.0 112.395 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 88.6 mt-10 -84.43 -42.47 15.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.0 0.92 . . . . 0.0 110.902 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -57.22 -50.46 72.8 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.555 1.142 . . . . 0.0 111.774 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.16 -39.08 69.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.819 -1.175 . . . . 0.0 112.569 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.62 69.47 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 tt -71.43 -39.23 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.825 0.738 . . . . 0.0 111.136 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.7 t -59.55 -29.21 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.065 1.346 . . . . 0.0 112.641 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -72.86 -41.01 65.21 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.284 1.434 . . . . 0.0 113.557 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.15 77.58 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.03 -49.42 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.961 0.905 . . . . 0.0 110.594 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -60.06 -24.68 64.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.07 -18.43 32.42 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.765 0.826 . . . . 0.0 111.985 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.95 -39.87 29.27 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.993 0.917 . . . . 0.0 111.262 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.59 -27.44 39.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.325 1.45 . . . . 0.0 112.557 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -90.66 1.7 56.57 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.706 -1.871 . . . . 0.0 113.615 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -112.81 -20.73 11.51 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.233 1.813 . . . . 0.0 111.938 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -160.56 148.55 16.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.526 1.13 . . . . 0.0 110.574 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.6 p -81.3 38.25 0.48 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.295 1.038 . . . . 0.0 111.815 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.49 143.27 14.93 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.041 1.781 . . . . 0.0 109.884 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.9 124.77 51.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.156 -165.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.84 130.89 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -145.93 150.15 35.55 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.353 1.461 . . . . 0.0 110.67 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.96 135.92 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.612 1.565 . . . . 0.0 109.887 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' HD11 ' A' ' 66' ' ' LEU . 18.5 t60 -117.4 122.66 44.42 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.974 170.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -114.43 130.31 56.7 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.457 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -155.21 163.44 40.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.043 0.925 . . . . 0.0 110.764 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.5 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -75.05 -75.88 0.16 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.736 1.215 . . . . 0.0 112.086 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 t -138.15 173.19 11.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.774 2.029 . . . . 0.0 109.044 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 p -140.99 141.11 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.413 -0.805 . . . . 0.0 111.036 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.29 -7.19 59.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.76 -150.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.219 1.808 . . . . 0.0 111.137 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -85.83 121.07 27.96 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.29 -1.506 . . . . 0.0 111.365 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.58 -42.53 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.98 -47.54 84.38 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.107 -0.995 . . . . 0.0 112.444 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.17 -36.59 69.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.362 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -68.99 -40.92 78.46 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.528 -0.732 . . . . 0.0 112.319 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.0 74.8 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.365 -0.834 . . . . 0.0 110.649 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.2 ttp -65.56 -44.37 86.98 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.976 0.807 . . . . 0.0 111.072 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.09 -52.46 65.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.335 0.97 . . . . 0.0 111.433 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.07 -45.06 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.964 1.305 . . . . 0.0 111.542 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.93 -50.46 73.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.431 1.014 . . . . 0.0 112.402 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -69.53 -36.48 76.43 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.427 1.091 . . . . 0.0 112.338 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -63.87 -40.24 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.853 1.261 . . . . 0.0 112.079 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.26 -6.37 45.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.326 1.05 . . . . 0.0 113.582 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 57.66 39.3 27.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.888 1.275 . . . . 0.0 111.79 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.8 mtp -66.81 -20.66 65.98 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.919 -1.113 . . . . 0.0 112.469 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.94 -15.78 14.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.998 2.119 . . . . 0.0 112.318 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -73.79 50.66 0.35 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.169 2.188 . . . . 0.0 111.818 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -125.3 123.95 40.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.734 2.014 . . . . 0.0 107.972 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -45.61 -50.34 13.35 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.672 1.189 . . . . 0.0 113.617 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.9 mt -87.0 -6.59 58.7 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 68.04 40.14 2.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.19 1.396 . . . . 0.0 110.966 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -114.65 41.46 2.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.361 1.464 . . . . 0.0 112.33 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.07 10.51 Favored Glycine 0 N--CA 1.477 1.388 0 O-C-N 121.451 -0.781 . . . . 0.0 112.843 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.97 133.67 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.808 1.304 . . . . 0.0 111.043 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.4 tp -116.51 133.54 55.9 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.372 1.069 . . . . 0.0 111.485 172.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.5 mt -106.83 93.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.658 0.742 . . . . 0.0 109.633 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -77.34 113.67 15.36 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.955 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.32 134.26 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.861 1.264 . . . . 0.0 110.595 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.82 15.15 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 110.042 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' LYS . 13.6 m -75.78 -18.32 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -81.62 -37.95 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.515 1.126 . . . . 0.0 111.908 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.23 -10.15 31.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.082 1.353 . . . . 0.0 112.53 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt 65.4 32.27 9.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.658 1.583 . . . . 0.0 112.257 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.1 p -111.15 160.42 16.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.265 1.826 . . . . 0.0 111.848 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.98 134.64 23.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.649 1.18 . . . . 0.0 110.065 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.53 138.38 54.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.994 1.318 . . . . 0.0 108.098 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.19 131.55 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -137.25 136.81 38.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.631 0.772 . . . . 0.0 110.245 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 139.43 11.95 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -59.66 160.19 7.61 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 123.626 1.679 . . . . 0.0 110.628 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.3 -34.25 60.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.545 1.938 . . . . 0.0 113.71 -168.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.64 77.56 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-O 118.666 -1.075 . . . . 0.0 112.85 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.97 -55.78 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.277 1.538 . . . . 0.0 109.399 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -50.84 -34.58 28.46 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.78 -25.79 44.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.06 -27.16 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.8 161.54 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.059 0.845 . . . . 0.0 113.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 m -113.63 173.27 6.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.57 1.548 . . . . 0.0 113.829 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -50.97 -41.67 59.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.929 1.692 . . . . 0.0 114.553 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.6 -12.88 60.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.366 1.467 . . . . 0.0 113.395 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.7 t80 -83.96 -28.0 28.1 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.927 -1.733 . . . . 0.0 111.227 166.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -84.98 -21.0 29.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 113.279 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -60.72 -44.27 96.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.438 1.095 . . . . 0.0 111.576 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.1 p -57.52 -45.82 84.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.574 1.149 . . . . 0.0 111.351 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -57.36 -51.33 69.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.385 1.474 . . . . 0.0 111.028 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.68 -48.75 80.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.615 1.166 . . . . 0.0 111.627 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.63 -45.58 93.5 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.07 50.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.938 0.79 . . . . 0.0 112.577 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.44 -46.3 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.704 -0.622 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.72 -36.99 86.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.215 1.006 . . . . 0.0 112.743 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.88 -41.83 97.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.703 1.138 . . . . 0.0 111.2 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -83.32 -31.19 26.98 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.901 -0.571 . . . . 0.0 112.282 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -63.47 -38.06 89.69 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 119.122 0.874 . . . . 0.0 112.699 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.44 -35.82 82.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.885 0.874 . . . . 0.0 111.908 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -71.29 -36.38 71.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.031 0.932 . . . . 0.0 111.267 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 7.01 32.56 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 126.324 1.916 . . . . 0.0 113.936 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -90.32 72.05 7.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.645 1.222 . . . . 0.0 110.984 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -57.16 -36.79 71.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.352 1.061 . . . . 0.0 113.539 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 12' ' ' GLU . 79.3 tttt -56.29 -51.95 66.32 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 111.323 174.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.41 -34.26 77.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.107 1.363 . . . . 0.0 111.262 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.72 47.09 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 118.744 0.702 . . . . 0.0 112.733 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 -47.02 76.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.174 0.487 . . . . 0.0 111.177 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.81 -40.95 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.357 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.77 -37.5 79.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 111.608 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 -41.78 99.8 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.19 -47.75 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.211 1.004 . . . . 0.0 110.443 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -56.48 -52.68 63.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.571 1.149 . . . . 0.0 111.569 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.62 -38.79 84.41 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.603 0.761 . . . . 0.0 111.817 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.71 90.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 118.898 0.772 . . . . 0.0 111.252 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.3 98.6 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 119.032 0.833 . . . . 0.0 112.068 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mmm -62.34 -39.64 93.74 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.041 1.42 . . . . 0.0 113.078 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.63 -44.35 50.93 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.57 0.748 . . . . 0.0 111.546 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.84 -35.23 77.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.163 0.985 . . . . 0.0 111.424 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.63 -16.18 35.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.973 1.309 . . . . 0.0 114.305 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.3 -30.14 57.62 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.736 -1.227 . . . . 0.0 112.177 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -93.28 -31.12 14.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.735 1.214 . . . . 0.0 112.919 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -139.94 88.26 12.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.431 1.492 . . . . 0.0 109.236 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.14 148.02 55.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.399 2.066 . . . . 0.0 110.972 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -64.49 155.81 31.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.218 1.008 . . . . 0.0 113.456 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -136.18 151.23 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.704 1.601 . . . . 0.0 110.371 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.8 -25.57 67.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.534 -1.979 . . . . 0.0 112.684 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.9 15.71 28.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.015 1.726 . . . . 0.0 112.091 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.72 162.78 6.23 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.848 0.859 . . . . 0.0 112.483 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.324 -0.528 0 C-N-CA 124.129 0.972 . . . . 0.0 111.23 -168.932 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 0 N--CA 1.445 -1.356 0 CA-C-O 121.805 0.669 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.35 4.5 20.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.526 1.93 . . . . 0.0 114.844 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.2 p -74.92 161.82 29.17 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.207 1.403 . . . . 0.0 111.224 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.96 119.32 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.697 -1.252 . . . . 0.0 110.079 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.7 m -76.03 139.23 41.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.459 0.647 . . . . 0.0 111.427 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -136.61 131.54 33.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 C-N-CA 125.067 1.318 . . . . 0.0 114.646 177.061 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 m -65.94 157.1 31.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.1 0.96 . . . . 0.0 109.2 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.53 52.97 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.302 -1.499 . . . . 0.0 112.484 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -69.23 -23.6 63.9 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.711 1.204 . . . . 0.0 112.916 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.4 -46.24 9.82 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.529 1.532 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.29 -48.38 80.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 111.233 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.52 -47.79 69.62 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.968 -1.083 . . . . 0.0 111.883 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.23 83.84 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.302 1.041 . . . . 0.0 113.349 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -72.73 -38.66 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.852 0.751 . . . . 0.0 111.92 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.12 -40.38 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.807 0.843 . . . . 0.0 112.061 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.37 -33.43 74.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.254 0.934 . . . . 0.0 112.427 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.22 66.76 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.9 mt -61.21 -50.04 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.506 1.122 . . . . 0.0 109.935 167.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -57.97 -33.97 69.43 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.66 -26.38 60.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.03 42.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.095 0.958 . . . . 0.0 112.385 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -61.33 -23.67 65.9 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.264 1.026 . . . . 0.0 111.573 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -84.05 6.05 23.61 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.449 -2.032 . . . . 0.0 112.348 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -125.18 -7.8 7.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.111 1.764 . . . . 0.0 114.047 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -169.92 152.38 4.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.198 1.399 . . . . 0.0 110.491 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -82.27 21.65 0.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.249 1.42 . . . . 0.0 112.637 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.67 138.32 14.85 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 126.588 2.042 . . . . 0.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.62 125.25 52.39 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.03 0.915 . . . . 0.0 110.274 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 mt -117.39 125.95 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 119.935 -1.728 . . . . 0.0 112.628 -175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -129.22 131.18 47.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.475 1.51 . . . . 0.0 112.417 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.46 139.44 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.748 1.219 . . . . 0.0 112.867 170.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -128.55 125.81 39.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.974 1.31 . . . . 0.0 112.626 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 tp -115.76 133.01 56.46 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 111.294 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -159.09 158.24 32.6 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 109.546 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 71' ' ' VAL . 96.1 mttt -75.2 -63.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.123 -1.611 . . . . 0.0 113.852 -170.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -157.74 164.28 37.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.395 1.478 . . . . 0.0 110.825 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.9 p -114.56 144.79 42.81 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.419 1.487 . . . . 0.0 112.557 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.25 -19.1 43.81 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.043 -1.036 . . . . 0.0 111.948 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.12 -162.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.666 1.587 . . . . 0.0 111.516 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -77.71 139.09 39.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.895 0.878 . . . . 0.0 112.373 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.49 -35.09 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.988 0.915 . . . . 0.0 112.714 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -65.46 -51.47 59.92 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.779 0.718 . . . . 0.0 110.834 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.66 -42.29 98.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.613 1.165 . . . . 0.0 112.324 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -62.1 -47.28 85.32 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.371 -0.831 . . . . 0.0 112.129 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.89 89.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.495 -0.753 . . . . 0.0 111.469 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.6 ttp -62.01 -48.95 78.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.707 0.803 . . . . 0.0 111.891 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -61.01 -46.48 90.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.273 1.029 . . . . 0.0 110.952 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.21 -45.91 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.111 0.964 . . . . 0.0 111.88 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -56.75 -50.72 71.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.673 1.189 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.91 -35.45 74.6 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.31 0.644 . . . . 0.0 111.202 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -68.09 -32.36 72.63 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.365 1.066 . . . . 0.0 113.853 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.7 mt -78.61 -0.51 30.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.237 1.015 . . . . 0.0 112.534 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 58.44 32.2 21.83 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.285 1.834 . . . . 0.0 112.032 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.6 mtp -69.51 -16.67 63.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.991 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.23 -15.8 63.91 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.658 1.183 . . . . 0.0 113.193 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -85.04 55.55 3.54 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.389 -1.444 . . . . 0.0 112.083 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -110.0 160.82 16.09 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 0.0 110.369 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -72.21 -42.12 66.13 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.974 -1.078 . . . . 0.0 113.62 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.07 -11.63 32.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 74.21 28.15 1.44 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.382 1.473 . . . . 0.0 110.145 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -112.66 45.46 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.572 1.549 . . . . 0.0 111.481 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.9 131.03 10.58 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.782 1.182 . . . . 0.0 112.331 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.2 t -111.62 136.39 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.052 1.341 . . . . 0.0 110.8 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 tp -115.28 134.18 55.36 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.148 1.379 . . . . 0.0 111.405 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.23 89.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.002 1.321 . . . . 0.0 108.725 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -78.92 123.13 26.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.3 1.44 . . . . 0.0 111.547 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.3 t -124.85 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.066 -1.022 . . . . 0.0 111.825 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.06 116.17 28.57 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.195 1.398 . . . . 0.0 110.44 164.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 37' ' ' LYS . 16.3 m -77.43 -25.19 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.93 -57.99 3.56 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 118.205 0.457 . . . . 0.0 110.216 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.65 -4.13 55.36 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.2 tttt 68.39 27.53 6.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.682 1.593 . . . . 0.0 111.79 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 m -100.44 113.7 26.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.958 1.703 . . . . 0.0 110.491 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -88.95 141.9 28.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.0 0.92 . . . . 0.0 110.155 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.34 149.5 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.867 2.067 . . . . 0.0 108.143 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.8 mt -134.12 131.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -145.29 127.18 15.42 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.65 1.18 . . . . 0.0 109.534 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.38 149.68 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.6 162.82 3.59 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 122.964 1.364 . . . . 0.0 110.954 168.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -54.31 -35.67 62.91 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.488 1.515 . . . . 0.0 112.872 -168.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.83 -41.61 98.75 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.615 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mt -61.15 -56.16 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.294 1.547 . . . . 0.0 109.649 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -64.46 -19.47 65.58 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.07 -35.02 22.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.485 1.114 . . . . 0.0 111.367 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 88' ' ' VAL . 2.5 p -93.57 -24.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 87' ' ' VAL . 7.2 m -118.04 171.07 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 119.858 1.208 . . . . 0.0 111.998 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.5 p -113.13 172.22 7.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.989 1.316 . . . . 0.0 113.184 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -61.45 -30.82 70.83 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.839 -1.163 . . . . 0.0 112.551 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 -18.52 63.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.206 1.402 . . . . 0.0 112.668 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.0 t80 -81.22 -37.3 28.84 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.869 1.267 . . . . 0.0 111.915 168.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -73.71 -26.61 60.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.816 1.246 . . . . 0.0 113.568 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.37 -31.18 68.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.716 1.207 . . . . 0.0 113.677 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.7 p -70.02 -43.32 71.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.925 1.29 . . . . 0.0 111.517 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.0 m -56.88 -51.38 69.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.881 2.072 . . . . 0.0 110.779 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -58.71 -47.0 86.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.308 1.043 . . . . 0.0 111.63 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.12 -32.75 74.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.5 -53.39 29.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.326 0.967 . . . . 0.0 111.854 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt -61.28 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.625 0.37 . . . . 0.0 110.799 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.43 -44.05 92.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.399 1.08 . . . . 0.0 112.752 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.64 -39.83 85.65 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.785 0.72 . . . . 0.0 112.433 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.42 -32.66 20.77 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.43 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.71 -41.06 98.96 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.809 1.186 . . . . 0.0 111.063 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.01 -38.11 72.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.2 1.0 . . . . 0.0 111.625 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -75.67 -35.82 60.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.598 0.759 . . . . 0.0 111.988 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.65 5.99 21.83 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.802 1.667 . . . . 0.0 114.582 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -99.25 78.41 2.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.729 1.212 . . . . 0.0 110.428 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.09 -49.35 69.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.128 0.971 . . . . 0.0 112.416 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -50.58 -53.81 27.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.052 0.541 . . . . 0.0 111.353 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -62.53 -42.88 99.81 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.524 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.7 -35.56 74.07 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.504 1.047 . . . . 0.0 112.946 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.49 -44.71 77.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.306 0.642 . . . . 0.0 111.142 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.64 -52.58 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.434 1.094 . . . . 0.0 111.279 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -57.77 -40.72 80.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.293 0.951 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -43.32 87.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.044 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.25 -41.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.2 1.5 . . . . 0.0 112.123 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -63.73 -47.47 80.94 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.749 0.704 . . . . 0.0 110.944 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -66.56 -44.07 83.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.845 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.11 69.57 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.259 0.624 . . . . 0.0 111.028 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.14 89.39 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.045 0.839 . . . . 0.0 112.891 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.6 mtp -64.06 -36.31 83.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.871 1.335 . . . . 0.0 112.288 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -76.67 -43.62 37.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.049 0.939 . . . . 0.0 111.229 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -62.38 -35.15 78.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.134 0.974 . . . . 0.0 111.534 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.92 -20.9 62.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.696 1.198 . . . . 0.0 114.03 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -71.59 -41.98 68.31 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.022 -1.049 . . . . 0.0 111.444 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -75.12 -46.64 33.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.926 0.89 . . . . 0.0 111.611 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -122.87 88.34 50.48 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.623 1.569 . . . . 0.0 109.986 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.59 138.48 35.27 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.458 2.105 . . . . 0.0 110.454 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -62.86 135.51 57.36 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -106.53 154.31 21.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.155 0.982 . . . . 0.0 110.205 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.68 -27.04 68.65 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.933 -1.729 . . . . 0.0 112.259 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.71 19.64 15.54 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 126.184 1.794 . . . . 0.0 113.108 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -58.99 159.6 6.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.281 1.032 . . . . 0.0 113.321 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 123.086 1.422 . . . . 0.0 113.083 -167.768 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.453 -0.875 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.04 21.83 0.68 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.304 1.042 . . . . 0.0 112.857 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -77.24 150.55 35.37 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.925 2.09 . . . . 0.0 111.887 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.5 mt -80.97 130.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.149 0.98 . . . . 0.0 109.532 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.2 m -87.89 142.42 27.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.429 170.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.76 140.82 31.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.667 0.787 . . . . 0.0 110.837 -174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.28 1.895 . . . . 0.0 109.972 164.484 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -74.78 162.93 28.22 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.429 1.092 . . . . 0.0 109.532 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.46 -41.21 39.58 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -61.79 -30.49 70.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.88 1.272 . . . . 0.0 113.55 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -81.87 -47.49 12.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -62.37 -41.55 98.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.908 1.283 . . . . 0.0 110.691 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -55.56 -55.16 35.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.857 -1.152 . . . . 0.0 111.444 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.36 81.28 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -74.16 -30.34 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.167 0.894 . . . . 0.0 113.302 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.22 -42.46 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.478 -1.389 . . . . 0.0 111.047 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -63.58 -32.44 73.9 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.811 0.844 . . . . 0.0 112.347 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.26 85.71 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.273 -0.892 . . . . 0.0 112.596 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 mm -59.05 -45.99 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.093 0.957 . . . . 0.0 111.285 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -58.29 -31.16 67.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -81.97 -29.05 32.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.74 84.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.815 0.734 . . . . 0.0 111.34 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -56.12 -26.98 52.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.794 1.638 . . . . 0.0 113.41 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.84 5.18 37.98 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 112.826 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.83 -8.05 5.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.983 1.713 . . . . 0.0 114.29 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -148.37 159.88 43.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.926 1.69 . . . . 0.0 109.316 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.2 p -94.26 37.01 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.17 0.988 . . . . 0.0 111.688 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.44 146.24 15.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 123.955 0.788 . . . . 0.0 112.611 -171.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -108.33 131.8 54.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.689 0.756 . . . . 0.0 111.605 -151.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.47 134.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.802 -1.186 . . . . 0.0 110.661 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -144.26 153.48 42.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.18 1.392 . . . . 0.0 111.862 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.03 136.91 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.081 1.352 . . . . 0.0 109.704 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -118.57 118.52 31.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.003 1.721 . . . . 0.0 111.937 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.8 tp -107.15 129.28 54.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 112.086 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.52 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.0 tt0 -154.78 168.15 27.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.015 1.326 . . . . 0.0 111.897 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.18 -95.25 0.06 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.222 1.409 . . . . 0.0 113.479 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 p -116.05 165.21 13.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.332 2.253 . . . . 0.0 109.548 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 p -113.07 162.28 16.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.864 0.84 . . . . 0.0 111.977 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -95.36 -15.19 23.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.989 1.316 . . . . 0.0 113.009 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.42 -150.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.978 2.111 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -85.47 137.63 32.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.486 1.039 . . . . 0.0 112.01 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.29 -39.02 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.566 1.146 . . . . 0.0 112.422 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.94 -49.93 70.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.961 0.801 . . . . 0.0 111.764 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.59 -41.78 96.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 111.272 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CD ' ' A' ' 36' ' ' GLU . 59.0 ttt85 -59.52 -48.89 79.9 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.042 0.937 . . . . 0.0 112.574 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.97 97.11 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.537 0.735 . . . . 0.0 111.077 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.18 -47.24 87.09 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.972 0.909 . . . . 0.0 112.172 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.87 -42.59 97.48 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.061 -1.024 . . . . 0.0 112.57 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.7 -41.99 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.867 0.867 . . . . 0.0 111.969 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.26 -48.77 78.46 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 111.971 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -75.16 -31.64 61.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.799 0.84 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -62.09 -48.28 80.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.096 0.959 . . . . 0.0 111.132 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -72.77 -7.59 51.38 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.105 0.962 . . . . 0.0 113.524 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 63.45 42.82 6.38 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 112.208 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.4 mtt -71.29 -21.53 62.06 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -8.96 8.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.026 2.13 . . . . 0.0 113.705 171.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -79.41 56.49 2.15 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.349 1.86 . . . . 0.0 111.081 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.7 p -128.99 145.18 51.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.549 1.94 . . . . 0.0 108.637 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -59.76 -39.66 85.59 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.5 mt -100.3 -8.82 23.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.081 -1.438 . . . . 0.0 114.519 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 69.93 39.73 1.38 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.708 1.203 . . . . 0.0 110.355 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -106.72 20.29 19.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.445 1.898 . . . . 0.0 113.735 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.07 121.36 6.52 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.296 -0.878 . . . . 0.0 112.569 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.5 t -104.43 133.57 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.357 1.863 . . . . 0.0 109.932 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.5 tp -120.79 130.16 53.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.318 1.047 . . . . 0.0 111.988 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 53.5 mt -105.78 100.16 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 0.0 108.593 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -81.36 125.88 30.92 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.282 0.633 . . . . 0.0 110.051 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.93 131.54 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.916 0.886 . . . . 0.0 110.954 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 102.0 11.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.114 1.366 . . . . 0.0 109.721 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.22 -19.3 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 -44.28 20.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.332 0.653 . . . . 0.0 111.1 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -86.73 -11.17 51.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.068 0.947 . . . . 0.0 112.524 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.4 tttt 72.77 29.08 1.98 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.108 2.163 . . . . 0.0 111.614 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -109.57 162.83 14.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.189 1.396 . . . . 0.0 111.198 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.45 146.13 41.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.135 1.374 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.01 135.5 45.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 126.119 1.768 . . . . 0.0 107.256 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.3 mt -118.52 127.85 75.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -136.21 125.46 24.72 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 125.342 1.457 . . . . 0.0 109.961 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 158.26 14.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.855 1.217 . . . . 0.0 110.644 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -65.31 164.8 12.81 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.605 1.669 . . . . 0.0 111.874 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -50.72 -33.67 23.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.04 2.136 . . . . 0.0 114.075 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.54 -43.36 98.18 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 119.985 1.266 . . . . 0.0 111.906 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.66 -58.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.585 1.192 . . . . 0.0 109.86 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -60.05 -25.37 65.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.083 -1.011 . . . . 0.0 113.571 -173.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.94 -8.09 44.18 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 88' ' ' VAL . 2.8 p -113.59 -22.84 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 118.191 -0.909 . . . . 0.0 113.035 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 87' ' ' VAL . 4.0 m -119.8 172.46 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.045 1.293 . . . . 0.0 112.233 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.66 171.98 7.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.669 1.588 . . . . 0.0 112.631 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.89 -34.01 75.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.01 -35.12 79.18 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.826 0.739 . . . . 0.0 111.97 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 44.0 t80 -64.41 -41.99 96.33 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.027 0.531 . . . . 0.0 110.761 172.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -70.02 -26.81 64.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.89 -35.65 75.3 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.153 0.888 . . . . 0.0 111.575 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 p -60.39 -46.84 88.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.494 0.717 . . . . 0.0 111.938 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 m -61.18 -48.94 79.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.591 1.957 . . . . 0.0 111.071 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -60.0 -47.36 86.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.263 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -62.54 -43.78 97.98 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.63 -48.74 76.86 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.021 0.828 . . . . 0.0 111.928 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.78 -48.28 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.749 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -59.99 -44.15 94.69 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.99 -38.25 87.89 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.152 -0.968 . . . . 0.0 112.497 -176.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -80.88 -37.59 29.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.28 1.032 . . . . 0.0 111.67 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.44 -38.96 82.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.442 -0.786 . . . . 0.0 111.645 171.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.01 -28.83 70.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.961 0.904 . . . . 0.0 113.136 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -79.59 -27.86 41.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.751 1.16 . . . . 0.0 110.802 172.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.91 25.12 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 126.309 1.909 . . . . 0.0 113.631 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -107.34 73.07 0.9 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.356 1.462 . . . . 0.0 110.951 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -58.08 -40.33 80.83 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.771 0.828 . . . . 0.0 113.225 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -60.22 -53.92 51.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.013 -0.429 . . . . 0.0 111.456 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.6 -39.49 88.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.646 0.778 . . . . 0.0 111.069 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.33 96.51 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.738 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.58 -48.44 66.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.457 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.71 -45.23 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.528 1.058 . . . . 0.0 112.391 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -67.26 -36.96 82.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.463 1.105 . . . . 0.0 112.14 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.5 95.89 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 121.649 -0.657 . . . . 0.0 112.547 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.02 -45.62 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.789 1.236 . . . . 0.0 110.564 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.68 -50.6 71.81 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.824 0.849 . . . . 0.0 111.33 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -66.59 -41.88 87.81 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.079 0.952 . . . . 0.0 111.24 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.18 79.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.448 172.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.62 97.42 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.402 1.001 . . . . 0.0 113.18 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.74 -40.4 95.24 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.603 1.202 . . . . 0.0 112.839 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.55 -47.58 31.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.411 1.084 . . . . 0.0 111.368 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.78 -38.74 79.18 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 125.567 1.547 . . . . 0.0 110.735 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.6 -19.11 46.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.45 -32.62 64.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.536 -1.353 . . . . 0.0 111.837 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -89.32 -33.93 16.74 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.857 1.263 . . . . 0.0 112.676 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.52 85.93 41.54 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.733 2.013 . . . . 0.0 110.275 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.49 135.02 25.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.65 2.233 . . . . 0.0 109.513 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -57.19 137.18 56.24 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -106.6 148.04 28.77 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.15 -0.968 . . . . 0.0 110.421 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.67 -33.23 72.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.295 -1.503 . . . . 0.0 112.487 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.71 17.16 13.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.447 1.499 . . . . 0.0 113.528 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.21 157.92 5.78 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 124.049 0.939 . . . . 0.0 111.554 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.534 0.483 0 CA-C-O 121.029 0.346 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -78.47 14.26 1.31 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.829 1.251 . . . . 0.0 113.568 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.0 p -85.56 165.25 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.049 1.74 . . . . 0.0 111.383 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.07 134.0 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.796 -0.565 . . . . 0.0 109.602 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.0 m -91.16 141.21 29.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.624 0.726 . . . . 0.0 110.669 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -140.8 154.75 46.38 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.73 -1.231 . . . . 0.0 111.157 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 C-N-CA 126.427 1.965 . . . . 0.0 111.862 173.786 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -63.34 152.5 37.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.17 0.988 . . . . 0.0 111.019 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.29 16.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.84 -41.91 77.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.851 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -72.1 -42.37 66.21 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.658 1.183 . . . . 0.0 110.088 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.87 -39.36 94.21 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.503 1.521 . . . . 0.0 113.135 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -61.11 -50.17 74.32 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 119.65 -1.906 . . . . 0.0 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.54 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 tt -69.13 -41.56 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.588 1.085 . . . . 0.0 112.676 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.2 -40.58 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.092 1.315 . . . . 0.0 111.244 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.57 -28.5 67.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.226 0.921 . . . . 0.0 113.076 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.6 75.63 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.46 -0.775 . . . . 0.0 112.246 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.77 -45.38 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.772 0.829 . . . . 0.0 109.946 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -62.54 -23.78 67.16 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -84.37 -29.4 26.27 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.978 -1.076 . . . . 0.0 111.308 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.73 75.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.7 1.136 . . . . 0.0 112.361 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.08 -15.35 62.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.506 1.523 . . . . 0.0 113.454 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -92.71 4.67 53.29 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.754 -1.216 . . . . 0.0 111.866 171.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -131.91 -14.35 3.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.93 1.692 . . . . 0.0 115.139 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -153.44 145.58 23.78 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.493 1.497 . . . . 0.0 110.652 171.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -82.17 24.9 0.62 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.997 1.719 . . . . 0.0 113.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 -179.82 21.19 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 124.828 1.204 . . . . 0.0 110.997 166.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -135.73 133.48 38.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.767 0.794 . . . . 0.0 111.495 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mt -124.56 141.04 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.057 -1.652 . . . . 0.0 110.626 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -142.73 147.82 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.4 1.88 . . . . 0.0 111.027 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.41 137.13 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.214 1.006 . . . . 0.0 111.071 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -120.47 121.02 37.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.116 1.766 . . . . 0.0 112.759 172.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' CG1' ' A' ' 71' ' ' VAL . 13.4 tp -102.92 131.47 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.883 1.273 . . . . 0.0 111.87 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -152.25 162.78 40.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.521 -0.737 . . . . 0.0 110.686 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -78.75 -75.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.736 -1.227 . . . . 0.0 112.366 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 p -142.07 148.65 38.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.477 1.911 . . . . 0.0 110.42 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -85.04 161.08 19.86 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.039 0.936 . . . . 0.0 112.976 170.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -98.23 -16.73 19.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.228 1.811 . . . . 0.0 112.31 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -119.56 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.101 1.76 . . . . 0.0 110.934 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -78.67 134.56 37.12 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.57 . . . . 0.0 111.41 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.04 -38.12 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.046 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.7 -46.52 89.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.79 -42.67 70.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.507 0.323 . . . . 0.0 110.785 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -56.68 -47.79 79.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.485 0.314 . . . . 0.0 111.687 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.06 75.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.899 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.9 ttp -67.19 -50.59 60.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 0.0 112.049 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -64.48 -43.95 92.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.245 0.93 . . . . 0.0 111.72 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.64 -45.02 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.129 0.971 . . . . 0.0 110.738 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.92 -50.19 74.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.117 0.967 . . . . 0.0 112.111 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -74.37 -30.96 62.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.328 1.051 . . . . 0.0 112.891 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -73.1 -35.84 66.66 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.659 -1.276 . . . . 0.0 111.917 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.28 -7.25 52.13 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.728 1.211 . . . . 0.0 112.947 170.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 62.21 31.1 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.468 1.507 . . . . 0.0 111.991 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.7 mmm -64.43 -19.79 65.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.304 1.042 . . . . 0.0 113.078 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.25 -12.48 60.29 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.258 1.823 . . . . 0.0 113.65 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -83.58 73.48 10.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.335 1.054 . . . . 0.0 111.249 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -123.74 151.42 43.25 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.717 2.007 . . . . 0.0 110.431 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -63.14 -37.97 89.32 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.378 -0.826 . . . . 0.0 113.02 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.41 -6.98 21.34 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 117.766 -1.112 . . . . 0.0 113.589 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 66.22 47.97 1.74 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.668 1.187 . . . . 0.0 109.433 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -119.8 26.27 9.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.807 1.243 . . . . 0.0 113.456 -172.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.75 127.23 7.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.312 0.958 . . . . 0.0 112.357 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.03 132.77 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 126.7 2.0 . . . . 0.0 109.985 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.5 tp -121.84 129.51 52.66 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.116 0.967 . . . . 0.0 110.781 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.15 99.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.984 0.914 . . . . 0.0 108.632 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -80.2 122.69 27.16 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.529 0.732 . . . . 0.0 110.744 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.863 0.865 . . . . 0.0 110.807 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.95 102.72 15.29 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.367 1.467 . . . . 0.0 109.277 171.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.1 m -73.16 -24.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -74.13 -40.75 62.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.962 -0.462 . . . . 0.0 111.472 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -97.27 -6.47 34.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.538 1.535 . . . . 0.0 112.837 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt 67.29 33.19 5.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.779 1.632 . . . . 0.0 112.156 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 m -107.6 129.43 54.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.353 1.461 . . . . 0.0 110.053 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -106.66 141.45 37.91 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.765 1.226 . . . . 0.0 109.876 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.0 t -138.8 140.86 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.198 1.399 . . . . 0.0 108.103 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 mt -125.39 127.57 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -129.74 138.18 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.863 0.865 . . . . 0.0 109.72 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.87 160.41 16.27 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.69 162.32 16.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.518 1.627 . . . . 0.0 112.618 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.84 -38.98 65.19 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.603 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.35 -37.22 93.64 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.612 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -63.0 -58.28 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.317 1.559 . . . . 0.0 110.166 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -59.26 -25.35 63.99 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -80.43 -27.68 37.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.466 1.507 . . . . 0.0 112.462 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.475 HG11 ' HE2' ' A' ' 128' ' ' PHE . 3.4 p -105.96 -22.82 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 87' ' ' VAL . 4.8 m -119.99 167.65 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.836 1.198 . . . . 0.0 112.21 175.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 m -116.29 169.91 8.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.618 1.167 . . . . 0.0 113.122 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -56.88 -33.0 66.42 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.533 -1.354 . . . . 0.0 113.764 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -20.88 62.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.791 1.236 . . . . 0.0 113.249 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 26.6 t80 -77.66 -34.17 53.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.449 0.7 . . . . 0.0 110.647 170.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -75.76 -25.66 56.7 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -65.56 -32.96 74.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.402 -0.811 . . . . 0.0 112.376 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.3 p -65.86 -42.67 90.14 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 111.755 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 m -53.7 -55.37 26.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.908 2.083 . . . . 0.0 110.275 172.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -55.95 -49.27 74.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.92 0.888 . . . . 0.0 111.202 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.65 -37.32 81.14 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.46 -51.84 52.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.055 0.843 . . . . 0.0 111.78 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.2 mt -58.22 -51.68 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.044 0.538 . . . . 0.0 110.126 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.797 1.639 . . . . 0.0 113.035 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.09 -46.08 89.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.18 -30.42 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -64.69 -39.35 93.51 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.304 0.956 . . . . 0.0 111.29 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.9 -27.76 69.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.054 0.942 . . . . 0.0 112.331 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -77.77 -38.58 46.45 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.575 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.82 12.46 14.4 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.379 1.942 . . . . 0.0 113.791 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.26 84.89 2.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.204 1.401 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -61.39 -46.62 89.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.575 0.75 . . . . 0.0 111.928 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -49.11 -54.95 13.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -63.51 -41.77 98.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.061 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.42 -36.38 77.64 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.1 0.864 . . . . 0.0 113.346 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.96 -40.7 78.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 111.798 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.8 t -67.28 -50.43 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 111.5 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -73.47 -26.12 60.77 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.15 0.886 . . . . 0.0 112.495 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.09 -38.31 92.29 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.275 -0.891 . . . . 0.0 111.833 169.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.8 mt -62.24 -51.49 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.479 1.139 . . . . 0.0 110.872 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -61.01 -40.14 92.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.495 1.043 . . . . 0.0 112.854 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -73.91 -36.85 64.77 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.723 -1.235 . . . . 0.0 111.422 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.21 73.85 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.803 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.16 -46.66 93.82 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.481 1.037 . . . . 0.0 112.628 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 41.9 tpp -60.8 -43.35 98.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.924 0.862 . . . . 0.0 112.976 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -68.38 -44.19 75.69 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.994 0.361 . . . . 0.0 111.215 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.27 -37.9 87.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.455 1.502 . . . . 0.0 111.143 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.43 -24.49 63.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.538 1.135 . . . . 0.0 113.83 173.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -67.8 -27.64 66.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.206 -1.559 . . . . 0.0 112.561 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -93.18 -38.89 11.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.033 1.333 . . . . 0.0 112.031 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.475 ' HE2' HG11 ' A' ' 87' ' ' VAL . 95.3 m-85 -130.4 76.19 78.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.126 1.77 . . . . 0.0 111.484 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.26 132.19 35.24 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.144 2.563 . . . . 0.0 111.339 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -57.92 146.29 32.69 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -118.57 150.45 39.63 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.004 1.322 . . . . 0.0 109.816 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.53 -27.4 67.73 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.438 -2.039 . . . . 0.0 112.888 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.79 15.04 23.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.659 1.584 . . . . 0.0 112.242 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.38 158.34 9.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.515 1.126 . . . . 0.0 113.185 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.294 0 C-N-CA 124.53 1.132 . . . . 0.0 110.64 -172.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 N--CA 1.457 -0.622 0 CA-C-O 122.119 0.8 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -89.0 -5.76 57.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 m -56.23 141.26 41.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.19 1.396 . . . . 0.0 109.683 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.54 130.95 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.61 152.71 18.38 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.107 0.563 . . . . 0.0 110.848 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -160.99 158.02 27.29 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.074 0 CA-C-O 116.592 -2.226 . . . . 0.0 112.803 171.025 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -69.52 160.6 31.15 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.739 0.7 . . . . 0.0 110.737 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.64 53.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.33 -40.99 77.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.508 1.523 . . . . 0.0 110.92 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -72.06 -44.38 63.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.551 1.141 . . . . 0.0 111.376 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -63.74 -44.77 92.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.322 1.049 . . . . 0.0 111.823 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -55.56 -47.2 76.76 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.706 -1.246 . . . . 0.0 111.461 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.67 84.45 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.4 tt -76.59 -38.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.568 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.86 -40.34 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.98 1.264 . . . . 0.0 111.253 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.98 -33.45 75.42 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.827 0.851 . . . . 0.0 112.966 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.11 62.0 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.709 0.804 . . . . 0.0 112.412 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.51 -48.66 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -55.49 -27.64 49.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.3 -28.76 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.239 -0.913 . . . . 0.0 113.086 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.07 75.62 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.574 1.149 . . . . 0.0 111.922 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -71.94 14.11 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.824 0.85 . . . . 0.0 113.282 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -120.72 12.5 11.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.322 1.849 . . . . 0.0 112.43 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.92 -14.33 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.807 2.043 . . . . 0.0 113.512 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -159.88 176.03 12.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.445 2.298 . . . . 0.0 108.531 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -125.51 6.22 7.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.347 1.459 . . . . 0.0 114.594 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.98 161.06 31.53 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 155.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -126.84 136.08 51.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 118.192 0.996 . . . . 0.0 112.0 -165.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.7 mt -113.05 124.69 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 110.746 -169.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -135.51 153.59 51.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.124 0.964 . . . . 0.0 111.456 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.9 t -133.99 128.43 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.494 1.518 . . . . 0.0 108.601 -168.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.87 108.75 13.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.569 1.548 . . . . 0.0 113.987 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 tt -93.96 130.94 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.514 0.726 . . . . 0.0 111.023 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.11 163.11 37.95 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.02 1.328 . . . . 0.0 111.317 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.3 -79.38 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.595 1.558 . . . . 0.0 113.369 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -144.54 147.81 33.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.982 2.513 . . . . 0.0 109.044 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -99.38 169.96 8.97 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.39 1.09 . . . . 0.0 112.163 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -101.66 -19.62 15.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.786 1.635 . . . . 0.0 112.685 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 pt -125.04 -148.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -85.17 142.5 29.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.278 1.399 . . . . 0.0 112.604 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.42 -32.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.449 0.7 . . . . 0.0 111.164 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.06 -50.08 73.41 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.736 0.815 . . . . 0.0 111.54 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.39 -39.55 94.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.329 0.652 . . . . 0.0 111.451 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.9 -43.43 98.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.354 0.662 . . . . 0.0 111.841 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.9 96.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.927 0.785 . . . . 0.0 110.982 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.8 ttp -63.26 -47.36 82.73 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.908 0.777 . . . . 0.0 112.327 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.57 -44.25 97.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.217 -0.927 . . . . 0.0 112.131 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.55 -43.96 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.63 1.172 . . . . 0.0 111.109 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.56 -49.71 76.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.995 0.816 . . . . 0.0 111.182 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -67.44 -44.23 79.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.481 1.112 . . . . 0.0 111.828 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.06 -39.84 91.38 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.857 -1.152 . . . . 0.0 113.816 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.56 1.64 18.89 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 56.5 36.59 27.81 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.706 1.202 . . . . 0.0 111.632 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.8 mtp -72.09 -13.49 61.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.131 1.772 . . . . 0.0 113.294 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -75.58 -2.4 28.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.584 1.954 . . . . 0.0 114.25 167.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -79.36 60.53 3.18 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.003 1.321 . . . . 0.0 111.872 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.2 p -129.53 149.97 51.07 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.86 0.838 . . . . 0.0 110.134 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.74 -27.79 68.57 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 113.063 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -107.25 -5.7 17.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.435 1.094 . . . . 0.0 113.1 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 60.05 40.23 18.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.967 1.307 . . . . 0.0 110.87 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -109.78 36.7 2.89 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.391 1.476 . . . . 0.0 112.073 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.11 121.95 5.69 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.714 -1.241 . . . . 0.0 112.464 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.31 135.84 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.118 0.959 . . . . 0.0 110.603 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -120.55 129.73 53.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.448 1.499 . . . . 0.0 111.502 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.47 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.915 0.886 . . . . 0.0 109.957 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -79.64 120.39 23.9 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.473 0.709 . . . . 0.0 110.8 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.61 132.8 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.809 0.844 . . . . 0.0 110.48 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.37 97.15 7.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.199 1.4 . . . . 0.0 109.173 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.29 -13.49 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -77.16 -56.78 4.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.379 0.536 . . . . 0.0 111.038 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.95 -8.4 59.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.278 1.431 . . . . 0.0 114.154 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttt 72.21 27.78 2.52 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.846 1.659 . . . . 0.0 112.443 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -102.39 173.4 6.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.123 0.969 . . . . 0.0 111.475 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -147.64 139.45 24.06 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.359 1.464 . . . . 0.0 109.353 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.0 t -127.9 134.32 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.695 1.198 . . . . 0.0 107.923 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.1 mt -111.97 131.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -137.33 124.95 22.24 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.559 1.544 . . . . 0.0 110.46 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.31 17.48 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -64.37 163.71 12.65 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.325 1.06 . . . . 0.0 111.534 165.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -57.87 -31.83 67.09 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.19 0.996 . . . . 0.0 112.84 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.04 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.724 1.147 . . . . 0.0 113.786 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.13 -61.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.2 1.5 . . . . 0.0 108.638 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -51.5 -41.55 61.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.335 1.054 . . . . 0.0 112.921 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.32 -13.61 59.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.692 1.197 . . . . 0.0 112.932 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.11 -31.92 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.588 1.086 . . . . 0.0 113.525 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 m -108.08 165.94 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.49 1.041 . . . . 0.0 112.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.04 172.39 6.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.427 1.091 . . . . 0.0 113.456 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.867 -1.145 . . . . 0.0 112.84 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -61.42 -25.75 67.41 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.388 1.075 . . . . 0.0 113.57 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -74.96 -46.17 37.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.612 0.765 . . . . 0.0 109.544 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.64 -31.24 72.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.497 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -57.63 -33.75 68.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.771 1.228 . . . . 0.0 112.193 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 p -66.54 -43.11 86.01 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.895 0.478 . . . . 0.0 111.699 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -52.09 66.9 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.285 1.834 . . . . 0.0 110.131 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -59.0 -50.04 75.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.61 0.764 . . . . 0.0 111.148 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -58.23 -43.69 87.86 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.21 -49.75 68.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.46 -47.97 90.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.013 0.925 . . . . 0.0 110.515 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -60.31 -45.98 91.5 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.571 1.148 . . . . 0.0 112.879 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.22 -35.82 76.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.341 0.656 . . . . 0.0 112.528 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -87.01 -34.87 19.09 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.207 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.21 -35.59 73.88 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.933 0.788 . . . . 0.0 111.631 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -68.42 -31.73 71.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 112.979 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.37 -35.12 70.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.464 1.105 . . . . 0.0 110.441 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 6.85 25.43 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.957 1.741 . . . . 0.0 114.533 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -98.64 94.13 6.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.071 0.949 . . . . 0.0 111.259 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -70.52 -37.2 74.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.46 0.704 . . . . 0.0 111.826 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -54.76 -56.94 13.94 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.964 0.906 . . . . 0.0 111.03 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HA ' HG12 ' A' ' 114' ' ' VAL . 84.9 mt-30 -61.09 -42.6 98.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.27 97.13 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.191 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.17 -46.57 67.21 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.834 -1.079 . . . . 0.0 111.207 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 111' ' ' GLN . 4.2 p -70.73 -41.0 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.681 1.128 . . . . 0.0 113.064 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.6 -35.78 81.82 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.832 0.742 . . . . 0.0 110.982 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.58 95.52 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.976 174.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.25 -43.49 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.575 1.187 . . . . 0.0 111.352 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -58.87 -52.18 66.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 0.0 110.671 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -66.62 -39.75 88.46 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.835 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.84 72.44 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.729 0.695 . . . . 0.0 111.389 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.87 95.74 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.689 1.131 . . . . 0.0 112.496 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.55 -39.24 88.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.135 -1.214 . . . . 0.0 112.919 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 -48.15 48.85 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.895 0.878 . . . . 0.0 110.602 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.1 mt -60.63 -36.2 78.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.74 1.616 . . . . 0.0 110.767 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.14 50.3 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.34 -37.59 68.81 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.406 -1.434 . . . . 0.0 111.995 170.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -85.04 -32.56 22.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 112.586 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.07 88.34 31.81 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.436 1.895 . . . . 0.0 109.329 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.81 139.82 34.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.541 2.827 . . . . 0.0 110.097 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -64.46 131.46 47.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -103.7 145.8 29.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.007 0.923 . . . . 0.0 110.299 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.43 -30.09 68.24 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 119.675 -1.891 . . . . 0.0 113.908 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -92.2 12.18 23.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.311 1.444 . . . . 0.0 113.177 -176.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.82 154.19 7.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -172.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 122.304 1.049 . . . . 0.0 111.562 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 N-CA-C 111.018 -0.416 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -77.51 8.55 4.16 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.712 1.205 . . . . 0.0 113.663 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -75.76 153.25 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.907 1.683 . . . . 0.0 110.9 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.24 130.78 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.173 0.989 . . . . 0.0 108.664 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.1 m -82.8 142.41 31.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.351 1.06 . . . . 0.0 110.251 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -140.73 138.57 34.28 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.581 -1.325 . . . . 0.0 111.686 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.83 2.633 . . . . 0.0 114.082 -179.025 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -71.57 157.53 37.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.923 0.889 . . . . 0.0 109.406 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -24.31 8.43 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -75.13 -36.46 61.61 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.742 -1.224 . . . . 0.0 112.37 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -76.8 -42.82 39.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.17 1.788 . . . . 0.0 110.209 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.68 -49.08 76.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.32 -46.98 69.64 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.28 -0.888 . . . . 0.0 111.645 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.54 -28.57 67.91 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -80.59 -37.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 120.692 1.587 . . . . 0.0 112.191 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.54 -44.16 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.459 1.027 . . . . 0.0 110.944 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -57.97 -39.56 78.46 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.216 1.406 . . . . 0.0 112.707 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.59 -32.23 71.99 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.59 -0.693 . . . . 0.0 112.384 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.5 mt -67.9 -46.56 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.072 0.851 . . . . 0.0 110.008 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.64 -31.63 64.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.298 1.039 . . . . 0.0 113.157 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -79.35 -27.78 42.02 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.038 0.835 . . . . 0.0 113.109 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.48 -35.83 70.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.479 0.712 . . . . 0.0 111.695 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.43 -1.56 0.56 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.024 2.13 . . . . 0.0 113.933 167.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -117.61 9.66 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.055 1.742 . . . . 0.0 112.388 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -126.22 -14.66 5.92 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.045 1.338 . . . . 0.0 114.097 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -162.28 140.62 8.89 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.722 1.209 . . . . 0.0 109.459 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -83.11 46.5 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.73 0.812 . . . . 0.0 111.243 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.92 137.86 7.69 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.203 1.383 . . . . 0.0 109.686 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -113.84 128.08 56.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.933 0.873 . . . . 0.0 112.064 -152.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.7 mt -120.74 116.66 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.284 -1.51 . . . . 0.0 110.733 -172.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.74 147.92 37.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.887 2.075 . . . . 0.0 110.78 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.83 136.86 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.416 1.086 . . . . 0.0 110.695 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -118.32 118.97 33.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.403 1.881 . . . . 0.0 112.374 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 tp -108.11 129.06 55.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.949 0.9 . . . . 0.0 111.972 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.87 166.96 27.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.108 1.363 . . . . 0.0 110.312 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 71' ' ' VAL . 95.0 mttt -81.03 -72.48 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.548 -1.345 . . . . 0.0 113.14 -173.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -144.18 -175.95 4.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 128.22 2.608 . . . . 0.0 108.433 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.5 p -152.27 160.1 43.4 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.215 -0.928 . . . . 0.0 113.226 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.08 -3.27 41.61 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 pt -135.2 -146.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.501 -1.374 . . . . 0.0 110.997 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -95.54 141.24 29.3 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.564 1.529 . . . . 0.0 111.796 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.81 -32.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.259 -0.901 . . . . 0.0 112.544 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.65 -46.27 72.91 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.295 0.498 . . . . 0.0 110.904 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -60.06 -43.52 95.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.152 0.581 . . . . 0.0 111.537 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -60.5 -47.1 87.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.83 77.08 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.014 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.6 ttp -66.21 -52.46 47.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.764 0.711 . . . . 0.0 111.644 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.82 -44.99 91.0 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.989 0.813 . . . . 0.0 112.499 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.04 -40.8 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.247 1.019 . . . . 0.0 110.73 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.41 -51.09 70.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.985 0.811 . . . . 0.0 110.933 173.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.75 -39.13 80.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.578 0.751 . . . . 0.0 112.564 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.68 -38.21 89.46 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.212 1.405 . . . . 0.0 113.554 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.12 -4.74 46.0 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.061 -1.024 . . . . 0.0 113.274 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 58.85 34.04 23.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.711 1.204 . . . . 0.0 112.311 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.3 mmm -59.14 -22.43 60.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.044 2.138 . . . . 0.0 113.93 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -72.52 -6.94 47.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.38 2.272 . . . . 0.0 113.534 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.4 56.64 2.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.469 1.907 . . . . 0.0 110.956 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.1 p -127.75 137.79 52.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.113 2.165 . . . . 0.0 109.317 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -60.99 -36.45 79.51 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.29 -0.881 . . . . 0.0 112.456 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.9 mt -93.82 -9.44 37.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.932 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 66.63 49.35 1.31 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.397 1.453 . . . . 0.0 109.456 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.9 16.12 13.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.828 1.651 . . . . 0.0 113.994 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.38 136.47 30.13 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.05 -1.032 . . . . 0.0 112.187 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.58 138.4 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.649 1.179 . . . . 0.0 110.61 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 tp -117.98 127.57 53.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.277 1.431 . . . . 0.0 110.122 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.2 mt -103.66 96.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -81.06 126.45 31.45 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.903 -0.498 . . . . 0.0 110.391 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.18 127.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.128 0.971 . . . . 0.0 110.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.66 118.0 34.39 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.257 1.023 . . . . 0.0 110.483 167.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 37' ' ' LYS . 29.0 m -76.59 -24.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -77.0 -55.97 4.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.207 0.458 . . . . 0.0 110.288 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -84.69 -1.31 55.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.629 1.171 . . . . 0.0 112.54 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.2 tttt 67.4 19.88 10.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 113.393 172.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.3 m -94.67 115.43 27.54 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.365 1.466 . . . . 0.0 110.874 -170.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -90.35 143.56 26.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.984 1.314 . . . . 0.0 110.004 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.08 150.86 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.726 1.61 . . . . 0.0 108.462 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.69 127.66 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -140.19 127.08 20.67 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.924 0.89 . . . . 0.0 110.599 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.6 158.2 14.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.579 1.085 . . . . 0.0 111.373 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.87 173.77 7.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 123.155 1.455 . . . . 0.0 112.638 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -60.72 -37.46 81.78 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.505 1.522 . . . . 0.0 113.685 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.09 -47.13 55.62 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.732 1.158 . . . . 0.0 112.588 -175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -54.7 -55.6 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.601 1.2 . . . . 0.0 109.36 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -79.16 -38.76 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.127 1.371 . . . . 0.0 111.598 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.5 m -92.75 -26.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 169.6 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 119.929 1.24 . . . . 0.0 113.055 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 p -119.17 171.59 8.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.125 1.37 . . . . 0.0 113.31 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.24 -30.25 71.11 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.674 -1.266 . . . . 0.0 113.338 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 0.0 112.344 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.5 t80 -76.22 -38.88 55.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.747 172.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -70.12 -28.86 65.72 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 125.08 1.352 . . . . 0.0 113.432 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.56 -31.62 72.84 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.6 m -62.32 -43.26 99.23 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.689 0.677 . . . . 0.0 111.062 171.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -60.21 -48.44 81.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.329 1.452 . . . . 0.0 111.516 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -59.57 -48.09 83.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.693 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -63.67 -35.26 79.96 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.91 61.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.18 0.9 . . . . 0.0 111.793 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.64 -49.9 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.315 0.646 . . . . 0.0 110.583 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.64 -39.9 85.88 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.907 1.283 . . . . 0.0 112.724 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.31 -45.06 96.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.649 1.113 . . . . 0.0 111.954 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -79.14 -37.04 39.51 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.944 -0.473 . . . . 0.0 110.971 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -59.55 -39.83 85.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.186 0.903 . . . . 0.0 111.887 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -64.39 -31.59 72.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.786 1.634 . . . . 0.0 113.034 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -73.06 -34.8 66.49 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 118.756 0.707 . . . . 0.0 111.299 168.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 8.18 11.74 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 126.192 1.853 . . . . 0.0 113.793 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -107.43 78.52 1.22 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 0.0 111.816 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -53.39 -46.5 69.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.412 1.485 . . . . 0.0 112.952 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.7 -49.62 74.58 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.545 -0.722 . . . . 0.0 111.539 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.61 -44.35 90.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.826 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.74 97.08 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 119.003 0.819 . . . . 0.0 113.387 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.31 -47.19 68.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.46 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.54 -51.65 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.364 1.066 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.26 -41.94 98.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.114 0.966 . . . . 0.0 111.2 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -17.78 76.28 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 121.049 -1.032 . . . . 0.0 113.5 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.96 -50.63 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.649 1.58 . . . . 0.0 109.825 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.91 -51.65 68.28 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.775 1.171 . . . . 0.0 111.982 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.35 -37.6 86.29 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.058 -1.026 . . . . 0.0 112.122 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.27 88.41 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.886 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.41 87.09 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.116 0.871 . . . . 0.0 111.231 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 59.9 ttm -59.96 -43.47 95.04 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.027 0.913 . . . . 0.0 112.503 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -69.45 -47.31 64.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.25 0.62 . . . . 0.0 111.78 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.55 -36.41 82.55 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.284 1.034 . . . . 0.0 111.466 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.27 -22.47 61.2 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -66.14 -41.71 90.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.866 1.212 . . . . 0.0 111.438 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -81.59 -27.39 34.29 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.029 1.731 . . . . 0.0 113.001 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -138.86 76.35 34.48 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 126.594 1.957 . . . . 0.0 110.097 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.56 143.86 64.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.326 2.684 . . . . 0.0 111.144 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -66.7 137.21 56.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -118.03 150.82 38.65 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.787 1.635 . . . . 0.0 110.149 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -67.15 -19.63 65.62 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.181 -1.574 . . . . 0.0 113.524 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -106.72 17.75 22.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.054 2.941 . . . . 0.0 112.037 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -52.7 153.84 3.0 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.044 1.338 . . . . 0.0 112.19 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.316 0 O-C-N 120.735 -1.228 . . . . 0.0 111.848 -167.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 CA--C 1.533 0.455 0 N-CA-C 111.669 -0.166 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -57.39 -14.07 4.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.7 m -50.32 140.39 13.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.44 134.82 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.551 1.14 . . . . 0.0 109.582 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 m -93.56 138.62 31.64 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.387 1.089 . . . . 0.0 111.982 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.21 157.29 46.19 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.778 1.631 . . . . 0.0 109.28 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 C-N-CA 125.169 1.366 . . . . 0.0 111.786 172.786 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -86.33 170.22 12.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.739 0.781 . . . . 0.0 110.375 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.26 -29.47 5.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.137 1.375 . . . . 0.0 114.636 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -80.22 -38.47 31.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 0.0 111.979 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -76.67 -44.49 33.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.949 1.3 . . . . 0.0 111.036 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.47 -45.66 92.04 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.057 1.343 . . . . 0.0 111.168 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.04 -40.01 79.83 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.895 -1.128 . . . . 0.0 111.603 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.94 80.32 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 0.594 . . . . 0.0 111.962 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.05 -37.32 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.319 0.963 . . . . 0.0 112.909 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.95 -40.88 84.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 118.953 0.797 . . . . 0.0 111.283 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -72.64 -29.28 63.32 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.143 0.883 . . . . 0.0 113.31 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.01 76.68 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.522 -0.736 . . . . 0.0 112.645 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.54 -40.53 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -61.43 -31.21 71.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.865 0.866 . . . . 0.0 112.134 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.01 -31.13 62.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.422 1.089 . . . . 0.0 112.685 172.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.37 -39.25 59.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.824 1.25 . . . . 0.0 113.027 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.94 -23.72 63.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 112.564 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.8 8.84 26.99 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.527 -1.358 . . . . 0.0 113.39 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -130.62 -8.96 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.912 1.685 . . . . 0.0 113.78 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -157.48 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.501 1.521 . . . . 0.0 108.888 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 27.8 1.52 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.686 0.794 . . . . 0.0 112.162 174.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.09 151.35 17.34 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.248 1.404 . . . . 0.0 111.443 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -112.28 127.89 56.11 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -161.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.37 119.96 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.401 -1.437 . . . . 0.0 110.216 -172.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -128.58 147.07 50.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.443 1.097 . . . . 0.0 112.071 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.23 141.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.024 1.33 . . . . 0.0 110.203 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.54 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.8 t60 -126.96 123.38 37.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.172 0.989 . . . . 0.0 110.869 168.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 tp -104.77 147.79 27.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 0.0 111.463 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.44 166.36 32.41 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.882 1.325 . . . . 0.0 109.644 159.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -59.62 -78.28 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 C-N-CA 126.236 1.814 . . . . 0.0 113.073 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -138.08 -177.03 4.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.536 1.534 . . . . 0.0 110.71 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -137.46 142.57 41.56 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.397 1.479 . . . . 0.0 111.434 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -81.07 -27.84 35.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.041 0.936 . . . . 0.0 112.947 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 pt -115.71 -146.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.099 1.759 . . . . 0.0 110.636 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.85 133.74 36.28 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.578 -1.326 . . . . 0.0 111.875 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.21 -36.89 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.853 0.861 . . . . 0.0 112.314 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.78 -49.75 64.89 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.866 1.212 . . . . 0.0 111.7 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -60.63 -42.59 97.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.158 0.583 . . . . 0.0 112.192 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -36.93 85.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.65 88.32 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.848 -1.157 . . . . 0.0 111.763 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.6 ttp -63.18 -49.93 72.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.376 0.67 . . . . 0.0 111.439 170.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.08 -47.96 79.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.845 0.748 . . . . 0.0 111.087 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.29 -42.02 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 111.814 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.59 -53.2 60.84 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.598 1.09 . . . . 0.0 111.054 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.21 -32.3 62.98 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.376 0.67 . . . . 0.0 112.353 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.626 -1.296 . . . . 0.0 112.824 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.1 -6.55 58.95 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.164 0.985 . . . . 0.0 112.559 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 tttt 61.44 36.02 17.43 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.802 1.641 . . . . 0.0 111.625 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.5 mtp -72.7 -5.5 38.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -77.57 -2.5 36.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.631 1.972 . . . . 0.0 113.18 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -73.26 33.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.293 1.837 . . . . 0.0 114.318 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 p -111.44 153.98 25.33 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.037 1.735 . . . . 0.0 111.947 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.75 -39.17 87.81 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.04 -4.2 22.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.188 -0.91 . . . . 0.0 113.39 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 67.78 31.49 5.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.662 1.585 . . . . 0.0 110.021 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.37 33.03 3.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.454 1.902 . . . . 0.0 112.594 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.31 123.55 6.38 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.358 0.98 . . . . 0.0 112.999 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -112.18 138.42 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.449 1.1 . . . . 0.0 112.011 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 34' ' ' HIS . 33.9 tp -117.01 128.54 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.475 1.51 . . . . 0.0 111.228 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -104.38 97.93 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.456 1.102 . . . . 0.0 108.963 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -81.12 125.0 29.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 111.017 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.38 134.29 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.108 0.963 . . . . 0.0 111.115 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.24 105.93 16.14 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.107 1.763 . . . . 0.0 110.613 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -77.77 -13.03 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -78.46 -40.74 34.72 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.174 0.897 . . . . 0.0 112.07 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.81 -10.6 26.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.824 1.249 . . . . 0.0 112.219 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.0 tttt 71.96 24.28 3.32 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.738 1.615 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.3 p -105.85 165.03 11.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.313 1.045 . . . . 0.0 111.607 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -143.32 144.52 32.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 109.616 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -138.97 139.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.95 1.7 . . . . 0.0 107.719 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.7 mt -116.0 133.3 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -138.58 126.94 23.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.207 1.003 . . . . 0.0 110.401 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.93 150.54 18.42 Favored Glycine 0 N--CA 1.462 0.398 0 C-N-CA 125.174 1.368 . . . . 0.0 112.208 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -64.17 164.03 11.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 122.598 1.19 . . . . 0.0 112.319 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -53.85 -35.12 61.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.435 1.494 . . . . 0.0 112.377 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -28.08 73.65 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 119.626 1.103 . . . . 0.0 114.387 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.39 -58.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.283 1.541 . . . . 0.0 109.798 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -54.6 -32.94 59.58 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.308 1.443 . . . . 0.0 113.869 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -76.87 -24.13 52.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 88' ' ' VAL . 10.3 m -103.91 -35.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.908 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 87' ' ' VAL . 3.0 m -104.7 169.17 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 120.004 1.274 . . . . 0.0 112.632 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -119.46 177.77 4.79 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.563 1.545 . . . . 0.0 113.271 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -61.73 -33.46 74.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.683 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.39 -20.21 62.96 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.03 0.932 . . . . 0.0 112.557 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -77.87 -30.66 50.97 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 169.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -83.99 -26.34 29.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -54.86 -44.03 73.65 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.963 1.305 . . . . 0.0 112.416 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.8 p -63.12 -35.29 79.78 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 m -66.43 -51.16 59.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.476 1.91 . . . . 0.0 110.245 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -60.9 -44.57 96.95 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.146 0.978 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -57.19 -47.22 81.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.874 0.761 . . . . 0.0 112.524 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.45 -48.2 82.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.436 1.017 . . . . 0.0 111.841 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.12 -49.15 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.946 0.898 . . . . 0.0 110.352 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -59.86 -42.13 93.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.999 1.32 . . . . 0.0 112.356 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.89 -38.36 86.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.74 -32.84 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.391 0.541 . . . . 0.0 111.172 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -62.39 -39.05 91.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.637 0.775 . . . . 0.0 111.645 168.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -59.38 -31.32 69.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.683 1.193 . . . . 0.0 113.038 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.36 -41.04 22.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.378 1.071 . . . . 0.0 111.257 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.36 1.23 8.58 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.581 1.563 . . . . 0.0 114.843 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -93.63 80.69 4.28 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.815 1.307 . . . . 0.0 111.532 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -59.77 -44.44 93.87 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.789 1.235 . . . . 0.0 112.609 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -50.99 -58.67 5.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.314 1.045 . . . . 0.0 111.363 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.004 0.921 . . . . 0.0 111.698 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.04 -37.41 94.18 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 118.72 0.691 . . . . 0.0 113.664 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.08 -44.94 59.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.448 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.68 -51.67 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.326 0.65 . . . . 0.0 111.12 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.88 -33.75 76.77 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.346 0.659 . . . . 0.0 112.3 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.23 83.77 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.338 -0.851 . . . . 0.0 112.667 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.94 -46.67 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.167 1.483 . . . . 0.0 109.877 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.24 -47.63 81.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.305 0.642 . . . . 0.0 111.29 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -61.63 -38.69 88.58 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 121.547 -0.72 . . . . 0.0 112.202 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.66 64.24 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.322 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.3 -45.61 74.21 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 120.37 1.441 . . . . 0.0 113.284 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mtp -63.37 -38.11 89.89 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.158 -1.201 . . . . 0.0 112.907 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.497 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -78.38 -38.84 40.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 110.901 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.49 -33.14 70.89 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.453 1.501 . . . . 0.0 112.549 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.49 41.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -71.85 -29.56 64.52 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.112 -0.992 . . . . 0.0 113.429 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -91.62 -35.54 14.17 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.777 1.231 . . . . 0.0 111.527 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -136.34 90.99 16.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.328 1.851 . . . . 0.0 109.879 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.37 144.17 60.81 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.639 2.226 . . . . 0.0 111.299 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -62.93 161.53 12.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.6 0.76 . . . . 0.0 112.747 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -142.9 159.28 42.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -62.27 -29.25 70.29 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.542 -1.349 . . . . 0.0 113.236 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -99.82 29.15 4.3 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.651 1.581 . . . . 0.0 112.4 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.33 151.17 44.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.834 -1.166 . . . . 0.0 112.003 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.219 -0.523 0 C-N-CA 124.24 1.016 . . . . 0.0 110.887 -167.146 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 111.046 -0.405 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -83.83 2.52 37.87 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.6 p -76.33 160.9 29.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.989 1.316 . . . . 0.0 112.325 -166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.94 140.49 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.536 0.735 . . . . 0.0 109.815 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.4 t -110.07 140.66 43.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.668 -1.27 . . . . 0.0 111.942 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -134.88 137.37 43.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 C-N-CA 124.993 1.282 . . . . 0.0 114.793 169.976 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -64.05 150.64 44.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.066 1.346 . . . . 0.0 109.38 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.45 55.73 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.249 -1.532 . . . . 0.0 113.983 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -68.67 -35.63 77.47 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.357 1.463 . . . . 0.0 113.566 174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.54 -35.24 78.67 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.499 -1.376 . . . . 0.0 111.152 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.82 -44.19 97.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.875 0.87 . . . . 0.0 110.956 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -45.3 87.22 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.013 -1.054 . . . . 0.0 111.162 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.58 76.27 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.0 -38.8 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 119.846 1.203 . . . . 0.0 112.21 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.75 -39.63 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 119.67 1.123 . . . . 0.0 111.934 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.42 -35.37 77.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.477 1.111 . . . . 0.0 112.741 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.34 87.63 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.859 0.463 . . . . 0.0 111.631 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.6 mt -66.31 -46.56 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.79 1.236 . . . . 0.0 110.243 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -57.7 -28.9 64.25 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.23 -30.29 34.23 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.048 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.74 85.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.922 1.289 . . . . 0.0 112.25 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.02 -17.4 2.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.514 1.525 . . . . 0.0 113.787 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -106.63 14.42 26.98 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.034 -1.666 . . . . 0.0 112.396 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -130.68 -15.92 3.43 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.83 1.652 . . . . 0.0 113.961 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -152.39 152.84 32.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.845 1.258 . . . . 0.0 110.577 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -81.03 3.5 22.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.276 1.03 . . . . 0.0 112.812 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 -161.74 21.85 Favored Glycine 0 C--N 1.343 0.934 0 C-N-CA 125.996 1.76 . . . . 0.0 111.668 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -162.86 129.52 3.48 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.246 0.618 . . . . 0.0 112.159 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.78 116.15 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.37 1.068 . . . . 0.0 110.634 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -121.78 153.09 38.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.622 1.169 . . . . 0.0 111.218 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.11 132.78 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.65 1.18 . . . . 0.0 110.725 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -117.3 124.22 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.257 1.027 . . . . 0.0 112.515 169.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.41 HD11 ' CG1' ' A' ' 71' ' ' VAL . 12.7 tp -108.33 126.15 52.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.069 1.347 . . . . 0.0 112.401 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -150.6 161.63 42.21 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.462 1.105 . . . . 0.0 110.21 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -73.7 -68.98 0.46 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.645 -1.284 . . . . 0.0 113.302 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -156.57 157.66 35.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.434 1.894 . . . . 0.0 110.277 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.1 p -115.8 147.93 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.585 1.554 . . . . 0.0 112.77 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -80.5 -29.23 37.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.15 0.98 . . . . 0.0 111.566 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -107.8 -167.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.843 1.657 . . . . 0.0 111.447 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -68.75 134.39 49.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.594 1.158 . . . . 0.0 112.678 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.87 -38.06 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.967 0.907 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.24 -51.25 68.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.682 0.674 . . . . 0.0 112.109 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.17 -43.02 93.07 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.135 0.574 . . . . 0.0 111.47 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -58.51 -42.33 87.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.669 0.788 . . . . 0.0 112.418 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.29 -35.13 77.38 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.902 0.881 . . . . 0.0 111.555 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.2 ttp -63.68 -49.21 74.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.545 0.738 . . . . 0.0 111.119 170.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.08 -52.45 65.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.049 0.939 . . . . 0.0 111.464 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.14 -42.5 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.506 1.122 . . . . 0.0 111.448 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.54 -46.44 90.15 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.45 1.1 . . . . 0.0 112.003 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -70.15 -36.96 75.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.443 1.497 . . . . 0.0 111.872 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.24 -22.36 59.37 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.768 1.227 . . . . 0.0 114.058 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.79 -8.82 57.87 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.684 1.194 . . . . 0.0 112.421 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 65.74 32.89 8.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.232 1.413 . . . . 0.0 112.712 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.7 mtp -64.98 -23.63 67.28 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.36 -13.41 1.4 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.584 1.954 . . . . 0.0 114.709 168.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -73.79 43.89 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.486 1.915 . . . . 0.0 112.915 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.2 m -120.74 129.7 53.74 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.658 1.583 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.78 -39.45 65.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.449 1.499 . . . . 0.0 113.83 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.44 2.82 42.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 0.0 113.707 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 62.87 32.73 15.63 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.288 1.035 . . . . 0.0 111.169 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -107.82 27.15 9.5 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.372 1.469 . . . . 0.0 113.12 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.18 125.8 7.29 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.203 0.906 . . . . 0.0 112.077 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.23 135.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.979 1.312 . . . . 0.0 109.714 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.17 127.99 54.66 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.241 1.02 . . . . 0.0 111.315 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -101.55 96.19 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.621 1.568 . . . . 0.0 109.215 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -84.16 124.37 31.08 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.151 -0.968 . . . . 0.0 110.805 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -120.9 131.92 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.224 1.01 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 90.96 3.54 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.131 1.773 . . . . 0.0 110.609 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG1' HD11 ' A' ' 35' ' ' LEU . 27.2 m -73.29 -14.82 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -167.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -75.61 -34.97 60.62 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 122.847 0.459 . . . . 0.0 111.252 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.45 -12.22 16.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.116 2.167 . . . . 0.0 112.757 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 73.03 26.0 2.26 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.127 1.771 . . . . 0.0 112.441 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -110.01 167.44 10.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.073 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -148.39 148.64 30.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.298 1.039 . . . . 0.0 110.644 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.9 142.37 40.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.63 128.26 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -145.84 125.64 13.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.621 1.168 . . . . 0.0 109.606 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.35 161.98 13.38 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.527 1.061 . . . . 0.0 112.023 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -64.58 162.91 14.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 123.212 1.482 . . . . 0.0 111.798 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.008 1.723 . . . . 0.0 113.451 -170.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.48 -25.44 72.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.259 -1.301 . . . . 0.0 114.534 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 -58.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.971 1.885 . . . . 0.0 109.302 167.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -59.69 -25.15 64.53 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.5 -18.24 34.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.472 1.109 . . . . 0.0 113.884 174.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 88' ' ' VAL . 1.4 p -104.11 -20.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 87' ' ' VAL . 4.7 m -129.11 167.47 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.844 1.257 . . . . 0.0 111.287 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -120.25 173.06 7.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.54 1.136 . . . . 0.0 113.101 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -49.41 -38.49 29.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -31.0 72.04 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.9 t80 -70.88 -32.78 69.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.656 0.782 . . . . 0.0 111.636 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -78.99 -26.35 43.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.289 1.436 . . . . 0.0 113.334 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.99 -41.56 87.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.57 0.748 . . . . 0.0 112.646 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -59.53 -43.05 93.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.255 0.479 . . . . 0.0 111.287 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -61.34 -51.16 70.0 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 125.72 1.608 . . . . 0.0 110.401 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.08 -48.51 79.93 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 118.075 -0.965 . . . . 0.0 110.587 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.85 -41.69 96.35 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.207 1.367 . . . . 0.0 113.362 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.09 79.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.917 1.235 . . . . 0.0 111.327 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.33 -54.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.934 0.894 . . . . 0.0 110.451 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -52.37 -44.94 65.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.304 1.842 . . . . 0.0 113.174 -175.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.37 -30.54 62.03 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.215 0.606 . . . . 0.0 112.557 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -82.36 -39.65 22.45 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.75 0.82 . . . . 0.0 111.063 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.98 -43.25 91.37 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.407 0.683 . . . . 0.0 111.406 170.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.06 -37.31 71.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.264 1.025 . . . . 0.0 112.06 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -71.89 -41.08 68.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.337 1.055 . . . . 0.0 111.409 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.13 4.78 6.42 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 126.323 1.916 . . . . 0.0 113.648 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -102.46 81.4 2.05 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 119.0 1.4 . . . . 0.0 111.71 -171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -60.03 -43.61 95.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.754 0.822 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.43 -52.69 64.37 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.783 -0.573 . . . . 0.0 111.515 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -56.93 -44.76 82.79 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.06 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.92 96.08 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.344 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.75 -52.22 64.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.754 0.777 . . . . 0.0 111.021 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.3 t -63.77 -49.15 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.163 . . . . 0.0 110.907 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.37 -32.72 74.29 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.845 0.748 . . . . 0.0 111.834 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.99 -45.42 73.14 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.57 -47.85 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.015 1.326 . . . . 0.0 111.309 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.87 -49.56 76.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.577 0.751 . . . . 0.0 111.483 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -63.48 -34.75 78.45 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.387 -0.82 . . . . 0.0 112.466 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.52 79.52 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.023 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.76 -39.76 97.89 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.51 1.05 . . . . 0.0 112.776 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 78.5 mtp -61.46 -48.41 81.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.046 0.923 . . . . 0.0 112.379 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.62 -41.85 65.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.657 0.783 . . . . 0.0 112.308 -176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.65 -37.92 85.8 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 111.185 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.12 -23.59 67.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -62.22 -45.6 92.61 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.494 -1.379 . . . . 0.0 111.225 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -74.03 -39.44 63.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.21 1.004 . . . . 0.0 111.988 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.42 82.56 65.95 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 125.986 1.715 . . . . 0.0 110.567 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.83 136.58 53.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.36 2.04 . . . . 0.0 109.622 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -57.54 135.75 56.67 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -108.75 146.29 33.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.885 1.274 . . . . 0.0 110.003 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -24.48 67.39 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.426 -1.421 . . . . 0.0 113.541 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -105.51 19.42 20.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.016 1.326 . . . . 0.0 113.467 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.8 162.1 1.91 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.269 1.428 . . . . 0.0 113.66 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 122.622 1.201 . . . . 0.0 112.221 -170.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 CA-C-O 121.169 0.404 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -72.63 -1.33 15.79 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -62.62 150.49 40.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.077 0.951 . . . . 0.0 111.445 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.6 133.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.67 0.788 . . . . 0.0 108.996 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.76 143.88 27.32 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.614 -0.678 . . . . 0.0 112.295 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -145.85 147.45 31.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.217 -0.927 . . . . 0.0 112.168 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 C-N-CA 126.731 2.11 . . . . 0.0 112.026 165.954 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 m -58.79 157.15 10.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.066 0.947 . . . . 0.0 110.31 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.81 -44.03 18.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -51.14 -40.43 58.52 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 173.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -79.49 -39.95 30.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.025 0.93 . . . . 0.0 111.434 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.06 -46.03 75.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -57.95 -48.93 78.48 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.355 -1.466 . . . . 0.0 110.7 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.35 85.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.18 -38.68 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.951 1.25 . . . . 0.0 112.678 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.12 -46.19 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.634 0.652 . . . . 0.0 110.719 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.15 -35.73 79.67 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.885 0.874 . . . . 0.0 112.828 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.38 96.93 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.897 0.772 . . . . 0.0 111.437 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.39 -45.01 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.628 -0.67 . . . . 0.0 110.51 172.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -56.92 -27.46 60.95 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -83.64 -28.85 28.13 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.105 0.866 . . . . 0.0 112.3 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.37 97.63 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.767 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.58 18.4 0.17 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.952 1.301 . . . . 0.0 113.637 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.96 11.44 8.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.823 2.049 . . . . 0.0 111.376 166.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.44 -10.74 3.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.832 1.653 . . . . 0.0 113.378 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -150.5 171.0 17.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.021 1.728 . . . . 0.0 110.171 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -101.35 5.09 42.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.974 1.71 . . . . 0.0 112.776 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.5 126.44 6.52 Favored Glycine 0 C--N 1.343 0.959 0 C-N-CA 124.992 1.282 . . . . 0.0 112.425 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -94.23 142.32 27.55 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -156.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mt -114.76 134.91 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.505 1.122 . . . . 0.0 111.293 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -144.11 149.35 36.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.947 1.299 . . . . 0.0 112.131 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.79 141.79 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.918 1.687 . . . . 0.0 110.327 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.528 ' HB2' HD11 ' A' ' 66' ' ' LEU . 37.8 t60 -124.39 127.0 46.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.686 1.594 . . . . 0.0 112.0 170.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -112.77 123.05 49.43 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.393 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 46' ' ' ARG . 26.1 tt0 -143.14 159.07 42.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.036 0.934 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -68.61 -73.29 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.739 -1.226 . . . . 0.0 110.824 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -153.98 159.19 41.55 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.27 1.828 . . . . 0.0 110.671 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -105.21 159.8 15.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.69 1.596 . . . . 0.0 110.361 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -94.48 -27.58 15.92 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.227 -0.921 . . . . 0.0 112.766 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.33 -150.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 126.112 1.765 . . . . 0.0 111.334 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.84 136.51 34.1 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.549 1.139 . . . . 0.0 111.696 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.27 -37.24 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.076 0.95 . . . . 0.0 112.146 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -64.3 -47.43 79.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.372 0.987 . . . . 0.0 111.933 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -44.32 97.09 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.473 1.509 . . . . 0.0 110.387 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 36' ' ' GLU . 47.6 ttt85 -61.04 -45.69 93.75 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.623 1.169 . . . . 0.0 113.409 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.4 98.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.791 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.0 ttp -60.58 -43.17 97.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.963 0.905 . . . . 0.0 113.048 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -61.47 -54.46 43.09 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.933 -1.104 . . . . 0.0 112.228 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.98 -41.57 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.116 0.566 . . . . 0.0 111.86 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.99 -49.89 76.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.88 1.272 . . . . 0.0 111.919 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -74.76 -32.91 62.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.144 0.978 . . . . 0.0 112.059 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -64.99 -36.31 84.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.045 -1.659 . . . . 0.0 112.463 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.97 -8.04 57.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.823 1.249 . . . . 0.0 113.279 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 65.45 35.89 7.07 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 126.226 1.81 . . . . 0.0 112.214 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.4 mtp -69.64 -25.26 63.85 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.865 -1.147 . . . . 0.0 112.79 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -69.64 -12.73 61.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.304 2.241 . . . . 0.0 114.411 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -84.77 63.45 8.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.24 1.416 . . . . 0.0 110.937 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.2 m -132.01 133.94 45.0 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.884 1.673 . . . . 0.0 109.546 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -48.99 -54.73 14.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 113.45 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.24 -9.9 51.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.736 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 62.72 55.39 2.14 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.174 1.79 . . . . 0.0 109.956 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -125.8 28.93 6.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.537 1.135 . . . . 0.0 111.904 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.86 133.78 17.69 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 120.669 -1.269 . . . . 0.0 111.335 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.79 135.84 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.014 1.326 . . . . 0.0 111.273 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.0 tp -118.52 121.37 40.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.916 1.286 . . . . 0.0 110.781 171.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -95.14 96.55 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -78.64 123.02 26.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.391 0.677 . . . . 0.0 110.03 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.4 127.13 75.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.637 1.175 . . . . 0.0 110.212 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.62 92.69 4.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.77 1.228 . . . . 0.0 109.531 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.05 -6.11 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -171.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.24 -49.89 15.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.786 0.721 . . . . 0.0 109.726 170.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.2 -9.43 53.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 112.629 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.3 tttt 71.72 20.59 4.58 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.005 2.122 . . . . 0.0 113.133 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.3 p -102.6 169.34 8.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.957 1.303 . . . . 0.0 111.805 -174.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.46 145.92 31.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.59 1.156 . . . . 0.0 110.595 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.49 136.46 48.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 126.241 1.817 . . . . 0.0 107.103 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.39 127.62 73.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -130.11 147.0 51.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 109.758 173.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.64 154.78 26.04 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -58.52 162.54 3.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.174 1.464 . . . . 0.0 113.767 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -53.23 -36.71 61.35 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.344 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -45.18 94.6 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 120.647 1.567 . . . . 0.0 112.433 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 61.2 mt -58.97 -57.44 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 118.301 1.05 . . . . 0.0 109.854 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -58.57 -29.7 66.59 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -81.59 -16.68 50.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 112.851 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.89 -34.79 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.63 165.93 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.176 1.353 . . . . 0.0 112.016 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.1 m -115.39 165.4 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.055 1.342 . . . . 0.0 112.382 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -61.03 -26.03 67.33 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.83 -1.169 . . . . 0.0 112.997 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.68 -23.3 56.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.154 0.981 . . . . 0.0 112.81 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 53.0 t80 -78.21 -27.4 47.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.639 1.576 . . . . 0.0 111.578 170.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -79.8 -29.43 40.28 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -49.52 -48.04 48.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.566 1.147 . . . . 0.0 112.599 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -54.33 -44.72 72.31 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.533 1.533 . . . . 0.0 112.293 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.3 m -64.94 -48.67 73.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.911 1.284 . . . . 0.0 110.691 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -56.74 -46.39 81.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.377 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.58 -45.6 92.19 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 112.817 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.62 -50.52 71.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.922 1.237 . . . . 0.0 112.362 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.5 -50.99 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.652 0.781 . . . . 0.0 110.655 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -60.29 -46.79 88.63 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.534 1.533 . . . . 0.0 112.012 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.11 -33.61 74.77 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.224 0.609 . . . . 0.0 112.381 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -84.1 -40.18 18.59 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.442 1.097 . . . . 0.0 112.191 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.7 -36.81 77.26 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.569 -0.707 . . . . 0.0 111.186 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -62.7 -29.93 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.996 1.318 . . . . 0.0 113.505 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -80.31 -29.31 38.12 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.942 -1.099 . . . . 0.0 110.866 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 -1.8 33.37 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 126.015 1.769 . . . . 0.0 113.801 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -86.57 92.14 8.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.39 1.095 . . . . 0.0 111.039 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.73 -38.26 88.66 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.032 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -59.98 -59.66 5.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.265 0.626 . . . . 0.0 111.153 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.45 -40.94 96.31 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.913 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.85 97.16 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.923 1.238 . . . . 0.0 114.019 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.1 mt -71.16 -45.65 63.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.395 0.598 . . . . 0.0 111.481 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.87 -50.45 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.307 0.958 . . . . 0.0 112.009 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.501 1.12 . . . . 0.0 111.104 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.53 -47.55 88.54 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 123.574 0.607 . . . . 0.0 111.633 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.27 -42.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.734 1.214 . . . . 0.0 111.333 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.65 -39.82 94.37 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.198 1.399 . . . . 0.0 112.001 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -72.46 -43.59 63.51 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.905 -1.122 . . . . 0.0 111.526 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.02 75.47 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.343 1.057 . . . . 0.0 111.095 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.47 -44.22 96.87 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.256 0.935 . . . . 0.0 112.088 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -67.16 -26.2 66.54 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.566 -0.961 . . . . 0.0 113.557 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -78.22 -50.27 12.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.084 1.353 . . . . 0.0 111.426 172.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.2 mt -58.63 -38.17 77.47 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.763 2.025 . . . . 0.0 111.789 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.55 -14.15 12.0 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -80.53 -35.39 34.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 120.454 -1.404 . . . . 0.0 111.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -84.18 -38.81 20.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 113.041 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.52 86.26 53.72 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.02 1.728 . . . . 0.0 109.235 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.42 135.32 26.35 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.712 2.275 . . . . 0.0 110.466 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -56.33 146.28 24.49 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -125.45 153.64 43.2 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.709 1.204 . . . . 0.0 110.986 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -62.04 -35.86 79.88 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.858 -1.151 . . . . 0.0 113.063 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.3 13.77 9.13 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 113.64 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.38 158.62 28.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.853 0.861 . . . . 0.0 112.732 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 126.041 1.736 . . . . 0.0 110.73 -173.392 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.451 -0.983 0 CA-C-O 121.245 0.435 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -64.92 1.39 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.1 1.76 . . . . 0.0 115.189 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 p -71.39 141.99 50.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.826 -1.171 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 82.4 mt -73.46 136.36 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.245 1.018 . . . . 0.0 109.706 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -96.1 145.91 25.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 120.906 -1.122 . . . . 0.0 111.009 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -144.98 142.46 29.83 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.416 -1.427 . . . . 0.0 112.816 -172.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.406 0 C-N-CA 125.761 1.648 . . . . 0.0 112.814 169.453 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 p -84.7 166.48 17.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 111.889 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.28 77.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 112.121 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.7 -48.74 78.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.147 1.379 . . . . 0.0 111.052 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -64.32 -44.23 92.19 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.282 0.633 . . . . 0.0 111.366 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.85 -29.51 62.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.486 1.514 . . . . 0.0 113.424 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -65.93 -37.73 86.8 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.01 -1.681 . . . . 0.0 111.7 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.86 -39.42 35.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.84 -37.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.505 -1.372 . . . . 0.0 112.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.13 -36.14 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.662 0.664 . . . . 0.0 110.846 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -72.2 -25.24 61.59 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.556 1.142 . . . . 0.0 112.754 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -40.32 72.87 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.687 -0.633 . . . . 0.0 111.587 172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.93 -44.89 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.349 -0.844 . . . . 0.0 110.991 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -57.52 -32.5 67.11 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -79.74 -30.36 40.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.636 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.75 74.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -55.39 -19.41 9.0 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.276 1.431 . . . . 0.0 112.461 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -103.51 9.9 37.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.526 . . . . 0.0 112.926 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -124.95 -12.92 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.983 1.313 . . . . 0.0 113.712 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -164.35 149.28 10.02 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 109.391 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.9 p -85.32 5.7 29.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.054 0.942 . . . . 0.0 112.92 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.94 168.65 43.42 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.831 1.205 . . . . 0.0 110.304 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -137.18 121.95 18.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.934 . . . . 0.0 113.054 -166.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.45 137.72 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.209 1.404 . . . . 0.0 111.04 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -146.55 153.85 40.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.274 1.429 . . . . 0.0 110.433 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.48 138.4 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.919 1.287 . . . . 0.0 110.203 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.431 ' HB2' HD11 ' A' ' 66' ' ' LEU . 25.0 t60 -116.3 115.69 26.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 110.964 165.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.9 tp -98.17 134.22 41.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.484 0.714 . . . . 0.0 111.143 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.03 162.36 41.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.181 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.83 -69.37 0.44 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.722 1.209 . . . . 0.0 112.673 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -160.36 152.38 20.24 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.539 1.135 . . . . 0.0 113.289 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.6 p -109.96 141.64 42.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.667 1.587 . . . . 0.0 113.181 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.57 -28.51 56.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.482 0.658 . . . . 0.0 112.498 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -109.95 -172.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.113 2.165 . . . . 0.0 111.641 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.12 132.74 51.36 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.755 1.222 . . . . 0.0 112.812 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.57 -41.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.816 1.246 . . . . 0.0 111.467 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -48.5 79.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.645 0.778 . . . . 0.0 112.11 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.51 -42.09 83.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.871 0.868 . . . . 0.0 110.992 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -60.02 -46.34 89.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.213 1.005 . . . . 0.0 112.156 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.58 -37.92 88.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.211 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.7 ttp -63.94 -48.89 74.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.859 0.754 . . . . 0.0 111.654 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.78 -46.8 89.07 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.238 0.615 . . . . 0.0 111.054 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.61 -43.04 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.66 1.184 . . . . 0.0 111.79 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.04 -48.43 81.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.497 1.044 . . . . 0.0 112.185 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -72.39 -33.41 67.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.582 1.153 . . . . 0.0 112.606 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -65.36 -42.79 92.41 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.607 -1.308 . . . . 0.0 111.809 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.42 -1.21 32.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.537 1.135 . . . . 0.0 112.947 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 59.75 37.92 21.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.811 1.244 . . . . 0.0 112.28 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtp -75.44 -21.17 58.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 112.511 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.81 -13.12 9.08 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.308 2.643 . . . . 0.0 114.415 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -64.45 -7.89 11.57 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -55.02 140.01 39.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.642 1.977 . . . . 0.0 111.074 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -66.43 -36.07 81.89 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.381 -0.824 . . . . 0.0 112.177 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.52 -1.45 56.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 62.06 27.86 16.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.247 1.023 . . . . 0.0 111.311 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -107.92 39.42 1.95 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.161 1.784 . . . . 0.0 112.752 -171.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.13 128.33 9.44 Favored Glycine 0 N--CA 1.479 1.53 0 C-N-CA 124.473 1.035 . . . . 0.0 112.262 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.66 132.26 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.209 1.803 . . . . 0.0 109.911 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 34' ' ' HIS . 28.6 tp -117.39 128.1 54.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.122 0.969 . . . . 0.0 111.194 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.61 97.41 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.671 1.189 . . . . 0.0 107.804 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -81.84 122.74 28.11 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.081 0.952 . . . . 0.0 111.039 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.34 125.62 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.913 0.885 . . . . 0.0 110.284 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 100.27 11.28 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.657 1.583 . . . . 0.0 110.188 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.19 -19.47 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -74.23 -47.14 37.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.655 1.116 . . . . 0.0 111.153 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -88.86 -11.61 44.18 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.7 1.2 . . . . 0.0 113.612 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.5 tttt 71.82 30.11 2.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.01 1.724 . . . . 0.0 112.717 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -113.3 133.39 55.14 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.391 1.477 . . . . 0.0 110.052 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -114.43 143.23 45.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.022 1.329 . . . . 0.0 109.371 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.99 134.27 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.027 1.331 . . . . 0.0 108.194 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 mt -112.48 129.58 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -135.84 124.13 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.728 0.811 . . . . 0.0 110.45 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.83 154.49 17.0 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.559 1.076 . . . . 0.0 110.785 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -67.93 168.4 11.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 122.374 1.083 . . . . 0.0 111.929 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.38 -26.52 63.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.952 1.301 . . . . 0.0 114.452 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.66 55.0 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.812 1.187 . . . . 0.0 111.492 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.93 -54.91 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.538 1.169 . . . . 0.0 109.272 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -60.9 -30.72 70.34 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -78.24 -38.12 43.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.873 0.869 . . . . 0.0 112.113 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 88' ' ' VAL . 19.8 m -89.17 -23.06 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 87' ' ' VAL . 2.5 m -119.59 162.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.231 0.923 . . . . 0.0 112.232 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -113.11 173.38 6.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.424 1.49 . . . . 0.0 112.462 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -58.24 -29.41 65.73 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.281 -1.512 . . . . 0.0 114.598 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.73 -23.78 61.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.89 1.276 . . . . 0.0 111.994 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -76.12 -31.02 58.43 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.314 -0.866 . . . . 0.0 111.065 168.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -80.55 -32.18 36.76 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.25 -45.04 68.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.268 1.427 . . . . 0.0 113.005 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -58.12 -34.97 70.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.528 1.131 . . . . 0.0 113.067 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.5 m -72.5 -50.21 27.55 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 127.029 2.132 . . . . 0.0 109.345 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -60.93 -43.29 98.83 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.787 0.435 . . . . 0.0 111.2 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.46 -38.3 80.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.03 -50.72 65.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.566 0.621 . . . . 0.0 111.371 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.68 -48.75 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.067 0.947 . . . . 0.0 110.783 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -61.93 -40.55 95.89 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.292 1.437 . . . . 0.0 113.091 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.2 tp -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.6 0.636 . . . . 0.0 111.484 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -34.99 48.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.543 -0.723 . . . . 0.0 112.665 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.39 -40.81 98.24 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.839 0.855 . . . . 0.0 111.16 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.09 -35.43 80.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 112.143 172.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.87 -21.59 60.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.723 1.209 . . . . 0.0 113.138 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.38 -5.43 44.82 Favored Glycine 0 N--CA 1.48 1.585 0 C-N-CA 126.16 1.838 . . . . 0.0 114.943 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -97.82 82.8 3.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.832 1.253 . . . . 0.0 111.54 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.56 -48.2 82.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.506 0.722 . . . . 0.0 112.469 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -54.57 -53.62 52.16 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.283 0.492 . . . . 0.0 111.644 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.81 -41.21 77.35 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.591 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.92 -36.76 65.22 Favored Glycine 0 N--CA 1.472 1.075 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.775 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.5 -52.07 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.536 0.668 . . . . 0.0 109.995 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.74 -45.18 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.647 0.779 . . . . 0.0 111.585 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.6 -45.65 93.22 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.343 1.457 . . . . 0.0 111.3 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.91 -36.84 91.65 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.742 0.686 . . . . 0.0 113.388 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.22 -51.58 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.461 1.104 . . . . 0.0 110.424 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.43 -41.03 98.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.234 1.014 . . . . 0.0 111.856 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.08 -39.56 78.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.34 0.656 . . . . 0.0 112.586 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.08 96.13 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.632 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.7 -49.36 78.26 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-N 119.162 0.892 . . . . 0.0 112.004 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.32 -34.45 73.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.692 1.246 . . . . 0.0 113.793 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.92 -46.52 15.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.368 0.667 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -59.52 -37.59 78.74 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 110.675 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.99 -15.66 57.0 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -76.57 -33.73 58.47 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.512 -1.368 . . . . 0.0 111.295 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -81.58 -39.78 24.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.061 1.344 . . . . 0.0 111.224 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.54 79.52 72.04 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.752 2.021 . . . . 0.0 111.501 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 138.35 39.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.229 2.62 . . . . 0.0 112.192 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.7 t90 -64.87 135.88 56.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.37 151.86 30.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.799 1.639 . . . . 0.0 111.605 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -69.99 -3.09 14.66 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.542 -1.349 . . . . 0.0 114.353 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -115.86 7.4 14.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.151 1.781 . . . . 0.0 112.576 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -58.22 148.62 26.48 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.434 1.093 . . . . 0.0 112.236 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 111.317 -169.047 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 CA-C-O 121.103 0.376 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -7.07 2.37 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.612 2.365 . . . . 0.0 116.836 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.2 m -58.11 152.5 16.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.584 1.154 . . . . 0.0 111.788 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.45 130.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.648 1.179 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t -88.11 141.34 28.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.404 0.682 . . . . 0.0 110.651 171.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -151.7 135.39 16.3 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 116.595 -2.225 . . . . 0.0 114.164 -174.295 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -77.17 166.15 23.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.23 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.847 -1.158 . . . . 0.0 111.726 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.3 -48.08 82.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.733 1.213 . . . . 0.0 110.917 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.9 -39.91 72.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.479 1.111 . . . . 0.0 111.235 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.87 -46.45 74.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.044 1.338 . . . . 0.0 112.325 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -56.91 -47.31 80.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.448 -1.408 . . . . 0.0 111.081 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.89 84.8 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 tt -74.16 -35.84 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.047 -1.033 . . . . 0.0 112.171 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.42 -42.86 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.625 1.102 . . . . 0.0 111.392 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.92 -27.42 68.17 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.22 -43.37 74.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.474 0.579 . . . . 0.0 111.548 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.63 -43.75 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.391 0.677 . . . . 0.0 110.256 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -60.31 -25.57 65.87 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.97 -36.27 23.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.256 1.389 . . . . 0.0 111.986 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.53 97.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.175 0.99 . . . . 0.0 112.198 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.72 -4.63 9.42 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -106.85 11.76 29.69 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.009 -1.682 . . . . 0.0 112.529 170.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.77 -6.44 5.09 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.65 1.98 . . . . 0.0 114.084 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -164.3 151.4 11.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.148 2.179 . . . . 0.0 109.729 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -88.11 11.57 15.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.742 1.217 . . . . 0.0 113.853 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.41 133.13 10.37 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 125.742 1.639 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -104.19 138.21 40.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.349 1.06 . . . . 0.0 112.642 -155.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.03 139.66 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 120.356 -1.465 . . . . 0.0 111.247 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -139.13 146.45 40.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.932 1.693 . . . . 0.0 111.296 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.76 136.26 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.929 1.291 . . . . 0.0 109.608 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -122.3 120.3 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.272 1.429 . . . . 0.0 113.058 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.55 125.23 54.03 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.557 1.143 . . . . 0.0 111.392 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -154.08 160.63 42.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.961 1.304 . . . . 0.0 109.983 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.26 -72.1 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 m -143.26 165.19 28.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.363 2.265 . . . . 0.0 107.892 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.7 m -124.7 155.85 38.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.315 1.046 . . . . 0.0 110.46 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.94 -1.75 57.79 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 pt -134.55 -131.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 126.57 1.948 . . . . 0.0 111.181 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -101.77 142.11 33.6 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.438 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.18 -36.0 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.006 0.522 . . . . 0.0 111.84 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.49 -50.39 71.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.743 0.817 . . . . 0.0 111.937 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.26 -33.46 75.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.106 0.563 . . . . 0.0 111.47 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -65.66 -46.63 78.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.902 0.881 . . . . 0.0 112.568 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.15 90.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.664 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -59.12 -49.9 76.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.337 0.655 . . . . 0.0 111.715 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.4 -45.89 91.1 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.759 -0.588 . . . . 0.0 111.717 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.38 -35.17 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.715 -0.659 . . . . 0.0 110.785 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.7 -50.56 73.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.536 1.062 . . . . 0.0 111.718 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -72.72 -34.46 67.1 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.436 0.695 . . . . 0.0 111.608 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -70.37 -26.74 63.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.56 6.91 47.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.355 1.462 . . . . 0.0 112.425 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 60.92 26.39 16.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.625 1.57 . . . . 0.0 112.284 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.0 -18.1 60.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.723 1.209 . . . . 0.0 112.326 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -74.06 -8.21 55.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.424 2.29 . . . . 0.0 113.756 169.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -98.83 82.69 2.82 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 121.562 -0.711 . . . . 0.0 110.474 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.5 p -139.2 152.82 47.67 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.044 1.337 . . . . 0.0 110.501 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -57.86 -37.34 73.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.9 mt -105.96 -7.95 17.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.61 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 70.94 29.26 3.05 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.953 1.301 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -105.41 35.11 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.094 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.75 117.0 4.79 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.127 -0.818 . . . . 0.0 111.851 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.6 t -98.98 139.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.583 1.553 . . . . 0.0 110.232 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.5 tp -129.16 133.94 47.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.29 100.12 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.705 1.202 . . . . 0.0 109.409 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.58 128.0 32.91 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.072 -1.018 . . . . 0.0 109.994 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -124.26 127.52 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.911 0.884 . . . . 0.0 110.657 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.11 95.12 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.542 1.537 . . . . 0.0 110.035 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.42 -21.0 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -165.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.64 -28.69 45.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.51 1.05 . . . . 0.0 111.825 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -97.47 -4.99 37.02 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.443 1.097 . . . . 0.0 112.714 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 61.39 23.01 13.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.996 1.718 . . . . 0.0 112.003 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -105.36 169.02 8.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.597 1.559 . . . . 0.0 110.781 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -146.73 143.95 29.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.173 1.789 . . . . 0.0 108.749 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.8 140.43 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.146 1.378 . . . . 0.0 107.299 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.3 mt -118.68 133.34 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -139.4 138.18 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.259 1.423 . . . . 0.0 109.128 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.85 155.42 21.21 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -66.72 172.48 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 123.556 1.646 . . . . 0.0 111.82 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -61.45 -33.56 73.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.64 -1.172 . . . . 0.0 112.707 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -48.7 76.39 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 120.242 1.383 . . . . 0.0 112.31 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.97 -56.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.202 1.001 . . . . 0.0 109.774 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.6 -24.71 66.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -78.25 -38.36 43.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.014 1.325 . . . . 0.0 110.397 173.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 88' ' ' VAL . 2.0 p -90.8 -29.22 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 87' ' ' VAL . 2.9 m -119.89 156.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.842 1.656 . . . . 0.0 113.004 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.7 m -102.36 172.72 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.531 1.533 . . . . 0.0 114.803 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -61.12 -34.33 74.8 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.88 -24.42 67.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 0.0 113.029 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 47.6 t80 -77.22 -39.36 48.83 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.18 -0.95 . . . . 0.0 111.281 171.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -70.85 -29.62 65.79 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.191 1.396 . . . . 0.0 114.108 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.62 -37.97 74.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.505 0.722 . . . . 0.0 112.759 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 m -62.05 -43.57 98.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.696 0.798 . . . . 0.0 111.086 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -59.11 -53.81 54.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.673 1.989 . . . . 0.0 110.583 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -56.68 -50.26 72.66 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.659 1.184 . . . . 0.0 111.204 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -57.91 -36.44 72.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.248 1.019 . . . . 0.0 113.621 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.46 20.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.788 0.835 . . . . 0.0 112.019 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.12 -49.54 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.187 0.995 . . . . 0.0 109.639 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.3 -42.54 91.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.118 1.367 . . . . 0.0 113.382 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.64 -45.44 90.19 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.063 0.545 . . . . 0.0 110.869 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.02 -29.35 55.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.16 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.51 -39.64 81.16 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.358 0.981 . . . . 0.0 111.481 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.85 -43.54 94.58 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.555 0.742 . . . . 0.0 111.09 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.49 -35.23 79.77 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.991 -0.528 . . . . 0.0 111.935 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.88 10.28 24.89 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.834 1.683 . . . . 0.0 114.674 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.79 83.44 2.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -62.52 -39.62 94.15 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.764 1.225 . . . . 0.0 112.705 -171.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -54.78 -56.01 23.97 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -60.81 -42.21 97.19 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.904 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.93 -41.58 97.32 Favored Glycine 0 N--CA 1.473 1.101 0 CA-C-N 120.187 1.358 . . . . 0.0 112.378 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.63 -47.21 73.31 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.547 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.32 -48.49 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 118.852 0.751 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -63.41 -35.36 80.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.982 0.81 . . . . 0.0 112.021 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.91 -43.98 92.7 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.067 -0.852 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.9 -47.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.929 1.292 . . . . 0.0 111.362 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.98 -49.51 77.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.712 0.805 . . . . 0.0 111.504 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -65.28 -38.73 91.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.828 -0.545 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.39 74.08 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.844 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.15 87.57 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 119.669 1.122 . . . . 0.0 112.469 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.3 mtp -58.36 -42.22 86.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.987 0.894 . . . . 0.0 112.908 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.23 -41.69 57.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.501 0.721 . . . . 0.0 111.586 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.1 mt -62.07 -36.58 82.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.795 1.238 . . . . 0.0 111.131 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.05 -18.22 32.82 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -70.99 -34.58 71.52 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.246 -1.534 . . . . 0.0 112.198 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -90.12 -35.78 15.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.37 1.468 . . . . 0.0 112.981 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -131.89 85.2 51.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.937 1.695 . . . . 0.0 110.044 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.52 147.47 93.1 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.381 2.054 . . . . 0.0 110.497 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -69.54 146.68 51.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.332 1.063 . . . . 0.0 111.783 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -134.73 151.17 50.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.604 1.161 . . . . 0.0 109.611 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.42 -35.95 72.85 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.373 -0.83 . . . . 0.0 112.814 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -90.32 18.09 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.881 1.672 . . . . 0.0 113.224 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.31 151.12 28.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.094 1.358 . . . . 0.0 113.203 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 125.626 1.57 . . . . 0.0 113.332 -154.964 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 CA-C-O 121.763 0.651 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -74.13 3.39 7.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.4 p -70.65 156.33 39.6 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 128.21 2.604 . . . . 0.0 112.487 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 84.2 mt -78.26 134.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.699 1.2 . . . . 0.0 108.406 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.3 m -91.93 142.14 27.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.464 0.649 . . . . 0.0 109.458 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -129.8 151.15 50.69 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.171 -0.956 . . . . 0.0 110.698 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.966 0 C-N-CA 126.192 1.853 . . . . 0.0 113.76 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -74.65 167.29 22.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.148 0.431 . . . . 0.0 110.214 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.74 58.57 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 113.21 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -55.2 -41.79 72.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.291 1.436 . . . . 0.0 113.278 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.14 -42.69 25.61 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 110.63 -173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -62.69 -45.14 94.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.362 1.065 . . . . 0.0 111.373 172.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -57.74 -47.55 82.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.344 -0.847 . . . . 0.0 111.888 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.75 88.51 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.347 1.059 . . . . 0.0 113.438 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.18 -41.64 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 117.935 -1.031 . . . . 0.0 112.269 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.53 -42.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.783 1.174 . . . . 0.0 111.464 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.37 -28.73 69.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.138 0.881 . . . . 0.0 113.149 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.98 67.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.93 0.786 . . . . 0.0 112.015 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mm -64.78 -50.51 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.91 0.884 . . . . 0.0 110.127 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -54.28 -29.28 46.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.33 1.052 . . . . 0.0 113.475 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -83.19 -30.2 27.95 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.019 1.328 . . . . 0.0 112.185 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.0 75.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.69 1.132 . . . . 0.0 111.424 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.13 2.34 0.81 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.606 1.562 . . . . 0.0 114.099 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.79 5.41 24.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 119.39 -2.069 . . . . 0.0 113.031 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -126.96 -8.08 6.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.72 1.608 . . . . 0.0 113.522 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -160.07 161.29 33.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.235 1.814 . . . . 0.0 109.157 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -99.04 10.79 40.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.57 172.49 17.64 Favored Glycine 0 N--CA 1.473 1.16 0 O-C-N 120.549 -1.344 . . . . 0.0 110.823 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -123.67 122.24 37.61 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 122.803 0.441 . . . . 0.0 111.67 -160.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 mt -108.71 112.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.336 1.054 . . . . 0.0 110.693 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -123.24 151.1 42.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.754 0.822 . . . . 0.0 113.19 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 t -130.52 134.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.581 1.153 . . . . 0.0 109.008 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -122.11 121.99 38.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 111.991 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 35' ' ' LEU . 13.8 tp -107.16 132.37 53.11 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.178 0.991 . . . . 0.0 111.462 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -160.23 155.18 24.48 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.786 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.35 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.744 1.218 . . . . 0.0 113.233 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.6 t -137.47 169.76 17.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.193 1.797 . . . . 0.0 110.316 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 p -123.23 157.26 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.501 1.52 . . . . 0.0 113.162 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -90.75 -9.85 45.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.955 1.302 . . . . 0.0 113.293 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 -141.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.049 1.739 . . . . 0.0 111.159 -164.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -102.42 135.24 44.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.634 1.561 . . . . 0.0 112.266 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -62.47 -38.97 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.019 0.928 . . . . 0.0 112.099 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.02 0.827 . . . . 0.0 111.856 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.44 -39.88 85.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.804 0.842 . . . . 0.0 110.781 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -59.02 -47.53 84.86 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.583 -0.698 . . . . 0.0 111.788 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.97 -42.28 99.78 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.604 0.762 . . . . 0.0 110.978 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -58.55 -53.91 52.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.556 1.142 . . . . 0.0 111.247 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -64.63 -37.15 86.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.776 -1.203 . . . . 0.0 112.054 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.85 -47.22 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.346 1.058 . . . . 0.0 111.326 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -56.71 -45.92 81.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.421 1.488 . . . . 0.0 111.987 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -73.39 -40.47 64.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.834 1.254 . . . . 0.0 112.979 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -63.89 -39.31 93.89 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.992 0.815 . . . . 0.0 112.378 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.52 0.23 20.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 113.418 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 62.33 24.41 14.53 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.036 1.334 . . . . 0.0 113.271 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.69 -30.09 68.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 0.0 112.412 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -49.73 -31.14 10.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.073 1.749 . . . . 0.0 112.601 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -77.67 65.05 3.08 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.085 -1.01 . . . . 0.0 113.02 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.0 m -118.9 134.78 54.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.155 2.182 . . . . 0.0 106.705 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.32 -44.5 72.08 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.826 1.194 . . . . 0.0 112.776 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.64 -2.27 58.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 114.017 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 66.2 19.37 11.08 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.727 1.211 . . . . 0.0 113.222 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -99.33 46.83 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.211 1.005 . . . . 0.0 112.061 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.19 121.45 6.71 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.775 1.179 . . . . 0.0 111.907 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.39 140.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 118.311 1.056 . . . . 0.0 109.567 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 tp -120.97 127.16 51.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.985 0.898 . . . . 0.0 111.5 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.1 mt -102.75 97.59 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.492 1.517 . . . . 0.0 108.31 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -82.1 125.3 30.69 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.604 -0.685 . . . . 0.0 110.514 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.11 131.07 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.729 -0.607 . . . . 0.0 110.695 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 100.15 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.892 1.677 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.6 m -80.52 -14.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -81.26 -49.45 10.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.057 0.844 . . . . 0.0 110.58 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -76.09 -16.84 59.84 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.818 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 67.93 41.41 2.11 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.955 1.702 . . . . 0.0 111.172 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.1 p -119.26 172.33 7.67 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.486 1.914 . . . . 0.0 110.245 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -154.74 134.27 12.69 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.005 0.922 . . . . 0.0 109.597 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.17 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.085 1.754 . . . . 0.0 108.214 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.8 mt -125.99 136.9 59.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -154.92 121.29 5.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.225 1.41 . . . . 0.0 109.086 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.99 168.27 12.52 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 124.15 0.881 . . . . 0.0 111.178 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -69.84 165.61 21.17 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.126 1.441 . . . . 0.0 112.278 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.23 -33.29 8.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.93 2.092 . . . . 0.0 113.588 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.67 -44.2 98.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 120.885 1.675 . . . . 0.0 112.296 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.2 -56.53 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.371 1.086 . . . . 0.0 109.787 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -57.43 -31.28 65.73 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.34 -14.75 42.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.572 1.549 . . . . 0.0 113.161 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.95 -18.45 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.01 172.6 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.789 1.177 . . . . 0.0 111.943 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.3 p -118.17 175.67 5.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.949 1.7 . . . . 0.0 113.725 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.75 -21.16 65.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 119.675 -1.891 . . . . 0.0 112.96 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.2 -29.02 66.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.521 1.128 . . . . 0.0 111.936 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.432 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 65.1 t80 -79.02 -32.75 45.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 111.907 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -80.0 -30.02 39.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.452 1.501 . . . . 0.0 114.035 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.37 -33.63 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.941 0.791 . . . . 0.0 112.42 -174.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 p -65.36 -42.87 92.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.69 0.796 . . . . 0.0 111.162 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.0 m -57.83 -49.42 76.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 111.497 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -58.05 -50.93 71.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.985 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -60.22 -37.56 80.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.69 58.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.171 0.896 . . . . 0.0 111.549 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.01 -48.54 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.421 0.688 . . . . 0.0 110.727 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -58.64 -40.86 84.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.576 1.55 . . . . 0.0 113.893 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.01 -45.23 67.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.889 0.768 . . . . 0.0 111.152 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -35.61 74.64 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.038 0.535 . . . . 0.0 111.629 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.961 0.801 . . . . 0.0 111.57 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -59.34 -39.26 82.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.858 0.753 . . . . 0.0 111.533 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -74.68 -22.49 58.83 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.893 0.877 . . . . 0.0 112.363 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.11 55.07 Favored Glycine 0 N--CA 1.48 1.6 0 C-N-CA 125.1 1.333 . . . . 0.0 114.162 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -96.09 71.37 2.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.878 1.271 . . . . 0.0 111.369 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -55.88 -46.06 78.39 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -51.24 -57.52 8.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.89 0.876 . . . . 0.0 111.014 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -59.99 -42.73 94.85 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.492 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.68 95.57 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 119.866 1.212 . . . . 0.0 113.225 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 mt -69.09 -48.61 62.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.57 0.685 . . . . 0.0 111.341 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.88 -53.2 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.76 0.709 . . . . 0.0 111.605 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.42 -35.69 81.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.078 0.951 . . . . 0.0 111.858 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.18 -38.05 63.41 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 121.378 -0.827 . . . . 0.0 112.824 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.38 -42.77 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.009 1.324 . . . . 0.0 111.378 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -55.38 -52.45 63.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.694 1.198 . . . . 0.0 110.579 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -65.57 -34.71 78.89 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.09 90.81 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.338 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.42 -44.99 97.03 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 119.431 -0.649 . . . . 0.0 112.286 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.4 mtp -59.85 -42.47 93.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.395 1.097 . . . . 0.0 113.59 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.37 -44.56 51.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.741 0.816 . . . . 0.0 111.129 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.03 -36.64 84.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.408 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.92 -26.87 62.78 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.059 0.944 . . . . 0.0 113.327 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -65.66 -34.78 79.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.401 -1.437 . . . . 0.0 111.472 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.82 -39.9 23.33 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.796 1.238 . . . . 0.0 111.879 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.08 79.51 73.75 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.607 1.563 . . . . 0.0 111.454 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.98 135.32 27.28 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.628 2.218 . . . . 0.0 110.959 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -56.89 147.9 22.36 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -125.62 150.48 47.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.479 1.112 . . . . 0.0 110.157 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -67.14 -26.09 66.5 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.053 -1.655 . . . . 0.0 113.235 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.14 9.11 34.93 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.241 2.216 . . . . 0.0 112.206 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -58.13 138.96 55.71 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 126.132 1.773 . . . . 0.0 113.282 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.19 0 C-N-CA 124.571 1.148 . . . . 0.0 110.597 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.459 -0.511 0 N-CA-C 109.51 -0.996 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -71.63 -4.94 29.97 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -60.68 140.15 57.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.089 2.155 . . . . 0.0 111.207 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.7 mt -64.59 140.21 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.012 1.325 . . . . 0.0 110.392 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 m -96.57 143.46 27.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.191 0.596 . . . . 0.0 110.452 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -143.79 137.24 27.9 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.364 -0.835 . . . . 0.0 110.551 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.392 0 CA-C-O 117.984 -1.454 . . . . 0.0 112.649 176.155 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 t -66.73 -36.27 82.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.383 1.473 . . . . 0.0 112.043 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -81.05 109.23 15.42 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.51 -1.369 . . . . 0.0 110.812 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -81.57 -16.37 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -64.49 -33.77 76.67 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.787 1.635 . . . . 0.0 113.857 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -135.97 108.17 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.716 1.207 . . . . 0.0 108.448 -173.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 71' ' ' VAL . 88.4 m-85 -65.1 -26.79 68.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.426 1.091 . . . . 0.0 113.865 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.21 149.6 47.3 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.999 1.32 . . . . 0.0 108.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -80.15 164.23 23.48 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.762 -1.211 . . . . 0.0 110.364 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.09 65.06 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.34 -44.12 97.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.392 1.477 . . . . 0.0 111.572 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.77 -43.19 56.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.163 0.985 . . . . 0.0 111.013 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.32 -47.53 83.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 111.289 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.11 -47.46 78.07 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.13 -0.981 . . . . 0.0 111.296 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.46 69.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 tt -80.02 -39.01 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.196 1.362 . . . . 0.0 112.715 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.5 t -58.64 -43.28 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 120.145 1.339 . . . . 0.0 110.808 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -62.23 -27.94 69.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.96 69.79 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.48 -0.762 . . . . 0.0 112.672 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.36 -42.8 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.211 1.005 . . . . 0.0 109.612 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.47 -34.26 66.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.061 1.344 . . . . 0.0 113.493 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.49 -24.93 41.98 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.58 58.77 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.424 1.011 . . . . 0.0 111.952 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -54.74 -28.53 49.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.088 1.355 . . . . 0.0 112.267 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.69 6.58 37.82 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.719 -1.863 . . . . 0.0 112.623 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.49 -15.01 6.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 113.922 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 t -160.95 140.06 10.34 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.186 1.394 . . . . 0.0 109.541 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -80.63 39.01 0.46 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 112.727 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.97 158.0 27.03 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 125.536 1.541 . . . . 0.0 110.892 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.34 142.91 46.52 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -155.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.83 97.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.592 1.157 . . . . 0.0 111.084 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -106.9 145.05 32.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.659 1.184 . . . . 0.0 111.856 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.61 133.54 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.066 1.346 . . . . 0.0 109.243 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -119.15 115.96 25.34 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.939 1.296 . . . . 0.0 111.927 168.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.2 tp -103.52 126.92 50.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.323 1.049 . . . . 0.0 111.315 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.65 162.15 39.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.663 1.22 . . . . 0.0 111.396 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -68.33 -77.15 0.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.464 1.106 . . . . 0.0 112.013 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 t -153.69 165.23 36.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.648 1.979 . . . . 0.0 109.902 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.5 m -115.33 154.66 28.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.325 1.45 . . . . 0.0 111.235 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -92.06 -13.48 30.8 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.054 -1.029 . . . . 0.0 112.645 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 pt -130.37 -163.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.126 1.77 . . . . 0.0 110.702 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -72.52 136.57 45.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.405 0.622 . . . . 0.0 112.464 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.53 -35.14 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.98 0.912 . . . . 0.0 111.716 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.57 -54.89 28.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.299 0.954 . . . . 0.0 112.423 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -63.14 -39.26 94.15 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.647 0.779 . . . . 0.0 111.184 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -61.45 -45.22 95.19 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.713 -0.617 . . . . 0.0 111.754 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.43 94.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.824 0.738 . . . . 0.0 111.277 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.9 ttp -62.52 -43.0 99.88 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 112.386 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.3 -48.65 77.2 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.953 -1.092 . . . . 0.0 111.748 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.6 -42.53 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.899 0.88 . . . . 0.0 111.789 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -57.3 -49.15 77.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.536 1.135 . . . . 0.0 111.157 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -71.59 -38.03 70.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.202 1.001 . . . . 0.0 112.056 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.9 -43.15 93.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.104 1.362 . . . . 0.0 112.773 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.05 -3.62 20.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.193 0.997 . . . . 0.0 112.901 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.8 tttt 64.76 38.21 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.648 1.979 . . . . 0.0 112.296 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.7 mtp -77.04 -12.78 59.98 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -0.89 7.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.226 1.01 . . . . 0.0 113.057 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -74.48 31.08 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.633 1.973 . . . . 0.0 114.457 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -99.87 156.16 17.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.682 1.993 . . . . 0.0 110.881 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -73.85 -30.48 62.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.454 1.102 . . . . 0.0 112.429 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.14 -7.21 16.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 67.33 47.41 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.306 . . . . 0.0 110.851 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -137.97 40.45 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.323 1.049 . . . . 0.0 113.607 -164.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.54 142.68 16.19 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 167.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.72 144.44 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.594 1.158 . . . . 0.0 110.463 169.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -117.2 129.25 55.82 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.167 1.387 . . . . 0.0 109.939 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 mt -103.23 96.85 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.11 119.0 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.193 0.597 . . . . 0.0 110.114 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.66 129.78 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.703 0.801 . . . . 0.0 110.143 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.11 102.88 12.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.717 1.207 . . . . 0.0 109.256 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 7' ' ' PHE . 33.3 m -70.91 -22.18 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -170.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.14 -49.42 23.8 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.229 0.538 . . . . 0.0 111.689 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.37 -15.08 56.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.455 1.102 . . . . 0.0 111.729 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 tttt 75.23 19.8 2.17 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.517 2.327 . . . . 0.0 112.415 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.1 p -98.13 162.59 13.13 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 111.785 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.87 139.32 36.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.741 1.217 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.59 147.62 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.516 1.527 . . . . 0.0 107.786 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.38 125.96 60.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -139.04 120.76 15.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.0 110.244 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.3 152.91 17.63 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 125.523 1.535 . . . . 0.0 111.025 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -66.75 164.57 16.81 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 123.141 1.448 . . . . 0.0 111.654 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -53.54 -37.6 62.99 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 114.39 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.7 -18.92 70.73 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.47 1.033 . . . . 0.0 113.807 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -81.12 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.122 1.461 . . . . 0.0 108.783 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -53.52 -37.6 62.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.657 0.783 . . . . 0.0 113.032 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.14 -17.46 58.59 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.719 1.207 . . . . 0.0 113.011 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.14 -21.62 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.9 m -114.9 179.47 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.756 1.162 . . . . 0.0 111.838 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.1 p -121.98 171.1 9.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.368 1.867 . . . . 0.0 112.392 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.0 -29.09 70.56 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.864 -1.147 . . . . 0.0 112.448 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.3 -38.81 91.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.893 1.277 . . . . 0.0 111.537 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 52.1 t80 -63.65 -46.13 87.04 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.376 0.67 . . . . 0.0 110.351 172.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.244 1.418 . . . . 0.0 114.63 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.81 -39.59 74.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.444 1.098 . . . . 0.0 111.613 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -61.21 -47.12 87.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.636 0.774 . . . . 0.0 111.807 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 m -58.31 -50.34 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.269 1.828 . . . . 0.0 110.413 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -59.13 -51.05 71.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.393 1.077 . . . . 0.0 111.994 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.34 -41.28 96.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.014 0.824 . . . . 0.0 112.698 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.53 79.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.897 0.771 . . . . 0.0 112.928 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.97 -50.37 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.52 1.128 . . . . 0.0 110.956 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -53.87 -48.03 70.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.619 1.167 . . . . 0.0 111.403 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.67 -33.41 75.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -85.61 -38.14 18.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.32 -37.21 79.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.506 0.594 . . . . 0.0 111.432 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.19 -27.27 67.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.969 1.308 . . . . 0.0 113.387 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.71 -32.65 53.08 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.896 0.771 . . . . 0.0 110.445 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.01 3.18 26.52 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 126.636 2.065 . . . . 0.0 114.252 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.49 84.17 2.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.492 1.146 . . . . 0.0 111.109 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -56.94 -41.52 78.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.813 0.845 . . . . 0.0 112.585 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.93 -57.65 11.58 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.467 -0.771 . . . . 0.0 112.465 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.46 -43.15 83.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.223 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.2 98.42 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.351 0.978 . . . . 0.0 113.618 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.73 -48.43 66.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.755 -1.117 . . . . 0.0 111.035 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.03 -48.36 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.309 1.044 . . . . 0.0 112.241 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -67.3 -34.68 77.9 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.266 0.485 . . . . 0.0 111.688 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.58 -41.05 90.55 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.228 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.07 -44.39 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.663 1.185 . . . . 0.0 109.617 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.17 -51.78 65.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.877 0.871 . . . . 0.0 111.976 -178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.96 -41.78 95.18 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.615 0.766 . . . . 0.0 111.269 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.23 78.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.554 0.742 . . . . 0.0 110.928 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.5 -46.53 87.78 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.01 0.823 . . . . 0.0 112.108 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.7 mtp -65.55 -35.96 82.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.049 0.925 . . . . 0.0 113.087 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.483 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.93 -44.6 61.01 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 111.112 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.85 -37.36 85.99 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.371 1.468 . . . . 0.0 111.46 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.33 -18.51 11.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.392 1.477 . . . . 0.0 114.355 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -72.43 -40.88 66.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.33 -1.481 . . . . 0.0 112.105 170.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -85.9 -28.89 24.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.735 1.214 . . . . 0.0 112.276 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -136.58 76.62 47.96 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.668 1.987 . . . . 0.0 108.669 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.83 143.1 78.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.841 1.694 . . . . 0.0 110.498 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -63.1 143.89 57.38 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -118.99 144.84 46.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.412 1.485 . . . . 0.0 109.402 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -60.71 -32.95 72.18 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 112.636 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -82.93 5.43 21.96 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.881 1.272 . . . . 0.0 113.446 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -58.84 150.46 23.95 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.013 0.925 . . . . 0.0 112.943 -172.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.63 138.06 54.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-O 122.721 1.248 . . . . 0.0 111.509 -165.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -98.57 101.24 12.61 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.052 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -95.55 -37.46 10.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.428 1.491 . . . . 0.0 113.195 -166.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.87 165.4 13.32 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.125 0.97 . . . . 0.0 110.353 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -99.41 157.13 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 124.248 3.298 . . . . 0.0 112.344 170.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -77.84 -10.23 59.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.2 m -57.3 131.24 49.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.363 1.465 . . . . 0.0 109.72 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.03 137.76 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.43 -0.794 . . . . 0.0 108.863 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.7 m -92.28 142.92 26.94 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.422 -0.798 . . . . 0.0 111.844 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.86 150.68 52.14 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.424 1.09 . . . . 0.0 110.568 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.714 170.868 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -66.95 146.24 54.6 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.012 1.733 . . . . 0.0 110.833 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -56.27 -30.37 62.37 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.089 -1.007 . . . . 0.0 113.59 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.25 -61.51 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.846 1.658 . . . . 0.0 109.904 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.93 -20.51 63.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.011 2.124 . . . . 0.0 113.414 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -68.53 -36.31 78.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.881 1.272 . . . . 0.0 111.835 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -81.15 -63.63 1.36 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.098 0.959 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt -145.24 146.55 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.176 1.791 . . . . 0.0 108.895 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 p -75.11 167.39 22.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.6 64.34 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.772 -1.205 . . . . 0.0 112.759 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -66.94 -36.0 81.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.17 1.388 . . . . 0.0 111.701 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.71 -45.46 13.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.32 1.048 . . . . 0.0 111.228 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -60.96 -40.95 95.32 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.802 1.241 . . . . 0.0 111.166 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.14 -48.15 81.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.163 -0.961 . . . . 0.0 112.07 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.25 97.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 tt -72.01 -35.46 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.52 -32.76 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.014 0.825 . . . . 0.0 111.462 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.92 -35.99 75.0 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.342 -0.849 . . . . 0.0 112.588 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.82 93.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.926 0.49 . . . . 0.0 111.388 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.38 -48.02 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.816 0.846 . . . . 0.0 110.814 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -55.08 -33.73 63.01 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.85 -25.74 32.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.91 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.091 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -73.27 14.65 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.699 1.2 . . . . 0.0 113.373 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -116.96 3.21 12.81 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.892 -1.755 . . . . 0.0 112.272 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -121.26 -18.36 7.4 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.23 1.412 . . . . 0.0 113.207 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -144.14 163.43 33.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.559 2.343 . . . . 0.0 108.771 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -100.83 31.41 3.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.53 1.532 . . . . 0.0 112.384 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.88 118.06 1.5 Allowed Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.352 -1.468 . . . . 0.0 111.902 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -85.21 137.11 33.21 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -156.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.18 119.83 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 123.003 1.382 . . . . 0.0 111.485 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -124.74 151.68 44.76 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.308 1.443 . . . . 0.0 112.452 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 144.3 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.011 1.724 . . . . 0.0 110.692 171.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 66' ' ' LEU . 27.6 t60 -125.12 122.4 37.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.09 130.64 54.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.558 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 14.8 tt0 -146.87 169.2 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.892 1.33 . . . . 0.0 110.682 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 65.4 mttt -78.85 -73.36 0.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.393 1.077 . . . . 0.0 112.508 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -148.42 142.97 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.574 1.949 . . . . 0.0 109.247 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.8 p -86.84 146.81 26.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.965 0.888 . . . . 0.0 112.484 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 -10.61 38.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.235 1.014 . . . . 0.0 112.301 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.5 -163.46 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.392 2.677 . . . . 0.0 108.946 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.31 138.62 55.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.678 -1.264 . . . . 0.0 112.072 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.92 -37.6 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.366 0.666 . . . . 0.0 111.794 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.46 -52.56 64.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.581 0.752 . . . . 0.0 112.197 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.02 -39.65 87.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.91 0.484 . . . . 0.0 111.178 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -58.81 -47.04 86.2 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.118 -0.989 . . . . 0.0 112.118 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.75 96.76 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.568 0.747 . . . . 0.0 111.419 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 ttp -62.37 -43.75 98.07 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 111.815 173.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.07 -46.59 86.74 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.254 -0.904 . . . . 0.0 112.021 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.13 -43.62 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.22 -46.66 85.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.335 1.054 . . . . 0.0 111.808 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.69 -35.78 60.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.278 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -63.84 -44.07 94.28 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.429 -1.419 . . . . 0.0 111.159 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.75 -6.38 44.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.714 1.205 . . . . 0.0 113.268 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 62.33 41.14 10.55 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 66' ' ' LEU . 72.3 mtp -73.29 -22.54 60.34 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.43 -8.74 6.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 114.046 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 62.95 0.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.179 1.792 . . . . 0.0 110.793 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -133.4 140.32 47.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.613 1.165 . . . . 0.0 110.581 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -58.16 -43.64 87.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 111.889 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.3 mt -94.82 -3.68 48.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 59.73 57.06 3.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.04 28.94 3.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 112.255 -168.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.87 131.57 10.48 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.393 -0.817 . . . . 0.0 111.206 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.6 t -102.65 138.79 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.268 1.027 . . . . 0.0 110.321 168.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' HIS . 17.8 tp -119.04 121.54 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.062 1.345 . . . . 0.0 110.963 164.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.4 mt -97.25 101.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -81.93 125.19 30.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.256 0.622 . . . . 0.0 110.917 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.1 129.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.753 0.706 . . . . 0.0 111.406 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.27 100.78 12.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.894 1.678 . . . . 0.0 110.273 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.27 -12.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.88 -54.49 5.54 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.474 -0.766 . . . . 0.0 110.495 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.33 -11.85 59.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.179 0.992 . . . . 0.0 112.315 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt 71.68 27.27 2.95 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.6 2.36 . . . . 0.0 112.356 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -106.06 134.36 49.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.995 1.318 . . . . 0.0 110.53 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -106.41 143.78 34.04 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 110.199 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 t -134.36 143.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.505 1.922 . . . . 0.0 108.259 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.0 mt -123.63 130.12 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -140.62 132.54 27.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.996 1.319 . . . . 0.0 110.026 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.52 163.68 21.2 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 123.872 0.749 . . . . 0.0 111.309 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.69 161.31 4.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.899 1.333 . . . . 0.0 114.121 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.4 -35.61 65.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.522 1.529 . . . . 0.0 113.777 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.37 -27.95 73.06 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 120.259 1.39 . . . . 0.0 112.939 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.6 mt -69.43 -60.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.2 1.5 . . . . 0.0 109.425 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -52.01 -37.57 53.78 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.71 0.804 . . . . 0.0 112.973 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.92 -21.7 59.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.032 -1.043 . . . . 0.0 113.436 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 88' ' ' VAL . 1.5 p -106.73 -32.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 87' ' ' VAL . 4.4 m -110.6 179.31 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.701 1.2 . . . . 0.0 111.004 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 -178.9 6.13 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.666 -1.271 . . . . 0.0 113.775 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -52.44 -36.31 54.24 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -71.69 -20.01 61.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.498 1.045 . . . . 0.0 112.943 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 29.1 t80 -78.57 -49.24 13.63 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.285 1.034 . . . . 0.0 109.275 168.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -62.68 -31.43 72.31 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.611 1.564 . . . . 0.0 113.611 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.72 -29.75 68.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.225 1.01 . . . . 0.0 111.621 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.5 p -69.96 -43.07 72.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.542 0.61 . . . . 0.0 111.651 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 m -55.94 -51.62 67.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.371 1.869 . . . . 0.0 111.014 172.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -59.3 -48.42 81.69 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.61 0.764 . . . . 0.0 111.528 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -59.76 -45.89 90.84 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.585 1.084 . . . . 0.0 112.581 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.52 93.89 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.217 0.917 . . . . 0.0 112.826 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.57 -52.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.953 0.901 . . . . 0.0 110.212 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -57.36 -44.48 84.4 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.045 1.338 . . . . 0.0 112.626 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.42 -34.0 77.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.533 0.606 . . . . 0.0 112.161 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -85.89 -38.84 17.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.04 0.936 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.29 -40.37 77.63 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.233 -0.917 . . . . 0.0 111.767 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.91 -23.05 67.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.951 1.3 . . . . 0.0 113.364 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.36 -25.26 21.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.631 0.772 . . . . 0.0 112.153 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.51 37.62 Favored Glycine 0 N--CA 1.477 1.431 0 C-N-CA 125.468 1.509 . . . . 0.0 113.664 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.9 64.35 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.415 1.486 . . . . 0.0 110.839 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -53.43 -44.0 68.47 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.942 0.897 . . . . 0.0 112.876 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.02 -54.01 45.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.395 1.078 . . . . 0.0 111.872 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -63.74 -43.36 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.05 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.74 96.08 Favored Glycine 0 N--CA 1.469 0.877 0 CA-C-N 119.167 0.894 . . . . 0.0 113.065 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -72.5 -45.38 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.999 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.59 -51.21 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.484 1.038 . . . . 0.0 111.473 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.3 -40.35 90.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 0.0 111.423 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.75 92.08 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.916 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.51 -52.67 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.556 1.178 . . . . 0.0 109.744 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.91 -46.15 88.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.158 0.583 . . . . 0.0 111.868 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.67 -40.66 76.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.917 0.887 . . . . 0.0 111.729 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.84 76.17 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.56 0.618 . . . . 0.0 109.926 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.15 -48.74 77.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.583 0.611 . . . . 0.0 113.347 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.29 -35.97 82.13 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.95 -41.26 59.95 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.118 -0.364 . . . . 0.0 110.799 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.3 mt -63.06 -40.1 96.71 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.927 1.691 . . . . 0.0 111.882 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.47 44.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 113.847 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.82 -41.01 92.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.503 -0.748 . . . . 0.0 111.842 172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.0 -46.75 13.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.204 1.402 . . . . 0.0 111.344 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.97 83.5 37.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 126.641 1.977 . . . . 0.0 110.516 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.34 143.16 62.81 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.837 2.358 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -60.16 145.58 46.45 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.32 0.581 . . . . 0.0 112.038 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -120.59 144.81 47.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.039 0.936 . . . . 0.0 109.423 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.14 -20.09 65.75 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 120.671 -1.268 . . . . 0.0 113.318 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -95.99 2.52 53.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.167 2.587 . . . . 0.0 113.739 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -58.6 151.87 19.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.426 1.49 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.54 142.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 123.657 0.783 . . . . 0.0 110.988 -165.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -93.58 107.42 19.28 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 111.546 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.66 -29.91 17.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.491 1.116 . . . . 0.0 113.217 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.82 152.76 50.41 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 119.991 1.269 . . . . 0.0 111.571 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.98 147.94 19.25 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.249 2.633 . . . . 0.0 111.255 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.79 -3.54 44.94 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.6 p -70.16 161.87 29.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.173 1.789 . . . . 0.0 113.01 -171.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 66.5 mt -82.79 138.41 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.849 1.26 . . . . 0.0 110.05 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.5 t -101.65 142.95 32.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.614 0.766 . . . . 0.0 110.395 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -145.61 151.46 38.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 C-N-CA 125.949 1.738 . . . . 0.0 113.045 165.277 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 C--O 1.209 -1.044 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -52.85 -34.9 56.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 122.063 2.21 . . . . 0.0 114.232 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -77.48 -17.28 58.18 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 pt -164.87 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.848 2.459 . . . . 0.0 110.984 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.71 44.5 0.82 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.599 -1.313 . . . . 0.0 114.005 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 69.32 -6.11 1.01 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.515 2.326 . . . . 0.0 114.356 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -51.87 -60.28 3.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.636 1.974 . . . . 0.0 114.0 -173.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.7 mt -134.66 149.48 50.53 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.155 1.382 . . . . 0.0 110.167 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -78.47 163.38 25.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.861 0.864 . . . . 0.0 111.208 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.08 19.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.276 1.43 . . . . 0.0 112.988 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -61.41 -45.88 92.46 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.618 1.567 . . . . 0.0 112.552 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.78 -45.26 83.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.02 -38.78 89.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.785 0.834 . . . . 0.0 112.305 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 -44.83 92.28 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.257 -0.902 . . . . 0.0 111.004 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.53 97.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.146 0.979 . . . . 0.0 113.354 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -72.11 -37.53 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.175 0.898 . . . . 0.0 112.696 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.3 t -61.61 -32.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.231 0.923 . . . . 0.0 112.27 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -41.64 97.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.181 0.992 . . . . 0.0 112.06 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.64 95.38 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.908 -0.495 . . . . 0.0 111.729 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.58 -40.1 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.831 0.852 . . . . 0.0 111.449 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -64.38 -38.53 91.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.778 0.831 . . . . 0.0 112.567 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.43 -31.44 65.48 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 112.952 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.36 -38.85 85.43 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.498 0.719 . . . . 0.0 112.711 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -62.01 -17.48 57.37 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.268 1.033 . . . . 0.0 113.316 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -94.45 3.79 54.69 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.278 -1.514 . . . . 0.0 112.659 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -119.78 -13.51 9.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 114.221 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -155.86 161.79 40.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.766 2.026 . . . . 0.0 109.417 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 p -104.08 26.27 8.97 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 112.823 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.11 148.12 19.52 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 124.497 1.046 . . . . 0.0 111.124 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -103.07 134.84 45.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.72 0.771 . . . . 0.0 112.443 -151.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.97 129.83 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 119.003 -2.311 . . . . 0.0 111.286 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -142.56 152.5 42.66 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.129 1.372 . . . . 0.0 110.931 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -121.12 141.0 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.922 1.689 . . . . 0.0 110.555 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 66' ' ' LEU . 51.3 t60 -127.24 130.99 50.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.636 1.174 . . . . 0.0 112.336 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tp -119.38 120.85 38.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 111.63 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -138.08 156.04 48.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.525 1.13 . . . . 0.0 110.564 171.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.48 -69.7 0.26 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.283 -1.511 . . . . 0.0 113.852 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.3 t -152.75 142.25 21.74 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.896 1.678 . . . . 0.0 109.307 -166.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 p -100.12 144.51 29.06 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -81.79 -26.46 34.38 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 pt -110.62 -177.1 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 110.411 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.36 136.48 57.16 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.65 0.738 . . . . 0.0 112.489 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.03 -32.88 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.853 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -64.11 -49.36 72.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.609 1.095 . . . . 0.0 111.986 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.96 -43.08 88.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.3 1.04 . . . . 0.0 110.398 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -57.04 -48.87 77.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.997 0.519 . . . . 0.0 111.999 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.47 88.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.486 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -61.23 -46.84 88.76 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 111.703 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.72 -44.29 82.02 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.48 -44.48 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 0.0 110.2 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.26 -55.81 30.16 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.813 1.245 . . . . 0.0 111.197 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -68.57 -34.04 75.12 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -67.57 -41.81 83.59 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.431 -0.793 . . . . 0.0 112.325 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.31 0.12 15.33 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.9 0.88 . . . . 0.0 112.873 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 tttt 63.73 31.86 14.03 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.914 1.686 . . . . 0.0 112.295 168.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 66' ' ' LEU . 29.8 mtt -66.7 -33.91 76.68 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.115 -0.99 . . . . 0.0 111.867 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.4 -16.54 9.49 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.171 2.589 . . . . 0.0 114.904 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.04 76.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.723 -1.236 . . . . 0.0 111.293 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -123.3 160.57 26.39 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.234 1.014 . . . . 0.0 110.148 162.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -59.4 -44.78 92.76 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.067 -1.021 . . . . 0.0 112.429 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.68 -8.94 27.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.444 -1.265 . . . . 0.0 113.443 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 68.54 47.61 0.89 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.67 1.588 . . . . 0.0 109.512 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -116.85 25.64 10.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.839 1.256 . . . . 0.0 112.557 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.33 124.76 10.1 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 111.154 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.64 133.6 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 110.234 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.2 tp -114.44 132.46 56.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.872 1.32 . . . . 0.0 111.685 164.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.2 mt -110.27 92.7 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -76.18 120.64 21.74 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.734 0.814 . . . . 0.0 110.516 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -117.07 130.06 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.046 1.338 . . . . 0.0 109.917 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.94 105.47 15.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.408 1.083 . . . . 0.0 110.373 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.43 -19.79 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.81 -47.62 20.96 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.474 1.488 . . . . 0.0 111.157 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -79.98 -15.84 56.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.444 1.097 . . . . 0.0 113.317 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 70.11 33.14 2.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.656 1.582 . . . . 0.0 112.205 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -114.09 167.92 10.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.39 1.476 . . . . 0.0 111.018 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.26 141.67 22.47 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.718 1.207 . . . . 0.0 109.63 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.86 135.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.088 1.355 . . . . 0.0 108.213 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 mt -115.13 130.28 69.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -140.88 149.79 42.39 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.738 0.815 . . . . 0.0 110.113 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.76 158.77 27.82 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.92 170.07 5.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.388 1.566 . . . . 0.0 114.084 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.65 -30.28 70.61 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.585 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.55 -48.0 59.27 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 119.916 1.235 . . . . 0.0 111.612 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.75 -56.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.068 0.934 . . . . 0.0 109.365 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -53.05 -44.7 67.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.982 0.913 . . . . 0.0 112.588 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.86 -8.28 58.68 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.848 1.659 . . . . 0.0 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -23.49 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.87 173.79 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.808 1.64 . . . . 0.0 111.955 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -125.13 171.06 10.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.13 -31.63 63.5 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.12 -31.36 69.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 112.548 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 57.7 t80 -74.3 -33.42 63.2 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.644 0.778 . . . . 0.0 110.558 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -77.04 -23.68 52.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.241 1.816 . . . . 0.0 114.16 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.35 -36.05 81.91 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.711 -1.243 . . . . 0.0 112.163 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.1 m -58.35 -39.71 80.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.363 1.465 . . . . 0.0 111.675 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -60.67 -54.98 38.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.377 1.871 . . . . 0.0 111.381 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -60.29 -45.11 94.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 110.471 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -56.96 -45.13 83.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -47.98 83.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.262 0.937 . . . . 0.0 112.642 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.5 mt -66.02 -48.36 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.798 0.839 . . . . 0.0 110.091 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.36 -42.32 98.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.073 0.949 . . . . 0.0 113.294 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.68 -41.22 96.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.821 0.737 . . . . 0.0 111.489 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -74.19 -37.11 64.02 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.553 0.741 . . . . 0.0 111.765 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.84 -40.26 96.17 Favored 'General case' 0 C--N 1.346 0.444 0 O-C-N 121.428 -0.795 . . . . 0.0 111.81 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.26 -40.35 97.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.169 174.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -65.39 -41.53 93.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.812 0.845 . . . . 0.0 111.493 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.09 6.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.49 1.043 . . . . 0.0 114.439 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -110.4 84.08 1.87 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.414 1.486 . . . . 0.0 111.287 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -64.64 -45.66 85.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -57.33 -51.68 68.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.152 -0.927 . . . . 0.0 111.402 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -56.86 -42.37 79.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.67 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.44 -39.04 97.29 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 119.456 1.025 . . . . 0.0 113.915 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.13 -48.27 30.53 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 110.722 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.15 -57.71 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.781 1.633 . . . . 0.0 110.788 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -61.94 -29.77 70.45 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.579 0.751 . . . . 0.0 111.256 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 -37.31 59.62 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.434 0.54 . . . . 0.0 113.427 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.1 mt -66.53 -44.82 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.601 1.2 . . . . 0.0 110.137 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -59.17 -44.25 92.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.918 0.887 . . . . 0.0 112.253 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -67.95 -30.06 69.26 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.891 -1.13 . . . . 0.0 113.082 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.98 -53.43 26.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 118.814 -0.612 . . . . 0.0 109.786 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.06 -48.31 80.56 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.554 1.073 . . . . 0.0 112.327 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.7 ttm -62.81 -38.85 92.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.373 1.087 . . . . 0.0 112.595 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -74.63 -45.4 45.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.52 0.6 . . . . 0.0 111.436 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt -62.84 -35.42 79.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.492 1.517 . . . . 0.0 111.046 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.06 37.4 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.13 -31.34 61.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.589 1.086 . . . . 0.0 111.603 171.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.52 -37.48 15.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.143 1.377 . . . . 0.0 111.916 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.95 82.34 68.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.552 1.941 . . . . 0.0 110.585 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.92 134.89 30.99 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.422 2.748 . . . . 0.0 111.003 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -63.14 139.03 58.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.244 1.018 . . . . 0.0 112.731 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -116.16 155.53 28.09 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.764 1.625 . . . . 0.0 110.567 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.32 -21.59 66.26 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 119.243 -2.16 . . . . 0.0 112.913 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -101.36 18.2 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.861 1.664 . . . . 0.0 112.892 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.28 153.25 22.95 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.123 0.963 . . . . 0.0 112.739 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.99 106.51 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 121.418 -0.801 . . . . 0.0 112.019 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -54.32 102.96 0.07 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.227 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.83 -24.65 26.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.11 134.22 9.4 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.505 1.122 . . . . 0.0 109.915 -162.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.97 153.59 67.79 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.771 2.314 . . . . 0.0 112.514 -170.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -89.35 3.75 51.16 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.8 p -72.23 159.04 34.75 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.24 137.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.689 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 t -98.26 139.06 34.61 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.258 1.023 . . . . 0.0 109.797 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -140.69 164.69 29.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.612 0.765 . . . . 0.0 110.711 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 CA-C-O 117.991 -1.45 . . . . 0.0 113.725 177.711 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -29.64 67.91 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.532 1.515 . . . . 0.0 113.692 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -135.63 136.78 41.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 109.965 172.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.41 -43.39 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.838 0.744 . . . . 0.0 111.867 -174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.06 -16.76 63.82 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -114.57 79.07 1.22 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.369 1.467 . . . . 0.0 109.159 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 71' ' ' VAL . 41.4 m-85 -56.9 -36.19 69.86 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.91 140.4 45.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.664 1.586 . . . . 0.0 108.334 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -73.23 162.59 29.21 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.607 -0.683 . . . . 0.0 109.85 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.13 41.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.36 -42.9 87.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.484 1.114 . . . . 0.0 111.334 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -71.16 -45.12 64.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.409 1.484 . . . . 0.0 111.345 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.52 -46.03 90.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.224 1.41 . . . . 0.0 111.778 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -56.76 -43.28 80.64 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.368 -0.832 . . . . 0.0 111.834 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.64 89.36 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.764 0.711 . . . . 0.0 112.761 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -75.35 -33.41 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.224 -0.923 . . . . 0.0 112.831 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.07 -37.78 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.665 1.12 . . . . 0.0 111.259 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -63.81 -30.98 72.02 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.211 1.004 . . . . 0.0 112.775 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.76 85.95 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.073 -1.017 . . . . 0.0 111.911 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mm -59.89 -47.71 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.611 0.641 . . . . 0.0 110.003 172.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm105 -59.68 -34.04 72.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.24 -23.93 32.53 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.92 68.4 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.111 0.964 . . . . 0.0 112.734 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CD ' HD21 ' A' ' 140' ' ' ASN . 92.6 mt-10 -56.5 -40.94 75.83 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 110.882 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -73.59 6.06 3.39 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 119.733 -1.854 . . . . 0.0 113.325 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -123.63 -7.98 7.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.382 2.273 . . . . 0.0 114.284 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -163.79 147.25 10.0 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.24 1.382 . . . . 0.0 110.545 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -81.79 12.12 4.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 113.987 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.11 143.74 16.82 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.21 1.386 . . . . 0.0 111.16 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -101.75 139.0 37.98 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.018 0.927 . . . . 0.0 113.074 -164.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.11 138.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.291 1.436 . . . . 0.0 109.573 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -153.39 155.59 36.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.474 1.11 . . . . 0.0 111.0 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.42 139.47 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.921 1.689 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.427 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.9 t60 -122.43 125.86 46.73 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.751 1.221 . . . . 0.0 112.244 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.86 115.15 26.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.888 0.875 . . . . 0.0 110.169 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.26 163.19 29.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.083 1.753 . . . . 0.0 109.812 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.8 mttt -80.35 -72.51 0.41 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.666 -1.271 . . . . 0.0 113.264 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.6 t -148.8 158.27 44.04 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 126.676 1.991 . . . . 0.0 109.292 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -107.03 159.0 16.62 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 126.189 1.796 . . . . 0.0 110.18 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.58 -27.79 18.89 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.738 -1.226 . . . . 0.0 112.148 166.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 mt -100.1 -125.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.329 1.052 . . . . 0.0 108.697 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -115.88 142.55 46.62 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.001 1.72 . . . . 0.0 109.349 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.09 -46.72 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.54 -50.21 74.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.039 0.836 . . . . 0.0 112.441 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -70.03 -39.47 75.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.344 0.658 . . . . 0.0 111.251 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -59.7 -46.55 88.73 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.646 0.778 . . . . 0.0 111.889 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.07 93.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.307 1.043 . . . . 0.0 111.691 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.0 ttp -63.56 -46.16 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 111.606 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.06 -48.81 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.165 0.439 . . . . 0.0 110.929 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.8 -45.39 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.518 1.127 . . . . 0.0 111.553 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -56.29 -53.52 56.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.64 1.176 . . . . 0.0 110.803 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -69.05 -33.73 74.05 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 112.05 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.26 -33.4 75.24 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.238 -1.539 . . . . 0.0 112.453 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.58 -3.18 52.61 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.98 0.912 . . . . 0.0 112.987 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 60.23 34.29 20.98 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.904 1.682 . . . . 0.0 112.697 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.2 mtp -65.02 -18.37 65.24 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -3.94 7.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.492 1.517 . . . . 0.0 113.066 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.79 59.8 2.65 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 111.422 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.1 p -125.93 143.28 51.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.463 1.905 . . . . 0.0 109.142 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -63.09 -48.69 77.54 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.848 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.17 -2.0 57.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.633 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 57.54 37.68 27.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.98 1.263 . . . . 0.0 109.463 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 27.45 9.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.543 1.537 . . . . 0.0 112.0 -172.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.1 124.52 6.78 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 124.098 0.856 . . . . 0.0 112.093 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.3 t -111.55 132.44 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.384 1.073 . . . . 0.0 110.147 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 34' ' ' HIS . 27.1 tp -118.6 123.81 45.92 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.245 1.022 . . . . 0.0 111.455 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.67 96.33 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 125.474 1.509 . . . . 0.0 108.328 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.07 127.7 34.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.644 0.778 . . . . 0.0 111.379 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.36 125.86 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.318 0.647 . . . . 0.0 110.646 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.35 108.02 20.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.661 1.584 . . . . 0.0 110.236 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 37' ' ' LYS . 29.6 m -75.79 -20.71 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -73.67 -64.11 1.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.988 0.813 . . . . 0.0 108.808 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.2 -9.52 58.62 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.8 tttt 65.45 32.57 9.44 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 m -100.76 132.55 46.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.603 1.561 . . . . 0.0 109.207 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.62 139.41 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.534 1.134 . . . . 0.0 108.385 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.58 143.83 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.012 1.325 . . . . 0.0 108.229 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 100' ' ' ILE . 12.3 mt -122.79 135.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -147.64 129.36 15.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.857 1.663 . . . . 0.0 108.604 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.13 172.55 16.62 Favored Glycine 0 C--O 1.236 0.28 0 C-N-CA 125.353 1.454 . . . . 0.0 112.002 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -60.81 166.64 3.24 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.664 1.586 . . . . 0.0 113.551 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -53.08 -34.67 57.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.226 1.41 . . . . 0.0 113.717 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.95 -29.25 69.33 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.968 1.258 . . . . 0.0 114.185 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.65 -56.2 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.17 1.485 . . . . 0.0 108.529 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -51.64 -34.35 37.5 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.522 1.529 . . . . 0.0 113.747 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -78.42 -24.61 46.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.408 1.483 . . . . 0.0 113.081 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.48 -22.85 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.78 159.98 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.495 1.043 . . . . 0.0 112.715 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.7 p -95.01 174.13 7.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.69 -21.74 66.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.926 -1.109 . . . . 0.0 113.535 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.28 -17.91 55.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 48.1 t80 -73.17 -46.18 52.21 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 165.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -65.56 -32.2 73.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.543 1.137 . . . . 0.0 113.492 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.66 -36.85 70.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.969 1.308 . . . . 0.0 112.297 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.2 p -61.21 -45.25 95.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.752 0.821 . . . . 0.0 112.01 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 m -65.34 -45.87 82.5 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.811 1.644 . . . . 0.0 110.961 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.98 -51.42 67.79 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.542 . . . . 0.0 111.187 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -56.61 -48.09 78.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.884 0.766 . . . . 0.0 111.711 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.57 82.93 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.908 -1.12 . . . . 0.0 113.453 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 78' ' ' ILE . 29.1 mt -70.46 -50.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.165 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -55.6 -44.27 76.81 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.282 1.033 . . . . 0.0 112.559 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.91 -34.02 74.03 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.01 -38.84 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.721 1.208 . . . . 0.0 111.251 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.98 -38.59 82.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.473 -0.767 . . . . 0.0 111.174 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.13 -27.08 67.77 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.272 1.429 . . . . 0.0 113.419 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.2 -20.98 39.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.935 0.894 . . . . 0.0 111.736 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.07 7.03 44.68 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.219 1.39 . . . . 0.0 114.549 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.08 97.81 7.54 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.805 1.303 . . . . 0.0 111.586 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -72.5 -37.05 68.5 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.604 -0.685 . . . . 0.0 110.898 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -57.73 -57.91 10.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.336 -0.852 . . . . 0.0 111.381 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.6 -41.1 94.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.268 0.627 . . . . 0.0 111.396 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.81 98.32 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 118.598 0.635 . . . . 0.0 113.469 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.41 -50.44 59.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.149 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.1 t -59.11 -48.31 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.0 0.818 . . . . 0.0 111.743 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.6 -29.84 66.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.286 0.493 . . . . 0.0 112.268 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.2 -34.48 64.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 118.722 0.692 . . . . 0.0 112.522 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.31 -52.59 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.454 1.102 . . . . 0.0 110.828 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.36 -42.33 91.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.597 1.09 . . . . 0.0 111.04 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.69 -46.58 89.08 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.177 -0.952 . . . . 0.0 112.116 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.01 96.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.426 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.77 -44.63 97.19 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.172 0.897 . . . . 0.0 112.425 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.1 mtp -65.02 -35.97 82.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.831 0.816 . . . . 0.0 113.112 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.411 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.87 -44.39 61.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.972 0.509 . . . . 0.0 111.644 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.55 -38.12 88.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 0.0 111.925 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.16 -24.81 43.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -73.08 -31.4 64.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.625 -1.297 . . . . 0.0 112.502 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -83.36 -38.01 22.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.88 1.272 . . . . 0.0 111.95 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -130.64 90.8 39.41 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.543 1.537 . . . . 0.0 109.178 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 139.82 50.85 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.478 2.119 . . . . 0.0 110.173 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -64.95 149.13 50.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.597 0.713 . . . . 0.0 112.698 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.03 145.89 50.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.122 1.369 . . . . 0.0 110.427 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -62.51 -20.68 64.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.8 0.18 54.67 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.564 1.946 . . . . 0.0 112.629 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -50.36 151.99 1.98 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.358 2.263 . . . . 0.0 115.735 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.28 112.12 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.328 1.051 . . . . 0.0 112.389 -163.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -94.05 105.31 17.32 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.393 1.477 . . . . 0.0 108.661 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -116.21 5.33 13.68 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.59 152.56 46.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 120.326 1.421 . . . . 0.0 113.58 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.26 137.73 13.61 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 110.262 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.404 HD21 ' CD ' ' A' ' 24' ' ' GLU . 2.3 m-80 -85.23 0.23 52.53 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.1 p -71.73 153.52 41.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.264 1.425 . . . . 0.0 111.106 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.5 mt -72.25 139.38 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.566 0.747 . . . . 0.0 109.109 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.4 t -101.17 139.1 37.32 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.824 -1.172 . . . . 0.0 110.533 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -136.43 151.02 49.04 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 112.204 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.455 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.217 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mmm . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -61.07 -32.5 72.14 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.75 119.89 39.29 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.997 -1.064 . . . . 0.0 111.233 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.2 mt -57.66 -25.28 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.58 1.152 . . . . 0.0 112.454 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -49.97 -34.43 20.88 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.342 1.857 . . . . 0.0 114.046 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.06 120.8 5.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.257 1.023 . . . . 0.0 108.356 -166.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.87 -58.36 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.832 0.853 . . . . 0.0 111.893 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -94.26 177.35 5.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.37 1.468 . . . . 0.0 110.221 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -101.05 162.22 13.05 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.573 -1.329 . . . . 0.0 109.98 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.83 -18.13 58.88 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.33 -48.15 57.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.225 1.375 . . . . 0.0 110.531 166.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.74 -40.82 92.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.144 0.978 . . . . 0.0 111.471 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -70.04 -42.95 72.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.357 1.063 . . . . 0.0 112.402 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.64 -45.42 85.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.503 -0.748 . . . . 0.0 111.817 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -59.84 -43.17 94.75 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.35 -0.844 . . . . 0.0 113.095 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.78 -49.33 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.427 1.091 . . . . 0.0 110.25 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.36 -48.2 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.527 1.131 . . . . 0.0 111.846 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.62 -27.75 66.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.04 -32.57 67.25 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.134 -0.978 . . . . 0.0 112.487 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.49 -52.82 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.353 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -51.76 -23.96 5.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -89.95 -25.22 21.03 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.176 1.39 . . . . 0.0 113.019 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.11 74.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.522 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -63.61 -20.37 65.61 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.762 0.71 . . . . 0.0 112.736 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -83.86 3.97 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 119.641 -1.912 . . . . 0.0 113.136 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -129.97 -5.72 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.281 1.432 . . . . 0.0 113.427 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -162.55 155.54 19.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.565 1.546 . . . . 0.0 109.339 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -79.87 7.02 9.6 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.239 1.016 . . . . 0.0 113.722 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.9 152.85 20.2 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -111.17 129.55 55.91 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.497 1.119 . . . . 0.0 110.572 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.74 128.73 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.394 -0.816 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -141.3 160.36 40.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.484 1.114 . . . . 0.0 111.903 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.7 t -132.45 136.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.3 1.44 . . . . 0.0 109.216 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.506 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.3 t60 -119.55 119.4 33.69 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.816 1.246 . . . . 0.0 112.593 172.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.47 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.9 tp -100.88 130.8 46.95 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.97 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.26 165.14 34.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.152 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -80.85 -67.37 0.78 Allowed 'General case' 0 C--O 1.24 0.564 0 O-C-N 120.24 -1.537 . . . . 0.0 112.335 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 142.42 24.94 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.545 1.538 . . . . 0.0 110.125 -167.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -92.6 133.02 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.375 0.67 . . . . 0.0 111.961 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.68 -28.07 60.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 112.63 171.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -118.01 -164.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.432 1.893 . . . . 0.0 109.66 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.27 137.11 48.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.808 -1.183 . . . . 0.0 112.647 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.45 -37.79 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.433 0.693 . . . . 0.0 111.905 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -64.06 -48.98 74.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.324 0.65 . . . . 0.0 111.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.94 -37.01 81.09 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 112.098 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -62.75 -47.19 84.61 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.439 0.563 . . . . 0.0 111.24 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.17 96.33 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.727 0.811 . . . . 0.0 110.824 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.2 ttp -60.96 -47.49 86.18 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.509 0.723 . . . . 0.0 112.568 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.1 -37.93 81.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.315 0.961 . . . . 0.0 111.944 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.07 -41.46 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.856 0.753 . . . . 0.0 111.819 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.7 -47.78 83.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.465 1.106 . . . . 0.0 111.882 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -75.45 -34.72 60.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.594 0.757 . . . . 0.0 112.288 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -61.65 -41.91 98.17 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.466 1.107 . . . . 0.0 112.03 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.42 -0.67 20.78 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.359 -0.838 . . . . 0.0 112.938 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 59.67 33.51 21.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.317 1.447 . . . . 0.0 112.352 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.8 mtp -71.21 -23.35 62.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.483 1.113 . . . . 0.0 112.853 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -67.7 -16.3 64.07 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.353 1.861 . . . . 0.0 113.598 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.44 72.61 8.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.045 1.338 . . . . 0.0 111.291 172.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.0 m -135.85 135.67 39.96 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.243 1.817 . . . . 0.0 107.803 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -49.09 -49.94 39.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -93.07 0.57 57.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.258 1.023 . . . . 0.0 113.749 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 61.65 43.95 9.39 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.777 1.231 . . . . 0.0 111.041 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -121.03 47.37 1.84 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.493 1.517 . . . . 0.0 112.347 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 131.6 10.8 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.929 0.776 . . . . 0.0 112.749 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.35 139.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 118.221 1.01 . . . . 0.0 111.605 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.1 tp -125.93 120.81 31.37 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.457 1.503 . . . . 0.0 111.085 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -96.76 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.812 0.845 . . . . 0.0 109.796 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -78.06 119.92 22.17 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.696 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.38 130.71 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.744 0.818 . . . . 0.0 110.159 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.24 94.75 5.68 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.389 1.476 . . . . 0.0 110.231 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 35' ' ' LEU . 20.1 m -70.5 -15.81 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -170.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -83.01 -34.23 26.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.825 0.85 . . . . 0.0 111.176 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -97.44 -15.63 20.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.99 1.316 . . . . 0.0 113.833 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.5 tttt 71.98 21.91 3.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.134 2.174 . . . . 0.0 112.43 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.8 p -99.94 163.59 12.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.193 -0.942 . . . . 0.0 111.48 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.21 145.61 35.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.137 1.375 . . . . 0.0 108.863 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -137.68 136.12 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 125.748 1.619 . . . . 0.0 107.54 175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 mt -111.56 126.06 68.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -121.85 150.56 41.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.298 1.439 . . . . 0.0 109.702 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.78 149.65 21.69 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -65.32 160.86 20.79 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 123.249 1.499 . . . . 0.0 112.156 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -53.46 -35.89 61.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.233 1.813 . . . . 0.0 113.334 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.51 76.83 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.344 -1.253 . . . . 0.0 114.083 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.35 -54.4 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.916 1.858 . . . . 0.0 108.731 167.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -52.87 -35.41 57.69 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.22 -16.14 56.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.922 1.289 . . . . 0.0 113.171 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 m -111.51 -29.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 119.555 1.071 . . . . 0.0 113.84 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.79 163.08 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.032 0.833 . . . . 0.0 111.287 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.1 m -119.42 169.58 9.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.318 1.447 . . . . 0.0 111.736 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -56.82 -32.59 65.89 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.237 1.38 . . . . 0.0 113.681 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.55 -21.05 66.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.554 1.142 . . . . 0.0 113.297 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -79.01 -41.91 27.83 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.476 -0.765 . . . . 0.0 110.462 171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -69.47 -30.35 68.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.74 -36.17 69.44 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.183 0.593 . . . . 0.0 112.548 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -62.13 -44.76 95.92 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.915 0.779 . . . . 0.0 111.289 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -61.73 -47.63 84.39 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.136 1.775 . . . . 0.0 110.896 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.82 -43.7 98.31 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.369 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -65.18 -42.98 93.13 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.754 1.161 . . . . 0.0 112.45 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.88 78.28 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.718 1.145 . . . . 0.0 112.34 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.49 -51.38 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.822 0.449 . . . . 0.0 111.031 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.02 -44.74 96.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.935 1.294 . . . . 0.0 113.341 -174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.21 -38.47 91.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.631 0.772 . . . . 0.0 111.573 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.11 -38.46 36.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.067 0.947 . . . . 0.0 111.352 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -59.29 -40.05 84.92 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.333 -0.854 . . . . 0.0 111.637 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.67 -25.46 68.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.183 0.993 . . . . 0.0 113.267 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -87.41 -25.48 23.78 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.822 1.249 . . . . 0.0 111.797 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 10.55 40.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.301 1.429 . . . . 0.0 113.58 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.58 59.05 0.8 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.431 1.493 . . . . 0.0 110.83 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -49.46 -44.82 46.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 114.047 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 49.9 tttm -52.19 -51.43 58.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 124.584 1.154 . . . . 0.0 112.592 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -68.87 -33.86 74.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.76 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.54 -42.79 97.29 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-N 119.035 0.834 . . . . 0.0 112.75 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.86 -51.63 57.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.225 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.32 -47.38 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.089 0.956 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.73 -40.98 92.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.87 -39.39 75.59 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.856 -0.528 . . . . 0.0 112.312 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.05 -39.08 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.671 1.188 . . . . 0.0 110.648 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.74 -51.07 66.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.193 0.997 . . . . 0.0 112.363 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.44 -40.04 96.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.532 -0.73 . . . . 0.0 112.053 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -50.88 72.01 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.652 172.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.46 -49.18 75.29 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.076 0.853 . . . . 0.0 112.585 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.0 mtp -60.99 -35.72 77.56 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.929 0.864 . . . . 0.0 112.898 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -80.13 -39.56 29.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.193 0.997 . . . . 0.0 111.868 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.6 mt -62.18 -36.0 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.83 -17.52 36.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.338 1.455 . . . . 0.0 114.449 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.01 -38.48 64.08 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.062 -1.024 . . . . 0.0 112.223 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -80.98 -49.81 10.48 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 124.486 1.114 . . . . 0.0 111.68 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -123.96 91.59 49.44 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.409 1.483 . . . . 0.0 109.682 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.41 148.94 68.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.877 2.385 . . . . 0.0 110.828 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -70.75 127.63 33.31 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.813 -0.554 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -100.35 155.89 17.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.203 1.801 . . . . 0.0 109.596 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.28 -24.46 63.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 119.866 -1.771 . . . . 0.0 112.768 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -98.33 16.5 21.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.865 2.066 . . . . 0.0 113.18 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.02 163.0 5.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.682 1.23 . . . . 0.0 112.065 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.51 163.44 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.539 1.536 . . . . 0.0 110.903 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.8 107.6 10.02 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -92.32 -31.14 15.48 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.661 0.785 . . . . 0.0 111.627 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.51 151.71 45.48 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.084 0.954 . . . . 0.0 110.592 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -82.0 144.46 13.49 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.246 1.964 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.87 31.76 0.26 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.395 1.878 . . . . 0.0 111.726 -172.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 t -97.08 164.0 12.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.774 1.629 . . . . 0.0 111.285 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.29 131.22 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -93.17 144.61 25.12 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.781 0.832 . . . . 0.0 109.633 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -142.29 135.99 29.3 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.511 -0.743 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.564 0 CA-C-O 115.983 -2.565 . . . . 0.0 113.963 173.835 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.66 -29.82 70.82 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 121.01 1.732 . . . . 0.0 113.801 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -127.55 132.81 49.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.583 1.553 . . . . 0.0 110.641 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.2 mt -134.44 135.28 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.367 1.867 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.89 59.93 0.75 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.121 1.368 . . . . 0.0 110.047 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.58 21.92 10.62 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.229 1.012 . . . . 0.0 113.189 167.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -85.94 -85.05 0.16 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.347 1.459 . . . . 0.0 111.059 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 mt -128.88 142.85 50.82 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.727 1.611 . . . . 0.0 108.386 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -73.6 169.43 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.339 0.656 . . . . 0.0 111.059 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.56 -42.57 64.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.107 -0.996 . . . . 0.0 113.66 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.4 -31.27 63.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.263 0.625 . . . . 0.0 112.264 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.57 -43.93 65.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.323 -0.861 . . . . 0.0 110.943 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -63.48 -31.07 72.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.979 1.312 . . . . 0.0 112.004 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.59 -46.33 59.6 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.533 -1.355 . . . . 0.0 111.279 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.6 96.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.438 1.095 . . . . 0.0 112.701 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.65 -39.86 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.394 0.997 . . . . 0.0 113.17 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.76 -34.31 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.578 0.626 . . . . 0.0 111.26 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.88 -28.9 67.11 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.55 71.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.234 0.47 . . . . 0.0 111.761 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.65 -46.54 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.67 0.788 . . . . 0.0 109.681 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.57 -43.28 93.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.836 1.255 . . . . 0.0 112.439 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.62 -37.66 85.31 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.182 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.97 93.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.09 0.556 . . . . 0.0 112.022 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.22 -18.99 61.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.735 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -98.39 11.14 39.05 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.232 -1.542 . . . . 0.0 112.737 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -121.97 -16.15 7.63 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.024 1.729 . . . . 0.0 113.752 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.3 t -163.65 154.54 16.13 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.88 1.672 . . . . 0.0 109.682 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.0 m -78.38 1.65 21.31 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.82 154.78 27.14 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 124.999 1.285 . . . . 0.0 111.51 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -131.74 123.78 28.38 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -163.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.1 mt -115.63 101.08 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 120.837 -1.164 . . . . 0.0 111.812 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -97.34 156.2 16.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.33 1.452 . . . . 0.0 111.66 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 140.98 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.34 1.456 . . . . 0.0 110.876 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.435 ' HB2' HD11 ' A' ' 66' ' ' LEU . 41.9 t60 -125.81 132.38 52.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 112.324 171.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -118.2 132.94 56.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.401 1.08 . . . . 0.0 111.289 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -153.23 160.49 42.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.573 1.549 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.57 -80.54 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.728 -1.233 . . . . 0.0 112.231 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -140.86 154.01 45.99 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.577 1.551 . . . . 0.0 111.205 -176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -98.83 142.98 29.66 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -79.16 -15.37 58.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.267 1.427 . . . . 0.0 112.984 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 pt -136.32 -171.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 128.687 2.795 . . . . 0.0 109.134 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -62.63 140.32 58.67 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.41 -34.53 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.93 -51.62 66.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.341 0.656 . . . . 0.0 111.497 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -66.51 -37.62 85.44 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.612 -0.68 . . . . 0.0 111.258 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -59.41 -49.59 77.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.985 -1.072 . . . . 0.0 111.638 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.79 96.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.474 0.71 . . . . 0.0 111.212 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.28 -41.58 89.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.144 0.978 . . . . 0.0 112.691 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.99 -33.67 59.74 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.161 -0.962 . . . . 0.0 112.72 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.33 -43.2 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.728 1.149 . . . . 0.0 110.931 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.36 -47.07 82.59 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.787 1.235 . . . . 0.0 110.849 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -76.12 -35.21 59.38 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.302 1.041 . . . . 0.0 112.404 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -62.39 -41.09 98.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.315 1.046 . . . . 0.0 111.459 172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.75 -2.2 25.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.091 1.356 . . . . 0.0 113.669 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 55.82 38.84 30.53 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.343 1.457 . . . . 0.0 112.851 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.73 -18.33 64.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.31 -3.66 0.99 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.623 1.969 . . . . 0.0 115.148 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -73.28 5.84 3.29 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.118 1.767 . . . . 0.0 115.347 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.1 p -83.18 156.46 23.2 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.45 -40.1 70.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.677 0.791 . . . . 0.0 112.637 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.81 -13.39 33.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.511 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 69.26 58.39 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.105 1.362 . . . . 0.0 108.657 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -145.66 33.92 1.04 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.746 1.218 . . . . 0.0 113.121 -162.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.01 147.57 23.82 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.684 1.135 . . . . 0.0 110.407 166.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.23 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.722 1.609 . . . . 0.0 108.809 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 34' ' ' HIS . 26.3 tp -125.5 118.93 26.85 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.834 1.254 . . . . 0.0 111.122 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -90.22 97.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -78.88 125.08 28.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.157 -0.964 . . . . 0.0 110.187 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -121.75 127.24 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.247 1.019 . . . . 0.0 111.28 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.54 95.98 8.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.555 1.542 . . . . 0.0 109.866 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.16 -19.55 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -76.99 -41.36 43.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.166 0.587 . . . . 0.0 112.156 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.36 -27.81 24.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.301 1.441 . . . . 0.0 111.331 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 88.42 14.76 0.07 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.24 2.616 . . . . 0.0 111.383 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -97.78 157.64 15.96 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.063 -1.023 . . . . 0.0 111.059 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -134.78 149.58 50.42 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.453 1.101 . . . . 0.0 109.389 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.11 139.98 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 108.101 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 50.3 mt -108.9 129.08 64.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -141.17 138.55 33.47 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.835 0.743 . . . . 0.0 110.553 172.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.7 159.18 24.11 Favored Glycine 0 C--O 1.24 0.517 0 C-N-CA 124.722 1.153 . . . . 0.0 110.314 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.45 161.93 21.68 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 123.194 1.474 . . . . 0.0 114.629 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.38 -31.49 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.375 1.47 . . . . 0.0 114.119 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.08 -31.43 57.67 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 119.552 1.069 . . . . 0.0 113.641 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.29 -57.25 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.554 1.177 . . . . 0.0 109.231 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -55.37 -38.08 68.36 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.031 0.932 . . . . 0.0 113.133 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.66 -11.75 60.76 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -114.0 -30.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -105.25 147.86 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.02 1.282 . . . . 0.0 112.446 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -92.22 171.75 8.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.547 1.139 . . . . 0.0 112.888 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -52.45 -38.6 59.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.387 1.875 . . . . 0.0 115.181 165.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.51 -28.15 67.59 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.804 -1.185 . . . . 0.0 112.895 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.426 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.5 t80 -73.03 -30.08 63.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.909 0.484 . . . . 0.0 110.953 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 8.4 m95 -80.31 -29.46 38.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.515 1.126 . . . . 0.0 113.502 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.41 -42.82 70.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.43 1.492 . . . . 0.0 113.085 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.0 p -59.0 -37.24 76.42 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.9 0.88 . . . . 0.0 112.281 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -54.99 40.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 0.0 110.834 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -57.35 -48.33 79.29 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 124.21 1.004 . . . . 0.0 110.112 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.1 -36.78 84.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.72 73.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.049 0.84 . . . . 0.0 112.308 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.25 -53.93 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.858 0.863 . . . . 0.0 109.89 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.17 1.788 . . . . 0.0 112.804 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.23 -51.64 62.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.55 1.068 . . . . 0.0 111.183 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.94 -35.32 62.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 119.047 -0.502 . . . . 0.0 110.806 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -58.8 -45.94 88.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.048 0.84 . . . . 0.0 110.448 171.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -58.8 -41.79 87.59 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.944 0.793 . . . . 0.0 111.699 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.28 -12.76 61.55 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.03 1.75 67.01 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.019 1.771 . . . . 0.0 114.559 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.99 75.03 1.64 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.477 1.511 . . . . 0.0 111.855 -174.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -51.85 -43.86 63.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.191 1.396 . . . . 0.0 112.909 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -54.34 -57.59 10.66 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.27 0.628 . . . . 0.0 111.517 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -62.23 -34.31 76.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.628 1.171 . . . . 0.0 111.585 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.72 83.22 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 118.585 0.63 . . . . 0.0 113.382 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.93 -48.79 64.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.333 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.77 -51.52 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.091 0.956 . . . . 0.0 111.115 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.33 -25.35 63.26 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.155 -0.965 . . . . 0.0 113.054 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.35 -41.68 84.82 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.391 171.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.71 -53.03 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.982 1.313 . . . . 0.0 110.229 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -55.76 -48.4 75.34 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.936 0.895 . . . . 0.0 113.36 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -70.92 -36.61 72.73 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.953 -0.467 . . . . 0.0 111.447 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.53 99.11 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.565 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.9 -48.17 86.94 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-N 119.429 1.013 . . . . 0.0 111.773 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 50.9 ttp -56.23 -48.76 75.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.226 1.013 . . . . 0.0 111.674 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -70.8 -42.83 69.8 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.104 0.562 . . . . 0.0 111.839 -172.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.87 -33.62 76.26 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.323 1.449 . . . . 0.0 111.336 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.04 -16.77 60.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.42 -45.81 75.03 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.557 -1.339 . . . . 0.0 110.823 168.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -76.19 -47.3 24.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.329 1.452 . . . . 0.0 111.538 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -127.87 85.2 61.25 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 109.864 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.49 151.29 80.11 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.874 2.383 . . . . 0.0 111.11 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -62.95 149.95 43.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -132.07 152.03 51.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.38 -30.02 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.243 . . . . 0.0 113.722 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.2 18.6 13.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.575 1.15 . . . . 0.0 112.702 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.11 146.55 27.29 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.976 0.893 . . . . 0.0 112.247 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.1 176.12 2.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 124.899 1.28 . . . . 0.0 111.241 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.1 114.59 9.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -105.36 -27.54 11.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.809 1.644 . . . . 0.0 111.778 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.6 mt -114.5 143.95 30.87 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.28 148.54 61.92 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.757 2.971 . . . . 0.0 112.852 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -78.35 -4.28 47.31 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.594 1.557 . . . . 0.0 114.354 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 p -76.38 155.88 33.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.791 -1.193 . . . . 0.0 112.18 -170.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.3 mt -79.69 128.4 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.95 0.9 . . . . 0.0 109.578 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 t -89.87 145.12 25.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.986 0.514 . . . . 0.0 111.684 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.63 147.35 31.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 111.351 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 C-N-CA 125.899 1.714 . . . . 0.0 116.191 -176.8 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -166.69 150.06 6.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.109 0.868 . . . . 0.0 110.923 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 5' ' ' GLU . 56.6 tttt -84.25 113.26 20.98 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.135 -0.978 . . . . 0.0 111.409 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.03 -39.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.583 -0.698 . . . . 0.0 111.823 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 36.2 mt-10 -77.39 53.87 1.08 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.906 2.082 . . . . 0.0 111.399 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -94.34 -41.62 9.33 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.856 -1.152 . . . . 0.0 111.338 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -61.33 -34.48 75.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 113.018 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt -132.54 154.66 49.76 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.081 1.752 . . . . 0.0 109.512 -172.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.35 155.98 19.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.878 0.471 . . . . 0.0 110.545 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.95 -29.04 26.47 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -74.41 -35.32 63.41 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -73.17 -48.08 38.31 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.643 1.577 . . . . 0.0 109.938 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.44 -45.64 92.14 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.796 1.638 . . . . 0.0 111.241 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.79 -33.91 73.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.566 -1.334 . . . . 0.0 112.794 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -44.13 67.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -67.86 -39.34 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.136 0.88 . . . . 0.0 111.974 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.46 -39.13 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 121.65 -0.656 . . . . 0.0 111.955 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.8 -27.49 63.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.02 87.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.016 0.825 . . . . 0.0 111.776 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.18 -47.87 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.193 0.597 . . . . 0.0 111.19 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -60.28 -30.76 69.67 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.26 -35.86 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.72 -1.238 . . . . 0.0 111.141 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.75 98.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.38 1.072 . . . . 0.0 112.336 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -57.05 -29.77 63.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.222 1.409 . . . . 0.0 112.12 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -88.31 3.23 50.45 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.042 -1.662 . . . . 0.0 112.326 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.63 -15.64 7.45 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.376 1.871 . . . . 0.0 113.682 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 29' ' ' GLY . 6.7 t -154.24 160.16 41.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.547 1.939 . . . . 0.0 109.82 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 p -92.11 23.04 3.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.53 ' H ' HG23 ' A' ' 27' ' ' THR . . . -125.61 153.66 18.32 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 126.385 1.945 . . . . 0.0 112.187 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -106.0 137.26 44.22 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -166.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.8 128.69 75.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -135.37 142.37 45.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.635 0.774 . . . . 0.0 111.541 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 81.2 t -107.82 135.28 47.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.694 1.197 . . . . 0.0 109.465 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' HB2' HD11 ' A' ' 66' ' ' LEU . 68.6 t60 -115.99 138.51 51.14 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.705 1.202 . . . . 0.0 112.326 166.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.9 tp -126.11 129.44 49.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.518 1.127 . . . . 0.0 111.822 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -158.88 156.62 29.91 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.521 1.528 . . . . 0.0 109.312 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -79.83 -70.61 0.5 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 121.034 -1.041 . . . . 0.0 112.464 -173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 t -144.04 152.05 40.49 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 111.552 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -104.48 137.18 42.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.267 1.427 . . . . 0.0 111.524 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.87 -14.57 57.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 112.977 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.81 -152.64 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.589 1.955 . . . . 0.0 110.171 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.46 134.71 36.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 112.349 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -39.73 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.271 -0.893 . . . . 0.0 112.151 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.12 -43.47 82.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.551 1.069 . . . . 0.0 111.527 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.62 -43.04 98.02 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.679 -0.638 . . . . 0.0 111.88 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -58.43 -45.45 88.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.784 0.72 . . . . 0.0 111.669 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.4 87.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 117.442 -1.266 . . . . 0.0 111.405 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 51.1 ttp -60.29 -50.01 75.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.175 1.352 . . . . 0.0 111.077 170.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.495 0.588 . . . . 0.0 111.724 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.5 t -63.68 -45.31 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.397 1.079 . . . . 0.0 111.703 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.26 -48.82 80.1 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.632 0.773 . . . . 0.0 111.068 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -70.28 -39.67 74.76 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.139 0.976 . . . . 0.0 111.619 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -61.65 -42.96 99.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.412 1.485 . . . . 0.0 112.926 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.93 -2.83 10.7 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.479 -0.763 . . . . 0.0 112.882 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.81 37.49 18.66 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.797 1.639 . . . . 0.0 111.713 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.6 mtp -74.48 -17.96 60.69 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.48 -4.87 9.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 170.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.03 52.16 0.7 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.531 1.532 . . . . 0.0 113.38 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 p -135.3 149.63 49.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.147 0.979 . . . . 0.0 112.05 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -67.4 -25.58 66.02 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.17 -1.81 13.57 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.139 1.376 . . . . 0.0 113.4 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 56.22 54.88 7.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.089 1.356 . . . . 0.0 111.112 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -133.09 41.99 3.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.526 0.731 . . . . 0.0 112.699 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.48 147.51 18.66 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.756 1.17 . . . . 0.0 111.552 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.77 138.84 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.531 1.133 . . . . 0.0 110.354 172.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.5 tp -115.06 128.52 56.29 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.79 1.236 . . . . 0.0 110.14 165.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -101.95 93.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 124.132 0.973 . . . . 0.0 109.005 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -75.52 123.42 25.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.034 0.934 . . . . 0.0 109.912 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.11 122.43 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.67 1.188 . . . . 0.0 110.731 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.07 89.22 5.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.901 1.28 . . . . 0.0 109.621 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.51 -16.49 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -75.24 -35.17 61.45 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.439 -0.788 . . . . 0.0 112.274 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -95.77 -8.01 35.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.095 1.358 . . . . 0.0 112.54 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.3 tttt 70.17 24.75 4.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.658 1.983 . . . . 0.0 112.722 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 p -108.93 167.96 9.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.086 1.354 . . . . 0.0 112.519 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.81 147.39 31.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 110.585 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.3 149.28 24.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.544 1.937 . . . . 0.0 108.166 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.85 127.02 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -136.92 129.73 30.57 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.429 0.691 . . . . 0.0 110.235 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.27 15.19 Favored Glycine 0 CA--C 1.513 -0.078 0 C-N-CA 124.825 1.202 . . . . 0.0 112.065 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -69.9 161.35 30.1 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.384 1.087 . . . . 0.0 113.378 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -52.14 -38.31 57.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.604 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.72 -11.6 69.35 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.009 -1.44 . . . . 0.0 115.047 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 93.3 mt -89.02 -57.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.483 1.641 . . . . 0.0 108.752 160.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -55.58 -33.76 64.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.87 -15.57 58.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.099 1.76 . . . . 0.0 113.639 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.86 -28.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.39 168.63 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.655 1.116 . . . . 0.0 112.673 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.9 p -114.85 177.75 4.53 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.912 1.285 . . . . 0.0 112.681 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -63.16 -26.8 68.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.656 -1.278 . . . . 0.0 113.574 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.75 -34.92 79.47 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.996 1.319 . . . . 0.0 111.701 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.1 t80 -71.09 -30.59 66.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.987 174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -82.33 -31.87 29.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 0.0 112.666 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.39 -41.46 84.92 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.001 0.92 . . . . 0.0 111.689 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -60.83 -33.92 73.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.766 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 m -64.53 -52.13 59.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.673 0.789 . . . . 0.0 110.083 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.5 -45.99 91.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.407 0.683 . . . . 0.0 111.207 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.81 -41.93 96.65 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.11 -50.83 68.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.999 0.428 . . . . 0.0 112.085 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.48 -49.19 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.449 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -57.93 -42.71 85.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.099 1.36 . . . . 0.0 112.608 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.49 -53.29 57.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 111.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.92 -31.1 66.02 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 122.161 -0.337 . . . . 0.0 111.695 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -67.82 -39.98 83.88 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.737 0.699 . . . . 0.0 112.288 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.27 -34.22 77.19 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.159 0.984 . . . . 0.0 111.855 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -71.35 -31.08 66.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.994 0.918 . . . . 0.0 112.316 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 7.53 30.78 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.266 1.412 . . . . 0.0 114.593 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -101.87 72.59 1.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.803 1.641 . . . . 0.0 110.897 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -51.17 -46.52 62.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.84 1.256 . . . . 0.0 113.082 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -46.76 -60.25 2.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -65.8 -35.91 82.03 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.984 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.43 75.21 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 120.04 1.291 . . . . 0.0 113.327 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.03 -51.63 52.42 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.455 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.11 -51.63 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.717 0.807 . . . . 0.0 111.5 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.93 -34.18 77.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.307 0.958 . . . . 0.0 111.768 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -42.24 95.04 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.303 0.954 . . . . 0.0 112.16 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.25 -44.26 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.608 1.563 . . . . 0.0 111.348 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.12 -42.13 94.13 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.845 0.831 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -71.39 -39.79 70.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 120.642 -1.286 . . . . 0.0 112.049 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.99 90.4 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.359 0.664 . . . . 0.0 110.409 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.85 39.1 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.846 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.9 mmm -64.04 -26.36 68.52 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.26 -52.21 11.41 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.781 170.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -58.23 -37.39 74.76 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 112.296 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.7 62.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.447 1.499 . . . . 0.0 113.312 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -67.53 -29.07 68.37 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.105 -0.997 . . . . 0.0 112.52 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.43 -32.62 11.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.112 1.365 . . . . 0.0 112.161 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.79 79.11 75.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.132 1.773 . . . . 0.0 110.053 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.11 136.01 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.259 1.972 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -63.44 139.66 58.79 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.309 1.043 . . . . 0.0 112.896 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -113.37 156.05 24.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.683 1.23 . . . . 0.0 112.911 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.49 -14.77 58.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.81 -1.806 . . . . 0.0 114.267 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -121.43 35.64 4.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.166 1.786 . . . . 0.0 110.571 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 151.24 26.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.538 -0.726 . . . . 0.0 112.887 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.16 105.44 10.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 124.341 1.056 . . . . 0.0 111.752 -166.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.25 111.24 10.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.82 -32.7 12.55 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 126.608 1.963 . . . . 0.0 111.466 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.27 163.0 18.76 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 123.827 0.851 . . . . 0.0 111.42 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.52 154.28 7.75 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.273 2.648 . . . . 0.0 110.415 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -2.64 12.38 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.0 m -78.18 124.45 28.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.831 1.252 . . . . 0.0 110.763 -163.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.81 128.47 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.703 1.201 . . . . 0.0 108.905 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.8 t -87.22 135.43 33.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.55 139.35 42.13 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.903 -1.123 . . . . 0.0 109.998 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 CA-C-O 117.135 -1.925 . . . . 0.0 110.947 170.914 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 mtm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.623 -1.18 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -51.1 -39.03 55.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 121.844 2.111 . . . . 0.0 114.433 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -59.43 -24.74 63.75 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.8 pt -112.74 -3.64 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 126.374 1.87 . . . . 0.0 113.05 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -72.14 -54.48 9.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 109.897 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -102.28 113.79 27.39 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.01 -34.23 74.51 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.987 -0.446 . . . . 0.0 111.628 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.478 HD13 ' CD ' ' A' ' 110' ' ' LYS . 23.0 mt -143.36 138.85 29.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.509 2.324 . . . . 0.0 109.184 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -73.57 143.04 46.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.087 0.955 . . . . 0.0 110.673 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.09 -29.26 3.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.17 -46.81 79.21 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.067 0.947 . . . . 0.0 112.754 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.26 -31.68 58.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.231 1.012 . . . . 0.0 111.17 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 37.3 mt-10 -70.89 -38.16 73.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.865 0.866 . . . . 0.0 111.558 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.23 -41.59 99.13 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.493 -1.379 . . . . 0.0 111.628 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.09 98.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.616 0.767 . . . . 0.0 112.833 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.28 -38.25 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 120.979 -1.076 . . . . 0.0 112.167 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.55 -40.17 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.546 0.612 . . . . 0.0 110.845 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.68 -32.99 73.21 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.92 65.54 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -72.28 -46.49 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.41 1.084 . . . . 0.0 110.521 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -56.28 -30.67 62.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.024 0.93 . . . . 0.0 112.967 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.06 -28.17 60.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 113.548 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.86 62.37 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.101 0.96 . . . . 0.0 111.936 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.55 -7.88 23.08 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.733 1.254 . . . . 0.0 113.27 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -95.16 3.08 55.07 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.428 -2.045 . . . . 0.0 112.944 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -125.49 -17.66 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.941 2.097 . . . . 0.0 114.053 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 t -151.41 151.75 32.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.85 1.66 . . . . 0.0 108.927 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -90.84 49.72 1.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.179 0.991 . . . . 0.0 110.859 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.02 128.88 2.41 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.144 -1.597 . . . . 0.0 111.062 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -96.9 126.9 42.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.733 0.813 . . . . 0.0 112.843 -153.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -113.43 115.29 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 111.397 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.499 HH11 ' CG ' ' A' ' 56' ' ' MET . 73.4 mtp180 -118.21 153.55 33.7 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.384 1.473 . . . . 0.0 112.647 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.63 141.94 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.913 1.685 . . . . 0.0 111.3 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -131.46 123.25 27.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.251 1.02 . . . . 0.0 112.358 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.3 tp -111.06 127.84 55.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.819 0.848 . . . . 0.0 111.216 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -149.46 163.47 37.7 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.134 0.974 . . . . 0.0 110.301 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -79.34 -66.63 0.84 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.374 -1.454 . . . . 0.0 112.016 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -159.6 151.77 20.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.47 1.108 . . . . 0.0 112.53 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 p -105.26 144.02 32.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 112.321 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -77.87 -11.96 59.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.692 1.197 . . . . 0.0 113.518 170.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.68 -164.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 127.962 2.505 . . . . 0.0 110.028 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -79.42 136.76 37.04 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.43 -1.419 . . . . 0.0 112.579 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -58.66 -40.33 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -59.12 -46.83 87.32 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.934 0.788 . . . . 0.0 112.211 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -72.6 -38.72 67.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.718 0.407 . . . . 0.0 111.86 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -60.28 -47.58 85.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.24 -0.287 . . . . 0.0 111.026 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.02 89.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.3 ttp -62.56 -50.67 70.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.768 0.827 . . . . 0.0 111.543 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.73 -49.06 79.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.987 0.915 . . . . 0.0 111.918 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.41 -41.1 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.041 0.936 . . . . 0.0 112.026 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.09 -46.09 90.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.988 0.813 . . . . 0.0 111.842 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -72.99 -32.78 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 112.438 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.35 -32.75 70.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.895 1.278 . . . . 0.0 112.807 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.9 mt -78.72 -11.51 59.98 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.3 -0.875 . . . . 0.0 112.82 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 64.49 35.68 9.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.34 1.456 . . . . 0.0 112.909 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.499 ' CG ' HH11 ' A' ' 32' ' ' ARG . 69.3 mtp -67.25 -22.62 65.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.898 1.279 . . . . 0.0 114.275 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.5 -7.93 8.16 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.722 2.009 . . . . 0.0 112.715 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -74.98 47.21 0.34 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.263 1.825 . . . . 0.0 112.719 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.6 p -119.34 150.74 39.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.864 1.666 . . . . 0.0 110.657 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -64.64 -43.9 92.2 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.911 -1.118 . . . . 0.0 112.494 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.45 -9.69 37.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 67.5 55.18 0.65 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.668 1.587 . . . . 0.0 108.58 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -126.17 29.87 5.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.554 1.141 . . . . 0.0 112.975 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.99 132.44 12.2 Favored Glycine 0 N--CA 1.47 0.964 0 O-C-N 120.424 -1.423 . . . . 0.0 110.988 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -111.77 134.5 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.528 1.131 . . . . 0.0 109.5 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 34' ' ' HIS . 16.2 tp -117.75 130.59 56.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.81 0.844 . . . . 0.0 110.693 166.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.5 mt -106.16 95.34 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -75.32 125.63 29.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.6 1.16 . . . . 0.0 110.723 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -117.27 131.19 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.04 1.336 . . . . 0.0 110.332 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.27 95.32 6.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.003 1.721 . . . . 0.0 110.414 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 35' ' ' LEU . 19.5 m -72.65 -16.36 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -75.27 -51.62 12.83 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.43 -5.75 55.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.94 1.296 . . . . 0.0 113.861 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.1 tttt 65.02 31.17 11.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.23 2.212 . . . . 0.0 112.751 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.5 p -111.06 163.54 13.76 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.028 0.931 . . . . 0.0 111.115 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 147.65 42.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.164 1.385 . . . . 0.0 109.534 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.89 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.758 1.623 . . . . 0.0 108.126 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.5 133.93 63.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -147.04 138.45 24.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.077 1.351 . . . . 0.0 110.036 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.71 164.3 21.15 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 124.756 1.169 . . . . 0.0 112.214 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -70.83 166.54 20.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 123.257 1.503 . . . . 0.0 112.705 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.42 -39.16 67.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.153 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.33 -46.49 78.11 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.386 1.47 . . . . 0.0 112.991 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.41 -59.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 118.208 1.004 . . . . 0.0 109.46 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.01 -22.67 64.75 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.72 -29.34 25.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.65 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -24.63 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.14 164.14 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.668 1.187 . . . . 0.0 112.649 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.2 p -107.93 174.42 5.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.694 1.198 . . . . 0.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.94 -33.41 73.12 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.342 -1.474 . . . . 0.0 113.359 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.1 -23.92 63.12 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -68.12 -37.59 81.29 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 117.698 0.226 . . . . 0.0 110.608 169.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -77.01 -25.57 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.3 -36.3 79.72 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.687 0.676 . . . . 0.0 112.715 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.3 m -55.98 -45.39 78.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.634 0.773 . . . . 0.0 111.427 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -47.68 84.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.305 1.442 . . . . 0.0 110.842 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -59.34 -47.84 83.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -64.86 -35.5 81.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.448 1.099 . . . . 0.0 113.368 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.67 -53.26 43.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.936 0.789 . . . . 0.0 111.692 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.33 -48.46 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.014 0.526 . . . . 0.0 110.459 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -60.07 -43.2 95.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.073 1.349 . . . . 0.0 112.905 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.26 -42.17 93.51 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 119.55 1.068 . . . . 0.0 111.827 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -74.88 -38.9 61.79 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.799 0.44 . . . . 0.0 111.926 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.76 -40.11 91.25 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.353 0.978 . . . . 0.0 112.054 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.57 -32.14 73.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.918 1.287 . . . . 0.0 112.078 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -74.59 -39.28 62.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.792 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.41 -2.21 12.59 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.23 1.872 . . . . 0.0 113.062 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.24 71.27 8.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.367 1.467 . . . . 0.0 111.102 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -52.73 -42.34 64.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.144 0.977 . . . . 0.0 112.407 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' CD ' HD13 ' A' ' 8' ' ' LEU . 19.2 tptt -64.93 -48.52 73.82 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -55.37 -47.51 75.69 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.528 0.731 . . . . 0.0 109.695 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.31 95.95 Favored Glycine 0 N--CA 1.467 0.741 0 CA-C-N 119.245 0.929 . . . . 0.0 113.695 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.45 -43.03 74.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.14 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.66 -50.42 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.599 1.16 . . . . 0.0 110.68 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -69.47 -25.05 63.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.875 1.27 . . . . 0.0 112.718 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.93 -41.85 26.74 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.083 0.849 . . . . 0.0 112.614 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.0 mt -60.61 -43.61 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.109 0.955 . . . . 0.0 111.166 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.23 -49.21 77.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.831 0.853 . . . . 0.0 112.621 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -71.55 -36.5 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.012 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.21 78.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.875 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.09 68.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.703 1.138 . . . . 0.0 112.341 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -64.17 -33.58 76.11 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.5 -46.55 38.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.794 0.725 . . . . 0.0 111.193 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.46 -39.26 83.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.215 1.406 . . . . 0.0 110.47 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.09 52.33 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.1 -41.67 99.42 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.859 -1.151 . . . . 0.0 110.805 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -84.84 -47.58 10.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.262 1.825 . . . . 0.0 111.144 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -114.38 78.18 4.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.725 2.01 . . . . 0.0 111.061 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.91 140.57 42.45 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.838 2.358 . . . . 0.0 111.256 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -59.39 141.75 53.86 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -115.42 149.26 38.29 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 123.892 0.877 . . . . 0.0 110.937 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.69 -25.82 67.65 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.29 -1.506 . . . . 0.0 112.297 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.07 22.14 7.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.655 1.582 . . . . 0.0 113.452 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.55 158.75 5.59 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.8 124.25 53.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.721 1.209 . . . . 0.0 112.572 -172.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -84.27 95.67 8.77 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 125.998 1.719 . . . . 0.0 109.087 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.2 -31.62 17.83 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.873 -1.142 . . . . 0.0 113.151 -170.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 32' ' ' ARG . 93.2 mt -111.7 166.04 11.66 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.29 1.036 . . . . 0.0 109.489 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -95.05 146.51 1.53 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.417 2.078 . . . . 0.0 111.332 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -74.29 4.15 6.22 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.2 p -72.72 168.97 17.64 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.653 1.181 . . . . 0.0 111.387 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.42 144.45 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 120.535 -1.353 . . . . 0.0 111.132 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 t -99.99 146.78 26.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.682 1.193 . . . . 0.0 111.026 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -153.18 94.86 1.88 Allowed 'General case' 0 CA--C 1.553 1.094 0 O-C-N 120.908 -1.12 . . . . 0.0 112.92 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 C-N-CA 125.05 1.31 . . . . 0.0 114.904 -173.698 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -53.63 -42.55 67.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.434 -1.416 . . . . 0.0 111.841 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.87 -18.54 65.26 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.62 -20.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.486 1.114 . . . . 0.0 112.827 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.25 -34.23 77.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.599 1.56 . . . . 0.0 112.613 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -146.58 125.96 13.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.857 1.263 . . . . 0.0 109.038 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -68.46 -41.76 79.73 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.651 0.781 . . . . 0.0 112.709 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt -142.76 137.33 29.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.958 2.103 . . . . 0.0 108.245 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -72.59 170.2 14.93 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.371 0.532 . . . . 0.0 111.386 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.38 68.64 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.111 -0.993 . . . . 0.0 112.752 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -60.7 -34.79 74.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.661 1.184 . . . . 0.0 112.395 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 88.6 mt-10 -84.43 -42.47 15.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.0 0.92 . . . . 0.0 110.902 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -57.22 -50.46 72.8 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.555 1.142 . . . . 0.0 111.774 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.16 -39.08 69.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.819 -1.175 . . . . 0.0 112.569 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.62 69.47 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 tt -71.43 -39.23 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.825 0.738 . . . . 0.0 111.136 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.7 t -59.55 -29.21 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.065 1.346 . . . . 0.0 112.641 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -72.86 -41.01 65.21 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.284 1.434 . . . . 0.0 113.557 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.15 77.58 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.03 -49.42 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.961 0.905 . . . . 0.0 110.594 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -60.06 -24.68 64.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.07 -18.43 32.42 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.765 0.826 . . . . 0.0 111.985 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.95 -39.87 29.27 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.993 0.917 . . . . 0.0 111.262 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.59 -27.44 39.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.325 1.45 . . . . 0.0 112.557 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -90.66 1.7 56.57 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.706 -1.871 . . . . 0.0 113.615 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -112.81 -20.73 11.51 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.233 1.813 . . . . 0.0 111.938 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -160.56 148.55 16.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.526 1.13 . . . . 0.0 110.574 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.6 p -81.3 38.25 0.48 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.295 1.038 . . . . 0.0 111.815 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.49 143.27 14.93 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.041 1.781 . . . . 0.0 109.884 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.9 124.77 51.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.156 -165.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.84 130.89 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -145.93 150.15 35.55 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.353 1.461 . . . . 0.0 110.67 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.96 135.92 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.612 1.565 . . . . 0.0 109.887 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' HD11 ' A' ' 66' ' ' LEU . 18.5 t60 -117.4 122.66 44.42 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.974 170.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -114.43 130.31 56.7 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.457 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -155.21 163.44 40.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.043 0.925 . . . . 0.0 110.764 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.5 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -75.05 -75.88 0.16 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.736 1.215 . . . . 0.0 112.086 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 t -138.15 173.19 11.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.774 2.029 . . . . 0.0 109.044 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 p -140.99 141.11 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.413 -0.805 . . . . 0.0 111.036 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.29 -7.19 59.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.76 -150.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.219 1.808 . . . . 0.0 111.137 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -85.83 121.07 27.96 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.29 -1.506 . . . . 0.0 111.365 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.58 -42.53 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.98 -47.54 84.38 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.107 -0.995 . . . . 0.0 112.444 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.17 -36.59 69.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.362 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -68.99 -40.92 78.46 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.528 -0.732 . . . . 0.0 112.319 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.0 74.8 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.365 -0.834 . . . . 0.0 110.649 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.2 ttp -65.56 -44.37 86.98 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.976 0.807 . . . . 0.0 111.072 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.09 -52.46 65.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.335 0.97 . . . . 0.0 111.433 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.07 -45.06 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.964 1.305 . . . . 0.0 111.542 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.93 -50.46 73.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.431 1.014 . . . . 0.0 112.402 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -69.53 -36.48 76.43 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.427 1.091 . . . . 0.0 112.338 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -63.87 -40.24 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.853 1.261 . . . . 0.0 112.079 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.26 -6.37 45.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.326 1.05 . . . . 0.0 113.582 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 57.66 39.3 27.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.888 1.275 . . . . 0.0 111.79 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.8 mtp -66.81 -20.66 65.98 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.919 -1.113 . . . . 0.0 112.469 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.94 -15.78 14.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.998 2.119 . . . . 0.0 112.318 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -73.79 50.66 0.35 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.169 2.188 . . . . 0.0 111.818 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -125.3 123.95 40.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.734 2.014 . . . . 0.0 107.972 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -45.61 -50.34 13.35 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.672 1.189 . . . . 0.0 113.617 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.9 mt -87.0 -6.59 58.7 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 68.04 40.14 2.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.19 1.396 . . . . 0.0 110.966 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -114.65 41.46 2.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.361 1.464 . . . . 0.0 112.33 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.07 10.51 Favored Glycine 0 N--CA 1.477 1.388 0 O-C-N 121.451 -0.781 . . . . 0.0 112.843 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.97 133.67 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.808 1.304 . . . . 0.0 111.043 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.4 tp -116.51 133.54 55.9 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.372 1.069 . . . . 0.0 111.485 172.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.5 mt -106.83 93.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.658 0.742 . . . . 0.0 109.633 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -77.34 113.67 15.36 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.955 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.32 134.26 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.861 1.264 . . . . 0.0 110.595 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.82 15.15 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 110.042 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' LYS . 13.6 m -75.78 -18.32 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -81.62 -37.95 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.515 1.126 . . . . 0.0 111.908 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.23 -10.15 31.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.082 1.353 . . . . 0.0 112.53 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt 65.4 32.27 9.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.658 1.583 . . . . 0.0 112.257 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.1 p -111.15 160.42 16.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.265 1.826 . . . . 0.0 111.848 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.98 134.64 23.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.649 1.18 . . . . 0.0 110.065 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.53 138.38 54.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.994 1.318 . . . . 0.0 108.098 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.19 131.55 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -137.25 136.81 38.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.631 0.772 . . . . 0.0 110.245 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 139.43 11.95 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -59.66 160.19 7.61 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 123.626 1.679 . . . . 0.0 110.628 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.3 -34.25 60.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.545 1.938 . . . . 0.0 113.71 -168.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.64 77.56 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-O 118.666 -1.075 . . . . 0.0 112.85 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.97 -55.78 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.277 1.538 . . . . 0.0 109.399 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -50.84 -34.58 28.46 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.78 -25.79 44.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.06 -27.16 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.8 161.54 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.059 0.845 . . . . 0.0 113.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 m -113.63 173.27 6.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.57 1.548 . . . . 0.0 113.829 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -50.97 -41.67 59.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.929 1.692 . . . . 0.0 114.553 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.6 -12.88 60.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.366 1.467 . . . . 0.0 113.395 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.7 t80 -83.96 -28.0 28.1 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.927 -1.733 . . . . 0.0 111.227 166.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -84.98 -21.0 29.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 113.279 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -60.72 -44.27 96.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.438 1.095 . . . . 0.0 111.576 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.1 p -57.52 -45.82 84.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.574 1.149 . . . . 0.0 111.351 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -57.36 -51.33 69.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.385 1.474 . . . . 0.0 111.028 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.68 -48.75 80.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.615 1.166 . . . . 0.0 111.627 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.63 -45.58 93.5 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.07 50.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.938 0.79 . . . . 0.0 112.577 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.44 -46.3 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.704 -0.622 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.72 -36.99 86.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.215 1.006 . . . . 0.0 112.743 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.88 -41.83 97.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.703 1.138 . . . . 0.0 111.2 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -83.32 -31.19 26.98 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.901 -0.571 . . . . 0.0 112.282 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -63.47 -38.06 89.69 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 119.122 0.874 . . . . 0.0 112.699 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.44 -35.82 82.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.885 0.874 . . . . 0.0 111.908 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -71.29 -36.38 71.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.031 0.932 . . . . 0.0 111.267 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 7.01 32.56 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 126.324 1.916 . . . . 0.0 113.936 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -90.32 72.05 7.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.645 1.222 . . . . 0.0 110.984 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -57.16 -36.79 71.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.352 1.061 . . . . 0.0 113.539 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 12' ' ' GLU . 79.3 tttt -56.29 -51.95 66.32 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 111.323 174.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.41 -34.26 77.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.107 1.363 . . . . 0.0 111.262 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.72 47.09 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 118.744 0.702 . . . . 0.0 112.733 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 -47.02 76.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.174 0.487 . . . . 0.0 111.177 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.81 -40.95 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.357 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.77 -37.5 79.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 111.608 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 -41.78 99.8 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.19 -47.75 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.211 1.004 . . . . 0.0 110.443 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -56.48 -52.68 63.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.571 1.149 . . . . 0.0 111.569 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.62 -38.79 84.41 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.603 0.761 . . . . 0.0 111.817 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.71 90.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 118.898 0.772 . . . . 0.0 111.252 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.3 98.6 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 119.032 0.833 . . . . 0.0 112.068 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mmm -62.34 -39.64 93.74 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.041 1.42 . . . . 0.0 113.078 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.63 -44.35 50.93 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.57 0.748 . . . . 0.0 111.546 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.84 -35.23 77.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.163 0.985 . . . . 0.0 111.424 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.63 -16.18 35.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.973 1.309 . . . . 0.0 114.305 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.3 -30.14 57.62 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.736 -1.227 . . . . 0.0 112.177 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -93.28 -31.12 14.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.735 1.214 . . . . 0.0 112.919 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -139.94 88.26 12.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.431 1.492 . . . . 0.0 109.236 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.14 148.02 55.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.399 2.066 . . . . 0.0 110.972 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -64.49 155.81 31.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.218 1.008 . . . . 0.0 113.456 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -136.18 151.23 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.704 1.601 . . . . 0.0 110.371 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.8 -25.57 67.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.534 -1.979 . . . . 0.0 112.684 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.9 15.71 28.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.015 1.726 . . . . 0.0 112.091 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.72 162.78 6.23 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.848 0.859 . . . . 0.0 112.483 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp -131.83 122.57 49.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 124.129 0.972 . . . . 0.0 111.23 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.81 106.88 18.38 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -94.61 -26.87 16.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.047 -0.978 . . . . 0.0 113.296 -171.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.9 mp -107.35 158.94 31.91 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 120.327 1.422 . . . . 0.0 111.652 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.83 149.94 14.16 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 124.069 3.179 . . . . 0.0 110.658 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.35 4.5 20.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.526 1.93 . . . . 0.0 114.844 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.2 p -74.92 161.82 29.17 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.207 1.403 . . . . 0.0 111.224 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.96 119.32 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.697 -1.252 . . . . 0.0 110.079 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.7 m -76.03 139.23 41.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.459 0.647 . . . . 0.0 111.427 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -136.61 131.54 33.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 C-N-CA 125.067 1.318 . . . . 0.0 114.646 177.061 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -76.07 -27.91 57.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.522 1.51 . . . . 0.0 112.625 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -56.2 -26.52 51.26 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 pt -94.28 -10.32 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 124.617 1.167 . . . . 0.0 113.701 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -81.37 -34.9 31.41 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.405 1.082 . . . . 0.0 110.119 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -160.23 140.27 11.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.514 1.926 . . . . 0.0 108.988 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 71' ' ' VAL . 55.7 m-85 -76.03 -32.89 59.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.86 140.55 34.62 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 126.95 2.1 . . . . 0.0 106.774 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 m -65.94 157.1 31.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.1 0.96 . . . . 0.0 109.2 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.53 52.97 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.302 -1.499 . . . . 0.0 112.484 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -69.23 -23.6 63.9 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.711 1.204 . . . . 0.0 112.916 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.4 -46.24 9.82 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.529 1.532 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.29 -48.38 80.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 111.233 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.52 -47.79 69.62 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.968 -1.083 . . . . 0.0 111.883 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.23 83.84 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.302 1.041 . . . . 0.0 113.349 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -72.73 -38.66 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.852 0.751 . . . . 0.0 111.92 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.12 -40.38 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.807 0.843 . . . . 0.0 112.061 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.37 -33.43 74.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.254 0.934 . . . . 0.0 112.427 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.22 66.76 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.9 mt -61.21 -50.04 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.506 1.122 . . . . 0.0 109.935 167.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -57.97 -33.97 69.43 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.66 -26.38 60.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.03 42.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.095 0.958 . . . . 0.0 112.385 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -61.33 -23.67 65.9 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.264 1.026 . . . . 0.0 111.573 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -84.05 6.05 23.61 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.449 -2.032 . . . . 0.0 112.348 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -125.18 -7.8 7.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.111 1.764 . . . . 0.0 114.047 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -169.92 152.38 4.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.198 1.399 . . . . 0.0 110.491 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -82.27 21.65 0.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.249 1.42 . . . . 0.0 112.637 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.67 138.32 14.85 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 126.588 2.042 . . . . 0.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.62 125.25 52.39 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.03 0.915 . . . . 0.0 110.274 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 mt -117.39 125.95 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 119.935 -1.728 . . . . 0.0 112.628 -175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -129.22 131.18 47.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.475 1.51 . . . . 0.0 112.417 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.46 139.44 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.748 1.219 . . . . 0.0 112.867 170.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -128.55 125.81 39.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.974 1.31 . . . . 0.0 112.626 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 tp -115.76 133.01 56.46 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 111.294 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -159.09 158.24 32.6 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 109.546 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 71' ' ' VAL . 96.1 mttt -75.2 -63.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.123 -1.611 . . . . 0.0 113.852 -170.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -157.74 164.28 37.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.395 1.478 . . . . 0.0 110.825 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.9 p -114.56 144.79 42.81 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.419 1.487 . . . . 0.0 112.557 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.25 -19.1 43.81 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.043 -1.036 . . . . 0.0 111.948 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.12 -162.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.666 1.587 . . . . 0.0 111.516 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -77.71 139.09 39.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.895 0.878 . . . . 0.0 112.373 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.49 -35.09 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.988 0.915 . . . . 0.0 112.714 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -65.46 -51.47 59.92 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.779 0.718 . . . . 0.0 110.834 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.66 -42.29 98.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.613 1.165 . . . . 0.0 112.324 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -62.1 -47.28 85.32 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.371 -0.831 . . . . 0.0 112.129 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.89 89.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.495 -0.753 . . . . 0.0 111.469 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.6 ttp -62.01 -48.95 78.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.707 0.803 . . . . 0.0 111.891 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -61.01 -46.48 90.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.273 1.029 . . . . 0.0 110.952 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.21 -45.91 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.111 0.964 . . . . 0.0 111.88 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -56.75 -50.72 71.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.673 1.189 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.91 -35.45 74.6 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.31 0.644 . . . . 0.0 111.202 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -68.09 -32.36 72.63 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.365 1.066 . . . . 0.0 113.853 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.7 mt -78.61 -0.51 30.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.237 1.015 . . . . 0.0 112.534 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 58.44 32.2 21.83 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.285 1.834 . . . . 0.0 112.032 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.6 mtp -69.51 -16.67 63.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.991 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.23 -15.8 63.91 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.658 1.183 . . . . 0.0 113.193 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -85.04 55.55 3.54 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.389 -1.444 . . . . 0.0 112.083 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -110.0 160.82 16.09 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 0.0 110.369 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -72.21 -42.12 66.13 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.974 -1.078 . . . . 0.0 113.62 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.07 -11.63 32.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 74.21 28.15 1.44 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.382 1.473 . . . . 0.0 110.145 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -112.66 45.46 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.572 1.549 . . . . 0.0 111.481 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.9 131.03 10.58 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.782 1.182 . . . . 0.0 112.331 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.2 t -111.62 136.39 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.052 1.341 . . . . 0.0 110.8 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 tp -115.28 134.18 55.36 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.148 1.379 . . . . 0.0 111.405 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.23 89.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.002 1.321 . . . . 0.0 108.725 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -78.92 123.13 26.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.3 1.44 . . . . 0.0 111.547 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.3 t -124.85 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.066 -1.022 . . . . 0.0 111.825 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.06 116.17 28.57 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.195 1.398 . . . . 0.0 110.44 164.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.51 HG21 ' CE1' ' A' ' 7' ' ' PHE . 16.3 m -77.43 -25.19 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.93 -57.99 3.56 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 118.205 0.457 . . . . 0.0 110.216 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.65 -4.13 55.36 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.2 tttt 68.39 27.53 6.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.682 1.593 . . . . 0.0 111.79 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 m -100.44 113.7 26.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.958 1.703 . . . . 0.0 110.491 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -88.95 141.9 28.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.0 0.92 . . . . 0.0 110.155 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.34 149.5 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.867 2.067 . . . . 0.0 108.143 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.8 mt -134.12 131.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -145.29 127.18 15.42 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.65 1.18 . . . . 0.0 109.534 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.38 149.68 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.6 162.82 3.59 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 122.964 1.364 . . . . 0.0 110.954 168.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -54.31 -35.67 62.91 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.488 1.515 . . . . 0.0 112.872 -168.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.83 -41.61 98.75 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.615 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mt -61.15 -56.16 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.294 1.547 . . . . 0.0 109.649 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -64.46 -19.47 65.58 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.07 -35.02 22.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.485 1.114 . . . . 0.0 111.367 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 88' ' ' VAL . 2.5 p -93.57 -24.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 87' ' ' VAL . 7.2 m -118.04 171.07 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 119.858 1.208 . . . . 0.0 111.998 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.5 p -113.13 172.22 7.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.989 1.316 . . . . 0.0 113.184 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -61.45 -30.82 70.83 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.839 -1.163 . . . . 0.0 112.551 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 -18.52 63.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.206 1.402 . . . . 0.0 112.668 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.0 t80 -81.22 -37.3 28.84 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.869 1.267 . . . . 0.0 111.915 168.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -73.71 -26.61 60.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.816 1.246 . . . . 0.0 113.568 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.37 -31.18 68.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.716 1.207 . . . . 0.0 113.677 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.7 p -70.02 -43.32 71.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.925 1.29 . . . . 0.0 111.517 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.0 m -56.88 -51.38 69.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.881 2.072 . . . . 0.0 110.779 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -58.71 -47.0 86.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.308 1.043 . . . . 0.0 111.63 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.12 -32.75 74.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.5 -53.39 29.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.326 0.967 . . . . 0.0 111.854 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt -61.28 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.625 0.37 . . . . 0.0 110.799 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.43 -44.05 92.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.399 1.08 . . . . 0.0 112.752 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.64 -39.83 85.65 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.785 0.72 . . . . 0.0 112.433 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.42 -32.66 20.77 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.43 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.71 -41.06 98.96 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.809 1.186 . . . . 0.0 111.063 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.01 -38.11 72.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.2 1.0 . . . . 0.0 111.625 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -75.67 -35.82 60.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.598 0.759 . . . . 0.0 111.988 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.65 5.99 21.83 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.802 1.667 . . . . 0.0 114.582 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -99.25 78.41 2.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.729 1.212 . . . . 0.0 110.428 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.09 -49.35 69.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.128 0.971 . . . . 0.0 112.416 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -50.58 -53.81 27.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.052 0.541 . . . . 0.0 111.353 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -62.53 -42.88 99.81 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.524 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.7 -35.56 74.07 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.504 1.047 . . . . 0.0 112.946 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.49 -44.71 77.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.306 0.642 . . . . 0.0 111.142 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.64 -52.58 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.434 1.094 . . . . 0.0 111.279 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -57.77 -40.72 80.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.293 0.951 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -43.32 87.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.044 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.25 -41.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.2 1.5 . . . . 0.0 112.123 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -63.73 -47.47 80.94 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.749 0.704 . . . . 0.0 110.944 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -66.56 -44.07 83.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.845 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.11 69.57 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.259 0.624 . . . . 0.0 111.028 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.14 89.39 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.045 0.839 . . . . 0.0 112.891 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.6 mtp -64.06 -36.31 83.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.871 1.335 . . . . 0.0 112.288 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -76.67 -43.62 37.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.049 0.939 . . . . 0.0 111.229 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -62.38 -35.15 78.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.134 0.974 . . . . 0.0 111.534 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.92 -20.9 62.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.696 1.198 . . . . 0.0 114.03 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -71.59 -41.98 68.31 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.022 -1.049 . . . . 0.0 111.444 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -75.12 -46.64 33.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.926 0.89 . . . . 0.0 111.611 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -122.87 88.34 50.48 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.623 1.569 . . . . 0.0 109.986 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.59 138.48 35.27 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.458 2.105 . . . . 0.0 110.454 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -62.86 135.51 57.36 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -106.53 154.31 21.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.155 0.982 . . . . 0.0 110.205 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.68 -27.04 68.65 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.933 -1.729 . . . . 0.0 112.259 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.71 19.64 15.54 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 126.184 1.794 . . . . 0.0 113.108 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -58.99 159.6 6.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.281 1.032 . . . . 0.0 113.321 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.12 109.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 123.086 1.422 . . . . 0.0 113.083 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -93.21 100.58 12.93 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.214 1.406 . . . . 0.0 108.512 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -98.28 -8.44 27.22 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.001 0.921 . . . . 0.0 112.818 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp -99.12 154.46 37.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 120.329 -1.482 . . . . 0.0 111.578 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.84 141.2 10.62 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.751 2.301 . . . . 0.0 110.151 167.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.04 21.83 0.68 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.304 1.042 . . . . 0.0 112.857 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -77.24 150.55 35.37 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.925 2.09 . . . . 0.0 111.887 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.5 mt -80.97 130.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.149 0.98 . . . . 0.0 109.532 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.2 m -87.89 142.42 27.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.429 170.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.76 140.82 31.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.667 0.787 . . . . 0.0 110.837 -174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.28 1.895 . . . . 0.0 109.972 164.484 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttp . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.6 p -71.14 -16.51 62.55 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.8 1.636 . . . . 0.0 114.517 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -88.92 129.59 35.59 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.132 -0.98 . . . . 0.0 110.533 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.61 -27.31 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.55 -21.38 62.71 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -134.62 81.49 1.91 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.705 1.202 . . . . 0.0 109.497 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.628 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 30.1 m-85 -50.82 -45.43 59.44 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.083 1.353 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.5 mt -129.11 133.12 47.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.789 1.636 . . . . 0.0 108.382 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -74.78 162.93 28.22 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.429 1.092 . . . . 0.0 109.532 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.46 -41.21 39.58 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -61.79 -30.49 70.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.88 1.272 . . . . 0.0 113.55 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -81.87 -47.49 12.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -62.37 -41.55 98.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.908 1.283 . . . . 0.0 110.691 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -55.56 -55.16 35.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.857 -1.152 . . . . 0.0 111.444 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.36 81.28 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -74.16 -30.34 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.167 0.894 . . . . 0.0 113.302 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.22 -42.46 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.478 -1.389 . . . . 0.0 111.047 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -63.58 -32.44 73.9 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.811 0.844 . . . . 0.0 112.347 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.26 85.71 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.273 -0.892 . . . . 0.0 112.596 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 mm -59.05 -45.99 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.093 0.957 . . . . 0.0 111.285 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -58.29 -31.16 67.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -81.97 -29.05 32.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.74 84.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.815 0.734 . . . . 0.0 111.34 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -56.12 -26.98 52.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.794 1.638 . . . . 0.0 113.41 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.84 5.18 37.98 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 112.826 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.83 -8.05 5.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.983 1.713 . . . . 0.0 114.29 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -148.37 159.88 43.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.926 1.69 . . . . 0.0 109.316 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.2 p -94.26 37.01 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.17 0.988 . . . . 0.0 111.688 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.44 146.24 15.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 123.955 0.788 . . . . 0.0 112.611 -171.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -108.33 131.8 54.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.689 0.756 . . . . 0.0 111.605 -151.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.47 134.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.802 -1.186 . . . . 0.0 110.661 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -144.26 153.48 42.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.18 1.392 . . . . 0.0 111.862 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.03 136.91 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.081 1.352 . . . . 0.0 109.704 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -118.57 118.52 31.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.003 1.721 . . . . 0.0 111.937 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.8 tp -107.15 129.28 54.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 112.086 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.52 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.0 tt0 -154.78 168.15 27.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.015 1.326 . . . . 0.0 111.897 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.18 -95.25 0.06 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.222 1.409 . . . . 0.0 113.479 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 p -116.05 165.21 13.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.332 2.253 . . . . 0.0 109.548 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 p -113.07 162.28 16.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.864 0.84 . . . . 0.0 111.977 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -95.36 -15.19 23.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.989 1.316 . . . . 0.0 113.009 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.42 -150.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.978 2.111 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -85.47 137.63 32.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.486 1.039 . . . . 0.0 112.01 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.29 -39.02 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.566 1.146 . . . . 0.0 112.422 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.94 -49.93 70.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.961 0.801 . . . . 0.0 111.764 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.59 -41.78 96.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 111.272 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CD ' ' A' ' 36' ' ' GLU . 59.0 ttt85 -59.52 -48.89 79.9 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.042 0.937 . . . . 0.0 112.574 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.97 97.11 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.537 0.735 . . . . 0.0 111.077 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.18 -47.24 87.09 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.972 0.909 . . . . 0.0 112.172 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.87 -42.59 97.48 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.061 -1.024 . . . . 0.0 112.57 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.7 -41.99 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.867 0.867 . . . . 0.0 111.969 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.26 -48.77 78.46 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 111.971 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -75.16 -31.64 61.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.799 0.84 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -62.09 -48.28 80.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.096 0.959 . . . . 0.0 111.132 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -72.77 -7.59 51.38 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.105 0.962 . . . . 0.0 113.524 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 63.45 42.82 6.38 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 112.208 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.4 mtt -71.29 -21.53 62.06 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -8.96 8.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.026 2.13 . . . . 0.0 113.705 171.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -79.41 56.49 2.15 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.349 1.86 . . . . 0.0 111.081 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.7 p -128.99 145.18 51.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.549 1.94 . . . . 0.0 108.637 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -59.76 -39.66 85.59 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.5 mt -100.3 -8.82 23.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.081 -1.438 . . . . 0.0 114.519 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 69.93 39.73 1.38 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.708 1.203 . . . . 0.0 110.355 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -106.72 20.29 19.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.445 1.898 . . . . 0.0 113.735 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.07 121.36 6.52 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.296 -0.878 . . . . 0.0 112.569 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.5 t -104.43 133.57 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.357 1.863 . . . . 0.0 109.932 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.5 tp -120.79 130.16 53.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.318 1.047 . . . . 0.0 111.988 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 53.5 mt -105.78 100.16 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 0.0 108.593 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -81.36 125.88 30.92 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.282 0.633 . . . . 0.0 110.051 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.93 131.54 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.916 0.886 . . . . 0.0 110.954 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 102.0 11.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.114 1.366 . . . . 0.0 109.721 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.628 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 31.0 m -68.22 -19.3 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 -44.28 20.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.332 0.653 . . . . 0.0 111.1 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -86.73 -11.17 51.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.068 0.947 . . . . 0.0 112.524 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.4 tttt 72.77 29.08 1.98 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.108 2.163 . . . . 0.0 111.614 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -109.57 162.83 14.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.189 1.396 . . . . 0.0 111.198 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.45 146.13 41.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.135 1.374 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.01 135.5 45.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 126.119 1.768 . . . . 0.0 107.256 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.3 mt -118.52 127.85 75.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -136.21 125.46 24.72 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 125.342 1.457 . . . . 0.0 109.961 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 158.26 14.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.855 1.217 . . . . 0.0 110.644 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -65.31 164.8 12.81 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.605 1.669 . . . . 0.0 111.874 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -50.72 -33.67 23.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.04 2.136 . . . . 0.0 114.075 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.54 -43.36 98.18 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 119.985 1.266 . . . . 0.0 111.906 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.66 -58.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.585 1.192 . . . . 0.0 109.86 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -60.05 -25.37 65.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.083 -1.011 . . . . 0.0 113.571 -173.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.94 -8.09 44.18 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 88' ' ' VAL . 2.8 p -113.59 -22.84 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 118.191 -0.909 . . . . 0.0 113.035 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 87' ' ' VAL . 4.0 m -119.8 172.46 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.045 1.293 . . . . 0.0 112.233 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.66 171.98 7.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.669 1.588 . . . . 0.0 112.631 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.89 -34.01 75.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.01 -35.12 79.18 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.826 0.739 . . . . 0.0 111.97 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 44.0 t80 -64.41 -41.99 96.33 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.027 0.531 . . . . 0.0 110.761 172.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -70.02 -26.81 64.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.89 -35.65 75.3 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.153 0.888 . . . . 0.0 111.575 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 p -60.39 -46.84 88.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.494 0.717 . . . . 0.0 111.938 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 m -61.18 -48.94 79.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.591 1.957 . . . . 0.0 111.071 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -60.0 -47.36 86.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.263 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -62.54 -43.78 97.98 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.63 -48.74 76.86 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.021 0.828 . . . . 0.0 111.928 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.78 -48.28 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.749 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -59.99 -44.15 94.69 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.99 -38.25 87.89 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.152 -0.968 . . . . 0.0 112.497 -176.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -80.88 -37.59 29.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.28 1.032 . . . . 0.0 111.67 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.44 -38.96 82.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.442 -0.786 . . . . 0.0 111.645 171.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.01 -28.83 70.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.961 0.904 . . . . 0.0 113.136 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -79.59 -27.86 41.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.751 1.16 . . . . 0.0 110.802 172.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.91 25.12 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 126.309 1.909 . . . . 0.0 113.631 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -107.34 73.07 0.9 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.356 1.462 . . . . 0.0 110.951 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -58.08 -40.33 80.83 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.771 0.828 . . . . 0.0 113.225 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -60.22 -53.92 51.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.013 -0.429 . . . . 0.0 111.456 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.6 -39.49 88.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.646 0.778 . . . . 0.0 111.069 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.33 96.51 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.738 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.58 -48.44 66.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.457 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.71 -45.23 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.528 1.058 . . . . 0.0 112.391 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -67.26 -36.96 82.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.463 1.105 . . . . 0.0 112.14 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.5 95.89 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 121.649 -0.657 . . . . 0.0 112.547 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.02 -45.62 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.789 1.236 . . . . 0.0 110.564 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.68 -50.6 71.81 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.824 0.849 . . . . 0.0 111.33 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -66.59 -41.88 87.81 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.079 0.952 . . . . 0.0 111.24 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.18 79.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.448 172.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.62 97.42 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.402 1.001 . . . . 0.0 113.18 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.74 -40.4 95.24 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.603 1.202 . . . . 0.0 112.839 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.55 -47.58 31.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.411 1.084 . . . . 0.0 111.368 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.78 -38.74 79.18 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 125.567 1.547 . . . . 0.0 110.735 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.6 -19.11 46.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.45 -32.62 64.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.536 -1.353 . . . . 0.0 111.837 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -89.32 -33.93 16.74 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.857 1.263 . . . . 0.0 112.676 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.52 85.93 41.54 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.733 2.013 . . . . 0.0 110.275 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.49 135.02 25.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.65 2.233 . . . . 0.0 109.513 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -57.19 137.18 56.24 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -106.6 148.04 28.77 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.15 -0.968 . . . . 0.0 110.421 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.67 -33.23 72.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.295 -1.503 . . . . 0.0 112.487 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.71 17.16 13.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.447 1.499 . . . . 0.0 113.528 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.21 157.92 5.78 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.25 116.52 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.049 0.939 . . . . 0.0 111.554 -171.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -86.58 99.59 11.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 109.679 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -80.61 -31.05 36.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.737 1.215 . . . . 0.0 113.787 -172.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.2 mt -116.67 147.27 39.48 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.708 1.203 . . . . 0.0 110.702 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.94 147.23 26.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.152 1.901 . . . . 0.0 111.685 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -78.47 14.26 1.31 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.829 1.251 . . . . 0.0 113.568 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.0 p -85.56 165.25 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.049 1.74 . . . . 0.0 111.383 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.07 134.0 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.796 -0.565 . . . . 0.0 109.602 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.0 m -91.16 141.21 29.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.624 0.726 . . . . 0.0 110.669 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -140.8 154.75 46.38 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.73 -1.231 . . . . 0.0 111.157 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 C-N-CA 126.427 1.965 . . . . 0.0 111.862 173.786 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -156.35 156.05 33.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.03 0.932 . . . . 0.0 110.837 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -51.0 -44.5 60.93 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 0.0 112.199 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -115.65 139.1 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.807 1.243 . . . . 0.0 108.311 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -109.22 -57.04 2.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.423 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -115.28 127.24 55.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.309 1.844 . . . . 0.0 108.451 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -19.23 42.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.772 1.229 . . . . 0.0 112.972 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.05 137.22 49.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.56 2.344 . . . . 0.0 108.529 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -63.34 152.5 37.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.17 0.988 . . . . 0.0 111.019 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.29 16.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.84 -41.91 77.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.851 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -72.1 -42.37 66.21 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.658 1.183 . . . . 0.0 110.088 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.87 -39.36 94.21 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.503 1.521 . . . . 0.0 113.135 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -61.11 -50.17 74.32 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 119.65 -1.906 . . . . 0.0 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.54 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 tt -69.13 -41.56 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.588 1.085 . . . . 0.0 112.676 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.2 -40.58 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.092 1.315 . . . . 0.0 111.244 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.57 -28.5 67.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.226 0.921 . . . . 0.0 113.076 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.6 75.63 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.46 -0.775 . . . . 0.0 112.246 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.77 -45.38 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.772 0.829 . . . . 0.0 109.946 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -62.54 -23.78 67.16 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -84.37 -29.4 26.27 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.978 -1.076 . . . . 0.0 111.308 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.73 75.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.7 1.136 . . . . 0.0 112.361 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.08 -15.35 62.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.506 1.523 . . . . 0.0 113.454 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -92.71 4.67 53.29 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.754 -1.216 . . . . 0.0 111.866 171.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -131.91 -14.35 3.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.93 1.692 . . . . 0.0 115.139 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -153.44 145.58 23.78 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.493 1.497 . . . . 0.0 110.652 171.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -82.17 24.9 0.62 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.997 1.719 . . . . 0.0 113.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 -179.82 21.19 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 124.828 1.204 . . . . 0.0 110.997 166.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -135.73 133.48 38.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.767 0.794 . . . . 0.0 111.495 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mt -124.56 141.04 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.057 -1.652 . . . . 0.0 110.626 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -142.73 147.82 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.4 1.88 . . . . 0.0 111.027 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.41 137.13 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.214 1.006 . . . . 0.0 111.071 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -120.47 121.02 37.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.116 1.766 . . . . 0.0 112.759 172.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' CG1' ' A' ' 71' ' ' VAL . 13.4 tp -102.92 131.47 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.883 1.273 . . . . 0.0 111.87 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -152.25 162.78 40.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.521 -0.737 . . . . 0.0 110.686 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -78.75 -75.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.736 -1.227 . . . . 0.0 112.366 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 p -142.07 148.65 38.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.477 1.911 . . . . 0.0 110.42 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -85.04 161.08 19.86 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.039 0.936 . . . . 0.0 112.976 170.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -98.23 -16.73 19.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.228 1.811 . . . . 0.0 112.31 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -119.56 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.101 1.76 . . . . 0.0 110.934 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -78.67 134.56 37.12 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.57 . . . . 0.0 111.41 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.04 -38.12 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.046 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.7 -46.52 89.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.79 -42.67 70.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.507 0.323 . . . . 0.0 110.785 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -56.68 -47.79 79.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.485 0.314 . . . . 0.0 111.687 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.06 75.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.899 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.9 ttp -67.19 -50.59 60.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 0.0 112.049 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -64.48 -43.95 92.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.245 0.93 . . . . 0.0 111.72 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.64 -45.02 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.129 0.971 . . . . 0.0 110.738 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.92 -50.19 74.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.117 0.967 . . . . 0.0 112.111 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -74.37 -30.96 62.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.328 1.051 . . . . 0.0 112.891 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -73.1 -35.84 66.66 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.659 -1.276 . . . . 0.0 111.917 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.28 -7.25 52.13 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.728 1.211 . . . . 0.0 112.947 170.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 62.21 31.1 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.468 1.507 . . . . 0.0 111.991 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.7 mmm -64.43 -19.79 65.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.304 1.042 . . . . 0.0 113.078 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.25 -12.48 60.29 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.258 1.823 . . . . 0.0 113.65 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -83.58 73.48 10.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.335 1.054 . . . . 0.0 111.249 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -123.74 151.42 43.25 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.717 2.007 . . . . 0.0 110.431 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -63.14 -37.97 89.32 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.378 -0.826 . . . . 0.0 113.02 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.41 -6.98 21.34 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 117.766 -1.112 . . . . 0.0 113.589 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 66.22 47.97 1.74 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.668 1.187 . . . . 0.0 109.433 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -119.8 26.27 9.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.807 1.243 . . . . 0.0 113.456 -172.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.75 127.23 7.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.312 0.958 . . . . 0.0 112.357 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.03 132.77 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 126.7 2.0 . . . . 0.0 109.985 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.5 tp -121.84 129.51 52.66 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.116 0.967 . . . . 0.0 110.781 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.15 99.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.984 0.914 . . . . 0.0 108.632 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -80.2 122.69 27.16 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.529 0.732 . . . . 0.0 110.744 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.863 0.865 . . . . 0.0 110.807 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.95 102.72 15.29 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.367 1.467 . . . . 0.0 109.277 171.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.1 m -73.16 -24.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -74.13 -40.75 62.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.962 -0.462 . . . . 0.0 111.472 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -97.27 -6.47 34.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.538 1.535 . . . . 0.0 112.837 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt 67.29 33.19 5.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.779 1.632 . . . . 0.0 112.156 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 m -107.6 129.43 54.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.353 1.461 . . . . 0.0 110.053 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -106.66 141.45 37.91 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.765 1.226 . . . . 0.0 109.876 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.0 t -138.8 140.86 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.198 1.399 . . . . 0.0 108.103 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 mt -125.39 127.57 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -129.74 138.18 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.863 0.865 . . . . 0.0 109.72 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.87 160.41 16.27 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.69 162.32 16.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.518 1.627 . . . . 0.0 112.618 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.84 -38.98 65.19 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.603 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.35 -37.22 93.64 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.612 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -63.0 -58.28 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.317 1.559 . . . . 0.0 110.166 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -59.26 -25.35 63.99 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -80.43 -27.68 37.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.466 1.507 . . . . 0.0 112.462 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.475 HG11 ' HE2' ' A' ' 128' ' ' PHE . 3.4 p -105.96 -22.82 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 87' ' ' VAL . 4.8 m -119.99 167.65 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.836 1.198 . . . . 0.0 112.21 175.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 m -116.29 169.91 8.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.618 1.167 . . . . 0.0 113.122 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -56.88 -33.0 66.42 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.533 -1.354 . . . . 0.0 113.764 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -20.88 62.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.791 1.236 . . . . 0.0 113.249 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 26.6 t80 -77.66 -34.17 53.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.449 0.7 . . . . 0.0 110.647 170.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -75.76 -25.66 56.7 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -65.56 -32.96 74.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.402 -0.811 . . . . 0.0 112.376 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.3 p -65.86 -42.67 90.14 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 111.755 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 m -53.7 -55.37 26.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.908 2.083 . . . . 0.0 110.275 172.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -55.95 -49.27 74.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.92 0.888 . . . . 0.0 111.202 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.65 -37.32 81.14 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.46 -51.84 52.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.055 0.843 . . . . 0.0 111.78 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.2 mt -58.22 -51.68 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.044 0.538 . . . . 0.0 110.126 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.797 1.639 . . . . 0.0 113.035 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.09 -46.08 89.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.18 -30.42 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -64.69 -39.35 93.51 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.304 0.956 . . . . 0.0 111.29 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.9 -27.76 69.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.054 0.942 . . . . 0.0 112.331 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -77.77 -38.58 46.45 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.575 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.82 12.46 14.4 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.379 1.942 . . . . 0.0 113.791 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.26 84.89 2.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.204 1.401 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -61.39 -46.62 89.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.575 0.75 . . . . 0.0 111.928 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -49.11 -54.95 13.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -63.51 -41.77 98.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.061 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.42 -36.38 77.64 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.1 0.864 . . . . 0.0 113.346 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.96 -40.7 78.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 111.798 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.8 t -67.28 -50.43 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 111.5 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -73.47 -26.12 60.77 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.15 0.886 . . . . 0.0 112.495 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.09 -38.31 92.29 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.275 -0.891 . . . . 0.0 111.833 169.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.8 mt -62.24 -51.49 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.479 1.139 . . . . 0.0 110.872 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -61.01 -40.14 92.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.495 1.043 . . . . 0.0 112.854 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -73.91 -36.85 64.77 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.723 -1.235 . . . . 0.0 111.422 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.21 73.85 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.803 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.16 -46.66 93.82 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.481 1.037 . . . . 0.0 112.628 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 41.9 tpp -60.8 -43.35 98.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.924 0.862 . . . . 0.0 112.976 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -68.38 -44.19 75.69 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.994 0.361 . . . . 0.0 111.215 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.27 -37.9 87.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.455 1.502 . . . . 0.0 111.143 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.43 -24.49 63.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.538 1.135 . . . . 0.0 113.83 173.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -67.8 -27.64 66.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.206 -1.559 . . . . 0.0 112.561 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -93.18 -38.89 11.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.033 1.333 . . . . 0.0 112.031 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.475 ' HE2' HG11 ' A' ' 87' ' ' VAL . 95.3 m-85 -130.4 76.19 78.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.126 1.77 . . . . 0.0 111.484 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.26 132.19 35.24 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.144 2.563 . . . . 0.0 111.339 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -57.92 146.29 32.69 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -118.57 150.45 39.63 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.004 1.322 . . . . 0.0 109.816 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.53 -27.4 67.73 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.438 -2.039 . . . . 0.0 112.888 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.79 15.04 23.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.659 1.584 . . . . 0.0 112.242 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.38 158.34 9.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.515 1.126 . . . . 0.0 113.185 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.32 120.7 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.53 1.132 . . . . 0.0 110.64 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.06 103.78 11.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -77.81 -21.08 52.11 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -119.28 169.1 8.67 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 124.87 1.268 . . . . 0.0 111.101 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -99.03 153.91 0.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.615 2.877 . . . . 0.0 111.153 168.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -89.0 -5.76 57.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 m -56.23 141.26 41.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.19 1.396 . . . . 0.0 109.683 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.54 130.95 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.61 152.71 18.38 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.107 0.563 . . . . 0.0 110.848 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -160.99 158.02 27.29 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.074 0 CA-C-O 116.592 -2.226 . . . . 0.0 112.803 171.025 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -76.11 131.47 39.45 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 119.954 -1.716 . . . . 0.0 112.056 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.75 -24.95 53.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.067 -1.02 . . . . 0.0 113.372 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.3 -38.57 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.568 1.147 . . . . 0.0 111.445 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.29 -6.46 58.52 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.552 1.141 . . . . 0.0 113.659 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.58 -17.7 61.15 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.401 -0.812 . . . . 0.0 112.238 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.43 -30.16 65.74 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -148.98 134.85 18.93 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.81 1.644 . . . . 0.0 108.017 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -69.52 160.6 31.15 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.739 0.7 . . . . 0.0 110.737 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.64 53.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.33 -40.99 77.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.508 1.523 . . . . 0.0 110.92 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -72.06 -44.38 63.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.551 1.141 . . . . 0.0 111.376 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -63.74 -44.77 92.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.322 1.049 . . . . 0.0 111.823 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -55.56 -47.2 76.76 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.706 -1.246 . . . . 0.0 111.461 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.67 84.45 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.4 tt -76.59 -38.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.568 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.86 -40.34 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.98 1.264 . . . . 0.0 111.253 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.98 -33.45 75.42 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.827 0.851 . . . . 0.0 112.966 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.11 62.0 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.709 0.804 . . . . 0.0 112.412 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.51 -48.66 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -55.49 -27.64 49.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.3 -28.76 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.239 -0.913 . . . . 0.0 113.086 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.07 75.62 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.574 1.149 . . . . 0.0 111.922 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -71.94 14.11 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.824 0.85 . . . . 0.0 113.282 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -120.72 12.5 11.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.322 1.849 . . . . 0.0 112.43 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.92 -14.33 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.807 2.043 . . . . 0.0 113.512 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -159.88 176.03 12.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.445 2.298 . . . . 0.0 108.531 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -125.51 6.22 7.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.347 1.459 . . . . 0.0 114.594 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.98 161.06 31.53 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 155.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -126.84 136.08 51.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 118.192 0.996 . . . . 0.0 112.0 -165.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.7 mt -113.05 124.69 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 110.746 -169.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -135.51 153.59 51.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.124 0.964 . . . . 0.0 111.456 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.9 t -133.99 128.43 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.494 1.518 . . . . 0.0 108.601 -168.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.87 108.75 13.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.569 1.548 . . . . 0.0 113.987 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 tt -93.96 130.94 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.514 0.726 . . . . 0.0 111.023 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.11 163.11 37.95 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.02 1.328 . . . . 0.0 111.317 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.3 -79.38 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.595 1.558 . . . . 0.0 113.369 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -144.54 147.81 33.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.982 2.513 . . . . 0.0 109.044 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -99.38 169.96 8.97 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.39 1.09 . . . . 0.0 112.163 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -101.66 -19.62 15.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.786 1.635 . . . . 0.0 112.685 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 pt -125.04 -148.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -85.17 142.5 29.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.278 1.399 . . . . 0.0 112.604 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.42 -32.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.449 0.7 . . . . 0.0 111.164 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.06 -50.08 73.41 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.736 0.815 . . . . 0.0 111.54 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.39 -39.55 94.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.329 0.652 . . . . 0.0 111.451 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.9 -43.43 98.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.354 0.662 . . . . 0.0 111.841 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.9 96.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.927 0.785 . . . . 0.0 110.982 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.8 ttp -63.26 -47.36 82.73 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.908 0.777 . . . . 0.0 112.327 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.57 -44.25 97.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.217 -0.927 . . . . 0.0 112.131 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.55 -43.96 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.63 1.172 . . . . 0.0 111.109 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.56 -49.71 76.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.995 0.816 . . . . 0.0 111.182 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -67.44 -44.23 79.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.481 1.112 . . . . 0.0 111.828 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.06 -39.84 91.38 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.857 -1.152 . . . . 0.0 113.816 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.56 1.64 18.89 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 56.5 36.59 27.81 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.706 1.202 . . . . 0.0 111.632 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.8 mtp -72.09 -13.49 61.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.131 1.772 . . . . 0.0 113.294 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -75.58 -2.4 28.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.584 1.954 . . . . 0.0 114.25 167.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -79.36 60.53 3.18 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.003 1.321 . . . . 0.0 111.872 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.2 p -129.53 149.97 51.07 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.86 0.838 . . . . 0.0 110.134 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.74 -27.79 68.57 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 113.063 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -107.25 -5.7 17.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.435 1.094 . . . . 0.0 113.1 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 60.05 40.23 18.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.967 1.307 . . . . 0.0 110.87 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -109.78 36.7 2.89 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.391 1.476 . . . . 0.0 112.073 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.11 121.95 5.69 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.714 -1.241 . . . . 0.0 112.464 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.31 135.84 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.118 0.959 . . . . 0.0 110.603 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -120.55 129.73 53.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.448 1.499 . . . . 0.0 111.502 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.47 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.915 0.886 . . . . 0.0 109.957 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -79.64 120.39 23.9 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.473 0.709 . . . . 0.0 110.8 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.61 132.8 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.809 0.844 . . . . 0.0 110.48 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.37 97.15 7.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.199 1.4 . . . . 0.0 109.173 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.29 -13.49 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -77.16 -56.78 4.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.379 0.536 . . . . 0.0 111.038 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.95 -8.4 59.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.278 1.431 . . . . 0.0 114.154 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttt 72.21 27.78 2.52 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.846 1.659 . . . . 0.0 112.443 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -102.39 173.4 6.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.123 0.969 . . . . 0.0 111.475 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -147.64 139.45 24.06 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.359 1.464 . . . . 0.0 109.353 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.0 t -127.9 134.32 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.695 1.198 . . . . 0.0 107.923 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.1 mt -111.97 131.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -137.33 124.95 22.24 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.559 1.544 . . . . 0.0 110.46 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.31 17.48 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -64.37 163.71 12.65 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.325 1.06 . . . . 0.0 111.534 165.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -57.87 -31.83 67.09 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.19 0.996 . . . . 0.0 112.84 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.04 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.724 1.147 . . . . 0.0 113.786 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.13 -61.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.2 1.5 . . . . 0.0 108.638 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -51.5 -41.55 61.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.335 1.054 . . . . 0.0 112.921 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.32 -13.61 59.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.692 1.197 . . . . 0.0 112.932 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.11 -31.92 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.588 1.086 . . . . 0.0 113.525 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 m -108.08 165.94 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.49 1.041 . . . . 0.0 112.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.04 172.39 6.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.427 1.091 . . . . 0.0 113.456 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.867 -1.145 . . . . 0.0 112.84 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -61.42 -25.75 67.41 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.388 1.075 . . . . 0.0 113.57 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -74.96 -46.17 37.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.612 0.765 . . . . 0.0 109.544 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.64 -31.24 72.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.497 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -57.63 -33.75 68.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.771 1.228 . . . . 0.0 112.193 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 p -66.54 -43.11 86.01 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.895 0.478 . . . . 0.0 111.699 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -52.09 66.9 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.285 1.834 . . . . 0.0 110.131 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -59.0 -50.04 75.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.61 0.764 . . . . 0.0 111.148 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -58.23 -43.69 87.86 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.21 -49.75 68.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.46 -47.97 90.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.013 0.925 . . . . 0.0 110.515 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -60.31 -45.98 91.5 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.571 1.148 . . . . 0.0 112.879 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.22 -35.82 76.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.341 0.656 . . . . 0.0 112.528 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -87.01 -34.87 19.09 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.207 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.21 -35.59 73.88 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.933 0.788 . . . . 0.0 111.631 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -68.42 -31.73 71.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 112.979 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.37 -35.12 70.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.464 1.105 . . . . 0.0 110.441 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 6.85 25.43 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.957 1.741 . . . . 0.0 114.533 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -98.64 94.13 6.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.071 0.949 . . . . 0.0 111.259 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -70.52 -37.2 74.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.46 0.704 . . . . 0.0 111.826 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -54.76 -56.94 13.94 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.964 0.906 . . . . 0.0 111.03 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HA ' HG12 ' A' ' 114' ' ' VAL . 84.9 mt-30 -61.09 -42.6 98.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.27 97.13 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.191 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.17 -46.57 67.21 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.834 -1.079 . . . . 0.0 111.207 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 111' ' ' GLN . 4.2 p -70.73 -41.0 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.681 1.128 . . . . 0.0 113.064 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.6 -35.78 81.82 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.832 0.742 . . . . 0.0 110.982 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.58 95.52 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.976 174.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.25 -43.49 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.575 1.187 . . . . 0.0 111.352 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -58.87 -52.18 66.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 0.0 110.671 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -66.62 -39.75 88.46 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.835 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.84 72.44 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.729 0.695 . . . . 0.0 111.389 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.87 95.74 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.689 1.131 . . . . 0.0 112.496 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.55 -39.24 88.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.135 -1.214 . . . . 0.0 112.919 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 -48.15 48.85 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.895 0.878 . . . . 0.0 110.602 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.1 mt -60.63 -36.2 78.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.74 1.616 . . . . 0.0 110.767 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.14 50.3 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.34 -37.59 68.81 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.406 -1.434 . . . . 0.0 111.995 170.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -85.04 -32.56 22.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 112.586 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.07 88.34 31.81 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.436 1.895 . . . . 0.0 109.329 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.81 139.82 34.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.541 2.827 . . . . 0.0 110.097 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -64.46 131.46 47.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -103.7 145.8 29.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.007 0.923 . . . . 0.0 110.299 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.43 -30.09 68.24 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 119.675 -1.891 . . . . 0.0 113.908 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -92.2 12.18 23.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.311 1.444 . . . . 0.0 113.177 -176.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.82 154.19 7.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -172.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.78 112.18 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 122.304 1.049 . . . . 0.0 111.562 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.2 111.99 23.76 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 106.577 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -115.25 -36.85 4.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.944 0.897 . . . . 0.0 112.412 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.82 143.11 34.96 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.872 1.269 . . . . 0.0 109.721 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.35 140.09 24.12 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.164 1.909 . . . . 0.0 111.018 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -77.51 8.55 4.16 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.712 1.205 . . . . 0.0 113.663 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -75.76 153.25 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.907 1.683 . . . . 0.0 110.9 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.24 130.78 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.173 0.989 . . . . 0.0 108.664 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.1 m -82.8 142.41 31.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.351 1.06 . . . . 0.0 110.251 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -140.73 138.57 34.28 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.581 -1.325 . . . . 0.0 111.686 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.83 2.633 . . . . 0.0 114.082 -179.025 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -64.32 147.74 51.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.382 1.446 . . . . 0.0 112.696 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.34 126.59 33.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.9 0.857 . . . . 0.0 111.765 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.1 pt -74.71 17.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 125.451 1.5 . . . . 0.0 114.189 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -88.47 -32.86 18.05 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.907 -1.121 . . . . 0.0 110.674 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -104.36 79.34 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.322 1.449 . . . . 0.0 109.407 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 71' ' ' VAL . 51.4 m-85 -61.87 -31.57 71.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.95 133.83 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.256 1.822 . . . . 0.0 108.333 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -71.57 157.53 37.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.923 0.889 . . . . 0.0 109.406 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -24.31 8.43 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -75.13 -36.46 61.61 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.742 -1.224 . . . . 0.0 112.37 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -76.8 -42.82 39.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.17 1.788 . . . . 0.0 110.209 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.68 -49.08 76.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.32 -46.98 69.64 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.28 -0.888 . . . . 0.0 111.645 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.54 -28.57 67.91 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -80.59 -37.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 120.692 1.587 . . . . 0.0 112.191 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.54 -44.16 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.459 1.027 . . . . 0.0 110.944 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -57.97 -39.56 78.46 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.216 1.406 . . . . 0.0 112.707 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.59 -32.23 71.99 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.59 -0.693 . . . . 0.0 112.384 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.5 mt -67.9 -46.56 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.072 0.851 . . . . 0.0 110.008 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.64 -31.63 64.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.298 1.039 . . . . 0.0 113.157 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -79.35 -27.78 42.02 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.038 0.835 . . . . 0.0 113.109 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.48 -35.83 70.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.479 0.712 . . . . 0.0 111.695 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.43 -1.56 0.56 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.024 2.13 . . . . 0.0 113.933 167.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -117.61 9.66 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.055 1.742 . . . . 0.0 112.388 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -126.22 -14.66 5.92 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.045 1.338 . . . . 0.0 114.097 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -162.28 140.62 8.89 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.722 1.209 . . . . 0.0 109.459 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -83.11 46.5 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.73 0.812 . . . . 0.0 111.243 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.92 137.86 7.69 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.203 1.383 . . . . 0.0 109.686 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -113.84 128.08 56.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.933 0.873 . . . . 0.0 112.064 -152.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.7 mt -120.74 116.66 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.284 -1.51 . . . . 0.0 110.733 -172.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.74 147.92 37.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.887 2.075 . . . . 0.0 110.78 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.83 136.86 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.416 1.086 . . . . 0.0 110.695 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -118.32 118.97 33.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.403 1.881 . . . . 0.0 112.374 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 tp -108.11 129.06 55.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.949 0.9 . . . . 0.0 111.972 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.87 166.96 27.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.108 1.363 . . . . 0.0 110.312 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 71' ' ' VAL . 95.0 mttt -81.03 -72.48 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.548 -1.345 . . . . 0.0 113.14 -173.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -144.18 -175.95 4.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 128.22 2.608 . . . . 0.0 108.433 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.5 p -152.27 160.1 43.4 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.215 -0.928 . . . . 0.0 113.226 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.08 -3.27 41.61 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 pt -135.2 -146.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.501 -1.374 . . . . 0.0 110.997 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -95.54 141.24 29.3 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.564 1.529 . . . . 0.0 111.796 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.81 -32.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.259 -0.901 . . . . 0.0 112.544 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.65 -46.27 72.91 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.295 0.498 . . . . 0.0 110.904 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -60.06 -43.52 95.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.152 0.581 . . . . 0.0 111.537 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -60.5 -47.1 87.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.83 77.08 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.014 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.6 ttp -66.21 -52.46 47.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.764 0.711 . . . . 0.0 111.644 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.82 -44.99 91.0 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.989 0.813 . . . . 0.0 112.499 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.04 -40.8 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.247 1.019 . . . . 0.0 110.73 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.41 -51.09 70.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.985 0.811 . . . . 0.0 110.933 173.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.75 -39.13 80.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.578 0.751 . . . . 0.0 112.564 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.68 -38.21 89.46 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.212 1.405 . . . . 0.0 113.554 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.12 -4.74 46.0 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.061 -1.024 . . . . 0.0 113.274 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 58.85 34.04 23.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.711 1.204 . . . . 0.0 112.311 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.3 mmm -59.14 -22.43 60.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.044 2.138 . . . . 0.0 113.93 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -72.52 -6.94 47.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.38 2.272 . . . . 0.0 113.534 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.4 56.64 2.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.469 1.907 . . . . 0.0 110.956 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.1 p -127.75 137.79 52.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.113 2.165 . . . . 0.0 109.317 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -60.99 -36.45 79.51 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.29 -0.881 . . . . 0.0 112.456 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.9 mt -93.82 -9.44 37.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.932 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 66.63 49.35 1.31 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.397 1.453 . . . . 0.0 109.456 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.9 16.12 13.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.828 1.651 . . . . 0.0 113.994 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.38 136.47 30.13 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.05 -1.032 . . . . 0.0 112.187 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.58 138.4 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.649 1.179 . . . . 0.0 110.61 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 tp -117.98 127.57 53.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.277 1.431 . . . . 0.0 110.122 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.2 mt -103.66 96.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -81.06 126.45 31.45 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.903 -0.498 . . . . 0.0 110.391 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.18 127.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.128 0.971 . . . . 0.0 110.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.66 118.0 34.39 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.257 1.023 . . . . 0.0 110.483 167.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG21 ' CE1' ' A' ' 7' ' ' PHE . 29.0 m -76.59 -24.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -77.0 -55.97 4.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.207 0.458 . . . . 0.0 110.288 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -84.69 -1.31 55.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.629 1.171 . . . . 0.0 112.54 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.2 tttt 67.4 19.88 10.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 113.393 172.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.3 m -94.67 115.43 27.54 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.365 1.466 . . . . 0.0 110.874 -170.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -90.35 143.56 26.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.984 1.314 . . . . 0.0 110.004 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.08 150.86 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.726 1.61 . . . . 0.0 108.462 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.69 127.66 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -140.19 127.08 20.67 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.924 0.89 . . . . 0.0 110.599 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.6 158.2 14.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.579 1.085 . . . . 0.0 111.373 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.87 173.77 7.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 123.155 1.455 . . . . 0.0 112.638 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -60.72 -37.46 81.78 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.505 1.522 . . . . 0.0 113.685 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.09 -47.13 55.62 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.732 1.158 . . . . 0.0 112.588 -175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -54.7 -55.6 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.601 1.2 . . . . 0.0 109.36 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -79.16 -38.76 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.127 1.371 . . . . 0.0 111.598 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.5 m -92.75 -26.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 169.6 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 119.929 1.24 . . . . 0.0 113.055 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 p -119.17 171.59 8.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.125 1.37 . . . . 0.0 113.31 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.24 -30.25 71.11 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.674 -1.266 . . . . 0.0 113.338 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 0.0 112.344 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.5 t80 -76.22 -38.88 55.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.747 172.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -70.12 -28.86 65.72 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 125.08 1.352 . . . . 0.0 113.432 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.56 -31.62 72.84 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.6 m -62.32 -43.26 99.23 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.689 0.677 . . . . 0.0 111.062 171.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -60.21 -48.44 81.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.329 1.452 . . . . 0.0 111.516 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -59.57 -48.09 83.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.693 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -63.67 -35.26 79.96 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.91 61.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.18 0.9 . . . . 0.0 111.793 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.64 -49.9 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.315 0.646 . . . . 0.0 110.583 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.64 -39.9 85.88 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.907 1.283 . . . . 0.0 112.724 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.31 -45.06 96.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.649 1.113 . . . . 0.0 111.954 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -79.14 -37.04 39.51 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.944 -0.473 . . . . 0.0 110.971 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -59.55 -39.83 85.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.186 0.903 . . . . 0.0 111.887 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -64.39 -31.59 72.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.786 1.634 . . . . 0.0 113.034 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -73.06 -34.8 66.49 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 118.756 0.707 . . . . 0.0 111.299 168.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 8.18 11.74 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 126.192 1.853 . . . . 0.0 113.793 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -107.43 78.52 1.22 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 0.0 111.816 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -53.39 -46.5 69.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.412 1.485 . . . . 0.0 112.952 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.7 -49.62 74.58 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.545 -0.722 . . . . 0.0 111.539 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.61 -44.35 90.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.826 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.74 97.08 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 119.003 0.819 . . . . 0.0 113.387 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.31 -47.19 68.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.46 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.54 -51.65 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.364 1.066 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.26 -41.94 98.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.114 0.966 . . . . 0.0 111.2 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -17.78 76.28 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 121.049 -1.032 . . . . 0.0 113.5 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.96 -50.63 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.649 1.58 . . . . 0.0 109.825 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.91 -51.65 68.28 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.775 1.171 . . . . 0.0 111.982 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.35 -37.6 86.29 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.058 -1.026 . . . . 0.0 112.122 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.27 88.41 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.886 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.41 87.09 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.116 0.871 . . . . 0.0 111.231 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 59.9 ttm -59.96 -43.47 95.04 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.027 0.913 . . . . 0.0 112.503 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -69.45 -47.31 64.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.25 0.62 . . . . 0.0 111.78 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.55 -36.41 82.55 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.284 1.034 . . . . 0.0 111.466 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.27 -22.47 61.2 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -66.14 -41.71 90.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.866 1.212 . . . . 0.0 111.438 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -81.59 -27.39 34.29 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.029 1.731 . . . . 0.0 113.001 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -138.86 76.35 34.48 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 126.594 1.957 . . . . 0.0 110.097 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.56 143.86 64.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.326 2.684 . . . . 0.0 111.144 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -66.7 137.21 56.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -118.03 150.82 38.65 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.787 1.635 . . . . 0.0 110.149 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -67.15 -19.63 65.62 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.181 -1.574 . . . . 0.0 113.524 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -106.72 17.75 22.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.054 2.941 . . . . 0.0 112.037 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -52.7 153.84 3.0 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.044 1.338 . . . . 0.0 112.19 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.08 125.38 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 120.735 -1.228 . . . . 0.0 111.848 -167.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.84 88.09 7.1 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.278 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -74.77 -30.34 61.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.57 0.748 . . . . 0.0 112.721 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.35 158.19 49.4 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.295 1.438 . . . . 0.0 110.953 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -91.31 136.76 1.97 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.347 2.698 . . . . 0.0 111.669 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -57.39 -14.07 4.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.7 m -50.32 140.39 13.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.44 134.82 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.551 1.14 . . . . 0.0 109.582 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 m -93.56 138.62 31.64 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.387 1.089 . . . . 0.0 111.982 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.21 157.29 46.19 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.778 1.631 . . . . 0.0 109.28 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 C-N-CA 125.169 1.366 . . . . 0.0 111.786 172.786 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mtp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -167.73 152.51 6.78 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.931 0.892 . . . . 0.0 109.937 -161.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.78 -4.17 55.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.832 0.853 . . . . 0.0 113.124 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -139.63 156.57 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 128.042 2.537 . . . . 0.0 108.68 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.85 -166.43 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -163.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -77.87 -24.96 48.36 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.386 -0.821 . . . . 0.0 112.469 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.6 -70.43 0.16 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.792 1.637 . . . . 0.0 111.622 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.8 mt -133.3 143.35 48.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 109.086 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -86.33 170.22 12.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.739 0.781 . . . . 0.0 110.375 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.26 -29.47 5.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.137 1.375 . . . . 0.0 114.636 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -80.22 -38.47 31.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 0.0 111.979 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -76.67 -44.49 33.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.949 1.3 . . . . 0.0 111.036 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.47 -45.66 92.04 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.057 1.343 . . . . 0.0 111.168 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.04 -40.01 79.83 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.895 -1.128 . . . . 0.0 111.603 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.94 80.32 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 0.594 . . . . 0.0 111.962 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.05 -37.32 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.319 0.963 . . . . 0.0 112.909 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.95 -40.88 84.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 118.953 0.797 . . . . 0.0 111.283 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -72.64 -29.28 63.32 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.143 0.883 . . . . 0.0 113.31 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.01 76.68 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.522 -0.736 . . . . 0.0 112.645 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.54 -40.53 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -61.43 -31.21 71.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.865 0.866 . . . . 0.0 112.134 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.01 -31.13 62.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.422 1.089 . . . . 0.0 112.685 172.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.37 -39.25 59.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.824 1.25 . . . . 0.0 113.027 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.94 -23.72 63.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 112.564 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.8 8.84 26.99 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.527 -1.358 . . . . 0.0 113.39 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -130.62 -8.96 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.912 1.685 . . . . 0.0 113.78 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -157.48 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.501 1.521 . . . . 0.0 108.888 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 27.8 1.52 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.686 0.794 . . . . 0.0 112.162 174.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.09 151.35 17.34 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.248 1.404 . . . . 0.0 111.443 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -112.28 127.89 56.11 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -161.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.37 119.96 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.401 -1.437 . . . . 0.0 110.216 -172.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -128.58 147.07 50.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.443 1.097 . . . . 0.0 112.071 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.23 141.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.024 1.33 . . . . 0.0 110.203 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.54 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.8 t60 -126.96 123.38 37.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.172 0.989 . . . . 0.0 110.869 168.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 tp -104.77 147.79 27.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 0.0 111.463 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.44 166.36 32.41 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.882 1.325 . . . . 0.0 109.644 159.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -59.62 -78.28 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 C-N-CA 126.236 1.814 . . . . 0.0 113.073 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -138.08 -177.03 4.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.536 1.534 . . . . 0.0 110.71 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -137.46 142.57 41.56 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.397 1.479 . . . . 0.0 111.434 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -81.07 -27.84 35.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.041 0.936 . . . . 0.0 112.947 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 pt -115.71 -146.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.099 1.759 . . . . 0.0 110.636 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.85 133.74 36.28 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.578 -1.326 . . . . 0.0 111.875 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.21 -36.89 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.853 0.861 . . . . 0.0 112.314 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.78 -49.75 64.89 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.866 1.212 . . . . 0.0 111.7 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -60.63 -42.59 97.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.158 0.583 . . . . 0.0 112.192 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -36.93 85.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.65 88.32 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.848 -1.157 . . . . 0.0 111.763 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.6 ttp -63.18 -49.93 72.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.376 0.67 . . . . 0.0 111.439 170.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.08 -47.96 79.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.845 0.748 . . . . 0.0 111.087 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.29 -42.02 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 111.814 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.59 -53.2 60.84 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.598 1.09 . . . . 0.0 111.054 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.21 -32.3 62.98 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.376 0.67 . . . . 0.0 112.353 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.626 -1.296 . . . . 0.0 112.824 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.1 -6.55 58.95 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.164 0.985 . . . . 0.0 112.559 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 tttt 61.44 36.02 17.43 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.802 1.641 . . . . 0.0 111.625 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.5 mtp -72.7 -5.5 38.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -77.57 -2.5 36.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.631 1.972 . . . . 0.0 113.18 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -73.26 33.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.293 1.837 . . . . 0.0 114.318 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 p -111.44 153.98 25.33 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.037 1.735 . . . . 0.0 111.947 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.75 -39.17 87.81 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.04 -4.2 22.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.188 -0.91 . . . . 0.0 113.39 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 67.78 31.49 5.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.662 1.585 . . . . 0.0 110.021 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.37 33.03 3.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.454 1.902 . . . . 0.0 112.594 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.31 123.55 6.38 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.358 0.98 . . . . 0.0 112.999 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -112.18 138.42 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.449 1.1 . . . . 0.0 112.011 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 34' ' ' HIS . 33.9 tp -117.01 128.54 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.475 1.51 . . . . 0.0 111.228 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -104.38 97.93 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.456 1.102 . . . . 0.0 108.963 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -81.12 125.0 29.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 111.017 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.38 134.29 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.108 0.963 . . . . 0.0 111.115 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.24 105.93 16.14 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.107 1.763 . . . . 0.0 110.613 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -77.77 -13.03 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -78.46 -40.74 34.72 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.174 0.897 . . . . 0.0 112.07 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.81 -10.6 26.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.824 1.249 . . . . 0.0 112.219 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.0 tttt 71.96 24.28 3.32 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.738 1.615 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.3 p -105.85 165.03 11.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.313 1.045 . . . . 0.0 111.607 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -143.32 144.52 32.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 109.616 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -138.97 139.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.95 1.7 . . . . 0.0 107.719 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.7 mt -116.0 133.3 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -138.58 126.94 23.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.207 1.003 . . . . 0.0 110.401 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.93 150.54 18.42 Favored Glycine 0 N--CA 1.462 0.398 0 C-N-CA 125.174 1.368 . . . . 0.0 112.208 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -64.17 164.03 11.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 122.598 1.19 . . . . 0.0 112.319 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -53.85 -35.12 61.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.435 1.494 . . . . 0.0 112.377 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -28.08 73.65 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 119.626 1.103 . . . . 0.0 114.387 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.39 -58.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.283 1.541 . . . . 0.0 109.798 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -54.6 -32.94 59.58 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.308 1.443 . . . . 0.0 113.869 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -76.87 -24.13 52.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 88' ' ' VAL . 10.3 m -103.91 -35.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.908 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 87' ' ' VAL . 3.0 m -104.7 169.17 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 120.004 1.274 . . . . 0.0 112.632 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -119.46 177.77 4.79 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.563 1.545 . . . . 0.0 113.271 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -61.73 -33.46 74.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.683 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.39 -20.21 62.96 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.03 0.932 . . . . 0.0 112.557 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -77.87 -30.66 50.97 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 169.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -83.99 -26.34 29.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -54.86 -44.03 73.65 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.963 1.305 . . . . 0.0 112.416 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.8 p -63.12 -35.29 79.78 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 m -66.43 -51.16 59.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.476 1.91 . . . . 0.0 110.245 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -60.9 -44.57 96.95 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.146 0.978 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -57.19 -47.22 81.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.874 0.761 . . . . 0.0 112.524 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.45 -48.2 82.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.436 1.017 . . . . 0.0 111.841 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.12 -49.15 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.946 0.898 . . . . 0.0 110.352 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -59.86 -42.13 93.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.999 1.32 . . . . 0.0 112.356 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.89 -38.36 86.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.74 -32.84 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.391 0.541 . . . . 0.0 111.172 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -62.39 -39.05 91.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.637 0.775 . . . . 0.0 111.645 168.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -59.38 -31.32 69.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.683 1.193 . . . . 0.0 113.038 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.36 -41.04 22.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.378 1.071 . . . . 0.0 111.257 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.36 1.23 8.58 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.581 1.563 . . . . 0.0 114.843 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -93.63 80.69 4.28 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.815 1.307 . . . . 0.0 111.532 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -59.77 -44.44 93.87 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.789 1.235 . . . . 0.0 112.609 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -50.99 -58.67 5.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.314 1.045 . . . . 0.0 111.363 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.004 0.921 . . . . 0.0 111.698 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.04 -37.41 94.18 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 118.72 0.691 . . . . 0.0 113.664 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.08 -44.94 59.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.448 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.68 -51.67 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.326 0.65 . . . . 0.0 111.12 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.88 -33.75 76.77 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.346 0.659 . . . . 0.0 112.3 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.23 83.77 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.338 -0.851 . . . . 0.0 112.667 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.94 -46.67 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.167 1.483 . . . . 0.0 109.877 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.24 -47.63 81.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.305 0.642 . . . . 0.0 111.29 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -61.63 -38.69 88.58 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 121.547 -0.72 . . . . 0.0 112.202 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.66 64.24 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.322 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.3 -45.61 74.21 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 120.37 1.441 . . . . 0.0 113.284 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mtp -63.37 -38.11 89.89 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.158 -1.201 . . . . 0.0 112.907 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.497 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -78.38 -38.84 40.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 110.901 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.49 -33.14 70.89 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.453 1.501 . . . . 0.0 112.549 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.49 41.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -71.85 -29.56 64.52 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.112 -0.992 . . . . 0.0 113.429 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -91.62 -35.54 14.17 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.777 1.231 . . . . 0.0 111.527 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -136.34 90.99 16.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.328 1.851 . . . . 0.0 109.879 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.37 144.17 60.81 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.639 2.226 . . . . 0.0 111.299 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -62.93 161.53 12.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.6 0.76 . . . . 0.0 112.747 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -142.9 159.28 42.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -62.27 -29.25 70.29 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.542 -1.349 . . . . 0.0 113.236 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -99.82 29.15 4.3 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.651 1.581 . . . . 0.0 112.4 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.33 151.17 44.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.834 -1.166 . . . . 0.0 112.003 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.79 114.4 35.24 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 C-N-CA 124.24 1.016 . . . . 0.0 110.887 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -78.21 93.65 4.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.515 0.726 . . . . 0.0 109.41 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.48 -27.28 34.63 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.14 158.95 32.35 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.202 1.401 . . . . 0.0 110.312 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.36 159.09 14.93 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.413 2.742 . . . . 0.0 111.046 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -83.83 2.52 37.87 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.6 p -76.33 160.9 29.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.989 1.316 . . . . 0.0 112.325 -166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.94 140.49 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.536 0.735 . . . . 0.0 109.815 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.4 t -110.07 140.66 43.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.668 -1.27 . . . . 0.0 111.942 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -134.88 137.37 43.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 C-N-CA 124.993 1.282 . . . . 0.0 114.793 169.976 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 p -45.44 -43.83 11.73 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -111.61 136.53 50.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.142 0.977 . . . . 0.0 113.362 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.1 tt -77.42 124.83 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.478 1.511 . . . . 0.0 111.882 172.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -72.65 152.5 41.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.975 0.91 . . . . 0.0 111.301 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -80.27 79.21 6.88 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.709 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -59.21 -38.42 79.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.149 0.979 . . . . 0.0 112.65 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.599 1.959 . . . . 0.0 109.724 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -64.05 150.64 44.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.066 1.346 . . . . 0.0 109.38 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.45 55.73 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.249 -1.532 . . . . 0.0 113.983 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -68.67 -35.63 77.47 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.357 1.463 . . . . 0.0 113.566 174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.54 -35.24 78.67 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.499 -1.376 . . . . 0.0 111.152 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.82 -44.19 97.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.875 0.87 . . . . 0.0 110.956 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -45.3 87.22 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.013 -1.054 . . . . 0.0 111.162 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.58 76.27 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.0 -38.8 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 119.846 1.203 . . . . 0.0 112.21 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.75 -39.63 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 119.67 1.123 . . . . 0.0 111.934 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.42 -35.37 77.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.477 1.111 . . . . 0.0 112.741 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.34 87.63 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.859 0.463 . . . . 0.0 111.631 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.6 mt -66.31 -46.56 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.79 1.236 . . . . 0.0 110.243 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -57.7 -28.9 64.25 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.23 -30.29 34.23 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.048 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.74 85.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.922 1.289 . . . . 0.0 112.25 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.02 -17.4 2.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.514 1.525 . . . . 0.0 113.787 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -106.63 14.42 26.98 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.034 -1.666 . . . . 0.0 112.396 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -130.68 -15.92 3.43 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.83 1.652 . . . . 0.0 113.961 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -152.39 152.84 32.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.845 1.258 . . . . 0.0 110.577 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -81.03 3.5 22.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.276 1.03 . . . . 0.0 112.812 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 -161.74 21.85 Favored Glycine 0 C--N 1.343 0.934 0 C-N-CA 125.996 1.76 . . . . 0.0 111.668 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -162.86 129.52 3.48 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.246 0.618 . . . . 0.0 112.159 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.78 116.15 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.37 1.068 . . . . 0.0 110.634 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -121.78 153.09 38.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.622 1.169 . . . . 0.0 111.218 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.11 132.78 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.65 1.18 . . . . 0.0 110.725 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -117.3 124.22 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.257 1.027 . . . . 0.0 112.515 169.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.41 HD11 ' CG1' ' A' ' 71' ' ' VAL . 12.7 tp -108.33 126.15 52.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.069 1.347 . . . . 0.0 112.401 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -150.6 161.63 42.21 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.462 1.105 . . . . 0.0 110.21 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -73.7 -68.98 0.46 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.645 -1.284 . . . . 0.0 113.302 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -156.57 157.66 35.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.434 1.894 . . . . 0.0 110.277 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.1 p -115.8 147.93 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.585 1.554 . . . . 0.0 112.77 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -80.5 -29.23 37.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.15 0.98 . . . . 0.0 111.566 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -107.8 -167.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.843 1.657 . . . . 0.0 111.447 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -68.75 134.39 49.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.594 1.158 . . . . 0.0 112.678 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.87 -38.06 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.967 0.907 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.24 -51.25 68.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.682 0.674 . . . . 0.0 112.109 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.17 -43.02 93.07 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.135 0.574 . . . . 0.0 111.47 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -58.51 -42.33 87.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.669 0.788 . . . . 0.0 112.418 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.29 -35.13 77.38 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.902 0.881 . . . . 0.0 111.555 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.2 ttp -63.68 -49.21 74.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.545 0.738 . . . . 0.0 111.119 170.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.08 -52.45 65.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.049 0.939 . . . . 0.0 111.464 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.14 -42.5 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.506 1.122 . . . . 0.0 111.448 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.54 -46.44 90.15 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.45 1.1 . . . . 0.0 112.003 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -70.15 -36.96 75.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.443 1.497 . . . . 0.0 111.872 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.24 -22.36 59.37 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.768 1.227 . . . . 0.0 114.058 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.79 -8.82 57.87 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.684 1.194 . . . . 0.0 112.421 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 65.74 32.89 8.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.232 1.413 . . . . 0.0 112.712 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.7 mtp -64.98 -23.63 67.28 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.36 -13.41 1.4 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.584 1.954 . . . . 0.0 114.709 168.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -73.79 43.89 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.486 1.915 . . . . 0.0 112.915 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.2 m -120.74 129.7 53.74 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.658 1.583 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.78 -39.45 65.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.449 1.499 . . . . 0.0 113.83 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.44 2.82 42.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 0.0 113.707 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 62.87 32.73 15.63 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.288 1.035 . . . . 0.0 111.169 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -107.82 27.15 9.5 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.372 1.469 . . . . 0.0 113.12 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.18 125.8 7.29 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.203 0.906 . . . . 0.0 112.077 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.23 135.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.979 1.312 . . . . 0.0 109.714 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.17 127.99 54.66 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.241 1.02 . . . . 0.0 111.315 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -101.55 96.19 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.621 1.568 . . . . 0.0 109.215 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -84.16 124.37 31.08 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.151 -0.968 . . . . 0.0 110.805 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -120.9 131.92 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.224 1.01 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 90.96 3.54 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.131 1.773 . . . . 0.0 110.609 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG1' HD11 ' A' ' 35' ' ' LEU . 27.2 m -73.29 -14.82 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -167.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -75.61 -34.97 60.62 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 122.847 0.459 . . . . 0.0 111.252 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.45 -12.22 16.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.116 2.167 . . . . 0.0 112.757 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 73.03 26.0 2.26 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.127 1.771 . . . . 0.0 112.441 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -110.01 167.44 10.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.073 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -148.39 148.64 30.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.298 1.039 . . . . 0.0 110.644 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.9 142.37 40.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.63 128.26 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -145.84 125.64 13.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.621 1.168 . . . . 0.0 109.606 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.35 161.98 13.38 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.527 1.061 . . . . 0.0 112.023 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -64.58 162.91 14.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 123.212 1.482 . . . . 0.0 111.798 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.008 1.723 . . . . 0.0 113.451 -170.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.48 -25.44 72.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.259 -1.301 . . . . 0.0 114.534 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 -58.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.971 1.885 . . . . 0.0 109.302 167.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -59.69 -25.15 64.53 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.5 -18.24 34.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.472 1.109 . . . . 0.0 113.884 174.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 88' ' ' VAL . 1.4 p -104.11 -20.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 87' ' ' VAL . 4.7 m -129.11 167.47 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.844 1.257 . . . . 0.0 111.287 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -120.25 173.06 7.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.54 1.136 . . . . 0.0 113.101 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -49.41 -38.49 29.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -31.0 72.04 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.9 t80 -70.88 -32.78 69.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.656 0.782 . . . . 0.0 111.636 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -78.99 -26.35 43.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.289 1.436 . . . . 0.0 113.334 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.99 -41.56 87.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.57 0.748 . . . . 0.0 112.646 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -59.53 -43.05 93.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.255 0.479 . . . . 0.0 111.287 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -61.34 -51.16 70.0 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 125.72 1.608 . . . . 0.0 110.401 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.08 -48.51 79.93 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 118.075 -0.965 . . . . 0.0 110.587 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.85 -41.69 96.35 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.207 1.367 . . . . 0.0 113.362 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.09 79.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.917 1.235 . . . . 0.0 111.327 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.33 -54.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.934 0.894 . . . . 0.0 110.451 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -52.37 -44.94 65.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.304 1.842 . . . . 0.0 113.174 -175.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.37 -30.54 62.03 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.215 0.606 . . . . 0.0 112.557 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -82.36 -39.65 22.45 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.75 0.82 . . . . 0.0 111.063 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.98 -43.25 91.37 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.407 0.683 . . . . 0.0 111.406 170.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.06 -37.31 71.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.264 1.025 . . . . 0.0 112.06 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -71.89 -41.08 68.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.337 1.055 . . . . 0.0 111.409 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.13 4.78 6.42 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 126.323 1.916 . . . . 0.0 113.648 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -102.46 81.4 2.05 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 119.0 1.4 . . . . 0.0 111.71 -171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -60.03 -43.61 95.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.754 0.822 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.43 -52.69 64.37 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.783 -0.573 . . . . 0.0 111.515 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -56.93 -44.76 82.79 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.06 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.92 96.08 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.344 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.75 -52.22 64.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.754 0.777 . . . . 0.0 111.021 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.3 t -63.77 -49.15 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.163 . . . . 0.0 110.907 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.37 -32.72 74.29 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.845 0.748 . . . . 0.0 111.834 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.99 -45.42 73.14 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.57 -47.85 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.015 1.326 . . . . 0.0 111.309 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.87 -49.56 76.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.577 0.751 . . . . 0.0 111.483 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -63.48 -34.75 78.45 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.387 -0.82 . . . . 0.0 112.466 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.52 79.52 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.023 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.76 -39.76 97.89 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.51 1.05 . . . . 0.0 112.776 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 78.5 mtp -61.46 -48.41 81.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.046 0.923 . . . . 0.0 112.379 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.62 -41.85 65.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.657 0.783 . . . . 0.0 112.308 -176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.65 -37.92 85.8 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 111.185 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.12 -23.59 67.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -62.22 -45.6 92.61 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.494 -1.379 . . . . 0.0 111.225 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -74.03 -39.44 63.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.21 1.004 . . . . 0.0 111.988 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.42 82.56 65.95 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 125.986 1.715 . . . . 0.0 110.567 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.83 136.58 53.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.36 2.04 . . . . 0.0 109.622 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -57.54 135.75 56.67 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -108.75 146.29 33.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.885 1.274 . . . . 0.0 110.003 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -24.48 67.39 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.426 -1.421 . . . . 0.0 113.541 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -105.51 19.42 20.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.016 1.326 . . . . 0.0 113.467 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.8 162.1 1.91 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.269 1.428 . . . . 0.0 113.66 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.89 116.66 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 122.622 1.201 . . . . 0.0 112.221 -170.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -101.31 104.13 15.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.088 1.755 . . . . 0.0 109.597 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -115.63 -17.84 11.03 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 mp -84.67 160.07 56.85 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 120.201 1.364 . . . . 0.0 110.533 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -95.95 141.91 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.162 3.241 . . . . 0.0 111.271 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -72.63 -1.33 15.79 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -62.62 150.49 40.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.077 0.951 . . . . 0.0 111.445 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.6 133.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.67 0.788 . . . . 0.0 108.996 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.76 143.88 27.32 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.614 -0.678 . . . . 0.0 112.295 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -145.85 147.45 31.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.217 -0.927 . . . . 0.0 112.168 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 C-N-CA 126.731 2.11 . . . . 0.0 112.026 165.954 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mtp . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -81.87 -27.95 33.22 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -130.59 147.1 52.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.408 1.083 . . . . 0.0 109.666 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -104.75 -1.63 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.423 1.089 . . . . 0.0 113.112 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.77 -34.38 75.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.755 1.622 . . . . 0.0 112.788 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -136.62 122.73 20.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.781 2.032 . . . . 0.0 108.085 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -75.53 -25.31 57.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.3 126.53 18.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.601 1.56 . . . . 0.0 107.516 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 m -58.79 157.15 10.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.066 0.947 . . . . 0.0 110.31 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.81 -44.03 18.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -51.14 -40.43 58.52 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 173.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -79.49 -39.95 30.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.025 0.93 . . . . 0.0 111.434 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.06 -46.03 75.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -57.95 -48.93 78.48 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.355 -1.466 . . . . 0.0 110.7 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.35 85.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.18 -38.68 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.951 1.25 . . . . 0.0 112.678 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.12 -46.19 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.634 0.652 . . . . 0.0 110.719 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.15 -35.73 79.67 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.885 0.874 . . . . 0.0 112.828 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.38 96.93 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.897 0.772 . . . . 0.0 111.437 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.39 -45.01 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.628 -0.67 . . . . 0.0 110.51 172.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -56.92 -27.46 60.95 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -83.64 -28.85 28.13 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.105 0.866 . . . . 0.0 112.3 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.37 97.63 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.767 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.58 18.4 0.17 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.952 1.301 . . . . 0.0 113.637 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.96 11.44 8.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.823 2.049 . . . . 0.0 111.376 166.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.44 -10.74 3.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.832 1.653 . . . . 0.0 113.378 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -150.5 171.0 17.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.021 1.728 . . . . 0.0 110.171 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -101.35 5.09 42.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.974 1.71 . . . . 0.0 112.776 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.5 126.44 6.52 Favored Glycine 0 C--N 1.343 0.959 0 C-N-CA 124.992 1.282 . . . . 0.0 112.425 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -94.23 142.32 27.55 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -156.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mt -114.76 134.91 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.505 1.122 . . . . 0.0 111.293 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -144.11 149.35 36.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.947 1.299 . . . . 0.0 112.131 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.79 141.79 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.918 1.687 . . . . 0.0 110.327 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' HB2' HD11 ' A' ' 66' ' ' LEU . 37.8 t60 -124.39 127.0 46.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.686 1.594 . . . . 0.0 112.0 170.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -112.77 123.05 49.43 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.393 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 46' ' ' ARG . 26.1 tt0 -143.14 159.07 42.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.036 0.934 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -68.61 -73.29 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.739 -1.226 . . . . 0.0 110.824 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -153.98 159.19 41.55 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.27 1.828 . . . . 0.0 110.671 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -105.21 159.8 15.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.69 1.596 . . . . 0.0 110.361 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -94.48 -27.58 15.92 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.227 -0.921 . . . . 0.0 112.766 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.33 -150.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 126.112 1.765 . . . . 0.0 111.334 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.84 136.51 34.1 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.549 1.139 . . . . 0.0 111.696 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.27 -37.24 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.076 0.95 . . . . 0.0 112.146 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -64.3 -47.43 79.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.372 0.987 . . . . 0.0 111.933 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -44.32 97.09 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.473 1.509 . . . . 0.0 110.387 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 36' ' ' GLU . 47.6 ttt85 -61.04 -45.69 93.75 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.623 1.169 . . . . 0.0 113.409 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.4 98.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.791 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.0 ttp -60.58 -43.17 97.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.963 0.905 . . . . 0.0 113.048 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -61.47 -54.46 43.09 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.933 -1.104 . . . . 0.0 112.228 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.98 -41.57 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.116 0.566 . . . . 0.0 111.86 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.99 -49.89 76.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.88 1.272 . . . . 0.0 111.919 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -74.76 -32.91 62.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.144 0.978 . . . . 0.0 112.059 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -64.99 -36.31 84.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.045 -1.659 . . . . 0.0 112.463 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.97 -8.04 57.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.823 1.249 . . . . 0.0 113.279 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 65.45 35.89 7.07 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 126.226 1.81 . . . . 0.0 112.214 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.4 mtp -69.64 -25.26 63.85 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.865 -1.147 . . . . 0.0 112.79 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -69.64 -12.73 61.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.304 2.241 . . . . 0.0 114.411 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -84.77 63.45 8.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.24 1.416 . . . . 0.0 110.937 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.2 m -132.01 133.94 45.0 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.884 1.673 . . . . 0.0 109.546 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -48.99 -54.73 14.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 113.45 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.24 -9.9 51.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.736 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 62.72 55.39 2.14 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.174 1.79 . . . . 0.0 109.956 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -125.8 28.93 6.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.537 1.135 . . . . 0.0 111.904 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.86 133.78 17.69 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 120.669 -1.269 . . . . 0.0 111.335 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.79 135.84 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.014 1.326 . . . . 0.0 111.273 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.0 tp -118.52 121.37 40.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.916 1.286 . . . . 0.0 110.781 171.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -95.14 96.55 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -78.64 123.02 26.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.391 0.677 . . . . 0.0 110.03 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.4 127.13 75.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.637 1.175 . . . . 0.0 110.212 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.62 92.69 4.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.77 1.228 . . . . 0.0 109.531 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.05 -6.11 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -171.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.24 -49.89 15.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.786 0.721 . . . . 0.0 109.726 170.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.2 -9.43 53.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 112.629 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.3 tttt 71.72 20.59 4.58 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.005 2.122 . . . . 0.0 113.133 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.3 p -102.6 169.34 8.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.957 1.303 . . . . 0.0 111.805 -174.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.46 145.92 31.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.59 1.156 . . . . 0.0 110.595 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.49 136.46 48.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 126.241 1.817 . . . . 0.0 107.103 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.39 127.62 73.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -130.11 147.0 51.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 109.758 173.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.64 154.78 26.04 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -58.52 162.54 3.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.174 1.464 . . . . 0.0 113.767 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -53.23 -36.71 61.35 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.344 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -45.18 94.6 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 120.647 1.567 . . . . 0.0 112.433 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 61.2 mt -58.97 -57.44 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 118.301 1.05 . . . . 0.0 109.854 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -58.57 -29.7 66.59 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -81.59 -16.68 50.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 112.851 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.89 -34.79 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.63 165.93 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.176 1.353 . . . . 0.0 112.016 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.1 m -115.39 165.4 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.055 1.342 . . . . 0.0 112.382 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -61.03 -26.03 67.33 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.83 -1.169 . . . . 0.0 112.997 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.68 -23.3 56.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.154 0.981 . . . . 0.0 112.81 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 53.0 t80 -78.21 -27.4 47.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.639 1.576 . . . . 0.0 111.578 170.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -79.8 -29.43 40.28 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -49.52 -48.04 48.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.566 1.147 . . . . 0.0 112.599 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -54.33 -44.72 72.31 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.533 1.533 . . . . 0.0 112.293 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.3 m -64.94 -48.67 73.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.911 1.284 . . . . 0.0 110.691 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -56.74 -46.39 81.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.377 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.58 -45.6 92.19 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 112.817 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.62 -50.52 71.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.922 1.237 . . . . 0.0 112.362 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.5 -50.99 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.652 0.781 . . . . 0.0 110.655 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -60.29 -46.79 88.63 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.534 1.533 . . . . 0.0 112.012 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.11 -33.61 74.77 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.224 0.609 . . . . 0.0 112.381 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -84.1 -40.18 18.59 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.442 1.097 . . . . 0.0 112.191 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.7 -36.81 77.26 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.569 -0.707 . . . . 0.0 111.186 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -62.7 -29.93 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.996 1.318 . . . . 0.0 113.505 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -80.31 -29.31 38.12 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.942 -1.099 . . . . 0.0 110.866 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 -1.8 33.37 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 126.015 1.769 . . . . 0.0 113.801 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -86.57 92.14 8.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.39 1.095 . . . . 0.0 111.039 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.73 -38.26 88.66 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.032 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -59.98 -59.66 5.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.265 0.626 . . . . 0.0 111.153 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.45 -40.94 96.31 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.913 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.85 97.16 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.923 1.238 . . . . 0.0 114.019 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.1 mt -71.16 -45.65 63.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.395 0.598 . . . . 0.0 111.481 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.87 -50.45 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.307 0.958 . . . . 0.0 112.009 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.501 1.12 . . . . 0.0 111.104 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.53 -47.55 88.54 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 123.574 0.607 . . . . 0.0 111.633 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.27 -42.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.734 1.214 . . . . 0.0 111.333 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.65 -39.82 94.37 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.198 1.399 . . . . 0.0 112.001 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -72.46 -43.59 63.51 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.905 -1.122 . . . . 0.0 111.526 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.02 75.47 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.343 1.057 . . . . 0.0 111.095 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.47 -44.22 96.87 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.256 0.935 . . . . 0.0 112.088 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -67.16 -26.2 66.54 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.566 -0.961 . . . . 0.0 113.557 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -78.22 -50.27 12.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.084 1.353 . . . . 0.0 111.426 172.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.2 mt -58.63 -38.17 77.47 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.763 2.025 . . . . 0.0 111.789 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.55 -14.15 12.0 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -80.53 -35.39 34.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 120.454 -1.404 . . . . 0.0 111.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -84.18 -38.81 20.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 113.041 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.52 86.26 53.72 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.02 1.728 . . . . 0.0 109.235 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.42 135.32 26.35 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.712 2.275 . . . . 0.0 110.466 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -56.33 146.28 24.49 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -125.45 153.64 43.2 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.709 1.204 . . . . 0.0 110.986 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -62.04 -35.86 79.88 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.858 -1.151 . . . . 0.0 113.063 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.3 13.77 9.13 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 113.64 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.38 158.62 28.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.853 0.861 . . . . 0.0 112.732 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.2 168.28 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.041 1.736 . . . . 0.0 110.73 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.61 106.13 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.044 1.738 . . . . 0.0 106.905 -174.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.96 -32.07 20.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.02 0.928 . . . . 0.0 113.087 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.7 mt -109.97 141.72 24.36 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.153 0.981 . . . . 0.0 111.174 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.81 141.08 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.398 2.065 . . . . 0.0 111.288 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -64.92 1.39 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.1 1.76 . . . . 0.0 115.189 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 p -71.39 141.99 50.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.826 -1.171 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 82.4 mt -73.46 136.36 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.245 1.018 . . . . 0.0 109.706 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -96.1 145.91 25.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 120.906 -1.122 . . . . 0.0 111.009 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -144.98 142.46 29.83 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.416 -1.427 . . . . 0.0 112.816 -172.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.406 0 C-N-CA 125.761 1.648 . . . . 0.0 112.814 169.453 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 115.513 -2.184 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -24.77 -32.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -159.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -34.6 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 119.983 -1.698 . . . . 0.0 114.133 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 pt -142.85 138.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.26 2.624 . . . . 0.0 109.499 -173.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -133.98 -95.69 0.29 Allowed 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.055 -1.028 . . . . 0.0 110.785 -168.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.31 -35.54 7.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.46 1.027 . . . . 0.0 112.06 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -46.19 -55.41 7.14 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -148.78 157.46 43.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.329 1.852 . . . . 0.0 110.292 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 p -84.7 166.48 17.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 111.889 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.28 77.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 112.121 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.7 -48.74 78.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.147 1.379 . . . . 0.0 111.052 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -64.32 -44.23 92.19 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.282 0.633 . . . . 0.0 111.366 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.85 -29.51 62.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.486 1.514 . . . . 0.0 113.424 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -65.93 -37.73 86.8 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.01 -1.681 . . . . 0.0 111.7 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.86 -39.42 35.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.84 -37.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.505 -1.372 . . . . 0.0 112.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.13 -36.14 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.662 0.664 . . . . 0.0 110.846 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -72.2 -25.24 61.59 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.556 1.142 . . . . 0.0 112.754 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -40.32 72.87 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.687 -0.633 . . . . 0.0 111.587 172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.93 -44.89 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.349 -0.844 . . . . 0.0 110.991 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -57.52 -32.5 67.11 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -79.74 -30.36 40.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.636 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.75 74.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -55.39 -19.41 9.0 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.276 1.431 . . . . 0.0 112.461 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -103.51 9.9 37.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.526 . . . . 0.0 112.926 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -124.95 -12.92 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.983 1.313 . . . . 0.0 113.712 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -164.35 149.28 10.02 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 109.391 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.9 p -85.32 5.7 29.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.054 0.942 . . . . 0.0 112.92 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.94 168.65 43.42 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.831 1.205 . . . . 0.0 110.304 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -137.18 121.95 18.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.934 . . . . 0.0 113.054 -166.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.45 137.72 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.209 1.404 . . . . 0.0 111.04 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -146.55 153.85 40.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.274 1.429 . . . . 0.0 110.433 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.48 138.4 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.919 1.287 . . . . 0.0 110.203 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.431 ' HB2' HD11 ' A' ' 66' ' ' LEU . 25.0 t60 -116.3 115.69 26.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 110.964 165.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.9 tp -98.17 134.22 41.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.484 0.714 . . . . 0.0 111.143 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.03 162.36 41.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.181 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.83 -69.37 0.44 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.722 1.209 . . . . 0.0 112.673 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -160.36 152.38 20.24 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.539 1.135 . . . . 0.0 113.289 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.6 p -109.96 141.64 42.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.667 1.587 . . . . 0.0 113.181 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.57 -28.51 56.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.482 0.658 . . . . 0.0 112.498 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -109.95 -172.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.113 2.165 . . . . 0.0 111.641 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.12 132.74 51.36 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.755 1.222 . . . . 0.0 112.812 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.57 -41.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.816 1.246 . . . . 0.0 111.467 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -48.5 79.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.645 0.778 . . . . 0.0 112.11 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.51 -42.09 83.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.871 0.868 . . . . 0.0 110.992 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -60.02 -46.34 89.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.213 1.005 . . . . 0.0 112.156 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.58 -37.92 88.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.211 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.7 ttp -63.94 -48.89 74.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.859 0.754 . . . . 0.0 111.654 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.78 -46.8 89.07 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.238 0.615 . . . . 0.0 111.054 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.61 -43.04 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.66 1.184 . . . . 0.0 111.79 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.04 -48.43 81.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.497 1.044 . . . . 0.0 112.185 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -72.39 -33.41 67.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.582 1.153 . . . . 0.0 112.606 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -65.36 -42.79 92.41 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.607 -1.308 . . . . 0.0 111.809 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.42 -1.21 32.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.537 1.135 . . . . 0.0 112.947 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 59.75 37.92 21.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.811 1.244 . . . . 0.0 112.28 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtp -75.44 -21.17 58.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 112.511 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.81 -13.12 9.08 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.308 2.643 . . . . 0.0 114.415 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -64.45 -7.89 11.57 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -55.02 140.01 39.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.642 1.977 . . . . 0.0 111.074 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -66.43 -36.07 81.89 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.381 -0.824 . . . . 0.0 112.177 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.52 -1.45 56.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 62.06 27.86 16.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.247 1.023 . . . . 0.0 111.311 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -107.92 39.42 1.95 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.161 1.784 . . . . 0.0 112.752 -171.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.13 128.33 9.44 Favored Glycine 0 N--CA 1.479 1.53 0 C-N-CA 124.473 1.035 . . . . 0.0 112.262 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.66 132.26 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.209 1.803 . . . . 0.0 109.911 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 34' ' ' HIS . 28.6 tp -117.39 128.1 54.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.122 0.969 . . . . 0.0 111.194 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.61 97.41 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.671 1.189 . . . . 0.0 107.804 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -81.84 122.74 28.11 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.081 0.952 . . . . 0.0 111.039 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.34 125.62 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.913 0.885 . . . . 0.0 110.284 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 100.27 11.28 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.657 1.583 . . . . 0.0 110.188 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.19 -19.47 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -74.23 -47.14 37.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.655 1.116 . . . . 0.0 111.153 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -88.86 -11.61 44.18 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.7 1.2 . . . . 0.0 113.612 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.5 tttt 71.82 30.11 2.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.01 1.724 . . . . 0.0 112.717 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -113.3 133.39 55.14 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.391 1.477 . . . . 0.0 110.052 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -114.43 143.23 45.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.022 1.329 . . . . 0.0 109.371 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.99 134.27 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.027 1.331 . . . . 0.0 108.194 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 mt -112.48 129.58 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -135.84 124.13 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.728 0.811 . . . . 0.0 110.45 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.83 154.49 17.0 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.559 1.076 . . . . 0.0 110.785 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -67.93 168.4 11.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 122.374 1.083 . . . . 0.0 111.929 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.38 -26.52 63.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.952 1.301 . . . . 0.0 114.452 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.66 55.0 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.812 1.187 . . . . 0.0 111.492 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.93 -54.91 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.538 1.169 . . . . 0.0 109.272 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -60.9 -30.72 70.34 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -78.24 -38.12 43.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.873 0.869 . . . . 0.0 112.113 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 88' ' ' VAL . 19.8 m -89.17 -23.06 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 87' ' ' VAL . 2.5 m -119.59 162.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.231 0.923 . . . . 0.0 112.232 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -113.11 173.38 6.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.424 1.49 . . . . 0.0 112.462 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -58.24 -29.41 65.73 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.281 -1.512 . . . . 0.0 114.598 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.73 -23.78 61.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.89 1.276 . . . . 0.0 111.994 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -76.12 -31.02 58.43 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.314 -0.866 . . . . 0.0 111.065 168.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -80.55 -32.18 36.76 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.25 -45.04 68.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.268 1.427 . . . . 0.0 113.005 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -58.12 -34.97 70.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.528 1.131 . . . . 0.0 113.067 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.5 m -72.5 -50.21 27.55 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 127.029 2.132 . . . . 0.0 109.345 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -60.93 -43.29 98.83 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.787 0.435 . . . . 0.0 111.2 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.46 -38.3 80.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.03 -50.72 65.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.566 0.621 . . . . 0.0 111.371 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.68 -48.75 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.067 0.947 . . . . 0.0 110.783 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -61.93 -40.55 95.89 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.292 1.437 . . . . 0.0 113.091 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.2 tp -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.6 0.636 . . . . 0.0 111.484 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -34.99 48.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.543 -0.723 . . . . 0.0 112.665 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.39 -40.81 98.24 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.839 0.855 . . . . 0.0 111.16 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.09 -35.43 80.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 112.143 172.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.87 -21.59 60.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.723 1.209 . . . . 0.0 113.138 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.38 -5.43 44.82 Favored Glycine 0 N--CA 1.48 1.585 0 C-N-CA 126.16 1.838 . . . . 0.0 114.943 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -97.82 82.8 3.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.832 1.253 . . . . 0.0 111.54 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.56 -48.2 82.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.506 0.722 . . . . 0.0 112.469 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -54.57 -53.62 52.16 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.283 0.492 . . . . 0.0 111.644 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.81 -41.21 77.35 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.591 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.92 -36.76 65.22 Favored Glycine 0 N--CA 1.472 1.075 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.775 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.5 -52.07 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.536 0.668 . . . . 0.0 109.995 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.74 -45.18 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.647 0.779 . . . . 0.0 111.585 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.6 -45.65 93.22 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.343 1.457 . . . . 0.0 111.3 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.91 -36.84 91.65 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.742 0.686 . . . . 0.0 113.388 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.22 -51.58 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.461 1.104 . . . . 0.0 110.424 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.43 -41.03 98.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.234 1.014 . . . . 0.0 111.856 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.08 -39.56 78.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.34 0.656 . . . . 0.0 112.586 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.08 96.13 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.632 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.7 -49.36 78.26 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-N 119.162 0.892 . . . . 0.0 112.004 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.32 -34.45 73.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.692 1.246 . . . . 0.0 113.793 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.92 -46.52 15.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.368 0.667 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -59.52 -37.59 78.74 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 110.675 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.99 -15.66 57.0 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -76.57 -33.73 58.47 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.512 -1.368 . . . . 0.0 111.295 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -81.58 -39.78 24.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.061 1.344 . . . . 0.0 111.224 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.54 79.52 72.04 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.752 2.021 . . . . 0.0 111.501 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 138.35 39.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.229 2.62 . . . . 0.0 112.192 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.7 t90 -64.87 135.88 56.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.37 151.86 30.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.799 1.639 . . . . 0.0 111.605 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -69.99 -3.09 14.66 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.542 -1.349 . . . . 0.0 114.353 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -115.86 7.4 14.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.151 1.781 . . . . 0.0 112.576 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -58.22 148.62 26.48 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.434 1.093 . . . . 0.0 112.236 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.01 135.58 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 111.317 -169.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -75.75 108.48 8.62 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.507 1.123 . . . . 0.0 109.706 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -89.56 -35.91 15.64 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.211 -0.93 . . . . 0.0 112.283 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.56 157.69 43.63 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.472 1.509 . . . . 0.0 111.039 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -90.8 141.0 3.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.882 3.055 . . . . 0.0 111.254 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -7.07 2.37 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.612 2.365 . . . . 0.0 116.836 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.2 m -58.11 152.5 16.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.584 1.154 . . . . 0.0 111.788 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.45 130.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.648 1.179 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t -88.11 141.34 28.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.404 0.682 . . . . 0.0 110.651 171.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -151.7 135.39 16.3 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 116.595 -2.225 . . . . 0.0 114.164 -174.295 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 118.731 -0.652 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 m -54.9 146.58 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.667 1.121 . . . . 0.0 112.335 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.8 -30.07 70.17 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.643 -1.285 . . . . 0.0 113.662 -173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mt -111.83 121.7 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -116.94 -28.51 6.26 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.409 0.683 . . . . 0.0 110.99 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -141.66 125.54 17.1 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.162 1.785 . . . . 0.0 110.357 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.27 -5.3 57.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 112.59 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.78 144.74 50.51 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 109.212 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -77.17 166.15 23.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.23 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.847 -1.158 . . . . 0.0 111.726 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.3 -48.08 82.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.733 1.213 . . . . 0.0 110.917 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.9 -39.91 72.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.479 1.111 . . . . 0.0 111.235 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.87 -46.45 74.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.044 1.338 . . . . 0.0 112.325 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -56.91 -47.31 80.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.448 -1.408 . . . . 0.0 111.081 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.89 84.8 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 tt -74.16 -35.84 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.047 -1.033 . . . . 0.0 112.171 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.42 -42.86 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.625 1.102 . . . . 0.0 111.392 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.92 -27.42 68.17 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.22 -43.37 74.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.474 0.579 . . . . 0.0 111.548 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.63 -43.75 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.391 0.677 . . . . 0.0 110.256 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -60.31 -25.57 65.87 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.97 -36.27 23.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.256 1.389 . . . . 0.0 111.986 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.53 97.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.175 0.99 . . . . 0.0 112.198 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.72 -4.63 9.42 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -106.85 11.76 29.69 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.009 -1.682 . . . . 0.0 112.529 170.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.77 -6.44 5.09 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.65 1.98 . . . . 0.0 114.084 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -164.3 151.4 11.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.148 2.179 . . . . 0.0 109.729 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -88.11 11.57 15.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.742 1.217 . . . . 0.0 113.853 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.41 133.13 10.37 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 125.742 1.639 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -104.19 138.21 40.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.349 1.06 . . . . 0.0 112.642 -155.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.03 139.66 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 120.356 -1.465 . . . . 0.0 111.247 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HE ' HD23 ' A' ' 138' ' ' LEU . 78.5 mtt-85 -139.13 146.45 40.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.932 1.693 . . . . 0.0 111.296 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.76 136.26 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.929 1.291 . . . . 0.0 109.608 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -122.3 120.3 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.272 1.429 . . . . 0.0 113.058 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.55 125.23 54.03 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.557 1.143 . . . . 0.0 111.392 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -154.08 160.63 42.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.961 1.304 . . . . 0.0 109.983 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.26 -72.1 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 m -143.26 165.19 28.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.363 2.265 . . . . 0.0 107.892 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.7 m -124.7 155.85 38.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.315 1.046 . . . . 0.0 110.46 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.94 -1.75 57.79 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 pt -134.55 -131.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 126.57 1.948 . . . . 0.0 111.181 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -101.77 142.11 33.6 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.438 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.18 -36.0 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.006 0.522 . . . . 0.0 111.84 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.49 -50.39 71.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.743 0.817 . . . . 0.0 111.937 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.26 -33.46 75.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.106 0.563 . . . . 0.0 111.47 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -65.66 -46.63 78.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.902 0.881 . . . . 0.0 112.568 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.15 90.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.664 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -59.12 -49.9 76.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.337 0.655 . . . . 0.0 111.715 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.4 -45.89 91.1 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.759 -0.588 . . . . 0.0 111.717 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.38 -35.17 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.715 -0.659 . . . . 0.0 110.785 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.7 -50.56 73.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.536 1.062 . . . . 0.0 111.718 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -72.72 -34.46 67.1 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.436 0.695 . . . . 0.0 111.608 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -70.37 -26.74 63.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.56 6.91 47.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.355 1.462 . . . . 0.0 112.425 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 60.92 26.39 16.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.625 1.57 . . . . 0.0 112.284 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.0 -18.1 60.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.723 1.209 . . . . 0.0 112.326 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -74.06 -8.21 55.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.424 2.29 . . . . 0.0 113.756 169.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -98.83 82.69 2.82 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 121.562 -0.711 . . . . 0.0 110.474 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.5 p -139.2 152.82 47.67 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.044 1.337 . . . . 0.0 110.501 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -57.86 -37.34 73.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.9 mt -105.96 -7.95 17.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.61 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 70.94 29.26 3.05 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.953 1.301 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -105.41 35.11 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.094 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.75 117.0 4.79 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.127 -0.818 . . . . 0.0 111.851 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.6 t -98.98 139.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.583 1.553 . . . . 0.0 110.232 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.5 tp -129.16 133.94 47.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.29 100.12 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.705 1.202 . . . . 0.0 109.409 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.58 128.0 32.91 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.072 -1.018 . . . . 0.0 109.994 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -124.26 127.52 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.911 0.884 . . . . 0.0 110.657 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.11 95.12 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.542 1.537 . . . . 0.0 110.035 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.42 -21.0 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -165.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.64 -28.69 45.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.51 1.05 . . . . 0.0 111.825 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -97.47 -4.99 37.02 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.443 1.097 . . . . 0.0 112.714 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 61.39 23.01 13.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.996 1.718 . . . . 0.0 112.003 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -105.36 169.02 8.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.597 1.559 . . . . 0.0 110.781 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -146.73 143.95 29.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.173 1.789 . . . . 0.0 108.749 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.8 140.43 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.146 1.378 . . . . 0.0 107.299 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.3 mt -118.68 133.34 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -139.4 138.18 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.259 1.423 . . . . 0.0 109.128 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.85 155.42 21.21 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -66.72 172.48 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 123.556 1.646 . . . . 0.0 111.82 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -61.45 -33.56 73.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.64 -1.172 . . . . 0.0 112.707 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -48.7 76.39 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 120.242 1.383 . . . . 0.0 112.31 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.97 -56.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.202 1.001 . . . . 0.0 109.774 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.6 -24.71 66.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -78.25 -38.36 43.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.014 1.325 . . . . 0.0 110.397 173.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 88' ' ' VAL . 2.0 p -90.8 -29.22 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 87' ' ' VAL . 2.9 m -119.89 156.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.842 1.656 . . . . 0.0 113.004 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.7 m -102.36 172.72 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.531 1.533 . . . . 0.0 114.803 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -61.12 -34.33 74.8 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.88 -24.42 67.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 0.0 113.029 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 47.6 t80 -77.22 -39.36 48.83 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.18 -0.95 . . . . 0.0 111.281 171.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -70.85 -29.62 65.79 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.191 1.396 . . . . 0.0 114.108 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.62 -37.97 74.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.505 0.722 . . . . 0.0 112.759 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 m -62.05 -43.57 98.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.696 0.798 . . . . 0.0 111.086 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -59.11 -53.81 54.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.673 1.989 . . . . 0.0 110.583 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -56.68 -50.26 72.66 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.659 1.184 . . . . 0.0 111.204 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -57.91 -36.44 72.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.248 1.019 . . . . 0.0 113.621 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.46 20.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.788 0.835 . . . . 0.0 112.019 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.12 -49.54 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.187 0.995 . . . . 0.0 109.639 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.3 -42.54 91.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.118 1.367 . . . . 0.0 113.382 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.64 -45.44 90.19 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.063 0.545 . . . . 0.0 110.869 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.02 -29.35 55.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.16 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.51 -39.64 81.16 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.358 0.981 . . . . 0.0 111.481 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.85 -43.54 94.58 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.555 0.742 . . . . 0.0 111.09 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.49 -35.23 79.77 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.991 -0.528 . . . . 0.0 111.935 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.88 10.28 24.89 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.834 1.683 . . . . 0.0 114.674 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.79 83.44 2.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -62.52 -39.62 94.15 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.764 1.225 . . . . 0.0 112.705 -171.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -54.78 -56.01 23.97 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -60.81 -42.21 97.19 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.904 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.93 -41.58 97.32 Favored Glycine 0 N--CA 1.473 1.101 0 CA-C-N 120.187 1.358 . . . . 0.0 112.378 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.63 -47.21 73.31 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.547 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.32 -48.49 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 118.852 0.751 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -63.41 -35.36 80.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.982 0.81 . . . . 0.0 112.021 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.91 -43.98 92.7 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.067 -0.852 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.9 -47.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.929 1.292 . . . . 0.0 111.362 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.98 -49.51 77.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.712 0.805 . . . . 0.0 111.504 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -65.28 -38.73 91.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.828 -0.545 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.39 74.08 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.844 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.15 87.57 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 119.669 1.122 . . . . 0.0 112.469 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.3 mtp -58.36 -42.22 86.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.987 0.894 . . . . 0.0 112.908 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.23 -41.69 57.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.501 0.721 . . . . 0.0 111.586 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.1 mt -62.07 -36.58 82.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.795 1.238 . . . . 0.0 111.131 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.05 -18.22 32.82 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -70.99 -34.58 71.52 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.246 -1.534 . . . . 0.0 112.198 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -90.12 -35.78 15.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.37 1.468 . . . . 0.0 112.981 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -131.89 85.2 51.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.937 1.695 . . . . 0.0 110.044 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.52 147.47 93.1 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.381 2.054 . . . . 0.0 110.497 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -69.54 146.68 51.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.332 1.063 . . . . 0.0 111.783 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -134.73 151.17 50.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.604 1.161 . . . . 0.0 109.611 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.42 -35.95 72.85 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.373 -0.83 . . . . 0.0 112.814 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -90.32 18.09 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.881 1.672 . . . . 0.0 113.224 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.31 151.12 28.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.094 1.358 . . . . 0.0 113.203 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.0 74.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.626 1.57 . . . . 0.0 113.332 -154.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -64.64 108.99 1.86 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.125 1.37 . . . . 0.0 111.014 170.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -114.09 -6.2 13.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.148 1.379 . . . . 0.0 113.139 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.46 HD23 ' HE ' ' A' ' 32' ' ' ARG . 2.1 mp -115.39 145.37 34.2 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.493 1.117 . . . . 0.0 111.384 -165.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.47 132.07 5.77 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.611 2.207 . . . . 0.0 110.971 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -74.13 3.39 7.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.4 p -70.65 156.33 39.6 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 128.21 2.604 . . . . 0.0 112.487 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 84.2 mt -78.26 134.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.699 1.2 . . . . 0.0 108.406 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.3 m -91.93 142.14 27.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.464 0.649 . . . . 0.0 109.458 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -129.8 151.15 50.69 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.171 -0.956 . . . . 0.0 110.698 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.966 0 C-N-CA 126.192 1.853 . . . . 0.0 113.76 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.6 mtm . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 p -175.7 155.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.653 1.581 . . . . 0.0 108.396 -174.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt 56.23 52.76 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.235 1.017 . . . . 0.0 111.051 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.54 -33.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.303 -1.498 . . . . 0.0 111.936 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -76.53 -33.11 58.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.821 1.248 . . . . 0.0 113.016 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -137.44 125.92 23.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.873 1.669 . . . . 0.0 107.427 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.59 ' CE1' HG21 ' A' ' 71' ' ' VAL . 72.3 m-85 -68.23 -25.13 65.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.126 -0.984 . . . . 0.0 112.623 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.3 mt -140.99 142.6 34.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.978 2.511 . . . . 0.0 107.985 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -74.65 167.29 22.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.148 0.431 . . . . 0.0 110.214 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.74 58.57 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 113.21 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -55.2 -41.79 72.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.291 1.436 . . . . 0.0 113.278 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.14 -42.69 25.61 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 110.63 -173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -62.69 -45.14 94.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.362 1.065 . . . . 0.0 111.373 172.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -57.74 -47.55 82.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.344 -0.847 . . . . 0.0 111.888 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.75 88.51 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.347 1.059 . . . . 0.0 113.438 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.18 -41.64 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 117.935 -1.031 . . . . 0.0 112.269 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.53 -42.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.783 1.174 . . . . 0.0 111.464 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.37 -28.73 69.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.138 0.881 . . . . 0.0 113.149 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.98 67.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.93 0.786 . . . . 0.0 112.015 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mm -64.78 -50.51 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.91 0.884 . . . . 0.0 110.127 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -54.28 -29.28 46.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.33 1.052 . . . . 0.0 113.475 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -83.19 -30.2 27.95 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.019 1.328 . . . . 0.0 112.185 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.0 75.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.69 1.132 . . . . 0.0 111.424 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.13 2.34 0.81 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.606 1.562 . . . . 0.0 114.099 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.79 5.41 24.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 119.39 -2.069 . . . . 0.0 113.031 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -126.96 -8.08 6.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.72 1.608 . . . . 0.0 113.522 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -160.07 161.29 33.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.235 1.814 . . . . 0.0 109.157 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -99.04 10.79 40.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.57 172.49 17.64 Favored Glycine 0 N--CA 1.473 1.16 0 O-C-N 120.549 -1.344 . . . . 0.0 110.823 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -123.67 122.24 37.61 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 122.803 0.441 . . . . 0.0 111.67 -160.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 mt -108.71 112.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.336 1.054 . . . . 0.0 110.693 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -123.24 151.1 42.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.754 0.822 . . . . 0.0 113.19 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 t -130.52 134.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.581 1.153 . . . . 0.0 109.008 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -122.11 121.99 38.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 111.991 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 35' ' ' LEU . 13.8 tp -107.16 132.37 53.11 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.178 0.991 . . . . 0.0 111.462 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -160.23 155.18 24.48 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.786 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.35 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.744 1.218 . . . . 0.0 113.233 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.6 t -137.47 169.76 17.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.193 1.797 . . . . 0.0 110.316 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 p -123.23 157.26 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.501 1.52 . . . . 0.0 113.162 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -90.75 -9.85 45.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.955 1.302 . . . . 0.0 113.293 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 -141.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.049 1.739 . . . . 0.0 111.159 -164.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -102.42 135.24 44.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.634 1.561 . . . . 0.0 112.266 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -62.47 -38.97 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.019 0.928 . . . . 0.0 112.099 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.02 0.827 . . . . 0.0 111.856 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.44 -39.88 85.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.804 0.842 . . . . 0.0 110.781 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -59.02 -47.53 84.86 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.583 -0.698 . . . . 0.0 111.788 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.97 -42.28 99.78 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.604 0.762 . . . . 0.0 110.978 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -58.55 -53.91 52.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.556 1.142 . . . . 0.0 111.247 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -64.63 -37.15 86.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.776 -1.203 . . . . 0.0 112.054 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.85 -47.22 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.346 1.058 . . . . 0.0 111.326 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -56.71 -45.92 81.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.421 1.488 . . . . 0.0 111.987 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -73.39 -40.47 64.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.834 1.254 . . . . 0.0 112.979 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -63.89 -39.31 93.89 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.992 0.815 . . . . 0.0 112.378 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.52 0.23 20.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 113.418 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 62.33 24.41 14.53 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.036 1.334 . . . . 0.0 113.271 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.69 -30.09 68.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 0.0 112.412 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -49.73 -31.14 10.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.073 1.749 . . . . 0.0 112.601 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -77.67 65.05 3.08 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.085 -1.01 . . . . 0.0 113.02 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.0 m -118.9 134.78 54.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.155 2.182 . . . . 0.0 106.705 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.32 -44.5 72.08 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.826 1.194 . . . . 0.0 112.776 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.64 -2.27 58.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 114.017 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 66.2 19.37 11.08 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.727 1.211 . . . . 0.0 113.222 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -99.33 46.83 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.211 1.005 . . . . 0.0 112.061 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.19 121.45 6.71 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.775 1.179 . . . . 0.0 111.907 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.39 140.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 118.311 1.056 . . . . 0.0 109.567 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 tp -120.97 127.16 51.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.985 0.898 . . . . 0.0 111.5 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.1 mt -102.75 97.59 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.492 1.517 . . . . 0.0 108.31 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -82.1 125.3 30.69 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.604 -0.685 . . . . 0.0 110.514 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.11 131.07 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.729 -0.607 . . . . 0.0 110.695 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 100.15 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.892 1.677 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.59 HG21 ' CE1' ' A' ' 7' ' ' PHE . 32.6 m -80.52 -14.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -81.26 -49.45 10.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.057 0.844 . . . . 0.0 110.58 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -76.09 -16.84 59.84 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.818 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 67.93 41.41 2.11 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.955 1.702 . . . . 0.0 111.172 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.1 p -119.26 172.33 7.67 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.486 1.914 . . . . 0.0 110.245 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -154.74 134.27 12.69 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.005 0.922 . . . . 0.0 109.597 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.17 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.085 1.754 . . . . 0.0 108.214 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.8 mt -125.99 136.9 59.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -154.92 121.29 5.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.225 1.41 . . . . 0.0 109.086 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.99 168.27 12.52 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 124.15 0.881 . . . . 0.0 111.178 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -69.84 165.61 21.17 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.126 1.441 . . . . 0.0 112.278 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.23 -33.29 8.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.93 2.092 . . . . 0.0 113.588 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.67 -44.2 98.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 120.885 1.675 . . . . 0.0 112.296 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.2 -56.53 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.371 1.086 . . . . 0.0 109.787 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -57.43 -31.28 65.73 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.34 -14.75 42.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.572 1.549 . . . . 0.0 113.161 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.95 -18.45 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.01 172.6 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.789 1.177 . . . . 0.0 111.943 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.3 p -118.17 175.67 5.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.949 1.7 . . . . 0.0 113.725 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.75 -21.16 65.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 119.675 -1.891 . . . . 0.0 112.96 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.2 -29.02 66.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.521 1.128 . . . . 0.0 111.936 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.432 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 65.1 t80 -79.02 -32.75 45.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 111.907 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -80.0 -30.02 39.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.452 1.501 . . . . 0.0 114.035 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.37 -33.63 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.941 0.791 . . . . 0.0 112.42 -174.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 p -65.36 -42.87 92.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.69 0.796 . . . . 0.0 111.162 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.0 m -57.83 -49.42 76.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 111.497 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -58.05 -50.93 71.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.985 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -60.22 -37.56 80.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.69 58.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.171 0.896 . . . . 0.0 111.549 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.01 -48.54 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.421 0.688 . . . . 0.0 110.727 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -58.64 -40.86 84.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.576 1.55 . . . . 0.0 113.893 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.01 -45.23 67.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.889 0.768 . . . . 0.0 111.152 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -35.61 74.64 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.038 0.535 . . . . 0.0 111.629 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.961 0.801 . . . . 0.0 111.57 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -59.34 -39.26 82.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.858 0.753 . . . . 0.0 111.533 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -74.68 -22.49 58.83 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.893 0.877 . . . . 0.0 112.363 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.11 55.07 Favored Glycine 0 N--CA 1.48 1.6 0 C-N-CA 125.1 1.333 . . . . 0.0 114.162 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -96.09 71.37 2.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.878 1.271 . . . . 0.0 111.369 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -55.88 -46.06 78.39 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -51.24 -57.52 8.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.89 0.876 . . . . 0.0 111.014 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -59.99 -42.73 94.85 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.492 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.68 95.57 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 119.866 1.212 . . . . 0.0 113.225 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 mt -69.09 -48.61 62.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.57 0.685 . . . . 0.0 111.341 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.88 -53.2 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.76 0.709 . . . . 0.0 111.605 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.42 -35.69 81.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.078 0.951 . . . . 0.0 111.858 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.18 -38.05 63.41 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 121.378 -0.827 . . . . 0.0 112.824 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.38 -42.77 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.009 1.324 . . . . 0.0 111.378 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -55.38 -52.45 63.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.694 1.198 . . . . 0.0 110.579 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -65.57 -34.71 78.89 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.09 90.81 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.338 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.42 -44.99 97.03 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 119.431 -0.649 . . . . 0.0 112.286 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.4 mtp -59.85 -42.47 93.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.395 1.097 . . . . 0.0 113.59 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.37 -44.56 51.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.741 0.816 . . . . 0.0 111.129 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.03 -36.64 84.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.408 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.92 -26.87 62.78 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.059 0.944 . . . . 0.0 113.327 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -65.66 -34.78 79.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.401 -1.437 . . . . 0.0 111.472 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.82 -39.9 23.33 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.796 1.238 . . . . 0.0 111.879 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.08 79.51 73.75 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.607 1.563 . . . . 0.0 111.454 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.98 135.32 27.28 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.628 2.218 . . . . 0.0 110.959 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -56.89 147.9 22.36 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -125.62 150.48 47.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.479 1.112 . . . . 0.0 110.157 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -67.14 -26.09 66.5 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.053 -1.655 . . . . 0.0 113.235 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.14 9.11 34.93 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.241 2.216 . . . . 0.0 112.206 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -58.13 138.96 55.71 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 126.132 1.773 . . . . 0.0 113.282 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.83 135.68 49.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 124.571 1.148 . . . . 0.0 110.597 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -97.65 95.65 7.74 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 127.005 2.122 . . . . 0.0 107.198 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.62 -42.51 13.38 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -161.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.6 mt -97.92 160.56 28.17 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 120.137 1.335 . . . . 0.0 111.316 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.68 137.79 9.14 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.79 2.327 . . . . 0.0 109.51 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -71.63 -4.94 29.97 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -60.68 140.15 57.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.089 2.155 . . . . 0.0 111.207 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.7 mt -64.59 140.21 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.012 1.325 . . . . 0.0 110.392 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 m -96.57 143.46 27.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.191 0.596 . . . . 0.0 110.452 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -143.79 137.24 27.9 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.364 -0.835 . . . . 0.0 110.551 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.392 0 CA-C-O 117.984 -1.454 . . . . 0.0 112.649 176.155 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -80.15 164.23 23.48 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.762 -1.211 . . . . 0.0 110.364 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.09 65.06 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.34 -44.12 97.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.392 1.477 . . . . 0.0 111.572 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.77 -43.19 56.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.163 0.985 . . . . 0.0 111.013 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.32 -47.53 83.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 111.289 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.11 -47.46 78.07 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.13 -0.981 . . . . 0.0 111.296 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.46 69.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 tt -80.02 -39.01 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.196 1.362 . . . . 0.0 112.715 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.5 t -58.64 -43.28 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 120.145 1.339 . . . . 0.0 110.808 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -62.23 -27.94 69.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.96 69.79 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.48 -0.762 . . . . 0.0 112.672 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.36 -42.8 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.211 1.005 . . . . 0.0 109.612 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.47 -34.26 66.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.061 1.344 . . . . 0.0 113.493 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.49 -24.93 41.98 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.58 58.77 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.424 1.011 . . . . 0.0 111.952 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -54.74 -28.53 49.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.088 1.355 . . . . 0.0 112.267 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.69 6.58 37.82 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.719 -1.863 . . . . 0.0 112.623 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.49 -15.01 6.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 113.922 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 t -160.95 140.06 10.34 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.186 1.394 . . . . 0.0 109.541 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -80.63 39.01 0.46 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 112.727 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.97 158.0 27.03 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 125.536 1.541 . . . . 0.0 110.892 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.34 142.91 46.52 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -155.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.83 97.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.592 1.157 . . . . 0.0 111.084 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -106.9 145.05 32.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.659 1.184 . . . . 0.0 111.856 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.61 133.54 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.066 1.346 . . . . 0.0 109.243 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -119.15 115.96 25.34 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.939 1.296 . . . . 0.0 111.927 168.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.2 tp -103.52 126.92 50.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.323 1.049 . . . . 0.0 111.315 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.65 162.15 39.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.663 1.22 . . . . 0.0 111.396 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -68.33 -77.15 0.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.464 1.106 . . . . 0.0 112.013 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 t -153.69 165.23 36.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.648 1.979 . . . . 0.0 109.902 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.5 m -115.33 154.66 28.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.325 1.45 . . . . 0.0 111.235 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -92.06 -13.48 30.8 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.054 -1.029 . . . . 0.0 112.645 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 pt -130.37 -163.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.126 1.77 . . . . 0.0 110.702 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -72.52 136.57 45.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.405 0.622 . . . . 0.0 112.464 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.53 -35.14 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.98 0.912 . . . . 0.0 111.716 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.57 -54.89 28.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.299 0.954 . . . . 0.0 112.423 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -63.14 -39.26 94.15 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.647 0.779 . . . . 0.0 111.184 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -61.45 -45.22 95.19 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.713 -0.617 . . . . 0.0 111.754 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.43 94.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.824 0.738 . . . . 0.0 111.277 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.9 ttp -62.52 -43.0 99.88 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 112.386 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.3 -48.65 77.2 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.953 -1.092 . . . . 0.0 111.748 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.6 -42.53 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.899 0.88 . . . . 0.0 111.789 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -57.3 -49.15 77.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.536 1.135 . . . . 0.0 111.157 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -71.59 -38.03 70.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.202 1.001 . . . . 0.0 112.056 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.9 -43.15 93.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.104 1.362 . . . . 0.0 112.773 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.05 -3.62 20.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.193 0.997 . . . . 0.0 112.901 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.8 tttt 64.76 38.21 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.648 1.979 . . . . 0.0 112.296 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.7 mtp -77.04 -12.78 59.98 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -0.89 7.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.226 1.01 . . . . 0.0 113.057 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -74.48 31.08 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.633 1.973 . . . . 0.0 114.457 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -99.87 156.16 17.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.682 1.993 . . . . 0.0 110.881 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -73.85 -30.48 62.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.454 1.102 . . . . 0.0 112.429 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.14 -7.21 16.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 67.33 47.41 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.306 . . . . 0.0 110.851 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -137.97 40.45 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.323 1.049 . . . . 0.0 113.607 -164.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.54 142.68 16.19 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 167.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.72 144.44 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.594 1.158 . . . . 0.0 110.463 169.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -117.2 129.25 55.82 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.167 1.387 . . . . 0.0 109.939 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 mt -103.23 96.85 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.11 119.0 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.193 0.597 . . . . 0.0 110.114 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.66 129.78 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.703 0.801 . . . . 0.0 110.143 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.11 102.88 12.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.717 1.207 . . . . 0.0 109.256 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 37' ' ' LYS . 33.3 m -70.91 -22.18 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -170.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.14 -49.42 23.8 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.229 0.538 . . . . 0.0 111.689 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.37 -15.08 56.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.455 1.102 . . . . 0.0 111.729 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 tttt 75.23 19.8 2.17 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.517 2.327 . . . . 0.0 112.415 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.1 p -98.13 162.59 13.13 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 111.785 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.87 139.32 36.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.741 1.217 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.59 147.62 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.516 1.527 . . . . 0.0 107.786 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.38 125.96 60.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -139.04 120.76 15.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.0 110.244 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.3 152.91 17.63 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 125.523 1.535 . . . . 0.0 111.025 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -66.75 164.57 16.81 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 123.141 1.448 . . . . 0.0 111.654 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -53.54 -37.6 62.99 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 114.39 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.7 -18.92 70.73 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.47 1.033 . . . . 0.0 113.807 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -81.12 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.122 1.461 . . . . 0.0 108.783 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -53.52 -37.6 62.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.657 0.783 . . . . 0.0 113.032 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.14 -17.46 58.59 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.719 1.207 . . . . 0.0 113.011 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.14 -21.62 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.9 m -114.9 179.47 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.756 1.162 . . . . 0.0 111.838 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.1 p -121.98 171.1 9.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.368 1.867 . . . . 0.0 112.392 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.0 -29.09 70.56 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.864 -1.147 . . . . 0.0 112.448 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.3 -38.81 91.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.893 1.277 . . . . 0.0 111.537 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 52.1 t80 -63.65 -46.13 87.04 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.376 0.67 . . . . 0.0 110.351 172.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.244 1.418 . . . . 0.0 114.63 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.81 -39.59 74.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.444 1.098 . . . . 0.0 111.613 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -61.21 -47.12 87.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.636 0.774 . . . . 0.0 111.807 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 m -58.31 -50.34 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.269 1.828 . . . . 0.0 110.413 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -59.13 -51.05 71.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.393 1.077 . . . . 0.0 111.994 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.34 -41.28 96.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.014 0.824 . . . . 0.0 112.698 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.53 79.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.897 0.771 . . . . 0.0 112.928 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.97 -50.37 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.52 1.128 . . . . 0.0 110.956 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -53.87 -48.03 70.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.619 1.167 . . . . 0.0 111.403 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.67 -33.41 75.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -85.61 -38.14 18.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.32 -37.21 79.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.506 0.594 . . . . 0.0 111.432 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.19 -27.27 67.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.969 1.308 . . . . 0.0 113.387 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.71 -32.65 53.08 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.896 0.771 . . . . 0.0 110.445 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.01 3.18 26.52 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 126.636 2.065 . . . . 0.0 114.252 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.49 84.17 2.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.492 1.146 . . . . 0.0 111.109 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -56.94 -41.52 78.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.813 0.845 . . . . 0.0 112.585 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.93 -57.65 11.58 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.467 -0.771 . . . . 0.0 112.465 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.46 -43.15 83.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.223 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.2 98.42 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.351 0.978 . . . . 0.0 113.618 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.73 -48.43 66.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.755 -1.117 . . . . 0.0 111.035 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.03 -48.36 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.309 1.044 . . . . 0.0 112.241 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -67.3 -34.68 77.9 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.266 0.485 . . . . 0.0 111.688 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.58 -41.05 90.55 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.228 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.07 -44.39 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.663 1.185 . . . . 0.0 109.617 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.17 -51.78 65.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.877 0.871 . . . . 0.0 111.976 -178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.96 -41.78 95.18 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.615 0.766 . . . . 0.0 111.269 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.23 78.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.554 0.742 . . . . 0.0 110.928 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.5 -46.53 87.78 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.01 0.823 . . . . 0.0 112.108 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.7 mtp -65.55 -35.96 82.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.049 0.925 . . . . 0.0 113.087 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.483 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.93 -44.6 61.01 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 111.112 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.85 -37.36 85.99 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.371 1.468 . . . . 0.0 111.46 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.33 -18.51 11.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.392 1.477 . . . . 0.0 114.355 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -72.43 -40.88 66.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.33 -1.481 . . . . 0.0 112.105 170.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -85.9 -28.89 24.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.735 1.214 . . . . 0.0 112.276 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -136.58 76.62 47.96 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.668 1.987 . . . . 0.0 108.669 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.83 143.1 78.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.841 1.694 . . . . 0.0 110.498 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -63.1 143.89 57.38 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -118.99 144.84 46.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.412 1.485 . . . . 0.0 109.402 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -60.71 -32.95 72.18 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 112.636 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -82.93 5.43 21.96 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.881 1.272 . . . . 0.0 113.446 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -58.84 150.46 23.95 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.013 0.925 . . . . 0.0 112.943 -172.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.215 -0.743 0 CA-C-O 122.721 1.248 . . . . 0.0 111.509 -165.367 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 CA--C 1.532 0.406 0 CA-C-O 121.616 0.59 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -77.84 -10.23 59.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.2 m -57.3 131.24 49.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.363 1.465 . . . . 0.0 109.72 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.03 137.76 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.43 -0.794 . . . . 0.0 108.863 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.7 m -92.28 142.92 26.94 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.422 -0.798 . . . . 0.0 111.844 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.86 150.68 52.14 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.424 1.09 . . . . 0.0 110.568 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.714 170.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.23 0.078 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 p -75.11 167.39 22.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.6 64.34 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.772 -1.205 . . . . 0.0 112.759 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -66.94 -36.0 81.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.17 1.388 . . . . 0.0 111.701 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.71 -45.46 13.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.32 1.048 . . . . 0.0 111.228 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -60.96 -40.95 95.32 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.802 1.241 . . . . 0.0 111.166 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.14 -48.15 81.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.163 -0.961 . . . . 0.0 112.07 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.25 97.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 tt -72.01 -35.46 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.52 -32.76 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.014 0.825 . . . . 0.0 111.462 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.92 -35.99 75.0 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.342 -0.849 . . . . 0.0 112.588 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.82 93.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.926 0.49 . . . . 0.0 111.388 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.38 -48.02 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.816 0.846 . . . . 0.0 110.814 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -55.08 -33.73 63.01 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.85 -25.74 32.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.91 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.091 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -73.27 14.65 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.699 1.2 . . . . 0.0 113.373 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -116.96 3.21 12.81 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.892 -1.755 . . . . 0.0 112.272 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -121.26 -18.36 7.4 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.23 1.412 . . . . 0.0 113.207 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -144.14 163.43 33.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.559 2.343 . . . . 0.0 108.771 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -100.83 31.41 3.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.53 1.532 . . . . 0.0 112.384 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.88 118.06 1.5 Allowed Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.352 -1.468 . . . . 0.0 111.902 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -85.21 137.11 33.21 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -156.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.18 119.83 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 123.003 1.382 . . . . 0.0 111.485 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -124.74 151.68 44.76 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.308 1.443 . . . . 0.0 112.452 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 144.3 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.011 1.724 . . . . 0.0 110.692 171.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 66' ' ' LEU . 27.6 t60 -125.12 122.4 37.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.09 130.64 54.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.558 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 14.8 tt0 -146.87 169.2 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.892 1.33 . . . . 0.0 110.682 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 65.4 mttt -78.85 -73.36 0.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.393 1.077 . . . . 0.0 112.508 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -148.42 142.97 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.574 1.949 . . . . 0.0 109.247 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.8 p -86.84 146.81 26.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.965 0.888 . . . . 0.0 112.484 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 -10.61 38.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.235 1.014 . . . . 0.0 112.301 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.5 -163.46 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.392 2.677 . . . . 0.0 108.946 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.31 138.62 55.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.678 -1.264 . . . . 0.0 112.072 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.92 -37.6 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.366 0.666 . . . . 0.0 111.794 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.46 -52.56 64.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.581 0.752 . . . . 0.0 112.197 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.02 -39.65 87.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.91 0.484 . . . . 0.0 111.178 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -58.81 -47.04 86.2 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.118 -0.989 . . . . 0.0 112.118 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.75 96.76 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.568 0.747 . . . . 0.0 111.419 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 ttp -62.37 -43.75 98.07 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 111.815 173.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.07 -46.59 86.74 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.254 -0.904 . . . . 0.0 112.021 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.13 -43.62 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.22 -46.66 85.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.335 1.054 . . . . 0.0 111.808 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.69 -35.78 60.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.278 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -63.84 -44.07 94.28 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.429 -1.419 . . . . 0.0 111.159 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.75 -6.38 44.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.714 1.205 . . . . 0.0 113.268 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 62.33 41.14 10.55 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 66' ' ' LEU . 72.3 mtp -73.29 -22.54 60.34 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.43 -8.74 6.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 114.046 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 62.95 0.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.179 1.792 . . . . 0.0 110.793 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -133.4 140.32 47.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.613 1.165 . . . . 0.0 110.581 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -58.16 -43.64 87.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 111.889 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.3 mt -94.82 -3.68 48.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 59.73 57.06 3.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.04 28.94 3.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 112.255 -168.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.87 131.57 10.48 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.393 -0.817 . . . . 0.0 111.206 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.6 t -102.65 138.79 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.268 1.027 . . . . 0.0 110.321 168.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' HIS . 17.8 tp -119.04 121.54 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.062 1.345 . . . . 0.0 110.963 164.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.4 mt -97.25 101.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -81.93 125.19 30.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.256 0.622 . . . . 0.0 110.917 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.1 129.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.753 0.706 . . . . 0.0 111.406 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.27 100.78 12.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.894 1.678 . . . . 0.0 110.273 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.27 -12.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.88 -54.49 5.54 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.474 -0.766 . . . . 0.0 110.495 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.33 -11.85 59.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.179 0.992 . . . . 0.0 112.315 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt 71.68 27.27 2.95 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.6 2.36 . . . . 0.0 112.356 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -106.06 134.36 49.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.995 1.318 . . . . 0.0 110.53 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -106.41 143.78 34.04 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 110.199 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 t -134.36 143.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.505 1.922 . . . . 0.0 108.259 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.0 mt -123.63 130.12 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -140.62 132.54 27.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.996 1.319 . . . . 0.0 110.026 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.52 163.68 21.2 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 123.872 0.749 . . . . 0.0 111.309 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.69 161.31 4.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.899 1.333 . . . . 0.0 114.121 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.4 -35.61 65.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.522 1.529 . . . . 0.0 113.777 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.37 -27.95 73.06 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 120.259 1.39 . . . . 0.0 112.939 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.6 mt -69.43 -60.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.2 1.5 . . . . 0.0 109.425 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -52.01 -37.57 53.78 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.71 0.804 . . . . 0.0 112.973 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.92 -21.7 59.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.032 -1.043 . . . . 0.0 113.436 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 88' ' ' VAL . 1.5 p -106.73 -32.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 87' ' ' VAL . 4.4 m -110.6 179.31 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.701 1.2 . . . . 0.0 111.004 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 -178.9 6.13 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.666 -1.271 . . . . 0.0 113.775 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -52.44 -36.31 54.24 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -71.69 -20.01 61.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.498 1.045 . . . . 0.0 112.943 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 29.1 t80 -78.57 -49.24 13.63 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.285 1.034 . . . . 0.0 109.275 168.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -62.68 -31.43 72.31 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.611 1.564 . . . . 0.0 113.611 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.72 -29.75 68.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.225 1.01 . . . . 0.0 111.621 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.5 p -69.96 -43.07 72.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.542 0.61 . . . . 0.0 111.651 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 m -55.94 -51.62 67.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.371 1.869 . . . . 0.0 111.014 172.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -59.3 -48.42 81.69 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.61 0.764 . . . . 0.0 111.528 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -59.76 -45.89 90.84 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.585 1.084 . . . . 0.0 112.581 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.52 93.89 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.217 0.917 . . . . 0.0 112.826 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.57 -52.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.953 0.901 . . . . 0.0 110.212 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -57.36 -44.48 84.4 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.045 1.338 . . . . 0.0 112.626 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.42 -34.0 77.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.533 0.606 . . . . 0.0 112.161 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -85.89 -38.84 17.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.04 0.936 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.29 -40.37 77.63 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.233 -0.917 . . . . 0.0 111.767 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.91 -23.05 67.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.951 1.3 . . . . 0.0 113.364 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.36 -25.26 21.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.631 0.772 . . . . 0.0 112.153 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.51 37.62 Favored Glycine 0 N--CA 1.477 1.431 0 C-N-CA 125.468 1.509 . . . . 0.0 113.664 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.9 64.35 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.415 1.486 . . . . 0.0 110.839 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -53.43 -44.0 68.47 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.942 0.897 . . . . 0.0 112.876 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.02 -54.01 45.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.395 1.078 . . . . 0.0 111.872 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -63.74 -43.36 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.05 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.74 96.08 Favored Glycine 0 N--CA 1.469 0.877 0 CA-C-N 119.167 0.894 . . . . 0.0 113.065 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -72.5 -45.38 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.999 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.59 -51.21 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.484 1.038 . . . . 0.0 111.473 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.3 -40.35 90.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 0.0 111.423 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.75 92.08 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.916 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.51 -52.67 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.556 1.178 . . . . 0.0 109.744 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.91 -46.15 88.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.158 0.583 . . . . 0.0 111.868 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.67 -40.66 76.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.917 0.887 . . . . 0.0 111.729 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.84 76.17 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.56 0.618 . . . . 0.0 109.926 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.15 -48.74 77.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.583 0.611 . . . . 0.0 113.347 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.29 -35.97 82.13 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.95 -41.26 59.95 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.118 -0.364 . . . . 0.0 110.799 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.3 mt -63.06 -40.1 96.71 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.927 1.691 . . . . 0.0 111.882 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.47 44.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 113.847 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.82 -41.01 92.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.503 -0.748 . . . . 0.0 111.842 172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.0 -46.75 13.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.204 1.402 . . . . 0.0 111.344 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.97 83.5 37.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 126.641 1.977 . . . . 0.0 110.516 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.34 143.16 62.81 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.837 2.358 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -60.16 145.58 46.45 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.32 0.581 . . . . 0.0 112.038 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -120.59 144.81 47.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.039 0.936 . . . . 0.0 109.423 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.14 -20.09 65.75 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 120.671 -1.268 . . . . 0.0 113.318 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -95.99 2.52 53.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.167 2.587 . . . . 0.0 113.739 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -58.6 151.87 19.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.426 1.49 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.51 0 C-N-CA 123.657 0.783 . . . . 0.0 110.988 -165.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 C--O 1.24 0.579 0 CA-C-O 121.052 0.355 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.79 -3.54 44.94 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.6 p -70.16 161.87 29.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.173 1.789 . . . . 0.0 113.01 -171.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 66.5 mt -82.79 138.41 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.849 1.26 . . . . 0.0 110.05 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.5 t -101.65 142.95 32.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.614 0.766 . . . . 0.0 110.395 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -145.61 151.46 38.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 C-N-CA 125.949 1.738 . . . . 0.0 113.045 165.277 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.241 0.641 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -78.47 163.38 25.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.861 0.864 . . . . 0.0 111.208 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.08 19.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.276 1.43 . . . . 0.0 112.988 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -61.41 -45.88 92.46 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.618 1.567 . . . . 0.0 112.552 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.78 -45.26 83.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.02 -38.78 89.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.785 0.834 . . . . 0.0 112.305 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 -44.83 92.28 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.257 -0.902 . . . . 0.0 111.004 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.53 97.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.146 0.979 . . . . 0.0 113.354 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -72.11 -37.53 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.175 0.898 . . . . 0.0 112.696 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.3 t -61.61 -32.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.231 0.923 . . . . 0.0 112.27 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -41.64 97.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.181 0.992 . . . . 0.0 112.06 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.64 95.38 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.908 -0.495 . . . . 0.0 111.729 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.58 -40.1 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.831 0.852 . . . . 0.0 111.449 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -64.38 -38.53 91.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.778 0.831 . . . . 0.0 112.567 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.43 -31.44 65.48 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 112.952 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.36 -38.85 85.43 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.498 0.719 . . . . 0.0 112.711 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -62.01 -17.48 57.37 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.268 1.033 . . . . 0.0 113.316 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -94.45 3.79 54.69 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.278 -1.514 . . . . 0.0 112.659 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -119.78 -13.51 9.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 114.221 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -155.86 161.79 40.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.766 2.026 . . . . 0.0 109.417 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 p -104.08 26.27 8.97 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 112.823 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.11 148.12 19.52 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 124.497 1.046 . . . . 0.0 111.124 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -103.07 134.84 45.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.72 0.771 . . . . 0.0 112.443 -151.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.97 129.83 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 119.003 -2.311 . . . . 0.0 111.286 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -142.56 152.5 42.66 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.129 1.372 . . . . 0.0 110.931 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -121.12 141.0 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.922 1.689 . . . . 0.0 110.555 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 66' ' ' LEU . 51.3 t60 -127.24 130.99 50.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.636 1.174 . . . . 0.0 112.336 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tp -119.38 120.85 38.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 111.63 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -138.08 156.04 48.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.525 1.13 . . . . 0.0 110.564 171.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.48 -69.7 0.26 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.283 -1.511 . . . . 0.0 113.852 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.3 t -152.75 142.25 21.74 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.896 1.678 . . . . 0.0 109.307 -166.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 p -100.12 144.51 29.06 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -81.79 -26.46 34.38 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 pt -110.62 -177.1 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 110.411 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.36 136.48 57.16 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.65 0.738 . . . . 0.0 112.489 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.03 -32.88 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.853 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -64.11 -49.36 72.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.609 1.095 . . . . 0.0 111.986 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.96 -43.08 88.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.3 1.04 . . . . 0.0 110.398 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -57.04 -48.87 77.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.997 0.519 . . . . 0.0 111.999 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.47 88.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.486 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -61.23 -46.84 88.76 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 111.703 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.72 -44.29 82.02 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.48 -44.48 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 0.0 110.2 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.26 -55.81 30.16 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.813 1.245 . . . . 0.0 111.197 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -68.57 -34.04 75.12 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -67.57 -41.81 83.59 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.431 -0.793 . . . . 0.0 112.325 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.31 0.12 15.33 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.9 0.88 . . . . 0.0 112.873 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 tttt 63.73 31.86 14.03 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.914 1.686 . . . . 0.0 112.295 168.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 66' ' ' LEU . 29.8 mtt -66.7 -33.91 76.68 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.115 -0.99 . . . . 0.0 111.867 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.4 -16.54 9.49 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.171 2.589 . . . . 0.0 114.904 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.04 76.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.723 -1.236 . . . . 0.0 111.293 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -123.3 160.57 26.39 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.234 1.014 . . . . 0.0 110.148 162.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -59.4 -44.78 92.76 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.067 -1.021 . . . . 0.0 112.429 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.68 -8.94 27.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.444 -1.265 . . . . 0.0 113.443 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 68.54 47.61 0.89 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.67 1.588 . . . . 0.0 109.512 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -116.85 25.64 10.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.839 1.256 . . . . 0.0 112.557 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.33 124.76 10.1 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 111.154 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.64 133.6 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 110.234 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.2 tp -114.44 132.46 56.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.872 1.32 . . . . 0.0 111.685 164.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.2 mt -110.27 92.7 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -76.18 120.64 21.74 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.734 0.814 . . . . 0.0 110.516 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -117.07 130.06 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.046 1.338 . . . . 0.0 109.917 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.94 105.47 15.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.408 1.083 . . . . 0.0 110.373 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.43 -19.79 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.81 -47.62 20.96 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.474 1.488 . . . . 0.0 111.157 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -79.98 -15.84 56.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.444 1.097 . . . . 0.0 113.317 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 70.11 33.14 2.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.656 1.582 . . . . 0.0 112.205 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -114.09 167.92 10.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.39 1.476 . . . . 0.0 111.018 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.26 141.67 22.47 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.718 1.207 . . . . 0.0 109.63 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.86 135.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.088 1.355 . . . . 0.0 108.213 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 mt -115.13 130.28 69.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -140.88 149.79 42.39 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.738 0.815 . . . . 0.0 110.113 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.76 158.77 27.82 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.92 170.07 5.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.388 1.566 . . . . 0.0 114.084 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.65 -30.28 70.61 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.585 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.55 -48.0 59.27 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 119.916 1.235 . . . . 0.0 111.612 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.75 -56.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.068 0.934 . . . . 0.0 109.365 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -53.05 -44.7 67.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.982 0.913 . . . . 0.0 112.588 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.86 -8.28 58.68 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.848 1.659 . . . . 0.0 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -23.49 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.87 173.79 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.808 1.64 . . . . 0.0 111.955 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -125.13 171.06 10.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.13 -31.63 63.5 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.12 -31.36 69.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 112.548 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 57.7 t80 -74.3 -33.42 63.2 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.644 0.778 . . . . 0.0 110.558 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -77.04 -23.68 52.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.241 1.816 . . . . 0.0 114.16 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.35 -36.05 81.91 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.711 -1.243 . . . . 0.0 112.163 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.1 m -58.35 -39.71 80.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.363 1.465 . . . . 0.0 111.675 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -60.67 -54.98 38.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.377 1.871 . . . . 0.0 111.381 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -60.29 -45.11 94.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 110.471 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -56.96 -45.13 83.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -47.98 83.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.262 0.937 . . . . 0.0 112.642 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.5 mt -66.02 -48.36 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.798 0.839 . . . . 0.0 110.091 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.36 -42.32 98.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.073 0.949 . . . . 0.0 113.294 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.68 -41.22 96.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.821 0.737 . . . . 0.0 111.489 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -74.19 -37.11 64.02 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.553 0.741 . . . . 0.0 111.765 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.84 -40.26 96.17 Favored 'General case' 0 C--N 1.346 0.444 0 O-C-N 121.428 -0.795 . . . . 0.0 111.81 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.26 -40.35 97.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.169 174.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -65.39 -41.53 93.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.812 0.845 . . . . 0.0 111.493 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.09 6.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.49 1.043 . . . . 0.0 114.439 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -110.4 84.08 1.87 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.414 1.486 . . . . 0.0 111.287 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -64.64 -45.66 85.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -57.33 -51.68 68.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.152 -0.927 . . . . 0.0 111.402 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -56.86 -42.37 79.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.67 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.44 -39.04 97.29 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 119.456 1.025 . . . . 0.0 113.915 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.13 -48.27 30.53 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 110.722 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.15 -57.71 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.781 1.633 . . . . 0.0 110.788 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -61.94 -29.77 70.45 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.579 0.751 . . . . 0.0 111.256 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 -37.31 59.62 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.434 0.54 . . . . 0.0 113.427 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.1 mt -66.53 -44.82 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.601 1.2 . . . . 0.0 110.137 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -59.17 -44.25 92.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.918 0.887 . . . . 0.0 112.253 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -67.95 -30.06 69.26 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.891 -1.13 . . . . 0.0 113.082 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.98 -53.43 26.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 118.814 -0.612 . . . . 0.0 109.786 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.06 -48.31 80.56 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.554 1.073 . . . . 0.0 112.327 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.7 ttm -62.81 -38.85 92.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.373 1.087 . . . . 0.0 112.595 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -74.63 -45.4 45.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.52 0.6 . . . . 0.0 111.436 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt -62.84 -35.42 79.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.492 1.517 . . . . 0.0 111.046 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.06 37.4 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.13 -31.34 61.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.589 1.086 . . . . 0.0 111.603 171.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.52 -37.48 15.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.143 1.377 . . . . 0.0 111.916 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.95 82.34 68.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.552 1.941 . . . . 0.0 110.585 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.92 134.89 30.99 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.422 2.748 . . . . 0.0 111.003 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -63.14 139.03 58.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.244 1.018 . . . . 0.0 112.731 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -116.16 155.53 28.09 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.764 1.625 . . . . 0.0 110.567 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.32 -21.59 66.26 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 119.243 -2.16 . . . . 0.0 112.913 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -101.36 18.2 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.861 1.664 . . . . 0.0 112.892 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.28 153.25 22.95 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.123 0.963 . . . . 0.0 112.739 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.466 0.347 0 O-C-N 121.418 -0.801 . . . . 0.0 112.019 -166.252 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.459 -0.532 0 CA-C-O 122.054 0.773 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -89.35 3.75 51.16 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.8 p -72.23 159.04 34.75 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.24 137.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.689 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 t -98.26 139.06 34.61 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.258 1.023 . . . . 0.0 109.797 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -140.69 164.69 29.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.612 0.765 . . . . 0.0 110.711 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 CA-C-O 117.991 -1.45 . . . . 0.0 113.725 177.711 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -73.23 162.59 29.21 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.607 -0.683 . . . . 0.0 109.85 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.13 41.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.36 -42.9 87.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.484 1.114 . . . . 0.0 111.334 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -71.16 -45.12 64.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.409 1.484 . . . . 0.0 111.345 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.52 -46.03 90.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.224 1.41 . . . . 0.0 111.778 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -56.76 -43.28 80.64 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.368 -0.832 . . . . 0.0 111.834 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.64 89.36 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.764 0.711 . . . . 0.0 112.761 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -75.35 -33.41 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.224 -0.923 . . . . 0.0 112.831 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.07 -37.78 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.665 1.12 . . . . 0.0 111.259 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -63.81 -30.98 72.02 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.211 1.004 . . . . 0.0 112.775 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.76 85.95 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.073 -1.017 . . . . 0.0 111.911 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mm -59.89 -47.71 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.611 0.641 . . . . 0.0 110.003 172.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm105 -59.68 -34.04 72.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.24 -23.93 32.53 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.92 68.4 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.111 0.964 . . . . 0.0 112.734 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CD ' HD21 ' A' ' 140' ' ' ASN . 92.6 mt-10 -56.5 -40.94 75.83 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 110.882 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -73.59 6.06 3.39 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 119.733 -1.854 . . . . 0.0 113.325 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -123.63 -7.98 7.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.382 2.273 . . . . 0.0 114.284 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -163.79 147.25 10.0 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.24 1.382 . . . . 0.0 110.545 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -81.79 12.12 4.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 113.987 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.11 143.74 16.82 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.21 1.386 . . . . 0.0 111.16 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -101.75 139.0 37.98 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.018 0.927 . . . . 0.0 113.074 -164.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.11 138.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.291 1.436 . . . . 0.0 109.573 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -153.39 155.59 36.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.474 1.11 . . . . 0.0 111.0 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.42 139.47 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.921 1.689 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.427 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.9 t60 -122.43 125.86 46.73 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.751 1.221 . . . . 0.0 112.244 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.86 115.15 26.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.888 0.875 . . . . 0.0 110.169 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.26 163.19 29.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.083 1.753 . . . . 0.0 109.812 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.8 mttt -80.35 -72.51 0.41 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.666 -1.271 . . . . 0.0 113.264 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.6 t -148.8 158.27 44.04 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 126.676 1.991 . . . . 0.0 109.292 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -107.03 159.0 16.62 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 126.189 1.796 . . . . 0.0 110.18 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.58 -27.79 18.89 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.738 -1.226 . . . . 0.0 112.148 166.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 mt -100.1 -125.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.329 1.052 . . . . 0.0 108.697 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -115.88 142.55 46.62 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.001 1.72 . . . . 0.0 109.349 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.09 -46.72 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.54 -50.21 74.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.039 0.836 . . . . 0.0 112.441 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -70.03 -39.47 75.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.344 0.658 . . . . 0.0 111.251 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -59.7 -46.55 88.73 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.646 0.778 . . . . 0.0 111.889 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.07 93.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.307 1.043 . . . . 0.0 111.691 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.0 ttp -63.56 -46.16 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 111.606 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.06 -48.81 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.165 0.439 . . . . 0.0 110.929 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.8 -45.39 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.518 1.127 . . . . 0.0 111.553 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -56.29 -53.52 56.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.64 1.176 . . . . 0.0 110.803 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -69.05 -33.73 74.05 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 112.05 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.26 -33.4 75.24 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.238 -1.539 . . . . 0.0 112.453 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.58 -3.18 52.61 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.98 0.912 . . . . 0.0 112.987 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 60.23 34.29 20.98 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.904 1.682 . . . . 0.0 112.697 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.2 mtp -65.02 -18.37 65.24 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -3.94 7.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.492 1.517 . . . . 0.0 113.066 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.79 59.8 2.65 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 111.422 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.1 p -125.93 143.28 51.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.463 1.905 . . . . 0.0 109.142 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -63.09 -48.69 77.54 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.848 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.17 -2.0 57.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.633 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 57.54 37.68 27.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.98 1.263 . . . . 0.0 109.463 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 27.45 9.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.543 1.537 . . . . 0.0 112.0 -172.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.1 124.52 6.78 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 124.098 0.856 . . . . 0.0 112.093 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.3 t -111.55 132.44 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.384 1.073 . . . . 0.0 110.147 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 34' ' ' HIS . 27.1 tp -118.6 123.81 45.92 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.245 1.022 . . . . 0.0 111.455 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.67 96.33 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 125.474 1.509 . . . . 0.0 108.328 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.07 127.7 34.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.644 0.778 . . . . 0.0 111.379 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.36 125.86 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.318 0.647 . . . . 0.0 110.646 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.35 108.02 20.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.661 1.584 . . . . 0.0 110.236 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 37' ' ' LYS . 29.6 m -75.79 -20.71 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -73.67 -64.11 1.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.988 0.813 . . . . 0.0 108.808 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.2 -9.52 58.62 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.8 tttt 65.45 32.57 9.44 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 m -100.76 132.55 46.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.603 1.561 . . . . 0.0 109.207 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.62 139.41 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.534 1.134 . . . . 0.0 108.385 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.58 143.83 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.012 1.325 . . . . 0.0 108.229 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 100' ' ' ILE . 12.3 mt -122.79 135.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -147.64 129.36 15.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.857 1.663 . . . . 0.0 108.604 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.13 172.55 16.62 Favored Glycine 0 C--O 1.236 0.28 0 C-N-CA 125.353 1.454 . . . . 0.0 112.002 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -60.81 166.64 3.24 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.664 1.586 . . . . 0.0 113.551 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -53.08 -34.67 57.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.226 1.41 . . . . 0.0 113.717 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.95 -29.25 69.33 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.968 1.258 . . . . 0.0 114.185 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.65 -56.2 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.17 1.485 . . . . 0.0 108.529 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -51.64 -34.35 37.5 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.522 1.529 . . . . 0.0 113.747 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -78.42 -24.61 46.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.408 1.483 . . . . 0.0 113.081 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.48 -22.85 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.78 159.98 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.495 1.043 . . . . 0.0 112.715 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.7 p -95.01 174.13 7.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.69 -21.74 66.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.926 -1.109 . . . . 0.0 113.535 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.28 -17.91 55.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 48.1 t80 -73.17 -46.18 52.21 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 165.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -65.56 -32.2 73.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.543 1.137 . . . . 0.0 113.492 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.66 -36.85 70.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.969 1.308 . . . . 0.0 112.297 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.2 p -61.21 -45.25 95.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.752 0.821 . . . . 0.0 112.01 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 m -65.34 -45.87 82.5 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.811 1.644 . . . . 0.0 110.961 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.98 -51.42 67.79 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.542 . . . . 0.0 111.187 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -56.61 -48.09 78.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.884 0.766 . . . . 0.0 111.711 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.57 82.93 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.908 -1.12 . . . . 0.0 113.453 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 78' ' ' ILE . 29.1 mt -70.46 -50.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.165 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -55.6 -44.27 76.81 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.282 1.033 . . . . 0.0 112.559 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.91 -34.02 74.03 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.01 -38.84 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.721 1.208 . . . . 0.0 111.251 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.98 -38.59 82.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.473 -0.767 . . . . 0.0 111.174 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.13 -27.08 67.77 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.272 1.429 . . . . 0.0 113.419 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.2 -20.98 39.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.935 0.894 . . . . 0.0 111.736 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.07 7.03 44.68 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.219 1.39 . . . . 0.0 114.549 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.08 97.81 7.54 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.805 1.303 . . . . 0.0 111.586 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -72.5 -37.05 68.5 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.604 -0.685 . . . . 0.0 110.898 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -57.73 -57.91 10.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.336 -0.852 . . . . 0.0 111.381 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.6 -41.1 94.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.268 0.627 . . . . 0.0 111.396 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.81 98.32 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 118.598 0.635 . . . . 0.0 113.469 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.41 -50.44 59.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.149 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.1 t -59.11 -48.31 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.0 0.818 . . . . 0.0 111.743 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.6 -29.84 66.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.286 0.493 . . . . 0.0 112.268 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.2 -34.48 64.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 118.722 0.692 . . . . 0.0 112.522 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.31 -52.59 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.454 1.102 . . . . 0.0 110.828 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.36 -42.33 91.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.597 1.09 . . . . 0.0 111.04 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.69 -46.58 89.08 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.177 -0.952 . . . . 0.0 112.116 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.01 96.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.426 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.77 -44.63 97.19 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.172 0.897 . . . . 0.0 112.425 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.1 mtp -65.02 -35.97 82.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.831 0.816 . . . . 0.0 113.112 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.411 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.87 -44.39 61.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.972 0.509 . . . . 0.0 111.644 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.55 -38.12 88.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 0.0 111.925 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.16 -24.81 43.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -73.08 -31.4 64.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.625 -1.297 . . . . 0.0 112.502 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -83.36 -38.01 22.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.88 1.272 . . . . 0.0 111.95 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -130.64 90.8 39.41 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.543 1.537 . . . . 0.0 109.178 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 139.82 50.85 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.478 2.119 . . . . 0.0 110.173 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -64.95 149.13 50.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.597 0.713 . . . . 0.0 112.698 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.03 145.89 50.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.122 1.369 . . . . 0.0 110.427 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -62.51 -20.68 64.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.8 0.18 54.67 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.564 1.946 . . . . 0.0 112.629 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -50.36 151.99 1.98 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.358 2.263 . . . . 0.0 115.735 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.328 1.051 . . . . 0.0 112.389 -163.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 110.262 -0.707 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.404 HD21 ' CD ' ' A' ' 24' ' ' GLU . 2.3 m-80 -85.23 0.23 52.53 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.1 p -71.73 153.52 41.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.264 1.425 . . . . 0.0 111.106 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.5 mt -72.25 139.38 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.566 0.747 . . . . 0.0 109.109 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.4 t -101.17 139.1 37.32 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.824 -1.172 . . . . 0.0 110.533 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -136.43 151.02 49.04 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 112.204 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.455 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.217 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -101.05 162.22 13.05 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.573 -1.329 . . . . 0.0 109.98 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.83 -18.13 58.88 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.33 -48.15 57.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.225 1.375 . . . . 0.0 110.531 166.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.74 -40.82 92.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.144 0.978 . . . . 0.0 111.471 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -70.04 -42.95 72.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.357 1.063 . . . . 0.0 112.402 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.64 -45.42 85.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.503 -0.748 . . . . 0.0 111.817 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -59.84 -43.17 94.75 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.35 -0.844 . . . . 0.0 113.095 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.78 -49.33 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.427 1.091 . . . . 0.0 110.25 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.36 -48.2 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.527 1.131 . . . . 0.0 111.846 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.62 -27.75 66.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.04 -32.57 67.25 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.134 -0.978 . . . . 0.0 112.487 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.49 -52.82 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.353 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -51.76 -23.96 5.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -89.95 -25.22 21.03 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.176 1.39 . . . . 0.0 113.019 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.11 74.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.522 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -63.61 -20.37 65.61 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.762 0.71 . . . . 0.0 112.736 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -83.86 3.97 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 119.641 -1.912 . . . . 0.0 113.136 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -129.97 -5.72 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.281 1.432 . . . . 0.0 113.427 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -162.55 155.54 19.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.565 1.546 . . . . 0.0 109.339 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -79.87 7.02 9.6 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.239 1.016 . . . . 0.0 113.722 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.9 152.85 20.2 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -111.17 129.55 55.91 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.497 1.119 . . . . 0.0 110.572 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.74 128.73 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.394 -0.816 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -141.3 160.36 40.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.484 1.114 . . . . 0.0 111.903 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.7 t -132.45 136.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.3 1.44 . . . . 0.0 109.216 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.3 t60 -119.55 119.4 33.69 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.816 1.246 . . . . 0.0 112.593 172.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.47 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.9 tp -100.88 130.8 46.95 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.97 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.26 165.14 34.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.152 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -80.85 -67.37 0.78 Allowed 'General case' 0 C--O 1.24 0.564 0 O-C-N 120.24 -1.537 . . . . 0.0 112.335 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 142.42 24.94 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.545 1.538 . . . . 0.0 110.125 -167.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -92.6 133.02 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.375 0.67 . . . . 0.0 111.961 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.68 -28.07 60.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 112.63 171.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -118.01 -164.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.432 1.893 . . . . 0.0 109.66 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.27 137.11 48.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.808 -1.183 . . . . 0.0 112.647 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.45 -37.79 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.433 0.693 . . . . 0.0 111.905 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -64.06 -48.98 74.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.324 0.65 . . . . 0.0 111.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.94 -37.01 81.09 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 112.098 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -62.75 -47.19 84.61 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.439 0.563 . . . . 0.0 111.24 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.17 96.33 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.727 0.811 . . . . 0.0 110.824 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.2 ttp -60.96 -47.49 86.18 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.509 0.723 . . . . 0.0 112.568 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.1 -37.93 81.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.315 0.961 . . . . 0.0 111.944 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.07 -41.46 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.856 0.753 . . . . 0.0 111.819 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.7 -47.78 83.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.465 1.106 . . . . 0.0 111.882 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -75.45 -34.72 60.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.594 0.757 . . . . 0.0 112.288 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -61.65 -41.91 98.17 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.466 1.107 . . . . 0.0 112.03 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.42 -0.67 20.78 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.359 -0.838 . . . . 0.0 112.938 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 59.67 33.51 21.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.317 1.447 . . . . 0.0 112.352 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.8 mtp -71.21 -23.35 62.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.483 1.113 . . . . 0.0 112.853 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -67.7 -16.3 64.07 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.353 1.861 . . . . 0.0 113.598 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.44 72.61 8.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.045 1.338 . . . . 0.0 111.291 172.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.0 m -135.85 135.67 39.96 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.243 1.817 . . . . 0.0 107.803 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -49.09 -49.94 39.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -93.07 0.57 57.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.258 1.023 . . . . 0.0 113.749 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 61.65 43.95 9.39 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.777 1.231 . . . . 0.0 111.041 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -121.03 47.37 1.84 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.493 1.517 . . . . 0.0 112.347 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 131.6 10.8 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.929 0.776 . . . . 0.0 112.749 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.35 139.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 118.221 1.01 . . . . 0.0 111.605 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.1 tp -125.93 120.81 31.37 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.457 1.503 . . . . 0.0 111.085 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -96.76 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.812 0.845 . . . . 0.0 109.796 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -78.06 119.92 22.17 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.696 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.38 130.71 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.744 0.818 . . . . 0.0 110.159 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.24 94.75 5.68 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.389 1.476 . . . . 0.0 110.231 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 35' ' ' LEU . 20.1 m -70.5 -15.81 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -170.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -83.01 -34.23 26.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.825 0.85 . . . . 0.0 111.176 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -97.44 -15.63 20.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.99 1.316 . . . . 0.0 113.833 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.5 tttt 71.98 21.91 3.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.134 2.174 . . . . 0.0 112.43 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.8 p -99.94 163.59 12.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.193 -0.942 . . . . 0.0 111.48 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.21 145.61 35.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.137 1.375 . . . . 0.0 108.863 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -137.68 136.12 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 125.748 1.619 . . . . 0.0 107.54 175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 mt -111.56 126.06 68.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -121.85 150.56 41.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.298 1.439 . . . . 0.0 109.702 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.78 149.65 21.69 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -65.32 160.86 20.79 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 123.249 1.499 . . . . 0.0 112.156 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -53.46 -35.89 61.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.233 1.813 . . . . 0.0 113.334 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.51 76.83 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.344 -1.253 . . . . 0.0 114.083 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.35 -54.4 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.916 1.858 . . . . 0.0 108.731 167.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -52.87 -35.41 57.69 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.22 -16.14 56.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.922 1.289 . . . . 0.0 113.171 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 m -111.51 -29.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 119.555 1.071 . . . . 0.0 113.84 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.79 163.08 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.032 0.833 . . . . 0.0 111.287 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.1 m -119.42 169.58 9.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.318 1.447 . . . . 0.0 111.736 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -56.82 -32.59 65.89 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.237 1.38 . . . . 0.0 113.681 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.55 -21.05 66.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.554 1.142 . . . . 0.0 113.297 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -79.01 -41.91 27.83 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.476 -0.765 . . . . 0.0 110.462 171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -69.47 -30.35 68.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.74 -36.17 69.44 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.183 0.593 . . . . 0.0 112.548 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -62.13 -44.76 95.92 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.915 0.779 . . . . 0.0 111.289 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -61.73 -47.63 84.39 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.136 1.775 . . . . 0.0 110.896 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.82 -43.7 98.31 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.369 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -65.18 -42.98 93.13 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.754 1.161 . . . . 0.0 112.45 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.88 78.28 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.718 1.145 . . . . 0.0 112.34 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.49 -51.38 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.822 0.449 . . . . 0.0 111.031 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.02 -44.74 96.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.935 1.294 . . . . 0.0 113.341 -174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.21 -38.47 91.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.631 0.772 . . . . 0.0 111.573 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.11 -38.46 36.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.067 0.947 . . . . 0.0 111.352 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -59.29 -40.05 84.92 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.333 -0.854 . . . . 0.0 111.637 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.67 -25.46 68.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.183 0.993 . . . . 0.0 113.267 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -87.41 -25.48 23.78 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.822 1.249 . . . . 0.0 111.797 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 10.55 40.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.301 1.429 . . . . 0.0 113.58 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.58 59.05 0.8 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.431 1.493 . . . . 0.0 110.83 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -49.46 -44.82 46.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 114.047 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 49.9 tttm -52.19 -51.43 58.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 124.584 1.154 . . . . 0.0 112.592 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -68.87 -33.86 74.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.76 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.54 -42.79 97.29 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-N 119.035 0.834 . . . . 0.0 112.75 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.86 -51.63 57.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.225 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.32 -47.38 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.089 0.956 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.73 -40.98 92.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.87 -39.39 75.59 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.856 -0.528 . . . . 0.0 112.312 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.05 -39.08 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.671 1.188 . . . . 0.0 110.648 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.74 -51.07 66.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.193 0.997 . . . . 0.0 112.363 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.44 -40.04 96.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.532 -0.73 . . . . 0.0 112.053 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -50.88 72.01 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.652 172.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.46 -49.18 75.29 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.076 0.853 . . . . 0.0 112.585 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.0 mtp -60.99 -35.72 77.56 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.929 0.864 . . . . 0.0 112.898 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -80.13 -39.56 29.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.193 0.997 . . . . 0.0 111.868 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.6 mt -62.18 -36.0 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.83 -17.52 36.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.338 1.455 . . . . 0.0 114.449 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.01 -38.48 64.08 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.062 -1.024 . . . . 0.0 112.223 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -80.98 -49.81 10.48 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 124.486 1.114 . . . . 0.0 111.68 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -123.96 91.59 49.44 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.409 1.483 . . . . 0.0 109.682 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.41 148.94 68.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.877 2.385 . . . . 0.0 110.828 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -70.75 127.63 33.31 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.813 -0.554 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -100.35 155.89 17.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.203 1.801 . . . . 0.0 109.596 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.28 -24.46 63.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 119.866 -1.771 . . . . 0.0 112.768 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -98.33 16.5 21.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.865 2.066 . . . . 0.0 113.18 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.02 163.0 5.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.682 1.23 . . . . 0.0 112.065 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--N 1.331 -0.223 0 C-N-CA 125.539 1.536 . . . . 0.0 110.903 -173.635 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.444 -1.401 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.87 31.76 0.26 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.395 1.878 . . . . 0.0 111.726 -172.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 t -97.08 164.0 12.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.774 1.629 . . . . 0.0 111.285 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.29 131.22 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -93.17 144.61 25.12 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.781 0.832 . . . . 0.0 109.633 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -142.29 135.99 29.3 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.511 -0.743 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.564 0 CA-C-O 115.983 -2.565 . . . . 0.0 113.963 173.835 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -73.6 169.43 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.339 0.656 . . . . 0.0 111.059 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.56 -42.57 64.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.107 -0.996 . . . . 0.0 113.66 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.4 -31.27 63.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.263 0.625 . . . . 0.0 112.264 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.57 -43.93 65.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.323 -0.861 . . . . 0.0 110.943 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -63.48 -31.07 72.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.979 1.312 . . . . 0.0 112.004 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.59 -46.33 59.6 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.533 -1.355 . . . . 0.0 111.279 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.6 96.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.438 1.095 . . . . 0.0 112.701 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.65 -39.86 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.394 0.997 . . . . 0.0 113.17 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.76 -34.31 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.578 0.626 . . . . 0.0 111.26 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.88 -28.9 67.11 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.55 71.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.234 0.47 . . . . 0.0 111.761 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.65 -46.54 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.67 0.788 . . . . 0.0 109.681 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.57 -43.28 93.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.836 1.255 . . . . 0.0 112.439 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.62 -37.66 85.31 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.182 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.97 93.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.09 0.556 . . . . 0.0 112.022 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.22 -18.99 61.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.735 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -98.39 11.14 39.05 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.232 -1.542 . . . . 0.0 112.737 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -121.97 -16.15 7.63 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.024 1.729 . . . . 0.0 113.752 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.3 t -163.65 154.54 16.13 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.88 1.672 . . . . 0.0 109.682 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.0 m -78.38 1.65 21.31 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.82 154.78 27.14 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 124.999 1.285 . . . . 0.0 111.51 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -131.74 123.78 28.38 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -163.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.1 mt -115.63 101.08 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 120.837 -1.164 . . . . 0.0 111.812 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -97.34 156.2 16.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.33 1.452 . . . . 0.0 111.66 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 140.98 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.34 1.456 . . . . 0.0 110.876 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.435 ' HB2' HD11 ' A' ' 66' ' ' LEU . 41.9 t60 -125.81 132.38 52.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 112.324 171.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -118.2 132.94 56.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.401 1.08 . . . . 0.0 111.289 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -153.23 160.49 42.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.573 1.549 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.57 -80.54 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.728 -1.233 . . . . 0.0 112.231 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -140.86 154.01 45.99 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.577 1.551 . . . . 0.0 111.205 -176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -98.83 142.98 29.66 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -79.16 -15.37 58.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.267 1.427 . . . . 0.0 112.984 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 pt -136.32 -171.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 128.687 2.795 . . . . 0.0 109.134 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -62.63 140.32 58.67 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.41 -34.53 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.93 -51.62 66.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.341 0.656 . . . . 0.0 111.497 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -66.51 -37.62 85.44 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.612 -0.68 . . . . 0.0 111.258 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -59.41 -49.59 77.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.985 -1.072 . . . . 0.0 111.638 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.79 96.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.474 0.71 . . . . 0.0 111.212 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.28 -41.58 89.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.144 0.978 . . . . 0.0 112.691 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.99 -33.67 59.74 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.161 -0.962 . . . . 0.0 112.72 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.33 -43.2 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.728 1.149 . . . . 0.0 110.931 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.36 -47.07 82.59 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.787 1.235 . . . . 0.0 110.849 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -76.12 -35.21 59.38 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.302 1.041 . . . . 0.0 112.404 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -62.39 -41.09 98.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.315 1.046 . . . . 0.0 111.459 172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.75 -2.2 25.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.091 1.356 . . . . 0.0 113.669 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 55.82 38.84 30.53 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.343 1.457 . . . . 0.0 112.851 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.73 -18.33 64.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.31 -3.66 0.99 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.623 1.969 . . . . 0.0 115.148 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -73.28 5.84 3.29 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.118 1.767 . . . . 0.0 115.347 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.1 p -83.18 156.46 23.2 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.45 -40.1 70.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.677 0.791 . . . . 0.0 112.637 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.81 -13.39 33.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.511 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 69.26 58.39 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.105 1.362 . . . . 0.0 108.657 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -145.66 33.92 1.04 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.746 1.218 . . . . 0.0 113.121 -162.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.01 147.57 23.82 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.684 1.135 . . . . 0.0 110.407 166.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.23 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.722 1.609 . . . . 0.0 108.809 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 34' ' ' HIS . 26.3 tp -125.5 118.93 26.85 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.834 1.254 . . . . 0.0 111.122 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -90.22 97.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -78.88 125.08 28.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.157 -0.964 . . . . 0.0 110.187 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -121.75 127.24 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.247 1.019 . . . . 0.0 111.28 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.54 95.98 8.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.555 1.542 . . . . 0.0 109.866 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.16 -19.55 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -76.99 -41.36 43.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.166 0.587 . . . . 0.0 112.156 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.36 -27.81 24.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.301 1.441 . . . . 0.0 111.331 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 88.42 14.76 0.07 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.24 2.616 . . . . 0.0 111.383 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -97.78 157.64 15.96 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.063 -1.023 . . . . 0.0 111.059 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -134.78 149.58 50.42 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.453 1.101 . . . . 0.0 109.389 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.11 139.98 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 108.101 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 50.3 mt -108.9 129.08 64.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -141.17 138.55 33.47 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.835 0.743 . . . . 0.0 110.553 172.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.7 159.18 24.11 Favored Glycine 0 C--O 1.24 0.517 0 C-N-CA 124.722 1.153 . . . . 0.0 110.314 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.45 161.93 21.68 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 123.194 1.474 . . . . 0.0 114.629 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.38 -31.49 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.375 1.47 . . . . 0.0 114.119 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.08 -31.43 57.67 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 119.552 1.069 . . . . 0.0 113.641 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.29 -57.25 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.554 1.177 . . . . 0.0 109.231 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -55.37 -38.08 68.36 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.031 0.932 . . . . 0.0 113.133 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.66 -11.75 60.76 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -114.0 -30.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -105.25 147.86 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.02 1.282 . . . . 0.0 112.446 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -92.22 171.75 8.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.547 1.139 . . . . 0.0 112.888 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -52.45 -38.6 59.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.387 1.875 . . . . 0.0 115.181 165.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.51 -28.15 67.59 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.804 -1.185 . . . . 0.0 112.895 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.426 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.5 t80 -73.03 -30.08 63.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.909 0.484 . . . . 0.0 110.953 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 8.4 m95 -80.31 -29.46 38.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.515 1.126 . . . . 0.0 113.502 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.41 -42.82 70.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.43 1.492 . . . . 0.0 113.085 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.0 p -59.0 -37.24 76.42 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.9 0.88 . . . . 0.0 112.281 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -54.99 40.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 0.0 110.834 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -57.35 -48.33 79.29 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 124.21 1.004 . . . . 0.0 110.112 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.1 -36.78 84.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.72 73.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.049 0.84 . . . . 0.0 112.308 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.25 -53.93 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.858 0.863 . . . . 0.0 109.89 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.17 1.788 . . . . 0.0 112.804 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.23 -51.64 62.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.55 1.068 . . . . 0.0 111.183 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.94 -35.32 62.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 119.047 -0.502 . . . . 0.0 110.806 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -58.8 -45.94 88.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.048 0.84 . . . . 0.0 110.448 171.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -58.8 -41.79 87.59 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.944 0.793 . . . . 0.0 111.699 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.28 -12.76 61.55 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.03 1.75 67.01 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.019 1.771 . . . . 0.0 114.559 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.99 75.03 1.64 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.477 1.511 . . . . 0.0 111.855 -174.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -51.85 -43.86 63.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.191 1.396 . . . . 0.0 112.909 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -54.34 -57.59 10.66 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.27 0.628 . . . . 0.0 111.517 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -62.23 -34.31 76.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.628 1.171 . . . . 0.0 111.585 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.72 83.22 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 118.585 0.63 . . . . 0.0 113.382 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.93 -48.79 64.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.333 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.77 -51.52 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.091 0.956 . . . . 0.0 111.115 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.33 -25.35 63.26 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.155 -0.965 . . . . 0.0 113.054 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.35 -41.68 84.82 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.391 171.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.71 -53.03 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.982 1.313 . . . . 0.0 110.229 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -55.76 -48.4 75.34 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.936 0.895 . . . . 0.0 113.36 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -70.92 -36.61 72.73 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.953 -0.467 . . . . 0.0 111.447 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.53 99.11 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.565 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.9 -48.17 86.94 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-N 119.429 1.013 . . . . 0.0 111.773 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 50.9 ttp -56.23 -48.76 75.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.226 1.013 . . . . 0.0 111.674 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -70.8 -42.83 69.8 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.104 0.562 . . . . 0.0 111.839 -172.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.87 -33.62 76.26 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.323 1.449 . . . . 0.0 111.336 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.04 -16.77 60.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.42 -45.81 75.03 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.557 -1.339 . . . . 0.0 110.823 168.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -76.19 -47.3 24.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.329 1.452 . . . . 0.0 111.538 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -127.87 85.2 61.25 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 109.864 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.49 151.29 80.11 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.874 2.383 . . . . 0.0 111.11 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -62.95 149.95 43.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -132.07 152.03 51.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.38 -30.02 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.243 . . . . 0.0 113.722 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.2 18.6 13.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.575 1.15 . . . . 0.0 112.702 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.11 146.55 27.29 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.976 0.893 . . . . 0.0 112.247 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.22 -0.473 0 C-N-CA 124.899 1.28 . . . . 0.0 111.241 -169.625 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 CA-C-O 121.817 0.674 . . . . 0.0 112.852 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -78.35 -4.28 47.31 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.594 1.557 . . . . 0.0 114.354 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 p -76.38 155.88 33.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.791 -1.193 . . . . 0.0 112.18 -170.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.3 mt -79.69 128.4 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.95 0.9 . . . . 0.0 109.578 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 t -89.87 145.12 25.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.986 0.514 . . . . 0.0 111.684 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.63 147.35 31.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 111.351 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 C-N-CA 125.899 1.714 . . . . 0.0 116.191 -176.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--O 1.237 0.397 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.35 155.98 19.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.878 0.471 . . . . 0.0 110.545 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.95 -29.04 26.47 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -74.41 -35.32 63.41 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -73.17 -48.08 38.31 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.643 1.577 . . . . 0.0 109.938 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.44 -45.64 92.14 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.796 1.638 . . . . 0.0 111.241 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.79 -33.91 73.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.566 -1.334 . . . . 0.0 112.794 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -44.13 67.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -67.86 -39.34 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.136 0.88 . . . . 0.0 111.974 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.46 -39.13 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 121.65 -0.656 . . . . 0.0 111.955 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.8 -27.49 63.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.02 87.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.016 0.825 . . . . 0.0 111.776 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.18 -47.87 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.193 0.597 . . . . 0.0 111.19 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -60.28 -30.76 69.67 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.26 -35.86 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.72 -1.238 . . . . 0.0 111.141 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.75 98.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.38 1.072 . . . . 0.0 112.336 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -57.05 -29.77 63.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.222 1.409 . . . . 0.0 112.12 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -88.31 3.23 50.45 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.042 -1.662 . . . . 0.0 112.326 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.63 -15.64 7.45 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.376 1.871 . . . . 0.0 113.682 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 29' ' ' GLY . 6.7 t -154.24 160.16 41.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.547 1.939 . . . . 0.0 109.82 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 p -92.11 23.04 3.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.53 ' H ' HG23 ' A' ' 27' ' ' THR . . . -125.61 153.66 18.32 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 126.385 1.945 . . . . 0.0 112.187 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -106.0 137.26 44.22 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -166.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.8 128.69 75.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -135.37 142.37 45.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.635 0.774 . . . . 0.0 111.541 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 81.2 t -107.82 135.28 47.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.694 1.197 . . . . 0.0 109.465 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.467 ' HB2' HD11 ' A' ' 66' ' ' LEU . 68.6 t60 -115.99 138.51 51.14 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.705 1.202 . . . . 0.0 112.326 166.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.9 tp -126.11 129.44 49.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.518 1.127 . . . . 0.0 111.822 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -158.88 156.62 29.91 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.521 1.528 . . . . 0.0 109.312 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -79.83 -70.61 0.5 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 121.034 -1.041 . . . . 0.0 112.464 -173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 t -144.04 152.05 40.49 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 111.552 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -104.48 137.18 42.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.267 1.427 . . . . 0.0 111.524 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.87 -14.57 57.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 112.977 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.81 -152.64 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.589 1.955 . . . . 0.0 110.171 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.46 134.71 36.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 112.349 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -39.73 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.271 -0.893 . . . . 0.0 112.151 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.12 -43.47 82.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.551 1.069 . . . . 0.0 111.527 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.62 -43.04 98.02 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.679 -0.638 . . . . 0.0 111.88 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -58.43 -45.45 88.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.784 0.72 . . . . 0.0 111.669 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.4 87.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 117.442 -1.266 . . . . 0.0 111.405 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 51.1 ttp -60.29 -50.01 75.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.175 1.352 . . . . 0.0 111.077 170.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.495 0.588 . . . . 0.0 111.724 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.5 t -63.68 -45.31 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.397 1.079 . . . . 0.0 111.703 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.26 -48.82 80.1 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.632 0.773 . . . . 0.0 111.068 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -70.28 -39.67 74.76 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.139 0.976 . . . . 0.0 111.619 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -61.65 -42.96 99.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.412 1.485 . . . . 0.0 112.926 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.93 -2.83 10.7 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.479 -0.763 . . . . 0.0 112.882 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.81 37.49 18.66 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.797 1.639 . . . . 0.0 111.713 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.6 mtp -74.48 -17.96 60.69 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.48 -4.87 9.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 170.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.03 52.16 0.7 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.531 1.532 . . . . 0.0 113.38 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 p -135.3 149.63 49.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.147 0.979 . . . . 0.0 112.05 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -67.4 -25.58 66.02 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.17 -1.81 13.57 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.139 1.376 . . . . 0.0 113.4 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 56.22 54.88 7.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.089 1.356 . . . . 0.0 111.112 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -133.09 41.99 3.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.526 0.731 . . . . 0.0 112.699 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.48 147.51 18.66 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.756 1.17 . . . . 0.0 111.552 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.77 138.84 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.531 1.133 . . . . 0.0 110.354 172.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.5 tp -115.06 128.52 56.29 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.79 1.236 . . . . 0.0 110.14 165.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -101.95 93.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 124.132 0.973 . . . . 0.0 109.005 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -75.52 123.42 25.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.034 0.934 . . . . 0.0 109.912 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.11 122.43 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.67 1.188 . . . . 0.0 110.731 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.07 89.22 5.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.901 1.28 . . . . 0.0 109.621 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.51 -16.49 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -75.24 -35.17 61.45 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.439 -0.788 . . . . 0.0 112.274 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -95.77 -8.01 35.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.095 1.358 . . . . 0.0 112.54 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.3 tttt 70.17 24.75 4.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.658 1.983 . . . . 0.0 112.722 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 p -108.93 167.96 9.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.086 1.354 . . . . 0.0 112.519 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.81 147.39 31.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 110.585 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.3 149.28 24.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.544 1.937 . . . . 0.0 108.166 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.85 127.02 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -136.92 129.73 30.57 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.429 0.691 . . . . 0.0 110.235 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.27 15.19 Favored Glycine 0 CA--C 1.513 -0.078 0 C-N-CA 124.825 1.202 . . . . 0.0 112.065 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -69.9 161.35 30.1 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.384 1.087 . . . . 0.0 113.378 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -52.14 -38.31 57.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.604 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.72 -11.6 69.35 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.009 -1.44 . . . . 0.0 115.047 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 93.3 mt -89.02 -57.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.483 1.641 . . . . 0.0 108.752 160.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -55.58 -33.76 64.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.87 -15.57 58.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.099 1.76 . . . . 0.0 113.639 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.86 -28.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.39 168.63 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.655 1.116 . . . . 0.0 112.673 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.9 p -114.85 177.75 4.53 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.912 1.285 . . . . 0.0 112.681 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -63.16 -26.8 68.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.656 -1.278 . . . . 0.0 113.574 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.75 -34.92 79.47 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.996 1.319 . . . . 0.0 111.701 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.1 t80 -71.09 -30.59 66.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.987 174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -82.33 -31.87 29.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 0.0 112.666 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.39 -41.46 84.92 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.001 0.92 . . . . 0.0 111.689 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -60.83 -33.92 73.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.766 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 m -64.53 -52.13 59.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.673 0.789 . . . . 0.0 110.083 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.5 -45.99 91.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.407 0.683 . . . . 0.0 111.207 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.81 -41.93 96.65 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.11 -50.83 68.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.999 0.428 . . . . 0.0 112.085 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.48 -49.19 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.449 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -57.93 -42.71 85.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.099 1.36 . . . . 0.0 112.608 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.49 -53.29 57.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 111.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.92 -31.1 66.02 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 122.161 -0.337 . . . . 0.0 111.695 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -67.82 -39.98 83.88 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.737 0.699 . . . . 0.0 112.288 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.27 -34.22 77.19 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.159 0.984 . . . . 0.0 111.855 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -71.35 -31.08 66.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.994 0.918 . . . . 0.0 112.316 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 7.53 30.78 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.266 1.412 . . . . 0.0 114.593 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -101.87 72.59 1.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.803 1.641 . . . . 0.0 110.897 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -51.17 -46.52 62.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.84 1.256 . . . . 0.0 113.082 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -46.76 -60.25 2.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -65.8 -35.91 82.03 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.984 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.43 75.21 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 120.04 1.291 . . . . 0.0 113.327 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.03 -51.63 52.42 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.455 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.11 -51.63 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.717 0.807 . . . . 0.0 111.5 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.93 -34.18 77.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.307 0.958 . . . . 0.0 111.768 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -42.24 95.04 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.303 0.954 . . . . 0.0 112.16 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.25 -44.26 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.608 1.563 . . . . 0.0 111.348 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.12 -42.13 94.13 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.845 0.831 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -71.39 -39.79 70.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 120.642 -1.286 . . . . 0.0 112.049 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.99 90.4 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.359 0.664 . . . . 0.0 110.409 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.85 39.1 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.846 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.9 mmm -64.04 -26.36 68.52 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.26 -52.21 11.41 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.781 170.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -58.23 -37.39 74.76 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 112.296 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.7 62.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.447 1.499 . . . . 0.0 113.312 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -67.53 -29.07 68.37 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.105 -0.997 . . . . 0.0 112.52 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.43 -32.62 11.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.112 1.365 . . . . 0.0 112.161 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.79 79.11 75.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.132 1.773 . . . . 0.0 110.053 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.11 136.01 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.259 1.972 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -63.44 139.66 58.79 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.309 1.043 . . . . 0.0 112.896 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -113.37 156.05 24.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.683 1.23 . . . . 0.0 112.911 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.49 -14.77 58.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.81 -1.806 . . . . 0.0 114.267 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -121.43 35.64 4.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.166 1.786 . . . . 0.0 110.571 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 151.24 26.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.538 -0.726 . . . . 0.0 112.887 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.217 -0.61 0 C-N-CA 124.341 1.056 . . . . 0.0 111.752 -166.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.456 -0.702 0 N-CA-C 110.415 -0.648 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -2.64 12.38 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.0 m -78.18 124.45 28.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.831 1.252 . . . . 0.0 110.763 -163.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.81 128.47 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.703 1.201 . . . . 0.0 108.905 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.8 t -87.22 135.43 33.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.55 139.35 42.13 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.903 -1.123 . . . . 0.0 109.998 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 CA-C-O 117.135 -1.925 . . . . 0.0 110.947 170.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.478 HD13 ' CD ' ' A' ' 110' ' ' LYS . 23.0 mt . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -73.57 143.04 46.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.087 0.955 . . . . 0.0 110.673 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.09 -29.26 3.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.17 -46.81 79.21 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.067 0.947 . . . . 0.0 112.754 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.26 -31.68 58.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.231 1.012 . . . . 0.0 111.17 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 37.3 mt-10 -70.89 -38.16 73.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.865 0.866 . . . . 0.0 111.558 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.23 -41.59 99.13 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.493 -1.379 . . . . 0.0 111.628 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.09 98.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.616 0.767 . . . . 0.0 112.833 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.28 -38.25 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 120.979 -1.076 . . . . 0.0 112.167 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.55 -40.17 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.546 0.612 . . . . 0.0 110.845 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.68 -32.99 73.21 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.92 65.54 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -72.28 -46.49 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.41 1.084 . . . . 0.0 110.521 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -56.28 -30.67 62.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.024 0.93 . . . . 0.0 112.967 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.06 -28.17 60.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 113.548 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.86 62.37 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.101 0.96 . . . . 0.0 111.936 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.55 -7.88 23.08 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.733 1.254 . . . . 0.0 113.27 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -95.16 3.08 55.07 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.428 -2.045 . . . . 0.0 112.944 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -125.49 -17.66 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.941 2.097 . . . . 0.0 114.053 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 t -151.41 151.75 32.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.85 1.66 . . . . 0.0 108.927 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -90.84 49.72 1.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.179 0.991 . . . . 0.0 110.859 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.02 128.88 2.41 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.144 -1.597 . . . . 0.0 111.062 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -96.9 126.9 42.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.733 0.813 . . . . 0.0 112.843 -153.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -113.43 115.29 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 111.397 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.499 HH11 ' CG ' ' A' ' 56' ' ' MET . 73.4 mtp180 -118.21 153.55 33.7 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.384 1.473 . . . . 0.0 112.647 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.63 141.94 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.913 1.685 . . . . 0.0 111.3 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -131.46 123.25 27.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.251 1.02 . . . . 0.0 112.358 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.3 tp -111.06 127.84 55.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.819 0.848 . . . . 0.0 111.216 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -149.46 163.47 37.7 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.134 0.974 . . . . 0.0 110.301 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -79.34 -66.63 0.84 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.374 -1.454 . . . . 0.0 112.016 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -159.6 151.77 20.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.47 1.108 . . . . 0.0 112.53 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 p -105.26 144.02 32.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 112.321 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -77.87 -11.96 59.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.692 1.197 . . . . 0.0 113.518 170.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.68 -164.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 127.962 2.505 . . . . 0.0 110.028 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -79.42 136.76 37.04 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.43 -1.419 . . . . 0.0 112.579 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -58.66 -40.33 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -59.12 -46.83 87.32 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.934 0.788 . . . . 0.0 112.211 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -72.6 -38.72 67.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.718 0.407 . . . . 0.0 111.86 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -60.28 -47.58 85.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.24 -0.287 . . . . 0.0 111.026 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.02 89.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.3 ttp -62.56 -50.67 70.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.768 0.827 . . . . 0.0 111.543 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.73 -49.06 79.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.987 0.915 . . . . 0.0 111.918 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.41 -41.1 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.041 0.936 . . . . 0.0 112.026 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.09 -46.09 90.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.988 0.813 . . . . 0.0 111.842 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -72.99 -32.78 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 112.438 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.35 -32.75 70.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.895 1.278 . . . . 0.0 112.807 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.9 mt -78.72 -11.51 59.98 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.3 -0.875 . . . . 0.0 112.82 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 64.49 35.68 9.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.34 1.456 . . . . 0.0 112.909 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.499 ' CG ' HH11 ' A' ' 32' ' ' ARG . 69.3 mtp -67.25 -22.62 65.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.898 1.279 . . . . 0.0 114.275 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.5 -7.93 8.16 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.722 2.009 . . . . 0.0 112.715 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -74.98 47.21 0.34 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.263 1.825 . . . . 0.0 112.719 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.6 p -119.34 150.74 39.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.864 1.666 . . . . 0.0 110.657 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -64.64 -43.9 92.2 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.911 -1.118 . . . . 0.0 112.494 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.45 -9.69 37.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 67.5 55.18 0.65 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.668 1.587 . . . . 0.0 108.58 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -126.17 29.87 5.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.554 1.141 . . . . 0.0 112.975 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.99 132.44 12.2 Favored Glycine 0 N--CA 1.47 0.964 0 O-C-N 120.424 -1.423 . . . . 0.0 110.988 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -111.77 134.5 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.528 1.131 . . . . 0.0 109.5 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 34' ' ' HIS . 16.2 tp -117.75 130.59 56.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.81 0.844 . . . . 0.0 110.693 166.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.5 mt -106.16 95.34 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -75.32 125.63 29.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.6 1.16 . . . . 0.0 110.723 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -117.27 131.19 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.04 1.336 . . . . 0.0 110.332 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.27 95.32 6.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.003 1.721 . . . . 0.0 110.414 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 35' ' ' LEU . 19.5 m -72.65 -16.36 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -75.27 -51.62 12.83 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.43 -5.75 55.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.94 1.296 . . . . 0.0 113.861 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.1 tttt 65.02 31.17 11.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.23 2.212 . . . . 0.0 112.751 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.5 p -111.06 163.54 13.76 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.028 0.931 . . . . 0.0 111.115 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 147.65 42.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.164 1.385 . . . . 0.0 109.534 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.89 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.758 1.623 . . . . 0.0 108.126 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.5 133.93 63.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -147.04 138.45 24.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.077 1.351 . . . . 0.0 110.036 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.71 164.3 21.15 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 124.756 1.169 . . . . 0.0 112.214 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -70.83 166.54 20.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 123.257 1.503 . . . . 0.0 112.705 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.42 -39.16 67.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.153 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.33 -46.49 78.11 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.386 1.47 . . . . 0.0 112.991 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.41 -59.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 118.208 1.004 . . . . 0.0 109.46 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.01 -22.67 64.75 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.72 -29.34 25.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.65 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -24.63 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.14 164.14 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.668 1.187 . . . . 0.0 112.649 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.2 p -107.93 174.42 5.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.694 1.198 . . . . 0.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.94 -33.41 73.12 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.342 -1.474 . . . . 0.0 113.359 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.1 -23.92 63.12 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -68.12 -37.59 81.29 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 117.698 0.226 . . . . 0.0 110.608 169.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -77.01 -25.57 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.3 -36.3 79.72 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.687 0.676 . . . . 0.0 112.715 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.3 m -55.98 -45.39 78.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.634 0.773 . . . . 0.0 111.427 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -47.68 84.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.305 1.442 . . . . 0.0 110.842 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -59.34 -47.84 83.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -64.86 -35.5 81.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.448 1.099 . . . . 0.0 113.368 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.67 -53.26 43.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.936 0.789 . . . . 0.0 111.692 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.33 -48.46 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.014 0.526 . . . . 0.0 110.459 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -60.07 -43.2 95.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.073 1.349 . . . . 0.0 112.905 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.26 -42.17 93.51 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 119.55 1.068 . . . . 0.0 111.827 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -74.88 -38.9 61.79 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.799 0.44 . . . . 0.0 111.926 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.76 -40.11 91.25 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.353 0.978 . . . . 0.0 112.054 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.57 -32.14 73.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.918 1.287 . . . . 0.0 112.078 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -74.59 -39.28 62.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.792 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.41 -2.21 12.59 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.23 1.872 . . . . 0.0 113.062 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.24 71.27 8.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.367 1.467 . . . . 0.0 111.102 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -52.73 -42.34 64.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.144 0.977 . . . . 0.0 112.407 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' CD ' HD13 ' A' ' 8' ' ' LEU . 19.2 tptt -64.93 -48.52 73.82 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -55.37 -47.51 75.69 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.528 0.731 . . . . 0.0 109.695 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.31 95.95 Favored Glycine 0 N--CA 1.467 0.741 0 CA-C-N 119.245 0.929 . . . . 0.0 113.695 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.45 -43.03 74.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.14 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.66 -50.42 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.599 1.16 . . . . 0.0 110.68 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -69.47 -25.05 63.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.875 1.27 . . . . 0.0 112.718 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.93 -41.85 26.74 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.083 0.849 . . . . 0.0 112.614 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.0 mt -60.61 -43.61 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.109 0.955 . . . . 0.0 111.166 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.23 -49.21 77.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.831 0.853 . . . . 0.0 112.621 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -71.55 -36.5 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.012 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.21 78.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.875 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.09 68.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.703 1.138 . . . . 0.0 112.341 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -64.17 -33.58 76.11 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.5 -46.55 38.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.794 0.725 . . . . 0.0 111.193 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.46 -39.26 83.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.215 1.406 . . . . 0.0 110.47 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.09 52.33 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.1 -41.67 99.42 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.859 -1.151 . . . . 0.0 110.805 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -84.84 -47.58 10.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.262 1.825 . . . . 0.0 111.144 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -114.38 78.18 4.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.725 2.01 . . . . 0.0 111.061 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.91 140.57 42.45 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.838 2.358 . . . . 0.0 111.256 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -59.39 141.75 53.86 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -115.42 149.26 38.29 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 123.892 0.877 . . . . 0.0 110.937 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.69 -25.82 67.65 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.29 -1.506 . . . . 0.0 112.297 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.07 22.14 7.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.655 1.582 . . . . 0.0 113.452 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.55 158.75 5.59 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 C-N-CA 124.721 1.209 . . . . 0.0 112.572 -172.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.448 -1.168 0 CA-C-O 121.615 0.59 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -74.29 4.15 6.22 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.2 p -72.72 168.97 17.64 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.653 1.181 . . . . 0.0 111.387 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.42 144.45 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 120.535 -1.353 . . . . 0.0 111.132 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 t -99.99 146.78 26.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.682 1.193 . . . . 0.0 111.026 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -153.18 94.86 1.88 Allowed 'General case' 0 CA--C 1.553 1.094 0 O-C-N 120.908 -1.12 . . . . 0.0 112.92 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 C-N-CA 125.05 1.31 . . . . 0.0 114.904 -173.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -72.59 170.2 14.93 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.371 0.532 . . . . 0.0 111.386 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.38 68.64 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.111 -0.993 . . . . 0.0 112.752 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -60.7 -34.79 74.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.661 1.184 . . . . 0.0 112.395 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 88.6 mt-10 -84.43 -42.47 15.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.0 0.92 . . . . 0.0 110.902 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -57.22 -50.46 72.8 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.555 1.142 . . . . 0.0 111.774 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.16 -39.08 69.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.819 -1.175 . . . . 0.0 112.569 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.62 69.47 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 tt -71.43 -39.23 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.825 0.738 . . . . 0.0 111.136 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.7 t -59.55 -29.21 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.065 1.346 . . . . 0.0 112.641 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -72.86 -41.01 65.21 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.284 1.434 . . . . 0.0 113.557 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.15 77.58 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.03 -49.42 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.961 0.905 . . . . 0.0 110.594 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -60.06 -24.68 64.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.07 -18.43 32.42 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.765 0.826 . . . . 0.0 111.985 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.95 -39.87 29.27 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.993 0.917 . . . . 0.0 111.262 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.59 -27.44 39.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.325 1.45 . . . . 0.0 112.557 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -90.66 1.7 56.57 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.706 -1.871 . . . . 0.0 113.615 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -112.81 -20.73 11.51 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.233 1.813 . . . . 0.0 111.938 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -160.56 148.55 16.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.526 1.13 . . . . 0.0 110.574 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.6 p -81.3 38.25 0.48 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.295 1.038 . . . . 0.0 111.815 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.49 143.27 14.93 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.041 1.781 . . . . 0.0 109.884 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.9 124.77 51.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.156 -165.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.84 130.89 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -145.93 150.15 35.55 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.353 1.461 . . . . 0.0 110.67 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.96 135.92 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.612 1.565 . . . . 0.0 109.887 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' HD11 ' A' ' 66' ' ' LEU . 18.5 t60 -117.4 122.66 44.42 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.974 170.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -114.43 130.31 56.7 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.457 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -155.21 163.44 40.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.043 0.925 . . . . 0.0 110.764 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.5 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -75.05 -75.88 0.16 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.736 1.215 . . . . 0.0 112.086 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 t -138.15 173.19 11.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.774 2.029 . . . . 0.0 109.044 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 p -140.99 141.11 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.413 -0.805 . . . . 0.0 111.036 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.29 -7.19 59.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.76 -150.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.219 1.808 . . . . 0.0 111.137 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -85.83 121.07 27.96 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.29 -1.506 . . . . 0.0 111.365 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.58 -42.53 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.98 -47.54 84.38 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.107 -0.995 . . . . 0.0 112.444 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.17 -36.59 69.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.362 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -68.99 -40.92 78.46 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.528 -0.732 . . . . 0.0 112.319 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.0 74.8 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.365 -0.834 . . . . 0.0 110.649 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.2 ttp -65.56 -44.37 86.98 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.976 0.807 . . . . 0.0 111.072 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.09 -52.46 65.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.335 0.97 . . . . 0.0 111.433 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.07 -45.06 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.964 1.305 . . . . 0.0 111.542 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.93 -50.46 73.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.431 1.014 . . . . 0.0 112.402 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -69.53 -36.48 76.43 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.427 1.091 . . . . 0.0 112.338 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -63.87 -40.24 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.853 1.261 . . . . 0.0 112.079 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.26 -6.37 45.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.326 1.05 . . . . 0.0 113.582 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 57.66 39.3 27.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.888 1.275 . . . . 0.0 111.79 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.8 mtp -66.81 -20.66 65.98 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.919 -1.113 . . . . 0.0 112.469 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.94 -15.78 14.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.998 2.119 . . . . 0.0 112.318 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -73.79 50.66 0.35 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.169 2.188 . . . . 0.0 111.818 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -125.3 123.95 40.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.734 2.014 . . . . 0.0 107.972 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -45.61 -50.34 13.35 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.672 1.189 . . . . 0.0 113.617 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.9 mt -87.0 -6.59 58.7 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 68.04 40.14 2.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.19 1.396 . . . . 0.0 110.966 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -114.65 41.46 2.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.361 1.464 . . . . 0.0 112.33 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.07 10.51 Favored Glycine 0 N--CA 1.477 1.388 0 O-C-N 121.451 -0.781 . . . . 0.0 112.843 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.97 133.67 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.808 1.304 . . . . 0.0 111.043 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.4 tp -116.51 133.54 55.9 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.372 1.069 . . . . 0.0 111.485 172.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.5 mt -106.83 93.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.658 0.742 . . . . 0.0 109.633 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -77.34 113.67 15.36 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.955 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.32 134.26 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.861 1.264 . . . . 0.0 110.595 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.82 15.15 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 110.042 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' LYS . 13.6 m -75.78 -18.32 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -81.62 -37.95 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.515 1.126 . . . . 0.0 111.908 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.23 -10.15 31.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.082 1.353 . . . . 0.0 112.53 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt 65.4 32.27 9.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.658 1.583 . . . . 0.0 112.257 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.1 p -111.15 160.42 16.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.265 1.826 . . . . 0.0 111.848 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.98 134.64 23.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.649 1.18 . . . . 0.0 110.065 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.53 138.38 54.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.994 1.318 . . . . 0.0 108.098 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.19 131.55 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -137.25 136.81 38.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.631 0.772 . . . . 0.0 110.245 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 139.43 11.95 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -59.66 160.19 7.61 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 123.626 1.679 . . . . 0.0 110.628 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.3 -34.25 60.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.545 1.938 . . . . 0.0 113.71 -168.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.64 77.56 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-O 118.666 -1.075 . . . . 0.0 112.85 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.97 -55.78 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.277 1.538 . . . . 0.0 109.399 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -50.84 -34.58 28.46 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.78 -25.79 44.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.06 -27.16 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.8 161.54 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.059 0.845 . . . . 0.0 113.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 m -113.63 173.27 6.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.57 1.548 . . . . 0.0 113.829 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -50.97 -41.67 59.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.929 1.692 . . . . 0.0 114.553 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.6 -12.88 60.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.366 1.467 . . . . 0.0 113.395 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.7 t80 -83.96 -28.0 28.1 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.927 -1.733 . . . . 0.0 111.227 166.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -84.98 -21.0 29.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 113.279 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -60.72 -44.27 96.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.438 1.095 . . . . 0.0 111.576 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.1 p -57.52 -45.82 84.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.574 1.149 . . . . 0.0 111.351 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -57.36 -51.33 69.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.385 1.474 . . . . 0.0 111.028 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.68 -48.75 80.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.615 1.166 . . . . 0.0 111.627 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.63 -45.58 93.5 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.07 50.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.938 0.79 . . . . 0.0 112.577 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.44 -46.3 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.704 -0.622 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.72 -36.99 86.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.215 1.006 . . . . 0.0 112.743 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.88 -41.83 97.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.703 1.138 . . . . 0.0 111.2 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -83.32 -31.19 26.98 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.901 -0.571 . . . . 0.0 112.282 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -63.47 -38.06 89.69 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 119.122 0.874 . . . . 0.0 112.699 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.44 -35.82 82.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.885 0.874 . . . . 0.0 111.908 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -71.29 -36.38 71.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.031 0.932 . . . . 0.0 111.267 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 7.01 32.56 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 126.324 1.916 . . . . 0.0 113.936 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -90.32 72.05 7.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.645 1.222 . . . . 0.0 110.984 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -57.16 -36.79 71.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.352 1.061 . . . . 0.0 113.539 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 12' ' ' GLU . 79.3 tttt -56.29 -51.95 66.32 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 111.323 174.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.41 -34.26 77.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.107 1.363 . . . . 0.0 111.262 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.72 47.09 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 118.744 0.702 . . . . 0.0 112.733 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 -47.02 76.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.174 0.487 . . . . 0.0 111.177 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.81 -40.95 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.357 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.77 -37.5 79.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 111.608 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 -41.78 99.8 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.19 -47.75 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.211 1.004 . . . . 0.0 110.443 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -56.48 -52.68 63.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.571 1.149 . . . . 0.0 111.569 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.62 -38.79 84.41 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.603 0.761 . . . . 0.0 111.817 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.71 90.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 118.898 0.772 . . . . 0.0 111.252 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.3 98.6 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 119.032 0.833 . . . . 0.0 112.068 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mmm -62.34 -39.64 93.74 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.041 1.42 . . . . 0.0 113.078 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.63 -44.35 50.93 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.57 0.748 . . . . 0.0 111.546 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.84 -35.23 77.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.163 0.985 . . . . 0.0 111.424 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.63 -16.18 35.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.973 1.309 . . . . 0.0 114.305 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.3 -30.14 57.62 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.736 -1.227 . . . . 0.0 112.177 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -93.28 -31.12 14.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.735 1.214 . . . . 0.0 112.919 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -139.94 88.26 12.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.431 1.492 . . . . 0.0 109.236 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.14 148.02 55.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.399 2.066 . . . . 0.0 110.972 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -64.49 155.81 31.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.218 1.008 . . . . 0.0 113.456 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -136.18 151.23 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.704 1.601 . . . . 0.0 110.371 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.8 -25.57 67.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.534 -1.979 . . . . 0.0 112.684 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.9 15.71 28.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.015 1.726 . . . . 0.0 112.091 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.72 162.78 6.23 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.848 0.859 . . . . 0.0 112.483 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.324 -0.528 0 C-N-CA 124.129 0.972 . . . . 0.0 111.23 -168.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 0 N--CA 1.445 -1.356 0 CA-C-O 121.805 0.669 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.35 4.5 20.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.526 1.93 . . . . 0.0 114.844 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.2 p -74.92 161.82 29.17 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.207 1.403 . . . . 0.0 111.224 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.96 119.32 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.697 -1.252 . . . . 0.0 110.079 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.7 m -76.03 139.23 41.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.459 0.647 . . . . 0.0 111.427 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -136.61 131.54 33.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 C-N-CA 125.067 1.318 . . . . 0.0 114.646 177.061 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 m -65.94 157.1 31.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.1 0.96 . . . . 0.0 109.2 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.53 52.97 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.302 -1.499 . . . . 0.0 112.484 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -69.23 -23.6 63.9 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.711 1.204 . . . . 0.0 112.916 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.4 -46.24 9.82 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.529 1.532 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.29 -48.38 80.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 111.233 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.52 -47.79 69.62 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.968 -1.083 . . . . 0.0 111.883 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.23 83.84 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.302 1.041 . . . . 0.0 113.349 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -72.73 -38.66 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.852 0.751 . . . . 0.0 111.92 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.12 -40.38 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.807 0.843 . . . . 0.0 112.061 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.37 -33.43 74.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.254 0.934 . . . . 0.0 112.427 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.22 66.76 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.9 mt -61.21 -50.04 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.506 1.122 . . . . 0.0 109.935 167.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -57.97 -33.97 69.43 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.66 -26.38 60.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.03 42.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.095 0.958 . . . . 0.0 112.385 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -61.33 -23.67 65.9 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.264 1.026 . . . . 0.0 111.573 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -84.05 6.05 23.61 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.449 -2.032 . . . . 0.0 112.348 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -125.18 -7.8 7.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.111 1.764 . . . . 0.0 114.047 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -169.92 152.38 4.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.198 1.399 . . . . 0.0 110.491 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -82.27 21.65 0.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.249 1.42 . . . . 0.0 112.637 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.67 138.32 14.85 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 126.588 2.042 . . . . 0.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.62 125.25 52.39 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.03 0.915 . . . . 0.0 110.274 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 mt -117.39 125.95 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 119.935 -1.728 . . . . 0.0 112.628 -175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -129.22 131.18 47.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.475 1.51 . . . . 0.0 112.417 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.46 139.44 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.748 1.219 . . . . 0.0 112.867 170.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -128.55 125.81 39.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.974 1.31 . . . . 0.0 112.626 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 tp -115.76 133.01 56.46 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 111.294 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -159.09 158.24 32.6 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 109.546 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 71' ' ' VAL . 96.1 mttt -75.2 -63.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.123 -1.611 . . . . 0.0 113.852 -170.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -157.74 164.28 37.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.395 1.478 . . . . 0.0 110.825 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.9 p -114.56 144.79 42.81 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.419 1.487 . . . . 0.0 112.557 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.25 -19.1 43.81 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.043 -1.036 . . . . 0.0 111.948 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.12 -162.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.666 1.587 . . . . 0.0 111.516 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -77.71 139.09 39.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.895 0.878 . . . . 0.0 112.373 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.49 -35.09 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.988 0.915 . . . . 0.0 112.714 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -65.46 -51.47 59.92 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.779 0.718 . . . . 0.0 110.834 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.66 -42.29 98.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.613 1.165 . . . . 0.0 112.324 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -62.1 -47.28 85.32 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.371 -0.831 . . . . 0.0 112.129 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.89 89.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.495 -0.753 . . . . 0.0 111.469 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.6 ttp -62.01 -48.95 78.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.707 0.803 . . . . 0.0 111.891 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -61.01 -46.48 90.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.273 1.029 . . . . 0.0 110.952 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.21 -45.91 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.111 0.964 . . . . 0.0 111.88 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -56.75 -50.72 71.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.673 1.189 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.91 -35.45 74.6 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.31 0.644 . . . . 0.0 111.202 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -68.09 -32.36 72.63 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.365 1.066 . . . . 0.0 113.853 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.7 mt -78.61 -0.51 30.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.237 1.015 . . . . 0.0 112.534 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 58.44 32.2 21.83 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.285 1.834 . . . . 0.0 112.032 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.6 mtp -69.51 -16.67 63.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.991 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.23 -15.8 63.91 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.658 1.183 . . . . 0.0 113.193 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -85.04 55.55 3.54 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.389 -1.444 . . . . 0.0 112.083 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -110.0 160.82 16.09 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 0.0 110.369 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -72.21 -42.12 66.13 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.974 -1.078 . . . . 0.0 113.62 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.07 -11.63 32.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 74.21 28.15 1.44 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.382 1.473 . . . . 0.0 110.145 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -112.66 45.46 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.572 1.549 . . . . 0.0 111.481 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.9 131.03 10.58 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.782 1.182 . . . . 0.0 112.331 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.2 t -111.62 136.39 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.052 1.341 . . . . 0.0 110.8 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 tp -115.28 134.18 55.36 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.148 1.379 . . . . 0.0 111.405 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.23 89.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.002 1.321 . . . . 0.0 108.725 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -78.92 123.13 26.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.3 1.44 . . . . 0.0 111.547 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.3 t -124.85 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.066 -1.022 . . . . 0.0 111.825 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.06 116.17 28.57 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.195 1.398 . . . . 0.0 110.44 164.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 37' ' ' LYS . 16.3 m -77.43 -25.19 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.93 -57.99 3.56 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 118.205 0.457 . . . . 0.0 110.216 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.65 -4.13 55.36 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.2 tttt 68.39 27.53 6.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.682 1.593 . . . . 0.0 111.79 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 m -100.44 113.7 26.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.958 1.703 . . . . 0.0 110.491 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -88.95 141.9 28.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.0 0.92 . . . . 0.0 110.155 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.34 149.5 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.867 2.067 . . . . 0.0 108.143 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.8 mt -134.12 131.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -145.29 127.18 15.42 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.65 1.18 . . . . 0.0 109.534 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.38 149.68 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.6 162.82 3.59 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 122.964 1.364 . . . . 0.0 110.954 168.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -54.31 -35.67 62.91 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.488 1.515 . . . . 0.0 112.872 -168.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.83 -41.61 98.75 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.615 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mt -61.15 -56.16 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.294 1.547 . . . . 0.0 109.649 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -64.46 -19.47 65.58 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.07 -35.02 22.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.485 1.114 . . . . 0.0 111.367 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 88' ' ' VAL . 2.5 p -93.57 -24.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 87' ' ' VAL . 7.2 m -118.04 171.07 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 119.858 1.208 . . . . 0.0 111.998 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.5 p -113.13 172.22 7.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.989 1.316 . . . . 0.0 113.184 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -61.45 -30.82 70.83 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.839 -1.163 . . . . 0.0 112.551 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 -18.52 63.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.206 1.402 . . . . 0.0 112.668 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.0 t80 -81.22 -37.3 28.84 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.869 1.267 . . . . 0.0 111.915 168.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -73.71 -26.61 60.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.816 1.246 . . . . 0.0 113.568 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.37 -31.18 68.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.716 1.207 . . . . 0.0 113.677 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.7 p -70.02 -43.32 71.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.925 1.29 . . . . 0.0 111.517 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.0 m -56.88 -51.38 69.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.881 2.072 . . . . 0.0 110.779 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -58.71 -47.0 86.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.308 1.043 . . . . 0.0 111.63 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.12 -32.75 74.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.5 -53.39 29.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.326 0.967 . . . . 0.0 111.854 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt -61.28 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.625 0.37 . . . . 0.0 110.799 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.43 -44.05 92.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.399 1.08 . . . . 0.0 112.752 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.64 -39.83 85.65 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.785 0.72 . . . . 0.0 112.433 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.42 -32.66 20.77 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.43 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.71 -41.06 98.96 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.809 1.186 . . . . 0.0 111.063 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.01 -38.11 72.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.2 1.0 . . . . 0.0 111.625 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -75.67 -35.82 60.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.598 0.759 . . . . 0.0 111.988 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.65 5.99 21.83 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.802 1.667 . . . . 0.0 114.582 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -99.25 78.41 2.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.729 1.212 . . . . 0.0 110.428 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.09 -49.35 69.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.128 0.971 . . . . 0.0 112.416 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -50.58 -53.81 27.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.052 0.541 . . . . 0.0 111.353 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -62.53 -42.88 99.81 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.524 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.7 -35.56 74.07 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.504 1.047 . . . . 0.0 112.946 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.49 -44.71 77.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.306 0.642 . . . . 0.0 111.142 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.64 -52.58 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.434 1.094 . . . . 0.0 111.279 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -57.77 -40.72 80.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.293 0.951 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -43.32 87.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.044 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.25 -41.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.2 1.5 . . . . 0.0 112.123 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -63.73 -47.47 80.94 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.749 0.704 . . . . 0.0 110.944 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -66.56 -44.07 83.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.845 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.11 69.57 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.259 0.624 . . . . 0.0 111.028 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.14 89.39 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.045 0.839 . . . . 0.0 112.891 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.6 mtp -64.06 -36.31 83.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.871 1.335 . . . . 0.0 112.288 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -76.67 -43.62 37.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.049 0.939 . . . . 0.0 111.229 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -62.38 -35.15 78.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.134 0.974 . . . . 0.0 111.534 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.92 -20.9 62.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.696 1.198 . . . . 0.0 114.03 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -71.59 -41.98 68.31 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.022 -1.049 . . . . 0.0 111.444 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -75.12 -46.64 33.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.926 0.89 . . . . 0.0 111.611 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -122.87 88.34 50.48 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.623 1.569 . . . . 0.0 109.986 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.59 138.48 35.27 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.458 2.105 . . . . 0.0 110.454 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -62.86 135.51 57.36 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -106.53 154.31 21.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.155 0.982 . . . . 0.0 110.205 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.68 -27.04 68.65 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.933 -1.729 . . . . 0.0 112.259 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.71 19.64 15.54 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 126.184 1.794 . . . . 0.0 113.108 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -58.99 159.6 6.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.281 1.032 . . . . 0.0 113.321 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 123.086 1.422 . . . . 0.0 113.083 -167.768 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.453 -0.875 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.04 21.83 0.68 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.304 1.042 . . . . 0.0 112.857 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -77.24 150.55 35.37 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.925 2.09 . . . . 0.0 111.887 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.5 mt -80.97 130.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.149 0.98 . . . . 0.0 109.532 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.2 m -87.89 142.42 27.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.429 170.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.76 140.82 31.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.667 0.787 . . . . 0.0 110.837 -174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.28 1.895 . . . . 0.0 109.972 164.484 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -74.78 162.93 28.22 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.429 1.092 . . . . 0.0 109.532 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.46 -41.21 39.58 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -61.79 -30.49 70.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.88 1.272 . . . . 0.0 113.55 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -81.87 -47.49 12.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -62.37 -41.55 98.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.908 1.283 . . . . 0.0 110.691 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -55.56 -55.16 35.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.857 -1.152 . . . . 0.0 111.444 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.36 81.28 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -74.16 -30.34 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.167 0.894 . . . . 0.0 113.302 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.22 -42.46 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.478 -1.389 . . . . 0.0 111.047 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -63.58 -32.44 73.9 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.811 0.844 . . . . 0.0 112.347 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.26 85.71 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.273 -0.892 . . . . 0.0 112.596 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 mm -59.05 -45.99 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.093 0.957 . . . . 0.0 111.285 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -58.29 -31.16 67.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -81.97 -29.05 32.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.74 84.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.815 0.734 . . . . 0.0 111.34 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -56.12 -26.98 52.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.794 1.638 . . . . 0.0 113.41 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.84 5.18 37.98 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 112.826 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.83 -8.05 5.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.983 1.713 . . . . 0.0 114.29 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -148.37 159.88 43.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.926 1.69 . . . . 0.0 109.316 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.2 p -94.26 37.01 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.17 0.988 . . . . 0.0 111.688 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.44 146.24 15.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 123.955 0.788 . . . . 0.0 112.611 -171.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -108.33 131.8 54.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.689 0.756 . . . . 0.0 111.605 -151.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.47 134.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.802 -1.186 . . . . 0.0 110.661 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -144.26 153.48 42.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.18 1.392 . . . . 0.0 111.862 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.03 136.91 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.081 1.352 . . . . 0.0 109.704 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -118.57 118.52 31.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.003 1.721 . . . . 0.0 111.937 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.8 tp -107.15 129.28 54.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 112.086 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.52 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.0 tt0 -154.78 168.15 27.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.015 1.326 . . . . 0.0 111.897 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.18 -95.25 0.06 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.222 1.409 . . . . 0.0 113.479 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 p -116.05 165.21 13.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.332 2.253 . . . . 0.0 109.548 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 p -113.07 162.28 16.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.864 0.84 . . . . 0.0 111.977 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -95.36 -15.19 23.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.989 1.316 . . . . 0.0 113.009 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.42 -150.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.978 2.111 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -85.47 137.63 32.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.486 1.039 . . . . 0.0 112.01 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.29 -39.02 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.566 1.146 . . . . 0.0 112.422 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.94 -49.93 70.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.961 0.801 . . . . 0.0 111.764 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.59 -41.78 96.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 111.272 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CD ' ' A' ' 36' ' ' GLU . 59.0 ttt85 -59.52 -48.89 79.9 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.042 0.937 . . . . 0.0 112.574 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.97 97.11 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.537 0.735 . . . . 0.0 111.077 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.18 -47.24 87.09 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.972 0.909 . . . . 0.0 112.172 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.87 -42.59 97.48 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.061 -1.024 . . . . 0.0 112.57 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.7 -41.99 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.867 0.867 . . . . 0.0 111.969 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.26 -48.77 78.46 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 111.971 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -75.16 -31.64 61.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.799 0.84 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -62.09 -48.28 80.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.096 0.959 . . . . 0.0 111.132 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -72.77 -7.59 51.38 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.105 0.962 . . . . 0.0 113.524 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 63.45 42.82 6.38 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 112.208 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.4 mtt -71.29 -21.53 62.06 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -8.96 8.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.026 2.13 . . . . 0.0 113.705 171.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -79.41 56.49 2.15 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.349 1.86 . . . . 0.0 111.081 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.7 p -128.99 145.18 51.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.549 1.94 . . . . 0.0 108.637 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -59.76 -39.66 85.59 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.5 mt -100.3 -8.82 23.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.081 -1.438 . . . . 0.0 114.519 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 69.93 39.73 1.38 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.708 1.203 . . . . 0.0 110.355 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -106.72 20.29 19.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.445 1.898 . . . . 0.0 113.735 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.07 121.36 6.52 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.296 -0.878 . . . . 0.0 112.569 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.5 t -104.43 133.57 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.357 1.863 . . . . 0.0 109.932 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.5 tp -120.79 130.16 53.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.318 1.047 . . . . 0.0 111.988 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 53.5 mt -105.78 100.16 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 0.0 108.593 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -81.36 125.88 30.92 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.282 0.633 . . . . 0.0 110.051 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.93 131.54 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.916 0.886 . . . . 0.0 110.954 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 102.0 11.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.114 1.366 . . . . 0.0 109.721 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.22 -19.3 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 -44.28 20.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.332 0.653 . . . . 0.0 111.1 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -86.73 -11.17 51.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.068 0.947 . . . . 0.0 112.524 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.4 tttt 72.77 29.08 1.98 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.108 2.163 . . . . 0.0 111.614 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -109.57 162.83 14.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.189 1.396 . . . . 0.0 111.198 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.45 146.13 41.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.135 1.374 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.01 135.5 45.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 126.119 1.768 . . . . 0.0 107.256 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.3 mt -118.52 127.85 75.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -136.21 125.46 24.72 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 125.342 1.457 . . . . 0.0 109.961 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 158.26 14.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.855 1.217 . . . . 0.0 110.644 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -65.31 164.8 12.81 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.605 1.669 . . . . 0.0 111.874 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -50.72 -33.67 23.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.04 2.136 . . . . 0.0 114.075 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.54 -43.36 98.18 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 119.985 1.266 . . . . 0.0 111.906 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.66 -58.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.585 1.192 . . . . 0.0 109.86 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -60.05 -25.37 65.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.083 -1.011 . . . . 0.0 113.571 -173.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.94 -8.09 44.18 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 88' ' ' VAL . 2.8 p -113.59 -22.84 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 118.191 -0.909 . . . . 0.0 113.035 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 87' ' ' VAL . 4.0 m -119.8 172.46 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.045 1.293 . . . . 0.0 112.233 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.66 171.98 7.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.669 1.588 . . . . 0.0 112.631 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.89 -34.01 75.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.01 -35.12 79.18 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.826 0.739 . . . . 0.0 111.97 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 44.0 t80 -64.41 -41.99 96.33 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.027 0.531 . . . . 0.0 110.761 172.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -70.02 -26.81 64.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.89 -35.65 75.3 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.153 0.888 . . . . 0.0 111.575 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 p -60.39 -46.84 88.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.494 0.717 . . . . 0.0 111.938 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 m -61.18 -48.94 79.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.591 1.957 . . . . 0.0 111.071 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -60.0 -47.36 86.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.263 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -62.54 -43.78 97.98 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.63 -48.74 76.86 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.021 0.828 . . . . 0.0 111.928 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.78 -48.28 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.749 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -59.99 -44.15 94.69 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.99 -38.25 87.89 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.152 -0.968 . . . . 0.0 112.497 -176.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -80.88 -37.59 29.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.28 1.032 . . . . 0.0 111.67 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.44 -38.96 82.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.442 -0.786 . . . . 0.0 111.645 171.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.01 -28.83 70.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.961 0.904 . . . . 0.0 113.136 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -79.59 -27.86 41.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.751 1.16 . . . . 0.0 110.802 172.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.91 25.12 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 126.309 1.909 . . . . 0.0 113.631 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -107.34 73.07 0.9 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.356 1.462 . . . . 0.0 110.951 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -58.08 -40.33 80.83 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.771 0.828 . . . . 0.0 113.225 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -60.22 -53.92 51.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.013 -0.429 . . . . 0.0 111.456 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.6 -39.49 88.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.646 0.778 . . . . 0.0 111.069 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.33 96.51 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.738 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.58 -48.44 66.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.457 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.71 -45.23 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.528 1.058 . . . . 0.0 112.391 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -67.26 -36.96 82.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.463 1.105 . . . . 0.0 112.14 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.5 95.89 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 121.649 -0.657 . . . . 0.0 112.547 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.02 -45.62 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.789 1.236 . . . . 0.0 110.564 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.68 -50.6 71.81 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.824 0.849 . . . . 0.0 111.33 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -66.59 -41.88 87.81 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.079 0.952 . . . . 0.0 111.24 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.18 79.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.448 172.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.62 97.42 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.402 1.001 . . . . 0.0 113.18 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.74 -40.4 95.24 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.603 1.202 . . . . 0.0 112.839 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.55 -47.58 31.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.411 1.084 . . . . 0.0 111.368 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.78 -38.74 79.18 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 125.567 1.547 . . . . 0.0 110.735 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.6 -19.11 46.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.45 -32.62 64.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.536 -1.353 . . . . 0.0 111.837 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -89.32 -33.93 16.74 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.857 1.263 . . . . 0.0 112.676 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.52 85.93 41.54 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.733 2.013 . . . . 0.0 110.275 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.49 135.02 25.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.65 2.233 . . . . 0.0 109.513 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -57.19 137.18 56.24 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -106.6 148.04 28.77 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.15 -0.968 . . . . 0.0 110.421 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.67 -33.23 72.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.295 -1.503 . . . . 0.0 112.487 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.71 17.16 13.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.447 1.499 . . . . 0.0 113.528 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.21 157.92 5.78 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 124.049 0.939 . . . . 0.0 111.554 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.534 0.483 0 CA-C-O 121.029 0.346 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -78.47 14.26 1.31 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.829 1.251 . . . . 0.0 113.568 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.0 p -85.56 165.25 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.049 1.74 . . . . 0.0 111.383 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.07 134.0 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.796 -0.565 . . . . 0.0 109.602 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.0 m -91.16 141.21 29.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.624 0.726 . . . . 0.0 110.669 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -140.8 154.75 46.38 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.73 -1.231 . . . . 0.0 111.157 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 C-N-CA 126.427 1.965 . . . . 0.0 111.862 173.786 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -63.34 152.5 37.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.17 0.988 . . . . 0.0 111.019 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.29 16.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.84 -41.91 77.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.851 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -72.1 -42.37 66.21 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.658 1.183 . . . . 0.0 110.088 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.87 -39.36 94.21 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.503 1.521 . . . . 0.0 113.135 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -61.11 -50.17 74.32 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 119.65 -1.906 . . . . 0.0 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.54 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 tt -69.13 -41.56 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.588 1.085 . . . . 0.0 112.676 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.2 -40.58 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.092 1.315 . . . . 0.0 111.244 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.57 -28.5 67.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.226 0.921 . . . . 0.0 113.076 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.6 75.63 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.46 -0.775 . . . . 0.0 112.246 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.77 -45.38 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.772 0.829 . . . . 0.0 109.946 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -62.54 -23.78 67.16 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -84.37 -29.4 26.27 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.978 -1.076 . . . . 0.0 111.308 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.73 75.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.7 1.136 . . . . 0.0 112.361 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.08 -15.35 62.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.506 1.523 . . . . 0.0 113.454 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -92.71 4.67 53.29 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.754 -1.216 . . . . 0.0 111.866 171.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -131.91 -14.35 3.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.93 1.692 . . . . 0.0 115.139 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -153.44 145.58 23.78 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.493 1.497 . . . . 0.0 110.652 171.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -82.17 24.9 0.62 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.997 1.719 . . . . 0.0 113.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 -179.82 21.19 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 124.828 1.204 . . . . 0.0 110.997 166.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -135.73 133.48 38.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.767 0.794 . . . . 0.0 111.495 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mt -124.56 141.04 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.057 -1.652 . . . . 0.0 110.626 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -142.73 147.82 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.4 1.88 . . . . 0.0 111.027 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.41 137.13 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.214 1.006 . . . . 0.0 111.071 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -120.47 121.02 37.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.116 1.766 . . . . 0.0 112.759 172.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' CG1' ' A' ' 71' ' ' VAL . 13.4 tp -102.92 131.47 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.883 1.273 . . . . 0.0 111.87 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -152.25 162.78 40.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.521 -0.737 . . . . 0.0 110.686 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -78.75 -75.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.736 -1.227 . . . . 0.0 112.366 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 p -142.07 148.65 38.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.477 1.911 . . . . 0.0 110.42 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -85.04 161.08 19.86 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.039 0.936 . . . . 0.0 112.976 170.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -98.23 -16.73 19.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.228 1.811 . . . . 0.0 112.31 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -119.56 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.101 1.76 . . . . 0.0 110.934 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -78.67 134.56 37.12 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.57 . . . . 0.0 111.41 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.04 -38.12 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.046 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.7 -46.52 89.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.79 -42.67 70.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.507 0.323 . . . . 0.0 110.785 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -56.68 -47.79 79.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.485 0.314 . . . . 0.0 111.687 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.06 75.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.899 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.9 ttp -67.19 -50.59 60.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 0.0 112.049 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -64.48 -43.95 92.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.245 0.93 . . . . 0.0 111.72 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.64 -45.02 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.129 0.971 . . . . 0.0 110.738 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.92 -50.19 74.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.117 0.967 . . . . 0.0 112.111 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -74.37 -30.96 62.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.328 1.051 . . . . 0.0 112.891 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -73.1 -35.84 66.66 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.659 -1.276 . . . . 0.0 111.917 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.28 -7.25 52.13 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.728 1.211 . . . . 0.0 112.947 170.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 62.21 31.1 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.468 1.507 . . . . 0.0 111.991 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.7 mmm -64.43 -19.79 65.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.304 1.042 . . . . 0.0 113.078 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.25 -12.48 60.29 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.258 1.823 . . . . 0.0 113.65 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -83.58 73.48 10.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.335 1.054 . . . . 0.0 111.249 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -123.74 151.42 43.25 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.717 2.007 . . . . 0.0 110.431 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -63.14 -37.97 89.32 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.378 -0.826 . . . . 0.0 113.02 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.41 -6.98 21.34 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 117.766 -1.112 . . . . 0.0 113.589 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 66.22 47.97 1.74 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.668 1.187 . . . . 0.0 109.433 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -119.8 26.27 9.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.807 1.243 . . . . 0.0 113.456 -172.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.75 127.23 7.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.312 0.958 . . . . 0.0 112.357 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.03 132.77 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 126.7 2.0 . . . . 0.0 109.985 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.5 tp -121.84 129.51 52.66 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.116 0.967 . . . . 0.0 110.781 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.15 99.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.984 0.914 . . . . 0.0 108.632 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -80.2 122.69 27.16 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.529 0.732 . . . . 0.0 110.744 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.863 0.865 . . . . 0.0 110.807 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.95 102.72 15.29 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.367 1.467 . . . . 0.0 109.277 171.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.1 m -73.16 -24.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -74.13 -40.75 62.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.962 -0.462 . . . . 0.0 111.472 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -97.27 -6.47 34.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.538 1.535 . . . . 0.0 112.837 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt 67.29 33.19 5.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.779 1.632 . . . . 0.0 112.156 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 m -107.6 129.43 54.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.353 1.461 . . . . 0.0 110.053 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -106.66 141.45 37.91 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.765 1.226 . . . . 0.0 109.876 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.0 t -138.8 140.86 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.198 1.399 . . . . 0.0 108.103 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 mt -125.39 127.57 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -129.74 138.18 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.863 0.865 . . . . 0.0 109.72 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.87 160.41 16.27 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.69 162.32 16.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.518 1.627 . . . . 0.0 112.618 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.84 -38.98 65.19 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.603 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.35 -37.22 93.64 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.612 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -63.0 -58.28 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.317 1.559 . . . . 0.0 110.166 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -59.26 -25.35 63.99 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -80.43 -27.68 37.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.466 1.507 . . . . 0.0 112.462 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.475 HG11 ' HE2' ' A' ' 128' ' ' PHE . 3.4 p -105.96 -22.82 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 87' ' ' VAL . 4.8 m -119.99 167.65 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.836 1.198 . . . . 0.0 112.21 175.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 m -116.29 169.91 8.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.618 1.167 . . . . 0.0 113.122 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -56.88 -33.0 66.42 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.533 -1.354 . . . . 0.0 113.764 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -20.88 62.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.791 1.236 . . . . 0.0 113.249 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 26.6 t80 -77.66 -34.17 53.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.449 0.7 . . . . 0.0 110.647 170.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -75.76 -25.66 56.7 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -65.56 -32.96 74.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.402 -0.811 . . . . 0.0 112.376 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.3 p -65.86 -42.67 90.14 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 111.755 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 m -53.7 -55.37 26.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.908 2.083 . . . . 0.0 110.275 172.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -55.95 -49.27 74.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.92 0.888 . . . . 0.0 111.202 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.65 -37.32 81.14 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.46 -51.84 52.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.055 0.843 . . . . 0.0 111.78 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.2 mt -58.22 -51.68 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.044 0.538 . . . . 0.0 110.126 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.797 1.639 . . . . 0.0 113.035 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.09 -46.08 89.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.18 -30.42 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -64.69 -39.35 93.51 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.304 0.956 . . . . 0.0 111.29 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.9 -27.76 69.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.054 0.942 . . . . 0.0 112.331 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -77.77 -38.58 46.45 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.575 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.82 12.46 14.4 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.379 1.942 . . . . 0.0 113.791 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.26 84.89 2.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.204 1.401 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -61.39 -46.62 89.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.575 0.75 . . . . 0.0 111.928 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -49.11 -54.95 13.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -63.51 -41.77 98.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.061 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.42 -36.38 77.64 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.1 0.864 . . . . 0.0 113.346 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.96 -40.7 78.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 111.798 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.8 t -67.28 -50.43 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 111.5 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -73.47 -26.12 60.77 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.15 0.886 . . . . 0.0 112.495 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.09 -38.31 92.29 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.275 -0.891 . . . . 0.0 111.833 169.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.8 mt -62.24 -51.49 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.479 1.139 . . . . 0.0 110.872 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -61.01 -40.14 92.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.495 1.043 . . . . 0.0 112.854 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -73.91 -36.85 64.77 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.723 -1.235 . . . . 0.0 111.422 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.21 73.85 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.803 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.16 -46.66 93.82 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.481 1.037 . . . . 0.0 112.628 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 41.9 tpp -60.8 -43.35 98.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.924 0.862 . . . . 0.0 112.976 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -68.38 -44.19 75.69 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.994 0.361 . . . . 0.0 111.215 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.27 -37.9 87.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.455 1.502 . . . . 0.0 111.143 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.43 -24.49 63.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.538 1.135 . . . . 0.0 113.83 173.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -67.8 -27.64 66.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.206 -1.559 . . . . 0.0 112.561 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -93.18 -38.89 11.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.033 1.333 . . . . 0.0 112.031 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.475 ' HE2' HG11 ' A' ' 87' ' ' VAL . 95.3 m-85 -130.4 76.19 78.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.126 1.77 . . . . 0.0 111.484 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.26 132.19 35.24 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.144 2.563 . . . . 0.0 111.339 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -57.92 146.29 32.69 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -118.57 150.45 39.63 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.004 1.322 . . . . 0.0 109.816 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.53 -27.4 67.73 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.438 -2.039 . . . . 0.0 112.888 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.79 15.04 23.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.659 1.584 . . . . 0.0 112.242 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.38 158.34 9.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.515 1.126 . . . . 0.0 113.185 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.294 0 C-N-CA 124.53 1.132 . . . . 0.0 110.64 -172.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 N--CA 1.457 -0.622 0 CA-C-O 122.119 0.8 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -89.0 -5.76 57.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 m -56.23 141.26 41.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.19 1.396 . . . . 0.0 109.683 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.54 130.95 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.61 152.71 18.38 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.107 0.563 . . . . 0.0 110.848 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -160.99 158.02 27.29 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.074 0 CA-C-O 116.592 -2.226 . . . . 0.0 112.803 171.025 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -69.52 160.6 31.15 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.739 0.7 . . . . 0.0 110.737 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.64 53.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.33 -40.99 77.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.508 1.523 . . . . 0.0 110.92 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -72.06 -44.38 63.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.551 1.141 . . . . 0.0 111.376 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -63.74 -44.77 92.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.322 1.049 . . . . 0.0 111.823 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -55.56 -47.2 76.76 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.706 -1.246 . . . . 0.0 111.461 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.67 84.45 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.4 tt -76.59 -38.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.568 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.86 -40.34 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.98 1.264 . . . . 0.0 111.253 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.98 -33.45 75.42 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.827 0.851 . . . . 0.0 112.966 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.11 62.0 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.709 0.804 . . . . 0.0 112.412 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.51 -48.66 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -55.49 -27.64 49.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.3 -28.76 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.239 -0.913 . . . . 0.0 113.086 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.07 75.62 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.574 1.149 . . . . 0.0 111.922 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -71.94 14.11 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.824 0.85 . . . . 0.0 113.282 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -120.72 12.5 11.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.322 1.849 . . . . 0.0 112.43 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.92 -14.33 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.807 2.043 . . . . 0.0 113.512 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -159.88 176.03 12.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.445 2.298 . . . . 0.0 108.531 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -125.51 6.22 7.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.347 1.459 . . . . 0.0 114.594 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.98 161.06 31.53 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 155.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -126.84 136.08 51.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 118.192 0.996 . . . . 0.0 112.0 -165.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.7 mt -113.05 124.69 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 110.746 -169.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -135.51 153.59 51.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.124 0.964 . . . . 0.0 111.456 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.9 t -133.99 128.43 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.494 1.518 . . . . 0.0 108.601 -168.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.87 108.75 13.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.569 1.548 . . . . 0.0 113.987 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 tt -93.96 130.94 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.514 0.726 . . . . 0.0 111.023 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.11 163.11 37.95 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.02 1.328 . . . . 0.0 111.317 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.3 -79.38 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.595 1.558 . . . . 0.0 113.369 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -144.54 147.81 33.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.982 2.513 . . . . 0.0 109.044 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -99.38 169.96 8.97 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.39 1.09 . . . . 0.0 112.163 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -101.66 -19.62 15.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.786 1.635 . . . . 0.0 112.685 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 pt -125.04 -148.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -85.17 142.5 29.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.278 1.399 . . . . 0.0 112.604 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.42 -32.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.449 0.7 . . . . 0.0 111.164 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.06 -50.08 73.41 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.736 0.815 . . . . 0.0 111.54 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.39 -39.55 94.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.329 0.652 . . . . 0.0 111.451 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.9 -43.43 98.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.354 0.662 . . . . 0.0 111.841 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.9 96.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.927 0.785 . . . . 0.0 110.982 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.8 ttp -63.26 -47.36 82.73 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.908 0.777 . . . . 0.0 112.327 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.57 -44.25 97.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.217 -0.927 . . . . 0.0 112.131 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.55 -43.96 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.63 1.172 . . . . 0.0 111.109 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.56 -49.71 76.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.995 0.816 . . . . 0.0 111.182 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -67.44 -44.23 79.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.481 1.112 . . . . 0.0 111.828 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.06 -39.84 91.38 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.857 -1.152 . . . . 0.0 113.816 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.56 1.64 18.89 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 56.5 36.59 27.81 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.706 1.202 . . . . 0.0 111.632 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.8 mtp -72.09 -13.49 61.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.131 1.772 . . . . 0.0 113.294 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -75.58 -2.4 28.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.584 1.954 . . . . 0.0 114.25 167.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -79.36 60.53 3.18 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.003 1.321 . . . . 0.0 111.872 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.2 p -129.53 149.97 51.07 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.86 0.838 . . . . 0.0 110.134 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.74 -27.79 68.57 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 113.063 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -107.25 -5.7 17.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.435 1.094 . . . . 0.0 113.1 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 60.05 40.23 18.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.967 1.307 . . . . 0.0 110.87 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -109.78 36.7 2.89 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.391 1.476 . . . . 0.0 112.073 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.11 121.95 5.69 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.714 -1.241 . . . . 0.0 112.464 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.31 135.84 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.118 0.959 . . . . 0.0 110.603 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -120.55 129.73 53.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.448 1.499 . . . . 0.0 111.502 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.47 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.915 0.886 . . . . 0.0 109.957 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -79.64 120.39 23.9 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.473 0.709 . . . . 0.0 110.8 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.61 132.8 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.809 0.844 . . . . 0.0 110.48 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.37 97.15 7.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.199 1.4 . . . . 0.0 109.173 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.29 -13.49 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -77.16 -56.78 4.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.379 0.536 . . . . 0.0 111.038 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.95 -8.4 59.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.278 1.431 . . . . 0.0 114.154 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttt 72.21 27.78 2.52 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.846 1.659 . . . . 0.0 112.443 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -102.39 173.4 6.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.123 0.969 . . . . 0.0 111.475 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -147.64 139.45 24.06 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.359 1.464 . . . . 0.0 109.353 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.0 t -127.9 134.32 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.695 1.198 . . . . 0.0 107.923 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.1 mt -111.97 131.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -137.33 124.95 22.24 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.559 1.544 . . . . 0.0 110.46 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.31 17.48 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -64.37 163.71 12.65 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.325 1.06 . . . . 0.0 111.534 165.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -57.87 -31.83 67.09 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.19 0.996 . . . . 0.0 112.84 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.04 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.724 1.147 . . . . 0.0 113.786 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.13 -61.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.2 1.5 . . . . 0.0 108.638 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -51.5 -41.55 61.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.335 1.054 . . . . 0.0 112.921 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.32 -13.61 59.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.692 1.197 . . . . 0.0 112.932 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.11 -31.92 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.588 1.086 . . . . 0.0 113.525 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 m -108.08 165.94 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.49 1.041 . . . . 0.0 112.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.04 172.39 6.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.427 1.091 . . . . 0.0 113.456 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.867 -1.145 . . . . 0.0 112.84 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -61.42 -25.75 67.41 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.388 1.075 . . . . 0.0 113.57 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -74.96 -46.17 37.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.612 0.765 . . . . 0.0 109.544 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.64 -31.24 72.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.497 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -57.63 -33.75 68.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.771 1.228 . . . . 0.0 112.193 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 p -66.54 -43.11 86.01 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.895 0.478 . . . . 0.0 111.699 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -52.09 66.9 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.285 1.834 . . . . 0.0 110.131 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -59.0 -50.04 75.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.61 0.764 . . . . 0.0 111.148 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -58.23 -43.69 87.86 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.21 -49.75 68.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.46 -47.97 90.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.013 0.925 . . . . 0.0 110.515 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -60.31 -45.98 91.5 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.571 1.148 . . . . 0.0 112.879 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.22 -35.82 76.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.341 0.656 . . . . 0.0 112.528 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -87.01 -34.87 19.09 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.207 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.21 -35.59 73.88 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.933 0.788 . . . . 0.0 111.631 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -68.42 -31.73 71.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 112.979 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.37 -35.12 70.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.464 1.105 . . . . 0.0 110.441 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 6.85 25.43 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.957 1.741 . . . . 0.0 114.533 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -98.64 94.13 6.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.071 0.949 . . . . 0.0 111.259 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -70.52 -37.2 74.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.46 0.704 . . . . 0.0 111.826 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -54.76 -56.94 13.94 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.964 0.906 . . . . 0.0 111.03 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HA ' HG12 ' A' ' 114' ' ' VAL . 84.9 mt-30 -61.09 -42.6 98.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.27 97.13 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.191 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.17 -46.57 67.21 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.834 -1.079 . . . . 0.0 111.207 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 111' ' ' GLN . 4.2 p -70.73 -41.0 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.681 1.128 . . . . 0.0 113.064 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.6 -35.78 81.82 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.832 0.742 . . . . 0.0 110.982 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.58 95.52 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.976 174.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.25 -43.49 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.575 1.187 . . . . 0.0 111.352 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -58.87 -52.18 66.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 0.0 110.671 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -66.62 -39.75 88.46 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.835 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.84 72.44 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.729 0.695 . . . . 0.0 111.389 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.87 95.74 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.689 1.131 . . . . 0.0 112.496 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.55 -39.24 88.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.135 -1.214 . . . . 0.0 112.919 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 -48.15 48.85 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.895 0.878 . . . . 0.0 110.602 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.1 mt -60.63 -36.2 78.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.74 1.616 . . . . 0.0 110.767 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.14 50.3 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.34 -37.59 68.81 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.406 -1.434 . . . . 0.0 111.995 170.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -85.04 -32.56 22.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 112.586 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.07 88.34 31.81 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.436 1.895 . . . . 0.0 109.329 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.81 139.82 34.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.541 2.827 . . . . 0.0 110.097 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -64.46 131.46 47.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -103.7 145.8 29.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.007 0.923 . . . . 0.0 110.299 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.43 -30.09 68.24 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 119.675 -1.891 . . . . 0.0 113.908 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -92.2 12.18 23.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.311 1.444 . . . . 0.0 113.177 -176.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.82 154.19 7.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -172.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 122.304 1.049 . . . . 0.0 111.562 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 N-CA-C 111.018 -0.416 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -77.51 8.55 4.16 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.712 1.205 . . . . 0.0 113.663 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -75.76 153.25 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.907 1.683 . . . . 0.0 110.9 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.24 130.78 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.173 0.989 . . . . 0.0 108.664 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.1 m -82.8 142.41 31.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.351 1.06 . . . . 0.0 110.251 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -140.73 138.57 34.28 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.581 -1.325 . . . . 0.0 111.686 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.83 2.633 . . . . 0.0 114.082 -179.025 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -71.57 157.53 37.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.923 0.889 . . . . 0.0 109.406 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -24.31 8.43 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -75.13 -36.46 61.61 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.742 -1.224 . . . . 0.0 112.37 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -76.8 -42.82 39.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.17 1.788 . . . . 0.0 110.209 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.68 -49.08 76.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.32 -46.98 69.64 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.28 -0.888 . . . . 0.0 111.645 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.54 -28.57 67.91 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -80.59 -37.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 120.692 1.587 . . . . 0.0 112.191 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.54 -44.16 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.459 1.027 . . . . 0.0 110.944 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -57.97 -39.56 78.46 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.216 1.406 . . . . 0.0 112.707 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.59 -32.23 71.99 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.59 -0.693 . . . . 0.0 112.384 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.5 mt -67.9 -46.56 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.072 0.851 . . . . 0.0 110.008 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.64 -31.63 64.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.298 1.039 . . . . 0.0 113.157 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -79.35 -27.78 42.02 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.038 0.835 . . . . 0.0 113.109 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.48 -35.83 70.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.479 0.712 . . . . 0.0 111.695 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.43 -1.56 0.56 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.024 2.13 . . . . 0.0 113.933 167.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -117.61 9.66 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.055 1.742 . . . . 0.0 112.388 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -126.22 -14.66 5.92 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.045 1.338 . . . . 0.0 114.097 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -162.28 140.62 8.89 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.722 1.209 . . . . 0.0 109.459 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -83.11 46.5 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.73 0.812 . . . . 0.0 111.243 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.92 137.86 7.69 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.203 1.383 . . . . 0.0 109.686 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -113.84 128.08 56.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.933 0.873 . . . . 0.0 112.064 -152.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.7 mt -120.74 116.66 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.284 -1.51 . . . . 0.0 110.733 -172.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.74 147.92 37.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.887 2.075 . . . . 0.0 110.78 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.83 136.86 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.416 1.086 . . . . 0.0 110.695 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -118.32 118.97 33.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.403 1.881 . . . . 0.0 112.374 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 tp -108.11 129.06 55.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.949 0.9 . . . . 0.0 111.972 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.87 166.96 27.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.108 1.363 . . . . 0.0 110.312 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 71' ' ' VAL . 95.0 mttt -81.03 -72.48 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.548 -1.345 . . . . 0.0 113.14 -173.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -144.18 -175.95 4.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 128.22 2.608 . . . . 0.0 108.433 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.5 p -152.27 160.1 43.4 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.215 -0.928 . . . . 0.0 113.226 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.08 -3.27 41.61 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 pt -135.2 -146.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.501 -1.374 . . . . 0.0 110.997 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -95.54 141.24 29.3 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.564 1.529 . . . . 0.0 111.796 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.81 -32.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.259 -0.901 . . . . 0.0 112.544 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.65 -46.27 72.91 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.295 0.498 . . . . 0.0 110.904 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -60.06 -43.52 95.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.152 0.581 . . . . 0.0 111.537 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -60.5 -47.1 87.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.83 77.08 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.014 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.6 ttp -66.21 -52.46 47.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.764 0.711 . . . . 0.0 111.644 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.82 -44.99 91.0 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.989 0.813 . . . . 0.0 112.499 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.04 -40.8 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.247 1.019 . . . . 0.0 110.73 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.41 -51.09 70.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.985 0.811 . . . . 0.0 110.933 173.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.75 -39.13 80.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.578 0.751 . . . . 0.0 112.564 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.68 -38.21 89.46 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.212 1.405 . . . . 0.0 113.554 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.12 -4.74 46.0 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.061 -1.024 . . . . 0.0 113.274 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 58.85 34.04 23.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.711 1.204 . . . . 0.0 112.311 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.3 mmm -59.14 -22.43 60.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.044 2.138 . . . . 0.0 113.93 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -72.52 -6.94 47.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.38 2.272 . . . . 0.0 113.534 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.4 56.64 2.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.469 1.907 . . . . 0.0 110.956 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.1 p -127.75 137.79 52.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.113 2.165 . . . . 0.0 109.317 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -60.99 -36.45 79.51 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.29 -0.881 . . . . 0.0 112.456 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.9 mt -93.82 -9.44 37.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.932 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 66.63 49.35 1.31 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.397 1.453 . . . . 0.0 109.456 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.9 16.12 13.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.828 1.651 . . . . 0.0 113.994 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.38 136.47 30.13 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.05 -1.032 . . . . 0.0 112.187 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.58 138.4 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.649 1.179 . . . . 0.0 110.61 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 tp -117.98 127.57 53.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.277 1.431 . . . . 0.0 110.122 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.2 mt -103.66 96.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -81.06 126.45 31.45 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.903 -0.498 . . . . 0.0 110.391 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.18 127.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.128 0.971 . . . . 0.0 110.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.66 118.0 34.39 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.257 1.023 . . . . 0.0 110.483 167.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 37' ' ' LYS . 29.0 m -76.59 -24.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -77.0 -55.97 4.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.207 0.458 . . . . 0.0 110.288 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -84.69 -1.31 55.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.629 1.171 . . . . 0.0 112.54 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.2 tttt 67.4 19.88 10.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 113.393 172.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.3 m -94.67 115.43 27.54 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.365 1.466 . . . . 0.0 110.874 -170.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -90.35 143.56 26.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.984 1.314 . . . . 0.0 110.004 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.08 150.86 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.726 1.61 . . . . 0.0 108.462 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.69 127.66 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -140.19 127.08 20.67 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.924 0.89 . . . . 0.0 110.599 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.6 158.2 14.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.579 1.085 . . . . 0.0 111.373 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.87 173.77 7.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 123.155 1.455 . . . . 0.0 112.638 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -60.72 -37.46 81.78 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.505 1.522 . . . . 0.0 113.685 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.09 -47.13 55.62 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.732 1.158 . . . . 0.0 112.588 -175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -54.7 -55.6 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.601 1.2 . . . . 0.0 109.36 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -79.16 -38.76 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.127 1.371 . . . . 0.0 111.598 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.5 m -92.75 -26.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 169.6 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 119.929 1.24 . . . . 0.0 113.055 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 p -119.17 171.59 8.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.125 1.37 . . . . 0.0 113.31 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.24 -30.25 71.11 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.674 -1.266 . . . . 0.0 113.338 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 0.0 112.344 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.5 t80 -76.22 -38.88 55.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.747 172.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -70.12 -28.86 65.72 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 125.08 1.352 . . . . 0.0 113.432 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.56 -31.62 72.84 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.6 m -62.32 -43.26 99.23 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.689 0.677 . . . . 0.0 111.062 171.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -60.21 -48.44 81.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.329 1.452 . . . . 0.0 111.516 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -59.57 -48.09 83.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.693 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -63.67 -35.26 79.96 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.91 61.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.18 0.9 . . . . 0.0 111.793 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.64 -49.9 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.315 0.646 . . . . 0.0 110.583 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.64 -39.9 85.88 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.907 1.283 . . . . 0.0 112.724 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.31 -45.06 96.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.649 1.113 . . . . 0.0 111.954 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -79.14 -37.04 39.51 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.944 -0.473 . . . . 0.0 110.971 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -59.55 -39.83 85.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.186 0.903 . . . . 0.0 111.887 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -64.39 -31.59 72.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.786 1.634 . . . . 0.0 113.034 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -73.06 -34.8 66.49 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 118.756 0.707 . . . . 0.0 111.299 168.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 8.18 11.74 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 126.192 1.853 . . . . 0.0 113.793 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -107.43 78.52 1.22 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 0.0 111.816 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -53.39 -46.5 69.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.412 1.485 . . . . 0.0 112.952 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.7 -49.62 74.58 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.545 -0.722 . . . . 0.0 111.539 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.61 -44.35 90.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.826 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.74 97.08 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 119.003 0.819 . . . . 0.0 113.387 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.31 -47.19 68.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.46 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.54 -51.65 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.364 1.066 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.26 -41.94 98.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.114 0.966 . . . . 0.0 111.2 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -17.78 76.28 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 121.049 -1.032 . . . . 0.0 113.5 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.96 -50.63 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.649 1.58 . . . . 0.0 109.825 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.91 -51.65 68.28 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.775 1.171 . . . . 0.0 111.982 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.35 -37.6 86.29 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.058 -1.026 . . . . 0.0 112.122 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.27 88.41 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.886 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.41 87.09 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.116 0.871 . . . . 0.0 111.231 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 59.9 ttm -59.96 -43.47 95.04 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.027 0.913 . . . . 0.0 112.503 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -69.45 -47.31 64.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.25 0.62 . . . . 0.0 111.78 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.55 -36.41 82.55 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.284 1.034 . . . . 0.0 111.466 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.27 -22.47 61.2 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -66.14 -41.71 90.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.866 1.212 . . . . 0.0 111.438 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -81.59 -27.39 34.29 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.029 1.731 . . . . 0.0 113.001 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -138.86 76.35 34.48 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 126.594 1.957 . . . . 0.0 110.097 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.56 143.86 64.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.326 2.684 . . . . 0.0 111.144 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -66.7 137.21 56.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -118.03 150.82 38.65 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.787 1.635 . . . . 0.0 110.149 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -67.15 -19.63 65.62 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.181 -1.574 . . . . 0.0 113.524 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -106.72 17.75 22.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.054 2.941 . . . . 0.0 112.037 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -52.7 153.84 3.0 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.044 1.338 . . . . 0.0 112.19 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.316 0 O-C-N 120.735 -1.228 . . . . 0.0 111.848 -167.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 CA--C 1.533 0.455 0 N-CA-C 111.669 -0.166 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -57.39 -14.07 4.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.7 m -50.32 140.39 13.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.44 134.82 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.551 1.14 . . . . 0.0 109.582 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 m -93.56 138.62 31.64 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.387 1.089 . . . . 0.0 111.982 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.21 157.29 46.19 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.778 1.631 . . . . 0.0 109.28 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 C-N-CA 125.169 1.366 . . . . 0.0 111.786 172.786 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -86.33 170.22 12.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.739 0.781 . . . . 0.0 110.375 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.26 -29.47 5.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.137 1.375 . . . . 0.0 114.636 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -80.22 -38.47 31.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 0.0 111.979 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -76.67 -44.49 33.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.949 1.3 . . . . 0.0 111.036 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.47 -45.66 92.04 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.057 1.343 . . . . 0.0 111.168 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.04 -40.01 79.83 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.895 -1.128 . . . . 0.0 111.603 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.94 80.32 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 0.594 . . . . 0.0 111.962 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.05 -37.32 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.319 0.963 . . . . 0.0 112.909 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.95 -40.88 84.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 118.953 0.797 . . . . 0.0 111.283 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -72.64 -29.28 63.32 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.143 0.883 . . . . 0.0 113.31 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.01 76.68 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.522 -0.736 . . . . 0.0 112.645 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.54 -40.53 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -61.43 -31.21 71.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.865 0.866 . . . . 0.0 112.134 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.01 -31.13 62.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.422 1.089 . . . . 0.0 112.685 172.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.37 -39.25 59.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.824 1.25 . . . . 0.0 113.027 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.94 -23.72 63.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 112.564 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.8 8.84 26.99 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.527 -1.358 . . . . 0.0 113.39 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -130.62 -8.96 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.912 1.685 . . . . 0.0 113.78 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -157.48 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.501 1.521 . . . . 0.0 108.888 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 27.8 1.52 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.686 0.794 . . . . 0.0 112.162 174.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.09 151.35 17.34 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.248 1.404 . . . . 0.0 111.443 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -112.28 127.89 56.11 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -161.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.37 119.96 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.401 -1.437 . . . . 0.0 110.216 -172.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -128.58 147.07 50.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.443 1.097 . . . . 0.0 112.071 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.23 141.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.024 1.33 . . . . 0.0 110.203 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.54 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.8 t60 -126.96 123.38 37.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.172 0.989 . . . . 0.0 110.869 168.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 tp -104.77 147.79 27.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 0.0 111.463 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.44 166.36 32.41 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.882 1.325 . . . . 0.0 109.644 159.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -59.62 -78.28 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 C-N-CA 126.236 1.814 . . . . 0.0 113.073 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -138.08 -177.03 4.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.536 1.534 . . . . 0.0 110.71 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -137.46 142.57 41.56 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.397 1.479 . . . . 0.0 111.434 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -81.07 -27.84 35.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.041 0.936 . . . . 0.0 112.947 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 pt -115.71 -146.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.099 1.759 . . . . 0.0 110.636 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.85 133.74 36.28 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.578 -1.326 . . . . 0.0 111.875 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.21 -36.89 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.853 0.861 . . . . 0.0 112.314 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.78 -49.75 64.89 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.866 1.212 . . . . 0.0 111.7 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -60.63 -42.59 97.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.158 0.583 . . . . 0.0 112.192 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -36.93 85.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.65 88.32 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.848 -1.157 . . . . 0.0 111.763 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.6 ttp -63.18 -49.93 72.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.376 0.67 . . . . 0.0 111.439 170.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.08 -47.96 79.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.845 0.748 . . . . 0.0 111.087 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.29 -42.02 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 111.814 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.59 -53.2 60.84 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.598 1.09 . . . . 0.0 111.054 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.21 -32.3 62.98 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.376 0.67 . . . . 0.0 112.353 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.626 -1.296 . . . . 0.0 112.824 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.1 -6.55 58.95 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.164 0.985 . . . . 0.0 112.559 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 tttt 61.44 36.02 17.43 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.802 1.641 . . . . 0.0 111.625 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.5 mtp -72.7 -5.5 38.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -77.57 -2.5 36.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.631 1.972 . . . . 0.0 113.18 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -73.26 33.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.293 1.837 . . . . 0.0 114.318 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 p -111.44 153.98 25.33 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.037 1.735 . . . . 0.0 111.947 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.75 -39.17 87.81 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.04 -4.2 22.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.188 -0.91 . . . . 0.0 113.39 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 67.78 31.49 5.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.662 1.585 . . . . 0.0 110.021 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.37 33.03 3.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.454 1.902 . . . . 0.0 112.594 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.31 123.55 6.38 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.358 0.98 . . . . 0.0 112.999 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -112.18 138.42 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.449 1.1 . . . . 0.0 112.011 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 34' ' ' HIS . 33.9 tp -117.01 128.54 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.475 1.51 . . . . 0.0 111.228 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -104.38 97.93 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.456 1.102 . . . . 0.0 108.963 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -81.12 125.0 29.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 111.017 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.38 134.29 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.108 0.963 . . . . 0.0 111.115 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.24 105.93 16.14 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.107 1.763 . . . . 0.0 110.613 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -77.77 -13.03 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -78.46 -40.74 34.72 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.174 0.897 . . . . 0.0 112.07 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.81 -10.6 26.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.824 1.249 . . . . 0.0 112.219 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.0 tttt 71.96 24.28 3.32 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.738 1.615 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.3 p -105.85 165.03 11.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.313 1.045 . . . . 0.0 111.607 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -143.32 144.52 32.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 109.616 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -138.97 139.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.95 1.7 . . . . 0.0 107.719 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.7 mt -116.0 133.3 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -138.58 126.94 23.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.207 1.003 . . . . 0.0 110.401 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.93 150.54 18.42 Favored Glycine 0 N--CA 1.462 0.398 0 C-N-CA 125.174 1.368 . . . . 0.0 112.208 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -64.17 164.03 11.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 122.598 1.19 . . . . 0.0 112.319 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -53.85 -35.12 61.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.435 1.494 . . . . 0.0 112.377 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -28.08 73.65 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 119.626 1.103 . . . . 0.0 114.387 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.39 -58.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.283 1.541 . . . . 0.0 109.798 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -54.6 -32.94 59.58 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.308 1.443 . . . . 0.0 113.869 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -76.87 -24.13 52.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 88' ' ' VAL . 10.3 m -103.91 -35.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.908 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 87' ' ' VAL . 3.0 m -104.7 169.17 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 120.004 1.274 . . . . 0.0 112.632 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -119.46 177.77 4.79 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.563 1.545 . . . . 0.0 113.271 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -61.73 -33.46 74.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.683 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.39 -20.21 62.96 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.03 0.932 . . . . 0.0 112.557 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -77.87 -30.66 50.97 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 169.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -83.99 -26.34 29.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -54.86 -44.03 73.65 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.963 1.305 . . . . 0.0 112.416 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.8 p -63.12 -35.29 79.78 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 m -66.43 -51.16 59.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.476 1.91 . . . . 0.0 110.245 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -60.9 -44.57 96.95 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.146 0.978 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -57.19 -47.22 81.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.874 0.761 . . . . 0.0 112.524 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.45 -48.2 82.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.436 1.017 . . . . 0.0 111.841 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.12 -49.15 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.946 0.898 . . . . 0.0 110.352 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -59.86 -42.13 93.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.999 1.32 . . . . 0.0 112.356 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.89 -38.36 86.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.74 -32.84 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.391 0.541 . . . . 0.0 111.172 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -62.39 -39.05 91.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.637 0.775 . . . . 0.0 111.645 168.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -59.38 -31.32 69.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.683 1.193 . . . . 0.0 113.038 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.36 -41.04 22.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.378 1.071 . . . . 0.0 111.257 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.36 1.23 8.58 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.581 1.563 . . . . 0.0 114.843 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -93.63 80.69 4.28 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.815 1.307 . . . . 0.0 111.532 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -59.77 -44.44 93.87 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.789 1.235 . . . . 0.0 112.609 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -50.99 -58.67 5.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.314 1.045 . . . . 0.0 111.363 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.004 0.921 . . . . 0.0 111.698 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.04 -37.41 94.18 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 118.72 0.691 . . . . 0.0 113.664 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.08 -44.94 59.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.448 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.68 -51.67 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.326 0.65 . . . . 0.0 111.12 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.88 -33.75 76.77 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.346 0.659 . . . . 0.0 112.3 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.23 83.77 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.338 -0.851 . . . . 0.0 112.667 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.94 -46.67 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.167 1.483 . . . . 0.0 109.877 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.24 -47.63 81.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.305 0.642 . . . . 0.0 111.29 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -61.63 -38.69 88.58 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 121.547 -0.72 . . . . 0.0 112.202 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.66 64.24 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.322 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.3 -45.61 74.21 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 120.37 1.441 . . . . 0.0 113.284 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mtp -63.37 -38.11 89.89 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.158 -1.201 . . . . 0.0 112.907 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.497 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -78.38 -38.84 40.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 110.901 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.49 -33.14 70.89 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.453 1.501 . . . . 0.0 112.549 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.49 41.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -71.85 -29.56 64.52 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.112 -0.992 . . . . 0.0 113.429 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -91.62 -35.54 14.17 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.777 1.231 . . . . 0.0 111.527 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -136.34 90.99 16.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.328 1.851 . . . . 0.0 109.879 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.37 144.17 60.81 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.639 2.226 . . . . 0.0 111.299 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -62.93 161.53 12.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.6 0.76 . . . . 0.0 112.747 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -142.9 159.28 42.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -62.27 -29.25 70.29 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.542 -1.349 . . . . 0.0 113.236 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -99.82 29.15 4.3 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.651 1.581 . . . . 0.0 112.4 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.33 151.17 44.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.834 -1.166 . . . . 0.0 112.003 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.219 -0.523 0 C-N-CA 124.24 1.016 . . . . 0.0 110.887 -167.146 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 111.046 -0.405 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -83.83 2.52 37.87 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.6 p -76.33 160.9 29.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.989 1.316 . . . . 0.0 112.325 -166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.94 140.49 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.536 0.735 . . . . 0.0 109.815 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.4 t -110.07 140.66 43.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.668 -1.27 . . . . 0.0 111.942 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -134.88 137.37 43.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 C-N-CA 124.993 1.282 . . . . 0.0 114.793 169.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -64.05 150.64 44.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.066 1.346 . . . . 0.0 109.38 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.45 55.73 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.249 -1.532 . . . . 0.0 113.983 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -68.67 -35.63 77.47 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.357 1.463 . . . . 0.0 113.566 174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.54 -35.24 78.67 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.499 -1.376 . . . . 0.0 111.152 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.82 -44.19 97.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.875 0.87 . . . . 0.0 110.956 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -45.3 87.22 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.013 -1.054 . . . . 0.0 111.162 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.58 76.27 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.0 -38.8 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 119.846 1.203 . . . . 0.0 112.21 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.75 -39.63 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 119.67 1.123 . . . . 0.0 111.934 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.42 -35.37 77.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.477 1.111 . . . . 0.0 112.741 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.34 87.63 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.859 0.463 . . . . 0.0 111.631 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.6 mt -66.31 -46.56 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.79 1.236 . . . . 0.0 110.243 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -57.7 -28.9 64.25 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.23 -30.29 34.23 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.048 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.74 85.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.922 1.289 . . . . 0.0 112.25 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.02 -17.4 2.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.514 1.525 . . . . 0.0 113.787 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -106.63 14.42 26.98 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.034 -1.666 . . . . 0.0 112.396 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -130.68 -15.92 3.43 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.83 1.652 . . . . 0.0 113.961 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -152.39 152.84 32.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.845 1.258 . . . . 0.0 110.577 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -81.03 3.5 22.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.276 1.03 . . . . 0.0 112.812 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 -161.74 21.85 Favored Glycine 0 C--N 1.343 0.934 0 C-N-CA 125.996 1.76 . . . . 0.0 111.668 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -162.86 129.52 3.48 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.246 0.618 . . . . 0.0 112.159 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.78 116.15 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.37 1.068 . . . . 0.0 110.634 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -121.78 153.09 38.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.622 1.169 . . . . 0.0 111.218 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.11 132.78 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.65 1.18 . . . . 0.0 110.725 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -117.3 124.22 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.257 1.027 . . . . 0.0 112.515 169.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.41 HD11 ' CG1' ' A' ' 71' ' ' VAL . 12.7 tp -108.33 126.15 52.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.069 1.347 . . . . 0.0 112.401 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -150.6 161.63 42.21 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.462 1.105 . . . . 0.0 110.21 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -73.7 -68.98 0.46 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.645 -1.284 . . . . 0.0 113.302 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -156.57 157.66 35.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.434 1.894 . . . . 0.0 110.277 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.1 p -115.8 147.93 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.585 1.554 . . . . 0.0 112.77 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -80.5 -29.23 37.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.15 0.98 . . . . 0.0 111.566 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -107.8 -167.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.843 1.657 . . . . 0.0 111.447 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -68.75 134.39 49.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.594 1.158 . . . . 0.0 112.678 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.87 -38.06 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.967 0.907 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.24 -51.25 68.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.682 0.674 . . . . 0.0 112.109 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.17 -43.02 93.07 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.135 0.574 . . . . 0.0 111.47 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -58.51 -42.33 87.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.669 0.788 . . . . 0.0 112.418 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.29 -35.13 77.38 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.902 0.881 . . . . 0.0 111.555 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.2 ttp -63.68 -49.21 74.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.545 0.738 . . . . 0.0 111.119 170.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.08 -52.45 65.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.049 0.939 . . . . 0.0 111.464 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.14 -42.5 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.506 1.122 . . . . 0.0 111.448 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.54 -46.44 90.15 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.45 1.1 . . . . 0.0 112.003 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -70.15 -36.96 75.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.443 1.497 . . . . 0.0 111.872 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.24 -22.36 59.37 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.768 1.227 . . . . 0.0 114.058 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.79 -8.82 57.87 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.684 1.194 . . . . 0.0 112.421 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 65.74 32.89 8.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.232 1.413 . . . . 0.0 112.712 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.7 mtp -64.98 -23.63 67.28 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.36 -13.41 1.4 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.584 1.954 . . . . 0.0 114.709 168.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -73.79 43.89 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.486 1.915 . . . . 0.0 112.915 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.2 m -120.74 129.7 53.74 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.658 1.583 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.78 -39.45 65.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.449 1.499 . . . . 0.0 113.83 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.44 2.82 42.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 0.0 113.707 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 62.87 32.73 15.63 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.288 1.035 . . . . 0.0 111.169 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -107.82 27.15 9.5 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.372 1.469 . . . . 0.0 113.12 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.18 125.8 7.29 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.203 0.906 . . . . 0.0 112.077 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.23 135.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.979 1.312 . . . . 0.0 109.714 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.17 127.99 54.66 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.241 1.02 . . . . 0.0 111.315 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -101.55 96.19 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.621 1.568 . . . . 0.0 109.215 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -84.16 124.37 31.08 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.151 -0.968 . . . . 0.0 110.805 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -120.9 131.92 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.224 1.01 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 90.96 3.54 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.131 1.773 . . . . 0.0 110.609 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG1' HD11 ' A' ' 35' ' ' LEU . 27.2 m -73.29 -14.82 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -167.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -75.61 -34.97 60.62 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 122.847 0.459 . . . . 0.0 111.252 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.45 -12.22 16.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.116 2.167 . . . . 0.0 112.757 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 73.03 26.0 2.26 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.127 1.771 . . . . 0.0 112.441 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -110.01 167.44 10.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.073 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -148.39 148.64 30.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.298 1.039 . . . . 0.0 110.644 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.9 142.37 40.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.63 128.26 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -145.84 125.64 13.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.621 1.168 . . . . 0.0 109.606 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.35 161.98 13.38 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.527 1.061 . . . . 0.0 112.023 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -64.58 162.91 14.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 123.212 1.482 . . . . 0.0 111.798 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.008 1.723 . . . . 0.0 113.451 -170.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.48 -25.44 72.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.259 -1.301 . . . . 0.0 114.534 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 -58.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.971 1.885 . . . . 0.0 109.302 167.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -59.69 -25.15 64.53 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.5 -18.24 34.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.472 1.109 . . . . 0.0 113.884 174.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 88' ' ' VAL . 1.4 p -104.11 -20.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 87' ' ' VAL . 4.7 m -129.11 167.47 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.844 1.257 . . . . 0.0 111.287 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -120.25 173.06 7.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.54 1.136 . . . . 0.0 113.101 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -49.41 -38.49 29.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -31.0 72.04 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.9 t80 -70.88 -32.78 69.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.656 0.782 . . . . 0.0 111.636 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -78.99 -26.35 43.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.289 1.436 . . . . 0.0 113.334 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.99 -41.56 87.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.57 0.748 . . . . 0.0 112.646 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -59.53 -43.05 93.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.255 0.479 . . . . 0.0 111.287 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -61.34 -51.16 70.0 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 125.72 1.608 . . . . 0.0 110.401 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.08 -48.51 79.93 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 118.075 -0.965 . . . . 0.0 110.587 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.85 -41.69 96.35 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.207 1.367 . . . . 0.0 113.362 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.09 79.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.917 1.235 . . . . 0.0 111.327 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.33 -54.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.934 0.894 . . . . 0.0 110.451 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -52.37 -44.94 65.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.304 1.842 . . . . 0.0 113.174 -175.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.37 -30.54 62.03 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.215 0.606 . . . . 0.0 112.557 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -82.36 -39.65 22.45 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.75 0.82 . . . . 0.0 111.063 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.98 -43.25 91.37 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.407 0.683 . . . . 0.0 111.406 170.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.06 -37.31 71.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.264 1.025 . . . . 0.0 112.06 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -71.89 -41.08 68.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.337 1.055 . . . . 0.0 111.409 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.13 4.78 6.42 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 126.323 1.916 . . . . 0.0 113.648 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -102.46 81.4 2.05 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 119.0 1.4 . . . . 0.0 111.71 -171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -60.03 -43.61 95.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.754 0.822 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.43 -52.69 64.37 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.783 -0.573 . . . . 0.0 111.515 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -56.93 -44.76 82.79 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.06 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.92 96.08 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.344 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.75 -52.22 64.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.754 0.777 . . . . 0.0 111.021 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.3 t -63.77 -49.15 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.163 . . . . 0.0 110.907 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.37 -32.72 74.29 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.845 0.748 . . . . 0.0 111.834 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.99 -45.42 73.14 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.57 -47.85 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.015 1.326 . . . . 0.0 111.309 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.87 -49.56 76.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.577 0.751 . . . . 0.0 111.483 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -63.48 -34.75 78.45 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.387 -0.82 . . . . 0.0 112.466 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.52 79.52 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.023 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.76 -39.76 97.89 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.51 1.05 . . . . 0.0 112.776 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 78.5 mtp -61.46 -48.41 81.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.046 0.923 . . . . 0.0 112.379 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.62 -41.85 65.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.657 0.783 . . . . 0.0 112.308 -176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.65 -37.92 85.8 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 111.185 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.12 -23.59 67.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -62.22 -45.6 92.61 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.494 -1.379 . . . . 0.0 111.225 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -74.03 -39.44 63.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.21 1.004 . . . . 0.0 111.988 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.42 82.56 65.95 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 125.986 1.715 . . . . 0.0 110.567 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.83 136.58 53.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.36 2.04 . . . . 0.0 109.622 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -57.54 135.75 56.67 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -108.75 146.29 33.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.885 1.274 . . . . 0.0 110.003 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -24.48 67.39 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.426 -1.421 . . . . 0.0 113.541 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -105.51 19.42 20.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.016 1.326 . . . . 0.0 113.467 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.8 162.1 1.91 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.269 1.428 . . . . 0.0 113.66 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 122.622 1.201 . . . . 0.0 112.221 -170.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 CA-C-O 121.169 0.404 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -72.63 -1.33 15.79 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -62.62 150.49 40.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.077 0.951 . . . . 0.0 111.445 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.6 133.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.67 0.788 . . . . 0.0 108.996 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.76 143.88 27.32 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.614 -0.678 . . . . 0.0 112.295 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -145.85 147.45 31.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.217 -0.927 . . . . 0.0 112.168 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 C-N-CA 126.731 2.11 . . . . 0.0 112.026 165.954 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 m -58.79 157.15 10.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.066 0.947 . . . . 0.0 110.31 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.81 -44.03 18.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -51.14 -40.43 58.52 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 173.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -79.49 -39.95 30.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.025 0.93 . . . . 0.0 111.434 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.06 -46.03 75.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -57.95 -48.93 78.48 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.355 -1.466 . . . . 0.0 110.7 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.35 85.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.18 -38.68 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.951 1.25 . . . . 0.0 112.678 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.12 -46.19 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.634 0.652 . . . . 0.0 110.719 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.15 -35.73 79.67 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.885 0.874 . . . . 0.0 112.828 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.38 96.93 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.897 0.772 . . . . 0.0 111.437 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.39 -45.01 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.628 -0.67 . . . . 0.0 110.51 172.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -56.92 -27.46 60.95 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -83.64 -28.85 28.13 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.105 0.866 . . . . 0.0 112.3 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.37 97.63 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.767 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.58 18.4 0.17 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.952 1.301 . . . . 0.0 113.637 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.96 11.44 8.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.823 2.049 . . . . 0.0 111.376 166.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.44 -10.74 3.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.832 1.653 . . . . 0.0 113.378 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -150.5 171.0 17.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.021 1.728 . . . . 0.0 110.171 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -101.35 5.09 42.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.974 1.71 . . . . 0.0 112.776 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.5 126.44 6.52 Favored Glycine 0 C--N 1.343 0.959 0 C-N-CA 124.992 1.282 . . . . 0.0 112.425 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -94.23 142.32 27.55 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -156.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mt -114.76 134.91 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.505 1.122 . . . . 0.0 111.293 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -144.11 149.35 36.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.947 1.299 . . . . 0.0 112.131 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.79 141.79 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.918 1.687 . . . . 0.0 110.327 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.528 ' HB2' HD11 ' A' ' 66' ' ' LEU . 37.8 t60 -124.39 127.0 46.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.686 1.594 . . . . 0.0 112.0 170.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -112.77 123.05 49.43 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.393 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 46' ' ' ARG . 26.1 tt0 -143.14 159.07 42.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.036 0.934 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -68.61 -73.29 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.739 -1.226 . . . . 0.0 110.824 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -153.98 159.19 41.55 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.27 1.828 . . . . 0.0 110.671 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -105.21 159.8 15.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.69 1.596 . . . . 0.0 110.361 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -94.48 -27.58 15.92 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.227 -0.921 . . . . 0.0 112.766 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.33 -150.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 126.112 1.765 . . . . 0.0 111.334 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.84 136.51 34.1 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.549 1.139 . . . . 0.0 111.696 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.27 -37.24 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.076 0.95 . . . . 0.0 112.146 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -64.3 -47.43 79.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.372 0.987 . . . . 0.0 111.933 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -44.32 97.09 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.473 1.509 . . . . 0.0 110.387 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 36' ' ' GLU . 47.6 ttt85 -61.04 -45.69 93.75 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.623 1.169 . . . . 0.0 113.409 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.4 98.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.791 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.0 ttp -60.58 -43.17 97.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.963 0.905 . . . . 0.0 113.048 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -61.47 -54.46 43.09 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.933 -1.104 . . . . 0.0 112.228 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.98 -41.57 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.116 0.566 . . . . 0.0 111.86 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.99 -49.89 76.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.88 1.272 . . . . 0.0 111.919 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -74.76 -32.91 62.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.144 0.978 . . . . 0.0 112.059 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -64.99 -36.31 84.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.045 -1.659 . . . . 0.0 112.463 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.97 -8.04 57.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.823 1.249 . . . . 0.0 113.279 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 65.45 35.89 7.07 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 126.226 1.81 . . . . 0.0 112.214 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.4 mtp -69.64 -25.26 63.85 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.865 -1.147 . . . . 0.0 112.79 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -69.64 -12.73 61.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.304 2.241 . . . . 0.0 114.411 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -84.77 63.45 8.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.24 1.416 . . . . 0.0 110.937 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.2 m -132.01 133.94 45.0 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.884 1.673 . . . . 0.0 109.546 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -48.99 -54.73 14.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 113.45 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.24 -9.9 51.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.736 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 62.72 55.39 2.14 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.174 1.79 . . . . 0.0 109.956 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -125.8 28.93 6.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.537 1.135 . . . . 0.0 111.904 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.86 133.78 17.69 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 120.669 -1.269 . . . . 0.0 111.335 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.79 135.84 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.014 1.326 . . . . 0.0 111.273 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.0 tp -118.52 121.37 40.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.916 1.286 . . . . 0.0 110.781 171.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -95.14 96.55 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -78.64 123.02 26.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.391 0.677 . . . . 0.0 110.03 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.4 127.13 75.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.637 1.175 . . . . 0.0 110.212 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.62 92.69 4.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.77 1.228 . . . . 0.0 109.531 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.05 -6.11 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -171.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.24 -49.89 15.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.786 0.721 . . . . 0.0 109.726 170.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.2 -9.43 53.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 112.629 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.3 tttt 71.72 20.59 4.58 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.005 2.122 . . . . 0.0 113.133 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.3 p -102.6 169.34 8.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.957 1.303 . . . . 0.0 111.805 -174.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.46 145.92 31.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.59 1.156 . . . . 0.0 110.595 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.49 136.46 48.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 126.241 1.817 . . . . 0.0 107.103 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.39 127.62 73.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -130.11 147.0 51.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 109.758 173.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.64 154.78 26.04 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -58.52 162.54 3.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.174 1.464 . . . . 0.0 113.767 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -53.23 -36.71 61.35 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.344 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -45.18 94.6 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 120.647 1.567 . . . . 0.0 112.433 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 61.2 mt -58.97 -57.44 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 118.301 1.05 . . . . 0.0 109.854 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -58.57 -29.7 66.59 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -81.59 -16.68 50.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 112.851 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.89 -34.79 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.63 165.93 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.176 1.353 . . . . 0.0 112.016 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.1 m -115.39 165.4 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.055 1.342 . . . . 0.0 112.382 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -61.03 -26.03 67.33 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.83 -1.169 . . . . 0.0 112.997 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.68 -23.3 56.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.154 0.981 . . . . 0.0 112.81 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 53.0 t80 -78.21 -27.4 47.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.639 1.576 . . . . 0.0 111.578 170.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -79.8 -29.43 40.28 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -49.52 -48.04 48.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.566 1.147 . . . . 0.0 112.599 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -54.33 -44.72 72.31 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.533 1.533 . . . . 0.0 112.293 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.3 m -64.94 -48.67 73.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.911 1.284 . . . . 0.0 110.691 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -56.74 -46.39 81.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.377 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.58 -45.6 92.19 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 112.817 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.62 -50.52 71.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.922 1.237 . . . . 0.0 112.362 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.5 -50.99 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.652 0.781 . . . . 0.0 110.655 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -60.29 -46.79 88.63 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.534 1.533 . . . . 0.0 112.012 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.11 -33.61 74.77 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.224 0.609 . . . . 0.0 112.381 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -84.1 -40.18 18.59 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.442 1.097 . . . . 0.0 112.191 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.7 -36.81 77.26 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.569 -0.707 . . . . 0.0 111.186 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -62.7 -29.93 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.996 1.318 . . . . 0.0 113.505 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -80.31 -29.31 38.12 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.942 -1.099 . . . . 0.0 110.866 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 -1.8 33.37 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 126.015 1.769 . . . . 0.0 113.801 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -86.57 92.14 8.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.39 1.095 . . . . 0.0 111.039 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.73 -38.26 88.66 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.032 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -59.98 -59.66 5.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.265 0.626 . . . . 0.0 111.153 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.45 -40.94 96.31 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.913 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.85 97.16 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.923 1.238 . . . . 0.0 114.019 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.1 mt -71.16 -45.65 63.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.395 0.598 . . . . 0.0 111.481 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.87 -50.45 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.307 0.958 . . . . 0.0 112.009 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.501 1.12 . . . . 0.0 111.104 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.53 -47.55 88.54 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 123.574 0.607 . . . . 0.0 111.633 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.27 -42.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.734 1.214 . . . . 0.0 111.333 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.65 -39.82 94.37 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.198 1.399 . . . . 0.0 112.001 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -72.46 -43.59 63.51 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.905 -1.122 . . . . 0.0 111.526 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.02 75.47 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.343 1.057 . . . . 0.0 111.095 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.47 -44.22 96.87 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.256 0.935 . . . . 0.0 112.088 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -67.16 -26.2 66.54 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.566 -0.961 . . . . 0.0 113.557 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -78.22 -50.27 12.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.084 1.353 . . . . 0.0 111.426 172.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.2 mt -58.63 -38.17 77.47 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.763 2.025 . . . . 0.0 111.789 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.55 -14.15 12.0 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -80.53 -35.39 34.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 120.454 -1.404 . . . . 0.0 111.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -84.18 -38.81 20.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 113.041 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.52 86.26 53.72 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.02 1.728 . . . . 0.0 109.235 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.42 135.32 26.35 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.712 2.275 . . . . 0.0 110.466 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -56.33 146.28 24.49 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -125.45 153.64 43.2 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.709 1.204 . . . . 0.0 110.986 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -62.04 -35.86 79.88 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.858 -1.151 . . . . 0.0 113.063 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.3 13.77 9.13 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 113.64 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.38 158.62 28.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.853 0.861 . . . . 0.0 112.732 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 126.041 1.736 . . . . 0.0 110.73 -173.392 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.451 -0.983 0 CA-C-O 121.245 0.435 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -64.92 1.39 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.1 1.76 . . . . 0.0 115.189 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 p -71.39 141.99 50.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.826 -1.171 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 82.4 mt -73.46 136.36 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.245 1.018 . . . . 0.0 109.706 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -96.1 145.91 25.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 120.906 -1.122 . . . . 0.0 111.009 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -144.98 142.46 29.83 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.416 -1.427 . . . . 0.0 112.816 -172.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.406 0 C-N-CA 125.761 1.648 . . . . 0.0 112.814 169.453 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 p -84.7 166.48 17.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 111.889 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.28 77.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 112.121 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.7 -48.74 78.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.147 1.379 . . . . 0.0 111.052 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -64.32 -44.23 92.19 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.282 0.633 . . . . 0.0 111.366 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.85 -29.51 62.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.486 1.514 . . . . 0.0 113.424 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -65.93 -37.73 86.8 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.01 -1.681 . . . . 0.0 111.7 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.86 -39.42 35.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.84 -37.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.505 -1.372 . . . . 0.0 112.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.13 -36.14 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.662 0.664 . . . . 0.0 110.846 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -72.2 -25.24 61.59 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.556 1.142 . . . . 0.0 112.754 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -40.32 72.87 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.687 -0.633 . . . . 0.0 111.587 172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.93 -44.89 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.349 -0.844 . . . . 0.0 110.991 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -57.52 -32.5 67.11 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -79.74 -30.36 40.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.636 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.75 74.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -55.39 -19.41 9.0 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.276 1.431 . . . . 0.0 112.461 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -103.51 9.9 37.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.526 . . . . 0.0 112.926 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -124.95 -12.92 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.983 1.313 . . . . 0.0 113.712 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -164.35 149.28 10.02 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 109.391 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.9 p -85.32 5.7 29.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.054 0.942 . . . . 0.0 112.92 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.94 168.65 43.42 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.831 1.205 . . . . 0.0 110.304 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -137.18 121.95 18.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.934 . . . . 0.0 113.054 -166.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.45 137.72 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.209 1.404 . . . . 0.0 111.04 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -146.55 153.85 40.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.274 1.429 . . . . 0.0 110.433 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.48 138.4 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.919 1.287 . . . . 0.0 110.203 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.431 ' HB2' HD11 ' A' ' 66' ' ' LEU . 25.0 t60 -116.3 115.69 26.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 110.964 165.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.9 tp -98.17 134.22 41.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.484 0.714 . . . . 0.0 111.143 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.03 162.36 41.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.181 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.83 -69.37 0.44 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.722 1.209 . . . . 0.0 112.673 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -160.36 152.38 20.24 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.539 1.135 . . . . 0.0 113.289 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.6 p -109.96 141.64 42.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.667 1.587 . . . . 0.0 113.181 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.57 -28.51 56.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.482 0.658 . . . . 0.0 112.498 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -109.95 -172.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.113 2.165 . . . . 0.0 111.641 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.12 132.74 51.36 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.755 1.222 . . . . 0.0 112.812 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.57 -41.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.816 1.246 . . . . 0.0 111.467 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -48.5 79.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.645 0.778 . . . . 0.0 112.11 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.51 -42.09 83.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.871 0.868 . . . . 0.0 110.992 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -60.02 -46.34 89.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.213 1.005 . . . . 0.0 112.156 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.58 -37.92 88.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.211 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.7 ttp -63.94 -48.89 74.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.859 0.754 . . . . 0.0 111.654 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.78 -46.8 89.07 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.238 0.615 . . . . 0.0 111.054 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.61 -43.04 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.66 1.184 . . . . 0.0 111.79 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.04 -48.43 81.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.497 1.044 . . . . 0.0 112.185 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -72.39 -33.41 67.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.582 1.153 . . . . 0.0 112.606 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -65.36 -42.79 92.41 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.607 -1.308 . . . . 0.0 111.809 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.42 -1.21 32.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.537 1.135 . . . . 0.0 112.947 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 59.75 37.92 21.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.811 1.244 . . . . 0.0 112.28 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtp -75.44 -21.17 58.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 112.511 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.81 -13.12 9.08 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.308 2.643 . . . . 0.0 114.415 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -64.45 -7.89 11.57 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -55.02 140.01 39.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.642 1.977 . . . . 0.0 111.074 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -66.43 -36.07 81.89 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.381 -0.824 . . . . 0.0 112.177 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.52 -1.45 56.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 62.06 27.86 16.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.247 1.023 . . . . 0.0 111.311 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -107.92 39.42 1.95 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.161 1.784 . . . . 0.0 112.752 -171.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.13 128.33 9.44 Favored Glycine 0 N--CA 1.479 1.53 0 C-N-CA 124.473 1.035 . . . . 0.0 112.262 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.66 132.26 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.209 1.803 . . . . 0.0 109.911 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 34' ' ' HIS . 28.6 tp -117.39 128.1 54.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.122 0.969 . . . . 0.0 111.194 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.61 97.41 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.671 1.189 . . . . 0.0 107.804 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -81.84 122.74 28.11 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.081 0.952 . . . . 0.0 111.039 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.34 125.62 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.913 0.885 . . . . 0.0 110.284 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 100.27 11.28 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.657 1.583 . . . . 0.0 110.188 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.19 -19.47 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -74.23 -47.14 37.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.655 1.116 . . . . 0.0 111.153 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -88.86 -11.61 44.18 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.7 1.2 . . . . 0.0 113.612 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.5 tttt 71.82 30.11 2.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.01 1.724 . . . . 0.0 112.717 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -113.3 133.39 55.14 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.391 1.477 . . . . 0.0 110.052 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -114.43 143.23 45.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.022 1.329 . . . . 0.0 109.371 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.99 134.27 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.027 1.331 . . . . 0.0 108.194 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 mt -112.48 129.58 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -135.84 124.13 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.728 0.811 . . . . 0.0 110.45 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.83 154.49 17.0 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.559 1.076 . . . . 0.0 110.785 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -67.93 168.4 11.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 122.374 1.083 . . . . 0.0 111.929 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.38 -26.52 63.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.952 1.301 . . . . 0.0 114.452 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.66 55.0 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.812 1.187 . . . . 0.0 111.492 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.93 -54.91 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.538 1.169 . . . . 0.0 109.272 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -60.9 -30.72 70.34 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -78.24 -38.12 43.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.873 0.869 . . . . 0.0 112.113 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 88' ' ' VAL . 19.8 m -89.17 -23.06 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 87' ' ' VAL . 2.5 m -119.59 162.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.231 0.923 . . . . 0.0 112.232 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -113.11 173.38 6.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.424 1.49 . . . . 0.0 112.462 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -58.24 -29.41 65.73 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.281 -1.512 . . . . 0.0 114.598 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.73 -23.78 61.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.89 1.276 . . . . 0.0 111.994 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -76.12 -31.02 58.43 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.314 -0.866 . . . . 0.0 111.065 168.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -80.55 -32.18 36.76 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.25 -45.04 68.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.268 1.427 . . . . 0.0 113.005 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -58.12 -34.97 70.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.528 1.131 . . . . 0.0 113.067 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.5 m -72.5 -50.21 27.55 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 127.029 2.132 . . . . 0.0 109.345 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -60.93 -43.29 98.83 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.787 0.435 . . . . 0.0 111.2 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.46 -38.3 80.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.03 -50.72 65.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.566 0.621 . . . . 0.0 111.371 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.68 -48.75 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.067 0.947 . . . . 0.0 110.783 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -61.93 -40.55 95.89 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.292 1.437 . . . . 0.0 113.091 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.2 tp -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.6 0.636 . . . . 0.0 111.484 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -34.99 48.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.543 -0.723 . . . . 0.0 112.665 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.39 -40.81 98.24 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.839 0.855 . . . . 0.0 111.16 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.09 -35.43 80.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 112.143 172.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.87 -21.59 60.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.723 1.209 . . . . 0.0 113.138 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.38 -5.43 44.82 Favored Glycine 0 N--CA 1.48 1.585 0 C-N-CA 126.16 1.838 . . . . 0.0 114.943 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -97.82 82.8 3.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.832 1.253 . . . . 0.0 111.54 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.56 -48.2 82.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.506 0.722 . . . . 0.0 112.469 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -54.57 -53.62 52.16 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.283 0.492 . . . . 0.0 111.644 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.81 -41.21 77.35 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.591 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.92 -36.76 65.22 Favored Glycine 0 N--CA 1.472 1.075 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.775 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.5 -52.07 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.536 0.668 . . . . 0.0 109.995 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.74 -45.18 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.647 0.779 . . . . 0.0 111.585 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.6 -45.65 93.22 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.343 1.457 . . . . 0.0 111.3 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.91 -36.84 91.65 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.742 0.686 . . . . 0.0 113.388 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.22 -51.58 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.461 1.104 . . . . 0.0 110.424 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.43 -41.03 98.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.234 1.014 . . . . 0.0 111.856 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.08 -39.56 78.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.34 0.656 . . . . 0.0 112.586 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.08 96.13 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.632 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.7 -49.36 78.26 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-N 119.162 0.892 . . . . 0.0 112.004 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.32 -34.45 73.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.692 1.246 . . . . 0.0 113.793 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.92 -46.52 15.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.368 0.667 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -59.52 -37.59 78.74 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 110.675 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.99 -15.66 57.0 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -76.57 -33.73 58.47 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.512 -1.368 . . . . 0.0 111.295 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -81.58 -39.78 24.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.061 1.344 . . . . 0.0 111.224 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.54 79.52 72.04 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.752 2.021 . . . . 0.0 111.501 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 138.35 39.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.229 2.62 . . . . 0.0 112.192 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.7 t90 -64.87 135.88 56.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.37 151.86 30.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.799 1.639 . . . . 0.0 111.605 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -69.99 -3.09 14.66 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.542 -1.349 . . . . 0.0 114.353 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -115.86 7.4 14.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.151 1.781 . . . . 0.0 112.576 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -58.22 148.62 26.48 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.434 1.093 . . . . 0.0 112.236 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 111.317 -169.047 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 CA-C-O 121.103 0.376 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 140' ' ' ASN . 1.3 p30 -61.15 -7.07 2.37 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.612 2.365 . . . . 0.0 116.836 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.2 m -58.11 152.5 16.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.584 1.154 . . . . 0.0 111.788 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.45 130.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.648 1.179 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t -88.11 141.34 28.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.404 0.682 . . . . 0.0 110.651 171.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -151.7 135.39 16.3 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 116.595 -2.225 . . . . 0.0 114.164 -174.295 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -77.17 166.15 23.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.23 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.847 -1.158 . . . . 0.0 111.726 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.3 -48.08 82.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.733 1.213 . . . . 0.0 110.917 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.9 -39.91 72.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.479 1.111 . . . . 0.0 111.235 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.87 -46.45 74.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.044 1.338 . . . . 0.0 112.325 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -56.91 -47.31 80.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.448 -1.408 . . . . 0.0 111.081 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.89 84.8 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 tt -74.16 -35.84 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.047 -1.033 . . . . 0.0 112.171 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.42 -42.86 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.625 1.102 . . . . 0.0 111.392 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.92 -27.42 68.17 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.22 -43.37 74.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.474 0.579 . . . . 0.0 111.548 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.63 -43.75 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.391 0.677 . . . . 0.0 110.256 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -60.31 -25.57 65.87 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.97 -36.27 23.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.256 1.389 . . . . 0.0 111.986 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.53 97.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.175 0.99 . . . . 0.0 112.198 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.72 -4.63 9.42 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -106.85 11.76 29.69 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.009 -1.682 . . . . 0.0 112.529 170.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.77 -6.44 5.09 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.65 1.98 . . . . 0.0 114.084 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -164.3 151.4 11.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.148 2.179 . . . . 0.0 109.729 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -88.11 11.57 15.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.742 1.217 . . . . 0.0 113.853 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.41 133.13 10.37 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 125.742 1.639 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -104.19 138.21 40.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.349 1.06 . . . . 0.0 112.642 -155.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.03 139.66 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 120.356 -1.465 . . . . 0.0 111.247 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -139.13 146.45 40.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.932 1.693 . . . . 0.0 111.296 -176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.76 136.26 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.929 1.291 . . . . 0.0 109.608 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -122.3 120.3 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.272 1.429 . . . . 0.0 113.058 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.55 125.23 54.03 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.557 1.143 . . . . 0.0 111.392 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -154.08 160.63 42.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.961 1.304 . . . . 0.0 109.983 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.26 -72.1 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 m -143.26 165.19 28.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.363 2.265 . . . . 0.0 107.892 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.7 m -124.7 155.85 38.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.315 1.046 . . . . 0.0 110.46 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.94 -1.75 57.79 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 pt -134.55 -131.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 126.57 1.948 . . . . 0.0 111.181 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -101.77 142.11 33.6 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.438 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.18 -36.0 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.006 0.522 . . . . 0.0 111.84 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.49 -50.39 71.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.743 0.817 . . . . 0.0 111.937 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.26 -33.46 75.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.106 0.563 . . . . 0.0 111.47 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -65.66 -46.63 78.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.902 0.881 . . . . 0.0 112.568 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.15 90.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.664 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -59.12 -49.9 76.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.337 0.655 . . . . 0.0 111.715 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.4 -45.89 91.1 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.759 -0.588 . . . . 0.0 111.717 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.38 -35.17 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.715 -0.659 . . . . 0.0 110.785 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.7 -50.56 73.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.536 1.062 . . . . 0.0 111.718 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -72.72 -34.46 67.1 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.436 0.695 . . . . 0.0 111.608 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -70.37 -26.74 63.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.56 6.91 47.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.355 1.462 . . . . 0.0 112.425 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 60.92 26.39 16.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.625 1.57 . . . . 0.0 112.284 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.0 -18.1 60.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.723 1.209 . . . . 0.0 112.326 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -74.06 -8.21 55.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.424 2.29 . . . . 0.0 113.756 169.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -98.83 82.69 2.82 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 121.562 -0.711 . . . . 0.0 110.474 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.5 p -139.2 152.82 47.67 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.044 1.337 . . . . 0.0 110.501 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -57.86 -37.34 73.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.9 mt -105.96 -7.95 17.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.61 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 70.94 29.26 3.05 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.953 1.301 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -105.41 35.11 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.094 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.75 117.0 4.79 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.127 -0.818 . . . . 0.0 111.851 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.6 t -98.98 139.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.583 1.553 . . . . 0.0 110.232 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.5 tp -129.16 133.94 47.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.29 100.12 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.705 1.202 . . . . 0.0 109.409 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.58 128.0 32.91 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.072 -1.018 . . . . 0.0 109.994 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -124.26 127.52 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.911 0.884 . . . . 0.0 110.657 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.11 95.12 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.542 1.537 . . . . 0.0 110.035 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.42 -21.0 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -165.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.64 -28.69 45.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.51 1.05 . . . . 0.0 111.825 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -97.47 -4.99 37.02 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.443 1.097 . . . . 0.0 112.714 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 61.39 23.01 13.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.996 1.718 . . . . 0.0 112.003 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -105.36 169.02 8.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.597 1.559 . . . . 0.0 110.781 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -146.73 143.95 29.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.173 1.789 . . . . 0.0 108.749 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.8 140.43 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.146 1.378 . . . . 0.0 107.299 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.3 mt -118.68 133.34 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -139.4 138.18 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.259 1.423 . . . . 0.0 109.128 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.85 155.42 21.21 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -66.72 172.48 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 123.556 1.646 . . . . 0.0 111.82 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -61.45 -33.56 73.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.64 -1.172 . . . . 0.0 112.707 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -48.7 76.39 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 120.242 1.383 . . . . 0.0 112.31 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.97 -56.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.202 1.001 . . . . 0.0 109.774 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.6 -24.71 66.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -78.25 -38.36 43.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.014 1.325 . . . . 0.0 110.397 173.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 88' ' ' VAL . 2.0 p -90.8 -29.22 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 87' ' ' VAL . 2.9 m -119.89 156.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.842 1.656 . . . . 0.0 113.004 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.7 m -102.36 172.72 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.531 1.533 . . . . 0.0 114.803 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -61.12 -34.33 74.8 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.88 -24.42 67.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 0.0 113.029 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 47.6 t80 -77.22 -39.36 48.83 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.18 -0.95 . . . . 0.0 111.281 171.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -70.85 -29.62 65.79 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.191 1.396 . . . . 0.0 114.108 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.62 -37.97 74.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.505 0.722 . . . . 0.0 112.759 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 m -62.05 -43.57 98.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.696 0.798 . . . . 0.0 111.086 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -59.11 -53.81 54.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.673 1.989 . . . . 0.0 110.583 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -56.68 -50.26 72.66 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.659 1.184 . . . . 0.0 111.204 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -57.91 -36.44 72.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.248 1.019 . . . . 0.0 113.621 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.46 20.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.788 0.835 . . . . 0.0 112.019 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.12 -49.54 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.187 0.995 . . . . 0.0 109.639 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.3 -42.54 91.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.118 1.367 . . . . 0.0 113.382 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.64 -45.44 90.19 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.063 0.545 . . . . 0.0 110.869 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.02 -29.35 55.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.16 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.51 -39.64 81.16 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.358 0.981 . . . . 0.0 111.481 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.85 -43.54 94.58 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.555 0.742 . . . . 0.0 111.09 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.49 -35.23 79.77 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.991 -0.528 . . . . 0.0 111.935 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.88 10.28 24.89 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.834 1.683 . . . . 0.0 114.674 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.79 83.44 2.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -62.52 -39.62 94.15 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.764 1.225 . . . . 0.0 112.705 -171.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -54.78 -56.01 23.97 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -60.81 -42.21 97.19 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.904 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.93 -41.58 97.32 Favored Glycine 0 N--CA 1.473 1.101 0 CA-C-N 120.187 1.358 . . . . 0.0 112.378 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.63 -47.21 73.31 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.547 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.32 -48.49 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 118.852 0.751 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -63.41 -35.36 80.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.982 0.81 . . . . 0.0 112.021 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.91 -43.98 92.7 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.067 -0.852 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.9 -47.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.929 1.292 . . . . 0.0 111.362 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.98 -49.51 77.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.712 0.805 . . . . 0.0 111.504 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -65.28 -38.73 91.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.828 -0.545 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.39 74.08 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.844 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.15 87.57 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 119.669 1.122 . . . . 0.0 112.469 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.3 mtp -58.36 -42.22 86.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.987 0.894 . . . . 0.0 112.908 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.23 -41.69 57.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.501 0.721 . . . . 0.0 111.586 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.1 mt -62.07 -36.58 82.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.795 1.238 . . . . 0.0 111.131 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.05 -18.22 32.82 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -70.99 -34.58 71.52 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.246 -1.534 . . . . 0.0 112.198 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -90.12 -35.78 15.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.37 1.468 . . . . 0.0 112.981 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -131.89 85.2 51.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.937 1.695 . . . . 0.0 110.044 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.52 147.47 93.1 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.381 2.054 . . . . 0.0 110.497 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -69.54 146.68 51.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.332 1.063 . . . . 0.0 111.783 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -134.73 151.17 50.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.604 1.161 . . . . 0.0 109.611 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.42 -35.95 72.85 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.373 -0.83 . . . . 0.0 112.814 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -90.32 18.09 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.881 1.672 . . . . 0.0 113.224 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.31 151.12 28.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.094 1.358 . . . . 0.0 113.203 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.484 1.226 0 C-N-CA 125.626 1.57 . . . . 0.0 113.332 -154.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 CA-C-O 121.763 0.651 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -74.13 3.39 7.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.4 p -70.65 156.33 39.6 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 128.21 2.604 . . . . 0.0 112.487 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 84.2 mt -78.26 134.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.699 1.2 . . . . 0.0 108.406 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.3 m -91.93 142.14 27.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.464 0.649 . . . . 0.0 109.458 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -129.8 151.15 50.69 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.171 -0.956 . . . . 0.0 110.698 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.966 0 C-N-CA 126.192 1.853 . . . . 0.0 113.76 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -74.65 167.29 22.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.148 0.431 . . . . 0.0 110.214 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.74 58.57 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 113.21 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -55.2 -41.79 72.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.291 1.436 . . . . 0.0 113.278 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.14 -42.69 25.61 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 110.63 -173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -62.69 -45.14 94.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.362 1.065 . . . . 0.0 111.373 172.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -57.74 -47.55 82.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.344 -0.847 . . . . 0.0 111.888 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.75 88.51 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.347 1.059 . . . . 0.0 113.438 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.18 -41.64 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 117.935 -1.031 . . . . 0.0 112.269 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.53 -42.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.783 1.174 . . . . 0.0 111.464 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.37 -28.73 69.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.138 0.881 . . . . 0.0 113.149 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.98 67.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.93 0.786 . . . . 0.0 112.015 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mm -64.78 -50.51 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.91 0.884 . . . . 0.0 110.127 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -54.28 -29.28 46.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.33 1.052 . . . . 0.0 113.475 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -83.19 -30.2 27.95 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.019 1.328 . . . . 0.0 112.185 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.0 75.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.69 1.132 . . . . 0.0 111.424 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.13 2.34 0.81 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.606 1.562 . . . . 0.0 114.099 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.79 5.41 24.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 119.39 -2.069 . . . . 0.0 113.031 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -126.96 -8.08 6.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.72 1.608 . . . . 0.0 113.522 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -160.07 161.29 33.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.235 1.814 . . . . 0.0 109.157 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -99.04 10.79 40.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.57 172.49 17.64 Favored Glycine 0 N--CA 1.473 1.16 0 O-C-N 120.549 -1.344 . . . . 0.0 110.823 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -123.67 122.24 37.61 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 122.803 0.441 . . . . 0.0 111.67 -160.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 mt -108.71 112.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.336 1.054 . . . . 0.0 110.693 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -123.24 151.1 42.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.754 0.822 . . . . 0.0 113.19 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 t -130.52 134.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.581 1.153 . . . . 0.0 109.008 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -122.11 121.99 38.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 111.991 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 35' ' ' LEU . 13.8 tp -107.16 132.37 53.11 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.178 0.991 . . . . 0.0 111.462 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -160.23 155.18 24.48 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.786 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.35 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.744 1.218 . . . . 0.0 113.233 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.6 t -137.47 169.76 17.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.193 1.797 . . . . 0.0 110.316 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 p -123.23 157.26 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.501 1.52 . . . . 0.0 113.162 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -90.75 -9.85 45.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.955 1.302 . . . . 0.0 113.293 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 -141.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.049 1.739 . . . . 0.0 111.159 -164.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -102.42 135.24 44.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.634 1.561 . . . . 0.0 112.266 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -62.47 -38.97 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.019 0.928 . . . . 0.0 112.099 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.02 0.827 . . . . 0.0 111.856 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.44 -39.88 85.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.804 0.842 . . . . 0.0 110.781 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -59.02 -47.53 84.86 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.583 -0.698 . . . . 0.0 111.788 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.97 -42.28 99.78 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.604 0.762 . . . . 0.0 110.978 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -58.55 -53.91 52.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.556 1.142 . . . . 0.0 111.247 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -64.63 -37.15 86.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.776 -1.203 . . . . 0.0 112.054 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.85 -47.22 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.346 1.058 . . . . 0.0 111.326 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -56.71 -45.92 81.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.421 1.488 . . . . 0.0 111.987 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -73.39 -40.47 64.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.834 1.254 . . . . 0.0 112.979 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -63.89 -39.31 93.89 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.992 0.815 . . . . 0.0 112.378 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.52 0.23 20.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 113.418 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 62.33 24.41 14.53 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.036 1.334 . . . . 0.0 113.271 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.69 -30.09 68.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 0.0 112.412 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -49.73 -31.14 10.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.073 1.749 . . . . 0.0 112.601 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -77.67 65.05 3.08 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.085 -1.01 . . . . 0.0 113.02 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.0 m -118.9 134.78 54.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.155 2.182 . . . . 0.0 106.705 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.32 -44.5 72.08 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.826 1.194 . . . . 0.0 112.776 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.64 -2.27 58.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 114.017 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 66.2 19.37 11.08 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.727 1.211 . . . . 0.0 113.222 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -99.33 46.83 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.211 1.005 . . . . 0.0 112.061 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.19 121.45 6.71 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.775 1.179 . . . . 0.0 111.907 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.39 140.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 118.311 1.056 . . . . 0.0 109.567 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 tp -120.97 127.16 51.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.985 0.898 . . . . 0.0 111.5 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.1 mt -102.75 97.59 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.492 1.517 . . . . 0.0 108.31 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -82.1 125.3 30.69 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.604 -0.685 . . . . 0.0 110.514 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.11 131.07 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.729 -0.607 . . . . 0.0 110.695 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 100.15 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.892 1.677 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.6 m -80.52 -14.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -81.26 -49.45 10.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.057 0.844 . . . . 0.0 110.58 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -76.09 -16.84 59.84 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.818 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 67.93 41.41 2.11 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.955 1.702 . . . . 0.0 111.172 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.1 p -119.26 172.33 7.67 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.486 1.914 . . . . 0.0 110.245 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -154.74 134.27 12.69 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.005 0.922 . . . . 0.0 109.597 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.17 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.085 1.754 . . . . 0.0 108.214 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.8 mt -125.99 136.9 59.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -154.92 121.29 5.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.225 1.41 . . . . 0.0 109.086 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.99 168.27 12.52 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 124.15 0.881 . . . . 0.0 111.178 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -69.84 165.61 21.17 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.126 1.441 . . . . 0.0 112.278 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.23 -33.29 8.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.93 2.092 . . . . 0.0 113.588 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.67 -44.2 98.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 120.885 1.675 . . . . 0.0 112.296 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.2 -56.53 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.371 1.086 . . . . 0.0 109.787 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -57.43 -31.28 65.73 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.34 -14.75 42.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.572 1.549 . . . . 0.0 113.161 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.95 -18.45 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.01 172.6 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.789 1.177 . . . . 0.0 111.943 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.3 p -118.17 175.67 5.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.949 1.7 . . . . 0.0 113.725 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.75 -21.16 65.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 119.675 -1.891 . . . . 0.0 112.96 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.2 -29.02 66.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.521 1.128 . . . . 0.0 111.936 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.432 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 65.1 t80 -79.02 -32.75 45.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 111.907 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -80.0 -30.02 39.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.452 1.501 . . . . 0.0 114.035 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.37 -33.63 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.941 0.791 . . . . 0.0 112.42 -174.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 p -65.36 -42.87 92.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.69 0.796 . . . . 0.0 111.162 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.0 m -57.83 -49.42 76.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 111.497 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -58.05 -50.93 71.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.985 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -60.22 -37.56 80.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.69 58.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.171 0.896 . . . . 0.0 111.549 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.01 -48.54 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.421 0.688 . . . . 0.0 110.727 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -58.64 -40.86 84.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.576 1.55 . . . . 0.0 113.893 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.01 -45.23 67.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.889 0.768 . . . . 0.0 111.152 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -35.61 74.64 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.038 0.535 . . . . 0.0 111.629 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.961 0.801 . . . . 0.0 111.57 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -59.34 -39.26 82.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.858 0.753 . . . . 0.0 111.533 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -74.68 -22.49 58.83 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.893 0.877 . . . . 0.0 112.363 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.11 55.07 Favored Glycine 0 N--CA 1.48 1.6 0 C-N-CA 125.1 1.333 . . . . 0.0 114.162 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -96.09 71.37 2.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.878 1.271 . . . . 0.0 111.369 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -55.88 -46.06 78.39 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -51.24 -57.52 8.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.89 0.876 . . . . 0.0 111.014 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -59.99 -42.73 94.85 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.492 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.68 95.57 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 119.866 1.212 . . . . 0.0 113.225 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 mt -69.09 -48.61 62.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.57 0.685 . . . . 0.0 111.341 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.88 -53.2 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.76 0.709 . . . . 0.0 111.605 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.42 -35.69 81.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.078 0.951 . . . . 0.0 111.858 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.18 -38.05 63.41 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 121.378 -0.827 . . . . 0.0 112.824 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.38 -42.77 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.009 1.324 . . . . 0.0 111.378 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -55.38 -52.45 63.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.694 1.198 . . . . 0.0 110.579 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -65.57 -34.71 78.89 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.09 90.81 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.338 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.42 -44.99 97.03 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 119.431 -0.649 . . . . 0.0 112.286 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.4 mtp -59.85 -42.47 93.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.395 1.097 . . . . 0.0 113.59 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.37 -44.56 51.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.741 0.816 . . . . 0.0 111.129 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.03 -36.64 84.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.408 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.92 -26.87 62.78 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.059 0.944 . . . . 0.0 113.327 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -65.66 -34.78 79.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.401 -1.437 . . . . 0.0 111.472 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.82 -39.9 23.33 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.796 1.238 . . . . 0.0 111.879 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.08 79.51 73.75 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.607 1.563 . . . . 0.0 111.454 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.98 135.32 27.28 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.628 2.218 . . . . 0.0 110.959 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -56.89 147.9 22.36 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -125.62 150.48 47.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.479 1.112 . . . . 0.0 110.157 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -67.14 -26.09 66.5 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.053 -1.655 . . . . 0.0 113.235 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.14 9.11 34.93 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.241 2.216 . . . . 0.0 112.206 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -58.13 138.96 55.71 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 126.132 1.773 . . . . 0.0 113.282 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.19 0 C-N-CA 124.571 1.148 . . . . 0.0 110.597 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.459 -0.511 0 N-CA-C 109.51 -0.996 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -71.63 -4.94 29.97 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -60.68 140.15 57.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.089 2.155 . . . . 0.0 111.207 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.7 mt -64.59 140.21 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.012 1.325 . . . . 0.0 110.392 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 m -96.57 143.46 27.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.191 0.596 . . . . 0.0 110.452 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -143.79 137.24 27.9 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.364 -0.835 . . . . 0.0 110.551 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.392 0 CA-C-O 117.984 -1.454 . . . . 0.0 112.649 176.155 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 t -66.73 -36.27 82.08 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.383 1.473 . . . . 0.0 112.043 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -81.05 109.23 15.42 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.51 -1.369 . . . . 0.0 110.812 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.1 pt -81.57 -16.37 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -64.49 -33.77 76.67 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.787 1.635 . . . . 0.0 113.857 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -135.97 108.17 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.716 1.207 . . . . 0.0 108.448 -173.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 71' ' ' VAL . 88.4 m-85 -65.1 -26.79 68.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.426 1.091 . . . . 0.0 113.865 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.0 mt -137.21 149.6 47.3 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.999 1.32 . . . . 0.0 108.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -80.15 164.23 23.48 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.762 -1.211 . . . . 0.0 110.364 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.09 65.06 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.34 -44.12 97.72 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.392 1.477 . . . . 0.0 111.572 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -74.77 -43.19 56.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.163 0.985 . . . . 0.0 111.013 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.32 -47.53 83.83 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.586 1.554 . . . . 0.0 111.289 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.11 -47.46 78.07 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.13 -0.981 . . . . 0.0 111.296 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.46 69.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 tt -80.02 -39.01 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 120.196 1.362 . . . . 0.0 112.715 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.5 t -58.64 -43.28 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 120.145 1.339 . . . . 0.0 110.808 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -62.23 -27.94 69.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.96 69.79 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.48 -0.762 . . . . 0.0 112.672 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.36 -42.8 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.211 1.005 . . . . 0.0 109.612 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -56.47 -34.26 66.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.061 1.344 . . . . 0.0 113.493 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.49 -24.93 41.98 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.58 58.77 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.424 1.011 . . . . 0.0 111.952 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -54.74 -28.53 49.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.088 1.355 . . . . 0.0 112.267 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.69 6.58 37.82 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.719 -1.863 . . . . 0.0 112.623 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.49 -15.01 6.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 113.922 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 t -160.95 140.06 10.34 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.186 1.394 . . . . 0.0 109.541 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -80.63 39.01 0.46 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.313 1.045 . . . . 0.0 112.727 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.97 158.0 27.03 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 125.536 1.541 . . . . 0.0 110.892 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -117.34 142.91 46.52 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -155.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.83 97.81 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.592 1.157 . . . . 0.0 111.084 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -106.9 145.05 32.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.659 1.184 . . . . 0.0 111.856 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.61 133.54 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.066 1.346 . . . . 0.0 109.243 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -119.15 115.96 25.34 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.939 1.296 . . . . 0.0 111.927 168.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.2 tp -103.52 126.92 50.95 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.323 1.049 . . . . 0.0 111.315 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -146.65 162.15 39.05 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.663 1.22 . . . . 0.0 111.396 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.471 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -68.33 -77.15 0.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.464 1.106 . . . . 0.0 112.013 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 t -153.69 165.23 36.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.648 1.979 . . . . 0.0 109.902 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.5 m -115.33 154.66 28.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.325 1.45 . . . . 0.0 111.235 -173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -92.06 -13.48 30.8 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.054 -1.029 . . . . 0.0 112.645 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.3 pt -130.37 -163.72 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.126 1.77 . . . . 0.0 110.702 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -72.52 136.57 45.9 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.405 0.622 . . . . 0.0 112.464 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.53 -35.14 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.98 0.912 . . . . 0.0 111.716 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -63.57 -54.89 28.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.299 0.954 . . . . 0.0 112.423 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -63.14 -39.26 94.15 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.647 0.779 . . . . 0.0 111.184 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -61.45 -45.22 95.19 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.713 -0.617 . . . . 0.0 111.754 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.43 94.39 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.824 0.738 . . . . 0.0 111.277 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.9 ttp -62.52 -43.0 99.88 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 112.386 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.3 -48.65 77.2 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.953 -1.092 . . . . 0.0 111.748 173.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.6 -42.53 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.899 0.88 . . . . 0.0 111.789 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -57.3 -49.15 77.0 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.536 1.135 . . . . 0.0 111.157 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -71.59 -38.03 70.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.202 1.001 . . . . 0.0 112.056 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.9 -43.15 93.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.104 1.362 . . . . 0.0 112.773 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.05 -3.62 20.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.193 0.997 . . . . 0.0 112.901 171.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.8 tttt 64.76 38.21 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.648 1.979 . . . . 0.0 112.296 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.7 mtp -77.04 -12.78 59.98 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -0.89 7.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.226 1.01 . . . . 0.0 113.057 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -74.48 31.08 0.09 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.633 1.973 . . . . 0.0 114.457 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -99.87 156.16 17.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.682 1.993 . . . . 0.0 110.881 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -73.85 -30.48 62.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.454 1.102 . . . . 0.0 112.429 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.14 -7.21 16.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 67.33 47.41 1.29 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.964 1.306 . . . . 0.0 110.851 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -137.97 40.45 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.323 1.049 . . . . 0.0 113.607 -164.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.54 142.68 16.19 Favored Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 167.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.72 144.44 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.594 1.158 . . . . 0.0 110.463 169.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.1 tp -117.2 129.25 55.82 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.167 1.387 . . . . 0.0 109.939 164.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.8 mt -103.23 96.85 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.11 119.0 21.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.193 0.597 . . . . 0.0 110.114 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.66 129.78 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.703 0.801 . . . . 0.0 110.143 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.11 102.88 12.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.717 1.207 . . . . 0.0 109.256 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 7' ' ' PHE . 33.3 m -70.91 -22.18 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -170.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.14 -49.42 23.8 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.229 0.538 . . . . 0.0 111.689 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.37 -15.08 56.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.455 1.102 . . . . 0.0 111.729 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.6 tttt 75.23 19.8 2.17 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.517 2.327 . . . . 0.0 112.415 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.1 p -98.13 162.59 13.13 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 111.785 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.87 139.32 36.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.741 1.217 . . . . 0.0 109.679 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.59 147.62 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.516 1.527 . . . . 0.0 107.786 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 mt -130.38 125.96 60.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -139.04 120.76 15.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.929 0.892 . . . . 0.0 110.244 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.3 152.91 17.63 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 125.523 1.535 . . . . 0.0 111.025 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -66.75 164.57 16.81 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 123.141 1.448 . . . . 0.0 111.654 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -53.54 -37.6 62.99 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 114.39 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.7 -18.92 70.73 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.47 1.033 . . . . 0.0 113.807 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.9 mt -81.12 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.122 1.461 . . . . 0.0 108.783 167.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -53.52 -37.6 62.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.657 0.783 . . . . 0.0 113.032 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.14 -17.46 58.59 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.719 1.207 . . . . 0.0 113.011 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.14 -21.62 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.9 m -114.9 179.47 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 119.756 1.162 . . . . 0.0 111.838 175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 64.1 p -121.98 171.1 9.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.368 1.867 . . . . 0.0 112.392 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.0 -29.09 70.56 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.864 -1.147 . . . . 0.0 112.448 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.3 -38.81 91.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.893 1.277 . . . . 0.0 111.537 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 52.1 t80 -63.65 -46.13 87.04 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.376 0.67 . . . . 0.0 110.351 172.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -67.51 -26.38 66.31 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.244 1.418 . . . . 0.0 114.63 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.81 -39.59 74.44 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.444 1.098 . . . . 0.0 111.613 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -61.21 -47.12 87.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.636 0.774 . . . . 0.0 111.807 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 m -58.31 -50.34 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.269 1.828 . . . . 0.0 110.413 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -59.13 -51.05 71.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.393 1.077 . . . . 0.0 111.994 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -61.34 -41.28 96.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.014 0.824 . . . . 0.0 112.698 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.53 79.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.897 0.771 . . . . 0.0 112.928 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.2 mt -68.97 -50.37 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.52 1.128 . . . . 0.0 110.956 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -53.87 -48.03 70.45 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.619 1.167 . . . . 0.0 111.403 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.67 -33.41 75.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -85.61 -38.14 18.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.32 -37.21 79.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.506 0.594 . . . . 0.0 111.432 168.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -66.19 -27.27 67.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.969 1.308 . . . . 0.0 113.387 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.71 -32.65 53.08 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.896 0.771 . . . . 0.0 110.445 168.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.01 3.18 26.52 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 126.636 2.065 . . . . 0.0 114.252 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.49 84.17 2.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.492 1.146 . . . . 0.0 111.109 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -56.94 -41.52 78.39 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.813 0.845 . . . . 0.0 112.585 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -56.93 -57.65 11.58 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.467 -0.771 . . . . 0.0 112.465 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.46 -43.15 83.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 118.861 -0.59 . . . . 0.0 111.223 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.2 98.42 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 119.351 0.978 . . . . 0.0 113.618 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.73 -48.43 66.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.755 -1.117 . . . . 0.0 111.035 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.03 -48.36 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.309 1.044 . . . . 0.0 112.241 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -67.3 -34.68 77.9 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.266 0.485 . . . . 0.0 111.688 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.58 -41.05 90.55 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 119.066 -0.852 . . . . 0.0 111.228 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.07 -44.39 98.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.663 1.185 . . . . 0.0 109.617 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.17 -51.78 65.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.877 0.871 . . . . 0.0 111.976 -178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.96 -41.78 95.18 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.615 0.766 . . . . 0.0 111.269 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.79 -49.23 78.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.554 0.742 . . . . 0.0 110.928 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.5 -46.53 87.78 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.01 0.823 . . . . 0.0 112.108 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.7 mtp -65.55 -35.96 82.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.049 0.925 . . . . 0.0 113.087 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.483 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.93 -44.6 61.01 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.627 0.771 . . . . 0.0 111.112 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.85 -37.36 85.99 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.371 1.468 . . . . 0.0 111.46 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.33 -18.51 11.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.392 1.477 . . . . 0.0 114.355 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -72.43 -40.88 66.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.33 -1.481 . . . . 0.0 112.105 170.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -85.9 -28.89 24.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.735 1.214 . . . . 0.0 112.276 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -136.58 76.62 47.96 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.668 1.987 . . . . 0.0 108.669 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -64.83 143.1 78.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.841 1.694 . . . . 0.0 110.498 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -63.1 143.89 57.38 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -118.99 144.84 46.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.412 1.485 . . . . 0.0 109.402 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -60.71 -32.95 72.18 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 112.636 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -82.93 5.43 21.96 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.881 1.272 . . . . 0.0 113.446 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -58.84 150.46 23.95 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.013 0.925 . . . . 0.0 112.943 -172.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp -123.63 138.06 54.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-O 122.721 1.248 . . . . 0.0 111.509 -165.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -98.57 101.24 12.61 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.052 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -95.55 -37.46 10.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.428 1.491 . . . . 0.0 113.195 -166.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.87 165.4 13.32 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.125 0.97 . . . . 0.0 110.353 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -99.41 157.13 0.59 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 124.248 3.298 . . . . 0.0 112.344 170.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -77.84 -10.23 59.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.2 m -57.3 131.24 49.45 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.363 1.465 . . . . 0.0 109.72 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.4 mt -69.03 137.76 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 121.43 -0.794 . . . . 0.0 108.863 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 70.7 m -92.28 142.92 26.94 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.422 -0.798 . . . . 0.0 111.844 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.86 150.68 52.14 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.424 1.09 . . . . 0.0 110.568 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 CA-C-O 117.651 -1.638 . . . . 0.0 111.714 170.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 m -66.95 146.24 54.6 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 121.012 1.733 . . . . 0.0 110.833 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -56.27 -30.37 62.37 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.089 -1.007 . . . . 0.0 113.59 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.0 mt -65.25 -61.51 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.846 1.658 . . . . 0.0 109.904 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.93 -20.51 63.87 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.011 2.124 . . . . 0.0 113.414 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -68.53 -36.31 78.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.881 1.272 . . . . 0.0 111.835 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -81.15 -63.63 1.36 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.098 0.959 . . . . 0.0 110.659 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.4 mt -145.24 146.55 31.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.176 1.791 . . . . 0.0 108.895 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 p -75.11 167.39 22.02 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -30.6 64.34 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.772 -1.205 . . . . 0.0 112.759 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -66.94 -36.0 81.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.17 1.388 . . . . 0.0 111.701 173.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.71 -45.46 13.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.32 1.048 . . . . 0.0 111.228 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -60.96 -40.95 95.32 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.802 1.241 . . . . 0.0 111.166 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.14 -48.15 81.14 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.163 -0.961 . . . . 0.0 112.07 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.25 97.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.2 tt -72.01 -35.46 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.52 -32.76 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 119.014 0.825 . . . . 0.0 111.462 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.92 -35.99 75.0 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.342 -0.849 . . . . 0.0 112.588 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.44 -43.82 93.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.926 0.49 . . . . 0.0 111.388 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.38 -48.02 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.816 0.846 . . . . 0.0 110.814 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -55.08 -33.73 63.01 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.85 -25.74 32.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.94 -41.91 81.79 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.091 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -73.27 14.65 0.3 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.699 1.2 . . . . 0.0 113.373 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -116.96 3.21 12.81 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.892 -1.755 . . . . 0.0 112.272 166.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -121.26 -18.36 7.4 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.23 1.412 . . . . 0.0 113.207 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -144.14 163.43 33.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.559 2.343 . . . . 0.0 108.771 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.2 p -100.83 31.41 3.57 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.53 1.532 . . . . 0.0 112.384 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -138.88 118.06 1.5 Allowed Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.352 -1.468 . . . . 0.0 111.902 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -85.21 137.11 33.21 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -156.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.18 119.83 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 123.003 1.382 . . . . 0.0 111.485 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 -124.74 151.68 44.76 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.308 1.443 . . . . 0.0 112.452 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.71 144.3 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.011 1.724 . . . . 0.0 110.692 171.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.617 ' HB2' HD11 ' A' ' 66' ' ' LEU . 27.6 t60 -125.12 122.4 37.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.566 1.146 . . . . 0.0 111.145 167.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.1 tp -107.09 130.64 54.65 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.558 -175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 37' ' ' LYS . 14.8 tt0 -146.87 169.2 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.892 1.33 . . . . 0.0 110.682 173.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 65.4 mttt -78.85 -73.36 0.34 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.393 1.077 . . . . 0.0 112.508 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -148.42 142.97 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.574 1.949 . . . . 0.0 109.247 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 85.8 p -86.84 146.81 26.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.965 0.888 . . . . 0.0 112.484 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 -10.61 38.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.235 1.014 . . . . 0.0 112.301 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -134.5 -163.46 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 128.392 2.677 . . . . 0.0 108.946 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.31 138.62 55.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.678 -1.264 . . . . 0.0 112.072 174.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.92 -37.6 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.366 0.666 . . . . 0.0 111.794 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.46 -52.56 64.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.581 0.752 . . . . 0.0 112.197 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -67.02 -39.65 87.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.91 0.484 . . . . 0.0 111.178 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -58.81 -47.04 86.2 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.118 -0.989 . . . . 0.0 112.118 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.75 96.76 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.568 0.747 . . . . 0.0 111.419 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 ttp -62.37 -43.75 98.07 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 111.815 173.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.07 -46.59 86.74 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.254 -0.904 . . . . 0.0 112.021 174.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.13 -43.62 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.042 0.937 . . . . 0.0 111.538 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.22 -46.66 85.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.335 1.054 . . . . 0.0 111.808 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -75.69 -35.78 60.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.887 1.275 . . . . 0.0 112.278 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -63.84 -44.07 94.28 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.429 -1.419 . . . . 0.0 111.159 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -72.75 -6.38 44.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.714 1.205 . . . . 0.0 113.268 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 62.33 41.14 10.55 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.452 ' SD ' HD13 ' A' ' 66' ' ' LEU . 72.3 mtp -73.29 -22.54 60.34 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.43 -8.74 6.6 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.342 1.457 . . . . 0.0 114.046 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -73.37 62.95 0.74 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.179 1.792 . . . . 0.0 110.793 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -133.4 140.32 47.27 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.613 1.165 . . . . 0.0 110.581 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -58.16 -43.64 87.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 111.889 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.3 mt -94.82 -3.68 48.51 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.57 1.148 . . . . 0.0 113.882 -176.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 59.73 57.06 3.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.04 28.94 3.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.133 0.973 . . . . 0.0 112.255 -168.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.87 131.57 10.48 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.393 -0.817 . . . . 0.0 111.206 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.6 t -102.65 138.79 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.268 1.027 . . . . 0.0 110.321 168.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' HIS . 17.8 tp -119.04 121.54 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.062 1.345 . . . . 0.0 110.963 164.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.4 mt -97.25 101.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -81.93 125.19 30.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.256 0.622 . . . . 0.0 110.917 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.1 129.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 118.753 0.706 . . . . 0.0 111.406 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.27 100.78 12.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.894 1.678 . . . . 0.0 110.273 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.27 -12.48 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.88 -54.49 5.54 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.474 -0.766 . . . . 0.0 110.495 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.33 -11.85 59.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.179 0.992 . . . . 0.0 112.315 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt 71.68 27.27 2.95 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.6 2.36 . . . . 0.0 112.356 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.8 m -106.06 134.36 49.31 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.995 1.318 . . . . 0.0 110.53 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -106.41 143.78 34.04 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 110.199 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.2 t -134.36 143.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 126.505 1.922 . . . . 0.0 108.259 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.0 mt -123.63 130.12 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -140.62 132.54 27.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.996 1.319 . . . . 0.0 110.026 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.52 163.68 21.2 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 123.872 0.749 . . . . 0.0 111.309 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.69 161.31 4.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.899 1.333 . . . . 0.0 114.121 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.4 -35.61 65.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.522 1.529 . . . . 0.0 113.777 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.37 -27.95 73.06 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 120.259 1.39 . . . . 0.0 112.939 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.6 mt -69.43 -60.18 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.2 1.5 . . . . 0.0 109.425 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -52.01 -37.57 53.78 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.71 0.804 . . . . 0.0 112.973 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.92 -21.7 59.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.032 -1.043 . . . . 0.0 113.436 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 88' ' ' VAL . 1.5 p -106.73 -32.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG13 HG13 ' A' ' 87' ' ' VAL . 4.4 m -110.6 179.31 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.701 1.2 . . . . 0.0 111.004 174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 82.8 p -143.69 -178.9 6.13 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.666 -1.271 . . . . 0.0 113.775 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -52.44 -36.31 54.24 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -71.69 -20.01 61.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.498 1.045 . . . . 0.0 112.943 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 29.1 t80 -78.57 -49.24 13.63 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.285 1.034 . . . . 0.0 109.275 168.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -62.68 -31.43 72.31 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.611 1.564 . . . . 0.0 113.611 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.72 -29.75 68.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.225 1.01 . . . . 0.0 111.621 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.5 p -69.96 -43.07 72.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.542 0.61 . . . . 0.0 111.651 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 m -55.94 -51.62 67.0 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.371 1.869 . . . . 0.0 111.014 172.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -59.3 -48.42 81.69 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.61 0.764 . . . . 0.0 111.528 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -59.76 -45.89 90.84 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.585 1.084 . . . . 0.0 112.581 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.52 93.89 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.217 0.917 . . . . 0.0 112.826 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.3 mt -70.57 -52.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.953 0.901 . . . . 0.0 110.212 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -57.36 -44.48 84.4 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.045 1.338 . . . . 0.0 112.626 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.42 -34.0 77.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.533 0.606 . . . . 0.0 112.161 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -85.89 -38.84 17.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.04 0.936 . . . . 0.0 110.987 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -57.29 -40.37 77.63 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.233 -0.917 . . . . 0.0 111.767 169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.91 -23.05 67.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.951 1.3 . . . . 0.0 113.364 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.36 -25.26 21.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.631 0.772 . . . . 0.0 112.153 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.51 37.62 Favored Glycine 0 N--CA 1.477 1.431 0 C-N-CA 125.468 1.509 . . . . 0.0 113.664 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.9 64.35 1.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.415 1.486 . . . . 0.0 110.839 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -53.43 -44.0 68.47 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.942 0.897 . . . . 0.0 112.876 -174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.02 -54.01 45.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.395 1.078 . . . . 0.0 111.872 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -63.74 -43.36 96.71 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.05 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.13 -38.74 96.08 Favored Glycine 0 N--CA 1.469 0.877 0 CA-C-N 119.167 0.894 . . . . 0.0 113.065 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -72.5 -45.38 59.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.999 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.59 -51.21 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.484 1.038 . . . . 0.0 111.473 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.3 -40.35 90.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.488 0.715 . . . . 0.0 111.423 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.75 92.08 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.663 -1.076 . . . . 0.0 111.916 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.51 -52.67 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.556 1.178 . . . . 0.0 109.744 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -58.91 -46.15 88.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.158 0.583 . . . . 0.0 111.868 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.67 -40.66 76.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.917 0.887 . . . . 0.0 111.729 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.84 76.17 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.56 0.618 . . . . 0.0 109.926 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.15 -48.74 77.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.583 0.611 . . . . 0.0 113.347 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 94.7 mmm -63.29 -35.97 82.13 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.95 -41.26 59.95 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.118 -0.364 . . . . 0.0 110.799 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.3 mt -63.06 -40.1 96.71 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.927 1.691 . . . . 0.0 111.882 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.47 44.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 113.847 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -65.82 -41.01 92.34 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.503 -0.748 . . . . 0.0 111.842 172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -82.0 -46.75 13.54 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.204 1.402 . . . . 0.0 111.344 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -120.97 83.5 37.62 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 126.641 1.977 . . . . 0.0 110.516 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.34 143.16 62.81 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.837 2.358 . . . . 0.0 109.747 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -60.16 145.58 46.45 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.32 0.581 . . . . 0.0 112.038 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -120.59 144.81 47.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.039 0.936 . . . . 0.0 109.423 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.14 -20.09 65.75 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 120.671 -1.268 . . . . 0.0 113.318 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -95.99 2.52 53.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.167 2.587 . . . . 0.0 113.739 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -58.6 151.87 19.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.426 1.49 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.54 142.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 123.657 0.783 . . . . 0.0 110.988 -165.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -93.58 107.42 19.28 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 111.546 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.66 -29.91 17.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.491 1.116 . . . . 0.0 113.217 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.1 mp -117.82 152.76 50.41 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 119.991 1.269 . . . . 0.0 111.571 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.98 147.94 19.25 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.249 2.633 . . . . 0.0 111.255 172.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -78.79 -3.54 44.94 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.6 p -70.16 161.87 29.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.173 1.789 . . . . 0.0 113.01 -171.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 66.5 mt -82.79 138.41 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.849 1.26 . . . . 0.0 110.05 -176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.5 t -101.65 142.95 32.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.614 0.766 . . . . 0.0 110.395 174.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -145.61 151.46 38.11 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -167.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 C-N-CA 125.949 1.738 . . . . 0.0 113.045 165.277 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 C--O 1.209 -1.044 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -52.85 -34.9 56.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 122.063 2.21 . . . . 0.0 114.232 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -77.48 -17.28 58.18 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 pt -164.87 100.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.848 2.459 . . . . 0.0 110.984 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.71 44.5 0.82 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.599 -1.313 . . . . 0.0 114.005 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 69.32 -6.11 1.01 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.515 2.326 . . . . 0.0 114.356 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -51.87 -60.28 3.36 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.636 1.974 . . . . 0.0 114.0 -173.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.7 mt -134.66 149.48 50.53 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.155 1.382 . . . . 0.0 110.167 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -78.47 163.38 25.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.861 0.864 . . . . 0.0 111.208 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.96 -44.08 19.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.276 1.43 . . . . 0.0 112.988 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -61.41 -45.88 92.46 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.618 1.567 . . . . 0.0 112.552 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -65.78 -45.26 83.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -66.02 -38.78 89.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.785 0.834 . . . . 0.0 112.305 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 -44.83 92.28 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.257 -0.902 . . . . 0.0 111.004 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.53 97.02 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.146 0.979 . . . . 0.0 113.354 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -72.11 -37.53 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.175 0.898 . . . . 0.0 112.696 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.3 t -61.61 -32.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.231 0.923 . . . . 0.0 112.27 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -41.64 97.6 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.181 0.992 . . . . 0.0 112.06 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.01 -39.64 95.38 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.908 -0.495 . . . . 0.0 111.729 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.1 mt -62.58 -40.1 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.831 0.852 . . . . 0.0 111.449 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -64.38 -38.53 91.35 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.778 0.831 . . . . 0.0 112.567 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.43 -31.44 65.48 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 112.952 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.36 -38.85 85.43 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.498 0.719 . . . . 0.0 112.711 172.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -62.01 -17.48 57.37 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.268 1.033 . . . . 0.0 113.316 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -94.45 3.79 54.69 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.278 -1.514 . . . . 0.0 112.659 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -119.78 -13.51 9.09 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.498 1.919 . . . . 0.0 114.221 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -155.86 161.79 40.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.766 2.026 . . . . 0.0 109.417 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 p -104.08 26.27 8.97 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 112.823 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.11 148.12 19.52 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 124.497 1.046 . . . . 0.0 111.124 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -103.07 134.84 45.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.72 0.771 . . . . 0.0 112.443 -151.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mt -126.97 129.83 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 119.003 -2.311 . . . . 0.0 111.286 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -142.56 152.5 42.66 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.129 1.372 . . . . 0.0 110.931 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -121.12 141.0 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.922 1.689 . . . . 0.0 110.555 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' HD11 ' A' ' 66' ' ' LEU . 51.3 t60 -127.24 130.99 50.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.636 1.174 . . . . 0.0 112.336 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.4 tp -119.38 120.85 38.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 111.63 -173.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -138.08 156.04 48.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.525 1.13 . . . . 0.0 110.564 171.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.48 -69.7 0.26 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.283 -1.511 . . . . 0.0 113.852 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.3 t -152.75 142.25 21.74 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.896 1.678 . . . . 0.0 109.307 -166.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 p -100.12 144.51 29.06 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -81.79 -26.46 34.38 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 167.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.5 pt -110.62 -177.1 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.041 1.737 . . . . 0.0 110.411 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.36 136.48 57.16 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.65 0.738 . . . . 0.0 112.489 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.03 -32.88 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.853 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -64.11 -49.36 72.52 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.609 1.095 . . . . 0.0 111.986 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.96 -43.08 88.95 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.3 1.04 . . . . 0.0 110.398 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -57.04 -48.87 77.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.997 0.519 . . . . 0.0 111.999 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.72 -40.47 88.09 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.4 -0.81 . . . . 0.0 110.486 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -61.23 -46.84 88.76 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 118.995 0.816 . . . . 0.0 111.703 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -66.72 -44.29 82.02 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.48 -44.48 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 0.0 110.2 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -59.26 -55.81 30.16 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.813 1.245 . . . . 0.0 111.197 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -68.57 -34.04 75.12 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -67.57 -41.81 83.59 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.431 -0.793 . . . . 0.0 112.325 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.31 0.12 15.33 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.9 0.88 . . . . 0.0 112.873 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 tttt 63.73 31.86 14.03 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 125.914 1.686 . . . . 0.0 112.295 168.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.469 ' SD ' HD13 ' A' ' 66' ' ' LEU . 29.8 mtt -66.7 -33.91 76.68 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.115 -0.99 . . . . 0.0 111.867 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.4 -16.54 9.49 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.171 2.589 . . . . 0.0 114.904 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.04 76.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 120.723 -1.236 . . . . 0.0 111.293 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -123.3 160.57 26.39 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.234 1.014 . . . . 0.0 110.148 162.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -59.4 -44.78 92.76 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.067 -1.021 . . . . 0.0 112.429 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.68 -8.94 27.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 117.444 -1.265 . . . . 0.0 113.443 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 68.54 47.61 0.89 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.67 1.588 . . . . 0.0 109.512 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -116.85 25.64 10.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.839 1.256 . . . . 0.0 112.557 -175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.33 124.76 10.1 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 111.154 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.64 133.6 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 110.234 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.2 tp -114.44 132.46 56.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.872 1.32 . . . . 0.0 111.685 164.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.2 mt -110.27 92.7 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -76.18 120.64 21.74 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.734 0.814 . . . . 0.0 110.516 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -117.07 130.06 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.046 1.338 . . . . 0.0 109.917 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.94 105.47 15.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.408 1.083 . . . . 0.0 110.373 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.43 -19.79 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -76.81 -47.62 20.96 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.474 1.488 . . . . 0.0 111.157 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -79.98 -15.84 56.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.444 1.097 . . . . 0.0 113.317 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 70.11 33.14 2.77 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.656 1.582 . . . . 0.0 112.205 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -114.09 167.92 10.26 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.39 1.476 . . . . 0.0 111.018 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.26 141.67 22.47 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.718 1.207 . . . . 0.0 109.63 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -132.86 135.06 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 125.088 1.355 . . . . 0.0 108.213 177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 mt -115.13 130.28 69.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -140.88 149.79 42.39 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.738 0.815 . . . . 0.0 110.113 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.76 158.77 27.82 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -65.92 170.07 5.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.388 1.566 . . . . 0.0 114.084 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.65 -30.28 70.61 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.585 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.55 -48.0 59.27 Favored Glycine 0 N--CA 1.471 0.989 0 CA-C-N 119.916 1.235 . . . . 0.0 111.612 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.1 mt -59.75 -56.31 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 118.068 0.934 . . . . 0.0 109.365 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -53.05 -44.7 67.64 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.982 0.913 . . . . 0.0 112.588 -175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -78.86 -8.28 58.68 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.848 1.659 . . . . 0.0 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.84 -23.49 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.87 173.79 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 120.808 1.64 . . . . 0.0 111.955 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.2 p -125.13 171.06 10.61 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.13 -31.63 63.5 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.12 -31.36 69.98 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.393 1.477 . . . . 0.0 112.548 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 57.7 t80 -74.3 -33.42 63.2 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.644 0.778 . . . . 0.0 110.558 174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -77.04 -23.68 52.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.241 1.816 . . . . 0.0 114.16 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.35 -36.05 81.91 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.711 -1.243 . . . . 0.0 112.163 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.1 m -58.35 -39.71 80.24 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.363 1.465 . . . . 0.0 111.675 172.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -60.67 -54.98 38.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.377 1.871 . . . . 0.0 111.381 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -60.29 -45.11 94.49 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.272 0.629 . . . . 0.0 110.471 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -56.96 -45.13 83.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -47.98 83.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.262 0.937 . . . . 0.0 112.642 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.5 mt -66.02 -48.36 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.798 0.839 . . . . 0.0 110.091 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -61.36 -42.32 98.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.073 0.949 . . . . 0.0 113.294 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.5 mt -64.68 -41.22 96.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.821 0.737 . . . . 0.0 111.489 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -74.19 -37.11 64.02 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.553 0.741 . . . . 0.0 111.765 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -63.84 -40.26 96.17 Favored 'General case' 0 C--N 1.346 0.444 0 O-C-N 121.428 -0.795 . . . . 0.0 111.81 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -63.26 -40.35 97.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.169 174.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -65.39 -41.53 93.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.812 0.845 . . . . 0.0 111.493 172.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.65 18.09 6.24 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.49 1.043 . . . . 0.0 114.439 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -110.4 84.08 1.87 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.414 1.486 . . . . 0.0 111.287 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -64.64 -45.66 85.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -57.33 -51.68 68.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.152 -0.927 . . . . 0.0 111.402 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -56.86 -42.37 79.64 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.67 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.44 -39.04 97.29 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 119.456 1.025 . . . . 0.0 113.915 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.13 -48.27 30.53 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 110.722 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.15 -57.71 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 125.781 1.633 . . . . 0.0 110.788 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -61.94 -29.77 70.45 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.579 0.751 . . . . 0.0 111.256 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.21 -37.31 59.62 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.434 0.54 . . . . 0.0 113.427 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 29.1 mt -66.53 -44.82 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 118.601 1.2 . . . . 0.0 110.137 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -59.17 -44.25 92.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.918 0.887 . . . . 0.0 112.253 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -67.95 -30.06 69.26 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.891 -1.13 . . . . 0.0 113.082 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.98 -53.43 26.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 118.814 -0.612 . . . . 0.0 109.786 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.06 -48.31 80.56 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.554 1.073 . . . . 0.0 112.327 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.7 ttm -62.81 -38.85 92.33 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.373 1.087 . . . . 0.0 112.595 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -74.63 -45.4 45.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.52 0.6 . . . . 0.0 111.436 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.5 mt -62.84 -35.42 79.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.492 1.517 . . . . 0.0 111.046 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.06 37.4 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.13 -31.34 61.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.589 1.086 . . . . 0.0 111.603 171.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.52 -37.48 15.71 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.143 1.377 . . . . 0.0 111.916 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.95 82.34 68.96 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.552 1.941 . . . . 0.0 110.585 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.92 134.89 30.99 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.422 2.748 . . . . 0.0 111.003 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -63.14 139.03 58.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.244 1.018 . . . . 0.0 112.731 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -116.16 155.53 28.09 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.764 1.625 . . . . 0.0 110.567 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.32 -21.59 66.26 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 119.243 -2.16 . . . . 0.0 112.913 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -101.36 18.2 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.861 1.664 . . . . 0.0 112.892 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.28 153.25 22.95 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.123 0.963 . . . . 0.0 112.739 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.99 106.51 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 121.418 -0.801 . . . . 0.0 112.019 -166.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -54.32 102.96 0.07 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.209 1.404 . . . . 0.0 110.227 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.83 -24.65 26.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.11 134.22 9.4 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.505 1.122 . . . . 0.0 109.915 -162.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.97 153.59 67.79 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.771 2.314 . . . . 0.0 112.514 -170.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -89.35 3.75 51.16 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.8 p -72.23 159.04 34.75 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mt -83.24 137.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.689 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 t -98.26 139.06 34.61 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.258 1.023 . . . . 0.0 109.797 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -140.69 164.69 29.52 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.612 0.765 . . . . 0.0 110.711 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 CA-C-O 117.991 -1.45 . . . . 0.0 113.725 177.711 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -29.64 67.91 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.532 1.515 . . . . 0.0 113.692 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -135.63 136.78 41.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 109.965 172.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.4 mt -66.41 -43.39 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-N 118.838 0.744 . . . . 0.0 111.867 -174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.06 -16.76 63.82 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -114.57 79.07 1.22 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.369 1.467 . . . . 0.0 109.159 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 71' ' ' VAL . 41.4 m-85 -56.9 -36.19 69.86 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -134.91 140.4 45.73 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.664 1.586 . . . . 0.0 108.334 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -73.23 162.59 29.21 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.607 -0.683 . . . . 0.0 109.85 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.13 41.01 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.36 -42.9 87.38 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.484 1.114 . . . . 0.0 111.334 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -71.16 -45.12 64.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.409 1.484 . . . . 0.0 111.345 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -59.52 -46.03 90.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.224 1.41 . . . . 0.0 111.778 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -56.76 -43.28 80.64 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.368 -0.832 . . . . 0.0 111.834 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.64 89.36 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.764 0.711 . . . . 0.0 112.761 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -75.35 -33.41 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.224 -0.923 . . . . 0.0 112.831 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -63.07 -37.78 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.665 1.12 . . . . 0.0 111.259 171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -63.81 -30.98 72.02 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.211 1.004 . . . . 0.0 112.775 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.05 -41.76 85.95 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.073 -1.017 . . . . 0.0 111.911 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mm -59.89 -47.71 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.611 0.641 . . . . 0.0 110.003 172.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm105 -59.68 -34.04 72.35 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.24 -23.93 32.53 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.92 68.4 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.111 0.964 . . . . 0.0 112.734 177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' CD ' HD21 ' A' ' 140' ' ' ASN . 92.6 mt-10 -56.5 -40.94 75.83 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.908 0.861 . . . . 0.0 110.882 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -73.59 6.06 3.39 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 119.733 -1.854 . . . . 0.0 113.325 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -123.63 -7.98 7.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.382 2.273 . . . . 0.0 114.284 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.8 t -163.79 147.25 10.0 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.24 1.382 . . . . 0.0 110.545 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -81.79 12.12 4.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 113.987 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.11 143.74 16.82 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.21 1.386 . . . . 0.0 111.16 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -101.75 139.0 37.98 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.018 0.927 . . . . 0.0 113.074 -164.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.0 mt -123.11 138.6 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.291 1.436 . . . . 0.0 109.573 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -153.39 155.59 36.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.474 1.11 . . . . 0.0 111.0 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.5 t -117.42 139.47 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.921 1.689 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.427 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.9 t60 -122.43 125.86 46.73 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.751 1.221 . . . . 0.0 112.244 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.2 tp -114.86 115.15 26.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.888 0.875 . . . . 0.0 110.169 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -132.26 163.19 29.16 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.083 1.753 . . . . 0.0 109.812 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.8 mttt -80.35 -72.51 0.41 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.666 -1.271 . . . . 0.0 113.264 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.6 t -148.8 158.27 44.04 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 126.676 1.991 . . . . 0.0 109.292 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -107.03 159.0 16.62 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 126.189 1.796 . . . . 0.0 110.18 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.58 -27.79 18.89 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.738 -1.226 . . . . 0.0 112.148 166.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 mt -100.1 -125.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.329 1.052 . . . . 0.0 108.697 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -115.88 142.55 46.62 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.001 1.72 . . . . 0.0 109.349 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.09 -46.72 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.54 -50.21 74.47 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.039 0.836 . . . . 0.0 112.441 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -70.03 -39.47 75.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.344 0.658 . . . . 0.0 111.251 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -59.7 -46.55 88.73 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.646 0.778 . . . . 0.0 111.889 173.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.07 93.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.307 1.043 . . . . 0.0 111.691 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 59.0 ttp -63.56 -46.16 87.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.725 0.81 . . . . 0.0 111.606 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -59.06 -48.81 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.165 0.439 . . . . 0.0 110.929 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -56.8 -45.39 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.518 1.127 . . . . 0.0 111.553 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -56.29 -53.52 56.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.64 1.176 . . . . 0.0 110.803 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -69.05 -33.73 74.05 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 112.05 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.26 -33.4 75.24 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.238 -1.539 . . . . 0.0 112.453 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.58 -3.18 52.61 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.98 0.912 . . . . 0.0 112.987 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 60.23 34.29 20.98 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.904 1.682 . . . . 0.0 112.697 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.2 mtp -65.02 -18.37 65.24 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -3.94 7.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.492 1.517 . . . . 0.0 113.066 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -78.79 59.8 2.65 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.139 1.376 . . . . 0.0 111.422 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.1 p -125.93 143.28 51.15 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.463 1.905 . . . . 0.0 109.142 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -63.09 -48.69 77.54 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.17 -0.956 . . . . 0.0 110.848 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.2 mt -85.17 -2.0 57.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.633 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 57.54 37.68 27.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.98 1.263 . . . . 0.0 109.463 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 27.45 9.57 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.543 1.537 . . . . 0.0 112.0 -172.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.1 124.52 6.78 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 124.098 0.856 . . . . 0.0 112.093 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.3 t -111.55 132.44 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.384 1.073 . . . . 0.0 110.147 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 34' ' ' HIS . 27.1 tp -118.6 123.81 45.92 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 122.245 1.022 . . . . 0.0 111.455 174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.67 96.33 5.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 125.474 1.509 . . . . 0.0 108.328 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.07 127.7 34.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.644 0.778 . . . . 0.0 111.379 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.36 125.86 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.318 0.647 . . . . 0.0 110.646 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.35 108.02 20.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.661 1.584 . . . . 0.0 110.236 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 37' ' ' LYS . 29.6 m -75.79 -20.71 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -73.67 -64.11 1.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.988 0.813 . . . . 0.0 108.808 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.2 -9.52 58.62 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.8 tttt 65.45 32.57 9.44 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.1 m -100.76 132.55 46.1 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.603 1.561 . . . . 0.0 109.207 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.62 139.41 40.26 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.534 1.134 . . . . 0.0 108.385 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.58 143.83 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 125.012 1.325 . . . . 0.0 108.229 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.6 HD11 HD12 ' A' ' 100' ' ' ILE . 12.3 mt -122.79 135.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -147.64 129.36 15.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.857 1.663 . . . . 0.0 108.604 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.13 172.55 16.62 Favored Glycine 0 C--O 1.236 0.28 0 C-N-CA 125.353 1.454 . . . . 0.0 112.002 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -60.81 166.64 3.24 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.664 1.586 . . . . 0.0 113.551 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -53.08 -34.67 57.62 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.226 1.41 . . . . 0.0 113.717 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.95 -29.25 69.33 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.968 1.258 . . . . 0.0 114.185 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.65 -56.2 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 119.17 1.485 . . . . 0.0 108.529 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -51.64 -34.35 37.5 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.522 1.529 . . . . 0.0 113.747 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -78.42 -24.61 46.1 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.408 1.483 . . . . 0.0 113.081 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.5 p -106.48 -22.85 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.78 159.98 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.495 1.043 . . . . 0.0 112.715 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 56.7 p -95.01 174.13 7.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -64.69 -21.74 66.81 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.926 -1.109 . . . . 0.0 113.535 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.28 -17.91 55.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.411 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 48.1 t80 -73.17 -46.18 52.21 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 165.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -65.56 -32.2 73.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.543 1.137 . . . . 0.0 113.492 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.66 -36.85 70.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.969 1.308 . . . . 0.0 112.297 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.2 p -61.21 -45.25 95.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.752 0.821 . . . . 0.0 112.01 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 m -65.34 -45.87 82.5 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 125.811 1.644 . . . . 0.0 110.961 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.98 -51.42 67.79 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.542 . . . . 0.0 111.187 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -56.61 -48.09 78.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.884 0.766 . . . . 0.0 111.711 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.26 -46.57 82.93 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.908 -1.12 . . . . 0.0 113.453 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 78' ' ' ILE . 29.1 mt -70.46 -50.05 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.165 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -55.6 -44.27 76.81 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.282 1.033 . . . . 0.0 112.559 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.91 -34.02 74.03 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.01 -38.84 14.11 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.721 1.208 . . . . 0.0 111.251 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.98 -38.59 82.99 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.473 -0.767 . . . . 0.0 111.174 172.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -66.13 -27.08 67.77 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.272 1.429 . . . . 0.0 113.419 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.2 -20.98 39.98 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.935 0.894 . . . . 0.0 111.736 170.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.07 7.03 44.68 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.219 1.39 . . . . 0.0 114.549 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.08 97.81 7.54 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.805 1.303 . . . . 0.0 111.586 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -72.5 -37.05 68.5 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.604 -0.685 . . . . 0.0 110.898 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -57.73 -57.91 10.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.336 -0.852 . . . . 0.0 111.381 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.6 -41.1 94.07 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.268 0.627 . . . . 0.0 111.396 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.0 -43.81 98.32 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 118.598 0.635 . . . . 0.0 113.469 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.41 -50.44 59.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.504 -0.76 . . . . 0.0 111.149 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.1 t -59.11 -48.31 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.0 0.818 . . . . 0.0 111.743 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -70.6 -29.84 66.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.286 0.493 . . . . 0.0 112.268 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.2 -34.48 64.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 118.722 0.692 . . . . 0.0 112.522 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.31 -52.59 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.454 1.102 . . . . 0.0 110.828 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.36 -42.33 91.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.597 1.09 . . . . 0.0 111.04 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -61.69 -46.58 89.08 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.177 -0.952 . . . . 0.0 112.116 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.33 -43.01 96.81 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.426 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.77 -44.63 97.19 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.172 0.897 . . . . 0.0 112.425 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 83.1 mtp -65.02 -35.97 82.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.831 0.816 . . . . 0.0 113.112 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.411 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.87 -44.39 61.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.972 0.509 . . . . 0.0 111.644 176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.55 -38.12 88.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 0.0 111.925 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.16 -24.81 43.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -73.08 -31.4 64.35 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 120.625 -1.297 . . . . 0.0 112.502 174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -83.36 -38.01 22.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.88 1.272 . . . . 0.0 111.95 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -130.64 90.8 39.41 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.543 1.537 . . . . 0.0 109.178 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 139.82 50.85 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.478 2.119 . . . . 0.0 110.173 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 36.7 t90 -64.95 149.13 50.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.597 0.713 . . . . 0.0 112.698 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -128.03 145.89 50.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.122 1.369 . . . . 0.0 110.427 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -62.51 -20.68 64.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.8 0.18 54.67 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.564 1.946 . . . . 0.0 112.629 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -50.36 151.99 1.98 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.358 2.263 . . . . 0.0 115.735 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.28 112.12 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.328 1.051 . . . . 0.0 112.389 -163.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -94.05 105.31 17.32 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.393 1.477 . . . . 0.0 108.661 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -116.21 5.33 13.68 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 mp -114.59 152.56 46.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 120.326 1.421 . . . . 0.0 113.58 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.26 137.73 13.61 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.061 2.507 . . . . 0.0 110.262 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.404 HD21 ' CD ' ' A' ' 24' ' ' GLU . 2.3 m-80 -85.23 0.23 52.53 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 54.1 p -71.73 153.52 41.96 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.264 1.425 . . . . 0.0 111.106 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.5 mt -72.25 139.38 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.566 0.747 . . . . 0.0 109.109 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.4 t -101.17 139.1 37.32 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.824 -1.172 . . . . 0.0 110.533 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -136.43 151.02 49.04 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.273 1.029 . . . . 0.0 112.204 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.455 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.217 168.546 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mmm . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -61.07 -32.5 72.14 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.75 119.89 39.29 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.997 -1.064 . . . . 0.0 111.233 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.2 mt -57.66 -25.28 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.58 1.152 . . . . 0.0 112.454 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -49.97 -34.43 20.88 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.342 1.857 . . . . 0.0 114.046 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -154.06 120.8 5.56 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.257 1.023 . . . . 0.0 108.356 -166.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -59.87 -58.36 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.832 0.853 . . . . 0.0 111.893 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.6 mt -94.26 177.35 5.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.37 1.468 . . . . 0.0 110.221 175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -101.05 162.22 13.05 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.573 -1.329 . . . . 0.0 109.98 167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.83 -18.13 58.88 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.33 -48.15 57.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.225 1.375 . . . . 0.0 110.531 166.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.74 -40.82 92.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.144 0.978 . . . . 0.0 111.471 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -70.04 -42.95 72.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.357 1.063 . . . . 0.0 112.402 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.64 -45.42 85.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.503 -0.748 . . . . 0.0 111.817 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -59.84 -43.17 94.75 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.35 -0.844 . . . . 0.0 113.095 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.0 mt -58.78 -49.33 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.427 1.091 . . . . 0.0 110.25 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 t -56.36 -48.2 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.527 1.131 . . . . 0.0 111.846 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.62 -27.75 66.3 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.04 -32.57 67.25 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.134 -0.978 . . . . 0.0 112.487 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.49 -52.82 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.353 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -51.76 -23.96 5.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -89.95 -25.22 21.03 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.176 1.39 . . . . 0.0 113.019 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.11 74.52 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.522 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -63.61 -20.37 65.61 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.762 0.71 . . . . 0.0 112.736 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -83.86 3.97 31.42 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 119.641 -1.912 . . . . 0.0 113.136 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -129.97 -5.72 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.281 1.432 . . . . 0.0 113.427 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -162.55 155.54 19.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.565 1.546 . . . . 0.0 109.339 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -79.87 7.02 9.6 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.239 1.016 . . . . 0.0 113.722 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.9 152.85 20.2 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -111.17 129.55 55.91 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.497 1.119 . . . . 0.0 110.572 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.3 mt -115.74 128.73 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.394 -0.816 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -141.3 160.36 40.29 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.484 1.114 . . . . 0.0 111.903 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.7 t -132.45 136.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.3 1.44 . . . . 0.0 109.216 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.506 ' HB2' HD11 ' A' ' 66' ' ' LEU . 39.3 t60 -119.55 119.4 33.69 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.816 1.246 . . . . 0.0 112.593 172.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.47 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.9 tp -100.88 130.8 46.95 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.97 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.26 165.14 34.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.803 1.241 . . . . 0.0 110.152 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -80.85 -67.37 0.78 Allowed 'General case' 0 C--O 1.24 0.564 0 O-C-N 120.24 -1.537 . . . . 0.0 112.335 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 142.42 24.94 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.545 1.538 . . . . 0.0 110.125 -167.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -92.6 133.02 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.375 0.67 . . . . 0.0 111.961 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -74.68 -28.07 60.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.445 0.698 . . . . 0.0 112.63 171.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 pt -118.01 -164.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.432 1.893 . . . . 0.0 109.66 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.27 137.11 48.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.808 -1.183 . . . . 0.0 112.647 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.45 -37.79 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.433 0.693 . . . . 0.0 111.905 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -64.06 -48.98 74.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.324 0.65 . . . . 0.0 111.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.94 -37.01 81.09 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 112.098 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -62.75 -47.19 84.61 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.439 0.563 . . . . 0.0 111.24 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.53 -40.17 96.33 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.727 0.811 . . . . 0.0 110.824 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.2 ttp -60.96 -47.49 86.18 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.509 0.723 . . . . 0.0 112.568 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.1 -37.93 81.74 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.315 0.961 . . . . 0.0 111.944 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.07 -41.46 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.856 0.753 . . . . 0.0 111.819 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.7 -47.78 83.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.465 1.106 . . . . 0.0 111.882 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -75.45 -34.72 60.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.594 0.757 . . . . 0.0 112.288 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -61.65 -41.91 98.17 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.466 1.107 . . . . 0.0 112.03 171.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.42 -0.67 20.78 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.359 -0.838 . . . . 0.0 112.938 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 59.67 33.51 21.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.317 1.447 . . . . 0.0 112.352 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.8 mtp -71.21 -23.35 62.0 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.483 1.113 . . . . 0.0 112.853 -177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -67.7 -16.3 64.07 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.353 1.861 . . . . 0.0 113.598 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.44 72.61 8.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.045 1.338 . . . . 0.0 111.291 172.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 97.0 m -135.85 135.67 39.96 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.243 1.817 . . . . 0.0 107.803 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -49.09 -49.94 39.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.7 mt -93.07 0.57 57.34 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.258 1.023 . . . . 0.0 113.749 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 61.65 43.95 9.39 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.777 1.231 . . . . 0.0 111.041 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -121.03 47.37 1.84 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.493 1.517 . . . . 0.0 112.347 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 131.6 10.8 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.929 0.776 . . . . 0.0 112.749 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.35 139.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 118.221 1.01 . . . . 0.0 111.605 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 34' ' ' HIS . 31.1 tp -125.93 120.81 31.37 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.457 1.503 . . . . 0.0 111.085 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -96.76 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.812 0.845 . . . . 0.0 109.796 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -78.06 119.92 22.17 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.696 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.38 130.71 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.744 0.818 . . . . 0.0 110.159 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.24 94.75 5.68 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.389 1.476 . . . . 0.0 110.231 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' HD11 ' A' ' 35' ' ' LEU . 20.1 m -70.5 -15.81 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -170.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -83.01 -34.23 26.35 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.825 0.85 . . . . 0.0 111.176 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -97.44 -15.63 20.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.99 1.316 . . . . 0.0 113.833 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.5 tttt 71.98 21.91 3.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.134 2.174 . . . . 0.0 112.43 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.8 p -99.94 163.59 12.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.193 -0.942 . . . . 0.0 111.48 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -141.21 145.61 35.85 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.137 1.375 . . . . 0.0 108.863 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -137.68 136.12 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 125.748 1.619 . . . . 0.0 107.54 175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 mt -111.56 126.06 68.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -121.85 150.56 41.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.298 1.439 . . . . 0.0 109.702 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.78 149.65 21.69 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -65.32 160.86 20.79 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 123.249 1.499 . . . . 0.0 112.156 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -53.46 -35.89 61.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.233 1.813 . . . . 0.0 113.334 -174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.73 -22.51 76.83 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.344 -1.253 . . . . 0.0 114.083 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.35 -54.4 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.916 1.858 . . . . 0.0 108.731 167.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -52.87 -35.41 57.69 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -79.22 -16.14 56.98 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.922 1.289 . . . . 0.0 113.171 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.3 m -111.51 -29.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 119.555 1.071 . . . . 0.0 113.84 178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.79 163.08 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.032 0.833 . . . . 0.0 111.287 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.1 m -119.42 169.58 9.89 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.318 1.447 . . . . 0.0 111.736 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -56.82 -32.59 65.89 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 120.237 1.38 . . . . 0.0 113.681 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.55 -21.05 66.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.554 1.142 . . . . 0.0 113.297 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -79.01 -41.91 27.83 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.476 -0.765 . . . . 0.0 110.462 171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -69.47 -30.35 68.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.74 -36.17 69.44 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.183 0.593 . . . . 0.0 112.548 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -62.13 -44.76 95.92 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.915 0.779 . . . . 0.0 111.289 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 m -61.73 -47.63 84.39 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.136 1.775 . . . . 0.0 110.896 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.82 -43.7 98.31 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.369 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -65.18 -42.98 93.13 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.754 1.161 . . . . 0.0 112.45 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.88 78.28 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.718 1.145 . . . . 0.0 112.34 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.2 mt -64.49 -51.38 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 122.822 0.449 . . . . 0.0 111.031 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -61.02 -44.74 96.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.935 1.294 . . . . 0.0 113.341 -174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.21 -38.47 91.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.631 0.772 . . . . 0.0 111.573 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -79.11 -38.46 36.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.067 0.947 . . . . 0.0 111.352 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -59.29 -40.05 84.92 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.333 -0.854 . . . . 0.0 111.637 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -62.67 -25.46 68.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.183 0.993 . . . . 0.0 113.267 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -87.41 -25.48 23.78 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.822 1.249 . . . . 0.0 111.797 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.52 10.55 40.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.301 1.429 . . . . 0.0 113.58 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.58 59.05 0.8 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.431 1.493 . . . . 0.0 110.83 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -49.46 -44.82 46.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 114.047 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 49.9 tttm -52.19 -51.43 58.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 124.584 1.154 . . . . 0.0 112.592 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -68.87 -33.86 74.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.76 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.54 -42.79 97.29 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-N 119.035 0.834 . . . . 0.0 112.75 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.6 mt -65.86 -51.63 57.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.225 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.32 -47.38 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.089 0.956 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -65.73 -40.98 92.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.734 1.152 . . . . 0.0 111.841 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.87 -39.39 75.59 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.856 -0.528 . . . . 0.0 112.312 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.05 -39.08 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.671 1.188 . . . . 0.0 110.648 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.74 -51.07 66.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.193 0.997 . . . . 0.0 112.363 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -63.44 -40.04 96.09 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.532 -0.73 . . . . 0.0 112.053 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -50.88 72.01 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.461 -0.78 . . . . 0.0 110.652 172.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.46 -49.18 75.29 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.076 0.853 . . . . 0.0 112.585 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 93.0 mtp -60.99 -35.72 77.56 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.929 0.864 . . . . 0.0 112.898 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -80.13 -39.56 29.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.193 0.997 . . . . 0.0 111.868 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.6 mt -62.18 -36.0 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.83 -17.52 36.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.338 1.455 . . . . 0.0 114.449 172.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -74.01 -38.48 64.08 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.062 -1.024 . . . . 0.0 112.223 170.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -80.98 -49.81 10.48 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 124.486 1.114 . . . . 0.0 111.68 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -123.96 91.59 49.44 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 125.409 1.483 . . . . 0.0 109.682 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.41 148.94 68.47 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.877 2.385 . . . . 0.0 110.828 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -70.75 127.63 33.31 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 121.813 -0.554 . . . . 0.0 112.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -100.35 155.89 17.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.203 1.801 . . . . 0.0 109.596 174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.28 -24.46 63.96 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 119.866 -1.771 . . . . 0.0 112.768 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -98.33 16.5 21.34 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.865 2.066 . . . . 0.0 113.18 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.02 163.0 5.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.682 1.23 . . . . 0.0 112.065 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.51 163.44 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.539 1.536 . . . . 0.0 110.903 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.8 107.6 10.02 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -92.32 -31.14 15.48 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.661 0.785 . . . . 0.0 111.627 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.3 mp -114.51 151.71 45.48 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.084 0.954 . . . . 0.0 110.592 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -82.0 144.46 13.49 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.246 1.964 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.87 31.76 0.26 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 126.395 1.878 . . . . 0.0 111.726 -172.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 t -97.08 164.0 12.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.774 1.629 . . . . 0.0 111.285 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.29 131.22 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.7 m -93.17 144.61 25.12 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.781 0.832 . . . . 0.0 109.633 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -142.29 135.99 29.3 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.511 -0.743 . . . . 0.0 111.232 -174.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.564 0 CA-C-O 115.983 -2.565 . . . . 0.0 113.963 173.835 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.66 -29.82 70.82 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 121.01 1.732 . . . . 0.0 113.801 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -127.55 132.81 49.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.583 1.553 . . . . 0.0 110.641 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.2 mt -134.44 135.28 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.367 1.867 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -116.89 59.93 0.75 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.121 1.368 . . . . 0.0 110.047 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.58 21.92 10.62 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.229 1.012 . . . . 0.0 113.189 167.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -85.94 -85.05 0.16 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.347 1.459 . . . . 0.0 111.059 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 mt -128.88 142.85 50.82 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.727 1.611 . . . . 0.0 108.386 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.1 p -73.6 169.43 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.339 0.656 . . . . 0.0 111.059 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.56 -42.57 64.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.107 -0.996 . . . . 0.0 113.66 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.4 -31.27 63.78 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.263 0.625 . . . . 0.0 112.264 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -71.57 -43.93 65.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.323 -0.861 . . . . 0.0 110.943 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -63.48 -31.07 72.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.979 1.312 . . . . 0.0 112.004 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.59 -46.33 59.6 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.533 -1.355 . . . . 0.0 111.279 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.6 96.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.438 1.095 . . . . 0.0 112.701 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.65 -39.86 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.394 0.997 . . . . 0.0 113.17 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.76 -34.31 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 118.578 0.626 . . . . 0.0 111.26 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.88 -28.9 67.11 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.55 71.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.234 0.47 . . . . 0.0 111.761 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.65 -46.54 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.67 0.788 . . . . 0.0 109.681 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -59.57 -43.28 93.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.836 1.255 . . . . 0.0 112.439 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.62 -37.66 85.31 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.182 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.97 93.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.09 0.556 . . . . 0.0 112.022 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.22 -18.99 61.07 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.483 1.113 . . . . 0.0 113.735 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -98.39 11.14 39.05 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.232 -1.542 . . . . 0.0 112.737 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -121.97 -16.15 7.63 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.024 1.729 . . . . 0.0 113.752 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.3 t -163.65 154.54 16.13 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.88 1.672 . . . . 0.0 109.682 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.0 m -78.38 1.65 21.31 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.82 154.78 27.14 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 124.999 1.285 . . . . 0.0 111.51 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -131.74 123.78 28.38 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -163.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.1 mt -115.63 101.08 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 120.837 -1.164 . . . . 0.0 111.812 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -97.34 156.2 16.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.33 1.452 . . . . 0.0 111.66 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.77 140.98 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.34 1.456 . . . . 0.0 110.876 172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.435 ' HB2' HD11 ' A' ' 66' ' ' LEU . 41.9 t60 -125.81 132.38 52.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 112.324 171.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -118.2 132.94 56.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.401 1.08 . . . . 0.0 111.289 -173.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -153.23 160.49 42.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.573 1.549 . . . . 0.0 110.138 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.57 -80.54 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.728 -1.233 . . . . 0.0 112.231 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -140.86 154.01 45.99 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.577 1.551 . . . . 0.0 111.205 -176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.8 p -98.83 142.98 29.66 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -79.16 -15.37 58.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.267 1.427 . . . . 0.0 112.984 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 pt -136.32 -171.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 128.687 2.795 . . . . 0.0 109.134 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -62.63 140.32 58.67 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.8 t -72.41 -34.53 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.93 -51.62 66.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.341 0.656 . . . . 0.0 111.497 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -66.51 -37.62 85.44 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.612 -0.68 . . . . 0.0 111.258 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -59.41 -49.59 77.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.985 -1.072 . . . . 0.0 111.638 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.79 96.86 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.474 0.71 . . . . 0.0 111.212 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.28 -41.58 89.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.144 0.978 . . . . 0.0 112.691 174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.99 -33.67 59.74 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.161 -0.962 . . . . 0.0 112.72 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.4 t -69.33 -43.2 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 119.728 1.149 . . . . 0.0 110.931 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -57.36 -47.07 82.59 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.787 1.235 . . . . 0.0 110.849 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -76.12 -35.21 59.38 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.302 1.041 . . . . 0.0 112.404 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -62.39 -41.09 98.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.315 1.046 . . . . 0.0 111.459 172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.75 -2.2 25.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.091 1.356 . . . . 0.0 113.669 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 55.82 38.84 30.53 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.343 1.457 . . . . 0.0 112.851 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.73 -18.33 64.86 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.31 -3.66 0.99 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 126.623 1.969 . . . . 0.0 115.148 172.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -73.28 5.84 3.29 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.118 1.767 . . . . 0.0 115.347 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.1 p -83.18 156.46 23.2 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.45 -40.1 70.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.677 0.791 . . . . 0.0 112.637 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.5 mt -90.81 -13.39 33.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.511 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 69.26 58.39 0.34 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.105 1.362 . . . . 0.0 108.657 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -145.66 33.92 1.04 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.746 1.218 . . . . 0.0 113.121 -162.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.01 147.57 23.82 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.684 1.135 . . . . 0.0 110.407 166.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -128.23 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.722 1.609 . . . . 0.0 108.809 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 34' ' ' HIS . 26.3 tp -125.5 118.93 26.85 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.834 1.254 . . . . 0.0 111.122 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -90.22 97.37 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -78.88 125.08 28.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.157 -0.964 . . . . 0.0 110.187 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.8 t -121.75 127.24 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.247 1.019 . . . . 0.0 111.28 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.54 95.98 8.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.555 1.542 . . . . 0.0 109.866 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.16 -19.55 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -76.99 -41.36 43.21 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.166 0.587 . . . . 0.0 112.156 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -86.36 -27.81 24.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.301 1.441 . . . . 0.0 111.331 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 88.42 14.76 0.07 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 128.24 2.616 . . . . 0.0 111.383 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 p -97.78 157.64 15.96 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.063 -1.023 . . . . 0.0 111.059 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -134.78 149.58 50.42 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.453 1.101 . . . . 0.0 109.389 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.11 139.98 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 125.65 1.58 . . . . 0.0 108.101 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 50.3 mt -108.9 129.08 64.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -141.17 138.55 33.47 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.835 0.743 . . . . 0.0 110.553 172.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -135.7 159.18 24.11 Favored Glycine 0 C--O 1.24 0.517 0 C-N-CA 124.722 1.153 . . . . 0.0 110.314 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -66.45 161.93 21.68 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 123.194 1.474 . . . . 0.0 114.629 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -54.38 -31.49 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.375 1.47 . . . . 0.0 114.119 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.08 -31.43 57.67 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 119.552 1.069 . . . . 0.0 113.641 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -68.29 -57.25 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.554 1.177 . . . . 0.0 109.231 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -55.37 -38.08 68.36 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.031 0.932 . . . . 0.0 113.133 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.66 -11.75 60.76 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 m -114.0 -30.99 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -105.25 147.86 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 120.02 1.282 . . . . 0.0 112.446 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 t -92.22 171.75 8.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.547 1.139 . . . . 0.0 112.888 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -52.45 -38.6 59.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.387 1.875 . . . . 0.0 115.181 165.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.51 -28.15 67.59 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.804 -1.185 . . . . 0.0 112.895 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.426 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.5 t80 -73.03 -30.08 63.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.909 0.484 . . . . 0.0 110.953 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.546 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 8.4 m95 -80.31 -29.46 38.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.515 1.126 . . . . 0.0 113.502 177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.41 -42.82 70.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.43 1.492 . . . . 0.0 113.085 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.0 p -59.0 -37.24 76.42 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.9 0.88 . . . . 0.0 112.281 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.53 -54.99 40.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.8 1.64 . . . . 0.0 110.834 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -57.35 -48.33 79.29 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 124.21 1.004 . . . . 0.0 110.112 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.1 -36.78 84.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.97 -46.72 73.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.049 0.84 . . . . 0.0 112.308 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.25 -53.93 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.858 0.863 . . . . 0.0 109.89 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.17 1.788 . . . . 0.0 112.804 -175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.23 -51.64 62.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 119.55 1.068 . . . . 0.0 111.183 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.94 -35.32 62.16 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 119.047 -0.502 . . . . 0.0 110.806 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -58.8 -45.94 88.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.048 0.84 . . . . 0.0 110.448 171.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -58.8 -41.79 87.59 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.944 0.793 . . . . 0.0 111.699 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.28 -12.76 61.55 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.03 1.75 67.01 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.019 1.771 . . . . 0.0 114.559 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.99 75.03 1.64 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.477 1.511 . . . . 0.0 111.855 -174.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -51.85 -43.86 63.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.191 1.396 . . . . 0.0 112.909 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -54.34 -57.59 10.66 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.27 0.628 . . . . 0.0 111.517 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -62.23 -34.31 76.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.628 1.171 . . . . 0.0 111.585 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.72 83.22 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 118.585 0.63 . . . . 0.0 113.382 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.93 -48.79 64.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.333 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.77 -51.52 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.091 0.956 . . . . 0.0 111.115 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.33 -25.35 63.26 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.155 -0.965 . . . . 0.0 113.054 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.35 -41.68 84.82 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.391 171.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.5 mt -64.71 -53.03 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.982 1.313 . . . . 0.0 110.229 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -55.76 -48.4 75.34 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.936 0.895 . . . . 0.0 113.36 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -70.92 -36.61 72.73 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.953 -0.467 . . . . 0.0 111.447 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.53 99.11 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.565 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.9 -48.17 86.94 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-N 119.429 1.013 . . . . 0.0 111.773 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 50.9 ttp -56.23 -48.76 75.85 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.226 1.013 . . . . 0.0 111.674 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.426 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -70.8 -42.83 69.8 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.104 0.562 . . . . 0.0 111.839 -172.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.87 -33.62 76.26 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.323 1.449 . . . . 0.0 111.336 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.04 -16.77 60.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 173.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -67.42 -45.81 75.03 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.557 -1.339 . . . . 0.0 110.823 168.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -76.19 -47.3 24.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.329 1.452 . . . . 0.0 111.538 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -127.87 85.2 61.25 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.095 1.358 . . . . 0.0 109.864 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -67.49 151.29 80.11 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.874 2.383 . . . . 0.0 111.11 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -62.95 149.95 43.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -132.07 152.03 51.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.008 1.723 . . . . 0.0 109.661 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -63.38 -30.02 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.712 -1.243 . . . . 0.0 113.722 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.2 18.6 13.33 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.575 1.15 . . . . 0.0 112.702 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -57.11 146.55 27.29 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.976 0.893 . . . . 0.0 112.247 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 pp -115.1 176.12 2.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 124.899 1.28 . . . . 0.0 111.241 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.1 114.59 9.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -105.36 -27.54 11.42 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.809 1.644 . . . . 0.0 111.778 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 63.6 mt -114.5 143.95 30.87 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.28 148.54 61.92 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.757 2.971 . . . . 0.0 112.852 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -78.35 -4.28 47.31 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.594 1.557 . . . . 0.0 114.354 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 p -76.38 155.88 33.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.791 -1.193 . . . . 0.0 112.18 -170.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.3 mt -79.69 128.4 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.95 0.9 . . . . 0.0 109.578 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 t -89.87 145.12 25.38 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.986 0.514 . . . . 0.0 111.684 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.63 147.35 31.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 111.351 -172.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.961 0 C-N-CA 125.899 1.714 . . . . 0.0 116.191 -176.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -166.69 150.06 6.92 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.109 0.868 . . . . 0.0 110.923 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 5' ' ' GLU . 56.6 tttt -84.25 113.26 20.98 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.135 -0.978 . . . . 0.0 111.409 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.03 -39.03 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.583 -0.698 . . . . 0.0 111.823 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 36.2 mt-10 -77.39 53.87 1.08 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.906 2.082 . . . . 0.0 111.399 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -94.34 -41.62 9.33 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.856 -1.152 . . . . 0.0 111.338 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -61.33 -34.48 75.32 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.096 0.958 . . . . 0.0 113.018 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt -132.54 154.66 49.76 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.081 1.752 . . . . 0.0 109.512 -172.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.35 155.98 19.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.878 0.471 . . . . 0.0 110.545 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.95 -29.04 26.47 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -74.41 -35.32 63.41 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -73.17 -48.08 38.31 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.643 1.577 . . . . 0.0 109.938 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.44 -45.64 92.14 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.796 1.638 . . . . 0.0 111.241 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -60.79 -33.91 73.7 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.566 -1.334 . . . . 0.0 112.794 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.81 -44.13 67.19 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -67.86 -39.34 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 119.136 0.88 . . . . 0.0 111.974 173.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.46 -39.13 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 O-C-N 121.65 -0.656 . . . . 0.0 111.955 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.8 -27.49 63.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.02 87.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.016 0.825 . . . . 0.0 111.776 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.4 mm -60.18 -47.87 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.193 0.597 . . . . 0.0 111.19 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -60.28 -30.76 69.67 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.26 -35.86 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.72 -1.238 . . . . 0.0 111.141 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.75 98.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.38 1.072 . . . . 0.0 112.336 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -57.05 -29.77 63.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.222 1.409 . . . . 0.0 112.12 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -88.31 3.23 50.45 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.042 -1.662 . . . . 0.0 112.326 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.63 -15.64 7.45 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.376 1.871 . . . . 0.0 113.682 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 29' ' ' GLY . 6.7 t -154.24 160.16 41.67 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.547 1.939 . . . . 0.0 109.82 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 p -92.11 23.04 3.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.53 ' H ' HG23 ' A' ' 27' ' ' THR . . . -125.61 153.66 18.32 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 126.385 1.945 . . . . 0.0 112.187 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -106.0 137.26 44.22 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -166.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.8 128.69 75.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -135.37 142.37 45.71 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.635 0.774 . . . . 0.0 111.541 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 81.2 t -107.82 135.28 47.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.694 1.197 . . . . 0.0 109.465 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' HB2' HD11 ' A' ' 66' ' ' LEU . 68.6 t60 -115.99 138.51 51.14 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.705 1.202 . . . . 0.0 112.326 166.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.9 tp -126.11 129.44 49.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.518 1.127 . . . . 0.0 111.822 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -158.88 156.62 29.91 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.521 1.528 . . . . 0.0 109.312 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -79.83 -70.61 0.5 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 121.034 -1.041 . . . . 0.0 112.464 -173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 t -144.04 152.05 40.49 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 125.899 1.68 . . . . 0.0 111.552 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.8 m -104.48 137.18 42.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.267 1.427 . . . . 0.0 111.524 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.87 -14.57 57.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 112.977 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.81 -152.64 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.589 1.955 . . . . 0.0 110.171 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.46 134.71 36.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.21 1.004 . . . . 0.0 112.349 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -39.73 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.271 -0.893 . . . . 0.0 112.151 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.12 -43.47 82.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.551 1.069 . . . . 0.0 111.527 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.62 -43.04 98.02 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.679 -0.638 . . . . 0.0 111.88 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -58.43 -45.45 88.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.784 0.72 . . . . 0.0 111.669 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.4 87.29 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 117.442 -1.266 . . . . 0.0 111.405 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 51.1 ttp -60.29 -50.01 75.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.175 1.352 . . . . 0.0 111.077 170.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.495 0.588 . . . . 0.0 111.724 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.5 t -63.68 -45.31 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.397 1.079 . . . . 0.0 111.703 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.26 -48.82 80.1 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.632 0.773 . . . . 0.0 111.068 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -70.28 -39.67 74.76 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.139 0.976 . . . . 0.0 111.619 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -61.65 -42.96 99.63 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.412 1.485 . . . . 0.0 112.926 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.93 -2.83 10.7 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.479 -0.763 . . . . 0.0 112.882 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.81 37.49 18.66 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.797 1.639 . . . . 0.0 111.713 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.6 mtp -74.48 -17.96 60.69 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.48 -4.87 9.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 170.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.03 52.16 0.7 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.531 1.532 . . . . 0.0 113.38 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 p -135.3 149.63 49.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.147 0.979 . . . . 0.0 112.05 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -67.4 -25.58 66.02 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.17 -1.81 13.57 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.139 1.376 . . . . 0.0 113.4 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 56.22 54.88 7.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.089 1.356 . . . . 0.0 111.112 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -133.09 41.99 3.08 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.526 0.731 . . . . 0.0 112.699 -166.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.48 147.51 18.66 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.756 1.17 . . . . 0.0 111.552 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.77 138.84 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.531 1.133 . . . . 0.0 110.354 172.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.5 tp -115.06 128.52 56.29 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.79 1.236 . . . . 0.0 110.14 165.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -101.95 93.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 124.132 0.973 . . . . 0.0 109.005 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -75.52 123.42 25.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.034 0.934 . . . . 0.0 109.912 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.11 122.43 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.67 1.188 . . . . 0.0 110.731 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.07 89.22 5.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.901 1.28 . . . . 0.0 109.621 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.51 -16.49 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -75.24 -35.17 61.45 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.439 -0.788 . . . . 0.0 112.274 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -95.77 -8.01 35.6 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.095 1.358 . . . . 0.0 112.54 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.3 tttt 70.17 24.75 4.82 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.658 1.983 . . . . 0.0 112.722 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 p -108.93 167.96 9.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.086 1.354 . . . . 0.0 112.519 -173.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -145.81 147.39 31.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.557 1.543 . . . . 0.0 110.585 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.3 149.28 24.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 126.544 1.937 . . . . 0.0 108.166 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.85 127.02 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -136.92 129.73 30.57 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.429 0.691 . . . . 0.0 110.235 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.27 15.19 Favored Glycine 0 CA--C 1.513 -0.078 0 C-N-CA 124.825 1.202 . . . . 0.0 112.065 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -69.9 161.35 30.1 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.384 1.087 . . . . 0.0 113.378 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -52.14 -38.31 57.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.604 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.72 -11.6 69.35 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 118.009 -1.44 . . . . 0.0 115.047 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 93.3 mt -89.02 -57.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 119.483 1.641 . . . . 0.0 108.752 160.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -55.58 -33.76 64.2 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.87 -15.57 58.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.099 1.76 . . . . 0.0 113.639 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.86 -28.26 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 m -107.39 168.63 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.655 1.116 . . . . 0.0 112.673 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.9 p -114.85 177.75 4.53 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.912 1.285 . . . . 0.0 112.681 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -63.16 -26.8 68.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.656 -1.278 . . . . 0.0 113.574 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.75 -34.92 79.47 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.996 1.319 . . . . 0.0 111.701 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.1 t80 -71.09 -30.59 66.74 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.537 1.135 . . . . 0.0 111.987 174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -82.33 -31.87 29.68 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.226 1.01 . . . . 0.0 112.666 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -58.39 -41.46 84.92 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.001 0.92 . . . . 0.0 111.689 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p -60.83 -33.92 73.76 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.766 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.2 m -64.53 -52.13 59.33 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.673 0.789 . . . . 0.0 110.083 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.5 -45.99 91.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.407 0.683 . . . . 0.0 111.207 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.81 -41.93 96.65 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.11 -50.83 68.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.999 0.428 . . . . 0.0 112.085 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 79.8 mt -59.48 -49.19 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.449 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -57.93 -42.71 85.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.099 1.36 . . . . 0.0 112.608 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.49 -53.29 57.02 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 111.467 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.92 -31.1 66.02 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 122.161 -0.337 . . . . 0.0 111.695 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -67.82 -39.98 83.88 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.737 0.699 . . . . 0.0 112.288 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.27 -34.22 77.19 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.159 0.984 . . . . 0.0 111.855 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -71.35 -31.08 66.95 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.994 0.918 . . . . 0.0 112.316 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 7.53 30.78 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.266 1.412 . . . . 0.0 114.593 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -101.87 72.59 1.36 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.803 1.641 . . . . 0.0 110.897 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -51.17 -46.52 62.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.84 1.256 . . . . 0.0 113.082 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -46.76 -60.25 2.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.148 1.379 . . . . 0.0 112.792 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -65.8 -35.91 82.03 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.984 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.91 -38.43 75.21 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 120.04 1.291 . . . . 0.0 113.327 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.03 -51.63 52.42 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.455 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.11 -51.63 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.717 0.807 . . . . 0.0 111.5 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.93 -34.18 77.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.307 0.958 . . . . 0.0 111.768 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -42.24 95.04 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.303 0.954 . . . . 0.0 112.16 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 42.9 mt -64.25 -44.26 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.608 1.563 . . . . 0.0 111.348 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.12 -42.13 94.13 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.845 0.831 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -71.39 -39.79 70.95 Favored 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 120.642 -1.286 . . . . 0.0 112.049 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.99 90.4 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.359 0.664 . . . . 0.0 110.409 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.25 -53.85 39.1 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.846 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 80.9 mmm -64.04 -26.36 68.52 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.45 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.26 -52.21 11.41 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.781 170.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 mt -58.23 -37.39 74.76 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.737 1.215 . . . . 0.0 112.296 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.7 62.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.447 1.499 . . . . 0.0 113.312 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -67.53 -29.07 68.37 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.105 -0.997 . . . . 0.0 112.52 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.43 -32.62 11.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.112 1.365 . . . . 0.0 112.161 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -128.79 79.11 75.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.132 1.773 . . . . 0.0 110.053 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.11 136.01 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.259 1.972 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -63.44 139.66 58.79 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.309 1.043 . . . . 0.0 112.896 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -113.37 156.05 24.12 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.683 1.23 . . . . 0.0 112.911 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.49 -14.77 58.85 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.81 -1.806 . . . . 0.0 114.267 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -121.43 35.64 4.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.166 1.786 . . . . 0.0 110.571 174.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 151.24 26.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.538 -0.726 . . . . 0.0 112.887 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.16 105.44 10.75 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 124.341 1.056 . . . . 0.0 111.752 -166.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.25 111.24 10.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.82 -32.7 12.55 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 126.608 1.963 . . . . 0.0 111.466 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.27 163.0 18.76 Favored Pre-proline 0 N--CA 1.469 0.495 0 C-N-CA 123.827 0.851 . . . . 0.0 111.42 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.52 154.28 7.75 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.273 2.648 . . . . 0.0 110.415 169.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -2.64 12.38 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.0 m -78.18 124.45 28.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.831 1.252 . . . . 0.0 110.763 -163.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.0 mt -60.81 128.47 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.703 1.201 . . . . 0.0 108.905 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.8 t -87.22 135.43 33.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -136.55 139.35 42.13 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.903 -1.123 . . . . 0.0 109.998 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.304 0 CA-C-O 117.135 -1.925 . . . . 0.0 110.947 170.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 mtm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.623 -1.18 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -51.1 -39.03 55.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 121.844 2.111 . . . . 0.0 114.433 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -59.43 -24.74 63.75 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.8 pt -112.74 -3.64 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 126.374 1.87 . . . . 0.0 113.05 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -72.14 -54.48 9.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.427 1.491 . . . . 0.0 109.897 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -102.28 113.79 27.39 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.01 -34.23 74.51 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.987 -0.446 . . . . 0.0 111.628 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.478 HD13 ' CD ' ' A' ' 110' ' ' LYS . 23.0 mt -143.36 138.85 29.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.509 2.324 . . . . 0.0 109.184 -176.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -73.57 143.04 46.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.087 0.955 . . . . 0.0 110.673 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.09 -29.26 3.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.17 -46.81 79.21 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.067 0.947 . . . . 0.0 112.754 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -76.26 -31.68 58.43 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.231 1.012 . . . . 0.0 111.17 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 37.3 mt-10 -70.89 -38.16 73.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.865 0.866 . . . . 0.0 111.558 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.23 -41.59 99.13 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.493 -1.379 . . . . 0.0 111.628 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.09 98.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.616 0.767 . . . . 0.0 112.833 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.28 -38.25 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 120.979 -1.076 . . . . 0.0 112.167 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.55 -40.17 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 118.546 0.612 . . . . 0.0 110.845 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -68.68 -32.99 73.21 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.92 65.54 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -72.28 -46.49 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.41 1.084 . . . . 0.0 110.521 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -56.28 -30.67 62.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.024 0.93 . . . . 0.0 112.967 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.06 -28.17 60.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 113.548 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.86 62.37 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.101 0.96 . . . . 0.0 111.936 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -66.55 -7.88 23.08 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 122.733 1.254 . . . . 0.0 113.27 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -95.16 3.08 55.07 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 119.428 -2.045 . . . . 0.0 112.944 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -125.49 -17.66 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.941 2.097 . . . . 0.0 114.053 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 t -151.41 151.75 32.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.85 1.66 . . . . 0.0 108.927 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -90.84 49.72 1.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.179 0.991 . . . . 0.0 110.859 171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -155.02 128.88 2.41 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.144 -1.597 . . . . 0.0 111.062 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -96.9 126.9 42.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.733 0.813 . . . . 0.0 112.843 -153.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -113.43 115.29 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 122.066 0.936 . . . . 0.0 111.397 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.499 HH11 ' CG ' ' A' ' 56' ' ' MET . 73.4 mtp180 -118.21 153.55 33.7 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.384 1.473 . . . . 0.0 112.647 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.63 141.94 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.913 1.685 . . . . 0.0 111.3 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -131.46 123.25 27.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.251 1.02 . . . . 0.0 112.358 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD11 ' CG1' ' A' ' 71' ' ' VAL . 16.3 tp -111.06 127.84 55.68 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.819 0.848 . . . . 0.0 111.216 -175.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -149.46 163.47 37.7 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.134 0.974 . . . . 0.0 110.301 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -79.34 -66.63 0.84 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.374 -1.454 . . . . 0.0 112.016 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -159.6 151.77 20.85 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.47 1.108 . . . . 0.0 112.53 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 p -105.26 144.02 32.62 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 112.321 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -77.87 -11.96 59.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.692 1.197 . . . . 0.0 113.518 170.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.68 -164.97 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 127.962 2.505 . . . . 0.0 110.028 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -79.42 136.76 37.04 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.43 -1.419 . . . . 0.0 112.579 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 17.5 t -58.66 -40.33 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -59.12 -46.83 87.32 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.934 0.788 . . . . 0.0 112.211 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -72.6 -38.72 67.74 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.718 0.407 . . . . 0.0 111.86 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -60.28 -47.58 85.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.24 -0.287 . . . . 0.0 111.026 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.02 89.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.092 0.957 . . . . 0.0 111.348 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.3 ttp -62.56 -50.67 70.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.768 0.827 . . . . 0.0 111.543 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.73 -49.06 79.21 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.987 0.915 . . . . 0.0 111.918 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.41 -41.1 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.041 0.936 . . . . 0.0 112.026 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.09 -46.09 90.74 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.988 0.813 . . . . 0.0 111.842 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -72.99 -32.78 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 112.438 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.35 -32.75 70.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.895 1.278 . . . . 0.0 112.807 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.9 mt -78.72 -11.51 59.98 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.3 -0.875 . . . . 0.0 112.82 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 64.49 35.68 9.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.34 1.456 . . . . 0.0 112.909 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.499 ' CG ' HH11 ' A' ' 32' ' ' ARG . 69.3 mtp -67.25 -22.62 65.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.898 1.279 . . . . 0.0 114.275 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.5 -7.93 8.16 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 126.722 2.009 . . . . 0.0 112.715 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -74.98 47.21 0.34 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.263 1.825 . . . . 0.0 112.719 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.6 p -119.34 150.74 39.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.864 1.666 . . . . 0.0 110.657 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -64.64 -43.9 92.2 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.911 -1.118 . . . . 0.0 112.494 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -93.45 -9.69 37.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 67.5 55.18 0.65 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.668 1.587 . . . . 0.0 108.58 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -126.17 29.87 5.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.554 1.141 . . . . 0.0 112.975 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.99 132.44 12.2 Favored Glycine 0 N--CA 1.47 0.964 0 O-C-N 120.424 -1.423 . . . . 0.0 110.988 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -111.77 134.5 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 124.528 1.131 . . . . 0.0 109.5 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 34' ' ' HIS . 16.2 tp -117.75 130.59 56.41 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.81 0.844 . . . . 0.0 110.693 166.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.5 mt -106.16 95.34 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -75.32 125.63 29.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.6 1.16 . . . . 0.0 110.723 171.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 67.0 t -117.27 131.19 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.04 1.336 . . . . 0.0 110.332 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.27 95.32 6.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.003 1.721 . . . . 0.0 110.414 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.4 ' CG1' HD11 ' A' ' 35' ' ' LEU . 19.5 m -72.65 -16.36 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -75.27 -51.62 12.83 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -90.43 -5.75 55.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.94 1.296 . . . . 0.0 113.861 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.1 tttt 65.02 31.17 11.39 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.23 2.212 . . . . 0.0 112.751 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.5 p -111.06 163.54 13.76 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.028 0.931 . . . . 0.0 111.115 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -139.23 147.65 42.02 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.164 1.385 . . . . 0.0 109.534 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.89 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 125.758 1.623 . . . . 0.0 108.126 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.5 133.93 63.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -147.04 138.45 24.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.077 1.351 . . . . 0.0 110.036 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.71 164.3 21.15 Favored Glycine 0 N--CA 1.463 0.483 0 C-N-CA 124.756 1.169 . . . . 0.0 112.214 -171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -70.83 166.54 20.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 123.257 1.503 . . . . 0.0 112.705 170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.42 -39.16 67.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.174 -1.376 . . . . 0.0 113.153 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.33 -46.49 78.11 Favored Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.386 1.47 . . . . 0.0 112.991 -173.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.41 -59.26 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 118.208 1.004 . . . . 0.0 109.46 171.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.01 -22.67 64.75 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.72 -29.34 25.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.65 172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -24.63 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.2 m -117.14 164.14 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.668 1.187 . . . . 0.0 112.649 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 92.2 p -107.93 174.42 5.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.694 1.198 . . . . 0.0 113.32 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.94 -33.41 73.12 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 120.342 -1.474 . . . . 0.0 113.359 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.1 -23.92 63.12 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -68.12 -37.59 81.29 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 117.698 0.226 . . . . 0.0 110.608 169.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -77.01 -25.57 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.3 -36.3 79.72 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.687 0.676 . . . . 0.0 112.715 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.3 m -55.98 -45.39 78.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.634 0.773 . . . . 0.0 111.427 171.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -61.53 -47.68 84.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.305 1.442 . . . . 0.0 110.842 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -59.34 -47.84 83.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -64.86 -35.5 81.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.448 1.099 . . . . 0.0 113.368 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.67 -53.26 43.64 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.936 0.789 . . . . 0.0 111.692 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.5 mt -62.33 -48.46 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.014 0.526 . . . . 0.0 110.459 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -60.07 -43.2 95.63 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.073 1.349 . . . . 0.0 112.905 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.26 -42.17 93.51 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 119.55 1.068 . . . . 0.0 111.827 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -74.88 -38.9 61.79 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.799 0.44 . . . . 0.0 111.926 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -60.76 -40.11 91.25 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.353 0.978 . . . . 0.0 112.054 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.57 -32.14 73.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.918 1.287 . . . . 0.0 112.078 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -74.59 -39.28 62.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.792 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.41 -2.21 12.59 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.23 1.872 . . . . 0.0 113.062 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -89.24 71.27 8.26 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.367 1.467 . . . . 0.0 111.102 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -52.73 -42.34 64.81 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.144 0.977 . . . . 0.0 112.407 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' CD ' HD13 ' A' ' 8' ' ' LEU . 19.2 tptt -64.93 -48.52 73.82 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -55.37 -47.51 75.69 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.528 0.731 . . . . 0.0 109.695 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -58.8 -41.31 95.95 Favored Glycine 0 N--CA 1.467 0.741 0 CA-C-N 119.245 0.929 . . . . 0.0 113.695 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.45 -43.03 74.12 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.14 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.66 -50.42 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.599 1.16 . . . . 0.0 110.68 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -69.47 -25.05 63.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.875 1.27 . . . . 0.0 112.718 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.93 -41.85 26.74 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 124.083 0.849 . . . . 0.0 112.614 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 48.0 mt -60.61 -43.61 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.109 0.955 . . . . 0.0 111.166 174.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -58.23 -49.21 77.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.831 0.853 . . . . 0.0 112.621 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -71.55 -36.5 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 118.962 -0.542 . . . . 0.0 111.012 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -49.21 78.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.875 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.26 -50.09 68.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.703 1.138 . . . . 0.0 112.341 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -64.17 -33.58 76.11 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.5 -46.55 38.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.794 0.725 . . . . 0.0 111.193 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.46 -39.26 83.09 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.215 1.406 . . . . 0.0 110.47 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.09 52.33 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.1 -41.67 99.42 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.859 -1.151 . . . . 0.0 110.805 173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -84.84 -47.58 10.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.262 1.825 . . . . 0.0 111.144 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -114.38 78.18 4.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.725 2.01 . . . . 0.0 111.061 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.91 140.57 42.45 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.838 2.358 . . . . 0.0 111.256 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -59.39 141.75 53.86 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -115.42 149.26 38.29 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 123.892 0.877 . . . . 0.0 110.937 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -61.69 -25.82 67.65 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.29 -1.506 . . . . 0.0 112.297 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -96.07 22.14 7.92 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.655 1.582 . . . . 0.0 113.452 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.55 158.75 5.59 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.8 124.25 53.28 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.721 1.209 . . . . 0.0 112.572 -172.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -84.27 95.67 8.77 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 125.998 1.719 . . . . 0.0 109.087 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.2 -31.62 17.83 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.873 -1.142 . . . . 0.0 113.151 -170.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 32' ' ' ARG . 93.2 mt -111.7 166.04 11.66 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.29 1.036 . . . . 0.0 109.489 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -95.05 146.51 1.53 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.417 2.078 . . . . 0.0 111.332 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -74.29 4.15 6.22 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 60.2 p -72.72 168.97 17.64 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.653 1.181 . . . . 0.0 111.387 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.42 144.45 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 O-C-N 120.535 -1.353 . . . . 0.0 111.132 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.2 t -99.99 146.78 26.32 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.682 1.193 . . . . 0.0 111.026 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -153.18 94.86 1.88 Allowed 'General case' 0 CA--C 1.553 1.094 0 O-C-N 120.908 -1.12 . . . . 0.0 112.92 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 C-N-CA 125.05 1.31 . . . . 0.0 114.904 -173.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -53.63 -42.55 67.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.434 -1.416 . . . . 0.0 111.841 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -64.87 -18.54 65.26 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.62 -20.39 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.486 1.114 . . . . 0.0 112.827 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.25 -34.23 77.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.599 1.56 . . . . 0.0 112.613 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -146.58 125.96 13.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.857 1.263 . . . . 0.0 109.038 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -68.46 -41.76 79.73 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.651 0.781 . . . . 0.0 112.709 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.0 mt -142.76 137.33 29.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.958 2.103 . . . . 0.0 108.245 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -72.59 170.2 14.93 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.371 0.532 . . . . 0.0 111.386 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.38 68.64 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.111 -0.993 . . . . 0.0 112.752 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -60.7 -34.79 74.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.661 1.184 . . . . 0.0 112.395 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 110' ' ' LYS . 88.6 mt-10 -84.43 -42.47 15.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.0 0.92 . . . . 0.0 110.902 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -57.22 -50.46 72.8 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.555 1.142 . . . . 0.0 111.774 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -55.16 -39.08 69.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.819 -1.175 . . . . 0.0 112.569 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.62 69.47 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 tt -71.43 -39.23 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.825 0.738 . . . . 0.0 111.136 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.7 t -59.55 -29.21 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.065 1.346 . . . . 0.0 112.641 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -72.86 -41.01 65.21 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.284 1.434 . . . . 0.0 113.557 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.15 77.58 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.5 mt -61.03 -49.42 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.961 0.905 . . . . 0.0 110.594 173.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -60.06 -24.68 64.77 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -86.07 -18.43 32.42 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.765 0.826 . . . . 0.0 111.985 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.95 -39.87 29.27 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.993 0.917 . . . . 0.0 111.262 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.59 -27.44 39.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.325 1.45 . . . . 0.0 112.557 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -90.66 1.7 56.57 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.706 -1.871 . . . . 0.0 113.615 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -112.81 -20.73 11.51 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.233 1.813 . . . . 0.0 111.938 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -160.56 148.55 16.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.526 1.13 . . . . 0.0 110.574 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.6 p -81.3 38.25 0.48 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.295 1.038 . . . . 0.0 111.815 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.49 143.27 14.93 Favored Glycine 0 C--N 1.344 1.019 0 C-N-CA 126.041 1.781 . . . . 0.0 109.884 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -108.9 124.77 51.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.769 0.828 . . . . 0.0 110.156 -165.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -123.84 130.89 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -145.93 150.15 35.55 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.353 1.461 . . . . 0.0 110.67 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.2 t -114.96 135.92 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.612 1.565 . . . . 0.0 109.887 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' HD11 ' A' ' 66' ' ' LEU . 18.5 t60 -117.4 122.66 44.42 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.387 1.475 . . . . 0.0 111.974 170.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -114.43 130.31 56.7 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.457 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -155.21 163.44 40.18 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.043 0.925 . . . . 0.0 110.764 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.5 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.3 mttt -75.05 -75.88 0.16 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.736 1.215 . . . . 0.0 112.086 -177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 t -138.15 173.19 11.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.774 2.029 . . . . 0.0 109.044 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.7 p -140.99 141.11 34.42 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.413 -0.805 . . . . 0.0 111.036 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -84.29 -7.19 59.41 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.76 -150.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.219 1.808 . . . . 0.0 111.137 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -85.83 121.07 27.96 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.29 -1.506 . . . . 0.0 111.365 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.58 -42.53 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -175.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.98 -47.54 84.38 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.107 -0.995 . . . . 0.0 112.444 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -72.17 -36.59 69.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.564 0.745 . . . . 0.0 111.362 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -68.99 -40.92 78.46 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.528 -0.732 . . . . 0.0 112.319 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -33.0 74.8 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.365 -0.834 . . . . 0.0 110.649 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.2 ttp -65.56 -44.37 86.98 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.976 0.807 . . . . 0.0 111.072 169.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.09 -52.46 65.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.335 0.97 . . . . 0.0 111.433 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.9 t -59.07 -45.06 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.964 1.305 . . . . 0.0 111.542 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.93 -50.46 73.68 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.431 1.014 . . . . 0.0 112.402 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -69.53 -36.48 76.43 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.427 1.091 . . . . 0.0 112.338 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -63.87 -40.24 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.853 1.261 . . . . 0.0 112.079 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.26 -6.37 45.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.326 1.05 . . . . 0.0 113.582 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 57.66 39.3 27.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.888 1.275 . . . . 0.0 111.79 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.8 mtp -66.81 -20.66 65.98 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.919 -1.113 . . . . 0.0 112.469 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.94 -15.78 14.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.998 2.119 . . . . 0.0 112.318 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -73.79 50.66 0.35 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.169 2.188 . . . . 0.0 111.818 175.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -125.3 123.95 40.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.734 2.014 . . . . 0.0 107.972 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -45.61 -50.34 13.35 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.672 1.189 . . . . 0.0 113.617 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.9 mt -87.0 -6.59 58.7 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 68.04 40.14 2.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.19 1.396 . . . . 0.0 110.966 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -114.65 41.46 2.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.361 1.464 . . . . 0.0 112.33 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.07 10.51 Favored Glycine 0 N--CA 1.477 1.388 0 O-C-N 121.451 -0.781 . . . . 0.0 112.843 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.97 133.67 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.808 1.304 . . . . 0.0 111.043 175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.4 tp -116.51 133.54 55.9 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.372 1.069 . . . . 0.0 111.485 172.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.5 mt -106.83 93.34 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.658 0.742 . . . . 0.0 109.633 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -77.34 113.67 15.36 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.955 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.32 134.26 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.861 1.264 . . . . 0.0 110.595 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.82 15.15 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.991 1.316 . . . . 0.0 110.042 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 37' ' ' LYS . 13.6 m -75.78 -18.32 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -81.62 -37.95 26.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.515 1.126 . . . . 0.0 111.908 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.23 -10.15 31.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.082 1.353 . . . . 0.0 112.53 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt 65.4 32.27 9.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.658 1.583 . . . . 0.0 112.257 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.1 p -111.15 160.42 16.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.265 1.826 . . . . 0.0 111.848 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -144.98 134.64 23.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.649 1.18 . . . . 0.0 110.065 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.53 138.38 54.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 124.994 1.318 . . . . 0.0 108.098 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.1 mt -118.19 131.55 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -137.25 136.81 38.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.631 0.772 . . . . 0.0 110.245 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 139.43 11.95 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -59.66 160.19 7.61 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 123.626 1.679 . . . . 0.0 110.628 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.3 -34.25 60.54 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.545 1.938 . . . . 0.0 113.71 -168.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.34 -31.64 77.56 Favored Glycine 0 N--CA 1.469 0.894 0 CA-C-O 118.666 -1.075 . . . . 0.0 112.85 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.6 mt -76.97 -55.78 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.277 1.538 . . . . 0.0 109.399 170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -50.84 -34.58 28.46 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.78 -25.79 44.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.06 -27.16 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.8 161.54 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.059 0.845 . . . . 0.0 113.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 m -113.63 173.27 6.5 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.57 1.548 . . . . 0.0 113.829 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -50.97 -41.67 59.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.929 1.692 . . . . 0.0 114.553 174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.6 -12.88 60.9 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.366 1.467 . . . . 0.0 113.395 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.7 t80 -83.96 -28.0 28.1 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.927 -1.733 . . . . 0.0 111.227 166.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -84.98 -21.0 29.7 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 113.279 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -60.72 -44.27 96.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.438 1.095 . . . . 0.0 111.576 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.1 p -57.52 -45.82 84.53 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.574 1.149 . . . . 0.0 111.351 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.4 m -57.36 -51.33 69.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.385 1.474 . . . . 0.0 111.028 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -58.68 -48.75 80.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.615 1.166 . . . . 0.0 111.627 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.63 -45.58 93.5 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.07 50.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.938 0.79 . . . . 0.0 112.577 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 63.0 mt -62.44 -46.3 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.704 -0.622 . . . . 0.0 110.419 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.72 -36.99 86.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.215 1.006 . . . . 0.0 112.743 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 28.7 mt -63.88 -41.83 97.65 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.703 1.138 . . . . 0.0 111.2 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -83.32 -31.19 26.98 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.901 -0.571 . . . . 0.0 112.282 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -63.47 -38.06 89.69 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 119.122 0.874 . . . . 0.0 112.699 170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -64.44 -35.82 82.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.885 0.874 . . . . 0.0 111.908 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -71.29 -36.38 71.65 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.031 0.932 . . . . 0.0 111.267 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 7.01 32.56 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 126.324 1.916 . . . . 0.0 113.936 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -90.32 72.05 7.1 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.645 1.222 . . . . 0.0 110.984 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -57.16 -36.79 71.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.352 1.061 . . . . 0.0 113.539 -173.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 12' ' ' GLU . 79.3 tttt -56.29 -51.95 66.32 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.776 0.83 . . . . 0.0 111.323 174.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.41 -34.26 77.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.107 1.363 . . . . 0.0 111.262 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -72.12 -43.72 47.09 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 118.744 0.702 . . . . 0.0 112.733 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 -47.02 76.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.174 0.487 . . . . 0.0 111.177 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.81 -40.95 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.357 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.77 -37.5 79.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 111.608 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 -41.78 99.8 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.7 mt -65.19 -47.75 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.211 1.004 . . . . 0.0 110.443 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -56.48 -52.68 63.79 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.571 1.149 . . . . 0.0 111.569 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.62 -38.79 84.41 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.603 0.761 . . . . 0.0 111.817 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.71 90.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 118.898 0.772 . . . . 0.0 111.252 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.3 98.6 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 119.032 0.833 . . . . 0.0 112.068 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 87.6 mmm -62.34 -39.64 93.74 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.041 1.42 . . . . 0.0 113.078 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.63 -44.35 50.93 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.57 0.748 . . . . 0.0 111.546 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.84 -35.23 77.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.163 0.985 . . . . 0.0 111.424 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.63 -16.18 35.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.973 1.309 . . . . 0.0 114.305 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.3 -30.14 57.62 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.736 -1.227 . . . . 0.0 112.177 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -93.28 -31.12 14.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.735 1.214 . . . . 0.0 112.919 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -139.94 88.26 12.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.431 1.492 . . . . 0.0 109.236 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.14 148.02 55.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.399 2.066 . . . . 0.0 110.972 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -64.49 155.81 31.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.218 1.008 . . . . 0.0 113.456 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -136.18 151.23 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.704 1.601 . . . . 0.0 110.371 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -65.8 -25.57 67.3 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 119.534 -1.979 . . . . 0.0 112.684 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.9 15.71 28.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.015 1.726 . . . . 0.0 112.091 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.72 162.78 6.23 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.848 0.859 . . . . 0.0 112.483 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pp -131.83 122.57 49.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 124.129 0.972 . . . . 0.0 111.23 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.81 106.88 18.38 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -94.61 -26.87 16.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.047 -0.978 . . . . 0.0 113.296 -171.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.9 mp -107.35 158.94 31.91 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 120.327 1.422 . . . . 0.0 111.652 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -82.83 149.94 14.16 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 124.069 3.179 . . . . 0.0 110.658 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.35 4.5 20.49 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.526 1.93 . . . . 0.0 114.844 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 74.2 p -74.92 161.82 29.17 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.207 1.403 . . . . 0.0 111.224 -170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm -90.96 119.32 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 120.697 -1.252 . . . . 0.0 110.079 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 57.7 m -76.03 139.23 41.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.459 0.647 . . . . 0.0 111.427 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -136.61 131.54 33.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.545 -0.722 . . . . 0.0 110.233 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 C-N-CA 125.067 1.318 . . . . 0.0 114.646 177.061 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -76.07 -27.91 57.39 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 120.522 1.51 . . . . 0.0 112.625 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -56.2 -26.52 51.26 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 pt -94.28 -10.32 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 124.617 1.167 . . . . 0.0 113.701 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -81.37 -34.9 31.41 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.405 1.082 . . . . 0.0 110.119 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -160.23 140.27 11.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.514 1.926 . . . . 0.0 108.988 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 71' ' ' VAL . 55.7 m-85 -76.03 -32.89 59.58 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -140.86 140.55 34.62 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 126.95 2.1 . . . . 0.0 106.774 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.6 m -65.94 157.1 31.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.1 0.96 . . . . 0.0 109.2 175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.53 52.97 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.302 -1.499 . . . . 0.0 112.484 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -69.23 -23.6 63.9 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.711 1.204 . . . . 0.0 112.916 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -87.4 -46.24 9.82 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.529 1.532 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.29 -48.38 80.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 111.233 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.52 -47.79 69.62 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.968 -1.083 . . . . 0.0 111.883 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.99 -37.23 83.84 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.302 1.041 . . . . 0.0 113.349 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 tt -72.73 -38.66 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.852 0.751 . . . . 0.0 111.92 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.12 -40.38 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.807 0.843 . . . . 0.0 112.061 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.37 -33.43 74.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.254 0.934 . . . . 0.0 112.427 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.22 66.76 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.9 mt -61.21 -50.04 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.506 1.122 . . . . 0.0 109.935 167.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -57.97 -33.97 69.43 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -73.66 -26.38 60.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.5 -32.03 42.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.095 0.958 . . . . 0.0 112.385 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -61.33 -23.67 65.9 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.264 1.026 . . . . 0.0 111.573 167.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -84.05 6.05 23.61 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.449 -2.032 . . . . 0.0 112.348 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -125.18 -7.8 7.08 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.111 1.764 . . . . 0.0 114.047 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -169.92 152.38 4.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.198 1.399 . . . . 0.0 110.491 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -82.27 21.65 0.9 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.249 1.42 . . . . 0.0 112.637 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.67 138.32 14.85 Favored Glycine 0 N--CA 1.469 0.873 0 C-N-CA 126.588 2.042 . . . . 0.0 109.711 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -109.62 125.25 52.39 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 118.03 0.915 . . . . 0.0 110.274 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.1 mt -117.39 125.95 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 119.935 -1.728 . . . . 0.0 112.628 -175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -129.22 131.18 47.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.475 1.51 . . . . 0.0 112.417 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -92.46 139.44 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.748 1.219 . . . . 0.0 112.867 170.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 t60 -128.55 125.81 39.06 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.974 1.31 . . . . 0.0 112.626 166.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 18.6 tp -115.76 133.01 56.46 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 111.294 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -159.09 158.24 32.6 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.806 1.242 . . . . 0.0 109.546 -174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 71' ' ' VAL . 96.1 mttt -75.2 -63.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.123 -1.611 . . . . 0.0 113.852 -170.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -157.74 164.28 37.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.395 1.478 . . . . 0.0 110.825 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.9 p -114.56 144.79 42.81 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 125.419 1.487 . . . . 0.0 112.557 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -81.25 -19.1 43.81 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.043 -1.036 . . . . 0.0 111.948 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.5 pt -119.12 -162.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.666 1.587 . . . . 0.0 111.516 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -77.71 139.09 39.37 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.895 0.878 . . . . 0.0 112.373 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.49 -35.09 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.988 0.915 . . . . 0.0 112.714 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -65.46 -51.47 59.92 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.779 0.718 . . . . 0.0 110.834 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.66 -42.29 98.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.613 1.165 . . . . 0.0 112.324 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -62.1 -47.28 85.32 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.371 -0.831 . . . . 0.0 112.129 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.89 89.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.495 -0.753 . . . . 0.0 111.469 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.6 ttp -62.01 -48.95 78.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.707 0.803 . . . . 0.0 111.891 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -61.01 -46.48 90.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.273 1.029 . . . . 0.0 110.952 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.21 -45.91 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.111 0.964 . . . . 0.0 111.88 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -56.75 -50.72 71.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.673 1.189 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -69.91 -35.45 74.6 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.31 0.644 . . . . 0.0 111.202 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -68.09 -32.36 72.63 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.365 1.066 . . . . 0.0 113.853 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.7 mt -78.61 -0.51 30.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.237 1.015 . . . . 0.0 112.534 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 58.44 32.2 21.83 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.285 1.834 . . . . 0.0 112.032 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.6 mtp -69.51 -16.67 63.49 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 118.266 -0.873 . . . . 0.0 112.991 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.23 -15.8 63.91 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.658 1.183 . . . . 0.0 113.193 168.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -85.04 55.55 3.54 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.389 -1.444 . . . . 0.0 112.083 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -110.0 160.82 16.09 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 0.0 110.369 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -72.21 -42.12 66.13 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.974 -1.078 . . . . 0.0 113.62 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.07 -11.63 32.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 74.21 28.15 1.44 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.382 1.473 . . . . 0.0 110.145 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -112.66 45.46 1.32 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.572 1.549 . . . . 0.0 111.481 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.9 131.03 10.58 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.782 1.182 . . . . 0.0 112.331 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.2 t -111.62 136.39 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.052 1.341 . . . . 0.0 110.8 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.6 tp -115.28 134.18 55.36 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 125.148 1.379 . . . . 0.0 111.405 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.23 89.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.002 1.321 . . . . 0.0 108.725 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -78.92 123.13 26.95 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.3 1.44 . . . . 0.0 111.547 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.3 t -124.85 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.066 -1.022 . . . . 0.0 111.825 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.06 116.17 28.57 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.195 1.398 . . . . 0.0 110.44 164.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.51 HG21 ' CE1' ' A' ' 7' ' ' PHE . 16.3 m -77.43 -25.19 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -74.93 -57.99 3.56 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 118.205 0.457 . . . . 0.0 110.216 -174.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.65 -4.13 55.36 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.2 tttt 68.39 27.53 6.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.682 1.593 . . . . 0.0 111.79 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 m -100.44 113.7 26.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.958 1.703 . . . . 0.0 110.491 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -88.95 141.9 28.1 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.0 0.92 . . . . 0.0 110.155 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.34 149.5 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 126.867 2.067 . . . . 0.0 108.143 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.8 mt -134.12 131.35 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -145.29 127.18 15.42 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.65 1.18 . . . . 0.0 109.534 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.38 149.68 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.6 162.82 3.59 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 122.964 1.364 . . . . 0.0 110.954 168.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -54.31 -35.67 62.91 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.488 1.515 . . . . 0.0 112.872 -168.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.83 -41.61 98.75 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.615 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mt -61.15 -56.16 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.294 1.547 . . . . 0.0 109.649 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -64.46 -19.47 65.58 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -85.07 -35.02 22.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.485 1.114 . . . . 0.0 111.367 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 88' ' ' VAL . 2.5 p -93.57 -24.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -173.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 87' ' ' VAL . 7.2 m -118.04 171.07 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 119.858 1.208 . . . . 0.0 111.998 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.5 p -113.13 172.22 7.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.989 1.316 . . . . 0.0 113.184 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -61.45 -30.82 70.83 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.839 -1.163 . . . . 0.0 112.551 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.41 -18.52 63.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.206 1.402 . . . . 0.0 112.668 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 39.0 t80 -81.22 -37.3 28.84 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.869 1.267 . . . . 0.0 111.915 168.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -73.71 -26.61 60.79 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.816 1.246 . . . . 0.0 113.568 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.37 -31.18 68.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.716 1.207 . . . . 0.0 113.677 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.7 p -70.02 -43.32 71.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.925 1.29 . . . . 0.0 111.517 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.0 m -56.88 -51.38 69.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.881 2.072 . . . . 0.0 110.779 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -58.71 -47.0 86.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.308 1.043 . . . . 0.0 111.63 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -65.12 -32.75 74.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.5 -53.39 29.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.326 0.967 . . . . 0.0 111.854 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt -61.28 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 122.625 0.37 . . . . 0.0 110.799 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.43 -44.05 92.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.399 1.08 . . . . 0.0 112.752 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.6 tp -59.64 -39.83 85.65 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.785 0.72 . . . . 0.0 112.433 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.42 -32.66 20.77 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.43 -177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.71 -41.06 98.96 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.809 1.186 . . . . 0.0 111.063 170.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.01 -38.11 72.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.2 1.0 . . . . 0.0 111.625 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -75.67 -35.82 60.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.598 0.759 . . . . 0.0 111.988 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.65 5.99 21.83 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 125.802 1.667 . . . . 0.0 114.582 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -99.25 78.41 2.22 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.729 1.212 . . . . 0.0 110.428 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.09 -49.35 69.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.128 0.971 . . . . 0.0 112.416 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -50.58 -53.81 27.62 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.052 0.541 . . . . 0.0 111.353 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -62.53 -42.88 99.81 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.524 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.7 -35.56 74.07 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.504 1.047 . . . . 0.0 112.946 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.49 -44.71 77.84 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.306 0.642 . . . . 0.0 111.142 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.64 -52.58 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.434 1.094 . . . . 0.0 111.279 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -57.77 -40.72 80.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 119.293 0.951 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.81 -43.32 87.05 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.044 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.25 -41.8 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 119.2 1.5 . . . . 0.0 112.123 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -63.73 -47.47 80.94 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.749 0.704 . . . . 0.0 110.944 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -66.56 -44.07 83.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.845 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.39 -51.11 69.57 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.259 0.624 . . . . 0.0 111.028 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.14 89.39 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 119.045 0.839 . . . . 0.0 112.891 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.6 mtp -64.06 -36.31 83.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.871 1.335 . . . . 0.0 112.288 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -76.67 -43.62 37.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.049 0.939 . . . . 0.0 111.229 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 mt -62.38 -35.15 78.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.134 0.974 . . . . 0.0 111.534 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.92 -20.9 62.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.696 1.198 . . . . 0.0 114.03 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -71.59 -41.98 68.31 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.022 -1.049 . . . . 0.0 111.444 170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -75.12 -46.64 33.13 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.926 0.89 . . . . 0.0 111.611 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -122.87 88.34 50.48 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.623 1.569 . . . . 0.0 109.986 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.59 138.48 35.27 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.458 2.105 . . . . 0.0 110.454 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -62.86 135.51 57.36 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -106.53 154.31 21.06 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.155 0.982 . . . . 0.0 110.205 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.68 -27.04 68.65 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.933 -1.729 . . . . 0.0 112.259 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.71 19.64 15.54 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 126.184 1.794 . . . . 0.0 113.108 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -58.99 159.6 6.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.281 1.032 . . . . 0.0 113.321 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.12 109.24 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 123.086 1.422 . . . . 0.0 113.083 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -93.21 100.58 12.93 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.214 1.406 . . . . 0.0 108.512 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -98.28 -8.44 27.22 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.001 0.921 . . . . 0.0 112.818 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 tp -99.12 154.46 37.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 120.329 -1.482 . . . . 0.0 111.578 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -82.84 141.2 10.62 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.751 2.301 . . . . 0.0 110.151 167.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.04 21.83 0.68 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.304 1.042 . . . . 0.0 112.857 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -77.24 150.55 35.37 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.925 2.09 . . . . 0.0 111.887 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.5 mt -80.97 130.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.149 0.98 . . . . 0.0 109.532 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.2 m -87.89 142.42 27.82 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.429 170.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.76 140.82 31.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.667 0.787 . . . . 0.0 110.837 -174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.28 1.895 . . . . 0.0 109.972 164.484 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttp . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 118.04 -0.981 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.6 p -71.14 -16.51 62.55 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.8 1.636 . . . . 0.0 114.517 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -88.92 129.59 35.59 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.132 -0.98 . . . . 0.0 110.533 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.61 -27.31 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.55 -21.38 62.71 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -134.62 81.49 1.91 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.705 1.202 . . . . 0.0 109.497 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.628 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 30.1 m-85 -50.82 -45.43 59.44 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.083 1.353 . . . . 0.0 112.598 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.5 mt -129.11 133.12 47.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.789 1.636 . . . . 0.0 108.382 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 m -74.78 162.93 28.22 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.429 1.092 . . . . 0.0 109.532 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.46 -41.21 39.58 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -61.79 -30.49 70.84 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.88 1.272 . . . . 0.0 113.55 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -81.87 -47.49 12.72 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.954 1.302 . . . . 0.0 110.535 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -62.37 -41.55 98.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.908 1.283 . . . . 0.0 110.691 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -55.56 -55.16 35.17 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.857 -1.152 . . . . 0.0 111.444 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.36 81.28 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -74.16 -30.34 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.167 0.894 . . . . 0.0 113.302 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.22 -42.46 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 120.478 -1.389 . . . . 0.0 111.047 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -63.58 -32.44 73.9 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.811 0.844 . . . . 0.0 112.347 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.26 85.71 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.273 -0.892 . . . . 0.0 112.596 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.9 mm -59.05 -45.99 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.093 0.957 . . . . 0.0 111.285 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -58.29 -31.16 67.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -81.97 -29.05 32.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.49 -43.74 84.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.815 0.734 . . . . 0.0 111.34 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -56.12 -26.98 52.16 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.794 1.638 . . . . 0.0 113.41 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -86.84 5.18 37.98 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 112.826 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.83 -8.05 5.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.983 1.713 . . . . 0.0 114.29 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.5 t -148.37 159.88 43.57 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.926 1.69 . . . . 0.0 109.316 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.2 p -94.26 37.01 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.17 0.988 . . . . 0.0 111.688 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.44 146.24 15.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 123.955 0.788 . . . . 0.0 112.611 -171.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -108.33 131.8 54.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.689 0.756 . . . . 0.0 111.605 -151.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.47 134.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.802 -1.186 . . . . 0.0 110.661 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -144.26 153.48 42.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.18 1.392 . . . . 0.0 111.862 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.03 136.91 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.081 1.352 . . . . 0.0 109.704 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -118.57 118.52 31.9 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.003 1.721 . . . . 0.0 111.937 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.8 tp -107.15 129.28 54.86 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.218 1.007 . . . . 0.0 112.086 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.52 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.0 tt0 -154.78 168.15 27.83 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.015 1.326 . . . . 0.0 111.897 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.18 -95.25 0.06 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.222 1.409 . . . . 0.0 113.479 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 p -116.05 165.21 13.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.332 2.253 . . . . 0.0 109.548 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 p -113.07 162.28 16.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.864 0.84 . . . . 0.0 111.977 170.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -95.36 -15.19 23.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.989 1.316 . . . . 0.0 113.009 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.4 pt -129.42 -150.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 126.978 2.111 . . . . 0.0 111.022 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -85.47 137.63 32.77 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.486 1.039 . . . . 0.0 112.01 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.29 -39.02 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.566 1.146 . . . . 0.0 112.422 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.94 -49.93 70.66 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.961 0.801 . . . . 0.0 111.764 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -64.59 -41.78 96.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 111.272 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.52 HH21 ' CD ' ' A' ' 36' ' ' GLU . 59.0 ttt85 -59.52 -48.89 79.9 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.042 0.937 . . . . 0.0 112.574 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.97 97.11 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 123.537 0.735 . . . . 0.0 111.077 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.18 -47.24 87.09 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.972 0.909 . . . . 0.0 112.172 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -63.87 -42.59 97.48 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.061 -1.024 . . . . 0.0 112.57 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -61.7 -41.99 92.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.867 0.867 . . . . 0.0 111.969 174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.26 -48.77 78.46 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 111.971 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -75.16 -31.64 61.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.799 0.84 . . . . 0.0 112.842 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -62.09 -48.28 80.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.096 0.959 . . . . 0.0 111.132 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.1 mt -72.77 -7.59 51.38 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.105 0.962 . . . . 0.0 113.524 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 63.45 42.82 6.38 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 112.208 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 34.4 mtt -71.29 -21.53 62.06 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.02 -8.96 8.39 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 127.026 2.13 . . . . 0.0 113.705 171.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -79.41 56.49 2.15 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.349 1.86 . . . . 0.0 111.081 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.7 p -128.99 145.18 51.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.549 1.94 . . . . 0.0 108.637 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -59.76 -39.66 85.59 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.5 mt -100.3 -8.82 23.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 117.081 -1.438 . . . . 0.0 114.519 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 69.93 39.73 1.38 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.708 1.203 . . . . 0.0 110.355 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -106.72 20.29 19.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.445 1.898 . . . . 0.0 113.735 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.07 121.36 6.52 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.296 -0.878 . . . . 0.0 112.569 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.5 t -104.43 133.57 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.357 1.863 . . . . 0.0 109.932 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.5 tp -120.79 130.16 53.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.318 1.047 . . . . 0.0 111.988 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 53.5 mt -105.78 100.16 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 124.379 1.072 . . . . 0.0 108.593 174.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -81.36 125.88 30.92 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.282 0.633 . . . . 0.0 110.051 171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.93 131.54 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.916 0.886 . . . . 0.0 110.954 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.27 102.0 11.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.114 1.366 . . . . 0.0 109.721 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.628 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 31.0 m -68.22 -19.3 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 -44.28 20.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.332 0.653 . . . . 0.0 111.1 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -86.73 -11.17 51.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.068 0.947 . . . . 0.0 112.524 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.4 tttt 72.77 29.08 1.98 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.108 2.163 . . . . 0.0 111.614 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.9 p -109.57 162.83 14.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.189 1.396 . . . . 0.0 111.198 -171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.45 146.13 41.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.135 1.374 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 t -138.01 135.5 45.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 126.119 1.768 . . . . 0.0 107.256 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.3 mt -118.52 127.85 75.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -136.21 125.46 24.72 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 125.342 1.457 . . . . 0.0 109.961 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 158.26 14.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.855 1.217 . . . . 0.0 110.644 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -65.31 164.8 12.81 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.605 1.669 . . . . 0.0 111.874 172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -50.72 -33.67 23.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.04 2.136 . . . . 0.0 114.075 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.54 -43.36 98.18 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 119.985 1.266 . . . . 0.0 111.906 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.66 -58.03 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.585 1.192 . . . . 0.0 109.86 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -60.05 -25.37 65.3 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.083 -1.011 . . . . 0.0 113.571 -173.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -92.94 -8.09 44.18 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 88' ' ' VAL . 2.8 p -113.59 -22.84 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 118.191 -0.909 . . . . 0.0 113.035 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 87' ' ' VAL . 4.0 m -119.8 172.46 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.045 1.293 . . . . 0.0 112.233 176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.66 171.98 7.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.669 1.588 . . . . 0.0 112.631 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.89 -34.01 75.25 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.01 -35.12 79.18 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.826 0.739 . . . . 0.0 111.97 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 44.0 t80 -64.41 -41.99 96.33 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.027 0.531 . . . . 0.0 110.761 172.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -70.02 -26.81 64.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.89 -35.65 75.3 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 119.153 0.888 . . . . 0.0 111.575 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.0 p -60.39 -46.84 88.53 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.494 0.717 . . . . 0.0 111.938 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 m -61.18 -48.94 79.22 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.591 1.957 . . . . 0.0 111.071 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -60.0 -47.36 86.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.263 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -62.54 -43.78 97.98 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.63 -48.74 76.86 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.021 0.828 . . . . 0.0 111.928 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.5 mt -66.78 -48.28 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.749 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -59.99 -44.15 94.69 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.99 -38.25 87.89 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 121.152 -0.968 . . . . 0.0 112.497 -176.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -80.88 -37.59 29.51 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.28 1.032 . . . . 0.0 111.67 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -59.44 -38.96 82.07 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.442 -0.786 . . . . 0.0 111.645 171.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.01 -28.83 70.07 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.961 0.904 . . . . 0.0 113.136 172.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -79.59 -27.86 41.09 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.751 1.16 . . . . 0.0 110.802 172.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.91 25.12 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 126.309 1.909 . . . . 0.0 113.631 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -107.34 73.07 0.9 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.356 1.462 . . . . 0.0 110.951 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -58.08 -40.33 80.83 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.771 0.828 . . . . 0.0 113.225 -169.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -60.22 -53.92 51.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.013 -0.429 . . . . 0.0 111.456 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.6 -39.49 88.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.646 0.778 . . . . 0.0 111.069 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.33 96.51 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.738 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.0 mt -67.58 -48.44 66.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.457 174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.71 -45.23 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 119.528 1.058 . . . . 0.0 112.391 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -67.26 -36.96 82.7 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.463 1.105 . . . . 0.0 112.14 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.5 95.89 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 121.649 -0.657 . . . . 0.0 112.547 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.02 -45.62 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.789 1.236 . . . . 0.0 110.564 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -61.68 -50.6 71.81 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.824 0.849 . . . . 0.0 111.33 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -66.59 -41.88 87.81 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.079 0.952 . . . . 0.0 111.24 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.18 79.35 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.448 172.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.62 97.42 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.402 1.001 . . . . 0.0 113.18 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.74 -40.4 95.24 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.603 1.202 . . . . 0.0 112.839 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.455 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.55 -47.58 31.9 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.411 1.084 . . . . 0.0 111.368 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.78 -38.74 79.18 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 125.567 1.547 . . . . 0.0 110.735 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.6 -19.11 46.68 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -73.45 -32.62 64.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.536 -1.353 . . . . 0.0 111.837 170.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -89.32 -33.93 16.74 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.857 1.263 . . . . 0.0 112.676 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.52 85.93 41.54 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.733 2.013 . . . . 0.0 110.275 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.49 135.02 25.55 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.65 2.233 . . . . 0.0 109.513 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.0 t90 -57.19 137.18 56.24 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -106.6 148.04 28.77 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.15 -0.968 . . . . 0.0 110.421 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.67 -33.23 72.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.295 -1.503 . . . . 0.0 112.487 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -94.71 17.16 13.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.447 1.499 . . . . 0.0 113.528 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.21 157.92 5.78 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.25 116.52 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.049 0.939 . . . . 0.0 111.554 -171.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -86.58 99.59 11.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 109.679 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -80.61 -31.05 36.73 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.737 1.215 . . . . 0.0 113.787 -172.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.2 mt -116.67 147.27 39.48 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.708 1.203 . . . . 0.0 110.702 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.94 147.23 26.73 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.152 1.901 . . . . 0.0 111.685 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -78.47 14.26 1.31 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.829 1.251 . . . . 0.0 113.568 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 25.0 p -85.56 165.25 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.049 1.74 . . . . 0.0 111.383 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.7 mt -87.07 134.0 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 121.796 -0.565 . . . . 0.0 109.602 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.0 m -91.16 141.21 29.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.624 0.726 . . . . 0.0 110.669 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -140.8 154.75 46.38 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.73 -1.231 . . . . 0.0 111.157 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 C-N-CA 126.427 1.965 . . . . 0.0 111.862 173.786 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -156.35 156.05 33.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.03 0.932 . . . . 0.0 110.837 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -51.0 -44.5 60.93 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.721 0.808 . . . . 0.0 112.199 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt -115.65 139.1 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.807 1.243 . . . . 0.0 108.311 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -109.22 -57.04 2.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.89 1.676 . . . . 0.0 110.423 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -115.28 127.24 55.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.309 1.844 . . . . 0.0 108.451 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.45 -19.23 42.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.772 1.229 . . . . 0.0 112.972 -177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.05 137.22 49.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.56 2.344 . . . . 0.0 108.529 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -63.34 152.5 37.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.17 0.988 . . . . 0.0 111.019 170.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.71 -23.29 16.96 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -68.84 -41.91 77.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.979 -1.075 . . . . 0.0 111.851 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -72.1 -42.37 66.21 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.658 1.183 . . . . 0.0 110.088 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -62.87 -39.36 94.21 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.503 1.521 . . . . 0.0 113.135 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -61.11 -50.17 74.32 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 119.65 -1.906 . . . . 0.0 111.505 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.54 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 tt -69.13 -41.56 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.588 1.085 . . . . 0.0 112.676 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.2 -40.58 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.092 1.315 . . . . 0.0 111.244 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.57 -28.5 67.84 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.226 0.921 . . . . 0.0 113.076 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.6 75.63 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.46 -0.775 . . . . 0.0 112.246 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.77 -45.38 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.772 0.829 . . . . 0.0 109.946 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -62.54 -23.78 67.16 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -84.37 -29.4 26.27 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.978 -1.076 . . . . 0.0 111.308 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.73 75.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.7 1.136 . . . . 0.0 112.361 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -65.08 -15.35 62.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.506 1.523 . . . . 0.0 113.454 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -92.71 4.67 53.29 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.754 -1.216 . . . . 0.0 111.866 171.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -131.91 -14.35 3.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.93 1.692 . . . . 0.0 115.139 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.9 t -153.44 145.58 23.78 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.493 1.497 . . . . 0.0 110.652 171.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m -82.17 24.9 0.62 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.997 1.719 . . . . 0.0 113.275 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 -179.82 21.19 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 124.828 1.204 . . . . 0.0 110.997 166.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -135.73 133.48 38.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.767 0.794 . . . . 0.0 111.495 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mt -124.56 141.04 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.057 -1.652 . . . . 0.0 110.626 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -142.73 147.82 36.24 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.4 1.88 . . . . 0.0 111.027 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.41 137.13 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.214 1.006 . . . . 0.0 111.071 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -120.47 121.02 37.58 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.116 1.766 . . . . 0.0 112.759 172.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' CG1' ' A' ' 71' ' ' VAL . 13.4 tp -102.92 131.47 49.84 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.883 1.273 . . . . 0.0 111.87 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -152.25 162.78 40.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.521 -0.737 . . . . 0.0 110.686 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -78.75 -75.67 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.736 -1.227 . . . . 0.0 112.366 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 p -142.07 148.65 38.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.477 1.911 . . . . 0.0 110.42 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -85.04 161.08 19.86 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.039 0.936 . . . . 0.0 112.976 170.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -98.23 -16.73 19.31 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.228 1.811 . . . . 0.0 112.31 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.1 pt -119.56 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.101 1.76 . . . . 0.0 110.934 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -78.67 134.56 37.12 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.57 . . . . 0.0 111.41 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.6 t -57.04 -38.12 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 118.824 -0.608 . . . . 0.0 112.046 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.7 -46.52 89.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.79 -42.67 70.02 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.507 0.323 . . . . 0.0 110.785 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -56.68 -47.79 79.07 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 122.485 0.314 . . . . 0.0 111.687 173.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.06 75.76 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.899 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.9 ttp -67.19 -50.59 60.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 0.0 112.049 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -64.48 -43.95 92.58 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.245 0.93 . . . . 0.0 111.72 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -58.64 -45.02 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.129 0.971 . . . . 0.0 110.738 176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -58.92 -50.19 74.96 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.117 0.967 . . . . 0.0 112.111 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -74.37 -30.96 62.2 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.328 1.051 . . . . 0.0 112.891 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -73.1 -35.84 66.66 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 120.659 -1.276 . . . . 0.0 111.917 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.1 mt -74.28 -7.25 52.13 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.728 1.211 . . . . 0.0 112.947 170.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 62.21 31.1 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.468 1.507 . . . . 0.0 111.991 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.7 mmm -64.43 -19.79 65.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.304 1.042 . . . . 0.0 113.078 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -75.25 -12.48 60.29 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.258 1.823 . . . . 0.0 113.65 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -83.58 73.48 10.22 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.335 1.054 . . . . 0.0 111.249 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -123.74 151.42 43.25 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.717 2.007 . . . . 0.0 110.431 174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -63.14 -37.97 89.32 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.378 -0.826 . . . . 0.0 113.02 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.41 -6.98 21.34 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 117.766 -1.112 . . . . 0.0 113.589 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 66.22 47.97 1.74 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.668 1.187 . . . . 0.0 109.433 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -119.8 26.27 9.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.807 1.243 . . . . 0.0 113.456 -172.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.75 127.23 7.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.312 0.958 . . . . 0.0 112.357 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.03 132.77 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 126.7 2.0 . . . . 0.0 109.985 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.5 tp -121.84 129.51 52.66 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.116 0.967 . . . . 0.0 110.781 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.15 99.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.984 0.914 . . . . 0.0 108.632 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -80.2 122.69 27.16 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.529 0.732 . . . . 0.0 110.744 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.73 123.66 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.863 0.865 . . . . 0.0 110.807 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.95 102.72 15.29 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.367 1.467 . . . . 0.0 109.277 171.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.1 m -73.16 -24.83 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -74.13 -40.75 62.44 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.962 -0.462 . . . . 0.0 111.472 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -97.27 -6.47 34.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.538 1.535 . . . . 0.0 112.837 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt 67.29 33.19 5.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.779 1.632 . . . . 0.0 112.156 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 m -107.6 129.43 54.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.353 1.461 . . . . 0.0 110.053 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -106.66 141.45 37.91 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.765 1.226 . . . . 0.0 109.876 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.0 t -138.8 140.86 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.198 1.399 . . . . 0.0 108.103 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 mt -125.39 127.57 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -129.74 138.18 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.863 0.865 . . . . 0.0 109.72 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -121.87 160.41 16.27 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.69 162.32 16.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.518 1.627 . . . . 0.0 112.618 169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.84 -38.98 65.19 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.603 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.35 -37.22 93.64 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.612 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -63.0 -58.28 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.317 1.559 . . . . 0.0 110.166 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -59.26 -25.35 63.99 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -80.43 -27.68 37.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.466 1.507 . . . . 0.0 112.462 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.475 HG11 ' HE2' ' A' ' 128' ' ' PHE . 3.4 p -105.96 -22.82 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.446 HG13 HG13 ' A' ' 87' ' ' VAL . 4.8 m -119.99 167.65 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 119.836 1.198 . . . . 0.0 112.21 175.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 m -116.29 169.91 8.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.618 1.167 . . . . 0.0 113.122 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -56.88 -33.0 66.42 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.533 -1.354 . . . . 0.0 113.764 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.88 -20.88 62.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.791 1.236 . . . . 0.0 113.249 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 26.6 t80 -77.66 -34.17 53.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.449 0.7 . . . . 0.0 110.647 170.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -75.76 -25.66 56.7 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -65.56 -32.96 74.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.402 -0.811 . . . . 0.0 112.376 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.3 p -65.86 -42.67 90.14 Favored 'General case' 0 C--O 1.245 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 111.755 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 m -53.7 -55.37 26.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.908 2.083 . . . . 0.0 110.275 172.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -55.95 -49.27 74.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.92 0.888 . . . . 0.0 111.202 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.65 -37.32 81.14 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.46 -51.84 52.51 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.055 0.843 . . . . 0.0 111.78 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.2 mt -58.22 -51.68 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.044 0.538 . . . . 0.0 110.126 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -56.57 -41.92 77.73 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.797 1.639 . . . . 0.0 113.035 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.09 -46.08 89.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.966 0.803 . . . . 0.0 111.86 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.18 -30.42 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -64.69 -39.35 93.51 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.304 0.956 . . . . 0.0 111.29 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.9 -27.76 69.37 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.054 0.942 . . . . 0.0 112.331 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -77.77 -38.58 46.45 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.575 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.82 12.46 14.4 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.379 1.942 . . . . 0.0 113.791 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -100.26 84.89 2.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.204 1.401 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -61.39 -46.62 89.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.575 0.75 . . . . 0.0 111.928 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -49.11 -54.95 13.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -63.51 -41.77 98.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.061 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.42 -36.38 77.64 Favored Glycine 0 N--CA 1.471 0.993 0 CA-C-N 119.1 0.864 . . . . 0.0 113.346 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.96 -40.7 78.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.292 0.637 . . . . 0.0 111.798 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.8 t -67.28 -50.43 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.916 1.287 . . . . 0.0 111.5 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -73.47 -26.12 60.77 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.15 0.886 . . . . 0.0 112.495 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.09 -38.31 92.29 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 121.275 -0.891 . . . . 0.0 111.833 169.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.8 mt -62.24 -51.49 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.479 1.139 . . . . 0.0 110.872 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -61.01 -40.14 92.4 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.495 1.043 . . . . 0.0 112.854 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -73.91 -36.85 64.77 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.723 -1.235 . . . . 0.0 111.422 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.33 -50.21 73.85 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.803 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.16 -46.66 93.82 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.481 1.037 . . . . 0.0 112.628 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 41.9 tpp -60.8 -43.35 98.26 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.924 0.862 . . . . 0.0 112.976 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -68.38 -44.19 75.69 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.994 0.361 . . . . 0.0 111.215 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -62.27 -37.9 87.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.455 1.502 . . . . 0.0 111.143 177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.43 -24.49 63.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.538 1.135 . . . . 0.0 113.83 173.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -67.8 -27.64 66.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.206 -1.559 . . . . 0.0 112.561 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -93.18 -38.89 11.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.033 1.333 . . . . 0.0 112.031 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.475 ' HE2' HG11 ' A' ' 87' ' ' VAL . 95.3 m-85 -130.4 76.19 78.01 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.126 1.77 . . . . 0.0 111.484 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.26 132.19 35.24 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.144 2.563 . . . . 0.0 111.339 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 76.1 t90 -57.92 146.29 32.69 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -118.57 150.45 39.63 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.004 1.322 . . . . 0.0 109.816 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -66.53 -27.4 67.73 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.438 -2.039 . . . . 0.0 112.888 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.79 15.04 23.11 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.659 1.584 . . . . 0.0 112.242 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.38 158.34 9.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.515 1.126 . . . . 0.0 113.185 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.32 120.7 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.53 1.132 . . . . 0.0 110.64 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.06 103.78 11.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -77.81 -21.08 52.11 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -119.28 169.1 8.67 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 124.87 1.268 . . . . 0.0 111.101 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -99.03 153.91 0.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.615 2.877 . . . . 0.0 111.153 168.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -89.0 -5.76 57.7 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -170.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 m -56.23 141.26 41.79 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.19 1.396 . . . . 0.0 109.683 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.54 130.95 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.61 152.71 18.38 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.107 0.563 . . . . 0.0 110.848 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -160.99 158.02 27.29 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.074 0 CA-C-O 116.592 -2.226 . . . . 0.0 112.803 171.025 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -76.11 131.47 39.45 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 119.954 -1.716 . . . . 0.0 112.056 174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.75 -24.95 53.53 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.067 -1.02 . . . . 0.0 113.372 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.3 mt -61.3 -38.57 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.568 1.147 . . . . 0.0 111.445 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.29 -6.46 58.52 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.552 1.141 . . . . 0.0 113.659 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.58 -17.7 61.15 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.401 -0.812 . . . . 0.0 112.238 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.43 -30.16 65.74 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -148.98 134.85 18.93 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.81 1.644 . . . . 0.0 108.017 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 p -69.52 160.6 31.15 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.739 0.7 . . . . 0.0 110.737 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.64 53.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.33 -40.99 77.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.508 1.523 . . . . 0.0 110.92 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -72.06 -44.38 63.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.551 1.141 . . . . 0.0 111.376 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -63.74 -44.77 92.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.322 1.049 . . . . 0.0 111.823 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -55.56 -47.2 76.76 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.706 -1.246 . . . . 0.0 111.461 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.67 84.45 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.4 tt -76.59 -38.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.568 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.86 -40.34 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.98 1.264 . . . . 0.0 111.253 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.98 -33.45 75.42 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.827 0.851 . . . . 0.0 112.966 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.24 -30.11 62.0 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.709 0.804 . . . . 0.0 112.412 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.51 -48.66 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -55.49 -27.64 49.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.3 -28.76 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.239 -0.913 . . . . 0.0 113.086 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.14 -39.07 75.62 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.574 1.149 . . . . 0.0 111.922 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -71.94 14.11 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.824 0.85 . . . . 0.0 113.282 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -120.72 12.5 11.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.322 1.849 . . . . 0.0 112.43 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -120.92 -14.33 8.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.807 2.043 . . . . 0.0 113.512 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 t -159.88 176.03 12.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.445 2.298 . . . . 0.0 108.531 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -125.51 6.22 7.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.347 1.459 . . . . 0.0 114.594 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.98 161.06 31.53 Favored Glycine 0 N--CA 1.468 0.825 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 155.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -126.84 136.08 51.87 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 118.192 0.996 . . . . 0.0 112.0 -165.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.7 mt -113.05 124.69 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 110.746 -169.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -135.51 153.59 51.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.124 0.964 . . . . 0.0 111.456 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.9 t -133.99 128.43 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.494 1.518 . . . . 0.0 108.601 -168.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.87 108.75 13.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.569 1.548 . . . . 0.0 113.987 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 tt -93.96 130.94 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.514 0.726 . . . . 0.0 111.023 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.11 163.11 37.95 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.02 1.328 . . . . 0.0 111.317 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -72.3 -79.38 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.595 1.558 . . . . 0.0 113.369 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -144.54 147.81 33.66 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.982 2.513 . . . . 0.0 109.044 -173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -99.38 169.96 8.97 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.39 1.09 . . . . 0.0 112.163 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -101.66 -19.62 15.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.786 1.635 . . . . 0.0 112.685 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.9 pt -125.04 -148.42 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -85.17 142.5 29.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.278 1.399 . . . . 0.0 112.604 172.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.42 -32.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.449 0.7 . . . . 0.0 111.164 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.06 -50.08 73.41 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.736 0.815 . . . . 0.0 111.54 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.39 -39.55 94.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.329 0.652 . . . . 0.0 111.451 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.9 -43.43 98.86 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.354 0.662 . . . . 0.0 111.841 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.81 -40.9 96.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.927 0.785 . . . . 0.0 110.982 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.8 ttp -63.26 -47.36 82.73 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.908 0.777 . . . . 0.0 112.327 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.57 -44.25 97.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.217 -0.927 . . . . 0.0 112.131 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.55 -43.96 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.63 1.172 . . . . 0.0 111.109 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.56 -49.71 76.43 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.995 0.816 . . . . 0.0 111.182 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -67.44 -44.23 79.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.481 1.112 . . . . 0.0 111.828 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -61.06 -39.84 91.38 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.857 -1.152 . . . . 0.0 113.816 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.56 1.64 18.89 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 56.5 36.59 27.81 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.706 1.202 . . . . 0.0 111.632 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.8 mtp -72.09 -13.49 61.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.131 1.772 . . . . 0.0 113.294 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -75.58 -2.4 28.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.584 1.954 . . . . 0.0 114.25 167.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -79.36 60.53 3.18 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.003 1.321 . . . . 0.0 111.872 177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.2 p -129.53 149.97 51.07 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.86 0.838 . . . . 0.0 110.134 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -65.74 -27.79 68.57 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.218 -0.926 . . . . 0.0 113.063 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 91.9 mt -107.25 -5.7 17.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.435 1.094 . . . . 0.0 113.1 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 60.05 40.23 18.86 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.967 1.307 . . . . 0.0 110.87 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -109.78 36.7 2.89 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.391 1.476 . . . . 0.0 112.073 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.11 121.95 5.69 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.714 -1.241 . . . . 0.0 112.464 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -103.31 135.84 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 118.118 0.959 . . . . 0.0 110.603 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -120.55 129.73 53.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.448 1.499 . . . . 0.0 111.502 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.47 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.915 0.886 . . . . 0.0 109.957 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -79.64 120.39 23.9 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.473 0.709 . . . . 0.0 110.8 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.61 132.8 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.809 0.844 . . . . 0.0 110.48 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.37 97.15 7.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.199 1.4 . . . . 0.0 109.173 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.29 -13.49 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -170.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -77.16 -56.78 4.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.379 0.536 . . . . 0.0 111.038 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.95 -8.4 59.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.278 1.431 . . . . 0.0 114.154 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttt 72.21 27.78 2.52 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.846 1.659 . . . . 0.0 112.443 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.9 p -102.39 173.4 6.37 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.123 0.969 . . . . 0.0 111.475 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -147.64 139.45 24.06 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 125.359 1.464 . . . . 0.0 109.353 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.0 t -127.9 134.32 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.695 1.198 . . . . 0.0 107.923 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.1 mt -111.97 131.48 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -137.33 124.95 22.24 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.559 1.544 . . . . 0.0 110.46 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.28 148.31 17.48 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -64.37 163.71 12.65 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.325 1.06 . . . . 0.0 111.534 165.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -57.87 -31.83 67.09 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.19 0.996 . . . . 0.0 112.84 -169.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.04 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.724 1.147 . . . . 0.0 113.786 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.13 -61.15 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.2 1.5 . . . . 0.0 108.638 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -51.5 -41.55 61.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.335 1.054 . . . . 0.0 112.921 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.32 -13.61 59.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.692 1.197 . . . . 0.0 112.932 -177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.11 -31.92 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.588 1.086 . . . . 0.0 113.525 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 m -108.08 165.94 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.49 1.041 . . . . 0.0 112.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.04 172.39 6.83 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.427 1.091 . . . . 0.0 113.456 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -62.76 -34.31 76.96 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.867 -1.145 . . . . 0.0 112.84 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -61.42 -25.75 67.41 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 124.388 1.075 . . . . 0.0 113.57 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -74.96 -46.17 37.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.612 0.765 . . . . 0.0 109.544 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.64 -31.24 72.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.497 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -57.63 -33.75 68.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.771 1.228 . . . . 0.0 112.193 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 p -66.54 -43.11 86.01 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.895 0.478 . . . . 0.0 111.699 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -52.09 66.9 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.285 1.834 . . . . 0.0 110.131 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -59.0 -50.04 75.6 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.61 0.764 . . . . 0.0 111.148 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -58.23 -43.69 87.86 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.21 -49.75 68.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 87.9 mt -62.46 -47.97 90.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 124.013 0.925 . . . . 0.0 110.515 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -60.31 -45.98 91.5 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.571 1.148 . . . . 0.0 112.879 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.22 -35.82 76.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.341 0.656 . . . . 0.0 112.528 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -87.01 -34.87 19.09 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 119.234 -0.412 . . . . 0.0 111.207 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -59.21 -35.59 73.88 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.933 0.788 . . . . 0.0 111.631 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -68.42 -31.73 71.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 112.979 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -71.37 -35.12 70.99 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.464 1.105 . . . . 0.0 110.441 166.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 6.85 25.43 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 125.957 1.741 . . . . 0.0 114.533 175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -98.64 94.13 6.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.071 0.949 . . . . 0.0 111.259 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -70.52 -37.2 74.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.46 0.704 . . . . 0.0 111.826 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -54.76 -56.94 13.94 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.964 0.906 . . . . 0.0 111.03 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HA ' HG12 ' A' ' 114' ' ' VAL . 84.9 mt-30 -61.09 -42.6 98.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.27 97.13 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.069 -0.85 . . . . 0.0 113.191 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -69.17 -46.57 67.21 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.834 -1.079 . . . . 0.0 111.207 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 111' ' ' GLN . 4.2 p -70.73 -41.0 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 119.681 1.128 . . . . 0.0 113.064 -175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.6 -35.78 81.82 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.832 0.742 . . . . 0.0 110.982 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.58 95.52 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.035 -0.87 . . . . 0.0 111.976 174.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.25 -43.49 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.575 1.187 . . . . 0.0 111.352 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -58.87 -52.18 66.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 0.0 110.671 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -66.62 -39.75 88.46 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.835 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.84 72.44 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.729 0.695 . . . . 0.0 111.389 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.87 95.74 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.689 1.131 . . . . 0.0 112.496 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.55 -39.24 88.45 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.135 -1.214 . . . . 0.0 112.919 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.75 -48.15 48.85 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.895 0.878 . . . . 0.0 110.602 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.1 mt -60.63 -36.2 78.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.74 1.616 . . . . 0.0 110.767 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.01 -20.14 50.3 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -72.34 -37.59 68.81 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.406 -1.434 . . . . 0.0 111.995 170.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -85.04 -32.56 22.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.434 1.494 . . . . 0.0 112.586 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -134.07 88.34 31.81 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.436 1.895 . . . . 0.0 109.329 175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.81 139.82 34.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.541 2.827 . . . . 0.0 110.097 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -64.46 131.46 47.19 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -103.7 145.8 29.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.007 0.923 . . . . 0.0 110.299 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.43 -30.09 68.24 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 119.675 -1.891 . . . . 0.0 113.908 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -92.2 12.18 23.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.311 1.444 . . . . 0.0 113.177 -176.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.82 154.19 7.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -172.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.78 112.18 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 122.304 1.049 . . . . 0.0 111.562 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -92.2 111.99 23.76 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 106.577 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -115.25 -36.85 4.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.944 0.897 . . . . 0.0 112.412 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.82 143.11 34.96 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.872 1.269 . . . . 0.0 109.721 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.35 140.09 24.12 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.164 1.909 . . . . 0.0 111.018 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -77.51 8.55 4.16 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.712 1.205 . . . . 0.0 113.663 -177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -75.76 153.25 37.12 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.907 1.683 . . . . 0.0 110.9 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.5 mt -76.24 130.78 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.173 0.989 . . . . 0.0 108.664 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.1 m -82.8 142.41 31.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.351 1.06 . . . . 0.0 110.251 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -140.73 138.57 34.28 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.581 -1.325 . . . . 0.0 111.686 -172.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.83 2.633 . . . . 0.0 114.082 -179.025 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -64.32 147.74 51.85 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.382 1.446 . . . . 0.0 112.696 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.34 126.59 33.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.9 0.857 . . . . 0.0 111.765 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.1 pt -74.71 17.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 125.451 1.5 . . . . 0.0 114.189 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -88.47 -32.86 18.05 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.907 -1.121 . . . . 0.0 110.674 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -104.36 79.34 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.322 1.449 . . . . 0.0 109.407 -170.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 71' ' ' VAL . 51.4 m-85 -61.87 -31.57 71.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.95 133.83 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.256 1.822 . . . . 0.0 108.333 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -71.57 157.53 37.83 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.923 0.889 . . . . 0.0 109.406 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.72 -24.31 8.43 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -75.13 -36.46 61.61 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.742 -1.224 . . . . 0.0 112.37 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -76.8 -42.82 39.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.17 1.788 . . . . 0.0 110.209 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -62.68 -49.08 76.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.047 1.339 . . . . 0.0 111.6 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.32 -46.98 69.64 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.28 -0.888 . . . . 0.0 111.645 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.54 -28.57 67.91 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 tt -80.59 -37.91 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 120.692 1.587 . . . . 0.0 112.191 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.54 -44.16 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.459 1.027 . . . . 0.0 110.944 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -57.97 -39.56 78.46 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.216 1.406 . . . . 0.0 112.707 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.59 -32.23 71.99 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.59 -0.693 . . . . 0.0 112.384 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.5 mt -67.9 -46.56 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.072 0.851 . . . . 0.0 110.008 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -56.64 -31.63 64.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.298 1.039 . . . . 0.0 113.157 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -79.35 -27.78 42.02 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.038 0.835 . . . . 0.0 113.109 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.48 -35.83 70.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.479 0.712 . . . . 0.0 111.695 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -61.43 -1.56 0.56 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.024 2.13 . . . . 0.0 113.933 167.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -117.61 9.66 13.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.055 1.742 . . . . 0.0 112.388 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -126.22 -14.66 5.92 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.045 1.338 . . . . 0.0 114.097 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -162.28 140.62 8.89 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.722 1.209 . . . . 0.0 109.459 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.0 p -83.11 46.5 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.73 0.812 . . . . 0.0 111.243 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.92 137.86 7.69 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.203 1.383 . . . . 0.0 109.686 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -113.84 128.08 56.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.933 0.873 . . . . 0.0 112.064 -152.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.7 mt -120.74 116.66 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.284 -1.51 . . . . 0.0 110.733 -172.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ttm-85 -113.74 147.92 37.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.887 2.075 . . . . 0.0 110.78 175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.83 136.86 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.416 1.086 . . . . 0.0 110.695 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -118.32 118.97 33.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.403 1.881 . . . . 0.0 112.374 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 tp -108.11 129.06 55.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.949 0.9 . . . . 0.0 111.972 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.87 166.96 27.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.108 1.363 . . . . 0.0 110.312 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.469 ' HA ' HG22 ' A' ' 71' ' ' VAL . 95.0 mttt -81.03 -72.48 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.548 -1.345 . . . . 0.0 113.14 -173.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -144.18 -175.95 4.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 128.22 2.608 . . . . 0.0 108.433 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.5 p -152.27 160.1 43.4 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.215 -0.928 . . . . 0.0 113.226 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -97.08 -3.27 41.61 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 pt -135.2 -146.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.501 -1.374 . . . . 0.0 110.997 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -95.54 141.24 29.3 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 120.564 1.529 . . . . 0.0 111.796 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.81 -32.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.259 -0.901 . . . . 0.0 112.544 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.65 -46.27 72.91 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.295 0.498 . . . . 0.0 110.904 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -60.06 -43.52 95.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.152 0.581 . . . . 0.0 111.537 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.2 mtp85 -60.5 -47.1 87.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.83 77.08 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.014 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.6 ttp -66.21 -52.46 47.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.764 0.711 . . . . 0.0 111.644 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.82 -44.99 91.0 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.989 0.813 . . . . 0.0 112.499 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.04 -40.8 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.247 1.019 . . . . 0.0 110.73 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.41 -51.09 70.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.985 0.811 . . . . 0.0 110.933 173.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.75 -39.13 80.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.578 0.751 . . . . 0.0 112.564 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -62.68 -38.21 89.46 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.212 1.405 . . . . 0.0 113.554 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.12 -4.74 46.0 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.061 -1.024 . . . . 0.0 113.274 176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 58.85 34.04 23.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.711 1.204 . . . . 0.0 112.311 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.3 mmm -59.14 -22.43 60.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.044 2.138 . . . . 0.0 113.93 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -72.52 -6.94 47.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.38 2.272 . . . . 0.0 113.534 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.4 56.64 2.59 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.469 1.907 . . . . 0.0 110.956 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.1 p -127.75 137.79 52.55 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.113 2.165 . . . . 0.0 109.317 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -60.99 -36.45 79.51 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.29 -0.881 . . . . 0.0 112.456 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.9 mt -93.82 -9.44 37.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.314 -1.327 . . . . 0.0 113.932 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 66.63 49.35 1.31 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.397 1.453 . . . . 0.0 109.456 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -118.9 16.12 13.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.828 1.651 . . . . 0.0 113.994 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.38 136.47 30.13 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.05 -1.032 . . . . 0.0 112.187 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.58 138.4 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.649 1.179 . . . . 0.0 110.61 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 tp -117.98 127.57 53.95 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.277 1.431 . . . . 0.0 110.122 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.2 mt -103.66 96.77 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -81.06 126.45 31.45 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.903 -0.498 . . . . 0.0 110.391 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.7 t -126.18 127.72 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.128 0.971 . . . . 0.0 110.852 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.66 118.0 34.39 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 124.257 1.023 . . . . 0.0 110.483 167.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG21 ' CE1' ' A' ' 7' ' ' PHE . 29.0 m -76.59 -24.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -77.0 -55.97 4.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.207 0.458 . . . . 0.0 110.288 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -84.69 -1.31 55.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.629 1.171 . . . . 0.0 112.54 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.2 tttt 67.4 19.88 10.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.012 2.125 . . . . 0.0 113.393 172.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.3 m -94.67 115.43 27.54 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.365 1.466 . . . . 0.0 110.874 -170.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -90.35 143.56 26.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.984 1.314 . . . . 0.0 110.004 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.2 t -136.08 150.86 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 125.726 1.61 . . . . 0.0 108.462 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.9 mt -133.69 127.66 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -140.19 127.08 20.67 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.924 0.89 . . . . 0.0 110.599 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.6 158.2 14.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 124.579 1.085 . . . . 0.0 111.373 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -71.87 173.77 7.84 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 123.155 1.455 . . . . 0.0 112.638 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -60.72 -37.46 81.78 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.505 1.522 . . . . 0.0 113.685 -171.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.09 -47.13 55.62 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.732 1.158 . . . . 0.0 112.588 -175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.7 mt -54.7 -55.6 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.601 1.2 . . . . 0.0 109.36 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -65.54 -18.01 65.0 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -79.16 -38.76 35.16 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.127 1.371 . . . . 0.0 111.598 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.5 m -92.75 -26.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.34 169.6 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 119.929 1.24 . . . . 0.0 113.055 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 p -119.17 171.59 8.17 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.125 1.37 . . . . 0.0 113.31 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.24 -30.25 71.11 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.674 -1.266 . . . . 0.0 113.338 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.76 -27.15 69.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 0.0 112.344 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 23.5 t80 -76.22 -38.88 55.84 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.747 172.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -70.12 -28.86 65.72 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 125.08 1.352 . . . . 0.0 113.432 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.56 -31.62 72.84 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.6 m -62.32 -43.26 99.23 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.689 0.677 . . . . 0.0 111.062 171.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 m -60.21 -48.44 81.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.329 1.452 . . . . 0.0 111.516 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -59.57 -48.09 83.01 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.693 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -63.67 -35.26 79.96 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.91 61.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.18 0.9 . . . . 0.0 111.793 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.5 mt -64.64 -49.9 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.315 0.646 . . . . 0.0 110.583 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.64 -39.9 85.88 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.907 1.283 . . . . 0.0 112.724 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 67.6 tp -61.31 -45.06 96.02 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.649 1.113 . . . . 0.0 111.954 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -79.14 -37.04 39.51 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.944 -0.473 . . . . 0.0 110.971 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -59.55 -39.83 85.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.186 0.903 . . . . 0.0 111.887 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -64.39 -31.59 72.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.786 1.634 . . . . 0.0 113.034 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -73.06 -34.8 66.49 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 118.756 0.707 . . . . 0.0 111.299 168.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 8.18 11.74 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 126.192 1.853 . . . . 0.0 113.793 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -107.43 78.52 1.22 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 0.0 111.816 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -53.39 -46.5 69.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.412 1.485 . . . . 0.0 112.952 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.7 -49.62 74.58 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.545 -0.722 . . . . 0.0 111.539 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.61 -44.35 90.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.826 -174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.74 97.08 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 119.003 0.819 . . . . 0.0 113.387 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.9 mt -68.31 -47.19 68.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.46 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.54 -51.65 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.364 1.066 . . . . 0.0 110.422 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.26 -41.94 98.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.114 0.966 . . . . 0.0 111.2 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -17.78 76.28 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 121.049 -1.032 . . . . 0.0 113.5 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.4 mt -81.96 -50.63 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.649 1.58 . . . . 0.0 109.825 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -56.91 -51.65 68.28 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.775 1.171 . . . . 0.0 111.982 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.35 -37.6 86.29 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 121.058 -1.026 . . . . 0.0 112.122 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.27 88.41 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.886 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.41 87.09 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 119.116 0.871 . . . . 0.0 111.231 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 59.9 ttm -59.96 -43.47 95.04 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.027 0.913 . . . . 0.0 112.503 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -69.45 -47.31 64.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.25 0.62 . . . . 0.0 111.78 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.55 -36.41 82.55 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.284 1.034 . . . . 0.0 111.466 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.27 -22.47 61.2 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -66.14 -41.71 90.08 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 119.866 1.212 . . . . 0.0 111.438 171.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -81.59 -27.39 34.29 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.029 1.731 . . . . 0.0 113.001 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -138.86 76.35 34.48 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 126.594 1.957 . . . . 0.0 110.097 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.56 143.86 64.36 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.326 2.684 . . . . 0.0 111.144 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -66.7 137.21 56.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -118.03 150.82 38.65 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.787 1.635 . . . . 0.0 110.149 -177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -67.15 -19.63 65.62 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 120.181 -1.574 . . . . 0.0 113.524 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -106.72 17.75 22.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 129.054 2.941 . . . . 0.0 112.037 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -52.7 153.84 3.0 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.044 1.338 . . . . 0.0 112.19 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.08 125.38 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 120.735 -1.228 . . . . 0.0 111.848 -167.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.84 88.09 7.1 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.278 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -74.77 -30.34 61.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.57 0.748 . . . . 0.0 112.721 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.35 158.19 49.4 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.295 1.438 . . . . 0.0 110.953 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -91.31 136.76 1.97 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.347 2.698 . . . . 0.0 111.669 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -57.39 -14.07 4.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.7 m -50.32 140.39 13.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.915 1.686 . . . . 0.0 111.68 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.5 mt -69.44 134.82 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.551 1.14 . . . . 0.0 109.582 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 m -93.56 138.62 31.64 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.387 1.089 . . . . 0.0 111.982 167.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.21 157.29 46.19 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.778 1.631 . . . . 0.0 109.28 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.311 0 C-N-CA 125.169 1.366 . . . . 0.0 111.786 172.786 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mtp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 p -167.73 152.51 6.78 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.931 0.892 . . . . 0.0 109.937 -161.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.78 -4.17 55.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.832 0.853 . . . . 0.0 113.124 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -139.63 156.57 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 128.042 2.537 . . . . 0.0 108.68 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.85 -166.43 0.94 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -163.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -77.87 -24.96 48.36 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.386 -0.821 . . . . 0.0 112.469 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -59.6 -70.43 0.16 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.792 1.637 . . . . 0.0 111.622 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.8 mt -133.3 143.35 48.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.192 1.397 . . . . 0.0 109.086 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.3 p -86.33 170.22 12.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.739 0.781 . . . . 0.0 110.375 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.26 -29.47 5.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.137 1.375 . . . . 0.0 114.636 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -80.22 -38.47 31.03 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.922 1.289 . . . . 0.0 111.979 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -76.67 -44.49 33.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.949 1.3 . . . . 0.0 111.036 -176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.47 -45.66 92.04 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.057 1.343 . . . . 0.0 111.168 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -58.04 -40.01 79.83 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.895 -1.128 . . . . 0.0 111.603 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.94 80.32 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.506 0.594 . . . . 0.0 111.962 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.05 -37.32 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.319 0.963 . . . . 0.0 112.909 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.95 -40.88 84.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 118.953 0.797 . . . . 0.0 111.283 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -72.64 -29.28 63.32 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 119.143 0.883 . . . . 0.0 113.31 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.01 76.68 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.522 -0.736 . . . . 0.0 112.645 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mt -69.54 -40.53 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -61.43 -31.21 71.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.865 0.866 . . . . 0.0 112.134 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.01 -31.13 62.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.422 1.089 . . . . 0.0 112.685 172.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.37 -39.25 59.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.824 1.25 . . . . 0.0 113.027 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.94 -23.72 63.78 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 112.564 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.8 8.84 26.99 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 120.527 -1.358 . . . . 0.0 113.39 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -130.62 -8.96 4.07 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.912 1.685 . . . . 0.0 113.78 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -157.48 153.48 27.15 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.501 1.521 . . . . 0.0 108.888 173.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 27.8 1.52 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.686 0.794 . . . . 0.0 112.162 174.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.09 151.35 17.34 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.248 1.404 . . . . 0.0 111.443 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -112.28 127.89 56.11 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -161.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.37 119.96 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.401 -1.437 . . . . 0.0 110.216 -172.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -128.58 147.07 50.69 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.443 1.097 . . . . 0.0 112.071 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.2 t -105.23 141.05 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.024 1.33 . . . . 0.0 110.203 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.54 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.8 t60 -126.96 123.38 37.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.172 0.989 . . . . 0.0 110.869 168.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.6 tp -104.77 147.79 27.32 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 0.0 111.463 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -158.44 166.36 32.41 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.882 1.325 . . . . 0.0 109.644 159.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -59.62 -78.28 0.03 OUTLIER 'General case' 0 C--O 1.242 0.698 0 C-N-CA 126.236 1.814 . . . . 0.0 113.073 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -138.08 -177.03 4.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.536 1.534 . . . . 0.0 110.71 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.1 m -137.46 142.57 41.56 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.397 1.479 . . . . 0.0 111.434 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -81.07 -27.84 35.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.041 0.936 . . . . 0.0 112.947 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.9 pt -115.71 -146.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 126.099 1.759 . . . . 0.0 110.636 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.85 133.74 36.28 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.578 -1.326 . . . . 0.0 111.875 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.21 -36.89 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.853 0.861 . . . . 0.0 112.314 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.78 -49.75 64.89 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.866 1.212 . . . . 0.0 111.7 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -60.63 -42.59 97.21 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.158 0.583 . . . . 0.0 112.192 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -36.93 85.22 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.65 88.32 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.848 -1.157 . . . . 0.0 111.763 175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.6 ttp -63.18 -49.93 72.34 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.376 0.67 . . . . 0.0 111.439 170.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.08 -47.96 79.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.845 0.748 . . . . 0.0 111.087 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.29 -42.02 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.592 0.757 . . . . 0.0 111.814 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.59 -53.2 60.84 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.598 1.09 . . . . 0.0 111.054 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.21 -32.3 62.98 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.376 0.67 . . . . 0.0 112.353 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -66.97 -31.71 72.46 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.626 -1.296 . . . . 0.0 112.824 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.1 -6.55 58.95 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.164 0.985 . . . . 0.0 112.559 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.5 tttt 61.44 36.02 17.43 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.802 1.641 . . . . 0.0 111.625 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.5 mtp -72.7 -5.5 38.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -77.57 -2.5 36.0 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.631 1.972 . . . . 0.0 113.18 169.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -73.26 33.21 0.07 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.293 1.837 . . . . 0.0 114.318 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 p -111.44 153.98 25.33 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.037 1.735 . . . . 0.0 111.947 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.75 -39.17 87.81 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -105.04 -4.2 22.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.188 -0.91 . . . . 0.0 113.39 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 67.78 31.49 5.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.662 1.585 . . . . 0.0 110.021 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -101.37 33.03 3.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.454 1.902 . . . . 0.0 112.594 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.31 123.55 6.38 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.358 0.98 . . . . 0.0 112.999 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.1 t -112.18 138.42 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.449 1.1 . . . . 0.0 112.011 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 34' ' ' HIS . 33.9 tp -117.01 128.54 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.475 1.51 . . . . 0.0 111.228 173.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -104.38 97.93 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.456 1.102 . . . . 0.0 108.963 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -81.12 125.0 29.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 111.017 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.38 134.29 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.108 0.963 . . . . 0.0 111.115 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.24 105.93 16.14 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.107 1.763 . . . . 0.0 110.613 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 m -77.77 -13.03 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -173.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -78.46 -40.74 34.72 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.174 0.897 . . . . 0.0 112.07 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.81 -10.6 26.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.824 1.249 . . . . 0.0 112.219 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.0 tttt 71.96 24.28 3.32 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.738 1.615 . . . . 0.0 111.599 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.3 p -105.85 165.03 11.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.313 1.045 . . . . 0.0 111.607 -172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -143.32 144.52 32.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.201 1.401 . . . . 0.0 109.616 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -138.97 139.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.95 1.7 . . . . 0.0 107.719 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.7 mt -116.0 133.3 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -138.58 126.94 23.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.207 1.003 . . . . 0.0 110.401 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.93 150.54 18.42 Favored Glycine 0 N--CA 1.462 0.398 0 C-N-CA 125.174 1.368 . . . . 0.0 112.208 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -64.17 164.03 11.6 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 122.598 1.19 . . . . 0.0 112.319 168.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -53.85 -35.12 61.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.435 1.494 . . . . 0.0 112.377 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -28.08 73.65 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 119.626 1.103 . . . . 0.0 114.387 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -71.39 -58.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.283 1.541 . . . . 0.0 109.798 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -54.6 -32.94 59.58 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.308 1.443 . . . . 0.0 113.869 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -76.87 -24.13 52.61 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 88' ' ' VAL . 10.3 m -103.91 -35.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.908 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 87' ' ' VAL . 3.0 m -104.7 169.17 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 120.004 1.274 . . . . 0.0 112.632 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 p -119.46 177.77 4.79 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.563 1.545 . . . . 0.0 113.271 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -61.73 -33.46 74.08 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.926 -1.109 . . . . 0.0 112.683 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.39 -20.21 62.96 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.03 0.932 . . . . 0.0 112.557 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 50.5 t80 -77.87 -30.66 50.97 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 169.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -83.99 -26.34 29.26 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -54.86 -44.03 73.65 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.963 1.305 . . . . 0.0 112.416 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.8 p -63.12 -35.29 79.78 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 m -66.43 -51.16 59.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.476 1.91 . . . . 0.0 110.245 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -60.9 -44.57 96.95 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.146 0.978 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -57.19 -47.22 81.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.874 0.761 . . . . 0.0 112.524 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.45 -48.2 82.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.436 1.017 . . . . 0.0 111.841 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.12 -49.15 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.946 0.898 . . . . 0.0 110.352 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -59.86 -42.13 93.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.999 1.32 . . . . 0.0 112.356 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 mt -66.89 -38.36 86.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.74 -32.84 21.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 118.391 0.541 . . . . 0.0 111.172 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -62.39 -39.05 91.94 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.637 0.775 . . . . 0.0 111.645 168.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -59.38 -31.32 69.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.683 1.193 . . . . 0.0 113.038 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -81.36 -41.04 22.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.378 1.071 . . . . 0.0 111.257 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.36 1.23 8.58 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.581 1.563 . . . . 0.0 114.843 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -93.63 80.69 4.28 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.815 1.307 . . . . 0.0 111.532 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -59.77 -44.44 93.87 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.789 1.235 . . . . 0.0 112.609 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -50.99 -58.67 5.47 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.314 1.045 . . . . 0.0 111.363 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -58.41 -44.55 89.09 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.004 0.921 . . . . 0.0 111.698 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.04 -37.41 94.18 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 118.72 0.691 . . . . 0.0 113.664 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.4 mt -73.08 -44.94 59.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.448 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.68 -51.67 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.326 0.65 . . . . 0.0 111.12 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.88 -33.75 76.77 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.346 0.659 . . . . 0.0 112.3 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.23 83.77 Favored Glycine 0 N--CA 1.47 0.941 0 O-C-N 121.338 -0.851 . . . . 0.0 112.667 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mt -63.94 -46.67 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.167 1.483 . . . . 0.0 109.877 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -63.24 -47.63 81.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.305 0.642 . . . . 0.0 111.29 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -61.63 -38.69 88.58 Favored 'General case' 0 C--O 1.242 0.678 0 O-C-N 121.547 -0.72 . . . . 0.0 112.202 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.55 -52.66 64.24 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.322 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -54.3 -45.61 74.21 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 120.37 1.441 . . . . 0.0 113.284 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mtp -63.37 -38.11 89.89 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.158 -1.201 . . . . 0.0 112.907 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.497 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -78.38 -38.84 40.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.539 0.736 . . . . 0.0 110.901 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.49 -33.14 70.89 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.453 1.501 . . . . 0.0 112.549 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.49 41.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -71.85 -29.56 64.52 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.112 -0.992 . . . . 0.0 113.429 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -91.62 -35.54 14.17 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.777 1.231 . . . . 0.0 111.527 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -136.34 90.99 16.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.328 1.851 . . . . 0.0 109.879 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.37 144.17 60.81 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.639 2.226 . . . . 0.0 111.299 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -62.93 161.53 12.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.6 0.76 . . . . 0.0 112.747 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -142.9 159.28 42.53 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.537 1.135 . . . . 0.0 111.575 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -62.27 -29.25 70.29 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.542 -1.349 . . . . 0.0 113.236 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -99.82 29.15 4.3 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.651 1.581 . . . . 0.0 112.4 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.33 151.17 44.59 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.834 -1.166 . . . . 0.0 112.003 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -127.79 114.4 35.24 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 C-N-CA 124.24 1.016 . . . . 0.0 110.887 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -78.21 93.65 4.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.515 0.726 . . . . 0.0 109.41 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.48 -27.28 34.63 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.14 158.95 32.35 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.202 1.401 . . . . 0.0 110.312 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -83.36 159.09 14.93 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.413 2.742 . . . . 0.0 111.046 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -83.83 2.52 37.87 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.6 p -76.33 160.9 29.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.989 1.316 . . . . 0.0 112.325 -166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.94 140.49 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.536 0.735 . . . . 0.0 109.815 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 33.4 t -110.07 140.66 43.89 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.668 -1.27 . . . . 0.0 111.942 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -134.88 137.37 43.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 C-N-CA 124.993 1.282 . . . . 0.0 114.793 169.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 p -45.44 -43.83 11.73 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -111.61 136.53 50.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.142 0.977 . . . . 0.0 113.362 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.1 tt -77.42 124.83 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.478 1.511 . . . . 0.0 111.882 172.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -72.65 152.5 41.7 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.975 0.91 . . . . 0.0 111.301 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -80.27 79.21 6.88 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.709 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -59.21 -38.42 79.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.149 0.979 . . . . 0.0 112.65 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.8 mt -129.13 145.35 51.32 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.599 1.959 . . . . 0.0 109.724 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -64.05 150.64 44.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.066 1.346 . . . . 0.0 109.38 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.74 -33.45 55.73 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.249 -1.532 . . . . 0.0 113.983 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -68.67 -35.63 77.47 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.357 1.463 . . . . 0.0 113.566 174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -67.54 -35.24 78.67 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.499 -1.376 . . . . 0.0 111.152 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.82 -44.19 97.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.875 0.87 . . . . 0.0 110.956 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -58.04 -45.3 87.22 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.013 -1.054 . . . . 0.0 111.162 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.42 -33.58 76.27 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -76.0 -38.8 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 119.846 1.203 . . . . 0.0 112.21 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.75 -39.63 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 119.67 1.123 . . . . 0.0 111.934 174.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.42 -35.37 77.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.477 1.111 . . . . 0.0 112.741 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.26 -38.34 87.63 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.859 0.463 . . . . 0.0 111.631 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.6 mt -66.31 -46.56 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.79 1.236 . . . . 0.0 110.243 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -57.7 -28.9 64.25 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -81.23 -30.29 34.23 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.048 175.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.74 85.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.922 1.289 . . . . 0.0 112.25 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.02 -17.4 2.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.514 1.525 . . . . 0.0 113.787 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -106.63 14.42 26.98 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.034 -1.666 . . . . 0.0 112.396 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -130.68 -15.92 3.43 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.83 1.652 . . . . 0.0 113.961 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -152.39 152.84 32.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.845 1.258 . . . . 0.0 110.577 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.3 m -81.03 3.5 22.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.276 1.03 . . . . 0.0 112.812 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.14 -161.74 21.85 Favored Glycine 0 C--N 1.343 0.934 0 C-N-CA 125.996 1.76 . . . . 0.0 111.668 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -162.86 129.52 3.48 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.246 0.618 . . . . 0.0 112.159 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.8 mt -130.78 116.15 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.37 1.068 . . . . 0.0 110.634 -171.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -121.78 153.09 38.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.622 1.169 . . . . 0.0 111.218 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.11 132.78 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.65 1.18 . . . . 0.0 110.725 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -117.3 124.22 48.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.257 1.027 . . . . 0.0 112.515 169.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.41 HD11 ' CG1' ' A' ' 71' ' ' VAL . 12.7 tp -108.33 126.15 52.53 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.069 1.347 . . . . 0.0 112.401 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -150.6 161.63 42.21 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.462 1.105 . . . . 0.0 110.21 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -73.7 -68.98 0.46 Allowed 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.645 -1.284 . . . . 0.0 113.302 -175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -156.57 157.66 35.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.434 1.894 . . . . 0.0 110.277 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.1 p -115.8 147.93 40.45 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.585 1.554 . . . . 0.0 112.77 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -80.5 -29.23 37.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.15 0.98 . . . . 0.0 111.566 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -107.8 -167.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.843 1.657 . . . . 0.0 111.447 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -68.75 134.39 49.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.594 1.158 . . . . 0.0 112.678 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.7 t -60.87 -38.06 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 123.967 0.907 . . . . 0.0 111.299 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.24 -51.25 68.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.682 0.674 . . . . 0.0 112.109 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.17 -43.02 93.07 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.135 0.574 . . . . 0.0 111.47 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -58.51 -42.33 87.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.669 0.788 . . . . 0.0 112.418 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.29 -35.13 77.38 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.902 0.881 . . . . 0.0 111.555 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.2 ttp -63.68 -49.21 74.06 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 123.545 0.738 . . . . 0.0 111.119 170.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.08 -52.45 65.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.049 0.939 . . . . 0.0 111.464 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.14 -42.5 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.506 1.122 . . . . 0.0 111.448 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.54 -46.44 90.15 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.45 1.1 . . . . 0.0 112.003 178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -70.15 -36.96 75.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.443 1.497 . . . . 0.0 111.872 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -74.24 -22.36 59.37 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.768 1.227 . . . . 0.0 114.058 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -85.79 -8.82 57.87 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.684 1.194 . . . . 0.0 112.421 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.5 mttt 65.74 32.89 8.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.232 1.413 . . . . 0.0 112.712 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 85.7 mtp -64.98 -23.63 67.28 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -55.36 -13.41 1.4 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.584 1.954 . . . . 0.0 114.709 168.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -73.79 43.89 0.16 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.486 1.915 . . . . 0.0 112.915 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.2 m -120.74 129.7 53.74 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.658 1.583 . . . . 0.0 109.93 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -53.78 -39.45 65.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.449 1.499 . . . . 0.0 113.83 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -100.44 2.82 42.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 0.0 113.707 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 62.87 32.73 15.63 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.288 1.035 . . . . 0.0 111.169 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -107.82 27.15 9.5 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.372 1.469 . . . . 0.0 113.12 -167.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -84.18 125.8 7.29 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.203 0.906 . . . . 0.0 112.077 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.23 135.77 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.979 1.312 . . . . 0.0 109.714 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.17 127.99 54.66 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.241 1.02 . . . . 0.0 111.315 170.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.4 mt -101.55 96.19 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.621 1.568 . . . . 0.0 109.215 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -84.16 124.37 31.08 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.151 -0.968 . . . . 0.0 110.805 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -120.9 131.92 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.224 1.01 . . . . 0.0 110.952 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 90.96 3.54 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.131 1.773 . . . . 0.0 110.609 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' CG1' HD11 ' A' ' 35' ' ' LEU . 27.2 m -73.29 -14.82 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -167.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -75.61 -34.97 60.62 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 122.847 0.459 . . . . 0.0 111.252 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.45 -12.22 16.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.116 2.167 . . . . 0.0 112.757 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.8 tttt 73.03 26.0 2.26 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.127 1.771 . . . . 0.0 112.441 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.8 p -110.01 167.44 10.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.222 1.409 . . . . 0.0 111.073 -176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -148.39 148.64 30.56 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.298 1.039 . . . . 0.0 110.644 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.9 142.37 40.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.63 128.26 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -145.84 125.64 13.47 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.621 1.168 . . . . 0.0 109.606 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.35 161.98 13.38 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 124.527 1.061 . . . . 0.0 112.023 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -64.58 162.91 14.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 123.212 1.482 . . . . 0.0 111.798 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.008 1.723 . . . . 0.0 113.451 -170.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.48 -25.44 72.65 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 118.259 -1.301 . . . . 0.0 114.534 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.35 -58.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.971 1.885 . . . . 0.0 109.302 167.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -59.69 -25.15 64.53 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -85.5 -18.24 34.1 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.472 1.109 . . . . 0.0 113.884 174.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 88' ' ' VAL . 1.4 p -104.11 -20.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 87' ' ' VAL . 4.7 m -129.11 167.47 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.844 1.257 . . . . 0.0 111.287 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -120.25 173.06 7.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.54 1.136 . . . . 0.0 113.101 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -49.41 -38.49 29.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.44 -31.0 72.04 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.405 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 59.9 t80 -70.88 -32.78 69.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.656 0.782 . . . . 0.0 111.636 175.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -78.99 -26.35 43.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.289 1.436 . . . . 0.0 113.334 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -58.99 -41.56 87.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.57 0.748 . . . . 0.0 112.646 -176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.9 m -59.53 -43.05 93.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.255 0.479 . . . . 0.0 111.287 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.3 m -61.34 -51.16 70.0 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 125.72 1.608 . . . . 0.0 110.401 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.08 -48.51 79.93 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 118.075 -0.965 . . . . 0.0 110.587 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -60.85 -41.69 96.35 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.207 1.367 . . . . 0.0 113.362 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.09 79.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.917 1.235 . . . . 0.0 111.327 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.33 -54.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.934 0.894 . . . . 0.0 110.451 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -52.37 -44.94 65.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.304 1.842 . . . . 0.0 113.174 -175.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -74.37 -30.54 62.03 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.215 0.606 . . . . 0.0 112.557 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -82.36 -39.65 22.45 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.75 0.82 . . . . 0.0 111.063 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.98 -43.25 91.37 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.407 0.683 . . . . 0.0 111.406 170.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.06 -37.31 71.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.264 1.025 . . . . 0.0 112.06 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -71.89 -41.08 68.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.337 1.055 . . . . 0.0 111.409 173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.13 4.78 6.42 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 126.323 1.916 . . . . 0.0 113.648 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -102.46 81.4 2.05 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 119.0 1.4 . . . . 0.0 111.71 -171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -60.03 -43.61 95.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.754 0.822 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.43 -52.69 64.37 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.783 -0.573 . . . . 0.0 111.515 174.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -56.93 -44.76 82.79 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.452 0.701 . . . . 0.0 111.06 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.68 -40.92 96.08 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.344 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.75 -52.22 64.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.754 0.777 . . . . 0.0 111.021 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.3 t -63.77 -49.15 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.609 1.163 . . . . 0.0 110.907 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.37 -32.72 74.29 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.845 0.748 . . . . 0.0 111.834 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.99 -45.42 73.14 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.57 -47.85 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.015 1.326 . . . . 0.0 111.309 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.87 -49.56 76.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.577 0.751 . . . . 0.0 111.483 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -63.48 -34.75 78.45 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.387 -0.82 . . . . 0.0 112.466 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.52 79.52 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.023 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.76 -39.76 97.89 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.51 1.05 . . . . 0.0 112.776 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 78.5 mtp -61.46 -48.41 81.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.046 0.923 . . . . 0.0 112.379 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -72.62 -41.85 65.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.657 0.783 . . . . 0.0 112.308 -176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.65 -37.92 85.8 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.702 1.201 . . . . 0.0 111.185 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.12 -23.59 67.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -62.22 -45.6 92.61 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.494 -1.379 . . . . 0.0 111.225 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -74.03 -39.44 63.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.21 1.004 . . . . 0.0 111.988 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.42 82.56 65.95 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 125.986 1.715 . . . . 0.0 110.567 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.83 136.58 53.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.36 2.04 . . . . 0.0 109.622 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.3 t90 -57.54 135.75 56.67 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -108.75 146.29 33.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.885 1.274 . . . . 0.0 110.003 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -24.48 67.39 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.426 -1.421 . . . . 0.0 113.541 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -105.51 19.42 20.6 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.016 1.326 . . . . 0.0 113.467 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -55.8 162.1 1.91 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.269 1.428 . . . . 0.0 113.66 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.89 116.66 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 122.622 1.201 . . . . 0.0 112.221 -170.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -101.31 104.13 15.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.088 1.755 . . . . 0.0 109.597 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -115.63 -17.84 11.03 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 mp -84.67 160.07 56.85 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 120.201 1.364 . . . . 0.0 110.533 170.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -95.95 141.91 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.162 3.241 . . . . 0.0 111.271 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -72.63 -1.33 15.79 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -62.62 150.49 40.61 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.077 0.951 . . . . 0.0 111.445 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.6 133.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.67 0.788 . . . . 0.0 108.996 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.76 143.88 27.32 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.614 -0.678 . . . . 0.0 112.295 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -145.85 147.45 31.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.217 -0.927 . . . . 0.0 112.168 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.119 0 C-N-CA 126.731 2.11 . . . . 0.0 112.026 165.954 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mtp . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -81.87 -27.95 33.22 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -130.59 147.1 52.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.408 1.083 . . . . 0.0 109.666 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -104.75 -1.63 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.423 1.089 . . . . 0.0 113.112 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.77 -34.38 75.76 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.755 1.622 . . . . 0.0 112.788 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -136.62 122.73 20.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.781 2.032 . . . . 0.0 108.085 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -75.53 -25.31 57.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -141.3 126.53 18.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.601 1.56 . . . . 0.0 107.516 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 m -58.79 157.15 10.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.066 0.947 . . . . 0.0 110.31 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.81 -44.03 18.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -51.14 -40.43 58.52 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 173.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -79.49 -39.95 30.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.025 0.93 . . . . 0.0 111.434 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.06 -46.03 75.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.712 1.205 . . . . 0.0 111.424 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -57.95 -48.93 78.48 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.355 -1.466 . . . . 0.0 110.7 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.35 85.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.4 tt -70.18 -38.68 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.951 1.25 . . . . 0.0 112.678 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.12 -46.19 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.634 0.652 . . . . 0.0 110.719 174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -62.15 -35.73 79.67 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.885 0.874 . . . . 0.0 112.828 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.38 96.93 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.897 0.772 . . . . 0.0 111.437 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.39 -45.01 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.628 -0.67 . . . . 0.0 110.51 172.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -56.92 -27.46 60.95 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -83.64 -28.85 28.13 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.105 0.866 . . . . 0.0 112.3 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.37 97.63 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 120.339 -1.476 . . . . 0.0 110.767 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -74.58 18.4 0.17 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.952 1.301 . . . . 0.0 113.637 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -123.96 11.44 8.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.823 2.049 . . . . 0.0 111.376 166.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -132.44 -10.74 3.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.832 1.653 . . . . 0.0 113.378 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -150.5 171.0 17.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.021 1.728 . . . . 0.0 110.171 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -101.35 5.09 42.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.974 1.71 . . . . 0.0 112.776 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.5 126.44 6.52 Favored Glycine 0 C--N 1.343 0.959 0 C-N-CA 124.992 1.282 . . . . 0.0 112.425 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -94.23 142.32 27.55 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -156.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.4 mt -114.76 134.91 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.505 1.122 . . . . 0.0 111.293 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -144.11 149.35 36.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.947 1.299 . . . . 0.0 112.131 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.79 141.79 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.918 1.687 . . . . 0.0 110.327 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' HB2' HD11 ' A' ' 66' ' ' LEU . 37.8 t60 -124.39 127.0 46.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.686 1.594 . . . . 0.0 112.0 170.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 tp -112.77 123.05 49.43 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.393 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 46' ' ' ARG . 26.1 tt0 -143.14 159.07 42.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.036 0.934 . . . . 0.0 110.517 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -68.61 -73.29 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.739 -1.226 . . . . 0.0 110.824 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -153.98 159.19 41.55 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.27 1.828 . . . . 0.0 110.671 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -105.21 159.8 15.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.69 1.596 . . . . 0.0 110.361 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -94.48 -27.58 15.92 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.227 -0.921 . . . . 0.0 112.766 166.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.8 pt -110.33 -150.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 126.112 1.765 . . . . 0.0 111.334 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -83.84 136.51 34.1 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.549 1.139 . . . . 0.0 111.696 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.27 -37.24 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.076 0.95 . . . . 0.0 112.146 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -64.3 -47.43 79.51 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.372 0.987 . . . . 0.0 111.933 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -44.32 97.09 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.473 1.509 . . . . 0.0 110.387 176.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 36' ' ' GLU . 47.6 ttt85 -61.04 -45.69 93.75 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.623 1.169 . . . . 0.0 113.409 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.4 98.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.517 0.727 . . . . 0.0 110.791 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.0 ttp -60.58 -43.17 97.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.963 0.905 . . . . 0.0 113.048 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -61.47 -54.46 43.09 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.933 -1.104 . . . . 0.0 112.228 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.98 -41.57 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.116 0.566 . . . . 0.0 111.86 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.99 -49.89 76.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.88 1.272 . . . . 0.0 111.919 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -74.76 -32.91 62.19 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.144 0.978 . . . . 0.0 112.059 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -64.99 -36.31 84.0 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.045 -1.659 . . . . 0.0 112.463 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.97 -8.04 57.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.823 1.249 . . . . 0.0 113.279 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 65.45 35.89 7.07 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 126.226 1.81 . . . . 0.0 112.214 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.4 mtp -69.64 -25.26 63.85 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.865 -1.147 . . . . 0.0 112.79 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -69.64 -12.73 61.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.304 2.241 . . . . 0.0 114.411 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -84.77 63.45 8.0 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.24 1.416 . . . . 0.0 110.937 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.2 m -132.01 133.94 45.0 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.884 1.673 . . . . 0.0 109.546 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -48.99 -54.73 14.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 113.45 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.24 -9.9 51.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.736 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 62.72 55.39 2.14 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.174 1.79 . . . . 0.0 109.956 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -125.8 28.93 6.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.537 1.135 . . . . 0.0 111.904 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.86 133.78 17.69 Favored Glycine 0 CA--C 1.537 1.448 0 O-C-N 120.669 -1.269 . . . . 0.0 111.335 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.79 135.84 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.014 1.326 . . . . 0.0 111.273 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 34' ' ' HIS . 21.0 tp -118.52 121.37 40.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.916 1.286 . . . . 0.0 110.781 171.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -95.14 96.55 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -78.64 123.02 26.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.391 0.677 . . . . 0.0 110.03 171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.4 127.13 75.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.637 1.175 . . . . 0.0 110.212 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.62 92.69 4.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.77 1.228 . . . . 0.0 109.531 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.4 m -76.05 -6.11 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -171.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.24 -49.89 15.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.786 0.721 . . . . 0.0 109.726 170.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.2 -9.43 53.09 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.214 1.406 . . . . 0.0 112.629 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.3 tttt 71.72 20.59 4.58 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.005 2.122 . . . . 0.0 113.133 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.3 p -102.6 169.34 8.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.957 1.303 . . . . 0.0 111.805 -174.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.46 145.92 31.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.59 1.156 . . . . 0.0 110.595 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.49 136.46 48.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 126.241 1.817 . . . . 0.0 107.103 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.39 127.62 73.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -130.11 147.0 51.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.831 1.252 . . . . 0.0 109.758 173.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.64 154.78 26.04 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -58.52 162.54 3.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.174 1.464 . . . . 0.0 113.767 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -53.23 -36.71 61.35 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.344 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -45.18 94.6 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 120.647 1.567 . . . . 0.0 112.433 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 61.2 mt -58.97 -57.44 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 118.301 1.05 . . . . 0.0 109.854 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -58.57 -29.7 66.59 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -81.59 -16.68 50.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.597 1.159 . . . . 0.0 112.851 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 m -109.89 -34.79 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.63 165.93 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 120.176 1.353 . . . . 0.0 112.016 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.1 m -115.39 165.4 13.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.055 1.342 . . . . 0.0 112.382 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -61.03 -26.03 67.33 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.83 -1.169 . . . . 0.0 112.997 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.68 -23.3 56.2 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.154 0.981 . . . . 0.0 112.81 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 53.0 t80 -78.21 -27.4 47.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.639 1.576 . . . . 0.0 111.578 170.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -79.8 -29.43 40.28 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -49.52 -48.04 48.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.566 1.147 . . . . 0.0 112.599 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -54.33 -44.72 72.31 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.533 1.533 . . . . 0.0 112.293 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.3 m -64.94 -48.67 73.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.911 1.284 . . . . 0.0 110.691 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -56.74 -46.39 81.39 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.377 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -62.58 -45.6 92.19 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.833 0.742 . . . . 0.0 112.817 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.62 -50.52 71.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.922 1.237 . . . . 0.0 112.362 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.5 -50.99 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.652 0.781 . . . . 0.0 110.655 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -60.29 -46.79 88.63 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.534 1.533 . . . . 0.0 112.012 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -62.11 -33.61 74.77 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.224 0.609 . . . . 0.0 112.381 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -84.1 -40.18 18.59 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.442 1.097 . . . . 0.0 112.191 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.7 -36.81 77.26 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.569 -0.707 . . . . 0.0 111.186 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -62.7 -29.93 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.996 1.318 . . . . 0.0 113.505 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -80.31 -29.31 38.12 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.942 -1.099 . . . . 0.0 110.866 172.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.09 -1.8 33.37 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 126.015 1.769 . . . . 0.0 113.801 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -86.57 92.14 8.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.39 1.095 . . . . 0.0 111.039 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.73 -38.26 88.66 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.032 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -59.98 -59.66 5.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.265 0.626 . . . . 0.0 111.153 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -61.45 -40.94 96.31 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.913 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.85 97.16 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.923 1.238 . . . . 0.0 114.019 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.1 mt -71.16 -45.65 63.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.395 0.598 . . . . 0.0 111.481 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.87 -50.45 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.307 0.958 . . . . 0.0 112.009 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.501 1.12 . . . . 0.0 111.104 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.53 -47.55 88.54 Favored Glycine 0 C--N 1.345 1.075 0 C-N-CA 123.574 0.607 . . . . 0.0 111.633 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.27 -42.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.734 1.214 . . . . 0.0 111.333 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -64.65 -39.82 94.37 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.198 1.399 . . . . 0.0 112.001 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -72.46 -43.59 63.51 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.905 -1.122 . . . . 0.0 111.526 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.02 75.47 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 124.343 1.057 . . . . 0.0 111.095 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.47 -44.22 96.87 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 119.256 0.935 . . . . 0.0 112.088 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -67.16 -26.2 66.54 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.566 -0.961 . . . . 0.0 113.557 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -78.22 -50.27 12.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.084 1.353 . . . . 0.0 111.426 172.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 64.2 mt -58.63 -38.17 77.47 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.763 2.025 . . . . 0.0 111.789 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.55 -14.15 12.0 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -80.53 -35.39 34.6 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 120.454 -1.404 . . . . 0.0 111.641 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -84.18 -38.81 20.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 113.041 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.52 86.26 53.72 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.02 1.728 . . . . 0.0 109.235 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.42 135.32 26.35 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.712 2.275 . . . . 0.0 110.466 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 35.2 t90 -56.33 146.28 24.49 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -125.45 153.64 43.2 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 124.709 1.204 . . . . 0.0 110.986 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -62.04 -35.86 79.88 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.858 -1.151 . . . . 0.0 113.063 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -87.3 13.77 9.13 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.655 1.182 . . . . 0.0 113.64 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.38 158.62 28.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.853 0.861 . . . . 0.0 112.732 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.2 168.28 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.041 1.736 . . . . 0.0 110.73 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.61 106.13 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.044 1.738 . . . . 0.0 106.905 -174.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -86.96 -32.07 20.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.02 0.928 . . . . 0.0 113.087 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.7 mt -109.97 141.72 24.36 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.153 0.981 . . . . 0.0 111.174 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.81 141.08 14.99 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.398 2.065 . . . . 0.0 111.288 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -64.92 1.39 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.1 1.76 . . . . 0.0 115.189 175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 p -71.39 141.99 50.33 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.826 -1.171 . . . . 0.0 111.629 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 82.4 mt -73.46 136.36 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.245 1.018 . . . . 0.0 109.706 -173.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -96.1 145.91 25.09 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 120.906 -1.122 . . . . 0.0 111.009 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -144.98 142.46 29.83 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.416 -1.427 . . . . 0.0 112.816 -172.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.406 0 C-N-CA 125.761 1.648 . . . . 0.0 112.814 169.453 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 115.513 -2.184 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -24.77 -32.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -159.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.76 -34.6 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 119.983 -1.698 . . . . 0.0 114.133 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.2 pt -142.85 138.42 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 128.26 2.624 . . . . 0.0 109.499 -173.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -133.98 -95.69 0.29 Allowed 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.055 -1.028 . . . . 0.0 110.785 -168.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -105.31 -35.54 7.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.46 1.027 . . . . 0.0 112.06 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -46.19 -55.41 7.14 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.3 mt -148.78 157.46 43.45 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.329 1.852 . . . . 0.0 110.292 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 p -84.7 166.48 17.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 111.889 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.28 -37.28 77.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.078 -0.963 . . . . 0.0 112.121 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.7 -48.74 78.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.147 1.379 . . . . 0.0 111.052 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -64.32 -44.23 92.19 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.282 0.633 . . . . 0.0 111.366 -174.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.85 -29.51 62.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.486 1.514 . . . . 0.0 113.424 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -65.93 -37.73 86.8 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.01 -1.681 . . . . 0.0 111.7 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.86 -39.42 35.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.84 -37.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.505 -1.372 . . . . 0.0 112.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.13 -36.14 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.662 0.664 . . . . 0.0 110.846 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -72.2 -25.24 61.59 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.556 1.142 . . . . 0.0 112.754 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -40.32 72.87 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.687 -0.633 . . . . 0.0 111.587 172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.93 -44.89 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.349 -0.844 . . . . 0.0 110.991 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -57.52 -32.5 67.11 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -79.74 -30.36 40.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 118.757 -0.64 . . . . 0.0 112.636 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.75 74.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.13 0.972 . . . . 0.0 112.162 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -55.39 -19.41 9.0 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 125.276 1.431 . . . . 0.0 112.461 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -103.51 9.9 37.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.514 1.526 . . . . 0.0 112.926 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -124.95 -12.92 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.983 1.313 . . . . 0.0 113.712 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 t -164.35 149.28 10.02 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 109.391 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.9 p -85.32 5.7 29.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.054 0.942 . . . . 0.0 112.92 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.94 168.65 43.42 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.831 1.205 . . . . 0.0 110.304 167.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -137.18 121.95 18.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.934 . . . . 0.0 113.054 -166.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.8 mt -113.45 137.72 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.209 1.404 . . . . 0.0 111.04 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -146.55 153.85 40.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.274 1.429 . . . . 0.0 110.433 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.2 t -112.48 138.4 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 124.919 1.287 . . . . 0.0 110.203 176.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.431 ' HB2' HD11 ' A' ' 66' ' ' LEU . 25.0 t60 -116.3 115.69 26.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 110.964 165.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.9 tp -98.17 134.22 41.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.484 0.714 . . . . 0.0 111.143 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -154.03 162.36 41.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.66 0.743 . . . . 0.0 111.181 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -73.83 -69.37 0.44 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.722 1.209 . . . . 0.0 112.673 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 t -160.36 152.38 20.24 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.539 1.135 . . . . 0.0 113.289 -170.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.6 p -109.96 141.64 42.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.667 1.587 . . . . 0.0 113.181 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -76.57 -28.51 56.27 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.482 0.658 . . . . 0.0 112.498 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -109.95 -172.3 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.113 2.165 . . . . 0.0 111.641 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -64.12 132.74 51.36 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.755 1.222 . . . . 0.0 112.812 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.9 t -59.57 -41.18 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.816 1.246 . . . . 0.0 111.467 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -62.48 -48.5 79.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.645 0.778 . . . . 0.0 112.11 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -67.51 -42.09 83.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.871 0.868 . . . . 0.0 110.992 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -60.02 -46.34 89.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.213 1.005 . . . . 0.0 112.156 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.58 -37.92 88.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.211 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 48.7 ttp -63.94 -48.89 74.75 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.859 0.754 . . . . 0.0 111.654 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.78 -46.8 89.07 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.238 0.615 . . . . 0.0 111.054 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.61 -43.04 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.66 1.184 . . . . 0.0 111.79 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.04 -48.43 81.61 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.497 1.044 . . . . 0.0 112.185 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -72.39 -33.41 67.17 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.582 1.153 . . . . 0.0 112.606 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -65.36 -42.79 92.41 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.607 -1.308 . . . . 0.0 111.809 173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.4 mt -78.42 -1.21 32.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.537 1.135 . . . . 0.0 112.947 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 59.75 37.92 21.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.811 1.244 . . . . 0.0 112.28 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 76.9 mtp -75.44 -21.17 58.37 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 112.511 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -59.81 -13.12 9.08 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.308 2.643 . . . . 0.0 114.415 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -64.45 -7.89 11.57 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.5 t -55.02 140.01 39.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.642 1.977 . . . . 0.0 111.074 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -66.43 -36.07 81.89 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.381 -0.824 . . . . 0.0 112.177 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 81.0 mt -92.52 -1.45 56.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 62.06 27.86 16.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.247 1.023 . . . . 0.0 111.311 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -107.92 39.42 1.95 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.161 1.784 . . . . 0.0 112.752 -171.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.13 128.33 9.44 Favored Glycine 0 N--CA 1.479 1.53 0 C-N-CA 124.473 1.035 . . . . 0.0 112.262 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -111.66 132.26 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.209 1.803 . . . . 0.0 109.911 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 34' ' ' HIS . 28.6 tp -117.39 128.1 54.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.122 0.969 . . . . 0.0 111.194 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.61 97.41 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.671 1.189 . . . . 0.0 107.804 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -81.84 122.74 28.11 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.081 0.952 . . . . 0.0 111.039 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.34 125.62 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.913 0.885 . . . . 0.0 110.284 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 100.27 11.28 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.657 1.583 . . . . 0.0 110.188 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.19 -19.47 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -172.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -74.23 -47.14 37.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.655 1.116 . . . . 0.0 111.153 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -88.86 -11.61 44.18 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.7 1.2 . . . . 0.0 113.612 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.5 tttt 71.82 30.11 2.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.01 1.724 . . . . 0.0 112.717 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 m -113.3 133.39 55.14 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.391 1.477 . . . . 0.0 110.052 -171.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -114.43 143.23 45.27 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.022 1.329 . . . . 0.0 109.371 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.99 134.27 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.027 1.331 . . . . 0.0 108.194 174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 mt -112.48 129.58 67.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -135.84 124.13 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.728 0.811 . . . . 0.0 110.45 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.83 154.49 17.0 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 124.559 1.076 . . . . 0.0 110.785 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -67.93 168.4 11.82 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 122.374 1.083 . . . . 0.0 111.929 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.38 -26.52 63.3 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.952 1.301 . . . . 0.0 114.452 -170.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.3 -50.66 55.0 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.812 1.187 . . . . 0.0 111.492 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.93 -54.91 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 118.538 1.169 . . . . 0.0 109.272 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -60.9 -30.72 70.34 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -78.24 -38.12 43.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.873 0.869 . . . . 0.0 112.113 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 88' ' ' VAL . 19.8 m -89.17 -23.06 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 87' ' ' VAL . 2.5 m -119.59 162.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 119.231 0.923 . . . . 0.0 112.232 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -113.11 173.38 6.42 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.424 1.49 . . . . 0.0 112.462 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -58.24 -29.41 65.73 Favored 'General case' 0 CA--C 1.553 1.069 0 O-C-N 120.281 -1.512 . . . . 0.0 114.598 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.73 -23.78 61.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.89 1.276 . . . . 0.0 111.994 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -76.12 -31.02 58.43 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.314 -0.866 . . . . 0.0 111.065 168.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -80.55 -32.18 36.76 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.25 -45.04 68.62 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.268 1.427 . . . . 0.0 113.005 -177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -58.12 -34.97 70.81 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.528 1.131 . . . . 0.0 113.067 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.5 m -72.5 -50.21 27.55 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 127.029 2.132 . . . . 0.0 109.345 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -60.93 -43.29 98.83 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 122.787 0.435 . . . . 0.0 111.2 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -59.46 -38.3 80.42 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.03 -50.72 65.14 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.566 0.621 . . . . 0.0 111.371 176.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.68 -48.75 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.067 0.947 . . . . 0.0 110.783 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -61.93 -40.55 95.89 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.292 1.437 . . . . 0.0 113.091 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.2 tp -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.6 0.636 . . . . 0.0 111.484 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -34.99 48.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.543 -0.723 . . . . 0.0 112.665 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -63.39 -40.81 98.24 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.839 0.855 . . . . 0.0 111.16 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -63.09 -35.43 80.22 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 112.143 172.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.87 -21.59 60.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.723 1.209 . . . . 0.0 113.138 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.38 -5.43 44.82 Favored Glycine 0 N--CA 1.48 1.585 0 C-N-CA 126.16 1.838 . . . . 0.0 114.943 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -97.82 82.8 3.07 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.832 1.253 . . . . 0.0 111.54 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -60.56 -48.2 82.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.506 0.722 . . . . 0.0 112.469 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -54.57 -53.62 52.16 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.283 0.492 . . . . 0.0 111.644 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.81 -41.21 77.35 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.591 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.92 -36.76 65.22 Favored Glycine 0 N--CA 1.472 1.075 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.775 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.5 -52.07 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.536 0.668 . . . . 0.0 109.995 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.74 -45.18 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.647 0.779 . . . . 0.0 111.585 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.6 -45.65 93.22 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.343 1.457 . . . . 0.0 111.3 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.91 -36.84 91.65 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.742 0.686 . . . . 0.0 113.388 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.22 -51.58 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.461 1.104 . . . . 0.0 110.424 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.43 -41.03 98.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.234 1.014 . . . . 0.0 111.856 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.08 -39.56 78.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.34 0.656 . . . . 0.0 112.586 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.08 96.13 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.632 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.7 -49.36 78.26 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-N 119.162 0.892 . . . . 0.0 112.004 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 72.1 mtm -60.32 -34.45 73.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.692 1.246 . . . . 0.0 113.793 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.92 -46.52 15.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.368 0.667 . . . . 0.0 112.056 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.4 mt -59.52 -37.59 78.74 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.458 1.503 . . . . 0.0 110.675 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.99 -15.66 57.0 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -76.57 -33.73 58.47 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.512 -1.368 . . . . 0.0 111.295 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -81.58 -39.78 24.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.061 1.344 . . . . 0.0 111.224 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.54 79.52 72.04 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.752 2.021 . . . . 0.0 111.501 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 138.35 39.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.229 2.62 . . . . 0.0 112.192 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.7 t90 -64.87 135.88 56.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.37 151.86 30.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.799 1.639 . . . . 0.0 111.605 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -69.99 -3.09 14.66 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.542 -1.349 . . . . 0.0 114.353 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -115.86 7.4 14.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.151 1.781 . . . . 0.0 112.576 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -58.22 148.62 26.48 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.434 1.093 . . . . 0.0 112.236 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.01 135.58 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 111.317 -169.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -75.75 108.48 8.62 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.507 1.123 . . . . 0.0 109.706 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -89.56 -35.91 15.64 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.211 -0.93 . . . . 0.0 112.283 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.56 157.69 43.63 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.472 1.509 . . . . 0.0 111.039 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -90.8 141.0 3.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.882 3.055 . . . . 0.0 111.254 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 140' ' ' ASN . 1.3 p30 -61.15 -7.07 2.37 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.612 2.365 . . . . 0.0 116.836 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.2 m -58.11 152.5 16.66 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.584 1.154 . . . . 0.0 111.788 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.45 130.08 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.648 1.179 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.7 t -88.11 141.34 28.64 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.404 0.682 . . . . 0.0 110.651 171.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -151.7 135.39 16.3 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.534 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 116.595 -2.225 . . . . 0.0 114.164 -174.295 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 118.731 -0.652 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.8 m -54.9 146.58 17.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.667 1.121 . . . . 0.0 112.335 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -66.8 -30.07 70.17 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.643 -1.285 . . . . 0.0 113.662 -173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mt -111.83 121.7 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -116.94 -28.51 6.26 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.409 0.683 . . . . 0.0 110.99 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -141.66 125.54 17.1 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.162 1.785 . . . . 0.0 110.357 -175.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -89.27 -5.3 57.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 112.59 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.78 144.74 50.51 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 109.212 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -77.17 166.15 23.61 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.608 0.242 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.23 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 120.847 -1.158 . . . . 0.0 111.726 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.3 -48.08 82.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.733 1.213 . . . . 0.0 110.917 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.9 -39.91 72.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.479 1.111 . . . . 0.0 111.235 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -66.87 -46.45 74.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.044 1.338 . . . . 0.0 112.325 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -56.91 -47.31 80.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.448 -1.408 . . . . 0.0 111.081 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.89 84.8 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.8 tt -74.16 -35.84 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 121.047 -1.033 . . . . 0.0 112.171 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -58.42 -42.86 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.625 1.102 . . . . 0.0 111.392 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.92 -27.42 68.17 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.22 -43.37 74.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.474 0.579 . . . . 0.0 111.548 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 mm -58.63 -43.75 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.391 0.677 . . . . 0.0 110.256 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -60.31 -25.57 65.87 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.97 -36.27 23.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.256 1.389 . . . . 0.0 111.986 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.53 97.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.175 0.99 . . . . 0.0 112.198 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.72 -4.63 9.42 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -106.85 11.76 29.69 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.009 -1.682 . . . . 0.0 112.529 170.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -128.77 -6.44 5.09 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.65 1.98 . . . . 0.0 114.084 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.2 t -164.3 151.4 11.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.148 2.179 . . . . 0.0 109.729 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -88.11 11.57 15.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.742 1.217 . . . . 0.0 113.853 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.41 133.13 10.37 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 125.742 1.639 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -104.19 138.21 40.99 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.349 1.06 . . . . 0.0 112.642 -155.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -118.03 139.66 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 120.356 -1.465 . . . . 0.0 111.247 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HE ' HD23 ' A' ' 138' ' ' LEU . 78.5 mtt-85 -139.13 146.45 40.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.932 1.693 . . . . 0.0 111.296 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.76 136.26 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.929 1.291 . . . . 0.0 109.608 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -122.3 120.3 33.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.272 1.429 . . . . 0.0 113.058 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.5 tp -112.55 125.23 54.03 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.557 1.143 . . . . 0.0 111.392 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -154.08 160.63 42.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.961 1.304 . . . . 0.0 109.983 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.26 -72.1 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 m -143.26 165.19 28.14 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.363 2.265 . . . . 0.0 107.892 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.7 m -124.7 155.85 38.58 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.315 1.046 . . . . 0.0 110.46 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -90.94 -1.75 57.79 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 pt -134.55 -131.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 126.57 1.948 . . . . 0.0 111.181 -174.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -101.77 142.11 33.6 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.438 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.18 -36.0 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.006 0.522 . . . . 0.0 111.84 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.49 -50.39 71.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.743 0.817 . . . . 0.0 111.937 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.26 -33.46 75.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.106 0.563 . . . . 0.0 111.47 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -65.66 -46.63 78.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.902 0.881 . . . . 0.0 112.568 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.15 90.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.664 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 61.9 ttp -59.12 -49.9 76.1 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.337 0.655 . . . . 0.0 111.715 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.4 -45.89 91.1 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.759 -0.588 . . . . 0.0 111.717 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.38 -35.17 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 118.715 -0.659 . . . . 0.0 110.785 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.7 -50.56 73.44 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.536 1.062 . . . . 0.0 111.718 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -72.72 -34.46 67.1 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.436 0.695 . . . . 0.0 111.608 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -70.37 -26.74 63.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.9 mt -96.56 6.91 47.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.355 1.462 . . . . 0.0 112.425 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt 60.92 26.39 16.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.625 1.57 . . . . 0.0 112.284 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtt -75.0 -18.1 60.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.723 1.209 . . . . 0.0 112.326 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -74.06 -8.21 55.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.424 2.29 . . . . 0.0 113.756 169.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -98.83 82.69 2.82 Favored 'General case' 0 C--O 1.246 0.888 0 O-C-N 121.562 -0.711 . . . . 0.0 110.474 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 33.5 p -139.2 152.82 47.67 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.044 1.337 . . . . 0.0 110.501 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -57.86 -37.34 73.72 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.9 mt -105.96 -7.95 17.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.61 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 70.94 29.26 3.05 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.953 1.301 . . . . 0.0 110.952 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -105.41 35.11 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.094 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.75 117.0 4.79 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.127 -0.818 . . . . 0.0 111.851 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.6 t -98.98 139.05 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.583 1.553 . . . . 0.0 110.232 173.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.5 tp -129.16 133.94 47.82 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 174.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.29 100.12 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.705 1.202 . . . . 0.0 109.409 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.58 128.0 32.91 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.072 -1.018 . . . . 0.0 109.994 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.3 t -124.26 127.52 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.911 0.884 . . . . 0.0 110.657 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.11 95.12 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.542 1.537 . . . . 0.0 110.035 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -70.42 -21.0 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -165.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.64 -28.69 45.52 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.51 1.05 . . . . 0.0 111.825 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -97.47 -4.99 37.02 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.443 1.097 . . . . 0.0 112.714 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 61.39 23.01 13.32 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.996 1.718 . . . . 0.0 112.003 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -105.36 169.02 8.69 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.597 1.559 . . . . 0.0 110.781 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -146.73 143.95 29.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.173 1.789 . . . . 0.0 108.749 -174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.8 140.43 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.146 1.378 . . . . 0.0 107.299 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.3 mt -118.68 133.34 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -139.4 138.18 36.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.259 1.423 . . . . 0.0 109.128 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.85 155.42 21.21 Favored Glycine 0 N--CA 1.465 0.59 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -66.72 172.48 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 123.556 1.646 . . . . 0.0 111.82 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -61.45 -33.56 73.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.64 -1.172 . . . . 0.0 112.707 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.85 -48.7 76.39 Favored Glycine 0 N--CA 1.475 1.246 0 CA-C-N 120.242 1.383 . . . . 0.0 112.31 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.97 -56.13 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.202 1.001 . . . . 0.0 109.774 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.6 -24.71 66.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -78.25 -38.36 43.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.014 1.325 . . . . 0.0 110.397 173.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 88' ' ' VAL . 2.0 p -90.8 -29.22 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -174.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 87' ' ' VAL . 2.9 m -119.89 156.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.842 1.656 . . . . 0.0 113.004 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.7 m -102.36 172.72 6.72 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.531 1.533 . . . . 0.0 114.803 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -61.12 -34.33 74.8 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.88 -24.42 67.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 0.0 113.029 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 47.6 t80 -77.22 -39.36 48.83 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.18 -0.95 . . . . 0.0 111.281 171.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -70.85 -29.62 65.79 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.191 1.396 . . . . 0.0 114.108 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.62 -37.97 74.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.505 0.722 . . . . 0.0 112.759 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 m -62.05 -43.57 98.55 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.696 0.798 . . . . 0.0 111.086 178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 m -59.11 -53.81 54.17 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.673 1.989 . . . . 0.0 110.583 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -56.68 -50.26 72.66 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.659 1.184 . . . . 0.0 111.204 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -57.91 -36.44 72.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.248 1.019 . . . . 0.0 113.621 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.0 -53.46 20.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.788 0.835 . . . . 0.0 112.019 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.9 mt -58.12 -49.54 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.187 0.995 . . . . 0.0 109.639 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.3 -42.54 91.57 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.118 1.367 . . . . 0.0 113.382 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.64 -45.44 90.19 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.063 0.545 . . . . 0.0 110.869 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.02 -29.35 55.33 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 118.654 -0.689 . . . . 0.0 112.16 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.51 -39.64 81.16 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.358 0.981 . . . . 0.0 111.481 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.85 -43.54 94.58 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.555 0.742 . . . . 0.0 111.09 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.49 -35.23 79.77 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 118.991 -0.528 . . . . 0.0 111.935 173.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.88 10.28 24.89 Favored Glycine 0 N--CA 1.476 1.313 0 C-N-CA 125.834 1.683 . . . . 0.0 114.674 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.79 83.44 2.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.788 1.235 . . . . 0.0 110.648 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -62.52 -39.62 94.15 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.764 1.225 . . . . 0.0 112.705 -171.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -54.78 -56.01 23.97 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -60.81 -42.21 97.19 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.904 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.93 -41.58 97.32 Favored Glycine 0 N--CA 1.473 1.101 0 CA-C-N 120.187 1.358 . . . . 0.0 112.378 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.63 -47.21 73.31 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.547 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.32 -48.49 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 118.852 0.751 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -63.41 -35.36 80.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.982 0.81 . . . . 0.0 112.021 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.91 -43.98 92.7 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.067 -0.852 . . . . 0.0 111.53 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.0 mt -61.9 -47.58 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.929 1.292 . . . . 0.0 111.362 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -59.98 -49.51 77.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.712 0.805 . . . . 0.0 111.504 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -65.28 -38.73 91.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.828 -0.545 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.39 74.08 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.844 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.15 87.57 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 119.669 1.122 . . . . 0.0 112.469 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.3 mtp -58.36 -42.22 86.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.987 0.894 . . . . 0.0 112.908 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -75.23 -41.69 57.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.501 0.721 . . . . 0.0 111.586 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 53.1 mt -62.07 -36.58 82.08 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.795 1.238 . . . . 0.0 111.131 176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.05 -18.22 32.82 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -70.99 -34.58 71.52 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.246 -1.534 . . . . 0.0 112.198 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -90.12 -35.78 15.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.37 1.468 . . . . 0.0 112.981 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -131.89 85.2 51.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.937 1.695 . . . . 0.0 110.044 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.52 147.47 93.1 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.381 2.054 . . . . 0.0 110.497 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -69.54 146.68 51.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.332 1.063 . . . . 0.0 111.783 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -134.73 151.17 50.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.604 1.161 . . . . 0.0 109.611 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.42 -35.95 72.85 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.373 -0.83 . . . . 0.0 112.814 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -90.32 18.09 6.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.881 1.672 . . . . 0.0 113.224 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.31 151.12 28.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.094 1.358 . . . . 0.0 113.203 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.0 74.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.626 1.57 . . . . 0.0 113.332 -154.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -64.64 108.99 1.86 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.125 1.37 . . . . 0.0 111.014 170.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -114.09 -6.2 13.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.148 1.379 . . . . 0.0 113.139 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.46 HD23 ' HE ' ' A' ' 32' ' ' ARG . 2.1 mp -115.39 145.37 34.2 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.493 1.117 . . . . 0.0 111.384 -165.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.47 132.07 5.77 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.611 2.207 . . . . 0.0 110.971 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -74.13 3.39 7.13 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.4 p -70.65 156.33 39.6 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 128.21 2.604 . . . . 0.0 112.487 -173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 84.2 mt -78.26 134.64 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.699 1.2 . . . . 0.0 108.406 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.3 m -91.93 142.14 27.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.464 0.649 . . . . 0.0 109.458 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -129.8 151.15 50.69 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.171 -0.956 . . . . 0.0 110.698 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.966 0 C-N-CA 126.192 1.853 . . . . 0.0 113.76 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.6 mtm . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 p -175.7 155.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 125.653 1.581 . . . . 0.0 108.396 -174.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt 56.23 52.76 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 122.235 1.017 . . . . 0.0 111.051 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.54 -33.5 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.303 -1.498 . . . . 0.0 111.936 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -76.53 -33.11 58.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.821 1.248 . . . . 0.0 113.016 -178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -137.44 125.92 23.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.873 1.669 . . . . 0.0 107.427 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.59 ' CE1' HG21 ' A' ' 71' ' ' VAL . 72.3 m-85 -68.23 -25.13 65.05 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.126 -0.984 . . . . 0.0 112.623 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.3 mt -140.99 142.6 34.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.978 2.511 . . . . 0.0 107.985 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.7 t -74.65 167.29 22.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.148 0.431 . . . . 0.0 110.214 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.74 58.57 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.815 0.846 . . . . 0.0 113.21 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -55.2 -41.79 72.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.291 1.436 . . . . 0.0 113.278 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.14 -42.69 25.61 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.557 1.143 . . . . 0.0 110.63 -173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -62.69 -45.14 94.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.362 1.065 . . . . 0.0 111.373 172.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -57.74 -47.55 82.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.344 -0.847 . . . . 0.0 111.888 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.75 88.51 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.347 1.059 . . . . 0.0 113.438 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.1 tt -73.18 -41.64 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 117.935 -1.031 . . . . 0.0 112.269 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.53 -42.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.783 1.174 . . . . 0.0 111.464 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.37 -28.73 69.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.138 0.881 . . . . 0.0 113.149 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -31.98 67.32 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.93 0.786 . . . . 0.0 112.015 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 mm -64.78 -50.51 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.91 0.884 . . . . 0.0 110.127 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtp85 -54.28 -29.28 46.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.33 1.052 . . . . 0.0 113.475 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -83.19 -30.2 27.95 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.019 1.328 . . . . 0.0 112.185 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.0 75.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.69 1.132 . . . . 0.0 111.424 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.13 2.34 0.81 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.606 1.562 . . . . 0.0 114.099 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.79 5.41 24.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 119.39 -2.069 . . . . 0.0 113.031 167.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -126.96 -8.08 6.03 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.72 1.608 . . . . 0.0 113.522 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -160.07 161.29 33.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.235 1.814 . . . . 0.0 109.157 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.8 p -99.04 10.79 40.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.57 172.49 17.64 Favored Glycine 0 N--CA 1.473 1.16 0 O-C-N 120.549 -1.344 . . . . 0.0 110.823 173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -123.67 122.24 37.61 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 122.803 0.441 . . . . 0.0 111.67 -160.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.7 mt -108.71 112.36 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.336 1.054 . . . . 0.0 110.693 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -123.24 151.1 42.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.754 0.822 . . . . 0.0 113.19 -177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.6 t -130.52 134.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.581 1.153 . . . . 0.0 109.008 -175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -122.11 121.99 38.2 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.943 0.897 . . . . 0.0 111.991 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 35' ' ' LEU . 13.8 tp -107.16 132.37 53.11 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.178 0.991 . . . . 0.0 111.462 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -160.23 155.18 24.48 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.572 1.149 . . . . 0.0 110.786 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.35 -80.23 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.744 1.218 . . . . 0.0 113.233 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.6 t -137.47 169.76 17.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.193 1.797 . . . . 0.0 110.316 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.3 p -123.23 157.26 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.501 1.52 . . . . 0.0 113.162 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -90.75 -9.85 45.11 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.955 1.302 . . . . 0.0 113.293 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 pt -138.15 -141.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.049 1.739 . . . . 0.0 111.159 -164.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -102.42 135.24 44.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.634 1.561 . . . . 0.0 112.266 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 t -62.47 -38.97 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.019 0.928 . . . . 0.0 112.099 -172.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.02 0.827 . . . . 0.0 111.856 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.44 -39.88 85.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.804 0.842 . . . . 0.0 110.781 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -59.02 -47.53 84.86 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.583 -0.698 . . . . 0.0 111.788 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.97 -42.28 99.78 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.604 0.762 . . . . 0.0 110.978 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -58.55 -53.91 52.99 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.556 1.142 . . . . 0.0 111.247 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -64.63 -37.15 86.58 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.776 -1.203 . . . . 0.0 112.054 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.85 -47.22 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.346 1.058 . . . . 0.0 111.326 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -56.71 -45.92 81.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.421 1.488 . . . . 0.0 111.987 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -73.39 -40.47 64.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.834 1.254 . . . . 0.0 112.979 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -63.89 -39.31 93.89 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.992 0.815 . . . . 0.0 112.378 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.52 0.23 20.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 113.418 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 62.33 24.41 14.53 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.036 1.334 . . . . 0.0 113.271 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.69 -30.09 68.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 0.0 112.412 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -49.73 -31.14 10.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.073 1.749 . . . . 0.0 112.601 165.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -77.67 65.05 3.08 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.085 -1.01 . . . . 0.0 113.02 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.0 m -118.9 134.78 54.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.155 2.182 . . . . 0.0 106.705 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.32 -44.5 72.08 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.826 1.194 . . . . 0.0 112.776 -169.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.64 -2.27 58.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 114.017 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 66.2 19.37 11.08 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.727 1.211 . . . . 0.0 113.222 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -99.33 46.83 0.97 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.211 1.005 . . . . 0.0 112.061 -178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.19 121.45 6.71 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.775 1.179 . . . . 0.0 111.907 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.39 140.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 118.311 1.056 . . . . 0.0 109.567 175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 tp -120.97 127.16 51.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 121.985 0.898 . . . . 0.0 111.5 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.1 mt -102.75 97.59 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.492 1.517 . . . . 0.0 108.31 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -82.1 125.3 30.69 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.604 -0.685 . . . . 0.0 110.514 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.11 131.07 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.729 -0.607 . . . . 0.0 110.695 177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 100.15 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.892 1.677 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.59 HG21 ' CE1' ' A' ' 7' ' ' PHE . 32.6 m -80.52 -14.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -81.26 -49.45 10.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.057 0.844 . . . . 0.0 110.58 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -76.09 -16.84 59.84 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.818 171.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 67.93 41.41 2.11 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.955 1.702 . . . . 0.0 111.172 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.1 p -119.26 172.33 7.67 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.486 1.914 . . . . 0.0 110.245 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -154.74 134.27 12.69 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.005 0.922 . . . . 0.0 109.597 -167.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.6 t -133.17 142.45 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.085 1.754 . . . . 0.0 108.214 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.8 mt -125.99 136.9 59.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -154.92 121.29 5.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.225 1.41 . . . . 0.0 109.086 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.99 168.27 12.52 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 124.15 0.881 . . . . 0.0 111.178 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -69.84 165.61 21.17 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.126 1.441 . . . . 0.0 112.278 170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.23 -33.29 8.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.93 2.092 . . . . 0.0 113.588 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.67 -44.2 98.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 120.885 1.675 . . . . 0.0 112.296 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -66.2 -56.53 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.371 1.086 . . . . 0.0 109.787 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -57.43 -31.28 65.73 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -86.34 -14.75 42.61 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.572 1.549 . . . . 0.0 113.161 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.95 -18.45 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.01 172.6 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 119.789 1.177 . . . . 0.0 111.943 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.3 p -118.17 175.67 5.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.949 1.7 . . . . 0.0 113.725 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -67.75 -21.16 65.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 119.675 -1.891 . . . . 0.0 112.96 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -69.2 -29.02 66.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.521 1.128 . . . . 0.0 111.936 173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.432 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 65.1 t80 -79.02 -32.75 45.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 111.907 174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -80.0 -30.02 39.56 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.452 1.501 . . . . 0.0 114.035 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.37 -33.63 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.941 0.791 . . . . 0.0 112.42 -174.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 p -65.36 -42.87 92.32 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.69 0.796 . . . . 0.0 111.162 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.0 m -57.83 -49.42 76.72 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 111.497 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -58.05 -50.93 71.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.985 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -60.22 -37.56 80.69 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.69 58.05 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.171 0.896 . . . . 0.0 111.549 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.01 -48.54 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.421 0.688 . . . . 0.0 110.727 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -58.64 -40.86 84.6 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.576 1.55 . . . . 0.0 113.893 -176.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.01 -45.23 67.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.889 0.768 . . . . 0.0 111.152 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -35.61 74.64 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.038 0.535 . . . . 0.0 111.629 176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.961 0.801 . . . . 0.0 111.57 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -59.34 -39.26 82.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.858 0.753 . . . . 0.0 111.533 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -74.68 -22.49 58.83 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.893 0.877 . . . . 0.0 112.363 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.5 8.11 55.07 Favored Glycine 0 N--CA 1.48 1.6 0 C-N-CA 125.1 1.333 . . . . 0.0 114.162 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -96.09 71.37 2.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.878 1.271 . . . . 0.0 111.369 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -55.88 -46.06 78.39 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -51.24 -57.52 8.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.89 0.876 . . . . 0.0 111.014 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -59.99 -42.73 94.85 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.492 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.68 95.57 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 119.866 1.212 . . . . 0.0 113.225 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.0 mt -69.09 -48.61 62.18 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.57 0.685 . . . . 0.0 111.341 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.88 -53.2 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.76 0.709 . . . . 0.0 111.605 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -63.42 -35.69 81.27 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.078 0.951 . . . . 0.0 111.858 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.18 -38.05 63.41 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 121.378 -0.827 . . . . 0.0 112.824 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.38 -42.77 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.009 1.324 . . . . 0.0 111.378 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -55.38 -52.45 63.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.694 1.198 . . . . 0.0 110.579 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -65.57 -34.71 78.89 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.09 90.81 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 118.42 -0.8 . . . . 0.0 110.338 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.42 -44.99 97.03 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 119.431 -0.649 . . . . 0.0 112.286 174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.4 mtp -59.85 -42.47 93.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.395 1.097 . . . . 0.0 113.59 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -74.37 -44.56 51.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.741 0.816 . . . . 0.0 111.129 -177.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.03 -36.64 84.66 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.408 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.92 -26.87 62.78 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.059 0.944 . . . . 0.0 113.327 173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -65.66 -34.78 79.02 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.401 -1.437 . . . . 0.0 111.472 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.82 -39.9 23.33 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.796 1.238 . . . . 0.0 111.879 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.08 79.51 73.75 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.607 1.563 . . . . 0.0 111.454 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.98 135.32 27.28 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.628 2.218 . . . . 0.0 110.959 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -56.89 147.9 22.36 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -171.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -125.62 150.48 47.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.479 1.112 . . . . 0.0 110.157 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -67.14 -26.09 66.5 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.053 -1.655 . . . . 0.0 113.235 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.14 9.11 34.93 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.241 2.216 . . . . 0.0 112.206 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -58.13 138.96 55.71 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 126.132 1.773 . . . . 0.0 113.282 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.83 135.68 49.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 124.571 1.148 . . . . 0.0 110.597 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -97.65 95.65 7.74 Favored 'General case' 0 C--O 1.249 1.072 0 C-N-CA 127.005 2.122 . . . . 0.0 107.198 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.62 -42.51 13.38 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -161.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.6 mt -97.92 160.56 28.17 Favored Pre-proline 0 N--CA 1.474 0.759 0 CA-C-N 120.137 1.335 . . . . 0.0 111.316 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.68 137.79 9.14 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.79 2.327 . . . . 0.0 109.51 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -71.63 -4.94 29.97 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -60.68 140.15 57.6 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.089 2.155 . . . . 0.0 111.207 -178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 59.7 mt -64.59 140.21 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.012 1.325 . . . . 0.0 110.392 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.9 m -96.57 143.46 27.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.191 0.596 . . . . 0.0 110.452 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -143.79 137.24 27.9 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.364 -0.835 . . . . 0.0 110.551 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.392 0 CA-C-O 117.984 -1.454 . . . . 0.0 112.649 176.155 . . . . . . . . 0 0 . 1 stop_ save_